data_2k2n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k2n _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.83 0.348 . . . . 1.0 110.562 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' CG ' ' N ' ' A' ' 33' ' ' GLN . 24.1 p-10 -55.63 -54.46 43.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.967 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.404 ' N ' ' CG ' ' A' ' 32' ' ' ASP . 62.9 tt0 -54.35 -44.84 72.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.124 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.502 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.9 mp -60.91 -52.89 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.955 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.2 mt -58.71 -48.2 81.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.011 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -53.4 -39.41 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.6 -0.44 . . . . 1.0 109.871 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.5 65.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.042 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.5 m -73.22 -44.59 59.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.529 -0.76 . . . . 1.0 112.197 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 4.1 p -69.96 -35.79 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.916 0.339 . . . . 1.0 111.916 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.06 -48.92 61.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.753 0.311 . . . . 1.0 111.096 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -66.94 -50.65 61.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.745 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.1 t -58.38 -42.77 84.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.724 0.297 . . . . 1.0 111.169 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -56.21 -43.11 78.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.811 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.76 -33.53 61.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -77.08 -37.93 53.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.608 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -85.78 -27.8 24.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.446 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.93 20.0 24.65 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.458 -1.057 . . . . 1.0 110.458 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.5 p -72.11 142.52 49.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.859 0.361 . . . . 1.0 110.217 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -40.39 -47.5 2.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.664 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.53 ' NH1' ' CE1' ' A' ' 169' ' ' HIS . 54.0 ttp85 -154.02 131.29 11.17 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.029 -0.668 . . . . 1.0 112.629 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.418 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 48.9 t -135.38 127.36 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -140.94 156.07 46.14 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.478 -0.489 . . . . 1.0 111.967 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.08 140.56 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -127.19 111.48 14.02 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.364 -0.534 . . . . 1.0 111.209 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -84.39 133.72 34.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -95.77 125.66 40.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 1.0 112.096 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 60' ' ' GLY . 6.2 m-20 -95.14 138.57 21.96 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.79 -29.11 3.32 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.514 2.142 . . . . 1.0 112.453 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -82.82 -19.71 37.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 1.0 110.03 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.56 -10.91 38.94 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.517 -0.633 . . . . 1.0 111.517 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -82.18 88.26 6.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.63 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.06 154.29 23.6 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.5 p -124.97 148.85 48.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.971 0.415 . . . . 1.0 111.646 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.93 107.9 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.75 0.16 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.779 0.324 . . . . 1.0 111.413 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.33 120.44 3.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.062 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.5 tt0 -145.46 132.51 20.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 1.0 111.846 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.19 142.42 51.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 1.0 109.406 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -143.09 145.47 32.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.907 0.384 . . . . 1.0 110.76 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.07 -35.03 63.07 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -179.9 -164.49 32.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.037 -0.825 . . . . 1.0 111.037 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -72.42 16.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.309 . . . . 1.0 110.486 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 71' ' ' GLY . 61.5 ttm-85 -66.83 -46.66 74.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.15 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.6 mt -115.19 124.61 29.95 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.87 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.24 154.21 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.535 2.157 . . . . 1.0 112.134 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.7 m -90.13 130.39 36.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.934 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.507 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 23.6 mt -98.48 13.56 31.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.437 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 20.4 tp -71.41 130.42 41.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.224 0.535 . . . . 1.0 112.308 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.18 -10.0 70.54 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.496 -0.774 . . . . 1.0 111.581 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.7 mt -85.14 153.77 22.45 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.327 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.1 t -107.69 133.5 52.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.658 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -85.55 152.26 57.12 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.57 133.82 38.59 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.625 2.216 . . . . 1.0 111.808 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 131.13 45.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.712 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.89 0.64 42.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 50.9 t0 -53.71 -33.92 57.13 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.3 mt -91.44 110.37 42.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.377 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 87' ' ' ILE . 88.7 Cg_exo -51.47 -155.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.437 2.091 . . . . 1.0 112.448 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -107.11 -59.38 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.493 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.89 -40.27 79.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.369 . . . . 1.0 111.875 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.55 38.48 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.969 0.359 . . . . 1.0 111.969 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -53.85 -35.92 62.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.485 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -65.33 -33.42 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.78 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.72 -36.73 78.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.256 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.647 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 23.7 m-85 -58.19 -30.54 66.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.069 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -83.31 -23.93 32.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.824 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.2 mt -97.93 -47.51 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.526 ' N ' HE21 ' A' ' 99' ' ' GLN . . . -114.62 -12.64 12.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.089 1.514 . . . . 1.0 115.089 -173.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.667 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 3.0 mm-40 45.6 61.43 2.62 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.164 -1.014 . . . . 1.0 108.813 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.573 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 3.9 m -165.71 105.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.075 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.446 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 9.9 mmt180 -148.29 150.36 33.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.418 . . . . 1.0 110.742 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -169.09 146.7 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.522 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.1 mt -107.42 135.07 47.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.65 160.28 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.227 0.825 . . . . 1.0 113.227 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 4.3 p30 -45.52 121.0 2.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.881 -1.054 . . . . 1.0 112.209 -177.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.2 -22.11 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.816 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.428 ' C ' ' H ' ' A' ' 109' ' ' GLN . 46.6 tp10 -62.53 -49.03 76.94 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.65 -8.47 6.62 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.504 0.669 . . . . 1.0 109.391 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 107' ' ' GLU . 54.4 tt0 43.89 72.07 0.21 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.77 -1.105 . . . . 1.0 113.35 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.42 131.9 41.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.905 -1.517 . . . . 1.0 106.905 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -119.77 139.53 52.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.962 -0.695 . . . . 1.0 111.884 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -147.91 167.64 24.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.544 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 pt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.133 179.016 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo . . . . . 0 N--CA 1.493 1.466 0 CA-C-O 120.729 0.22 . . . . 1.0 111.908 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.5 t -106.96 128.03 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.829 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.547 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER -44.92 148.36 0.99 Allowed Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.16 -33.95 89.89 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.224 2.616 . . . . 1.0 113.988 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.724 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.8 p -48.32 -47.73 36.61 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.74 0.274 . . . . 1.0 111.74 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.724 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 29.4 t-80 -81.5 -29.38 33.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.274 0.472 . . . . 1.0 112.274 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.4 t -64.22 -53.7 40.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.928 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -64.34 -28.02 69.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -59.63 -41.08 89.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.868 -0.606 . . . . 1.0 109.759 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 146' ' ' MET . 12.7 mt -73.52 -39.33 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -51.08 -38.87 54.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.5 m -64.44 -24.72 67.72 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.738 -1.119 . . . . 1.0 109.223 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.58 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.4 mmm -92.0 -1.69 57.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.739 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.6 22.0 77.88 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.03 142.39 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 1.0 111.002 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.54 -39.9 5.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.015 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -133.41 125.38 28.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.118 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 m -119.06 138.37 52.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.449 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -116.27 141.13 48.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.29 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.6 t -126.24 122.65 61.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.157 0.503 . . . . 1.0 111.77 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.46 93.03 26.14 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.836 -1.172 . . . . 1.0 107.836 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -48.14 150.21 5.31 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.149 2.566 . . . . 1.0 114.648 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.9 mp -123.08 64.19 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -149.63 -161.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.138 0.792 . . . . 1.0 113.138 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.22 -178.72 5.23 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.315 -0.857 . . . . 1.0 111.397 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -73.8 -55.42 6.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 1.0 112.026 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -103.57 8.6 37.64 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.991 0.367 . . . . 1.0 111.991 -177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -140.6 133.45 29.07 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.877 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.7 OUTLIER -110.63 119.35 38.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.236 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -93.58 -36.65 12.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.241 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.41 -177.38 37.03 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.7 mp -141.16 138.89 33.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 1.0 111.564 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.0 tp -104.98 136.99 43.42 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.24 135.39 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.713 -0.395 . . . . 1.0 111.106 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.5 m -112.04 142.4 44.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.019 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.53 ' CE1' ' NH1' ' A' ' 50' ' ' ARG . 42.3 m80 -114.81 127.42 55.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.029 0.442 . . . . 1.0 111.698 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.533 ' CD2' ' OE2' ' A' ' 172' ' ' GLU . 1.7 t-80 -127.42 121.93 32.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.949 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.47 61.44 5.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.803 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.533 ' OE2' ' CD2' ' A' ' 170' ' ' HIS . 26.3 pt-20 -152.04 142.65 15.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.064 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.39 -0.49 10.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.986 2.457 . . . . 1.0 111.854 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -60.67 147.18 84.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.898 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.15 167.48 25.85 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.545 2.163 . . . . 1.0 111.924 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -86.42 142.44 28.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.42 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.2 m -115.0 150.87 35.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.622 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -60.54 -29.88 69.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.57 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 29.8 mp0 -55.34 -34.33 64.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.769 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -63.66 -37.54 87.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.503 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.56 -37.81 85.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.543 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.5 tm0? -54.49 -39.22 67.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.389 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 83.7 t -67.24 -53.9 28.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 188' ' ' ALA . 19.2 m -74.58 -29.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -51.61 -45.48 63.22 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.873 -0.331 . . . . 1.0 111.686 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 18.5 tp -76.25 -41.17 49.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.878 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.5 mt -78.39 -39.71 38.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.816 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -61.44 -44.45 97.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.472 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -61.53 -38.12 86.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 1.0 109.971 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.43 -26.4 60.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.136 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.73 -49.61 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.734 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 83.1 p -51.47 -30.27 19.24 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 56.9 mt -76.82 -33.85 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.495 -0.775 . . . . 1.0 109.214 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.61 -45.81 77.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.789 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.0 pt -63.43 -35.11 71.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.138 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.78 -44.51 69.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 1.0 111.199 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.26 -38.44 75.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 1.0 111.518 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.32 -32.88 74.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.666 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.55 -32.85 70.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.478 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.3 mt -60.68 -32.62 71.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.99 -0.284 . . . . 1.0 111.051 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -53.45 -53.0 57.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.563 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 21.7 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.53 179.594 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.899 0.38 . . . . 1.0 110.59 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -57.29 -52.05 66.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.03 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -55.99 -46.19 78.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.085 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 34' ' ' ILE . 88.7 mt -61.61 -53.4 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 1.0 110.91 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.507 ' O ' ' OG1' ' A' ' 38' ' ' THR . 84.8 mt -53.98 -43.52 70.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.995 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.478 HH12 ' CD2' ' A' ' 78' ' ' LEU . 59.8 ttm-85 -54.02 -35.46 61.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.617 -0.433 . . . . 1.0 109.895 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -36.23 72.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.078 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.564 ' HG1' ' N ' ' A' ' 39' ' ' VAL . 65.8 p -70.83 -42.11 70.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.527 -0.76 . . . . 1.0 112.295 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.564 ' N ' ' HG1' ' A' ' 38' ' ' THR . 9.8 p -69.05 -36.52 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.93 0.344 . . . . 1.0 111.93 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -71.6 -40.99 69.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.805 0.336 . . . . 1.0 111.094 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.25 -52.01 65.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.757 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.5 m -56.06 -34.42 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.721 0.296 . . . . 1.0 111.13 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 47' ' ' GLY . 60.9 ttp180 -54.01 -43.08 69.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 1.0 110.81 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.51 76.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.047 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -78.73 -45.63 20.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.611 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.0 mt -86.04 -31.98 21.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.49 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.9 22.6 48.56 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.459 -1.057 . . . . 1.0 110.459 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -73.34 141.99 47.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 1.0 110.229 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -42.12 -43.43 3.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.6 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -158.29 130.53 6.96 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.048 -0.661 . . . . 1.0 112.61 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.48 130.51 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.579 -0.897 . . . . 1.0 108.579 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -142.08 156.4 45.39 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.453 -0.499 . . . . 1.0 111.871 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.6 t -99.99 134.39 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 42.4 t80 -115.59 105.89 13.3 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.335 -0.546 . . . . 1.0 111.306 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -76.68 126.27 30.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.212 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.438 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 68.3 t80 -92.52 136.91 32.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.991 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 60' ' ' GLY . 4.8 m-20 -106.57 140.1 20.99 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.31 -28.86 6.22 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.53 2.153 . . . . 1.0 112.45 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -83.31 -17.76 41.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.882 0.373 . . . . 1.0 110.03 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 106.96 -13.73 41.11 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.574 -0.611 . . . . 1.0 111.574 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -78.15 91.16 4.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.808 0.337 . . . . 1.0 110.613 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.92 152.56 21.06 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.566 -1.014 . . . . 1.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.7 p -125.29 148.17 48.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 1.0 111.727 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -74.41 107.31 4.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.55 -1.58 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.351 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.94 115.87 3.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.112 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 85.4 tt0 -145.25 131.17 19.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.079 0.466 . . . . 1.0 111.854 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.81 137.47 49.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.409 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -143.33 148.7 36.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.875 0.369 . . . . 1.0 110.718 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.99 -120.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.852 -0.899 . . . . 1.0 110.852 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -78.78 -179.74 51.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.78 43.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 1.0 110.559 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 71' ' ' GLY . 77.6 ttt180 -82.91 -46.72 12.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.177 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 mt -111.68 146.44 34.7 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 1.0 109.84 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.2 160.31 50.01 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.525 2.15 . . . . 1.0 112.132 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 m -89.78 127.42 35.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.941 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.6 mt -98.28 11.33 38.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.399 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.488 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.4 tp -72.47 132.76 44.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.012 -0.54 . . . . 1.0 112.306 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.96 -9.72 71.11 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.604 -0.726 . . . . 1.0 111.529 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.5 mt -86.67 152.96 22.11 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.936 -0.305 . . . . 1.0 110.344 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.6 m -105.26 132.24 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.675 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -86.28 152.25 55.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.45 133.45 37.34 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.653 2.236 . . . . 1.0 111.873 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.78 131.48 46.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.693 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.62 2.12 40.3 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.548 -1.021 . . . . 1.0 110.548 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 54.3 t0 -57.59 -33.46 68.21 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.558 ' N ' ' CD1' ' A' ' 87' ' ' ILE . 1.6 mp -82.59 127.09 71.8 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.46 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.06 -164.86 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.411 2.074 . . . . 1.0 112.54 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -105.87 -58.68 1.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.535 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.19 -45.0 96.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.795 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.21 87.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -63.79 -37.77 88.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.424 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -62.05 -36.48 81.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.781 0.324 . . . . 1.0 110.835 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.82 -33.07 71.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.286 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.642 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 2.3 t80 -63.8 -31.42 72.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.003 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.46 ' C ' HE22 ' A' ' 99' ' ' GLN . 74.6 ttt180 -81.87 -27.12 33.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.865 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.85 -42.67 7.85 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 114.356 1.243 . . . . 1.0 114.356 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.74 -6.78 13.84 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -175.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.704 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.4 mm-40 42.58 75.31 0.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.226 -0.99 . . . . 1.0 108.864 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p 175.79 115.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.023 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.7 ttm-85 -159.18 153.25 23.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 1.0 110.758 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.1 p -168.99 148.07 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.504 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 56.2 mt -105.34 134.79 45.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.2 t -88.53 158.92 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.25 0.833 . . . . 1.0 113.25 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 3.7 p30 -49.23 121.0 4.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.937 -1.029 . . . . 1.0 112.151 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.1 p -56.09 -22.07 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.342 -0.845 . . . . 1.0 110.784 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -61.79 -50.31 72.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.26 -10.53 24.28 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.465 0.65 . . . . 1.0 109.347 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 44.51 70.74 0.31 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.785 -1.098 . . . . 1.0 113.267 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.55 131.99 42.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.965 -1.495 . . . . 1.0 106.965 175.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -121.13 134.89 55.25 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.967 -0.693 . . . . 1.0 111.937 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.61 156.23 43.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.63 -0.713 . . . . 1.0 110.529 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.2 pt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.103 179.537 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 N--CA 1.492 1.411 0 CA-C-O 120.727 0.22 . . . . 1.0 111.92 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 m -105.55 125.54 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.927 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -43.71 130.37 3.99 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -40.23 -46.28 4.18 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.178 2.585 . . . . 1.0 114.051 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.3 p -38.85 -45.24 1.14 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.688 0.255 . . . . 1.0 111.688 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.677 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 17.5 t60 -81.19 -28.68 34.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.87 -54.96 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.939 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -65.14 -28.7 69.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -59.78 -44.72 93.78 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.774 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 146' ' ' MET . 69.5 mt -72.96 -38.08 66.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -50.64 -39.27 50.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -63.87 -26.87 68.81 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.729 -1.123 . . . . 1.0 109.165 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.564 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.5 mmm -88.75 -1.27 58.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.452 -0.794 . . . . 1.0 110.709 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.98 22.01 77.5 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.9 t -111.62 140.75 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.905 0.383 . . . . 1.0 110.968 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.47 -40.54 4.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.0 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.6 m -133.4 122.53 23.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.12 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.446 ' OG ' ' CG2' ' A' ' 167' ' ' VAL . 3.7 t -116.75 133.63 55.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.436 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 tt -112.19 137.19 50.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.273 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.3 120.05 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.157 0.503 . . . . 1.0 111.774 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.03 103.74 47.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.409 ' HG3' ' CZ ' ' A' ' 95' ' ' PHE . 78.8 Cg_exo -40.38 125.91 2.0 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.197 2.598 . . . . 1.0 114.69 -175.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.9 tp -113.59 47.53 1.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.861 -1.533 . . . . 1.0 106.861 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.2 ptm -148.59 -174.75 4.69 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.069 0.766 . . . . 1.0 113.069 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.685 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 42.0 t-80 -75.13 -179.33 4.32 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.311 -0.859 . . . . 1.0 111.38 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 82.2 t60 -75.16 -55.64 5.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.396 -0.82 . . . . 1.0 112.057 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -104.62 9.48 35.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -139.76 137.15 34.84 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.701 -0.399 . . . . 1.0 110.906 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.454 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 5.7 tt -110.62 113.93 26.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.068 -0.515 . . . . 1.0 111.303 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -90.79 -35.45 14.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.28 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -163.02 -172.95 31.15 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.39 129.01 26.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 1.0 111.562 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.6 tp -103.54 129.1 50.69 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.446 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 11.5 p -139.14 139.71 39.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.069 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 84.2 p -110.86 140.33 45.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.049 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -111.71 132.3 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.979 0.418 . . . . 1.0 111.601 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -130.1 121.2 25.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 1.0 109.882 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -81.64 55.79 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.808 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -156.77 149.63 18.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.012 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.78 -11.55 31.03 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.907 2.405 . . . . 1.0 111.914 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -39.33 104.17 0.31 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.862 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.81 167.44 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.585 2.19 . . . . 1.0 111.902 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 49.5 p90 -80.09 129.66 34.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.462 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.5 t -111.93 143.0 43.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.635 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -58.04 -27.74 63.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.664 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -57.55 -38.48 74.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.666 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.86 -38.07 89.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.542 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 56.5 mt -64.18 -40.82 96.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.517 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -53.63 -38.21 63.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.33 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.23 -54.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 188' ' ' ALA . 29.3 m -77.34 -29.8 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.404 0.52 . . . . 1.0 112.404 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 189' ' ' ASP . 58.8 tp60 -50.98 -49.9 59.32 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.98 -0.288 . . . . 1.0 111.631 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.6 tp -76.84 -41.33 44.59 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.8 tp -76.75 -43.43 37.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.806 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -60.09 -40.42 89.53 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.511 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 93.5 m-20 -56.52 -38.37 71.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.018 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -71.23 -24.91 62.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.155 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 194' ' ' ALA . 93.8 t -82.85 -49.01 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 1.0 109.731 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.6 m -51.4 -29.92 17.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 57.9 mt -75.92 -33.28 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.236 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -67.07 -45.41 77.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.825 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 19.0 pt -63.93 -35.53 73.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.149 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -68.78 -43.37 75.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.135 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -70.94 -38.04 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.553 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.21 -32.08 73.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.725 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.92 -39.13 93.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.475 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.93 -35.67 80.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.723 0.297 . . . . 1.0 111.119 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.2 t -54.8 -53.68 52.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.612 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.48 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.814 0.34 . . . . 1.0 110.531 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -60.13 -52.7 64.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.985 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -54.9 -45.98 74.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.087 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 34' ' ' ILE . 17.3 mm -61.01 -48.24 89.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 1.0 110.966 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.561 ' O ' ' OG1' ' A' ' 38' ' ' THR . 35.5 mt -56.95 -42.78 80.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 1.0 111.03 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -52.91 -35.33 58.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.068 0.461 . . . . 1.0 109.869 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.91 -34.34 71.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.06 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.561 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 62.4 p -72.28 -40.23 67.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.524 -0.762 . . . . 1.0 112.263 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -73.57 -38.76 52.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 111.899 0.333 . . . . 1.0 111.899 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.2 -45.46 63.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.772 0.32 . . . . 1.0 111.104 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.85 -47.93 70.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.784 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.39 -39.06 79.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.982 -0.287 . . . . 1.0 111.12 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.4 tmm_? -57.25 -42.9 82.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 1.0 110.823 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.82 -33.59 68.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -78.42 -40.67 35.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.542 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.71 -31.2 22.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.448 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 61.7 21.78 61.09 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 169' ' ' HIS . 5.2 t -73.22 139.48 46.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.35 . . . . 1.0 110.17 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -44.57 -38.68 4.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.609 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.525 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 53.7 ttt85 -161.53 126.24 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.058 -0.657 . . . . 1.0 112.625 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.23 128.31 29.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -140.18 155.66 46.84 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.86 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.42 137.49 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.473 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -136.62 127.91 28.21 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.252 -0.579 . . . . 1.0 111.288 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -88.03 144.35 26.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.745 -0.662 . . . . 1.0 110.208 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.595 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 80.4 t80 -95.52 117.79 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 1.0 112.027 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.9 m-20 -85.27 135.85 38.56 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -45.83 -24.06 1.92 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.456 2.104 . . . . 1.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.21 -18.48 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.052 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.88 -13.36 38.11 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.583 -0.607 . . . . 1.0 111.583 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -75.07 92.25 2.62 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.642 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.54 142.54 18.0 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 p -121.39 142.75 49.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 1.0 111.751 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.65 110.94 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.748 -0.834 . . . . 1.0 108.748 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.458 ' CG1' ' O ' ' A' ' 65' ' ' VAL . 95.5 t -106.59 -0.89 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.942 -0.303 . . . . 1.0 111.372 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.97 120.79 3.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.149 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 68.6 tt0 -142.12 131.78 24.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.06 0.457 . . . . 1.0 111.818 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.95 143.11 50.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.375 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.528 ' NH1' ' OG ' ' A' ' 76' ' ' SER . 32.8 ptt180 -142.88 142.44 31.77 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.743 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.44 -33.01 85.04 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -171.48 -170.92 36.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 77.6 mm-40 -78.25 38.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 1.0 110.556 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.422 ' H ' ' C ' ' A' ' 71' ' ' GLY . 10.2 tpt180 -82.83 -48.11 11.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.148 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.46 149.26 36.85 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.826 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.95 146.69 59.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.532 2.155 . . . . 1.0 112.183 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.528 ' OG ' ' NH1' ' A' ' 69' ' ' ARG . 67.2 m -77.28 121.23 23.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.962 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.463 ' H ' HH22 ' A' ' 50' ' ' ARG . 27.5 mt -100.59 12.12 38.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.416 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.2 tp -73.49 132.68 43.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.307 0.575 . . . . 1.0 112.288 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.86 -10.04 63.89 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.505 -0.771 . . . . 1.0 111.546 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.0 mt -86.43 155.55 20.52 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.001 -0.28 . . . . 1.0 110.329 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.2 p -103.65 126.37 50.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.67 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -77.86 151.8 79.65 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.55 117.7 4.66 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.648 2.232 . . . . 1.0 111.818 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.01 125.09 11.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.677 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.7 0.13 42.59 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.574 -1.011 . . . . 1.0 110.574 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 2.6 p30 -56.76 -32.64 65.8 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.477 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 3.2 tp -84.25 131.05 51.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.384 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.19 -169.48 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.427 2.085 . . . . 1.0 112.487 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -107.1 -44.71 4.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.559 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -69.36 -41.15 76.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.796 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.35 -44.05 79.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.906 0.336 . . . . 1.0 111.906 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.595 ' NH2' ' CG ' ' A' ' 56' ' ' PHE . 51.6 ttt85 -65.23 -44.09 89.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.472 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -61.05 -34.14 74.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.34 . . . . 1.0 110.879 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.505 ' C ' HH22 ' A' ' 101' ' ' ARG . 47.4 mt -71.18 -38.75 72.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.298 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.609 ' N ' ' NH2' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -58.19 -28.51 64.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.061 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -74.91 -29.87 61.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.87 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.587 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 75.5 mt -97.17 -39.4 9.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.573 ' C ' ' NE2' ' A' ' 99' ' ' GLN . . . -118.34 -7.19 10.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.051 1.5 . . . . 1.0 115.051 -176.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.632 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER 38.51 77.4 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.161 -1.015 . . . . 1.0 108.847 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.45 ' CG1' ' O ' ' A' ' 100' ' ' VAL . 12.9 p 179.32 114.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.108 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.609 ' NH2' ' N ' ' A' ' 95' ' ' PHE . 4.0 tpp180 -156.79 150.84 24.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.954 0.407 . . . . 1.0 110.75 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.32 145.72 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.456 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.7 mt -108.6 131.84 58.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.141 -0.689 . . . . 1.0 109.141 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.1 m -91.66 164.9 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 113.23 0.826 . . . . 1.0 113.23 -176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -48.07 117.24 1.82 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.89 -1.05 . . . . 1.0 112.139 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.1 p -53.51 -19.34 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.347 -0.842 . . . . 1.0 110.799 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 109' ' ' GLN . 76.3 tt0 -66.37 -44.69 82.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.97 -4.77 10.43 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.596 0.712 . . . . 1.0 109.414 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 107' ' ' GLU . 13.6 pt20 36.6 69.45 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.713 -1.131 . . . . 1.0 113.295 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.3 p -75.22 131.06 40.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.997 -1.482 . . . . 1.0 106.997 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -121.91 142.14 50.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.888 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 t -130.3 122.57 28.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.55 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.191 -178.724 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo . . . . . 0 N--CA 1.492 1.417 0 CA-C-O 120.747 0.228 . . . . 1.0 111.997 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 t -105.84 122.82 59.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.85 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -42.43 152.74 0.33 Allowed Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.746 -0.464 . . . . 1.0 109.746 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -58.89 -34.72 99.21 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.223 2.615 . . . . 1.0 114.068 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.705 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -48.16 -46.31 34.48 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.684 0.253 . . . . 1.0 111.684 -178.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.705 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 19.1 t-80 -82.91 -27.75 30.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.272 0.471 . . . . 1.0 112.272 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.4 t -65.2 -52.26 55.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.965 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -66.47 -27.87 68.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.537 ' O ' ' OG ' ' A' ' 145' ' ' SER . 76.0 t80 -60.02 -41.98 93.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.732 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 146' ' ' MET . 8.9 mt -73.03 -37.83 66.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -51.95 -38.24 55.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 10.9 p -66.85 -20.66 65.97 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.761 -1.109 . . . . 1.0 109.188 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.568 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -95.43 -0.02 52.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.406 -0.816 . . . . 1.0 110.711 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.61 20.68 78.65 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.69 143.96 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 1.0 110.968 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.66 -42.29 4.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.982 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 t -135.35 122.85 22.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.135 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.6 m -110.99 141.91 43.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.503 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 tp -118.27 136.35 53.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.292 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.7 t -123.14 114.85 43.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.12 0.486 . . . . 1.0 111.772 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.5 t -113.26 131.2 23.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 107.806 -1.183 . . . . 1.0 107.806 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.75 125.45 8.17 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.152 2.568 . . . . 1.0 114.676 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.2 mt -118.52 48.95 1.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -146.14 176.55 9.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.509 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 49.9 t-80 -67.72 171.68 6.16 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.379 -0.828 . . . . 1.0 111.391 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.509 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 73.5 m80 -61.98 -52.82 62.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.039 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -103.79 -39.32 6.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.541 ' OE1' ' CD2' ' A' ' 163' ' ' TRP . 11.0 tm-20 -87.54 133.55 33.76 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.909 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.6 OUTLIER -107.2 117.52 34.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 1.0 111.301 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.541 ' CD2' ' OE1' ' A' ' 161' ' ' GLU . 54.2 m95 -92.0 -41.04 10.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.231 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.34 -176.86 35.76 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.204 -0.759 . . . . 1.0 111.204 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.87 140.19 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 1.0 111.569 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.5 tp -98.97 135.67 40.06 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.59 129.11 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.371 . . . . 1.0 111.051 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.5 t -107.6 150.7 26.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.996 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.442 ' O ' ' OG1' ' A' ' 48' ' ' THR . 91.7 m-70 -127.81 134.84 49.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.961 0.41 . . . . 1.0 111.626 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -132.62 113.93 13.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.015 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.78 -14.24 62.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.857 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -108.04 150.0 39.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.01 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.2 140.59 34.35 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.902 2.401 . . . . 1.0 111.896 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -172.31 129.66 0.62 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.898 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.58 157.81 28.55 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.517 2.144 . . . . 1.0 111.932 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -102.2 139.0 38.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.444 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.496 ' N ' ' OE1' ' A' ' 180' ' ' GLU . 8.7 t -126.94 -177.35 4.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.591 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' A' ' 182' ' ' GLN . 95.0 mt-30 -59.98 -34.1 72.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.657 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -56.17 -36.93 68.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.764 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 177' ' ' SER . 40.5 mp0 -65.15 -24.21 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.497 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.6 tp -80.88 -30.53 35.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.497 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.497 ' NE2' ' N ' ' A' ' 182' ' ' GLN . 0.3 OUTLIER -63.28 -43.36 98.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.32 -178.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 184' ' ' VAL . 22.9 m -73.7 -51.56 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.482 ' N ' ' CG2' ' A' ' 183' ' ' VAL . 16.9 m -68.57 -46.26 80.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.445 0.535 . . . . 1.0 112.445 -177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.442 ' N ' ' CG2' ' A' ' 184' ' ' VAL . 52.7 tp60 -53.09 -36.62 60.89 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.664 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.1 tt -74.55 -53.48 9.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 71.0 mt -78.91 -39.27 35.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.883 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 184' ' ' VAL . . . -62.18 -45.52 93.04 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.487 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.415 ' OD2' ' NE2' ' A' ' 185' ' ' GLN . 93.0 m-20 -60.01 -40.19 88.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.069 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -69.21 -23.85 63.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.117 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 57.9 t -83.79 -45.58 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.041 -0.527 . . . . 1.0 109.775 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.5 p -57.58 -34.59 69.38 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.677 -0.861 . . . . 1.0 108.677 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.8 mt -69.15 -34.3 62.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.394 -0.821 . . . . 1.0 109.156 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.6 -38.03 77.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.783 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.7 mm -64.24 -40.24 88.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.087 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.36 -49.06 53.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.132 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -69.99 -35.98 74.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.492 -178.005 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.441 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.49 -33.5 74.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.673 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.75 -33.25 72.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.449 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.79 -30.54 71.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.002 -0.279 . . . . 1.0 111.067 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -51.67 -51.99 51.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.551 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 23.7 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.56 179.495 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.847 0.356 . . . . 1.0 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -79.13 -29.73 43.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.942 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -77.41 -47.72 19.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.11 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 35' ' ' LEU . 2.9 tp -61.61 -41.15 89.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.74 0.305 . . . . 1.0 110.859 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.618 ' O ' ' OG1' ' A' ' 38' ' ' THR . 20.2 mt -57.0 -44.43 82.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.089 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 39' ' ' VAL . 61.1 mtp85 -55.35 -33.95 63.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.1 -33.22 69.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.154 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.618 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 82.8 p -72.15 -40.94 67.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.416 -0.811 . . . . 1.0 112.264 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' N ' ' HG1' ' A' ' 38' ' ' THR . 8.5 p -71.33 -37.23 64.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.04 -48.17 66.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 1.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.82 -52.69 59.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.687 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.6 t -53.49 -40.72 42.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.953 -0.299 . . . . 1.0 111.153 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.2 tmm_? -53.28 -39.3 63.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.737 0.303 . . . . 1.0 110.816 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.05 74.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.028 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -77.18 -42.22 38.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.578 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.14 -28.32 24.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.459 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.43 20.65 17.44 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.462 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 87.5 m -71.73 142.52 49.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 1.0 110.253 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -41.91 -45.53 3.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.596 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.51 HH21 ' CD ' ' A' ' 67' ' ' GLU . 64.0 ttt-85 -159.87 128.14 4.88 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.022 -0.671 . . . . 1.0 112.572 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.48 131.32 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -140.2 156.47 46.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.478 -0.489 . . . . 1.0 111.918 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.8 135.69 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -134.39 125.78 28.23 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.358 -0.537 . . . . 1.0 111.339 -178.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -84.17 143.47 29.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.235 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.609 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 72.7 t80 -95.51 119.23 33.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.065 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.43 149.48 52.06 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -60.93 -23.43 77.16 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.51 2.14 . . . . 1.0 112.456 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.5 -11.87 53.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.924 0.392 . . . . 1.0 110.116 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.69 -15.15 53.07 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.547 -0.621 . . . . 1.0 111.547 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -73.13 94.98 2.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.759 0.314 . . . . 1.0 110.6 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.6 139.59 16.04 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.1 p -120.64 142.14 49.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.862 0.363 . . . . 1.0 111.756 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 t -79.22 110.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.18 0.71 10.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.886 -0.325 . . . . 1.0 111.306 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.99 117.97 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.035 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.51 ' CD ' HH21 ' A' ' 50' ' ' ARG . 85.8 tt0 -143.58 132.4 22.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.122 0.487 . . . . 1.0 111.784 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.49 143.14 50.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.393 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -141.59 145.78 35.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.784 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -52.39 -34.09 40.93 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 177.31 -161.61 29.19 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.06 16.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 1.0 110.54 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 71' ' ' GLY . 30.3 ttm180 -65.31 -49.07 70.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.195 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.8 mt -111.82 146.77 35.42 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.887 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.33 159.32 54.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.486 2.124 . . . . 1.0 112.19 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.3 m -95.02 127.95 41.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.915 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.7 mt -94.95 11.29 32.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.371 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.5 tp -68.0 132.21 46.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 1.0 112.241 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.08 -11.65 66.61 Favored Glycine 0 CA--C 1.523 0.594 0 CA-C-N 115.615 -0.721 . . . . 1.0 111.54 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.4 mt -83.99 151.62 24.91 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.944 -0.303 . . . . 1.0 110.306 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.7 p -105.25 132.69 51.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.679 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -86.97 130.53 47.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -40.39 138.49 1.31 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.686 2.257 . . . . 1.0 111.864 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.86 125.63 25.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.676 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.32 -1.51 43.4 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -60.54 -33.38 72.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 87' ' ' ILE . 1.5 mp -69.31 130.28 91.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.417 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.59 168.9 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.35 2.033 . . . . 1.0 112.499 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -100.45 -56.04 2.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.572 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -64.59 -41.67 96.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.813 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.84 -44.01 82.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.609 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 42.2 ttt85 -62.42 -41.3 98.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.436 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -62.87 -34.88 78.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.768 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.489 ' C ' HH22 ' A' ' 101' ' ' ARG . 71.2 mt -70.84 -38.21 73.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.225 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.657 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 1.7 t80 -62.03 -20.71 64.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.557 ' C ' HE22 ' A' ' 99' ' ' GLN . 38.2 ttt180 -82.96 -28.38 29.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.824 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.24 -42.65 7.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.07 -8.06 13.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 115.07 1.508 . . . . 1.0 115.07 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.701 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.4 mm-40 42.43 81.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.186 -1.005 . . . . 1.0 108.817 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p 174.41 114.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.985 -0.552 . . . . 1.0 111.101 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.608 ' NH2' ' N ' ' A' ' 95' ' ' PHE . 3.8 tpp180 -155.23 147.02 23.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 1.0 110.714 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 p -170.76 146.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.514 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.2 mt -108.65 136.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -93.02 165.79 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.262 0.838 . . . . 1.0 113.262 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -48.07 117.22 1.82 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.899 -1.046 . . . . 1.0 112.109 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.4 p -58.38 -25.79 28.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.401 -0.818 . . . . 1.0 110.773 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 109' ' ' GLN . 84.5 tt0 -63.78 -44.98 91.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.47 -8.07 1.68 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.457 0.646 . . . . 1.0 109.338 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.636 ' NE2' HH21 ' A' ' 111' ' ' ARG . 45.9 tt0 45.04 60.91 2.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.744 -1.116 . . . . 1.0 113.266 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 t -75.15 133.46 41.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.954 -1.499 . . . . 1.0 106.954 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.636 HH21 ' NE2' ' A' ' 109' ' ' GLN . 80.0 mtt180 -119.57 139.52 52.01 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.038 -0.665 . . . . 1.0 111.9 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.29 163.51 32.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.564 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.9 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.153 179.355 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.492 1.414 0 CA-C-O 120.741 0.225 . . . . 1.0 111.977 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 26.4 t -125.89 140.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.808 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -43.68 138.88 2.92 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -58.48 -32.45 96.44 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.153 2.569 . . . . 1.0 114.005 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.6 p -49.79 -45.18 49.56 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.693 0.257 . . . . 1.0 111.693 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.668 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 6.5 t60 -81.39 -28.6 34.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.229 0.455 . . . . 1.0 112.229 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.77 -52.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.668 -0.413 . . . . 1.0 111.017 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -67.07 -24.84 66.01 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.53 ' O ' ' OG ' ' A' ' 145' ' ' SER . 87.3 t80 -64.56 -39.52 93.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.673 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 146' ' ' MET . 10.4 mt -73.35 -36.01 66.09 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -52.72 -38.22 60.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.625 -1.25 . . . . 1.0 107.625 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.53 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 11.3 p -66.69 -19.47 65.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.728 -1.124 . . . . 1.0 109.199 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.9 mmm -96.49 3.25 52.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.477 -0.783 . . . . 1.0 110.715 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.7 21.28 77.85 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 150' ' ' SER . 55.2 t -110.54 144.13 19.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.381 . . . . 1.0 110.971 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.95 -17.92 13.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.961 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.409 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 5.6 t -149.83 163.36 38.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.227 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.3 p -148.08 125.06 11.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.482 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -109.03 133.01 53.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.318 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.57 116.25 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.11 0.481 . . . . 1.0 111.77 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.11 129.27 25.21 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 107.81 -1.181 . . . . 1.0 107.81 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.21 123.48 8.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.091 2.527 . . . . 1.0 114.685 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.4 49.3 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.866 -1.531 . . . . 1.0 106.866 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -147.2 179.29 7.74 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.112 0.782 . . . . 1.0 113.112 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -67.6 164.58 18.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.286 -0.87 . . . . 1.0 111.434 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -57.89 -50.55 72.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.463 -0.789 . . . . 1.0 112.064 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -103.93 -39.64 6.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -88.28 137.92 31.9 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.863 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.474 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER -108.93 112.94 25.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.269 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -88.9 -42.56 11.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.195 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.71 -175.71 25.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.428 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 5.1 tp -145.44 134.15 22.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.352 . . . . 1.0 111.517 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.5 tp -101.63 131.33 47.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.61 131.33 43.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.811 -0.356 . . . . 1.0 111.12 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.9 m -108.59 139.77 42.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.071 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.462 ' O ' ' CG2' ' A' ' 48' ' ' THR . 62.0 m80 -110.43 125.37 53.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.006 0.432 . . . . 1.0 111.636 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.4 ' CE1' ' CG2' ' A' ' 48' ' ' THR . 88.8 m-70 -123.78 114.62 20.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.875 -0.602 . . . . 1.0 109.952 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.36 -14.8 63.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.837 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.89 148.33 34.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.051 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' A' ' 174' ' ' ARG . 80.9 Cg_endo -74.83 -98.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.891 2.394 . . . . 1.0 111.917 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.507 ' O ' ' O ' ' A' ' 173' ' ' PRO . 16.2 mtp-105 56.38 144.94 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.838 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.87 152.0 40.93 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.603 2.202 . . . . 1.0 111.921 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -90.69 146.98 23.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.473 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.435 ' OG ' ' OE1' ' A' ' 180' ' ' GLU . 95.2 p -121.97 156.66 32.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.652 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.758 ' NE2' ' H ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -60.31 -26.16 66.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.558 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -54.58 -39.55 67.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.765 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.435 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 1.5 mp0 -63.96 -39.39 94.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.525 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.27 -38.84 91.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.429 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -56.21 -37.61 69.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.361 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 73.3 t -67.69 -56.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.667 0.617 . . . . 1.0 112.667 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 1.8 t -73.47 -42.7 56.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -43.38 -47.7 6.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.605 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 19.7 tp -70.95 -41.06 71.6 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.919 0.34 . . . . 1.0 111.919 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 8.4 tp -77.91 -38.4 45.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.821 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.24 -37.97 87.42 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.53 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -61.37 -40.11 93.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.031 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.86 -25.36 63.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.12 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.25 -45.25 18.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.767 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.6 t -56.67 -37.02 70.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.3 mt -66.83 -33.65 64.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.448 -0.796 . . . . 1.0 109.171 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.9 -38.94 73.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.784 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.4 mm -65.21 -41.56 91.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.154 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.63 -47.96 61.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.115 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 0.5 OUTLIER -70.33 -34.52 72.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.532 -178.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -67.52 -32.78 73.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.667 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.14 -34.59 75.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.588 -0.278 . . . . 1.0 111.424 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 41.3 mt -61.09 -33.24 73.04 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.091 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 17.5 m -54.04 -53.19 56.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.796 0.331 . . . . 1.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.624 179.658 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 31' ' ' LEU . 10.9 mp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.815 0.341 . . . . 1.0 110.56 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -49.5 -35.25 19.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.993 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -75.4 -46.92 29.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.138 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 34' ' ' ILE . 18.1 mm -64.99 -38.79 83.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.544 -0.298 . . . . 1.0 110.962 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.584 ' O ' ' OG1' ' A' ' 38' ' ' THR . 18.9 mt -57.88 -35.83 71.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.005 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.417 ' O ' HG11 ' A' ' 39' ' ' VAL . 75.8 mtp180 -66.37 -33.47 75.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.084 0.468 . . . . 1.0 109.833 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.19 -30.94 67.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.107 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -73.0 -45.33 58.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.505 -0.77 . . . . 1.0 112.241 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 36' ' ' ARG . 6.1 p -65.41 -35.23 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 111.929 0.344 . . . . 1.0 111.929 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.85 -40.1 65.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 1.0 111.071 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.12 -51.63 67.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.749 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.21 -30.6 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.203 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.63 HH22 ' CA ' ' A' ' 70' ' ' GLY . 8.1 tpt180 -55.38 -43.9 75.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.76 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.74 77.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.041 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -80.31 -45.48 17.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.526 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.92 -34.74 20.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.427 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.87 20.04 17.37 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.471 -1.052 . . . . 1.0 110.471 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.541 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 10.1 t -69.15 141.06 54.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.796 0.331 . . . . 1.0 110.23 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD2' ' CB ' ' A' ' 171' ' ' ALA . 84.5 m-20 -38.03 -39.82 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.659 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.436 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 24.3 ttm180 -167.75 131.95 1.77 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.007 -0.677 . . . . 1.0 112.588 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 p -138.81 130.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -139.88 157.55 45.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.131 0.491 . . . . 1.0 111.948 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.5 t -99.88 135.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -118.25 108.46 15.15 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.257 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -83.17 125.08 31.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.236 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.523 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 84.1 t80 -90.68 141.19 29.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 1.0 112.039 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.523 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 7.1 m-20 -112.13 151.05 43.35 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.11 -23.5 69.32 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.512 2.141 . . . . 1.0 112.49 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -87.46 -11.72 48.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.17 -11.63 60.29 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.552 -0.619 . . . . 1.0 111.552 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -80.14 90.74 5.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 1.0 110.627 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.52 151.05 21.12 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.576 -1.009 . . . . 1.0 110.576 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 p -125.44 148.47 48.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 1.0 111.711 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.71 109.26 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.78 0.69 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.366 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.6 115.72 2.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.066 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 85.5 tt0 -144.98 134.41 23.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.047 0.451 . . . . 1.0 111.834 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.87 132.37 45.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.433 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.514 ' C ' HH12 ' A' ' 43' ' ' ARG . 35.6 ptt-85 -134.97 150.94 50.44 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.733 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.63 ' CA ' HH22 ' A' ' 43' ' ' ARG . . . -56.76 -119.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.18 -76.94 1.03 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -169.22 46.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.747 0.308 . . . . 1.0 110.546 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -83.43 -45.99 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.1 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 28.6 mt -108.17 145.46 31.51 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.474 . . . . 1.0 109.874 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.3 139.57 42.16 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.485 2.123 . . . . 1.0 112.17 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.8 m -66.9 124.31 22.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.957 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.9 mt -100.08 13.11 35.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.334 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.464 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 26.9 tp -71.65 128.36 35.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.284 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.42 -9.86 75.45 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.492 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.7 mt -84.88 151.6 24.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.757 0.313 . . . . 1.0 110.292 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.9 m -104.07 131.0 51.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.688 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -82.82 152.44 66.08 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.568 -0.53 . . . . 1.0 109.568 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.62 133.5 39.86 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.594 2.196 . . . . 1.0 111.877 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.27 127.88 33.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.681 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.09 2.76 45.26 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.539 -1.024 . . . . 1.0 110.539 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -58.44 -33.66 69.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.77 129.33 52.97 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.429 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.89 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.459 2.106 . . . . 1.0 112.484 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -109.95 -59.02 1.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.531 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -58.42 -44.65 89.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.833 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.03 70.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -54.72 -35.07 63.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.464 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -64.4 -34.15 77.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.0 mt -63.44 -37.58 87.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.281 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.66 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 56.2 m-85 -63.99 -27.18 68.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.04 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.522 ' C ' HE22 ' A' ' 99' ' ' GLN . 65.9 ttt180 -82.68 -29.36 29.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.77 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.1 mt -98.64 -42.41 7.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 114.416 1.265 . . . . 1.0 114.416 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.539 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.69 -7.87 13.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.019 1.489 . . . . 1.0 115.019 -174.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.717 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.7 mm-40 39.55 74.18 0.1 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.201 -1.0 . . . . 1.0 108.821 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 6.8 p 174.27 121.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.059 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.571 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -171.04 147.65 2.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 1.0 110.811 177.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.571 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 21.9 m -157.25 157.63 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.515 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.6 mt -106.06 135.59 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 t -87.12 158.2 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.248 0.833 . . . . 1.0 113.248 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -50.67 121.95 6.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.865 -1.061 . . . . 1.0 112.095 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.2 -23.06 12.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.792 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 109' ' ' GLN . 82.1 tt0 -63.15 -49.24 75.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.4 -4.56 8.41 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.554 0.692 . . . . 1.0 109.354 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 36.34 72.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.787 -1.097 . . . . 1.0 113.282 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.454 ' HG ' ' H ' ' A' ' 135' ' ' VAL . 10.4 p -72.83 129.75 38.88 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.968 -1.493 . . . . 1.0 106.968 175.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -118.4 133.18 56.09 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.918 -0.713 . . . . 1.0 111.835 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.42 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -125.91 153.47 44.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.556 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.1 pt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.172 179.474 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 CA-C-O 120.711 0.213 . . . . 1.0 111.948 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.454 ' H ' ' HG ' ' A' ' 110' ' ' SER . 1.4 p -109.01 122.74 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.87 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -43.32 151.76 0.43 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.56 -43.46 50.69 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.217 2.612 . . . . 1.0 114.005 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.666 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.3 p -38.97 -44.75 1.11 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.679 0.252 . . . . 1.0 111.679 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.666 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.3 t60 -82.76 -31.78 28.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.249 0.463 . . . . 1.0 112.249 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.64 -52.8 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.639 -0.425 . . . . 1.0 110.982 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -65.79 -29.39 69.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -63.53 -44.86 93.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.707 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 146' ' ' MET . 12.6 mt -73.33 -36.67 66.24 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -48.23 -39.07 20.08 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.507 -1.294 . . . . 1.0 107.507 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.3 m -58.26 -32.64 68.56 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.786 -1.097 . . . . 1.0 109.214 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.574 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.2 mmm -79.1 0.72 26.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.743 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.49 26.07 74.7 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.39 142.28 30.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.976 0.417 . . . . 1.0 110.932 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.54 -26.43 12.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.969 -0.559 . . . . 1.0 111.027 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 p -141.5 127.11 18.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.413 . . . . 1.0 111.137 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.15 131.43 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.47 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.3 mp -110.49 139.9 45.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.285 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 102' ' ' VAL . 2.4 t -123.97 116.24 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.113 0.482 . . . . 1.0 111.74 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.1 t -117.94 121.29 31.72 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 107.791 -1.189 . . . . 1.0 107.791 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.54 123.86 7.87 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.247 2.631 . . . . 1.0 114.7 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.85 56.15 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.807 -1.553 . . . . 1.0 106.807 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -147.84 178.51 8.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -65.76 161.54 20.6 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.299 -0.864 . . . . 1.0 111.427 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -55.04 -49.26 72.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.083 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -105.0 -39.76 6.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.404 ' OE1' ' CH2' ' A' ' 163' ' ' TRP . 96.1 mt-10 -88.05 138.04 31.8 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.689 -0.405 . . . . 1.0 110.876 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.414 ' H ' HD13 ' A' ' 162' ' ' LEU . 1.8 mp -109.09 112.51 24.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.288 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.404 ' CH2' ' OE1' ' A' ' 161' ' ' GLU . 46.9 m95 -88.04 -36.93 16.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.214 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.0 -171.85 28.64 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 42.1 tp -144.66 131.84 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 1.0 111.585 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.4 tp -105.16 134.18 48.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.03 133.83 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.631 -0.428 . . . . 1.0 111.039 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.5 t -107.8 136.99 46.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.02 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.464 ' O ' ' OG1' ' A' ' 48' ' ' THR . 27.7 m80 -111.71 131.37 55.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.999 0.428 . . . . 1.0 111.668 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.463 ' CD2' ' HG1' ' A' ' 48' ' ' THR . 69.2 m-70 -126.68 130.87 51.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.998 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.418 ' CB ' ' OD2' ' A' ' 49' ' ' ASP . . . -88.64 56.44 3.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.812 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -148.11 136.64 11.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.981 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.3 4.69 5.67 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.866 2.377 . . . . 1.0 111.924 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -64.87 148.39 97.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.895 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.78 165.28 31.82 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.603 2.202 . . . . 1.0 111.897 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 38.4 p90 -86.4 138.46 31.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.425 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 88.3 p -116.8 155.48 28.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.63 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -58.53 -31.78 68.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.676 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -55.81 -40.42 72.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.758 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.47 -38.5 90.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.54 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.5 tp -65.7 -37.71 87.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.547 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -55.34 -37.12 67.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.402 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.2 t -68.84 -52.91 30.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 188' ' ' ALA . 20.8 m -75.14 -36.87 38.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.411 0.523 . . . . 1.0 112.411 -177.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.401 ' O ' ' CG ' ' A' ' 189' ' ' ASP . 53.0 tp60 -50.88 -48.19 60.36 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.7 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.8 -44.33 41.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.963 0.357 . . . . 1.0 111.963 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.1 tp -77.43 -42.44 36.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.906 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -58.24 -39.3 78.74 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.544 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.401 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 86.8 m-20 -59.46 -38.86 81.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.999 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -65.8 -25.74 67.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.115 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.09 -42.29 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.719 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.4 t -58.05 -38.93 77.22 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.1 mt -65.98 -34.77 72.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.209 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -70.89 -39.3 72.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.781 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.6 mm -60.91 -47.53 93.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.199 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.23 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.132 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -70.86 -41.98 70.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.466 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -64.19 -34.49 78.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.73 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -54.83 -25.86 31.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.509 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.35 -34.54 75.46 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.043 -0.263 . . . . 1.0 111.057 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.9 t -45.1 -55.68 5.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.596 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.635 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.838 0.351 . . . . 1.0 110.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.97 -29.55 66.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.99 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -78.64 -46.51 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.161 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.448 HD12 HG23 ' A' ' 34' ' ' ILE . 16.0 mm -62.56 -46.2 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.758 0.313 . . . . 1.0 110.908 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.1 mt -58.29 -48.07 81.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.069 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -52.98 -38.72 62.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.23 -29.31 64.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.087 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.4 m -73.44 -47.02 44.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.547 -0.751 . . . . 1.0 112.263 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -65.73 -36.36 77.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 111.941 0.348 . . . . 1.0 111.941 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.75 -44.38 86.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.823 0.344 . . . . 1.0 111.077 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -42.0 98.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.705 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.9 t -59.64 -40.68 82.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.964 -0.294 . . . . 1.0 111.15 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 47' ' ' GLY . 52.1 ttp180 -50.67 -42.59 56.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.8 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.2 78.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.063 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -77.27 -47.01 21.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.549 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.71 -29.88 22.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.502 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.2 22.13 35.29 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.478 -1.049 . . . . 1.0 110.478 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.504 ' OG1' ' CG2' ' A' ' 51' ' ' VAL . 17.7 p -74.74 145.31 43.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.836 0.351 . . . . 1.0 110.193 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -40.77 -43.3 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.654 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -158.55 134.94 9.34 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.031 -0.668 . . . . 1.0 112.578 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.504 ' CG2' ' OG1' ' A' ' 48' ' ' THR . 10.0 t -135.69 129.04 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -140.11 153.94 46.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.449 -0.501 . . . . 1.0 111.872 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.8 t -100.71 136.74 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 30.3 t80 -119.06 107.45 13.51 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.382 -0.527 . . . . 1.0 111.258 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -79.48 127.15 31.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.217 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.493 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 87.5 t80 -90.97 141.31 28.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.971 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.493 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -112.22 150.81 43.07 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 178.009 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -59.91 -23.63 73.3 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.541 2.161 . . . . 1.0 112.494 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -87.88 -12.48 44.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 1.0 110.072 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.21 58.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.605 -0.598 . . . . 1.0 111.605 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -78.31 90.22 4.36 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.931 -0.307 . . . . 1.0 110.631 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.04 151.43 20.76 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -125.48 148.21 48.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.392 . . . . 1.0 111.719 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.01 108.34 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.462 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 96.7 t -106.02 0.03 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.341 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.79 122.79 3.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.052 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -147.78 133.78 19.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.136 0.493 . . . . 1.0 111.809 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.72 141.51 51.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.681 -0.69 . . . . 1.0 109.341 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.528 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 84.6 mtm-85 -138.7 142.81 38.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.74 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -47.43 -28.01 4.49 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.2 -88.91 0.07 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -152.17 52.09 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 1.0 110.509 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -86.22 -45.65 11.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.174 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.3 mt -109.15 146.35 33.7 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.902 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.87 145.84 63.68 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.551 2.168 . . . . 1.0 112.203 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 p -62.18 124.52 21.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.4 mt -98.57 3.48 48.04 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.366 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 tp -66.25 131.45 46.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.213 0.53 . . . . 1.0 112.26 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.17 -15.39 53.95 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.584 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 mt -82.05 153.84 25.94 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.987 -0.285 . . . . 1.0 110.35 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.0 p -107.04 131.29 54.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.686 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -85.63 154.32 58.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.11 129.6 26.25 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.638 2.225 . . . . 1.0 111.935 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.26 130.05 41.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.739 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.0 -1.11 44.46 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.614 -0.995 . . . . 1.0 110.614 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -53.19 -38.33 62.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mt -78.59 131.55 67.71 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.447 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.81 -165.57 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.438 2.092 . . . . 1.0 112.477 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -107.54 -60.99 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.506 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -57.46 -43.11 83.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.804 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.42 -40.58 85.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -69.04 -41.65 77.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.488 -0.323 . . . . 1.0 111.442 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -60.98 -31.82 71.4 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.8 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.46 ' CD1' HH12 ' A' ' 101' ' ' ARG . 78.1 mt -71.58 -38.02 70.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.227 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.73 -42.08 83.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 1.0 110.018 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 159' ' ' HIS . 77.1 ttt-85 -58.3 -33.09 69.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.798 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.574 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 56.6 mt -98.14 -35.85 10.26 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.584 ' C ' ' NE2' ' A' ' 99' ' ' GLN . . . -118.52 -10.19 10.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.115 1.524 . . . . 1.0 115.115 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.652 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 40.39 82.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.177 -1.009 . . . . 1.0 108.812 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p 175.98 116.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.056 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.471 ' O ' ' CG1' ' A' ' 102' ' ' VAL . 8.0 tpt180 -160.37 143.31 13.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 1.0 110.766 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' A' ' 101' ' ' ARG . 17.4 m -159.78 150.38 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.532 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.421 ' O ' ' OH ' ' A' ' 176' ' ' TYR . 42.9 mt -108.32 136.46 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.098 -0.704 . . . . 1.0 109.098 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.9 t -88.24 158.3 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.215 0.82 . . . . 1.0 113.215 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -48.05 123.95 6.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.904 -1.044 . . . . 1.0 112.193 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.63 -24.72 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.746 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 109' ' ' GLN . 83.9 tt0 -65.27 -47.76 75.59 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.8 -3.49 6.92 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.532 0.682 . . . . 1.0 109.388 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.452 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 36.03 71.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.794 -1.093 . . . . 1.0 113.296 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.7 t -72.44 130.68 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.984 -1.488 . . . . 1.0 106.984 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -118.53 138.57 52.44 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.937 -0.705 . . . . 1.0 111.885 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.62 166.41 26.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.694 -0.684 . . . . 1.0 110.502 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.103 179.074 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 120.692 0.205 . . . . 1.0 111.92 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.1 p -92.56 109.83 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.908 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.496 ' OD2' ' SG ' ' A' ' 138' ' ' CYS . 0.7 OUTLIER -45.36 142.31 3.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 140' ' ' VAL . 72.9 Cg_exo -43.87 -47.63 9.81 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.223 2.615 . . . . 1.0 113.988 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.719 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.3 p -35.83 -46.87 0.48 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.734 0.272 . . . . 1.0 111.734 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.719 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 2.1 t60 -82.99 -24.64 32.83 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 137' ' ' PRO . 44.7 t -65.92 -55.01 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.664 -0.414 . . . . 1.0 110.963 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -65.88 -29.25 69.66 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -60.24 -47.35 86.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.666 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.1 mt -73.0 -36.72 67.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.311 -0.625 . . . . 1.0 109.311 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -49.8 -39.68 39.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.597 -1.26 . . . . 1.0 107.597 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -63.69 -28.74 70.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.713 -1.13 . . . . 1.0 109.181 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.5 mmm -85.92 -1.92 57.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.726 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.05 22.01 78.41 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.18 142.32 23.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 1.0 110.966 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.76 -38.17 5.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.932 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.7 t -133.75 125.2 28.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.104 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.2 p -112.91 135.61 53.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.479 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.83 133.89 55.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.296 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.452 ' H ' HG13 ' A' ' 102' ' ' VAL . 2.0 t -122.23 108.76 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.099 0.476 . . . . 1.0 111.792 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.0 t -105.06 114.6 63.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 107.8 -1.185 . . . . 1.0 107.8 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -41.7 134.74 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 123.161 2.574 . . . . 1.0 114.664 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.4 tp -132.4 41.41 3.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.6 ptm -148.92 -172.69 4.17 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.133 0.79 . . . . 1.0 113.133 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.685 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 52.2 t-80 -77.84 178.1 7.67 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.436 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 72.4 m80 -74.84 -54.94 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.051 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -104.01 11.57 35.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.032 0.382 . . . . 1.0 112.032 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.536 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.8 tt0 -146.49 140.18 26.03 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.856 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.443 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 6.9 tt -109.55 116.18 31.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.243 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.536 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 69.0 m95 -92.68 -37.31 12.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.175 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -158.34 -171.72 24.57 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.152 -0.779 . . . . 1.0 111.152 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 16.0 tp -145.14 125.96 14.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 1.0 111.599 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.6 tp -100.58 131.53 46.44 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.17 138.23 41.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.702 -0.399 . . . . 1.0 111.069 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.1 m -110.86 141.76 43.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.96 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -115.57 131.61 56.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.01 0.433 . . . . 1.0 111.572 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -128.01 123.03 33.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.957 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.73 36.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.829 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -164.37 126.11 1.5 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.009 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -42.68 139.55 3.16 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.988 2.459 . . . . 1.0 111.847 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -176.57 97.75 0.24 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.825 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.98 155.64 4.13 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.596 2.197 . . . . 1.0 111.887 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.421 ' OH ' ' O ' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -85.25 133.66 34.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.51 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.2 m -118.31 150.79 38.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.597 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -50.61 -35.97 32.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.663 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.01 -38.24 85.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.729 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.43 -50.79 70.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.526 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.12 -36.07 80.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.569 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -53.67 -37.2 62.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.406 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.6 -54.47 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.743 0.646 . . . . 1.0 112.743 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.3 t -78.04 -40.13 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.451 0.537 . . . . 1.0 112.451 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -46.9 -45.64 20.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.653 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 55.1 mt -74.64 -39.09 62.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.6 tp -76.0 -41.45 51.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.851 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.55 85.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.479 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.27 -37.72 70.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.279 -0.418 . . . . 1.0 109.953 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -71.83 -24.21 61.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.114 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 194' ' ' ALA . 61.4 t -83.18 -47.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.793 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.5 m -51.97 -30.41 24.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.42 -33.29 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.154 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -70.36 -48.36 56.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.811 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.14 -37.07 78.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.132 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.83 -46.13 63.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.093 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -74.1 -35.14 64.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.549 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -61.92 -34.51 76.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.703 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.28 -27.61 47.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.475 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.07 -36.29 74.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.685 0.279 . . . . 1.0 111.054 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.9 m -52.45 -55.8 19.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.589 179.608 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.892 0.377 . . . . 1.0 110.577 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 35.6 p-10 -51.21 -32.62 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 62.8 tt0 -77.07 -48.33 18.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.147 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 34' ' ' ILE . 81.3 mt -60.33 -42.49 90.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 1.0 110.945 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.06 -46.55 82.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.412 . . . . 1.0 111.041 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.533 HH12 ' CD2' ' A' ' 78' ' ' LEU . 51.8 ttt85 -51.95 -38.27 55.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.95 -29.67 65.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.833 -0.622 . . . . 1.0 110.089 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -73.5 -45.07 56.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.557 -0.747 . . . . 1.0 112.21 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.12 -35.6 72.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 111.976 0.362 . . . . 1.0 111.976 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -70.17 -45.48 66.63 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.104 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -63.76 -44.42 93.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.779 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.37 -42.53 87.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.155 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 47' ' ' GLY . 63.7 ttp85 -53.99 -40.76 67.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.851 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.15 -37.28 74.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.03 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -78.29 -43.41 28.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.581 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.7 mt -85.2 -30.4 23.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.512 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 59.28 20.11 49.21 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.509 -1.036 . . . . 1.0 110.509 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 89.8 m -72.93 142.18 47.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.83 0.348 . . . . 1.0 110.224 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -39.89 -54.72 2.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.566 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.529 ' NH2' ' O ' ' A' ' 74' ' ' LEU . 80.6 mtt-85 -152.5 131.89 12.91 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.99 -0.684 . . . . 1.0 112.501 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.64 129.34 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -138.83 156.01 47.67 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.915 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -108.35 136.35 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.63 134.61 47.78 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.366 -0.534 . . . . 1.0 111.311 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -94.01 137.92 32.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.21 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 66.9 t80 -94.29 117.55 30.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 1.0 112.035 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -88.07 140.93 30.89 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.02 -26.77 5.27 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.55 2.167 . . . . 1.0 112.397 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.37 -19.64 38.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.915 0.388 . . . . 1.0 110.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.69 -13.45 38.71 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.556 -0.618 . . . . 1.0 111.556 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -71.92 99.57 2.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.339 . . . . 1.0 110.593 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.62 142.57 16.06 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.626 -0.99 . . . . 1.0 110.626 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.5 p -123.07 145.77 48.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 1.0 111.743 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 t -77.74 106.99 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.09 -2.03 9.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.341 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.86 116.51 3.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.106 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 81.6 tt0 -144.06 132.5 22.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.802 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.35 138.8 52.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.343 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -118.55 137.08 53.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.906 0.384 . . . . 1.0 110.722 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.42 -81.31 0.52 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.849 -0.9 . . . . 1.0 110.849 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.507 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -114.04 50.81 0.75 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.997 -0.841 . . . . 1.0 110.997 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' A' ' 71' ' ' GLY . 15.0 pt-20 31.18 55.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 1.0 110.491 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -84.52 -50.43 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.165 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.529 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 23.8 mt -109.4 153.46 42.76 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.86 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.28 164.71 3.61 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.486 2.124 . . . . 1.0 112.126 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.1 t -87.72 128.58 35.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.878 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.3 mt -101.08 13.48 35.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.39 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.533 ' CD2' HH12 ' A' ' 36' ' ' ARG . 23.9 tp -73.08 128.9 36.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.032 -0.531 . . . . 1.0 112.343 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.9 -8.62 77.37 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.541 -0.754 . . . . 1.0 111.532 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.8 mt -85.73 152.6 22.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.768 0.318 . . . . 1.0 110.31 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.7 t -106.26 133.67 50.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.702 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.59 152.09 51.4 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.68 137.01 56.69 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.61 2.207 . . . . 1.0 111.863 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.46 129.14 38.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.683 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.1 43.53 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.551 -1.019 . . . . 1.0 110.551 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.9 -37.78 66.77 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 88' ' ' PRO . 0.8 OUTLIER -80.08 113.57 39.53 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.394 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 87' ' ' ILE . 86.5 Cg_exo -48.76 -171.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.455 2.103 . . . . 1.0 112.509 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.93 -59.0 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.558 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 20.8 pt-20 -58.24 -42.74 87.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.813 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -66.27 -47.84 72.38 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.971 0.36 . . . . 1.0 111.971 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.519 ' NH2' ' CE2' ' A' ' 56' ' ' PHE . 72.1 ttt180 -52.99 -35.63 59.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.498 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -66.1 -35.95 81.89 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.838 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.69 -37.31 81.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.317 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.595 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 66.9 m-85 -60.73 -55.07 37.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.038 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -51.19 -29.72 14.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.773 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 63.2 mt -99.14 -42.42 7.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.335 1.235 . . . . 1.0 114.335 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.551 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.93 -14.47 10.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.053 1.501 . . . . 1.0 115.053 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.595 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 20.0 mm-40 37.58 81.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.148 -1.021 . . . . 1.0 108.835 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.7 p 176.49 97.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.103 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.475 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 6.6 mmt180 -147.99 146.35 28.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.992 0.425 . . . . 1.0 110.746 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 101' ' ' ARG . 62.8 t -159.79 150.07 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.514 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.5 mt -108.35 136.57 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.03 163.93 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 113.279 0.844 . . . . 1.0 113.279 -176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 21.8 p30 -46.46 119.68 2.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.93 -1.032 . . . . 1.0 112.125 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.7 p -55.18 -20.42 6.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.331 -0.849 . . . . 1.0 110.808 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -65.78 -43.51 88.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.02 -12.86 55.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.529 0.68 . . . . 1.0 109.362 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 45.17 73.44 0.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.782 -1.099 . . . . 1.0 113.284 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.7 p -74.23 129.9 38.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.025 -1.472 . . . . 1.0 107.025 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -118.29 132.86 56.27 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.937 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.467 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -134.65 162.55 31.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.595 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.6 pt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.164 179.45 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo . . . . . 0 N--CA 1.493 1.452 0 CA-C-O 120.763 0.234 . . . . 1.0 111.962 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -95.33 114.19 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.947 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -44.0 137.17 3.63 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.467 ' HD3' ' H ' ' A' ' 112' ' ' SER . 54.8 Cg_exo -41.97 -48.52 6.12 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.238 2.625 . . . . 1.0 114.001 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.702 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER -35.96 -45.93 0.44 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.8 0.296 . . . . 1.0 111.8 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.702 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 8.1 t-80 -82.2 -26.97 32.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' PRO . 48.0 t -63.92 -53.82 39.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.986 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -65.3 -29.1 69.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -58.97 -45.62 90.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.734 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.2 mt -73.23 -41.76 63.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -38.61 56.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.544 -1.28 . . . . 1.0 107.544 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.7 t -63.5 -26.61 68.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.823 -1.081 . . . . 1.0 109.209 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.6 mmm -90.21 3.55 53.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.731 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.25 20.31 79.11 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.08 143.56 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 1.0 110.964 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.59 -19.95 13.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.942 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.5 m -145.87 161.82 39.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 1.0 111.177 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.7 p -147.48 122.55 10.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.49 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 tp -106.27 131.67 53.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.287 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.44 120.38 58.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.126 0.489 . . . . 1.0 111.784 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.555 ' O ' ' CG1' ' A' ' 154' ' ' VAL . 12.6 p -130.76 91.53 36.94 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.829 -1.174 . . . . 1.0 107.829 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.27 152.09 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 123.175 2.583 . . . . 1.0 114.677 -176.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 56.2 mt -126.07 66.64 1.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.829 -1.545 . . . . 1.0 106.829 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.475 ' SD ' ' OE1' ' A' ' 99' ' ' GLN . 2.1 ptt? -146.98 -167.53 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.145 0.795 . . . . 1.0 113.145 -175.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.721 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 59.5 t60 -86.26 -176.0 5.73 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.446 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.721 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 59.3 t-80 -75.32 -55.27 5.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.463 -0.789 . . . . 1.0 112.103 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -105.66 13.72 29.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.014 0.376 . . . . 1.0 112.014 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -144.04 138.91 28.67 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.839 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.1 tt -110.52 116.67 31.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.239 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -92.4 -36.51 13.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.222 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.91 -171.35 27.9 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.6 tp -149.72 133.31 16.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 1.0 111.532 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.3 tp -98.71 135.91 39.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.0 p -139.25 131.68 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.047 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 m -109.11 142.9 39.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.017 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' A' ' 48' ' ' THR . 43.5 m80 -113.16 123.3 49.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.053 0.454 . . . . 1.0 111.69 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.431 ' CE1' ' OG1' ' A' ' 48' ' ' THR . 82.6 m-70 -123.55 115.23 21.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.859 -0.61 . . . . 1.0 109.97 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.12 -16.12 63.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.782 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -94.48 150.15 37.68 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.963 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 174' ' ' ARG . 59.9 Cg_endo -70.83 -2.6 11.2 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.96 2.44 . . . . 1.0 111.825 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 173' ' ' PRO . 0.0 OUTLIER -32.54 98.06 0.12 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.921 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 173' ' ' PRO . 78.2 Cg_exo -50.15 167.68 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.577 2.185 . . . . 1.0 111.933 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.539 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 46.4 p90 -86.75 125.66 34.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.471 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.2 t -115.74 154.1 30.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.681 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -54.34 -31.76 55.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.626 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.81 -39.99 86.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.748 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -63.47 -42.6 98.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.551 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.55 -38.47 87.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.502 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -55.36 -36.4 66.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.899 -0.591 . . . . 1.0 111.394 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.1 -55.93 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.735 0.643 . . . . 1.0 112.735 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 188' ' ' ALA . 26.8 m -74.09 -35.3 40.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.434 0.531 . . . . 1.0 112.434 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -50.28 -45.84 54.68 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.655 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 41.5 mt -79.61 -43.97 21.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.894 0.331 . . . . 1.0 111.894 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 34.2 tp -77.9 -40.53 39.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.835 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -60.67 -41.11 94.42 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.493 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.66 -40.26 87.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.991 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -67.81 -25.81 65.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.149 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 37.0 t -84.13 -45.01 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.78 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.563 ' HG ' ' N ' ' A' ' 193' ' ' ILE . 24.2 p -57.13 -35.33 69.34 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.563 ' N ' ' HG ' ' A' ' 192' ' ' SER . 38.7 mt -67.01 -34.81 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.465 -0.789 . . . . 1.0 109.24 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.93 77.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.819 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.4 mm -59.57 -48.58 86.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.128 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.52 -48.13 57.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.127 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -65.0 -42.77 94.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.466 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.441 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -65.63 -31.87 73.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.706 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.14 -30.97 66.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.464 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 9.7 mp -59.99 -34.17 72.96 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.981 -0.288 . . . . 1.0 111.072 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 87.3 p -55.56 -55.58 30.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.566 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.534 179.896 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.868 0.366 . . . . 1.0 110.605 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 33' ' ' GLN . 24.1 p-10 -50.74 -55.48 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.998 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.421 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 63.9 tt0 -52.65 -42.56 64.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.101 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.43 HD13 HG23 ' A' ' 34' ' ' ILE . 18.1 mm -59.64 -50.46 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 1.0 110.966 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 38' ' ' THR . 83.4 mt -58.42 -46.86 85.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.987 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -49.58 -39.68 35.98 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.816 -0.438 . . . . 1.0 109.816 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 -29.4 65.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.073 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 35' ' ' LEU . 24.1 m -74.53 -41.47 60.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 1.0 112.263 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 7.5 p -72.32 -37.82 59.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 111.922 0.341 . . . . 1.0 111.922 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -67.79 -41.61 82.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.783 0.325 . . . . 1.0 111.067 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -67.36 -44.72 78.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.734 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.77 -36.36 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.176 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.558 ' NH2' ' CA ' ' A' ' 70' ' ' GLY . 16.3 tpt85 -59.79 -47.47 85.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 1.0 110.802 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.55 -33.33 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 1.0 111.051 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -74.27 -41.2 61.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.607 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' A' ' 48' ' ' THR . 5.4 mt -87.12 -29.03 22.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.514 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.81 19.19 0.85 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.421 ' N ' ' C ' ' A' ' 46' ' ' LEU . 1.6 p -62.7 -97.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 1.0 110.211 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -155.13 -48.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.613 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -157.16 125.92 5.78 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.089 -0.644 . . . . 1.0 112.644 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 12.6 p -137.03 129.05 43.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.547 -0.908 . . . . 1.0 108.547 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -140.18 159.33 42.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.958 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -99.82 136.25 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.608 -0.886 . . . . 1.0 108.608 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 74.2 t80 -117.09 108.45 15.73 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.295 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -83.31 126.47 32.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.274 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.621 ' CZ ' ' NH2' ' A' ' 92' ' ' ARG . 77.8 t80 -93.32 137.12 32.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 1.0 112.035 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -108.84 140.85 22.26 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 177.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.88 -27.27 5.57 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.573 2.182 . . . . 1.0 112.442 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.97 -18.19 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 1.0 110.096 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 106.96 -13.85 41.06 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.574 -0.61 . . . . 1.0 111.574 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -78.22 90.39 4.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.765 0.317 . . . . 1.0 110.63 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.48 151.46 20.97 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.635 -0.986 . . . . 1.0 110.635 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.8 p -123.51 146.62 47.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 1.0 111.692 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.4 t -75.81 110.38 10.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.87 2.97 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.339 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.69 122.58 3.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.072 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -144.26 130.16 19.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.109 0.481 . . . . 1.0 111.826 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.62 139.25 52.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.359 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -140.85 145.8 36.69 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.793 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.558 ' CA ' ' NH2' ' A' ' 43' ' ' ARG . . . -47.31 -39.08 13.32 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.864 -0.894 . . . . 1.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.557 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 171.64 -154.27 21.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 72' ' ' GLU . 3.0 pp20? -72.54 20.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 1.0 110.523 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.557 ' H ' ' C ' ' A' ' 71' ' ' GLY . 35.0 mtm180 -76.44 -47.8 21.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.117 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.89 150.36 52.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.92 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.42 157.91 55.4 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.486 2.124 . . . . 1.0 112.155 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.7 p -95.55 132.04 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.918 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.6 17.16 7.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.41 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.44 128.8 37.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.016 -0.538 . . . . 1.0 112.28 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.91 -11.49 64.54 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.536 -0.756 . . . . 1.0 111.577 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.1 mt -82.92 152.05 25.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.914 -0.314 . . . . 1.0 110.341 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.8 m -107.16 134.15 50.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.713 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -84.95 152.19 58.69 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.36 130.66 27.5 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.636 2.224 . . . . 1.0 111.89 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 131.45 46.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.705 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.64 2.13 43.33 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -62.41 -17.02 58.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.573 ' O ' ' O ' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -105.1 103.24 40.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.397 178.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 87' ' ' ILE . 83.1 Cg_exo -49.74 -154.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.407 2.072 . . . . 1.0 112.489 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -109.21 -54.63 2.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.53 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -63.31 -45.04 93.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.78 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.4 -48.17 70.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.947 0.351 . . . . 1.0 111.947 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.621 ' NH2' ' CZ ' ' A' ' 56' ' ' PHE . 67.1 ttt180 -56.57 -34.68 67.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.426 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.5 ttt85 -64.25 -35.63 81.45 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.872 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.89 -38.47 91.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.281 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.62 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 40.0 m-85 -60.26 -29.97 69.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.977 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.463 ' C ' HE22 ' A' ' 99' ' ' GLN . 80.0 ttt-85 -84.2 -26.44 28.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.888 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.92 -46.92 6.03 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.434 1.272 . . . . 1.0 114.434 -175.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.526 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.58 -6.05 13.96 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.052 1.501 . . . . 1.0 115.052 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.716 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.7 mm-40 40.5 73.6 0.12 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.191 -1.004 . . . . 1.0 108.821 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 6.2 p 176.1 118.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.993 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.456 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 30.6 tpt85 -168.66 134.6 1.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 1.0 110.715 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.456 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 4.5 m -149.82 155.28 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.564 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.67 ' CD1' ' HE2' ' A' ' 139' ' ' HIS . 96.9 mt -112.04 134.42 54.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.074 -0.713 . . . . 1.0 109.074 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.01 163.62 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 113.315 0.857 . . . . 1.0 113.315 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 173' ' ' PRO . 49.7 m-20 -45.92 120.11 2.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.986 -1.006 . . . . 1.0 112.156 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.8 -20.62 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.792 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.98 -44.86 83.65 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.16 -13.45 60.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.491 0.662 . . . . 1.0 109.387 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 46.66 72.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.675 -1.148 . . . . 1.0 113.327 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.82 131.98 42.98 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.002 -1.481 . . . . 1.0 107.002 175.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -118.75 134.16 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.003 -0.679 . . . . 1.0 111.904 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.1 164.49 30.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.555 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.3 pt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.084 179.676 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo . . . . . 0 N--CA 1.492 1.405 0 CA-C-O 120.708 0.212 . . . . 1.0 111.951 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.71 147.46 6.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.869 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -92.32 136.13 25.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -41.65 -21.51 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.226 2.618 . . . . 1.0 114.018 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.683 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 4.8 p -71.24 -46.12 61.75 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.751 0.278 . . . . 1.0 111.751 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.683 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 42.1 t60 -84.13 -29.11 26.99 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 1.8 p -62.65 -44.56 99.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.941 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.537 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 83.5 t60 -69.53 -30.3 68.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.738 -0.467 . . . . 1.0 109.738 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -58.2 -43.01 87.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.76 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 146' ' ' MET . 63.6 mt -72.99 -40.11 65.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.279 -0.637 . . . . 1.0 109.279 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -51.01 -39.1 54.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.568 -1.271 . . . . 1.0 107.568 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 m -65.17 -22.94 66.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.783 -1.099 . . . . 1.0 109.203 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.4 mmm -94.52 0.64 55.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.645 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.7 21.11 79.72 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 64.9 t -110.7 142.74 22.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.841 0.353 . . . . 1.0 111.063 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.55 -40.78 5.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.945 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.1 m -131.98 127.14 35.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.217 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.498 ' HG ' ' CD1' ' A' ' 143' ' ' LEU . 0.0 OUTLIER -118.34 129.1 55.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.472 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.02 126.74 54.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.234 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.32 120.49 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 1.0 111.802 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.0 t -128.07 118.04 20.64 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -71.8 145.2 45.39 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.164 2.576 . . . . 1.0 114.721 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.3 mt -121.68 62.27 0.92 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -147.04 -163.31 1.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.099 0.777 . . . . 1.0 113.099 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.584 ' CE1' ' HE1' ' A' ' 163' ' ' TRP . 76.1 m80 -89.06 -178.4 5.68 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.357 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -74.22 -54.09 8.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.054 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.68 11.16 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.03 0.381 . . . . 1.0 112.03 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.5 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.7 tt0 -143.15 136.82 28.59 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.441 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 5.6 tt -111.89 119.64 39.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.044 -0.526 . . . . 1.0 111.259 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.584 ' HE1' ' CE1' ' A' ' 158' ' ' HIS . 82.1 m95 -92.85 -41.07 10.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.265 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.442 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -160.15 -176.31 32.1 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.179 -0.768 . . . . 1.0 111.179 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 97.0 mt -140.09 133.72 30.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 1.0 111.522 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.8 tp -105.23 134.17 48.78 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.33 138.2 40.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.048 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m -114.4 132.25 56.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 1.0 109.98 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -109.77 137.01 48.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.999 0.428 . . . . 1.0 111.676 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -130.04 130.4 44.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.015 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.17 45.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.773 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -144.05 150.74 50.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.07 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.446 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 65.4 Cg_endo -71.51 -12.31 29.22 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.905 2.404 . . . . 1.0 111.92 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -40.97 104.54 0.34 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.904 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.07 168.2 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.532 2.155 . . . . 1.0 111.95 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -97.71 136.46 38.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.518 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.2 m -120.65 152.47 38.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.638 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -51.05 -31.47 18.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.665 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -56.5 -34.86 67.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.731 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -64.3 -43.56 94.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.504 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 9.0 mp -67.76 -35.06 78.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.575 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -54.76 -39.74 68.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.367 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.35 -52.46 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.6 t -71.53 -34.92 54.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.401 0.519 . . . . 1.0 112.401 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -50.42 -46.99 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.646 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 51.2 mt -68.8 -40.1 79.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.914 0.339 . . . . 1.0 111.914 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.3 tp -78.45 -37.71 42.92 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.86 0.319 . . . . 1.0 111.86 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.92 86.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.482 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -63.38 -41.17 98.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.002 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -69.03 -29.11 67.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.085 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.4 -46.15 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.681 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.9 t -53.75 -35.6 61.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.0 mt -64.93 -34.69 72.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.2 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.65 -39.5 80.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.617 -0.72 . . . . 1.0 109.845 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.446 HG21 HD12 ' A' ' 195' ' ' ILE . 49.9 mm -59.55 -47.45 90.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.189 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.17 -46.28 61.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.09 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -66.54 -45.4 79.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.457 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.428 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -64.55 -32.7 74.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.669 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.43 -33.13 70.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.55 -0.296 . . . . 1.0 111.427 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.38 -35.09 76.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.664 0.269 . . . . 1.0 111.077 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 90.5 p -56.91 -55.69 31.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.564 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.551 179.567 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.882 0.372 . . . . 1.0 110.557 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -77.2 -29.76 54.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.942 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -78.53 -45.76 21.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.084 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 pt -64.8 -39.71 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.968 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.539 ' O ' ' OG1' ' A' ' 38' ' ' THR . 26.7 mt -59.72 -45.49 92.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.005 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -55.59 -34.46 64.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.42 -35.92 71.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.105 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.539 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 82.8 p -70.26 -43.35 70.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.548 -0.751 . . . . 1.0 112.188 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.91 -36.59 76.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 111.911 0.337 . . . . 1.0 111.911 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' A' ' 43' ' ' ARG . 39.6 tp10 -66.31 -46.32 77.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.808 0.337 . . . . 1.0 111.076 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.84 -46.69 86.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.722 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.6 t -52.73 -45.06 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.955 -0.298 . . . . 1.0 111.138 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 47' ' ' GLY . 56.5 ttp180 -49.59 -39.52 35.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.825 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.56 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -76.46 -46.46 26.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.546 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.58 -27.73 25.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.507 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.4 21.49 34.1 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 169' ' ' HIS . 7.3 t -74.11 143.93 45.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 1.0 110.234 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 94.6 m-20 -43.6 -43.89 5.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.662 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' NH1' ' CD1' ' A' ' 74' ' ' LEU . 58.4 mtm-85 -154.98 131.71 10.67 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.078 -0.649 . . . . 1.0 112.56 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.8 128.2 46.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -138.4 154.1 48.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.491 -0.484 . . . . 1.0 111.949 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.5 t -99.63 136.3 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 37.9 t80 -116.75 110.93 19.06 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.324 -0.55 . . . . 1.0 111.307 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.531 ' NH1' ' O ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -84.43 122.6 29.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.266 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.531 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 69.4 t80 -88.78 141.28 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 1.0 112.034 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 60' ' ' GLY . 41.0 m-20 -111.97 140.0 22.95 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -46.03 -30.65 7.55 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.458 2.105 . . . . 1.0 112.46 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -81.17 -19.22 43.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 1.0 110.043 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.84 -11.42 38.17 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.56 -0.616 . . . . 1.0 111.56 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -79.22 90.39 4.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.747 0.308 . . . . 1.0 110.699 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.85 152.09 21.2 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 p -125.69 148.87 48.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 1.0 111.711 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.78 109.3 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 65.1 t -107.87 0.8 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.925 -0.31 . . . . 1.0 111.292 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.34 118.69 2.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.017 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -147.04 133.85 20.09 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.874 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.97 148.36 51.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 1.0 109.388 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.524 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 36.3 ptt180 -141.73 145.38 34.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.797 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -50.34 -37.17 31.34 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -175.1 -167.97 35.04 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.952 -0.859 . . . . 1.0 110.952 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.78 43.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 1.0 110.546 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 71' ' ' GLY . 53.9 mtt-85 -84.05 -46.68 11.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.13 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.454 ' CD1' ' NH1' ' A' ' 50' ' ' ARG . 13.3 mt -123.37 150.85 61.66 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.881 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.57 165.28 31.27 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.532 2.155 . . . . 1.0 112.191 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.9 p -93.33 131.81 38.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.981 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.3 mt -89.78 9.04 28.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.454 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.83 130.46 45.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.989 -0.55 . . . . 1.0 112.263 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.62 -14.88 58.74 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.524 -0.762 . . . . 1.0 111.567 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.3 mt -80.77 150.37 29.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.282 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.2 m -104.59 129.53 52.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.75 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -82.16 128.72 66.74 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -40.26 125.34 1.82 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.663 2.242 . . . . 1.0 111.882 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.07 132.68 52.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.74 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.39 1.6 44.08 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.539 -1.024 . . . . 1.0 110.539 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -56.78 -35.66 68.94 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 mt -88.76 126.95 57.97 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.425 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.83 -155.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.477 2.118 . . . . 1.0 112.503 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -107.76 -68.78 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 1.0 111.557 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -49.44 -46.63 48.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.855 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.99 -45.48 81.43 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.702 HH12 ' NH2' ' A' ' 96' ' ' ARG . 71.8 ttt-85 -59.62 -35.34 74.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.475 -0.33 . . . . 1.0 111.513 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -63.51 -31.14 72.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.792 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.422 ' CD1' HH12 ' A' ' 101' ' ' ARG . 87.0 mt -69.25 -35.76 76.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.248 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.626 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 17.6 m-85 -59.14 -31.14 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.017 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.702 ' NH2' HH12 ' A' ' 92' ' ' ARG . 80.7 mtt180 -83.44 -23.61 32.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.815 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.4 mt -99.18 -47.5 5.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.0 -8.51 13.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -173.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.688 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.5 mm-40 39.21 80.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.16 -1.016 . . . . 1.0 108.817 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 4.2 p 173.69 120.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.037 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.472 HH11 ' HG3' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -169.72 146.58 3.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.011 0.434 . . . . 1.0 110.716 177.08 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 101' ' ' ARG . 54.1 t -159.35 150.24 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.565 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.6 mt -108.06 134.63 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.03 165.11 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 15.4 p30 -45.99 117.89 1.68 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.988 -1.005 . . . . 1.0 112.114 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.81 -21.46 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.326 -0.852 . . . . 1.0 110.769 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.54 -43.22 90.63 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.12 -11.83 44.31 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.502 0.668 . . . . 1.0 109.356 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 45.29 69.26 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.748 -1.115 . . . . 1.0 113.291 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 m -76.29 132.36 39.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 174.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -119.44 139.22 52.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.0 -0.68 . . . . 1.0 111.886 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.422 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -124.4 149.91 46.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.576 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.146 178.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 120.675 0.198 . . . . 1.0 111.945 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.38 123.61 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.909 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -41.3 153.48 0.25 Allowed Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -57.08 -21.59 43.1 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.194 2.596 . . . . 1.0 114.038 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.691 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 5.6 p -63.02 -46.57 86.97 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.691 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 16.4 t-80 -81.27 -27.15 35.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.245 0.461 . . . . 1.0 112.245 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.4 -53.61 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.915 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -65.74 -28.17 68.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.536 ' O ' ' OG ' ' A' ' 145' ' ' SER . 78.6 t80 -59.17 -42.98 92.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.7 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 146' ' ' MET . 17.5 mt -73.32 -38.85 65.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -52.12 -39.06 59.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.594 -1.261 . . . . 1.0 107.594 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.536 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 9.9 p -65.14 -20.55 66.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.769 -1.105 . . . . 1.0 109.186 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.538 ' N ' ' O ' ' A' ' 143' ' ' LEU . 81.5 mmm -95.65 2.81 54.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.412 -0.813 . . . . 1.0 110.707 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.81 21.86 78.85 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.88 142.54 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 1.0 111.02 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.38 -21.03 13.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.931 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -147.82 160.63 42.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.155 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 p -148.38 126.37 12.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.469 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.43 128.7 55.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.302 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.82 121.05 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.173 0.511 . . . . 1.0 111.801 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.509 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 3.1 m -126.16 92.99 44.51 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.816 -1.179 . . . . 1.0 107.816 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -44.84 143.86 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.148 2.565 . . . . 1.0 114.672 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 154' ' ' VAL . 10.9 mp -121.91 60.24 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.818 -1.549 . . . . 1.0 106.818 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.3 ptm -147.66 -178.63 6.36 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.139 0.792 . . . . 1.0 113.139 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.621 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 57.7 t-80 -71.08 172.66 8.74 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.289 -0.869 . . . . 1.0 111.368 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.621 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 55.9 t-80 -61.48 -50.59 72.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.326 -0.852 . . . . 1.0 112.039 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -105.36 -37.66 6.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -89.97 136.13 33.23 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.957 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.443 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 6.3 tt -107.39 118.46 36.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.279 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -92.55 -44.17 8.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.205 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -161.53 -176.11 33.28 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.63 138.16 34.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 1.0 111.534 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.5 tp -103.81 134.19 47.53 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.23 140.07 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.699 -0.401 . . . . 1.0 111.089 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.3 m -114.12 137.89 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.994 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.48 ' O ' ' OG1' ' A' ' 48' ' ' THR . 77.5 m-70 -111.46 135.65 51.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.003 0.43 . . . . 1.0 111.611 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -128.27 121.9 30.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.966 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.51 -12.54 60.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.817 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -129.83 148.02 67.81 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.018 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -44.32 146.48 1.93 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.952 2.435 . . . . 1.0 111.821 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -172.82 79.42 0.43 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.03 151.17 12.21 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.569 2.179 . . . . 1.0 111.933 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -99.41 136.16 39.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.482 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.7 m -125.65 172.45 9.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.593 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -50.47 -35.41 28.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.667 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -62.35 -50.11 72.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.682 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -62.34 -37.21 84.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.477 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.7 tp -61.47 -36.2 79.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.561 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -61.33 -30.12 70.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 1.0 111.36 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 74.4 t -71.35 -53.54 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 188' ' ' ALA . 34.7 m -77.94 -36.09 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.398 0.518 . . . . 1.0 112.398 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -54.9 -49.68 70.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.707 0.289 . . . . 1.0 111.631 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 33.4 tp -73.46 -39.73 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 28.3 tp -79.21 -40.15 31.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.418 -0.355 . . . . 1.0 111.813 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.527 ' O ' ' OG ' ' A' ' 192' ' ' SER . . . -55.8 -36.38 67.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.56 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -77.68 -38.8 46.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 1.0 109.97 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.98 -35.99 82.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.127 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -83.65 -40.06 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.722 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.527 ' OG ' ' O ' ' A' ' 188' ' ' ALA . 68.7 m -54.43 -35.8 63.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.1 mt -61.42 -35.67 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.217 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.33 -38.58 78.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.756 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.13 -49.5 83.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.154 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.39 -46.84 65.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.864 -0.607 . . . . 1.0 111.138 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -64.23 -40.58 96.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 1.0 111.518 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.97 67.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.321 -0.399 . . . . 1.0 111.699 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -63.1 -37.91 89.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.495 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 48.6 mt -61.42 -31.77 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.983 -0.287 . . . . 1.0 111.083 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.6 m -54.6 -52.55 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.529 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 31.0 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.521 179.655 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.534 ' CD2' ' NH2' ' A' ' 55' ' ' ARG . 39.4 tp . . . . . 0 C--O 1.23 0.028 0 CA-C-O 120.91 0.385 . . . . 1.0 110.594 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 65.5 t0 -79.61 -30.5 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.984 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -79.38 -45.16 20.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.08 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.3 tt -61.52 -39.92 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 1.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.7 mt -61.1 -45.51 94.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.049 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.458 HH12 ' CD2' ' A' ' 78' ' ' LEU . 77.9 mtt-85 -53.75 -38.55 64.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.564 -0.455 . . . . 1.0 109.938 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.92 -29.34 65.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.082 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.5 m -73.08 -44.52 60.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.544 -0.753 . . . . 1.0 112.249 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -69.16 -37.57 76.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.55 -37.23 71.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.796 0.332 . . . . 1.0 111.112 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -67.49 -49.01 65.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.78 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.4 -31.22 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.136 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.8 tmt_? -61.09 -45.83 93.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.811 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.02 72.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.09 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -78.33 -41.35 33.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.58 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.7 mt -85.55 -30.23 23.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.427 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.02 20.07 32.92 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.455 -1.058 . . . . 1.0 110.455 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.6 p -72.59 143.23 48.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.343 . . . . 1.0 110.239 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -39.58 -53.55 2.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.607 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -154.04 130.75 10.76 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.048 -0.661 . . . . 1.0 112.588 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -136.95 128.97 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.582 -0.896 . . . . 1.0 108.582 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -139.73 154.51 47.46 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.532 -0.467 . . . . 1.0 111.932 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.69 137.18 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -132.86 134.25 44.37 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.26 -178.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.534 ' NH2' ' CD2' ' A' ' 31' ' ' LEU . 42.4 ttm-85 -90.61 138.21 31.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.241 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -92.99 117.01 29.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 1.0 112.077 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -84.09 149.85 56.86 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.35 -23.97 72.43 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.517 2.145 . . . . 1.0 112.481 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.66 -16.48 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.0 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.67 -12.36 42.41 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.534 -0.626 . . . . 1.0 111.534 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -75.3 96.11 3.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.784 0.326 . . . . 1.0 110.662 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.15 143.09 16.78 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.7 p -122.21 146.02 47.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 1.0 111.693 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.73 109.47 13.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -108.74 -1.66 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.97 -0.292 . . . . 1.0 111.242 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.68 114.62 2.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.044 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.41 ' C ' ' OE1' ' A' ' 67' ' ' GLU . 1.6 pp20? -145.22 135.29 23.82 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.523 -0.471 . . . . 1.0 111.833 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.39 144.83 51.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.692 -0.685 . . . . 1.0 109.386 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.473 ' NH1' ' C ' ' A' ' 71' ' ' GLY . 34.3 ptt85 -136.55 143.65 43.78 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.746 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -49.17 -41.68 30.86 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -173.31 -167.46 33.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -70.96 39.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.735 0.302 . . . . 1.0 110.515 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.523 ' H ' ' C ' ' A' ' 71' ' ' GLY . 39.2 ttm180 -83.08 -49.72 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.18 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.93 151.18 49.95 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 1.0 109.849 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.66 164.2 35.33 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.522 2.148 . . . . 1.0 112.144 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.538 ' HG ' ' H ' ' A' ' 78' ' ' LEU . 33.3 t -94.88 131.14 41.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.988 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.7 mt -90.26 11.51 20.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.411 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.538 ' H ' ' HG ' ' A' ' 76' ' ' SER . 11.3 tp -63.2 130.19 43.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 1.0 112.288 -177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.99 -12.36 66.33 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.498 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -81.68 150.0 28.24 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.285 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -109.35 137.61 46.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.646 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -90.45 152.58 45.55 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.495 -0.557 . . . . 1.0 109.495 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.18 140.13 87.42 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.691 2.261 . . . . 1.0 111.816 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.02 126.83 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.709 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.89 -0.52 45.0 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.484 -1.046 . . . . 1.0 110.484 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -57.43 -37.87 73.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.507 ' N ' ' CD1' ' A' ' 87' ' ' ILE . 1.6 mp -70.96 114.34 26.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.429 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -46.55 173.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.467 2.111 . . . . 1.0 112.481 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.523 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 96.2 mt-10 -104.5 -52.1 2.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.495 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.586 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 3.1 pm0 -68.55 -41.51 79.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.762 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.04 -42.01 90.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.966 0.358 . . . . 1.0 111.966 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -60.44 -36.44 78.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.487 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 75.3 mtt85 -66.58 -41.49 88.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.833 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.9 -39.24 93.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.277 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.662 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 8.4 t80 -64.39 -28.76 69.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.02 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.435 ' C ' HE22 ' A' ' 99' ' ' GLN . 73.4 ttt-85 -81.95 -26.41 34.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.814 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.9 mt -98.18 -43.28 7.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.382 1.253 . . . . 1.0 114.382 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -111.8 -7.39 14.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.996 1.48 . . . . 1.0 114.996 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.665 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.6 mm-40 47.02 82.85 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.239 -0.984 . . . . 1.0 108.769 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 2.6 p 174.13 103.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.048 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.7 mmt-85 -143.87 139.54 29.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 1.0 110.825 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -171.6 147.25 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.539 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.75 138.06 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.95 165.37 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -48.31 119.83 3.23 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.133 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.27 -27.58 32.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.296 -0.866 . . . . 1.0 110.793 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 109' ' ' GLN . 82.7 tt0 -66.67 -42.84 85.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.68 -9.79 4.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.519 0.676 . . . . 1.0 109.395 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.433 ' H ' ' C ' ' A' ' 107' ' ' GLU . 45.1 tt0 45.41 58.42 4.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.704 -1.134 . . . . 1.0 113.28 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.8 p -77.55 134.65 38.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.919 -1.511 . . . . 1.0 106.919 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -123.1 144.64 49.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.952 -0.699 . . . . 1.0 111.903 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.37 156.48 46.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.527 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.193 178.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo . . . . . 0 N--CA 1.492 1.428 0 CA-C-O 120.76 0.233 . . . . 1.0 111.956 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.3 p -122.69 134.26 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.861 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.507 ' OD2' ' SG ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -46.53 151.22 1.05 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 138' ' ' CYS . 36.2 Cg_endo -59.62 -46.93 18.04 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.263 2.642 . . . . 1.0 113.991 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -36.66 -44.84 0.48 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.682 0.253 . . . . 1.0 111.682 -178.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.688 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.6 t60 -83.79 -27.87 28.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.7 t -68.09 -51.0 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.979 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -66.75 -30.86 71.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -58.54 -43.85 89.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.67 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 146' ' ' MET . 13.1 mt -73.28 -37.79 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -50.86 -39.17 53.09 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -64.38 -25.5 68.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.765 -1.107 . . . . 1.0 109.195 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.562 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.2 mmm -90.56 1.95 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.705 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.55 21.57 78.73 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.81 142.47 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.89 0.376 . . . . 1.0 111.062 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.47 -20.39 13.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.908 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -145.62 160.6 41.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.203 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.7 p -147.7 122.08 9.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.411 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.2 mp -108.6 139.81 42.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.293 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.81 118.41 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.128 0.49 . . . . 1.0 111.726 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.8 t -122.5 127.35 25.86 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 95' ' ' PHE . 83.4 Cg_endo -76.33 148.62 30.5 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.135 2.557 . . . . 1.0 114.692 -176.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.63 49.01 2.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.814 -1.551 . . . . 1.0 106.814 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.02 -175.72 4.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -174.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.38 163.09 28.36 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.383 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.526 ' ND1' ' OE1' ' A' ' 160' ' ' GLN . 58.4 t-80 -66.65 -53.99 28.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.37 -0.832 . . . . 1.0 112.023 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.526 ' OE1' ' ND1' ' A' ' 159' ' ' HIS . 12.1 mm100 -99.78 8.81 43.95 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.047 0.388 . . . . 1.0 112.047 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -143.13 134.83 26.57 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.834 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.609 ' N ' ' CD1' ' A' ' 162' ' ' LEU . 1.1 mp -110.41 116.98 32.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.188 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -92.19 -41.01 10.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.263 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.72 -177.95 27.71 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.02 143.71 29.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.897 0.379 . . . . 1.0 111.531 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.18 132.75 54.72 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.8 p -136.08 132.84 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.982 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 21.3 m -107.49 149.44 27.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.074 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -124.87 131.85 53.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.02 0.438 . . . . 1.0 111.648 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.6 113.8 14.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.98 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.45 -15.89 63.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.84 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -96.18 147.43 32.96 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.942 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.86 76.18 2.06 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.98 2.453 . . . . 1.0 111.886 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -113.77 97.76 45.37 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.836 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.75 164.83 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.494 2.129 . . . . 1.0 111.972 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 44.6 p90 -92.0 130.68 37.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.488 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 98.4 p -119.17 157.64 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.607 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -54.79 -34.75 63.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.638 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -57.12 -36.71 70.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.81 -36.59 83.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.499 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 9.4 mp -67.97 -38.13 82.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.53 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -53.58 -40.88 65.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.356 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 88.5 t -70.32 -56.43 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.39 -38.89 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.477 0.547 . . . . 1.0 112.477 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 181' ' ' LEU . 62.9 tt0 -49.98 -49.82 49.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.667 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 31.7 tp -70.16 -40.38 74.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.938 0.347 . . . . 1.0 111.938 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.7 tp -76.44 -38.79 54.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.787 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.46 77.93 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.517 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.68 -39.27 80.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.94 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -65.66 -27.87 68.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.084 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -83.71 -41.8 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.736 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.8 p -56.64 -33.24 66.14 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.4 mt -69.94 -38.23 74.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.213 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.11 76.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.602 -0.727 . . . . 1.0 109.832 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.6 mm -60.59 -46.55 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.162 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.98 -45.64 66.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -67.59 -41.21 84.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.517 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.448 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -66.94 -31.56 72.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.69 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.06 -39.79 93.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.559 -0.291 . . . . 1.0 111.492 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.32 -36.26 83.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.986 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 98.6 p -56.89 -52.92 63.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.784 0.326 . . . . 1.0 110.588 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.568 179.547 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.808 0.337 . . . . 1.0 110.585 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.7 -28.72 56.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.032 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -79.84 -46.49 16.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.128 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 35' ' ' LEU . 3.2 tp -63.8 -43.96 98.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.955 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.494 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 83.6 mt -61.39 -49.26 77.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.015 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 39' ' ' VAL . 60.5 ttp180 -53.84 -37.68 63.86 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 -30.14 66.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.013 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.4 m -73.54 -45.0 56.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.591 -0.731 . . . . 1.0 112.204 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 36' ' ' ARG . 9.1 p -67.39 -34.98 72.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -70.5 -39.33 74.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 1.0 111.098 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -65.54 -50.78 63.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.829 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.23 -28.81 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.683 0.278 . . . . 1.0 111.128 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.3 tmm_? -61.88 -46.4 89.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.865 0.364 . . . . 1.0 110.882 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.15 -33.45 69.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.097 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -79.68 -41.18 27.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.551 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 mt -85.34 -35.42 21.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.453 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 62.31 20.54 61.01 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.521 -1.031 . . . . 1.0 110.521 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -73.42 141.63 46.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.808 0.337 . . . . 1.0 110.173 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' CG ' HH21 ' A' ' 73' ' ' ARG . 92.3 m-20 -39.45 -44.3 1.36 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.622 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -164.76 130.43 2.77 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.025 -0.67 . . . . 1.0 112.57 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.16 129.01 42.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -140.83 154.81 46.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.867 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -98.47 135.04 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 47.5 t80 -115.74 105.36 12.64 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.323 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -76.16 124.81 28.04 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.232 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 86.7 t80 -90.87 142.18 28.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 1.0 112.02 -178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 1.1 m-20 -112.04 151.36 43.53 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 108.617 -0.882 . . . . 1.0 108.617 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.48 -23.65 75.78 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.541 2.161 . . . . 1.0 112.469 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -88.32 -12.12 44.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 1.0 110.045 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.61 -13.85 57.92 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.572 -0.611 . . . . 1.0 111.572 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -78.88 89.83 4.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.855 0.36 . . . . 1.0 110.606 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.47 151.63 21.07 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -125.07 146.39 49.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 1.0 111.679 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.96 108.98 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.5 t -105.79 -1.61 9.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.904 -0.318 . . . . 1.0 111.333 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.03 115.38 2.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.143 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.482 ' CD ' ' NH2' ' A' ' 69' ' ' ARG . 87.7 tt0 -143.14 132.49 23.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.074 0.464 . . . . 1.0 111.856 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.98 147.77 50.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.4 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.482 ' NH2' ' CD ' ' A' ' 67' ' ' GLU . 42.3 mtt85 -141.23 142.33 33.96 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.77 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.98 -31.21 80.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -171.41 -173.66 38.53 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -79.26 40.0 0.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 1.0 110.517 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.55 HH21 ' CG ' ' A' ' 49' ' ' ASP . 22.3 ttp-105 -83.19 -48.64 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.22 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -103.37 149.93 37.48 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.167 -0.47 . . . . 1.0 109.905 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.61 148.58 72.61 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.535 2.157 . . . . 1.0 112.138 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.0 m -76.83 125.2 28.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.907 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.1 mt -103.99 9.75 36.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.323 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.54 132.43 41.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.182 0.515 . . . . 1.0 112.305 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.88 -7.96 75.05 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.624 -0.716 . . . . 1.0 111.521 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.38 154.87 20.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.76 0.314 . . . . 1.0 110.246 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -103.07 129.02 49.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.663 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -82.49 152.06 66.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.57 132.08 31.89 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.617 2.211 . . . . 1.0 111.848 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 128.72 37.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.052 0.454 . . . . 1.0 110.686 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.42 -0.17 40.29 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -59.24 -15.71 17.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.57 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.7 mt -104.14 105.62 49.77 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.696 -0.683 . . . . 1.0 109.465 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 87' ' ' ILE . 92.8 Cg_exo -48.11 -162.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.4 2.067 . . . . 1.0 112.485 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -107.21 -58.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.543 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.55 -42.04 86.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.835 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.84 -48.63 68.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.98 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -59.38 -37.94 79.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.445 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -64.51 -33.31 75.6 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.9 -0.32 . . . . 1.0 110.807 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.49 -38.12 89.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.256 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.601 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 21.0 m-85 -61.45 -48.5 80.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.041 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -51.5 -34.57 36.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.835 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.4 mt -99.07 -38.01 9.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 114.4 1.259 . . . . 1.0 114.4 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.596 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.25 -13.25 11.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 115.105 1.52 . . . . 1.0 115.105 -174.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 21.6 mm-40 34.65 74.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.249 -0.98 . . . . 1.0 108.788 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p 177.17 117.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.122 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -176.0 145.36 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.922 0.391 . . . . 1.0 110.791 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.0 m -151.22 158.05 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.515 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.7 136.06 44.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 3.4 m -93.03 166.12 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 113.321 0.86 . . . . 1.0 113.321 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 173' ' ' PRO . 57.8 m-20 -46.31 118.42 1.93 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.918 -1.037 . . . . 1.0 112.166 -176.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.05 -22.73 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.789 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -62.56 -44.02 97.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.71 -10.97 31.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.56 0.695 . . . . 1.0 109.351 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 44.12 72.06 0.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.743 -1.117 . . . . 1.0 113.294 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.478 ' OG ' ' CG2' ' A' ' 104' ' ' VAL . 2.0 m -73.74 131.81 41.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.951 -1.499 . . . . 1.0 106.951 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -119.93 137.35 54.09 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.029 -0.668 . . . . 1.0 111.936 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.2 t -135.27 158.72 43.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.482 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.45 HG23 HD12 ' A' ' 113' ' ' ILE . 44.9 mm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.15 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo . . . . . 0 N--CA 1.492 1.409 0 CA-C-O 120.747 0.228 . . . . 1.0 111.895 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.77 119.0 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.887 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 112' ' ' SER . 18.7 t70 -44.13 137.38 3.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.754 -0.462 . . . . 1.0 109.754 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -37.82 -46.72 2.01 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.141 2.561 . . . . 1.0 114.034 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.684 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -41.31 -45.28 2.95 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.668 0.247 . . . . 1.0 111.668 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.684 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 17.4 t60 -81.86 -28.19 33.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.235 0.458 . . . . 1.0 112.235 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.2 t -66.97 -54.09 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -63.99 -29.36 70.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -57.68 -45.15 85.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.68 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 146' ' ' MET . 16.8 mt -73.02 -38.81 66.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -51.07 -39.7 56.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -63.78 -24.91 67.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.766 -1.106 . . . . 1.0 109.147 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.549 ' N ' ' O ' ' A' ' 143' ' ' LEU . 80.6 mmm -91.08 2.09 56.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.731 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.14 20.69 79.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.21 141.63 22.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 1.0 111.014 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.63 -21.65 13.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.919 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.6 p -146.35 161.29 40.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.166 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 p -146.54 131.93 18.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.449 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -119.51 125.15 48.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.315 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.32 114.14 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.129 0.49 . . . . 1.0 111.754 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.6 t -120.62 93.69 48.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.751 -1.203 . . . . 1.0 107.751 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -44.94 140.24 7.21 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.142 2.562 . . . . 1.0 114.666 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mp -122.04 50.31 1.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.87 -1.53 . . . . 1.0 106.87 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.446 ' CE ' ' O ' ' A' ' 164' ' ' GLY . 0.1 OUTLIER -146.45 -174.18 4.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.118 0.784 . . . . 1.0 113.118 -176.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.712 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 8.2 m-70 -65.37 154.1 39.32 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.305 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -56.23 -46.04 79.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.342 -0.845 . . . . 1.0 112.035 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -103.6 -44.02 5.21 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.049 0.388 . . . . 1.0 112.049 -177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.492 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 88.3 tt0 -84.75 138.03 32.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.895 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.409 ' HG ' ' SD ' ' A' ' 157' ' ' MET . 3.1 tt -105.72 113.85 27.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.324 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.712 ' HE1' ' CD2' ' A' ' 158' ' ' HIS . 68.7 m95 -94.15 -39.95 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.255 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -156.87 -173.4 25.27 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.179 -0.769 . . . . 1.0 111.179 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 tp -141.27 130.0 22.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.857 0.361 . . . . 1.0 111.526 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 56.5 tp -101.96 133.01 47.43 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.4 p -142.2 134.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.059 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.3 p -107.41 146.54 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.016 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -119.73 131.44 55.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.989 0.423 . . . . 1.0 111.634 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.89 113.76 13.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.971 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.83 -17.07 64.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.815 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -83.57 146.79 50.91 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.031 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.446 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 71.2 Cg_endo -72.38 5.99 2.49 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.898 2.399 . . . . 1.0 111.863 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -51.42 131.49 34.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.39 167.12 26.3 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.557 2.172 . . . . 1.0 111.883 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 50.4 p90 -88.95 132.8 34.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.466 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.1 t -117.25 147.22 42.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.565 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -50.96 -34.66 29.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.63 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -55.3 -41.1 71.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.709 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.47 -41.3 98.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.491 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.1 tp -63.82 -38.96 93.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.534 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -54.83 -35.03 63.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.308 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.7 t -70.61 -52.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.805 0.668 . . . . 1.0 112.805 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 t -77.31 -30.97 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -52.67 -49.87 64.38 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.026 -0.27 . . . . 1.0 111.646 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.537 ' N ' ' CD1' ' A' ' 186' ' ' LEU . 7.5 mp -70.71 -37.27 73.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 8.0 tp -77.57 -37.83 49.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.828 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.27 95.81 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.552 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -61.11 -39.29 89.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 1.0 109.958 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -71.99 -29.05 63.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.115 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 194' ' ' ALA . 26.3 t -82.38 -48.78 17.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.712 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 84.2 p -50.66 -27.57 7.23 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 193' ' ' ILE . 47.5 mt -77.51 -32.54 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.2 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -69.47 -47.69 63.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.617 -0.719 . . . . 1.0 109.803 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.1 pp -67.47 -35.53 73.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.134 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.447 ' CB ' ' HE2' ' A' ' 158' ' ' HIS . . . -70.68 -49.7 44.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.15 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.19 -32.36 66.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.496 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.433 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -64.09 -34.25 77.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.701 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -56.26 -29.85 61.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.575 -0.284 . . . . 1.0 111.445 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 9.9 mp -60.13 -33.28 71.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.702 0.287 . . . . 1.0 111.033 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.7 ' HG ' ' H ' ' A' ' 202' ' ' LEU . 63.3 p -52.95 -54.62 32.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.566 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.7 ' H ' ' HG ' ' A' ' 201' ' ' SER . 10.2 mp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.488 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.342 . . . . 1.0 110.542 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -48.43 -32.78 8.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.987 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -78.72 -45.56 20.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.065 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.8 mm -64.5 -39.93 87.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.878 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.7 mt -59.83 -45.94 90.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.006 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -57.31 -37.25 72.18 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.45 -28.48 65.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.079 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 m -74.05 -47.24 38.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.526 -0.761 . . . . 1.0 112.244 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.27 -34.52 71.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.949 0.351 . . . . 1.0 111.949 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.48 -49.55 70.95 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.9 -47.24 81.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.766 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.9 t -53.51 -46.49 59.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.989 -0.284 . . . . 1.0 111.165 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 47' ' ' GLY . 15.5 ttt-85 -49.87 -38.48 35.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.771 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.52 75.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -76.8 -44.12 33.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.552 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mt -86.2 -27.58 24.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.502 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.68 22.02 24.01 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.449 -1.061 . . . . 1.0 110.449 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.5 p -74.44 144.18 44.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.884 0.373 . . . . 1.0 110.194 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -42.35 -39.83 2.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.659 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 42.9 ttm180 -162.73 129.08 3.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.038 -0.665 . . . . 1.0 112.574 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.81 130.95 53.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.519 ' HZ3' ' CG1' ' A' ' 167' ' ' VAL . 17.4 pttp -141.57 158.64 43.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.073 0.464 . . . . 1.0 111.969 -177.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.7 t -100.48 136.85 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -119.08 104.78 10.78 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.392 -0.523 . . . . 1.0 111.272 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.622 HH22 ' CG2' ' A' ' 195' ' ' ILE . 42.5 mmt-85 -77.3 128.0 33.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.264 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.498 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 78.9 t80 -93.32 139.21 30.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 1.0 112.024 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.498 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 1.6 m-20 -109.03 151.24 41.82 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.658 -0.867 . . . . 1.0 108.658 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.44 -23.93 72.61 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.516 2.144 . . . . 1.0 112.483 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -87.08 -13.26 44.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.64 -11.56 57.91 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.569 -0.613 . . . . 1.0 111.569 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -80.69 90.54 5.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.793 0.33 . . . . 1.0 110.642 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.7 151.43 20.88 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.617 -0.993 . . . . 1.0 110.617 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -124.77 149.01 47.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 1.0 111.679 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.5 t -77.93 109.16 12.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.06 -0.3 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.327 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.39 115.97 2.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.038 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 86.0 tt0 -144.5 132.73 21.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.839 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.3 142.31 50.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.415 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -140.04 144.79 37.06 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.721 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' CA ' HH21 ' A' ' 43' ' ' ARG . . . -60.55 -35.31 88.86 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -172.7 -164.33 27.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.59 25.69 0.33 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.76 0.314 . . . . 1.0 110.536 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 71' ' ' GLY . 74.1 ttt-85 -72.19 -48.0 46.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.117 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.423 ' C ' HH22 ' A' ' 50' ' ' ARG . 15.1 mt -106.65 148.35 36.67 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.879 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.526 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 58.1 Cg_endo -69.59 137.99 37.27 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.49 2.127 . . . . 1.0 112.166 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.1 t -72.44 123.46 23.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.936 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.9 mt -99.02 11.32 39.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.397 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.7 tp -71.43 128.89 37.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.241 0.543 . . . . 1.0 112.261 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.79 -9.44 76.33 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.455 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 mt -85.7 152.06 23.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.307 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.1 p -104.51 132.89 50.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.731 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -87.23 128.15 56.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.557 -0.534 . . . . 1.0 109.557 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -41.28 133.08 3.24 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.675 2.25 . . . . 1.0 111.862 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.36 132.48 49.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.657 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.77 0.58 42.53 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.53 -1.028 . . . . 1.0 110.53 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -54.52 -33.85 60.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.9 mt -90.61 111.71 49.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.361 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' A' ' 87' ' ' ILE . 87.2 Cg_exo -51.89 -157.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.411 2.074 . . . . 1.0 112.467 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 74.8 mm-40 -109.43 -54.59 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.536 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.83 -43.86 97.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.822 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.27 76.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.436 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 51.2 ttt85 -56.06 -35.38 66.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.393 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 75.4 mtt85 -64.22 -34.01 77.12 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.812 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.19 -37.42 87.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.332 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 101' ' ' ARG . 32.2 m-85 -59.88 -30.78 69.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.096 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -79.93 -26.26 40.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.829 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.548 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 82.3 mt -100.65 -44.66 5.76 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.44 1.274 . . . . 1.0 114.44 -175.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.53 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -118.23 -12.45 9.97 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 115.078 1.511 . . . . 1.0 115.078 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.572 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 38.8 79.72 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.166 -1.014 . . . . 1.0 108.827 -178.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.496 ' CG1' ' O ' ' A' ' 100' ' ' VAL . 11.1 p -177.11 102.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.066 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 11.1 mmt180 -148.07 151.18 35.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.923 0.392 . . . . 1.0 110.746 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -169.54 147.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.476 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -109.41 134.8 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 m -92.16 164.65 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.331 0.863 . . . . 1.0 113.331 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 18.0 p30 -43.98 117.7 1.27 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.98 -1.009 . . . . 1.0 112.156 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.74 -19.55 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.734 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.28 -43.04 92.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.03 -13.28 62.07 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.56 0.695 . . . . 1.0 109.453 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.542 ' CD ' HH21 ' A' ' 111' ' ' ARG . 55.4 tt0 45.74 72.59 0.21 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.684 -1.143 . . . . 1.0 113.334 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.0 t -73.86 131.66 41.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.542 HH21 ' CD ' ' A' ' 109' ' ' GLN . 93.9 mtt180 -118.99 139.14 52.19 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.943 -0.703 . . . . 1.0 111.886 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.412 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -130.97 152.11 50.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.513 179.199 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.5 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.146 179.665 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 120.642 0.184 . . . . 1.0 111.956 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.88 116.51 42.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.797 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' A' ' 112' ' ' SER . 10.7 t70 -43.1 136.95 2.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 140' ' ' VAL . 62.3 Cg_exo -42.42 -49.5 6.22 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 123.213 2.609 . . . . 1.0 114.019 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.689 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -36.88 -45.33 0.55 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.645 0.239 . . . . 1.0 111.645 -178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.689 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.5 t60 -81.55 -27.73 34.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.254 0.464 . . . . 1.0 112.254 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 137' ' ' PRO . 40.2 t -65.39 -52.97 45.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.967 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -64.77 -27.62 69.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.528 ' O ' ' OG ' ' A' ' 145' ' ' SER . 76.4 t80 -61.21 -46.45 90.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.678 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 146' ' ' MET . 54.0 mt -73.11 -37.62 66.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -38.69 58.74 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.561 -1.274 . . . . 1.0 107.561 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.528 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 5.7 p -62.82 -20.4 65.01 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.782 -1.099 . . . . 1.0 109.201 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 143' ' ' LEU . 95.4 mmm -95.49 1.21 53.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.774 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.92 24.5 71.79 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.25 140.8 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 1.0 111.014 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.63 -38.12 6.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.934 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.3 m -133.59 125.77 29.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 1.0 111.109 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.8 m -115.42 138.29 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.45 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.5 mt -116.55 139.5 50.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.313 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.44 114.81 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.482 . . . . 1.0 111.818 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.43 91.28 49.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -48.31 144.57 12.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 123.144 2.563 . . . . 1.0 114.705 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.9 mp -121.54 66.87 0.89 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -149.58 -172.92 4.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.129 0.788 . . . . 1.0 113.129 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 54.8 t-80 -77.6 173.89 11.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.413 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 92.9 m-70 -61.73 -52.46 64.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.387 -0.824 . . . . 1.0 112.058 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -104.53 -40.52 6.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.054 0.391 . . . . 1.0 112.054 -177.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE1' ' CD2' ' A' ' 163' ' ' TRP . 7.7 tm-20 -87.81 136.6 32.89 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.691 -0.403 . . . . 1.0 110.93 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER -111.55 116.3 30.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.272 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.533 ' CD2' ' OE1' ' A' ' 161' ' ' GLU . 25.1 m95 -88.67 -33.91 17.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.277 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.82 -173.79 36.19 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.233 -0.747 . . . . 1.0 111.233 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.3 135.41 30.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 1.0 111.495 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.14 136.2 43.38 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.519 ' CG1' ' HZ3' ' A' ' 52' ' ' LYS . 9.5 p -140.36 135.01 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.121 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.5 m -108.93 139.86 43.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.029 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -116.33 133.68 55.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.948 0.404 . . . . 1.0 111.653 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.71 123.16 30.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.94 178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.43 41.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.794 -177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -165.07 148.52 7.3 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.041 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.475 ' O ' ' C ' ' A' ' 174' ' ' ARG . 77.8 Cg_exo -41.42 -75.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.884 2.389 . . . . 1.0 111.897 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.475 ' C ' ' O ' ' A' ' 173' ' ' PRO . 54.3 ttt85 33.65 84.59 0.18 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.875 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.0 162.93 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.541 2.161 . . . . 1.0 111.894 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 51.6 p90 -82.69 125.93 31.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.464 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.0 t -113.6 148.59 35.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.565 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -52.9 -27.01 16.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.631 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -58.14 -43.25 87.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.685 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -64.13 -35.85 82.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.479 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 18.8 tp -60.68 -41.78 95.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.536 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -58.35 -34.94 71.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.342 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 64.0 t -67.84 -53.33 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 188' ' ' ALA . 33.6 m -70.35 -43.71 78.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.395 0.517 . . . . 1.0 112.395 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -43.51 -42.12 4.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.954 -0.299 . . . . 1.0 111.644 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.9 mt -74.97 -44.9 45.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.459 ' O ' ' CG2' ' A' ' 191' ' ' VAL . 57.3 mt -80.55 -39.79 27.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.827 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -58.98 -47.64 84.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.492 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -65.84 -39.64 90.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.002 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -67.69 -29.43 68.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 187' ' ' LEU . 58.6 t -84.08 -45.03 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.714 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.403 ' HG ' ' N ' ' A' ' 193' ' ' ILE . 57.9 p -55.37 -31.38 61.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.403 ' N ' ' HG ' ' A' ' 192' ' ' SER . 52.6 mt -76.73 -34.31 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.234 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.11 -42.4 84.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.82 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.622 ' CG2' HH22 ' A' ' 55' ' ' ARG . 37.4 pt -68.15 -33.72 62.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.163 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.423 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -70.13 -50.71 37.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.14 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -71.67 -36.51 70.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.479 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.66 -35.04 79.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -56.93 -29.58 63.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.472 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 9.2 mp -61.91 -34.15 75.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.682 0.277 . . . . 1.0 111.069 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 35.0 m -49.92 -54.08 22.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.563 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.579 179.695 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.888 0.375 . . . . 1.0 110.604 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -55.71 -50.93 69.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.978 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.571 HE22 ' NH2' ' A' ' 36' ' ' ARG . 84.7 mm-40 -57.03 -45.54 83.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.077 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.22 -47.15 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 1.0 110.939 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -58.68 -48.41 81.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.048 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.571 ' NH2' HE22 ' A' ' 33' ' ' GLN . 66.3 mtm180 -56.42 -36.32 68.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.442 . . . . 1.0 109.83 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.88 65.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.061 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.2 m -73.29 -47.82 39.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.556 -0.747 . . . . 1.0 112.149 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -65.6 -35.07 74.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.38 -50.93 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 1.0 111.105 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -61.03 -43.36 99.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.784 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.8 t -57.36 -42.57 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.714 0.293 . . . . 1.0 111.166 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 47' ' ' GLY . 62.7 ttp85 -51.29 -40.18 58.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.763 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.41 78.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.041 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -78.38 -45.97 21.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 1.0 111.56 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.87 -31.8 22.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.53 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.93 20.71 27.71 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.6 p -70.92 142.0 51.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 1.0 110.167 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -40.98 -41.28 1.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.633 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.536 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -163.34 128.7 3.08 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.079 -0.648 . . . . 1.0 112.606 -178.582 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.9 130.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -139.98 157.2 46.05 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.441 -0.504 . . . . 1.0 111.903 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.23 136.95 29.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.525 -0.917 . . . . 1.0 108.525 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.473 ' OH ' ' O ' ' A' ' 61' ' ' HIS . 50.1 t80 -130.28 128.96 42.64 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.322 -0.551 . . . . 1.0 111.227 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -94.94 132.43 39.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.18 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -91.33 118.63 30.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -87.79 151.4 49.88 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 108.639 -0.875 . . . . 1.0 108.639 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.76 -20.85 60.84 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.48 2.12 . . . . 1.0 112.444 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -82.77 -17.51 43.92 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.06 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.73 -15.41 37.78 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.549 -0.621 . . . . 1.0 111.549 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.473 ' O ' ' OH ' ' A' ' 54' ' ' TYR . 40.5 m80 -64.14 -104.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.773 0.32 . . . . 1.0 110.632 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.453 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . 103.89 152.97 23.09 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -128.09 147.51 50.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 1.0 111.696 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.66 117.06 27.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.93 4.87 9.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.696 0.284 . . . . 1.0 111.37 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.99 118.58 2.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.104 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 85.8 tt0 -144.37 133.21 22.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 1.0 111.846 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.2 151.5 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.393 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -139.74 142.26 36.82 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.762 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -39.96 -68.96 0.5 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.96 83.84 0.13 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 41.7 38.65 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.746 0.308 . . . . 1.0 110.522 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -82.62 -53.53 5.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.215 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.2 mt -110.27 141.42 23.85 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.888 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.14 165.67 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.479 2.12 . . . . 1.0 112.176 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.8 t -93.38 123.41 36.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.871 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.9 mt -90.59 2.59 55.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.376 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.16 131.12 49.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.179 0.514 . . . . 1.0 112.28 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.67 -13.55 63.89 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.545 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.1 150.93 27.24 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.309 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.5 m -106.14 134.4 49.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.703 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.92 153.04 49.29 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.92 136.16 51.52 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.692 2.262 . . . . 1.0 111.879 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.21 130.56 43.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.708 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.4 -2.43 39.93 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.497 -1.041 . . . . 1.0 110.497 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 20.8 p-10 -54.61 -38.19 66.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 87' ' ' ILE . 14.4 mm -75.08 133.49 75.39 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.42 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.28 -175.21 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.426 2.084 . . . . 1.0 112.526 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -105.46 -51.25 3.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.556 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.43 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 21.5 pt-20 -67.5 -41.97 83.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.843 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.514 ' O ' ' NH1' ' A' ' 101' ' ' ARG . . . -68.16 -42.47 80.01 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.876 0.324 . . . . 1.0 111.876 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -63.83 -41.82 97.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.471 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -60.23 -32.96 71.62 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.879 -0.329 . . . . 1.0 110.847 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.4 mt -71.46 -35.91 71.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.289 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.53 -40.85 96.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.02 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -63.66 -33.57 75.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.81 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.55 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 72.0 mt -97.18 -37.11 10.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 114.389 1.255 . . . . 1.0 114.389 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.563 ' C ' ' NE2' ' A' ' 99' ' ' GLN . . . -118.01 -10.1 10.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.11 1.522 . . . . 1.0 115.11 -175.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.648 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 41.58 79.48 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.114 -1.034 . . . . 1.0 108.864 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.443 ' CG1' ' O ' ' A' ' 100' ' ' VAL . 7.8 p 179.78 107.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.096 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.514 ' NH1' ' O ' ' A' ' 91' ' ' ALA . 8.9 ttm105 -153.27 148.76 27.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.954 0.407 . . . . 1.0 110.803 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 p -167.62 150.26 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.502 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.3 mt -106.91 136.43 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.4 t -88.78 158.64 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 64.5 m-20 -48.37 122.77 5.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.913 -1.039 . . . . 1.0 112.121 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.19 -26.71 26.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.786 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.9 -46.75 83.45 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.79 -12.67 50.29 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.49 0.662 . . . . 1.0 109.359 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 45.86 72.2 0.24 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.767 -1.106 . . . . 1.0 113.275 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 p -73.74 130.53 40.17 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.915 -1.513 . . . . 1.0 106.915 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -118.57 133.99 55.44 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.946 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 t -125.96 145.32 50.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.55 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.201 179.777 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 120.723 0.218 . . . . 1.0 111.904 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.24 117.9 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.824 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 138' ' ' CYS . 19.4 t70 -43.72 137.8 3.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -39.45 -20.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 123.153 2.569 . . . . 1.0 114.005 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.701 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.1 p -64.91 -46.06 83.28 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.662 0.245 . . . . 1.0 111.662 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.701 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.8 t60 -82.75 -24.53 33.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.85 -52.03 54.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.651 -0.42 . . . . 1.0 110.947 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.9 -29.71 69.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.778 -0.452 . . . . 1.0 109.778 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -58.49 -46.66 86.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.74 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 146' ' ' MET . 11.6 mt -72.73 -38.13 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -51.29 -38.71 54.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -65.04 -25.33 67.78 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.153 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.1 mmm -90.77 0.36 57.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.668 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.87 79.1 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.06 142.19 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.889 0.376 . . . . 1.0 110.969 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.53 -29.31 9.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.912 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.441 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 37.8 m -138.5 155.3 48.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.198 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 p -145.49 126.77 14.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.446 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tp -110.3 134.91 51.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.284 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.81 120.92 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.182 0.515 . . . . 1.0 111.725 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.2 m -114.81 167.37 9.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -83.27 122.36 3.24 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.187 2.591 . . . . 1.0 114.667 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.3 tp -124.24 35.56 4.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -146.34 177.7 8.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.158 0.799 . . . . 1.0 113.158 -176.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.71 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 40.8 t60 -68.73 -171.51 0.29 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.344 -0.843 . . . . 1.0 111.365 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.71 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 56.1 t-80 -73.68 -54.27 8.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.403 -0.817 . . . . 1.0 112.097 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -104.95 -32.01 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.046 0.387 . . . . 1.0 112.046 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 85.1 tt0 -94.05 141.41 28.57 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.88 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.2 tt -108.15 116.02 31.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.263 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.515 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 77.8 m95 -89.86 -37.64 14.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.266 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.04 -174.69 35.01 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.56 132.61 31.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.807 0.337 . . . . 1.0 111.563 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.5 tp -101.61 133.79 45.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.13 133.25 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.796 -0.361 . . . . 1.0 111.147 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 78.6 p -109.76 139.89 44.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.025 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -113.66 133.34 55.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.026 0.441 . . . . 1.0 111.651 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -130.93 130.85 43.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.597 . . . . 1.0 109.973 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.32 59.02 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.785 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 174' ' ' ARG . 34.9 tp10 -160.14 128.7 2.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.993 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.426 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 90.0 Cg_endo -77.21 22.36 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.922 2.414 . . . . 1.0 111.883 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' A' ' 172' ' ' GLU . 47.9 ttp180 -72.57 126.24 90.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.883 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -46.7 153.01 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.609 2.206 . . . . 1.0 111.882 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -86.24 141.86 28.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.481 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.7 m -118.07 150.24 39.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.598 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -57.74 -29.4 64.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.623 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -56.24 -38.47 71.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.756 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.25 -40.03 94.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.548 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.03 -37.94 89.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.509 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -53.62 -39.36 64.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.917 -0.583 . . . . 1.0 111.382 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.25 -54.33 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.9 -36.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -47.53 -49.22 26.77 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.656 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 33.5 mt -75.19 -38.35 60.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.97 -41.32 51.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.801 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.39 86.96 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.504 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.29 -37.76 70.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.976 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -68.85 -24.73 64.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.118 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.8 t -83.99 -45.35 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.793 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 85.5 p -56.86 -35.25 68.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.0 mt -66.96 -33.95 66.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.426 -0.806 . . . . 1.0 109.185 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.42 -38.35 74.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.778 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.426 HG23 HD13 ' A' ' 195' ' ' ILE . 38.2 mm -59.28 -49.35 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.112 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.454 ' O ' ' CD1' ' A' ' 200' ' ' LEU . . . -71.59 -48.61 47.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.836 -0.62 . . . . 1.0 111.122 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -63.96 -42.9 97.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.496 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.89 -31.11 71.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.673 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -58.29 -31.97 67.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.592 -0.277 . . . . 1.0 111.417 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 196' ' ' ALA . 8.7 mp -60.63 -34.58 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.045 -0.262 . . . . 1.0 111.054 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 31.7 t -55.31 -56.72 16.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.538 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.587 179.829 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.911 0.386 . . . . 1.0 110.574 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.45 -51.07 69.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.964 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -56.64 -47.49 79.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.066 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 34' ' ' ILE . 80.5 mt -62.51 -47.85 91.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.787 0.327 . . . . 1.0 110.974 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.526 ' O ' ' OG1' ' A' ' 38' ' ' THR . 33.9 mt -55.91 -42.42 76.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 1.0 111.056 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.24 -35.29 62.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -34.6 70.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.065 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 64.5 p -73.1 -41.22 64.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.498 -0.774 . . . . 1.0 112.271 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.44 -37.66 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.23 -46.65 79.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.151 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -59.89 -47.92 83.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.78 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.0 t -53.58 -38.43 33.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.986 -0.285 . . . . 1.0 111.115 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.541 ' NH1' ' O ' ' A' ' 69' ' ' ARG . 54.1 ttp180 -53.62 -44.11 69.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.339 . . . . 1.0 110.85 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.38 -34.2 70.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.117 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -74.14 -43.92 55.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.549 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.57 -30.12 19.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.421 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.5 20.88 1.12 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.5 p -63.64 -96.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.81 0.338 . . . . 1.0 110.236 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -155.6 -47.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 1.0 111.658 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -154.76 124.23 6.47 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.954 -0.699 . . . . 1.0 112.515 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.8 t -128.35 129.39 69.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -141.08 149.74 42.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.888 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.8 t -111.84 138.16 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.495 ' CD1' ' C ' ' A' ' 54' ' ' TYR . 2.4 p90 -136.15 139.09 42.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.314 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -93.31 141.38 28.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.294 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.64 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 64.0 t80 -92.69 117.54 30.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 1.0 112.123 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 17.3 p-10 -88.17 150.72 47.83 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.41 -20.11 67.05 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.516 2.144 . . . . 1.0 112.476 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -87.02 -19.82 28.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 1.0 110.096 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.64 -16.07 37.53 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.589 -0.604 . . . . 1.0 111.589 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.547 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 93.7 m-70 -74.25 91.81 2.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 1.0 110.561 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.55 144.36 20.51 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.3 p -122.01 143.47 49.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 1.0 111.666 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.1 t -79.18 110.87 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.27 2.17 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.387 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.94 123.98 4.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.112 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -146.09 132.59 19.73 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.519 -0.472 . . . . 1.0 111.797 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.77 141.53 51.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.381 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.541 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 30.0 ptt180 -143.06 144.21 32.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.724 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.14 -34.81 47.87 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -173.27 -168.64 34.72 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.437 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 77.2 mm-40 -72.35 44.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 1.0 110.49 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 71' ' ' GLY . 56.9 ttm-85 -83.47 -48.85 9.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.141 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.36 149.77 41.54 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.906 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.13 165.19 33.21 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.577 2.185 . . . . 1.0 112.094 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.9 p -88.19 129.4 35.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.952 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.6 mt -98.47 2.57 47.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.364 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tp -62.01 131.35 49.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 1.0 112.337 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.17 -14.03 61.86 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.549 -0.75 . . . . 1.0 111.505 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.3 mt -82.12 151.06 27.15 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.963 -0.295 . . . . 1.0 110.29 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.4 p -104.83 130.55 52.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.657 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -85.61 153.76 58.58 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.28 135.68 59.53 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.704 2.269 . . . . 1.0 111.897 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.23 126.75 29.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.722 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.3 -0.58 43.64 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.49 -37.13 64.92 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.675 ' H ' ' CD1' ' A' ' 87' ' ' ILE . 0.6 OUTLIER -81.55 113.52 42.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.413 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 87' ' ' ILE . 80.4 Cg_exo -49.47 -171.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.468 2.112 . . . . 1.0 112.474 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 79.3 mm-40 -108.43 -55.85 2.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.553 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -59.88 -42.53 93.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.789 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.99 -51.05 59.91 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.922 0.342 . . . . 1.0 111.922 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.737 ' HE ' HH21 ' A' ' 96' ' ' ARG . 59.3 ttt85 -50.17 -35.44 26.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.504 -0.316 . . . . 1.0 111.427 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 78.5 mtt85 -67.78 -35.16 78.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.798 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.7 mt -58.37 -39.03 78.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.273 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.615 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 92.5 m-85 -61.57 -50.44 72.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.052 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.737 HH21 ' HE ' ' A' ' 92' ' ' ARG . 95.6 mtt180 -54.56 -32.68 58.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.811 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.2 mt -101.39 -44.04 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.428 1.27 . . . . 1.0 114.428 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.12 -15.3 11.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 115.057 1.502 . . . . 1.0 115.057 -173.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 19.9 mm-40 44.16 79.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.205 -0.998 . . . . 1.0 108.849 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -179.36 107.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.074 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -156.15 150.94 26.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 1.0 110.777 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -170.43 148.51 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.498 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.2 mt -109.37 135.13 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.39 165.16 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 113.243 0.831 . . . . 1.0 113.243 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -46.51 119.38 2.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.91 -1.041 . . . . 1.0 112.13 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.75 -22.36 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.737 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.01 -44.68 91.88 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.18 -10.17 29.14 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.494 0.664 . . . . 1.0 109.36 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 45.21 71.42 0.27 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.734 -1.121 . . . . 1.0 113.308 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -73.82 132.7 42.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.979 -1.489 . . . . 1.0 106.979 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -121.5 137.99 54.49 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.882 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.89 155.85 48.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.528 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.0 pt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.149 179.395 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.493 1.446 0 CA-C-O 120.671 0.196 . . . . 1.0 111.991 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.97 129.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.915 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -43.96 134.56 4.0 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -40.35 -46.53 4.32 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.124 2.549 . . . . 1.0 114.007 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 3.8 p -39.33 -45.4 1.43 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.686 0.254 . . . . 1.0 111.686 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.668 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.2 t60 -81.36 -29.34 34.09 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.276 0.473 . . . . 1.0 112.276 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.6 t -65.67 -52.53 49.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.961 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -66.75 -27.67 67.79 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.513 ' O ' ' OG ' ' A' ' 145' ' ' SER . 81.2 t80 -60.21 -45.51 92.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.775 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 146' ' ' MET . 65.1 mt -73.44 -35.82 65.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -52.18 -39.13 59.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.593 -1.262 . . . . 1.0 107.593 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 8.7 p -65.24 -20.63 66.51 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.779 -1.1 . . . . 1.0 109.158 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 143' ' ' LEU . 89.4 mmm -93.83 1.45 56.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.462 -0.79 . . . . 1.0 110.735 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.5 22.21 78.64 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.66 142.35 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 1.0 110.986 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.89 -42.99 4.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.485 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 7.2 t -129.84 125.8 36.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 1.0 111.17 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 m -112.96 135.49 53.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.458 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tp -115.13 136.85 52.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.291 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.24 113.96 39.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.15 0.5 . . . . 1.0 111.753 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.16 110.52 30.91 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.66 149.21 54.56 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.144 2.562 . . . . 1.0 114.671 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 29.6 mt -125.34 68.44 1.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.796 -1.557 . . . . 1.0 106.796 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.4 ptm -148.04 -173.84 4.41 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.619 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 30.7 t-80 -78.26 178.57 7.52 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.321 -0.854 . . . . 1.0 111.373 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 13.0 m-70 -74.13 -55.39 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.309 -0.859 . . . . 1.0 112.122 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -105.0 11.92 32.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -144.29 137.61 27.35 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.922 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.454 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 7.9 tt -112.38 117.42 32.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.258 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -92.19 -34.19 14.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.289 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.77 -167.58 25.55 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.4 mt -152.42 144.69 23.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 1.0 111.592 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.7 tp -114.51 139.18 49.77 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.4 p -140.4 140.6 34.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.999 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 69.5 m -113.53 143.11 45.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.968 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -113.54 131.8 55.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 1.0 111.572 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.666 ' N ' ' ND1' ' A' ' 170' ' ' HIS . 0.0 OUTLIER -124.67 121.19 34.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.844 -0.616 . . . . 1.0 109.961 178.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.0 -16.03 60.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.79 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -107.88 139.0 20.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.012 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 174' ' ' ARG . 72.7 Cg_exo -39.54 -73.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.885 2.39 . . . . 1.0 111.883 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 173' ' ' PRO . 17.0 ttp85 35.41 88.83 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.903 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.87 162.86 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.521 2.148 . . . . 1.0 111.986 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.454 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 50.8 p90 -90.88 131.33 36.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.43 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.1 t -121.21 157.39 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.599 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -53.01 -32.17 45.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.14 -39.38 86.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.731 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.1 -45.29 89.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.429 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.76 -36.29 83.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.581 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -55.41 -39.39 70.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.392 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.4 t -67.85 -55.54 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.82 -46.54 68.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.452 0.538 . . . . 1.0 112.452 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -41.48 -46.31 3.44 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.663 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 15.5 tp -71.6 -42.79 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 46.4 tp -77.2 -40.44 45.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.86 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.19 -37.9 72.86 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.473 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -61.56 -39.75 92.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.33 -0.395 . . . . 1.0 109.982 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -64.98 -28.62 69.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.104 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 20.6 t -84.04 -41.22 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.791 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m -56.7 -36.7 69.95 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 mt -65.46 -38.7 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.445 -0.798 . . . . 1.0 109.221 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.52 83.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.838 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.3 -47.34 92.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.171 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.82 -46.85 62.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.147 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -65.92 -42.54 90.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.508 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.73 -31.83 72.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.679 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.79 -40.14 95.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.521 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 20.5 tp -62.85 -36.58 83.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.67 0.272 . . . . 1.0 111.011 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 38.8 t -50.74 -51.48 49.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.594 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.532 179.654 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.8 tp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.9 0.381 . . . . 1.0 110.551 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 25.0 p-10 -76.83 -28.66 55.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.043 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -77.81 -47.09 19.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.086 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 pt -63.41 -38.58 82.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 1.0 110.964 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -60.84 -49.38 77.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.054 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -53.93 -39.5 65.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.71 -28.92 67.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.073 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.6 m -71.47 -47.46 55.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.445 -0.798 . . . . 1.0 112.196 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.09 -33.27 59.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 111.907 0.336 . . . . 1.0 111.907 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -69.1 -51.36 39.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.829 0.347 . . . . 1.0 111.14 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -61.73 -45.65 93.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.745 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.56 -35.73 68.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.696 0.284 . . . . 1.0 111.169 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.618 ' NH2' ' CA ' ' A' ' 70' ' ' GLY . 15.7 tpt85 -56.51 -42.19 77.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.803 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.97 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.112 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -79.08 -43.2 24.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.624 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.3 mt -86.43 -32.28 20.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.461 -0.336 . . . . 1.0 111.455 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.54 19.28 18.54 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.564 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 67.3 m -69.97 141.21 53.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.859 0.361 . . . . 1.0 110.209 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' THR . 92.3 m-20 -37.16 -45.9 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.578 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.618 ' NH2' ' CE1' ' A' ' 169' ' ' HIS . 19.2 ttp-105 -163.66 126.7 2.62 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.985 -0.686 . . . . 1.0 112.567 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.6 p -133.91 127.83 52.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 176.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -140.09 155.65 46.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.14 0.495 . . . . 1.0 111.878 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.96 133.65 40.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -115.01 112.27 22.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.262 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -84.45 127.18 33.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.219 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.442 ' CE2' ' CZ ' ' A' ' 92' ' ' ARG . 71.9 t80 -95.26 134.16 38.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 1.0 112.039 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 60' ' ' GLY . 0.9 OUTLIER -103.86 140.32 20.95 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.34 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.36 -27.83 7.55 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 C-N-CA 122.495 2.13 . . . . 1.0 112.441 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -83.39 -16.22 46.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 1.0 110.089 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 105.56 -13.55 46.9 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.572 -0.611 . . . . 1.0 111.572 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -78.23 90.86 4.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.771 0.319 . . . . 1.0 110.616 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.97 150.8 20.44 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.527 -1.029 . . . . 1.0 110.527 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.4 p -124.85 147.79 48.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.372 . . . . 1.0 111.741 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.82 107.93 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 37.2 t -106.51 -1.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.282 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.64 113.82 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.068 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.4 tt0 -143.74 135.78 26.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.087 0.47 . . . . 1.0 111.758 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.25 131.97 47.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.415 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -124.65 147.21 48.68 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.711 -0.396 . . . . 1.0 110.725 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.618 ' CA ' ' NH2' ' A' ' 43' ' ' ARG . . . -72.25 -134.79 0.18 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.794 -0.922 . . . . 1.0 110.794 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.26 59.12 1.12 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.006 -0.838 . . . . 1.0 111.006 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 41.83 46.73 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.667 0.27 . . . . 1.0 110.486 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 73' ' ' ARG . 2.0 tpm_? -82.73 -48.72 10.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.401 HD12 HH11 ' A' ' 50' ' ' ARG . 42.0 mt -107.38 131.44 21.71 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.862 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.48 145.65 11.73 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.575 2.183 . . . . 1.0 112.111 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 p -72.79 123.34 23.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.978 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 16.8 mt -98.62 13.6 31.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.309 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 23.9 tp -73.14 129.17 37.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.269 0.557 . . . . 1.0 112.209 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.56 -9.94 71.61 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.602 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.8 mt -85.12 153.07 22.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.808 0.337 . . . . 1.0 110.243 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.6 m -105.91 132.54 51.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -85.17 152.0 57.78 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.52 127.52 13.33 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.714 2.276 . . . . 1.0 111.854 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 142.33 57.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.623 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.35 1.18 37.99 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.571 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 20.2 p-10 -50.84 -52.95 36.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 86' ' ' ASP . 1.9 pp -171.42 50.63 0.14 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.437 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 87' ' ' ILE . 4.1 Cg_endo -94.57 -0.84 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.398 2.065 . . . . 1.0 112.531 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -90.67 -82.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.037 -0.528 . . . . 1.0 111.494 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -78.79 -48.23 15.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.772 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.33 74.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.868 0.321 . . . . 1.0 111.868 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.442 ' CZ ' ' CE2' ' A' ' 56' ' ' PHE . 58.5 ttt85 -71.68 -39.95 69.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.421 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -63.1 -43.32 98.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.824 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.407 ' CD1' HH22 ' A' ' 101' ' ' ARG . 76.1 mt -64.72 -41.73 95.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.297 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.431 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 1.2 t80 -55.04 -44.02 74.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.022 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -56.6 -28.58 60.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.803 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.67 ' C ' HE22 ' A' ' 99' ' ' GLN . 75.1 mt -98.24 -39.63 8.76 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -177.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.594 ' N ' ' NE2' ' A' ' 99' ' ' GLN . . . -119.38 -13.12 9.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.994 1.479 . . . . 1.0 114.994 -174.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.69 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 35.67 81.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.192 -1.003 . . . . 1.0 108.858 -178.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.478 ' CG1' ' O ' ' A' ' 100' ' ' VAL . 11.0 p -174.64 108.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.075 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.407 HH22 ' CD1' ' A' ' 94' ' ' LEU . 56.6 mmt-85 -141.87 146.01 35.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 1.0 110.781 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.5 p -171.83 135.93 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.573 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.8 137.0 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.459 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 32.8 m -91.04 165.04 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 17.8 p30 -48.65 119.35 3.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.895 -1.048 . . . . 1.0 112.106 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -53.77 -21.74 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.785 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -65.85 -45.28 82.77 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.9 -16.02 63.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.557 0.694 . . . . 1.0 109.411 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 46.4 72.71 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.757 -1.111 . . . . 1.0 113.314 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.459 ' OG ' ' CG2' ' A' ' 104' ' ' VAL . 1.1 p -73.51 129.01 37.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.97 -1.493 . . . . 1.0 106.97 174.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -116.61 134.9 54.28 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.96 -0.696 . . . . 1.0 111.937 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.96 163.96 31.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.514 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 pt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.209 178.838 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo . . . . . 0 N--CA 1.491 1.38 0 CA-C-O 120.743 0.226 . . . . 1.0 111.971 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.83 149.31 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.871 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -94.51 156.24 38.75 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -55.39 -29.03 66.36 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.195 2.597 . . . . 1.0 113.974 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.711 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.7 OUTLIER -60.4 -46.25 90.66 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.705 0.261 . . . . 1.0 111.705 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.711 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 4.4 t60 -80.64 -24.16 39.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.271 0.471 . . . . 1.0 112.271 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.33 -54.11 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.944 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -64.9 -28.84 69.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -60.26 -45.85 91.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.776 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 146' ' ' MET . 27.3 mt -73.02 -37.2 67.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -50.98 -39.52 55.63 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.2 m -64.36 -24.47 67.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.746 -1.115 . . . . 1.0 109.204 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.565 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -91.86 -2.92 56.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.437 -0.801 . . . . 1.0 110.684 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.91 20.36 79.74 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.4 t -108.48 143.06 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 1.0 110.933 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.51 -42.74 4.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.948 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.8 m -131.99 124.22 28.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 1.0 111.164 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.2 p -108.73 139.59 43.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.444 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 tp -121.95 125.82 47.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.232 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -119.74 113.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.182 0.515 . . . . 1.0 111.774 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.13 107.09 54.39 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.745 -1.205 . . . . 1.0 107.745 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -40.43 128.18 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.189 2.593 . . . . 1.0 114.681 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 tp -116.49 41.4 2.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.868 -1.53 . . . . 1.0 106.868 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 7.9 ptm -146.92 178.81 8.05 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.665 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 30.4 t-80 -69.04 -176.92 0.94 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.34 -0.846 . . . . 1.0 111.415 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.665 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 96.3 m-70 -68.77 -55.2 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.426 -0.806 . . . . 1.0 112.066 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -104.15 -42.3 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -83.47 129.43 34.98 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.882 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.446 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 6.7 tt -103.68 117.72 35.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.263 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -92.51 -39.78 11.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.244 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.58 -176.28 36.89 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.1 mt -138.24 136.46 36.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.778 0.323 . . . . 1.0 111.55 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.9 tp -105.84 130.95 53.71 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.63 142.14 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.743 -0.383 . . . . 1.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 m -112.59 138.52 49.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.054 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.618 ' CE1' ' NH2' ' A' ' 50' ' ' ARG . 56.1 m80 -106.98 121.6 44.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.977 0.418 . . . . 1.0 111.69 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -122.04 112.51 18.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.991 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.76 -15.09 63.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.884 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -87.51 148.39 44.12 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.3 -2.32 11.5 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.95 2.433 . . . . 1.0 111.88 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -41.59 131.25 2.3 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.878 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.82 167.23 25.67 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.578 2.185 . . . . 1.0 111.977 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 43.7 p90 -79.94 126.7 31.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.505 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.7 t -114.54 147.36 39.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.574 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.504 ' H ' ' CD ' ' A' ' 178' ' ' GLN . 11.1 mp0 -53.75 -32.45 52.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 1.0 110.622 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -62.35 -41.49 98.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.749 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -62.93 -43.79 97.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.465 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.5 mt -65.31 -37.76 88.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.558 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -54.1 -36.15 62.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.397 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.6 -54.47 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.1 -32.37 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -54.19 -50.31 67.34 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.627 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.8 tp -70.14 -38.41 75.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.005 0.372 . . . . 1.0 112.005 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 38.0 tp -77.75 -38.65 46.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.812 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.18 86.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.502 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.86 -40.14 91.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.964 0.411 . . . . 1.0 110.041 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -71.71 -24.44 61.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.146 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.79 -48.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.718 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 82.9 p -55.34 -35.4 65.15 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.4 mt -65.61 -33.83 66.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.215 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.58 -38.49 77.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.776 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.1 mm -60.04 -46.6 94.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.123 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.26 -45.51 69.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.087 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -65.99 -40.71 91.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.495 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.91 70.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.308 -0.405 . . . . 1.0 111.733 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.35 -35.68 78.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.51 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.04 -32.28 71.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -54.37 -53.16 57.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.648 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 10.1 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.559 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.887 0.375 . . . . 1.0 110.563 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -74.98 -50.04 17.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.975 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -57.01 -48.12 79.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.066 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 35' ' ' LEU . 18.8 tt -65.93 -43.31 92.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.759 0.314 . . . . 1.0 110.974 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.415 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 30.7 mt -61.37 -46.72 89.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.033 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -59.5 -37.5 78.46 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.66 -29.62 67.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.128 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.8 m -73.5 -48.0 36.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.476 -0.783 . . . . 1.0 112.259 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.14 -33.41 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.01 0.374 . . . . 1.0 112.01 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -65.72 -49.15 69.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.342 . . . . 1.0 111.112 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.92 -38.61 89.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.748 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.05 -44.8 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.169 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 47' ' ' GLY . 61.7 ttp85 -53.71 -39.42 65.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.778 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.57 -37.84 79.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -79.45 -44.0 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.539 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.12 -33.59 22.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 1.0 111.523 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 60.45 19.52 53.61 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.457 -1.057 . . . . 1.0 110.457 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.648 ' HG1' ' HE2' ' A' ' 170' ' ' HIS . 93.9 m -72.27 142.31 48.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.349 . . . . 1.0 110.244 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -39.35 -45.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.625 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -163.72 130.91 3.36 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.046 -0.661 . . . . 1.0 112.545 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.6 p -138.47 128.63 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -140.35 155.2 46.87 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.897 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.04 136.57 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.449 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 39.7 t80 -126.61 127.31 45.03 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.35 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -92.33 127.58 37.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.196 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 67.2 t80 -89.83 118.49 29.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 1.0 112.03 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 17.5 p-10 -90.04 152.37 46.13 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -59.43 -19.26 50.53 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.524 2.15 . . . . 1.0 112.458 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -82.6 -21.22 35.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.921 0.391 . . . . 1.0 110.04 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.11 -17.24 35.06 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.564 -0.614 . . . . 1.0 111.564 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.444 ' O ' ' OH ' ' A' ' 54' ' ' TYR . 40.9 m80 -63.36 -100.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.603 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . 102.3 154.84 25.54 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 p -126.74 149.57 49.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 1.0 111.726 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.3 t -78.21 111.15 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.796 -0.816 . . . . 1.0 108.796 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.19 -1.04 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.304 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.11 113.23 2.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.025 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 88.4 tt0 -143.12 134.1 25.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.133 0.492 . . . . 1.0 111.816 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.57 139.7 52.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.666 -0.697 . . . . 1.0 109.414 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -135.21 147.72 49.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.861 0.363 . . . . 1.0 110.74 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -51.34 -36.86 38.22 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 168.76 -160.26 33.67 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -65.08 4.31 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.312 . . . . 1.0 110.527 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' A' ' 71' ' ' GLY . 68.0 ttp85 -66.74 -46.8 74.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.165 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.7 mt -118.48 116.84 34.92 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.864 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.28 157.07 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.514 2.143 . . . . 1.0 112.183 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 p -96.61 130.21 43.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.925 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -91.29 13.59 16.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.422 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.9 tp -65.62 130.38 43.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.979 -0.555 . . . . 1.0 112.265 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.46 -10.66 72.55 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.54 -0.754 . . . . 1.0 111.498 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.0 mt -83.82 148.88 26.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.959 -0.296 . . . . 1.0 110.336 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.5 p -105.31 135.58 46.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.655 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -88.56 151.53 48.2 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.42 138.38 65.25 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.643 2.229 . . . . 1.0 111.863 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.38 128.28 35.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.429 . . . . 1.0 110.7 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.6 -1.6 42.46 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -55.44 -37.42 67.69 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 88' ' ' PRO . 8.5 mm -77.8 113.41 32.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.641 -0.709 . . . . 1.0 109.388 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 87' ' ' ILE . 92.7 Cg_exo -46.8 -176.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.429 2.086 . . . . 1.0 112.48 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.53 -49.34 3.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.502 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.81 -39.33 87.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.868 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.01 -51.71 43.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.928 0.344 . . . . 1.0 111.928 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.634 ' NH2' ' CE2' ' A' ' 56' ' ' PHE . 64.0 ttt180 -53.31 -39.62 64.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.465 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -62.8 -33.07 74.44 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.758 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.16 -36.43 74.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.304 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.669 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 11.0 m-85 -59.62 -29.88 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.996 0.427 . . . . 1.0 110.028 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.493 ' C ' HE22 ' A' ' 99' ' ' GLN . 79.6 ttt-85 -83.28 -25.82 31.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.865 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.6 mt -97.42 -45.42 6.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 114.416 1.265 . . . . 1.0 114.416 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.514 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.83 -6.66 12.65 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.702 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 3.0 mm-40 41.24 78.28 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.133 -1.027 . . . . 1.0 108.787 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 3.8 p 171.42 116.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.115 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.5 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -169.89 130.59 1.01 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.388 . . . . 1.0 110.808 177.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.5 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 3.5 m -147.02 157.55 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.439 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.6 mt -108.52 132.97 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.6 p -92.54 159.96 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.299 0.851 . . . . 1.0 113.299 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -45.21 119.65 2.13 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.94 -1.027 . . . . 1.0 112.128 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.32 -19.74 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.335 -0.848 . . . . 1.0 110.799 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.17 -46.32 84.54 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.64 -13.55 54.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.492 0.663 . . . . 1.0 109.356 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 44.5 70.37 0.34 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.745 -1.116 . . . . 1.0 113.212 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.6 t -74.97 131.17 40.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.968 -1.493 . . . . 1.0 106.968 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -118.89 134.47 55.15 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.974 -0.69 . . . . 1.0 111.859 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 0.6 OUTLIER -127.01 148.35 50.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.501 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.126 179.819 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.452 ' O ' ' OG ' ' A' ' 112' ' ' SER . 81.2 Cg_exo . . . . . 0 N--CA 1.492 1.436 0 CA-C-O 120.686 0.202 . . . . 1.0 111.957 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.69 115.2 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.871 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -43.58 139.01 2.79 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -40.51 -44.57 4.4 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 123.255 2.637 . . . . 1.0 114.014 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.738 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.9 p -40.74 -48.6 3.02 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.733 0.272 . . . . 1.0 111.733 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.738 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 15.2 t-80 -81.12 -27.2 35.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.278 0.473 . . . . 1.0 112.278 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.6 t -64.23 -53.21 46.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.636 -0.425 . . . . 1.0 111.023 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -65.7 -29.09 69.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.75 -43.46 94.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 1.0 109.737 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 146' ' ' MET . 9.3 mt -72.7 -39.21 67.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -50.82 -38.82 51.0 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 177.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.1 m -65.88 -24.53 66.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.847 -1.069 . . . . 1.0 109.171 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.8 mmm -92.4 -2.03 56.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.682 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.11 19.65 78.61 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.5 t -106.88 143.92 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 1.0 111.061 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.69 -43.91 3.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.993 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -134.35 121.0 20.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.198 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.3 t -111.99 142.98 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.402 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 tp -116.44 139.52 50.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.267 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.81 120.35 52.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.167 0.508 . . . . 1.0 111.745 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.1 t -126.09 120.0 23.82 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.63 124.35 9.72 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.243 2.629 . . . . 1.0 114.655 -175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.505 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 8.3 mp -102.37 58.98 0.81 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.846 -1.539 . . . . 1.0 106.846 177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.406 ' N ' ' OG ' ' A' ' 192' ' ' SER . 6.0 ptt? -147.95 -170.15 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.076 0.769 . . . . 1.0 113.076 -176.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.694 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 70.3 t60 -80.52 -179.56 7.24 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.424 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.694 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 60.0 t60 -74.79 -54.06 8.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.392 -0.822 . . . . 1.0 112.093 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -103.66 13.35 33.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.04 0.385 . . . . 1.0 112.04 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -146.39 140.21 26.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.714 -0.395 . . . . 1.0 110.904 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.421 ' H ' HD13 ' A' ' 162' ' ' LEU . 0.8 OUTLIER -112.61 119.68 38.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.267 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -92.43 -35.53 13.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.306 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -163.88 -178.02 37.13 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.208 -0.757 . . . . 1.0 111.208 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 87.5 mt -138.4 133.4 32.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.841 0.353 . . . . 1.0 111.551 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.5 tp -102.33 133.97 46.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.87 135.14 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.089 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.0 m -109.56 139.17 44.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.003 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.429 ' O ' ' CG2' ' A' ' 48' ' ' THR . 48.5 m80 -108.2 119.29 39.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.674 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.648 ' HE2' ' HG1' ' A' ' 48' ' ' THR . 72.9 m80 -120.59 113.83 20.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 1.0 109.952 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.2 -16.08 61.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.841 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.99 138.01 72.82 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.013 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.94 10.82 2.19 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.978 2.452 . . . . 1.0 111.919 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -68.76 148.43 98.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.846 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.2 161.92 41.86 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.512 2.141 . . . . 1.0 111.939 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 44.0 p90 -74.87 133.6 41.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.465 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.8 m -112.51 147.91 35.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.69 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -59.88 -28.39 67.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.616 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -55.51 -44.12 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.693 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.3 -36.46 83.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.473 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.4 tp -62.23 -42.16 99.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.516 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.84 -33.74 64.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 1.0 111.371 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.34 -56.86 11.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 188' ' ' ALA . 13.5 m -78.7 -30.61 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.435 0.531 . . . . 1.0 112.435 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -51.06 -54.19 27.05 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.614 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 24.4 tp -75.14 -39.24 60.6 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.2 tp -76.46 -41.47 47.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.891 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -57.19 -39.8 76.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.519 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -58.29 -39.22 78.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.012 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -66.21 -28.39 68.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.132 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 16.3 t -82.98 -44.57 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.782 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.406 ' OG ' ' N ' ' A' ' 157' ' ' MET . 1.5 t -53.71 -29.64 40.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.671 -0.862 . . . . 1.0 108.671 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.1 mm -77.19 -33.46 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.465 -0.789 . . . . 1.0 109.268 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.69 -47.81 44.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.893 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.53 -37.17 79.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.142 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.01 -47.01 55.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.134 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -71.53 -36.0 70.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.519 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.59 74.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.645 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -59.35 -32.49 70.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.483 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 8.8 mp -61.32 -33.68 74.0 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.025 -0.27 . . . . 1.0 111.029 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -51.52 -53.66 35.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.571 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.543 179.563 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.867 0.365 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -77.64 -29.34 51.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -77.87 -45.93 22.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.139 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 pt -64.23 -38.66 83.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.46 -0.337 . . . . 1.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 mt -61.17 -50.64 72.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.033 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -53.81 -38.23 64.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.27 -29.96 66.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.043 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.3 m -74.17 -45.32 49.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.509 -0.768 . . . . 1.0 112.269 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.77 -34.53 68.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -67.45 -46.14 73.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.85 0.357 . . . . 1.0 111.173 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -64.42 -41.09 96.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.783 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.19 -43.19 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.1 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 47' ' ' GLY . 66.8 ttp85 -55.03 -41.03 70.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 1.0 110.824 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.23 -36.55 73.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.026 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -79.37 -42.35 25.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.56 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mt -85.39 -32.52 22.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.466 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 61.81 20.31 59.57 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.474 -1.05 . . . . 1.0 110.474 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.447 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 69.7 m -73.1 141.18 47.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 1.0 110.132 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -40.03 -45.1 1.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 1.0 111.634 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.63 ' HE ' ' CE1' ' A' ' 169' ' ' HIS . 56.9 ttp180 -162.68 130.89 3.91 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.06 -0.656 . . . . 1.0 112.596 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.24 129.82 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' HZ2' ' CG1' ' A' ' 167' ' ' VAL . 24.8 pttm -141.69 152.86 44.27 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.912 -177.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.6 t -102.32 134.86 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.563 -0.902 . . . . 1.0 108.563 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.49 ' OH ' ' O ' ' A' ' 61' ' ' HIS . 52.1 t80 -120.89 126.29 49.64 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.299 -0.561 . . . . 1.0 111.293 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 163' ' ' TRP . 18.2 tpt85 -87.23 124.76 33.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.276 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -88.76 119.84 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.326 -0.397 . . . . 1.0 112.023 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.87 151.9 43.98 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.87 -21.84 59.53 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.491 2.127 . . . . 1.0 112.493 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -82.23 -15.59 52.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.378 . . . . 1.0 110.032 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.39 -15.79 49.67 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.489 -0.644 . . . . 1.0 111.489 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.49 ' O ' ' OH ' ' A' ' 54' ' ' TYR . 84.8 m-70 -64.09 -104.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.934 -0.307 . . . . 1.0 110.62 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.462 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . 102.61 155.95 25.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 p -127.58 151.07 49.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.935 0.398 . . . . 1.0 111.688 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.82 108.38 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.53 -0.76 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.314 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.09 113.02 2.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.099 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 87.6 tt0 -144.28 132.59 21.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.146 0.498 . . . . 1.0 111.798 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.16 140.97 50.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.413 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ptt-85 -142.91 150.1 39.34 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.02 -121.8 0.01 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.856 -0.898 . . . . 1.0 110.856 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -81.01 -175.94 50.39 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 1.1 pm0 -73.09 45.46 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.777 0.322 . . . . 1.0 110.488 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 71' ' ' GLY . 15.4 tpt180 -84.31 -47.84 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.175 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 23.3 mt -116.64 146.71 38.23 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.168 -0.469 . . . . 1.0 109.878 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.59 163.23 38.92 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.459 2.106 . . . . 1.0 112.218 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.43 ' HG ' ' H ' ' A' ' 78' ' ' LEU . 33.3 t -92.79 130.68 38.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.958 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.85 12.73 29.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.429 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 76' ' ' SER . 18.8 tp -70.89 131.12 43.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.284 0.564 . . . . 1.0 112.261 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.84 -8.8 78.67 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.608 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.01 151.97 22.79 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.325 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.2 p -105.18 134.27 48.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.675 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -89.65 151.24 45.55 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.94 135.87 36.46 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.681 2.254 . . . . 1.0 111.884 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.12 136.77 56.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.71 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.29 -3.47 40.41 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.528 -1.029 . . . . 1.0 110.528 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -52.35 -40.78 62.39 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.1 mt -80.99 133.23 54.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.445 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.89 -161.97 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.385 2.057 . . . . 1.0 112.513 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.02 -57.99 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.584 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -60.18 -45.76 92.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.8 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.1 -44.61 88.24 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -58.69 -34.99 71.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.459 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -63.71 -34.4 77.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.766 0.317 . . . . 1.0 110.805 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' ALA . 11.9 mt -65.31 -34.16 77.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.297 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.632 ' C ' HE21 ' A' ' 99' ' ' GLN . 17.7 m-85 -64.24 -55.13 23.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.014 0.435 . . . . 1.0 110.01 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 159' ' ' HIS . 79.5 ttt180 -48.04 -33.92 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.843 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 mt -100.69 -37.91 8.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.04 -16.48 11.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -173.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.632 HE21 ' C ' ' A' ' 95' ' ' PHE . 22.4 mm-40 38.06 77.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.205 -0.998 . . . . 1.0 108.826 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.8 p 176.35 113.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.101 -178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -175.31 141.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 1.0 110.737 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.0 161.51 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.542 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.2 mt -104.37 137.5 33.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 t -88.2 157.91 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 113.294 0.85 . . . . 1.0 113.294 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -47.16 121.29 3.65 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.974 -1.012 . . . . 1.0 112.082 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.6 p -57.14 -25.15 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.371 -0.832 . . . . 1.0 110.762 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -64.85 -45.5 85.81 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.93 -11.38 27.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.479 0.657 . . . . 1.0 109.326 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.1 tp60 45.94 70.26 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.801 -1.091 . . . . 1.0 113.308 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -74.43 131.85 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.903 -1.517 . . . . 1.0 106.903 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -120.27 137.12 54.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.023 -0.671 . . . . 1.0 111.931 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.538 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -139.36 162.76 34.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.705 -0.679 . . . . 1.0 110.538 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.0 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.105 179.088 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 N--CA 1.491 1.378 0 CA-C-O 120.698 0.207 . . . . 1.0 111.958 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.54 126.0 59.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.844 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.538 ' N ' ' OG ' ' A' ' 112' ' ' SER . 26.4 t70 -46.05 131.07 7.26 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 138' ' ' CYS . 59.5 Cg_exo -41.61 -47.11 6.1 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.194 2.596 . . . . 1.0 114.041 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.698 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.8 p -37.35 -46.4 0.76 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.723 0.268 . . . . 1.0 111.723 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.698 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 4.4 t60 -82.29 -30.43 30.58 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.2 t -67.73 -50.9 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.963 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -66.0 -29.18 69.51 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -60.03 -42.13 93.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.714 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' MET . 8.4 mt -73.49 -38.15 65.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -51.92 -39.17 58.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 t -63.69 -24.04 67.62 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.76 -1.109 . . . . 1.0 109.16 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -92.26 4.37 53.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.423 -0.808 . . . . 1.0 110.671 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.06 21.04 79.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.29 142.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 1.0 111.097 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.66 -23.2 12.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.964 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.4 m -141.96 160.52 40.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.202 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.73 121.01 9.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.496 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.7 mp -109.95 132.6 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.258 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.8 t -123.21 119.4 57.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.175 0.512 . . . . 1.0 111.775 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.6 t -131.65 92.47 30.94 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.79 -1.189 . . . . 1.0 107.79 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.04 150.37 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.203 2.602 . . . . 1.0 114.616 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.538 ' H ' ' HE2' ' A' ' 157' ' ' MET . 33.9 mt -124.88 54.5 1.41 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.868 -1.53 . . . . 1.0 106.868 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.538 ' HE2' ' H ' ' A' ' 156' ' ' LEU . 7.5 ptp -148.56 -167.94 2.96 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.141 0.793 . . . . 1.0 113.141 -175.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.644 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 18.1 m-70 -68.83 163.2 24.77 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.342 -0.845 . . . . 1.0 111.408 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 96' ' ' ARG . 80.1 m80 -70.45 -55.36 9.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.44 -0.8 . . . . 1.0 112.042 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -94.98 11.36 32.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.081 0.401 . . . . 1.0 112.081 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -148.12 140.82 24.6 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.93 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.0 mt -113.52 117.14 30.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.304 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.644 ' HE1' ' CD2' ' A' ' 158' ' ' HIS . 81.8 m95 -89.22 -26.07 21.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.246 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.485 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -163.58 -160.85 11.96 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.177 -0.769 . . . . 1.0 111.177 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 13.3 tp -150.37 124.27 9.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 1.0 111.506 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.3 tp -99.71 129.29 45.82 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.485 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 13.0 p -139.5 134.14 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.077 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.2 p -106.99 141.99 37.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.991 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.63 ' CE1' ' HE ' ' A' ' 50' ' ' ARG . 24.1 m80 -112.75 126.21 55.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.978 0.418 . . . . 1.0 111.689 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -126.12 113.84 17.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.955 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.4 -15.08 63.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.779 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -117.65 151.03 47.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.99 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.48 132.05 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.895 2.397 . . . . 1.0 111.895 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 53.3 ttt85 -157.87 95.02 2.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.895 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.48 161.24 25.39 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.531 2.154 . . . . 1.0 111.916 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 44.0 p90 -91.17 123.79 34.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.441 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 52.3 m -123.75 164.56 18.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.619 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -50.74 -38.38 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.582 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -67.84 -37.45 81.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.756 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -61.46 -49.92 74.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.573 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 185' ' ' GLN . 43.1 mt -64.28 -34.2 77.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.476 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -54.05 -42.13 68.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 88.1 t -69.45 -57.31 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.773 0.656 . . . . 1.0 112.773 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.11 -46.29 45.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.395 0.517 . . . . 1.0 112.395 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.416 ' CB ' ' O ' ' A' ' 181' ' ' LEU . 63.3 tt0 -42.74 -47.74 5.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.59 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.5 tp -72.36 -41.49 66.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.461 -0.336 . . . . 1.0 111.894 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.5 tp -77.11 -41.84 40.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.818 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -55.05 -39.55 69.3 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.506 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -61.66 -38.14 86.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.007 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.14 -30.58 71.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.076 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 13.0 t -83.8 -42.58 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.756 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.0 p -55.16 -32.85 62.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 193' ' ' ILE . 39.5 mt -69.03 -37.34 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.203 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.96 -39.95 83.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.626 -0.715 . . . . 1.0 109.779 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 195' ' ' ILE . 36.5 mm -61.04 -46.48 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.123 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.69 -47.24 60.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.1 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -65.48 -41.51 93.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.0 111.492 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.02 70.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.675 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.17 -40.95 97.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.509 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.52 -35.68 80.17 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.007 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.5 t -52.42 -52.22 55.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 1.0 110.595 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.583 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.6 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.902 0.382 . . . . 1.0 110.578 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 66.5 t0 -49.05 -34.99 14.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -77.29 -47.44 20.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.069 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.44 -42.44 93.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 1.0 110.977 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -56.87 -45.02 82.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.099 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -53.22 -38.69 63.16 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.56 71.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.055 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -69.08 -45.7 69.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.547 -0.752 . . . . 1.0 112.227 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 p -71.28 -35.26 57.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.995 0.368 . . . . 1.0 111.995 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -70.17 -35.7 74.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.776 0.322 . . . . 1.0 111.06 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -80.46 -53.54 6.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 1.0 111.755 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 9.6 p -55.08 -44.08 72.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.744 0.306 . . . . 1.0 111.118 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HG3' ' H ' ' A' ' 44' ' ' ALA . 2.6 ppt_? -56.21 -41.7 76.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.85 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.505 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.17 -33.91 59.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.022 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -79.61 -36.2 38.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 1.0 111.581 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -85.34 -30.64 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.501 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 59.33 19.29 46.3 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 93.3 m -72.24 140.77 48.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.792 0.33 . . . . 1.0 110.234 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -39.72 -50.43 2.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.623 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.467 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 59.6 ttp180 -157.97 130.56 7.25 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.018 -0.673 . . . . 1.0 112.591 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.95 131.06 36.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -139.62 155.24 47.55 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.9 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.5 t -106.03 138.91 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.23 131.45 28.22 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.323 -0.551 . . . . 1.0 111.284 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -92.74 145.46 24.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.275 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.469 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 85.6 t80 -96.46 122.13 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 1.0 112.04 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -87.73 164.68 33.51 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 178.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.25 -25.83 15.29 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.521 2.147 . . . . 1.0 112.522 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.94 -15.37 54.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 1.0 110.096 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.37 -17.22 37.31 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.514 -0.635 . . . . 1.0 111.514 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -67.21 101.85 0.97 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.909 -0.316 . . . . 1.0 110.592 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.61 134.89 12.64 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.562 -1.015 . . . . 1.0 110.562 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.6 p -122.24 142.23 50.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 1.0 111.665 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.77 120.53 38.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 t -110.41 5.84 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 1.0 111.356 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.08 118.36 3.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.126 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -143.67 135.91 26.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.073 0.463 . . . . 1.0 111.816 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.92 146.96 52.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.434 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -141.15 145.99 36.42 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.755 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.47 -32.81 46.16 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.881 -0.887 . . . . 1.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 176.63 -161.64 29.75 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -73.94 25.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.339 . . . . 1.0 110.523 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' A' ' 71' ' ' GLY . 43.1 mtm180 -77.47 -47.14 20.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.082 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.7 mt -113.04 145.56 33.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 1.0 109.921 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -70.93 160.31 49.77 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.516 2.144 . . . . 1.0 112.148 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.1 p -93.31 128.13 39.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.864 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.9 mt -94.44 6.4 48.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.372 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 tp -61.34 128.83 38.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.3 0.572 . . . . 1.0 112.246 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.45 -13.83 62.81 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.514 -0.767 . . . . 1.0 111.526 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.3 mt -81.29 150.55 28.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.296 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -106.86 133.85 50.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.652 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -87.02 133.28 39.48 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -41.15 132.87 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.633 2.222 . . . . 1.0 111.895 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.91 128.33 35.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 1.0 110.738 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.27 0.63 44.2 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.529 -1.028 . . . . 1.0 110.529 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -58.71 -33.11 69.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.4 mt -78.99 132.8 62.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.69 -0.687 . . . . 1.0 109.49 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.74 -171.99 0.99 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.452 2.102 . . . . 1.0 112.479 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -106.43 -55.07 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.546 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -63.21 -42.27 99.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.813 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.77 -44.32 77.72 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.928 0.344 . . . . 1.0 111.928 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -64.11 -39.64 94.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.47 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -60.6 -32.13 71.26 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.762 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 98' ' ' ALA . 96.5 mt -70.1 -28.14 65.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.905 0.383 . . . . 1.0 110.341 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.653 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 0.8 OUTLIER -65.33 -54.25 31.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.036 178.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.99 -31.69 65.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.878 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.3 mt -99.41 -44.51 6.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 114.357 1.243 . . . . 1.0 114.357 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -113.55 -12.51 12.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.112 1.523 . . . . 1.0 115.112 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.653 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 18.2 mm-40 45.34 86.73 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.198 -1.001 . . . . 1.0 108.75 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.54 99.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.12 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.501 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 9.8 mmp_? -139.49 133.24 30.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.998 0.428 . . . . 1.0 110.737 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 101' ' ' ARG . 71.3 t -161.4 141.81 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.536 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.15 133.65 53.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.89 164.97 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.318 0.858 . . . . 1.0 113.318 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 20.0 p30 -46.89 118.54 2.1 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.003 -0.999 . . . . 1.0 112.098 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.98 -22.2 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.311 -0.859 . . . . 1.0 110.801 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -67.83 -43.56 79.29 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.55 -11.75 12.44 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.525 0.678 . . . . 1.0 109.389 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 45.54 61.45 2.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.779 -1.1 . . . . 1.0 113.335 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 m -76.26 133.23 40.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 175.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -119.82 140.29 51.02 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.926 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.8 135.19 54.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.496 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.185 179.432 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo . . . . . 0 N--CA 1.492 1.41 0 CA-C-O 120.759 0.233 . . . . 1.0 111.93 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 p -100.37 119.98 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.811 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.51 ' OD2' ' SG ' ' A' ' 138' ' ' CYS . 49.7 p-10 -43.77 134.1 3.85 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.738 -0.468 . . . . 1.0 109.738 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -42.49 -16.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.095 2.53 . . . . 1.0 114.067 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.743 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -71.55 -48.38 48.91 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.713 0.264 . . . . 1.0 111.713 -176.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.743 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 35.7 t-80 -82.97 -28.24 29.91 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.279 0.474 . . . . 1.0 112.279 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 2.6 p -66.45 -43.76 90.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.004 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.523 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 79.2 t60 -69.86 -30.35 67.8 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.522 ' O ' ' OG ' ' A' ' 145' ' ' SER . 76.9 t80 -59.82 -42.21 93.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.76 178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 146' ' ' MET . 29.8 mt -74.36 -36.14 63.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -52.41 -39.32 60.81 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 9.7 p -65.08 -18.91 65.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.786 -1.097 . . . . 1.0 109.16 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.2 mmm -96.15 1.14 52.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.12 22.89 78.62 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.944 -0.863 . . . . 1.0 110.944 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.33 142.98 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 1.0 111.006 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.65 -39.76 5.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.964 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.7 t -135.96 126.44 26.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.199 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.4 m -113.91 140.78 48.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.428 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.96 138.48 53.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.262 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -128.3 119.45 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.167 0.508 . . . . 1.0 111.732 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.6 124.52 21.91 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.735 -1.209 . . . . 1.0 107.735 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.97 144.27 42.54 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 123.175 2.584 . . . . 1.0 114.678 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.462 ' H ' ' HE1' ' A' ' 157' ' ' MET . 11.3 mt -125.14 47.46 2.16 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.561 ' CE ' ' O ' ' A' ' 164' ' ' GLY . 4.4 ptp -147.36 -167.38 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.104 0.779 . . . . 1.0 113.104 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.451 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 20.7 m-70 -68.71 159.24 32.58 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.45 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -60.63 -50.11 74.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.414 -0.812 . . . . 1.0 112.107 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -97.74 -42.75 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.06 0.393 . . . . 1.0 112.06 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.473 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 85.2 tt0 -86.27 134.3 33.76 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.87 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 19.1 mt -109.17 115.58 30.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.215 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.473 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 77.8 m95 -88.85 -31.42 18.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.278 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.561 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -169.97 -166.95 29.76 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.229 -0.748 . . . . 1.0 111.229 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.416 ' CD1' ' C ' ' A' ' 164' ' ' GLY . 5.8 mp -148.65 136.37 20.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 1.0 111.506 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.4 tp -98.58 134.92 40.86 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.4 p -138.5 127.41 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.695 -0.402 . . . . 1.0 111.097 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.2 p -104.68 137.13 42.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.064 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.467 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 28.4 m80 -105.07 121.24 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.981 0.419 . . . . 1.0 111.601 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -122.1 113.45 19.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.936 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.46 -14.23 61.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.781 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.74 135.14 74.85 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.06 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.01 -4.54 14.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.905 2.404 . . . . 1.0 111.813 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 174' ' ' ARG . 1.0 OUTLIER -54.73 151.34 15.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.845 -179.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.65 160.96 46.75 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.53 2.153 . . . . 1.0 111.946 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -81.54 136.64 35.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.483 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -113.03 144.83 41.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.64 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -55.86 -29.32 59.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.537 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -55.82 -37.07 68.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.696 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.01 -37.72 88.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.505 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 9.0 mp -65.07 -38.94 92.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.48 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.53 -37.98 68.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.371 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.85 -55.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.737 0.643 . . . . 1.0 112.737 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 188' ' ' ALA . 10.9 p -68.38 -38.69 79.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.394 0.516 . . . . 1.0 112.394 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -52.52 -45.22 66.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.644 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 37.2 tp -65.04 -45.52 85.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 85.1 mt -78.92 -31.55 45.27 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -62.88 -44.46 96.06 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.494 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -62.25 -42.23 99.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.067 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -64.12 -27.34 69.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.095 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.4 t -84.8 -40.86 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.749 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -56.78 -36.11 69.48 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.5 mt -67.58 -38.44 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.228 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -68.02 -40.2 82.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.838 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.457 HG23 HD11 ' A' ' 195' ' ' ILE . 26.1 mm -59.23 -48.19 87.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.051 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.47 -48.75 47.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.031 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.15 -45.77 79.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.525 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -63.42 -32.65 74.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.711 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -57.32 -29.6 64.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.385 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.27 -32.88 73.65 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.058 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.0 t -52.15 -55.85 18.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.551 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.6 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.54 179.439 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.806 0.336 . . . . 1.0 110.589 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -53.01 -54.5 34.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.951 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -54.54 -46.95 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.114 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 mm -62.03 -46.99 95.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.826 0.346 . . . . 1.0 110.972 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.2 mt -56.46 -45.14 80.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.08 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -53.59 -38.41 63.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.65 -30.33 66.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.124 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.7 m -73.59 -44.76 56.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.528 -0.76 . . . . 1.0 112.228 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 p -68.56 -35.94 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.96 0.356 . . . . 1.0 111.96 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -67.16 -49.18 65.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 1.0 111.156 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -58.72 -45.26 90.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.683 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.94 -37.32 60.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.686 0.279 . . . . 1.0 111.149 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 47' ' ' GLY . 36.7 ttp180 -52.53 -40.83 62.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.832 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.89 -35.76 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.056 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.11 -46.36 20.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.538 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.6 mt -86.37 -31.59 21.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.494 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.57 22.22 31.22 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.461 -1.056 . . . . 1.0 110.461 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.2 p -74.02 144.96 44.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.332 . . . . 1.0 110.286 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -41.52 -42.01 2.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.617 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.532 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 56.3 ttm-85 -163.26 129.33 3.24 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.123 -0.631 . . . . 1.0 112.636 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.84 130.29 52.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' NZ ' ' HE2' ' A' ' 169' ' ' HIS . 23.5 pttm -140.6 154.97 46.68 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.442 -0.503 . . . . 1.0 111.874 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -109.17 138.76 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.34 133.47 33.01 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.348 -0.541 . . . . 1.0 111.283 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -92.62 145.58 24.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.201 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -95.62 117.73 31.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 1.0 112.089 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.09 149.47 59.02 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.52 -23.15 74.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.58 2.187 . . . . 1.0 112.45 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -86.14 -14.53 43.85 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.057 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.43 -13.13 47.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.469 -0.652 . . . . 1.0 111.469 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -76.0 94.79 3.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.804 0.335 . . . . 1.0 110.608 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.88 143.54 17.61 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -122.18 144.54 48.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.914 0.388 . . . . 1.0 111.638 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -80.51 112.49 18.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.07 3.63 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.276 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.28 119.71 2.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.076 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.532 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 84.8 tt0 -144.84 132.87 21.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.106 0.479 . . . . 1.0 111.847 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.96 148.82 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.336 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.613 ' NH2' ' N ' ' A' ' 76' ' ' SER . 6.8 ptp180 -139.68 142.21 36.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.895 0.379 . . . . 1.0 110.718 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.41 -33.18 86.54 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -171.26 -178.97 42.08 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -73.61 40.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 1.0 110.581 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 71' ' ' GLY . 10.1 tpt180 -83.06 -47.79 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.144 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.36 150.85 43.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.863 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.462 ' C ' ' NH2' ' A' ' 69' ' ' ARG . 58.3 Cg_endo -69.86 160.3 50.19 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.483 2.122 . . . . 1.0 112.131 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.613 ' N ' ' NH2' ' A' ' 69' ' ' ARG . 21.9 t -88.86 129.55 35.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.942 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.6 mt -98.14 10.22 41.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.383 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.08 132.58 45.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.003 -0.544 . . . . 1.0 112.305 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.13 -10.02 67.57 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.527 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.8 mt -85.5 154.11 22.0 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.336 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 p -105.37 130.72 53.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.688 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -84.66 152.67 60.42 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.84 133.94 41.28 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.678 2.252 . . . . 1.0 111.883 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.35 129.14 38.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.67 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.64 0.46 42.91 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -56.42 -35.58 67.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 87' ' ' ILE . 16.7 mm -80.16 132.39 59.91 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.66 -0.7 . . . . 1.0 109.434 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.39 -167.26 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.398 2.065 . . . . 1.0 112.483 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -107.63 -60.06 1.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.505 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 39.6 mp0 -57.95 -44.43 86.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.818 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.88 -44.62 80.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -58.62 -36.26 73.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.477 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -63.81 -32.03 73.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.811 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.1 mt -67.11 -36.36 81.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.295 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -57.18 -54.36 47.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.051 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -53.43 -29.81 37.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.838 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.555 ' C ' HE22 ' A' ' 99' ' ' GLN . 75.9 mt -98.97 -41.37 7.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.413 1.264 . . . . 1.0 114.413 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.561 ' N ' ' NE2' ' A' ' 99' ' ' GLN . . . -120.19 -17.09 8.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 115.031 1.493 . . . . 1.0 115.031 -173.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.592 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.2 OUTLIER 45.15 71.45 0.27 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.123 -1.031 . . . . 1.0 108.847 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 2.7 m -164.26 113.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.051 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.43 ' NE ' ' O ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -155.68 148.26 23.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.932 0.396 . . . . 1.0 110.774 178.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.13 143.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.505 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.7 mt -108.94 135.62 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.09 164.39 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 113.275 0.843 . . . . 1.0 113.275 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -43.98 117.27 1.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.95 -1.023 . . . . 1.0 112.145 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.88 -20.02 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.79 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -66.9 -42.27 85.76 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.09 -10.39 40.0 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.45 0.643 . . . . 1.0 109.408 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 45.26 70.63 0.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.734 -1.121 . . . . 1.0 113.354 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 p -75.35 134.43 40.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.984 -1.488 . . . . 1.0 106.984 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -122.02 139.78 53.28 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.893 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.28 153.51 48.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.6 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.121 178.852 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.492 1.403 0 CA-C-O 120.712 0.213 . . . . 1.0 111.95 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.49 124.3 61.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.878 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -43.22 141.97 1.71 Allowed Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -49.18 -13.52 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 123.224 2.616 . . . . 1.0 114.073 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.681 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.4 p -75.59 -44.43 43.1 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.746 0.276 . . . . 1.0 111.746 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.681 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.6 t60 -82.9 -32.86 27.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.226 0.454 . . . . 1.0 112.226 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 4.3 p -68.76 -45.03 81.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.936 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.51 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 35.5 m-70 -68.69 -28.97 67.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -60.83 -41.0 94.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.923 -0.581 . . . . 1.0 109.715 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.6 mt -72.86 -36.49 67.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -52.15 -38.73 58.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -64.44 -23.07 67.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.746 -1.115 . . . . 1.0 109.161 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.529 ' N ' ' O ' ' A' ' 143' ' ' LEU . 97.1 mmm -92.74 2.15 56.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.727 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.84 79.28 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.3 t -111.93 142.03 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 1.0 111.019 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.92 -26.67 11.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.012 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.2 m -136.45 160.83 37.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.166 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.35 127.72 13.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.44 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 tp -114.92 136.31 53.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.292 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.4 119.62 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.132 0.491 . . . . 1.0 111.793 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.62 91.1 41.71 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 107.862 -1.162 . . . . 1.0 107.862 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.22 151.68 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.175 2.584 . . . . 1.0 114.693 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.5 mt -126.05 63.18 1.24 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.832 -1.544 . . . . 1.0 106.832 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 ptm -146.35 179.61 7.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.163 0.801 . . . . 1.0 113.163 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.606 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 46.1 t-80 -68.07 176.24 2.76 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.394 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.606 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 97.8 m-70 -64.54 -51.64 61.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.401 -0.818 . . . . 1.0 112.082 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.68 -37.79 6.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.064 0.394 . . . . 1.0 112.064 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -87.67 136.29 33.01 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.689 -0.405 . . . . 1.0 110.846 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.436 ' H ' HD13 ' A' ' 162' ' ' LEU . 1.2 mp -108.63 112.14 24.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.317 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -88.27 -37.49 16.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.257 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.71 -175.75 36.5 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.17 141.56 30.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 1.0 111.5 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.4 tp -101.07 135.26 42.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.64 129.68 35.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 1.0 111.078 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.2 m -106.77 139.37 41.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.057 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.479 ' HE2' ' NZ ' ' A' ' 52' ' ' LYS . 85.7 m-70 -113.76 132.09 55.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.948 0.404 . . . . 1.0 111.667 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.561 ' CD2' ' N ' ' A' ' 170' ' ' HIS . 1.0 OUTLIER -124.57 125.32 43.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.929 177.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.43 33.63 0.69 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.832 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -161.35 154.38 17.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.029 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.16 112.82 2.18 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.928 2.419 . . . . 1.0 111.84 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -149.16 90.11 4.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.884 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.96 158.42 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.597 2.198 . . . . 1.0 111.905 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 41.6 p90 -84.79 127.27 34.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.487 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.6 p -121.06 162.37 20.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.581 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.59 ' H ' ' CD ' ' A' ' 178' ' ' GLN . 1.7 pm0 -50.33 -30.47 12.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.648 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -61.87 -36.24 80.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.739 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -66.01 -24.43 66.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.486 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.8 mt -81.33 -33.88 32.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.483 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.45 -43.09 99.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.34 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 184' ' ' VAL . 13.1 m -73.41 -49.16 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.708 0.633 . . . . 1.0 112.708 -177.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 183' ' ' VAL . 27.9 m -70.4 -43.87 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.403 0.52 . . . . 1.0 112.403 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -53.28 -43.43 67.46 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.983 -0.287 . . . . 1.0 111.67 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.73 -49.99 59.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.445 ' O ' ' CG2' ' A' ' 191' ' ' VAL . 71.2 mt -79.86 -35.07 38.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.795 -177.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -61.1 -43.38 98.97 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.488 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.58 -42.47 86.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 1.0 109.989 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.63 -28.23 68.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.135 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 187' ' ' LEU . 59.4 t -84.3 -43.71 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.785 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.2 p -57.83 -35.63 71.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.655 -0.868 . . . . 1.0 108.655 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.9 mt -67.84 -35.03 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.207 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.57 76.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.646 -0.707 . . . . 1.0 109.843 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.0 mm -61.38 -47.53 93.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.133 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.8 -48.02 60.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.045 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -65.68 -41.19 92.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.558 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.05 -31.3 72.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.677 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.72 -31.92 68.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.497 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 9.0 mp -60.62 -34.84 74.84 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.932 -0.307 . . . . 1.0 111.095 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.3 m -55.96 -56.14 24.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.58 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.536 179.715 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.6 tp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.795 0.331 . . . . 1.0 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -60.52 -51.95 67.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.048 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -55.89 -45.91 78.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.127 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 mm -61.4 -48.4 89.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.771 0.32 . . . . 1.0 110.877 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.02 -47.74 84.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.012 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -52.45 -39.54 61.21 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.622 -0.431 . . . . 1.0 109.846 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.56 -29.09 65.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.137 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.8 m -73.25 -45.32 56.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.477 -0.783 . . . . 1.0 112.312 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 7.8 p -68.45 -35.3 70.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -177.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -70.6 -42.31 71.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.784 0.326 . . . . 1.0 111.094 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.71 -54.67 24.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.77 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -52.45 -39.84 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.171 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -52.76 -41.76 64.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 1.0 110.811 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.3 -38.34 79.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.04 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -75.5 -42.82 51.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.603 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.2 mt -85.6 -26.81 25.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.457 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.76 19.95 16.39 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 91.3 m -73.01 143.39 47.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.832 0.349 . . . . 1.0 110.192 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -39.34 -55.43 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.668 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.617 HH22 ' CG2' ' A' ' 148' ' ' VAL . 61.2 mtm-85 -148.92 131.8 16.12 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.053 -0.659 . . . . 1.0 112.576 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 38.4 t -132.69 127.64 56.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.681 ' NZ ' ' HE2' ' A' ' 169' ' ' HIS . 20.4 pttm -141.4 154.92 45.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.13 0.49 . . . . 1.0 111.939 -178.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.15 135.56 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.626 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -133.76 120.06 20.05 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.243 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -74.04 140.2 45.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.273 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.629 ' CE1' ' NH2' ' A' ' 92' ' ' ARG . 58.9 t80 -92.91 117.21 29.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 1.0 112.048 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 41.2 p-10 -93.59 141.35 23.74 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.83 -14.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.573 2.182 . . . . 1.0 112.517 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 57' ' ' ASP . 96.3 mt-10 -87.97 -33.86 18.27 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.729 -0.389 . . . . 1.0 110.104 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.41 -10.79 39.37 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.514 -0.634 . . . . 1.0 111.514 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.685 ' O ' ' O ' ' A' ' 62' ' ' GLY . 64.2 m80 -66.54 -42.81 86.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.926 -0.31 . . . . 1.0 110.61 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.685 ' O ' ' O ' ' A' ' 61' ' ' HIS . . . 47.97 155.98 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.659 -0.976 . . . . 1.0 110.659 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 p -124.81 146.25 49.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 1.0 111.711 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.95 106.82 4.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.793 -0.818 . . . . 1.0 108.793 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.3 t -106.56 -1.85 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.719 0.295 . . . . 1.0 111.375 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.44 118.04 3.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.103 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -144.43 129.0 18.1 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.566 -0.454 . . . . 1.0 111.865 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.21 145.55 49.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.378 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -142.28 142.7 32.59 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.722 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.6 -36.1 83.85 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -163.63 -179.56 38.07 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -73.47 55.13 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 1.0 110.525 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -86.42 -48.88 8.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.131 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.9 mt -119.09 147.77 43.44 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.867 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.9 138.75 45.34 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.517 2.145 . . . . 1.0 112.131 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.1 m -60.43 130.26 45.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.89 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.7 mt -91.91 7.04 43.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.346 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tp -59.4 129.55 42.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.29 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.55 -12.82 65.73 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.526 -0.761 . . . . 1.0 111.507 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.5 mt -83.11 153.1 25.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.742 0.306 . . . . 1.0 110.327 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.7 p -107.65 135.06 49.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.646 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -87.68 154.46 53.28 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.22 124.92 12.75 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.684 2.256 . . . . 1.0 111.847 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.437 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . -62.44 137.67 58.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.696 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.87 -2.23 38.64 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -54.6 -38.73 67.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 88' ' ' PRO . 6.1 mm -83.65 111.92 35.85 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.433 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 87' ' ' ILE . 87.9 Cg_exo -51.46 -162.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.486 2.124 . . . . 1.0 112.499 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -107.82 -51.56 2.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.572 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.72 -41.32 92.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.768 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.94 79.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.936 0.346 . . . . 1.0 111.936 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.629 ' NH2' ' CE1' ' A' ' 56' ' ' PHE . 63.2 ttt180 -64.04 -39.15 93.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.519 -0.31 . . . . 1.0 111.457 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -62.3 -34.34 76.4 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.777 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.31 -34.7 75.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.266 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.652 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 2.3 t80 -63.54 -26.36 68.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.99 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.652 HH21 ' NE2' ' A' ' 160' ' ' GLN . 52.3 ttt180 -81.54 -28.32 33.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.786 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.9 mt -98.21 -41.21 8.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.36 -8.13 12.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 115.067 1.506 . . . . 1.0 115.067 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.695 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.6 mm-40 41.64 83.31 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.221 -0.991 . . . . 1.0 108.818 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.7 p 174.7 113.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.973 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.49 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 5.0 tpt180 -153.52 139.26 17.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 1.0 110.799 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 101' ' ' ARG . 55.9 t -161.22 145.91 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.547 -178.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 103' ' ' ILE . 65.4 mt -110.18 133.76 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.91 165.86 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 113.322 0.86 . . . . 1.0 113.322 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -45.81 119.72 2.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.964 -1.017 . . . . 1.0 112.139 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.13 -22.11 13.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.221 -0.899 . . . . 1.0 110.792 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -65.6 -44.11 87.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.6 -0.518 . . . . 1.0 109.6 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.93 -11.23 35.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.535 0.683 . . . . 1.0 109.42 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 44.72 71.12 0.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.731 -1.122 . . . . 1.0 113.327 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 p -74.27 132.75 42.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 176.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -118.8 128.96 54.96 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.017 -0.673 . . . . 1.0 111.884 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.478 ' HG ' ' H ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -124.77 152.09 44.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.623 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.1 pt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.117 179.373 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 N--CA 1.493 1.453 0 CA-C-O 120.757 0.232 . . . . 1.0 112.0 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.3 p -107.91 121.34 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.835 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.515 ' OD2' ' SG ' ' A' ' 138' ' ' CYS . 2.8 p-10 -45.13 140.57 3.64 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 138' ' ' CYS . 63.0 Cg_exo -42.63 -50.17 6.03 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.09 2.527 . . . . 1.0 114.047 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.757 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.0 OUTLIER -34.46 -49.26 0.39 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.72 0.267 . . . . 1.0 111.72 -177.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.757 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 20.5 t-80 -81.18 -25.66 36.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.319 0.488 . . . . 1.0 112.319 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 137' ' ' PRO . 42.1 t -65.88 -51.77 57.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.941 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.441 ' O ' ' OG ' ' A' ' 145' ' ' SER . 58.5 t-80 -63.57 -29.6 70.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.06 -44.32 94.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.694 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 146' ' ' MET . 61.8 mt -73.02 -41.54 64.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -50.63 -39.54 50.61 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 141' ' ' HIS . 2.6 m -62.93 -27.19 69.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.784 -1.098 . . . . 1.0 109.19 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.55 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.2 mmm -89.05 -0.46 57.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.7 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.77 21.5 78.48 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.976 -0.85 . . . . 1.0 110.976 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.617 ' CG2' HH22 ' A' ' 50' ' ' ARG . 47.7 t -109.45 142.25 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 1.0 111.035 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.1 -36.82 6.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.011 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 t -138.71 129.4 26.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.136 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.6 m -114.77 137.25 52.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.41 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tp -117.38 137.89 52.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.284 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 102' ' ' VAL . 2.1 t -126.58 113.77 34.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.082 0.468 . . . . 1.0 111.744 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.39 106.94 57.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 107.825 -1.176 . . . . 1.0 107.825 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.33 123.72 2.09 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.16 2.573 . . . . 1.0 114.77 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.4 tp -115.93 45.9 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.5 ptm -148.02 -178.36 6.24 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.091 0.775 . . . . 1.0 113.091 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.657 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 48.6 t-80 -69.3 178.64 2.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.306 -0.861 . . . . 1.0 111.411 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.657 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 83.6 t60 -67.89 -51.62 45.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 1.0 112.044 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.652 ' NE2' HH21 ' A' ' 96' ' ' ARG . 48.9 tt0 -105.17 -38.6 6.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.047 0.388 . . . . 1.0 112.047 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.512 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.7 tt0 -90.69 139.17 30.98 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.841 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.433 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 7.9 tt -107.03 115.39 30.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.357 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.512 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 78.6 m95 -91.75 -41.14 10.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.298 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.79 -173.71 24.75 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.422 ' CD1' ' CZ ' ' A' ' 95' ' ' PHE . 7.2 tp -144.26 128.13 17.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.332 . . . . 1.0 111.558 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.4 tp -98.04 129.06 44.9 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.53 136.7 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.087 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.1 m -111.24 149.65 30.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.053 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.681 ' HE2' ' NZ ' ' A' ' 52' ' ' LYS . 93.1 m-70 -124.6 131.21 53.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.003 0.43 . . . . 1.0 111.603 -177.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.03 114.42 15.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.984 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.94 -15.69 63.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.859 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -112.41 151.27 43.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.993 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.18 92.61 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.891 2.394 . . . . 1.0 111.929 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -120.85 91.27 47.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.901 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.97 152.36 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.533 2.156 . . . . 1.0 111.937 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -109.25 143.53 38.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.444 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.585 ' HG ' ' H ' ' A' ' 178' ' ' GLN . 23.2 t -125.24 171.35 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.607 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.585 ' H ' ' HG ' ' A' ' 177' ' ' SER . 98.2 mm-40 -50.89 -30.38 14.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.616 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -63.22 -39.45 94.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.708 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.54 -44.85 93.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.524 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 9.9 mp -63.92 -36.76 84.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.502 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -54.48 -36.64 64.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.884 -0.598 . . . . 1.0 111.331 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.34 -54.98 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.722 0.638 . . . . 1.0 112.722 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.1 t -77.68 -42.17 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -44.31 -45.28 8.64 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.951 -0.299 . . . . 1.0 111.631 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.535 ' N ' ' CD1' ' A' ' 186' ' ' LEU . 7.4 mp -75.96 -37.79 58.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.92 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.1 tp -77.65 -41.47 38.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.806 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.71 93.49 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.474 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -57.67 -39.6 77.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.294 -0.412 . . . . 1.0 109.924 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -71.8 -24.11 61.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.157 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 73.1 t -82.5 -48.92 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 1.0 109.798 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.454 ' HG ' ' N ' ' A' ' 193' ' ' ILE . 85.8 p -54.25 -34.19 60.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.454 ' N ' ' HG ' ' A' ' 192' ' ' SER . 30.9 mt -65.59 -33.85 66.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.161 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.74 -38.12 79.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.575 -0.738 . . . . 1.0 109.8 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.59 -46.46 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.14 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.03 -46.55 61.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.059 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -66.61 -44.54 81.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.515 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.34 -33.25 75.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.299 -0.409 . . . . 1.0 111.674 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -60.42 -32.87 71.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.578 -0.283 . . . . 1.0 111.498 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.61 -34.92 78.88 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.012 -0.275 . . . . 1.0 111.052 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.7 m -55.53 -54.74 40.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.802 0.334 . . . . 1.0 110.65 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 9.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.539 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.83 0.348 . . . . 1.0 110.562 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' CG ' ' N ' ' A' ' 33' ' ' GLN . 24.1 p-10 -55.63 -54.46 43.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.967 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.404 ' N ' ' CG ' ' A' ' 32' ' ' ASP . 62.9 tt0 -54.35 -44.84 72.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.124 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.502 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.9 mp -60.91 -52.89 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.955 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.2 mt -58.71 -48.2 81.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.011 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -53.4 -39.41 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.6 -0.44 . . . . 1.0 109.871 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.5 65.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.042 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.5 m -73.22 -44.59 59.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.529 -0.76 . . . . 1.0 112.197 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 4.1 p -69.96 -35.79 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.916 0.339 . . . . 1.0 111.916 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.06 -48.92 61.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.753 0.311 . . . . 1.0 111.096 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -66.94 -50.65 61.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.745 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.1 t -58.38 -42.77 84.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.724 0.297 . . . . 1.0 111.169 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -56.21 -43.11 78.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.811 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.76 -33.53 61.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -77.08 -37.93 53.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.608 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -85.78 -27.8 24.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.446 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.93 20.0 24.65 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.458 -1.057 . . . . 1.0 110.458 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.5 p -72.11 142.52 49.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.859 0.361 . . . . 1.0 110.217 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -40.39 -47.5 2.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.664 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.53 ' NH1' ' CE1' ' A' ' 169' ' ' HIS . 54.0 ttp85 -154.02 131.29 11.17 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.029 -0.668 . . . . 1.0 112.629 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.418 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 48.9 t -135.38 127.36 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -140.94 156.07 46.14 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.478 -0.489 . . . . 1.0 111.967 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.08 140.56 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -127.19 111.48 14.02 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.364 -0.534 . . . . 1.0 111.209 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -84.39 133.72 34.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -95.77 125.66 40.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 1.0 112.096 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 60' ' ' GLY . 6.2 m-20 -95.14 138.57 21.96 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.79 -29.11 3.32 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.514 2.142 . . . . 1.0 112.453 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -82.82 -19.71 37.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 1.0 110.03 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.56 -10.91 38.94 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.517 -0.633 . . . . 1.0 111.517 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -82.18 88.26 6.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.63 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.06 154.29 23.6 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.5 p -124.97 148.85 48.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.971 0.415 . . . . 1.0 111.646 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.93 107.9 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.75 0.16 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.779 0.324 . . . . 1.0 111.413 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.33 120.44 3.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.062 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.5 tt0 -145.46 132.51 20.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 1.0 111.846 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.19 142.42 51.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 1.0 109.406 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -143.09 145.47 32.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.907 0.384 . . . . 1.0 110.76 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.07 -35.03 63.07 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -179.9 -164.49 32.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.037 -0.825 . . . . 1.0 111.037 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -72.42 16.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.309 . . . . 1.0 110.486 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 71' ' ' GLY . 61.5 ttm-85 -66.83 -46.66 74.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.15 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.6 mt -115.19 124.61 29.95 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.87 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.24 154.21 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.535 2.157 . . . . 1.0 112.134 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.7 m -90.13 130.39 36.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.934 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.507 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 23.6 mt -98.48 13.56 31.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.437 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 20.4 tp -71.41 130.42 41.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.224 0.535 . . . . 1.0 112.308 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.18 -10.0 70.54 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.496 -0.774 . . . . 1.0 111.581 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.7 mt -85.14 153.77 22.45 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.327 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.1 t -107.69 133.5 52.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.658 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 7.4 m-85 -85.55 152.26 57.12 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.57 133.82 38.59 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.625 2.216 . . . . 1.0 111.808 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 131.13 45.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.712 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.89 0.64 42.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 50.9 t0 -53.71 -33.92 57.13 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.3 mt -91.44 110.37 42.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.377 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 87' ' ' ILE . 88.7 Cg_exo -51.47 -155.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.437 2.091 . . . . 1.0 112.448 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -107.11 -59.38 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.493 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.89 -40.27 79.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.369 . . . . 1.0 111.875 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.55 38.48 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.969 0.359 . . . . 1.0 111.969 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -53.85 -35.92 62.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.485 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -65.33 -33.42 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.78 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.72 -36.73 78.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.256 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.647 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 23.7 m-85 -58.19 -30.54 66.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.069 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -83.31 -23.93 32.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.824 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.2 mt -97.93 -47.51 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.526 ' N ' HE21 ' A' ' 99' ' ' GLN . . . -114.62 -12.64 12.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.089 1.514 . . . . 1.0 115.089 -173.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.667 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 3.0 mm-40 45.6 61.43 2.62 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.164 -1.014 . . . . 1.0 108.813 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.573 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 3.9 m -165.71 105.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.075 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.446 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 9.9 mmt180 -148.29 150.36 33.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.418 . . . . 1.0 110.742 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -169.09 146.7 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.522 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.41 ' CG1' HBA2 ' A' ' 203' ' ' CYC . 27.1 mt -107.42 135.07 47.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.65 160.28 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.227 0.825 . . . . 1.0 113.227 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 4.3 p30 -45.52 121.0 2.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.881 -1.054 . . . . 1.0 112.209 -177.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.2 -22.11 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.816 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.428 ' C ' ' H ' ' A' ' 109' ' ' GLN . 46.6 tp10 -62.53 -49.03 76.94 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.65 -8.47 6.62 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.504 0.669 . . . . 1.0 109.391 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 107' ' ' GLU . 54.4 tt0 43.89 72.07 0.21 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.77 -1.105 . . . . 1.0 113.35 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.42 131.9 41.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.905 -1.517 . . . . 1.0 106.905 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -119.77 139.53 52.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.962 -0.695 . . . . 1.0 111.884 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -147.91 167.64 24.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.544 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.56 ' C ' ' H ' ' A' ' 115' ' ' GLN . 15.8 pt -125.24 138.48 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.133 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.2 m -72.87 25.74 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.64 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.56 ' H ' ' C ' ' A' ' 113' ' ' ILE . 83.1 mm-40 -115.16 82.35 8.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.631 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -84.66 160.35 12.37 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.626 2.217 . . . . 1.0 112.336 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 118' ' ' SER . 84.5 tt0 -100.63 115.58 30.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.492 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 117' ' ' GLU . 4.5 m 39.93 -164.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.638 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.647 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 63.8 t-105 -141.97 170.18 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.543 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.647 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . -80.51 165.6 48.4 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 38.0 mt -90.48 170.23 10.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.715 0.293 . . . . 1.0 110.423 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.1 m -53.68 -42.69 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.478 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.32 84.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.711 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -83.04 141.05 32.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.56 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.415 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 7.6 p -130.54 85.51 55.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.201 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -48.73 131.49 24.52 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.616 2.21 . . . . 1.0 112.335 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.9 mt -132.32 76.21 1.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 40.39 87.98 0.01 OUTLIER Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.839 -0.904 . . . . 1.0 110.839 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.476 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 1.4 tt0 -48.53 -48.11 68.53 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.548 0.213 . . . . 1.0 110.859 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 40.2 Cg_endo -94.49 158.18 1.97 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.11 2.54 . . . . 1.0 111.671 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.7 mt -82.82 -15.71 50.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.32 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.63 ' O ' ' C ' ' A' ' 133' ' ' ARG . 93.4 mt-30 -91.09 -8.59 48.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.931 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.63 ' C ' ' O ' ' A' ' 132' ' ' GLN . 85.5 mtt180 17.83 68.58 0.22 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.582 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.28 141.77 96.64 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.777 2.318 . . . . 1.0 111.908 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.5 t -106.96 128.03 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.829 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.598 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -44.92 148.36 0.99 Allowed Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.16 -33.95 89.89 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.224 2.616 . . . . 1.0 113.988 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.724 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.8 p -48.32 -47.73 36.61 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.74 0.274 . . . . 1.0 111.74 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.724 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 29.4 t-80 -81.5 -29.38 33.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.274 0.472 . . . . 1.0 112.274 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.4 t -64.22 -53.7 40.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.928 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -64.34 -28.02 69.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -59.63 -41.08 89.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.868 -0.606 . . . . 1.0 109.759 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 146' ' ' MET . 12.7 mt -73.52 -39.33 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -51.08 -38.87 54.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.5 m -64.44 -24.72 67.72 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.738 -1.119 . . . . 1.0 109.223 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.58 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.4 mmm -92.0 -1.69 57.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.739 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.6 22.0 77.88 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.03 142.39 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 1.0 111.002 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.54 -39.9 5.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.015 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -133.41 125.38 28.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.118 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 m -119.06 138.37 52.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.449 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -116.27 141.13 48.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.29 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.493 HG22 HAA2 ' A' ' 203' ' ' CYC . 1.6 t -126.24 122.65 61.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.157 0.503 . . . . 1.0 111.77 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.46 93.03 26.14 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.836 -1.172 . . . . 1.0 107.836 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -48.14 150.21 5.31 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.149 2.566 . . . . 1.0 114.648 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.9 mp -123.08 64.19 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -149.63 -161.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.138 0.792 . . . . 1.0 113.138 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.22 -178.72 5.23 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.315 -0.857 . . . . 1.0 111.397 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -73.8 -55.42 6.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 1.0 112.026 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -103.57 8.6 37.64 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.991 0.367 . . . . 1.0 111.991 -177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -140.6 133.45 29.07 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.877 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.7 OUTLIER -110.63 119.35 38.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.236 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -93.58 -36.65 12.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.241 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.41 -177.38 37.03 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.7 mp -141.16 138.89 33.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 1.0 111.564 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.0 tp -104.98 136.99 43.42 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.24 135.39 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.713 -0.395 . . . . 1.0 111.106 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.5 m -112.04 142.4 44.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.019 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.53 ' CE1' ' NH1' ' A' ' 50' ' ' ARG . 42.3 m80 -114.81 127.42 55.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.029 0.442 . . . . 1.0 111.698 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.533 ' CD2' ' OE2' ' A' ' 172' ' ' GLU . 1.7 t-80 -127.42 121.93 32.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.949 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.47 61.44 5.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.803 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.533 ' OE2' ' CD2' ' A' ' 170' ' ' HIS . 26.3 pt-20 -152.04 142.65 15.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.064 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.39 -0.49 10.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.986 2.457 . . . . 1.0 111.854 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -60.67 147.18 84.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.898 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.15 167.48 25.85 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.545 2.163 . . . . 1.0 111.924 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -86.42 142.44 28.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.42 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.2 m -115.0 150.87 35.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.622 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -60.54 -29.88 69.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.57 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 29.8 mp0 -55.34 -34.33 64.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.769 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -63.66 -37.54 87.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.503 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.56 -37.81 85.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.543 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.5 tm0? -54.49 -39.22 67.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.389 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 83.7 t -67.24 -53.9 28.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 188' ' ' ALA . 19.2 m -74.58 -29.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -51.61 -45.48 63.22 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.873 -0.331 . . . . 1.0 111.686 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 18.5 tp -76.25 -41.17 49.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.878 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.5 mt -78.39 -39.71 38.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.816 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -61.44 -44.45 97.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.472 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -61.53 -38.12 86.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 1.0 109.971 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.43 -26.4 60.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.136 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.73 -49.61 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.734 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 83.1 p -51.47 -30.27 19.24 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 56.9 mt -76.82 -33.85 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.495 -0.775 . . . . 1.0 109.214 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.61 -45.81 77.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.789 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.0 pt -63.43 -35.11 71.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.138 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.78 -44.51 69.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 1.0 111.199 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.26 -38.44 75.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 1.0 111.518 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.32 -32.88 74.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.666 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.55 -32.85 70.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.478 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.3 mt -60.68 -32.62 71.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.99 -0.284 . . . . 1.0 111.051 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -53.45 -53.0 57.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.563 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 21.7 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.53 179.594 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.605 ' HHB' ' HE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.899 0.38 . . . . 1.0 110.59 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -57.29 -52.05 66.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.03 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -55.99 -46.19 78.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.085 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 34' ' ' ILE . 88.7 mt -61.61 -53.4 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 1.0 110.91 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.507 ' O ' ' OG1' ' A' ' 38' ' ' THR . 84.8 mt -53.98 -43.52 70.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.995 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.478 HH12 ' CD2' ' A' ' 78' ' ' LEU . 59.8 ttm-85 -54.02 -35.46 61.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.617 -0.433 . . . . 1.0 109.895 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -36.23 72.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.078 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.564 ' HG1' ' N ' ' A' ' 39' ' ' VAL . 65.8 p -70.83 -42.11 70.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.527 -0.76 . . . . 1.0 112.295 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.564 ' N ' ' HG1' ' A' ' 38' ' ' THR . 9.8 p -69.05 -36.52 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.93 0.344 . . . . 1.0 111.93 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -71.6 -40.99 69.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.805 0.336 . . . . 1.0 111.094 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.25 -52.01 65.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.757 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.5 m -56.06 -34.42 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.721 0.296 . . . . 1.0 111.13 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 47' ' ' GLY . 60.9 ttp180 -54.01 -43.08 69.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 1.0 110.81 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.51 76.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.047 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -78.73 -45.63 20.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.611 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.0 mt -86.04 -31.98 21.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.49 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.9 22.6 48.56 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.459 -1.057 . . . . 1.0 110.459 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -73.34 141.99 47.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 1.0 110.229 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -42.12 -43.43 3.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.6 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -158.29 130.53 6.96 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.048 -0.661 . . . . 1.0 112.61 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.48 130.51 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.579 -0.897 . . . . 1.0 108.579 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' NZ ' ' OB ' ' A' ' 203' ' ' CYC . 12.3 pttm -142.08 156.4 45.39 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.453 -0.499 . . . . 1.0 111.871 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.6 t -99.99 134.39 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 42.4 t80 -115.59 105.89 13.3 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.335 -0.546 . . . . 1.0 111.306 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -76.68 126.27 30.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.212 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.438 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 68.3 t80 -92.52 136.91 32.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.991 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 60' ' ' GLY . 4.8 m-20 -106.57 140.1 20.99 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.31 -28.86 6.22 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.53 2.153 . . . . 1.0 112.45 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -83.31 -17.76 41.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.882 0.373 . . . . 1.0 110.03 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 106.96 -13.73 41.11 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.574 -0.611 . . . . 1.0 111.574 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -78.15 91.16 4.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.808 0.337 . . . . 1.0 110.613 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.92 152.56 21.06 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.566 -1.014 . . . . 1.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.7 p -125.29 148.17 48.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 1.0 111.727 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -74.41 107.31 4.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.55 -1.58 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.351 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.94 115.87 3.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.112 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 85.4 tt0 -145.25 131.17 19.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.079 0.466 . . . . 1.0 111.854 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.81 137.47 49.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.409 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -143.33 148.7 36.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.875 0.369 . . . . 1.0 110.718 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.99 -120.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.852 -0.899 . . . . 1.0 110.852 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -78.78 -179.74 51.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.78 43.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 1.0 110.559 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 71' ' ' GLY . 77.6 ttt180 -82.91 -46.72 12.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.177 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 mt -111.68 146.44 34.7 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 1.0 109.84 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.2 160.31 50.01 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.525 2.15 . . . . 1.0 112.132 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 m -89.78 127.42 35.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.941 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.6 mt -98.28 11.33 38.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.399 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.488 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.4 tp -72.47 132.76 44.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.012 -0.54 . . . . 1.0 112.306 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.96 -9.72 71.11 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.604 -0.726 . . . . 1.0 111.529 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.5 mt -86.67 152.96 22.11 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.936 -0.305 . . . . 1.0 110.344 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.6 m -105.26 132.24 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.675 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.456 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 7.4 m-85 -86.28 152.25 55.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.45 133.45 37.34 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.653 2.236 . . . . 1.0 111.873 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.78 131.48 46.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.693 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.62 2.12 40.3 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.548 -1.021 . . . . 1.0 110.548 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 54.3 t0 -57.59 -33.46 68.21 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.558 ' N ' ' CD1' ' A' ' 87' ' ' ILE . 1.6 mp -82.59 127.09 71.8 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.46 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.06 -164.86 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.411 2.074 . . . . 1.0 112.54 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -105.87 -58.68 1.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.535 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.19 -45.0 96.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.795 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.21 87.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -63.79 -37.77 88.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.424 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -62.05 -36.48 81.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.781 0.324 . . . . 1.0 110.835 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.82 -33.07 71.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.286 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.642 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 2.3 t80 -63.8 -31.42 72.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.003 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.46 ' C ' HE22 ' A' ' 99' ' ' GLN . 74.6 ttt180 -81.87 -27.12 33.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.865 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.85 -42.67 7.85 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 114.356 1.243 . . . . 1.0 114.356 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.74 -6.78 13.84 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -175.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.704 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.4 mm-40 42.58 75.31 0.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.226 -0.99 . . . . 1.0 108.864 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p 175.79 115.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.023 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.464 ' HD3' HAA2 ' A' ' 203' ' ' CYC . 33.7 ttm-85 -159.18 153.25 23.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 1.0 110.758 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.1 p -168.99 148.07 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.504 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 56.2 mt -105.34 134.79 45.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.2 t -88.53 158.92 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.25 0.833 . . . . 1.0 113.25 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 3.7 p30 -49.23 121.0 4.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.937 -1.029 . . . . 1.0 112.151 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.1 p -56.09 -22.07 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.342 -0.845 . . . . 1.0 110.784 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -61.79 -50.31 72.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.26 -10.53 24.28 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.465 0.65 . . . . 1.0 109.347 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 44.51 70.74 0.31 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.785 -1.098 . . . . 1.0 113.267 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.55 131.99 42.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.965 -1.495 . . . . 1.0 106.965 175.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -121.13 134.89 55.25 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.967 -0.693 . . . . 1.0 111.937 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.61 156.23 43.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.63 -0.713 . . . . 1.0 110.529 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.2 pt -156.83 -179.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.103 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.9 p -59.91 154.01 19.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.685 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -137.9 152.3 71.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.698 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.46 -20.91 10.6 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.727 2.285 . . . . 1.0 112.416 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -122.29 158.2 30.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.357 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.3 m -121.02 148.64 43.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.671 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -86.45 -99.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.522 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.44 169.41 45.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.81 -37.9 88.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 1.0 110.416 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.9 p -57.54 -33.85 68.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.522 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 124' ' ' ARG . . . -71.77 -30.82 65.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.662 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 123' ' ' ALA . 70.2 mtt180 76.32 -178.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.505 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.571 ' O ' ' O ' ' A' ' 126' ' ' PRO . 10.7 t -146.92 86.77 6.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.242 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 125' ' ' VAL . 78.9 Cg_exo -50.5 -131.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.653 2.235 . . . . 1.0 112.239 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.6 mt -56.91 -31.94 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.579 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 117.44 129.01 4.12 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -70.66 149.45 95.35 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.57 0.224 . . . . 1.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -85.98 10.25 3.74 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.177 2.584 . . . . 1.0 111.635 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.8 mp -75.74 -17.42 59.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.336 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 64.77 5.99 3.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.942 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 60.13 71.61 0.85 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.555 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.7 155.23 70.83 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.758 2.305 . . . . 1.0 111.92 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 m -105.55 125.54 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.927 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -43.71 130.37 3.99 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -40.23 -46.28 4.18 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.178 2.585 . . . . 1.0 114.051 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.3 p -38.85 -45.24 1.14 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.688 0.255 . . . . 1.0 111.688 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.677 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 17.5 t60 -81.19 -28.68 34.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.87 -54.96 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.939 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -65.14 -28.7 69.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -59.78 -44.72 93.78 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.774 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 146' ' ' MET . 69.5 mt -72.96 -38.08 66.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -50.64 -39.27 50.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -63.87 -26.87 68.81 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.729 -1.123 . . . . 1.0 109.165 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.564 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.5 mmm -88.75 -1.27 58.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.452 -0.794 . . . . 1.0 110.709 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.98 22.01 77.5 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.9 t -111.62 140.75 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.905 0.383 . . . . 1.0 110.968 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.47 -40.54 4.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.0 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.6 m -133.4 122.53 23.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.12 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.446 ' OG ' ' CG2' ' A' ' 167' ' ' VAL . 3.7 t -116.75 133.63 55.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.436 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 tt -112.19 137.19 50.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.273 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.3 120.05 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.157 0.503 . . . . 1.0 111.774 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.03 103.74 47.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.409 ' HG3' ' CZ ' ' A' ' 95' ' ' PHE . 78.8 Cg_exo -40.38 125.91 2.0 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.197 2.598 . . . . 1.0 114.69 -175.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.9 tp -113.59 47.53 1.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.861 -1.533 . . . . 1.0 106.861 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.2 ptm -148.59 -174.75 4.69 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.069 0.766 . . . . 1.0 113.069 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.685 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 42.0 t-80 -75.13 -179.33 4.32 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.311 -0.859 . . . . 1.0 111.38 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 82.2 t60 -75.16 -55.64 5.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.396 -0.82 . . . . 1.0 112.057 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -104.62 9.48 35.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -139.76 137.15 34.84 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.701 -0.399 . . . . 1.0 110.906 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.454 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 5.7 tt -110.62 113.93 26.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.068 -0.515 . . . . 1.0 111.303 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -90.79 -35.45 14.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.28 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -163.02 -172.95 31.15 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.39 129.01 26.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 1.0 111.562 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.6 tp -103.54 129.1 50.69 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.446 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 11.5 p -139.14 139.71 39.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.069 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 84.2 p -110.86 140.33 45.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.049 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -111.71 132.3 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.979 0.418 . . . . 1.0 111.601 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -130.1 121.2 25.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 1.0 109.882 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -81.64 55.79 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.808 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -156.77 149.63 18.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.012 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.78 -11.55 31.03 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.907 2.405 . . . . 1.0 111.914 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -39.33 104.17 0.31 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.862 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.81 167.44 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.585 2.19 . . . . 1.0 111.902 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 49.5 p90 -80.09 129.66 34.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.462 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.5 t -111.93 143.0 43.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.635 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -58.04 -27.74 63.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.664 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -57.55 -38.48 74.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.666 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.86 -38.07 89.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.542 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 56.5 mt -64.18 -40.82 96.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.517 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -53.63 -38.21 63.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.33 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.23 -54.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 188' ' ' ALA . 29.3 m -77.34 -29.8 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.404 0.52 . . . . 1.0 112.404 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 189' ' ' ASP . 58.8 tp60 -50.98 -49.9 59.32 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.98 -0.288 . . . . 1.0 111.631 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.6 tp -76.84 -41.33 44.59 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.8 tp -76.75 -43.43 37.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.806 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -60.09 -40.42 89.53 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.511 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 93.5 m-20 -56.52 -38.37 71.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.018 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -71.23 -24.91 62.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.155 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 194' ' ' ALA . 93.8 t -82.85 -49.01 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 1.0 109.731 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.6 m -51.4 -29.92 17.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 57.9 mt -75.92 -33.28 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.236 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -67.07 -45.41 77.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.825 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 19.0 pt -63.93 -35.53 73.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.149 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -68.78 -43.37 75.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.135 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -70.94 -38.04 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.553 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.21 -32.08 73.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.725 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.92 -39.13 93.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.475 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.93 -35.67 80.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.723 0.297 . . . . 1.0 111.119 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.2 t -54.8 -53.68 52.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.612 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.48 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.464 HAA2 ' HD3' ' A' ' 101' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.814 0.34 . . . . 1.0 110.531 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -60.13 -52.7 64.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.985 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -54.9 -45.98 74.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.087 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 34' ' ' ILE . 17.3 mm -61.01 -48.24 89.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 1.0 110.966 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.561 ' O ' ' OG1' ' A' ' 38' ' ' THR . 35.5 mt -56.95 -42.78 80.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 1.0 111.03 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -52.91 -35.33 58.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.068 0.461 . . . . 1.0 109.869 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.91 -34.34 71.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.06 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.561 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 62.4 p -72.28 -40.23 67.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.524 -0.762 . . . . 1.0 112.263 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -73.57 -38.76 52.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 111.899 0.333 . . . . 1.0 111.899 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.2 -45.46 63.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.772 0.32 . . . . 1.0 111.104 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.85 -47.93 70.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.784 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.39 -39.06 79.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.982 -0.287 . . . . 1.0 111.12 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.4 tmm_? -57.25 -42.9 82.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 1.0 110.823 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.82 -33.59 68.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -78.42 -40.67 35.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.542 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.71 -31.2 22.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.448 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 61.7 21.78 61.09 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 169' ' ' HIS . 5.2 t -73.22 139.48 46.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.35 . . . . 1.0 110.17 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -44.57 -38.68 4.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.609 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.525 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 53.7 ttt85 -161.53 126.24 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.058 -0.657 . . . . 1.0 112.625 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.23 128.31 29.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.697 ' HZ1' HBB3 ' A' ' 203' ' ' CYC . 20.7 pttp -140.18 155.66 46.84 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.86 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.42 137.49 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.473 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -136.62 127.91 28.21 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.252 -0.579 . . . . 1.0 111.288 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -88.03 144.35 26.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.745 -0.662 . . . . 1.0 110.208 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.595 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 80.4 t80 -95.52 117.79 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 1.0 112.027 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.9 m-20 -85.27 135.85 38.56 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -45.83 -24.06 1.92 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.456 2.104 . . . . 1.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.21 -18.48 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.052 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.88 -13.36 38.11 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.583 -0.607 . . . . 1.0 111.583 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -75.07 92.25 2.62 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.642 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.54 142.54 18.0 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 p -121.39 142.75 49.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 1.0 111.751 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.65 110.94 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.748 -0.834 . . . . 1.0 108.748 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.458 ' CG1' ' O ' ' A' ' 65' ' ' VAL . 95.5 t -106.59 -0.89 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.942 -0.303 . . . . 1.0 111.372 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.97 120.79 3.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.149 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 68.6 tt0 -142.12 131.78 24.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.06 0.457 . . . . 1.0 111.818 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.95 143.11 50.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.375 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.528 ' NH1' ' OG ' ' A' ' 76' ' ' SER . 32.8 ptt180 -142.88 142.44 31.77 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.743 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.44 -33.01 85.04 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -171.48 -170.92 36.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 77.6 mm-40 -78.25 38.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 1.0 110.556 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.422 ' H ' ' C ' ' A' ' 71' ' ' GLY . 10.2 tpt180 -82.83 -48.11 11.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.148 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.46 149.26 36.85 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.826 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.95 146.69 59.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.532 2.155 . . . . 1.0 112.183 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.528 ' OG ' ' NH1' ' A' ' 69' ' ' ARG . 67.2 m -77.28 121.23 23.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.962 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.463 ' H ' HH22 ' A' ' 50' ' ' ARG . 27.5 mt -100.59 12.12 38.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.416 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.2 tp -73.49 132.68 43.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.307 0.575 . . . . 1.0 112.288 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.86 -10.04 63.89 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.505 -0.771 . . . . 1.0 111.546 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.0 mt -86.43 155.55 20.52 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.001 -0.28 . . . . 1.0 110.329 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.2 p -103.65 126.37 50.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.67 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -77.86 151.8 79.65 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.55 117.7 4.66 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.648 2.232 . . . . 1.0 111.818 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.01 125.09 11.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.677 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.7 0.13 42.59 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.574 -1.011 . . . . 1.0 110.574 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 2.6 p30 -56.76 -32.64 65.8 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.477 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 3.2 tp -84.25 131.05 51.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.384 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.19 -169.48 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.427 2.085 . . . . 1.0 112.487 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -107.1 -44.71 4.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.559 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -69.36 -41.15 76.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.796 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.35 -44.05 79.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.906 0.336 . . . . 1.0 111.906 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.595 ' NH2' ' CG ' ' A' ' 56' ' ' PHE . 51.6 ttt85 -65.23 -44.09 89.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.472 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -61.05 -34.14 74.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.34 . . . . 1.0 110.879 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.505 ' C ' HH22 ' A' ' 101' ' ' ARG . 47.4 mt -71.18 -38.75 72.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.298 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.609 ' N ' ' NH2' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -58.19 -28.51 64.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.061 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -74.91 -29.87 61.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.87 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.587 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 75.5 mt -97.17 -39.4 9.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.573 ' C ' ' NE2' ' A' ' 99' ' ' GLN . . . -118.34 -7.19 10.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.051 1.5 . . . . 1.0 115.051 -176.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.632 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER 38.51 77.4 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.161 -1.015 . . . . 1.0 108.847 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.45 ' CG1' ' O ' ' A' ' 100' ' ' VAL . 12.9 p 179.32 114.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.108 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.609 ' NH2' ' N ' ' A' ' 95' ' ' PHE . 4.0 tpp180 -156.79 150.84 24.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.954 0.407 . . . . 1.0 110.75 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.32 145.72 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.456 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.7 mt -108.6 131.84 58.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.141 -0.689 . . . . 1.0 109.141 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.1 m -91.66 164.9 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 113.23 0.826 . . . . 1.0 113.23 -176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -48.07 117.24 1.82 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.89 -1.05 . . . . 1.0 112.139 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.1 p -53.51 -19.34 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.347 -0.842 . . . . 1.0 110.799 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 109' ' ' GLN . 76.3 tt0 -66.37 -44.69 82.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.97 -4.77 10.43 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.596 0.712 . . . . 1.0 109.414 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 107' ' ' GLU . 13.6 pt20 36.6 69.45 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.713 -1.131 . . . . 1.0 113.295 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.3 p -75.22 131.06 40.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.997 -1.482 . . . . 1.0 106.997 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -121.91 142.14 50.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.888 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 t -130.3 122.57 28.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.55 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.797 ' O ' ' N ' ' A' ' 115' ' ' GLN . 69.3 mt -129.79 174.13 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.191 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.544 ' H ' ' CG2' ' A' ' 113' ' ' ILE . 29.3 t 38.48 -77.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.654 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.797 ' N ' ' O ' ' A' ' 113' ' ' ILE . 53.1 tp60 -54.23 107.49 0.87 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.639 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.406 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 35.5 Cg_endo -92.6 -43.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.638 2.225 . . . . 1.0 112.372 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 116' ' ' PRO . 98.9 mt-10 -96.6 169.55 9.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.418 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.406 ' CB ' ' NH1' ' A' ' 133' ' ' ARG . 95.8 p -130.11 160.4 33.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.646 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -57.88 120.1 7.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.511 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.43 92.12 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 124' ' ' ARG . 33.7 mt -87.92 139.73 30.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 1.0 110.357 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 t -60.94 -37.12 81.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.45 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.85 90.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.708 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 121' ' ' LEU . 10.4 tpp85 -139.43 144.75 38.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.56 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.29 84.81 23.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.18 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.59 153.94 1.97 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.671 2.247 . . . . 1.0 112.288 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 129' ' ' GLU . 9.0 mp -57.76 -19.77 30.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.58 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.67 74.79 0.01 OUTLIER Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.786 -0.925 . . . . 1.0 110.786 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 127' ' ' LEU . 42.4 mt-10 -143.78 74.74 16.45 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.559 0.219 . . . . 1.0 110.877 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -86.88 163.37 8.97 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 123.099 2.533 . . . . 1.0 111.679 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 48.8 mt -76.36 -5.87 49.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.361 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -85.52 88.33 7.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.939 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.406 ' NH1' ' CB ' ' A' ' 118' ' ' SER . 22.1 mmt180 -124.33 80.35 59.64 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.506 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.87 138.94 20.3 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.691 2.261 . . . . 1.0 111.997 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.416 HG13 HBD2 ' A' ' 203' ' ' CYC . 8.1 t -105.84 122.82 59.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.85 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -42.43 152.74 0.33 Allowed Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.746 -0.464 . . . . 1.0 109.746 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -58.89 -34.72 99.21 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.223 2.615 . . . . 1.0 114.068 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.705 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -48.16 -46.31 34.48 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.684 0.253 . . . . 1.0 111.684 -178.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.717 ' HE2' ' HHB' ' A' ' 203' ' ' CYC . 19.1 t-80 -82.91 -27.75 30.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.272 0.471 . . . . 1.0 112.272 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.4 t -65.2 -52.26 55.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.965 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -66.47 -27.87 68.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.537 ' O ' ' OG ' ' A' ' 145' ' ' SER . 76.0 t80 -60.02 -41.98 93.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.732 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 146' ' ' MET . 8.9 mt -73.03 -37.83 66.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -51.95 -38.24 55.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 10.9 p -66.85 -20.66 65.97 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.761 -1.109 . . . . 1.0 109.188 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.568 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -95.43 -0.02 52.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.406 -0.816 . . . . 1.0 110.711 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.61 20.68 78.65 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.69 143.96 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 1.0 110.968 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.66 -42.29 4.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.982 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 t -135.35 122.85 22.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.135 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.6 m -110.99 141.91 43.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.503 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 tp -118.27 136.35 53.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.292 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.7 t -123.14 114.85 43.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.12 0.486 . . . . 1.0 111.772 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.5 t -113.26 131.2 23.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 107.806 -1.183 . . . . 1.0 107.806 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.75 125.45 8.17 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.152 2.568 . . . . 1.0 114.676 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.2 mt -118.52 48.95 1.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -146.14 176.55 9.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.509 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 49.9 t-80 -67.72 171.68 6.16 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.379 -0.828 . . . . 1.0 111.391 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.509 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 73.5 m80 -61.98 -52.82 62.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.039 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -103.79 -39.32 6.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.541 ' OE1' ' CD2' ' A' ' 163' ' ' TRP . 11.0 tm-20 -87.54 133.55 33.76 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.909 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.6 OUTLIER -107.2 117.52 34.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 1.0 111.301 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.541 ' CD2' ' OE1' ' A' ' 161' ' ' GLU . 54.2 m95 -92.0 -41.04 10.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.231 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.34 -176.86 35.76 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.204 -0.759 . . . . 1.0 111.204 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.87 140.19 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 1.0 111.569 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.5 tp -98.97 135.67 40.06 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.59 129.11 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.371 . . . . 1.0 111.051 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.5 t -107.6 150.7 26.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.996 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.442 ' O ' ' OG1' ' A' ' 48' ' ' THR . 91.7 m-70 -127.81 134.84 49.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.961 0.41 . . . . 1.0 111.626 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -132.62 113.93 13.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.015 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.78 -14.24 62.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.857 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -108.04 150.0 39.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.01 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.2 140.59 34.35 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.902 2.401 . . . . 1.0 111.896 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -172.31 129.66 0.62 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.898 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.58 157.81 28.55 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.517 2.144 . . . . 1.0 111.932 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -102.2 139.0 38.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.444 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.496 ' N ' ' OE1' ' A' ' 180' ' ' GLU . 8.7 t -126.94 -177.35 4.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.591 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' A' ' 182' ' ' GLN . 95.0 mt-30 -59.98 -34.1 72.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.657 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -56.17 -36.93 68.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.764 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 177' ' ' SER . 40.5 mp0 -65.15 -24.21 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.497 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.6 tp -80.88 -30.53 35.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.497 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.497 ' NE2' ' N ' ' A' ' 182' ' ' GLN . 0.3 OUTLIER -63.28 -43.36 98.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.32 -178.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 184' ' ' VAL . 22.9 m -73.7 -51.56 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.482 ' N ' ' CG2' ' A' ' 183' ' ' VAL . 16.9 m -68.57 -46.26 80.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.445 0.535 . . . . 1.0 112.445 -177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.442 ' N ' ' CG2' ' A' ' 184' ' ' VAL . 52.7 tp60 -53.09 -36.62 60.89 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.664 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.1 tt -74.55 -53.48 9.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 71.0 mt -78.91 -39.27 35.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.883 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 184' ' ' VAL . . . -62.18 -45.52 93.04 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.487 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.415 ' OD2' ' NE2' ' A' ' 185' ' ' GLN . 93.0 m-20 -60.01 -40.19 88.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.069 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -69.21 -23.85 63.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.117 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 57.9 t -83.79 -45.58 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.041 -0.527 . . . . 1.0 109.775 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.5 p -57.58 -34.59 69.38 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.677 -0.861 . . . . 1.0 108.677 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.8 mt -69.15 -34.3 62.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.394 -0.821 . . . . 1.0 109.156 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.6 -38.03 77.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.783 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.7 mm -64.24 -40.24 88.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.087 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.36 -49.06 53.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.132 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -69.99 -35.98 74.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.492 -178.005 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.441 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.49 -33.5 74.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.673 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.75 -33.25 72.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.449 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.79 -30.54 71.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.002 -0.279 . . . . 1.0 111.067 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -51.67 -51.99 51.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.551 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 23.7 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.56 179.495 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.717 ' HHB' ' HE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.847 0.356 . . . . 1.0 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -79.13 -29.73 43.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.942 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -77.41 -47.72 19.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.11 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 35' ' ' LEU . 2.9 tp -61.61 -41.15 89.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.74 0.305 . . . . 1.0 110.859 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.618 ' O ' ' OG1' ' A' ' 38' ' ' THR . 20.2 mt -57.0 -44.43 82.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.089 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 39' ' ' VAL . 61.1 mtp85 -55.35 -33.95 63.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.1 -33.22 69.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.154 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.618 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 82.8 p -72.15 -40.94 67.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.416 -0.811 . . . . 1.0 112.264 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' N ' ' HG1' ' A' ' 38' ' ' THR . 8.5 p -71.33 -37.23 64.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.04 -48.17 66.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 1.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.82 -52.69 59.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.687 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.6 t -53.49 -40.72 42.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.953 -0.299 . . . . 1.0 111.153 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.2 tmm_? -53.28 -39.3 63.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.737 0.303 . . . . 1.0 110.816 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.05 74.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.028 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -77.18 -42.22 38.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.578 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.14 -28.32 24.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.459 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.43 20.65 17.44 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.462 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 87.5 m -71.73 142.52 49.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 1.0 110.253 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -41.91 -45.53 3.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.596 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.51 HH21 ' CD ' ' A' ' 67' ' ' GLU . 64.0 ttt-85 -159.87 128.14 4.88 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.022 -0.671 . . . . 1.0 112.572 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.48 131.32 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -140.2 156.47 46.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.478 -0.489 . . . . 1.0 111.918 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.8 135.69 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -134.39 125.78 28.23 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.358 -0.537 . . . . 1.0 111.339 -178.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -84.17 143.47 29.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.235 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.609 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 72.7 t80 -95.51 119.23 33.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.065 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.43 149.48 52.06 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -60.93 -23.43 77.16 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.51 2.14 . . . . 1.0 112.456 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.5 -11.87 53.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.924 0.392 . . . . 1.0 110.116 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.69 -15.15 53.07 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.547 -0.621 . . . . 1.0 111.547 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -73.13 94.98 2.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.759 0.314 . . . . 1.0 110.6 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.6 139.59 16.04 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.1 p -120.64 142.14 49.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.862 0.363 . . . . 1.0 111.756 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 t -79.22 110.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.18 0.71 10.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.886 -0.325 . . . . 1.0 111.306 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.99 117.97 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.035 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.51 ' CD ' HH21 ' A' ' 50' ' ' ARG . 85.8 tt0 -143.58 132.4 22.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.122 0.487 . . . . 1.0 111.784 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.49 143.14 50.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.393 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -141.59 145.78 35.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.784 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -52.39 -34.09 40.93 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 177.31 -161.61 29.19 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.06 16.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 1.0 110.54 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 71' ' ' GLY . 30.3 ttm180 -65.31 -49.07 70.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.195 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.8 mt -111.82 146.77 35.42 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.887 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.33 159.32 54.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.486 2.124 . . . . 1.0 112.19 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.3 m -95.02 127.95 41.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.915 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.7 mt -94.95 11.29 32.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.371 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.5 tp -68.0 132.21 46.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 1.0 112.241 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.08 -11.65 66.61 Favored Glycine 0 CA--C 1.523 0.594 0 CA-C-N 115.615 -0.721 . . . . 1.0 111.54 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.4 mt -83.99 151.62 24.91 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.944 -0.303 . . . . 1.0 110.306 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.7 p -105.25 132.69 51.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.679 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.683 ' CE2' HAB1 ' A' ' 203' ' ' CYC . 9.2 m-85 -86.97 130.53 47.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -40.39 138.49 1.31 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.686 2.257 . . . . 1.0 111.864 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.86 125.63 25.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.676 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.32 -1.51 43.4 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -60.54 -33.38 72.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 87' ' ' ILE . 1.5 mp -69.31 130.28 91.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.417 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.59 168.9 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.35 2.033 . . . . 1.0 112.499 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -100.45 -56.04 2.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.572 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -64.59 -41.67 96.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.813 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.524 ' CB ' HBD2 ' A' ' 203' ' ' CYC . . . -66.84 -44.01 82.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.609 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 42.2 ttt85 -62.42 -41.3 98.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.436 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -62.87 -34.88 78.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.768 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.489 ' C ' HH22 ' A' ' 101' ' ' ARG . 71.2 mt -70.84 -38.21 73.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.225 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.657 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 1.7 t80 -62.03 -20.71 64.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.557 ' C ' HE22 ' A' ' 99' ' ' GLN . 38.2 ttt180 -82.96 -28.38 29.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.824 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.24 -42.65 7.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.07 -8.06 13.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 115.07 1.508 . . . . 1.0 115.07 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.701 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.4 mm-40 42.43 81.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.186 -1.005 . . . . 1.0 108.817 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p 174.41 114.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.985 -0.552 . . . . 1.0 111.101 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.608 ' NH2' ' N ' ' A' ' 95' ' ' PHE . 3.8 tpp180 -155.23 147.02 23.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 1.0 110.714 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 p -170.76 146.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.514 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.2 mt -108.65 136.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.44 HG11 ' H ' ' A' ' 133' ' ' ARG . 3.2 m -93.02 165.79 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.262 0.838 . . . . 1.0 113.262 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -48.07 117.22 1.82 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.899 -1.046 . . . . 1.0 112.109 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.4 p -58.38 -25.79 28.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.401 -0.818 . . . . 1.0 110.773 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 109' ' ' GLN . 84.5 tt0 -63.78 -44.98 91.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.47 -8.07 1.68 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.457 0.646 . . . . 1.0 109.338 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.636 ' NE2' HH21 ' A' ' 111' ' ' ARG . 45.9 tt0 45.04 60.91 2.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.744 -1.116 . . . . 1.0 113.266 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 t -75.15 133.46 41.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.954 -1.499 . . . . 1.0 106.954 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.636 HH21 ' NE2' ' A' ' 109' ' ' GLN . 80.0 mtt180 -119.57 139.52 52.01 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.038 -0.665 . . . . 1.0 111.9 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.29 163.51 32.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.564 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.9 pt -127.31 140.96 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.153 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.489 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 28.6 p -80.47 15.22 1.71 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.644 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 116' ' ' PRO . 65.0 mt-30 -64.51 151.67 91.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.598 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' GLN . 33.9 Cg_exo -34.0 -64.96 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.655 2.237 . . . . 1.0 112.365 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 118' ' ' SER . 72.4 tt0 41.58 61.24 1.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.405 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 117' ' ' GLU . 51.6 p 50.39 176.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.668 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -118.55 144.27 46.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.548 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 72.21 179.34 33.61 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.6 mt -102.47 89.58 3.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 1.0 110.423 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.0 p -66.6 -32.3 73.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.481 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.75 -23.37 64.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.71 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.51 ' NH2' ' O ' ' A' ' 125' ' ' VAL . 2.1 tpm_? 51.45 83.28 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.55 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.51 ' O ' ' NH2' ' A' ' 124' ' ' ARG . 1.6 m -68.38 143.46 95.56 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.23 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -80.96 4.6 6.84 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.577 2.185 . . . . 1.0 112.322 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 127' ' ' LEU . 10.0 mp 55.59 26.15 8.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.571 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.73 -130.33 1.2 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 129' ' ' GLU . 10.7 mp0 -127.23 78.17 74.73 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.655 0.264 . . . . 1.0 110.875 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -87.35 -175.52 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.136 2.557 . . . . 1.0 111.654 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.8 mt -50.87 -61.21 2.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.339 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 179.5 153.74 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.956 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.44 ' H ' HG11 ' A' ' 104' ' ' VAL . 73.4 mtp180 -97.6 111.35 58.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.585 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.06 138.33 12.82 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.774 2.316 . . . . 1.0 111.977 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 26.4 t -125.89 140.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.808 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 114' ' ' SER . 3.7 t70 -43.68 138.88 2.92 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -58.48 -32.45 96.44 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.153 2.569 . . . . 1.0 114.005 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.6 p -49.79 -45.18 49.56 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.693 0.257 . . . . 1.0 111.693 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.668 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 6.5 t60 -81.39 -28.6 34.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.229 0.455 . . . . 1.0 112.229 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.77 -52.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.668 -0.413 . . . . 1.0 111.017 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -67.07 -24.84 66.01 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.53 ' O ' ' OG ' ' A' ' 145' ' ' SER . 87.3 t80 -64.56 -39.52 93.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.673 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 146' ' ' MET . 10.4 mt -73.35 -36.01 66.09 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -52.72 -38.22 60.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.625 -1.25 . . . . 1.0 107.625 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.53 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 11.3 p -66.69 -19.47 65.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.728 -1.124 . . . . 1.0 109.199 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.9 mmm -96.49 3.25 52.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.477 -0.783 . . . . 1.0 110.715 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.7 21.28 77.85 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 150' ' ' SER . 55.2 t -110.54 144.13 19.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.381 . . . . 1.0 110.971 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.95 -17.92 13.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.961 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.409 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 5.6 t -149.83 163.36 38.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.227 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.3 p -148.08 125.06 11.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.482 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -109.03 133.01 53.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.318 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.497 HG22 HAA1 ' A' ' 203' ' ' CYC . 3.7 t -123.57 116.25 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.11 0.481 . . . . 1.0 111.77 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.11 129.27 25.21 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 107.81 -1.181 . . . . 1.0 107.81 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.21 123.48 8.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.091 2.527 . . . . 1.0 114.685 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.4 49.3 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.866 -1.531 . . . . 1.0 106.866 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -147.2 179.29 7.74 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.112 0.782 . . . . 1.0 113.112 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -67.6 164.58 18.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.286 -0.87 . . . . 1.0 111.434 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -57.89 -50.55 72.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.463 -0.789 . . . . 1.0 112.064 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -103.93 -39.64 6.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -88.28 137.92 31.9 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.863 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.474 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER -108.93 112.94 25.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.269 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -88.9 -42.56 11.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.195 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.71 -175.71 25.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.428 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 5.1 tp -145.44 134.15 22.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.352 . . . . 1.0 111.517 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.5 tp -101.63 131.33 47.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.61 131.33 43.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.811 -0.356 . . . . 1.0 111.12 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.9 m -108.59 139.77 42.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.071 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.462 ' O ' ' CG2' ' A' ' 48' ' ' THR . 62.0 m80 -110.43 125.37 53.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.006 0.432 . . . . 1.0 111.636 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.4 ' CE1' ' CG2' ' A' ' 48' ' ' THR . 88.8 m-70 -123.78 114.62 20.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.875 -0.602 . . . . 1.0 109.952 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.36 -14.8 63.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.837 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.89 148.33 34.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.051 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' A' ' 174' ' ' ARG . 80.9 Cg_endo -74.83 -98.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.891 2.394 . . . . 1.0 111.917 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.507 ' O ' ' O ' ' A' ' 173' ' ' PRO . 16.2 mtp-105 56.38 144.94 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.838 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.87 152.0 40.93 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.603 2.202 . . . . 1.0 111.921 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -90.69 146.98 23.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.473 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.435 ' OG ' ' OE1' ' A' ' 180' ' ' GLU . 95.2 p -121.97 156.66 32.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.652 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.758 ' NE2' ' H ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -60.31 -26.16 66.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.558 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -54.58 -39.55 67.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.765 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.435 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 1.5 mp0 -63.96 -39.39 94.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.525 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.27 -38.84 91.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.429 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -56.21 -37.61 69.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.361 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 73.3 t -67.69 -56.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.667 0.617 . . . . 1.0 112.667 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 1.8 t -73.47 -42.7 56.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -43.38 -47.7 6.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.605 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 19.7 tp -70.95 -41.06 71.6 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.919 0.34 . . . . 1.0 111.919 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 8.4 tp -77.91 -38.4 45.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.821 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.24 -37.97 87.42 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.53 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -61.37 -40.11 93.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.031 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.86 -25.36 63.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.12 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.25 -45.25 18.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.767 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.6 t -56.67 -37.02 70.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.3 mt -66.83 -33.65 64.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.448 -0.796 . . . . 1.0 109.171 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.9 -38.94 73.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.784 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.4 mm -65.21 -41.56 91.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.154 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.63 -47.96 61.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.115 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 0.5 OUTLIER -70.33 -34.52 72.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.532 -178.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -67.52 -32.78 73.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.667 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.14 -34.59 75.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.588 -0.278 . . . . 1.0 111.424 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 41.3 mt -61.09 -33.24 73.04 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.091 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 17.5 m -54.04 -53.19 56.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.796 0.331 . . . . 1.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.624 179.658 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.683 HAB1 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 31' ' ' LEU . 10.9 mp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.815 0.341 . . . . 1.0 110.56 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -49.5 -35.25 19.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.993 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -75.4 -46.92 29.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.138 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 34' ' ' ILE . 18.1 mm -64.99 -38.79 83.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.544 -0.298 . . . . 1.0 110.962 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.584 ' O ' ' OG1' ' A' ' 38' ' ' THR . 18.9 mt -57.88 -35.83 71.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.005 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.417 ' O ' HG11 ' A' ' 39' ' ' VAL . 75.8 mtp180 -66.37 -33.47 75.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.084 0.468 . . . . 1.0 109.833 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.19 -30.94 67.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.107 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -73.0 -45.33 58.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.505 -0.77 . . . . 1.0 112.241 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 36' ' ' ARG . 6.1 p -65.41 -35.23 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 111.929 0.344 . . . . 1.0 111.929 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.85 -40.1 65.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 1.0 111.071 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.12 -51.63 67.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.749 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.21 -30.6 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.203 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.63 HH22 ' CA ' ' A' ' 70' ' ' GLY . 8.1 tpt180 -55.38 -43.9 75.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.76 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.74 77.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.041 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -80.31 -45.48 17.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.526 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.92 -34.74 20.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.427 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.87 20.04 17.37 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.471 -1.052 . . . . 1.0 110.471 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.541 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 10.1 t -69.15 141.06 54.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.796 0.331 . . . . 1.0 110.23 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD2' ' CB ' ' A' ' 171' ' ' ALA . 84.5 m-20 -38.03 -39.82 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.659 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.436 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 24.3 ttm180 -167.75 131.95 1.77 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.007 -0.677 . . . . 1.0 112.588 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 p -138.81 130.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -139.88 157.55 45.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.131 0.491 . . . . 1.0 111.948 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.5 t -99.88 135.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -118.25 108.46 15.15 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.257 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -83.17 125.08 31.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.236 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.523 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 84.1 t80 -90.68 141.19 29.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 1.0 112.039 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.523 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 7.1 m-20 -112.13 151.05 43.35 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.11 -23.5 69.32 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.512 2.141 . . . . 1.0 112.49 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -87.46 -11.72 48.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.17 -11.63 60.29 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.552 -0.619 . . . . 1.0 111.552 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -80.14 90.74 5.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 1.0 110.627 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.52 151.05 21.12 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.576 -1.009 . . . . 1.0 110.576 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 p -125.44 148.47 48.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 1.0 111.711 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.71 109.26 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.78 0.69 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.366 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.6 115.72 2.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.066 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 85.5 tt0 -144.98 134.41 23.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.047 0.451 . . . . 1.0 111.834 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.87 132.37 45.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.433 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.514 ' C ' HH12 ' A' ' 43' ' ' ARG . 35.6 ptt-85 -134.97 150.94 50.44 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.733 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.63 ' CA ' HH22 ' A' ' 43' ' ' ARG . . . -56.76 -119.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.18 -76.94 1.03 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -169.22 46.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.747 0.308 . . . . 1.0 110.546 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -83.43 -45.99 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.1 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 28.6 mt -108.17 145.46 31.51 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.474 . . . . 1.0 109.874 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.3 139.57 42.16 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.485 2.123 . . . . 1.0 112.17 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.8 m -66.9 124.31 22.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.957 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.9 mt -100.08 13.11 35.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.334 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.464 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 26.9 tp -71.65 128.36 35.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.284 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.42 -9.86 75.45 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.492 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.7 mt -84.88 151.6 24.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.757 0.313 . . . . 1.0 110.292 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.9 m -104.07 131.0 51.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.688 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 6.1 m-85 -82.82 152.44 66.08 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.568 -0.53 . . . . 1.0 109.568 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.62 133.5 39.86 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.594 2.196 . . . . 1.0 111.877 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.27 127.88 33.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.681 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.09 2.76 45.26 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.539 -1.024 . . . . 1.0 110.539 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -58.44 -33.66 69.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.77 129.33 52.97 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.429 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.89 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.459 2.106 . . . . 1.0 112.484 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -109.95 -59.02 1.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.531 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -58.42 -44.65 89.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.833 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.03 70.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -54.72 -35.07 63.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.464 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -64.4 -34.15 77.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.0 mt -63.44 -37.58 87.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.281 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.66 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 56.2 m-85 -63.99 -27.18 68.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.04 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.522 ' C ' HE22 ' A' ' 99' ' ' GLN . 65.9 ttt180 -82.68 -29.36 29.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.77 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.1 mt -98.64 -42.41 7.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 114.416 1.265 . . . . 1.0 114.416 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.539 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.69 -7.87 13.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.019 1.489 . . . . 1.0 115.019 -174.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.717 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.7 mm-40 39.55 74.18 0.1 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.201 -1.0 . . . . 1.0 108.821 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 6.8 p 174.27 121.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.059 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.571 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -171.04 147.65 2.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 1.0 110.811 177.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.571 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 21.9 m -157.25 157.63 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.515 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.63 ' CG1' HAA1 ' A' ' 203' ' ' CYC . 49.6 mt -106.06 135.59 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 t -87.12 158.2 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.248 0.833 . . . . 1.0 113.248 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -50.67 121.95 6.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.865 -1.061 . . . . 1.0 112.095 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.2 -23.06 12.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.792 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 109' ' ' GLN . 82.1 tt0 -63.15 -49.24 75.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.4 -4.56 8.41 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.554 0.692 . . . . 1.0 109.354 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 36.34 72.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.787 -1.097 . . . . 1.0 113.282 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.454 ' HG ' ' H ' ' A' ' 135' ' ' VAL . 10.4 p -72.83 129.75 38.88 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.968 -1.493 . . . . 1.0 106.968 175.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -118.4 133.18 56.09 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.918 -0.713 . . . . 1.0 111.835 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.42 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -125.91 153.47 44.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.556 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.1 pt -156.0 175.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.172 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.7 m -58.28 150.83 20.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.663 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -139.57 153.02 70.02 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.635 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.18 -12.15 19.3 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.709 2.273 . . . . 1.0 112.401 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -171.51 134.83 0.87 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.396 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.9 m -165.43 -23.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.635 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 81.3 t90 -68.85 137.42 53.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.507 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 72.31 -102.15 1.14 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.4 tp 47.39 93.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.332 . . . . 1.0 110.374 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 26.7 t -58.64 -34.13 70.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.489 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 124' ' ' ARG . . . -59.75 -52.11 66.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.681 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.495 ' CB ' ' O ' ' A' ' 123' ' ' ALA . 18.1 ttp180 80.54 -142.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.549 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.418 ' H ' ' HE ' ' A' ' 124' ' ' ARG . 3.2 m -115.82 83.65 11.98 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.186 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -86.86 -6.31 7.65 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.582 2.188 . . . . 1.0 112.309 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.24 146.27 39.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.567 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -76.43 161.19 51.46 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.754 -0.938 . . . . 1.0 110.754 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 42.24 62.6 7.67 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 121.144 -0.223 . . . . 1.0 110.823 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -86.61 160.78 9.34 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.197 2.598 . . . . 1.0 111.649 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.9 mt -73.22 -0.16 13.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.374 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 57.79 53.89 6.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.955 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? 64.11 89.87 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.593 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.37 146.31 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.733 2.289 . . . . 1.0 111.948 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.454 ' H ' ' HG ' ' A' ' 110' ' ' SER . 1.4 p -109.01 122.74 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.87 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -43.32 151.76 0.43 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.56 -43.46 50.69 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.217 2.612 . . . . 1.0 114.005 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.666 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.3 p -38.97 -44.75 1.11 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.679 0.252 . . . . 1.0 111.679 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.666 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.3 t60 -82.76 -31.78 28.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.249 0.463 . . . . 1.0 112.249 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.64 -52.8 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.639 -0.425 . . . . 1.0 110.982 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -65.79 -29.39 69.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -63.53 -44.86 93.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.707 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 146' ' ' MET . 12.6 mt -73.33 -36.67 66.24 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -48.23 -39.07 20.08 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.507 -1.294 . . . . 1.0 107.507 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.3 m -58.26 -32.64 68.56 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.786 -1.097 . . . . 1.0 109.214 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.574 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.2 mmm -79.1 0.72 26.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.743 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.49 26.07 74.7 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.39 142.28 30.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.976 0.417 . . . . 1.0 110.932 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.54 -26.43 12.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.969 -0.559 . . . . 1.0 111.027 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 p -141.5 127.11 18.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.413 . . . . 1.0 111.137 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.15 131.43 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.47 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.3 mp -110.49 139.9 45.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.285 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 102' ' ' VAL . 2.4 t -123.97 116.24 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.113 0.482 . . . . 1.0 111.74 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.1 t -117.94 121.29 31.72 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 107.791 -1.189 . . . . 1.0 107.791 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.54 123.86 7.87 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.247 2.631 . . . . 1.0 114.7 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.85 56.15 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.807 -1.553 . . . . 1.0 106.807 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -147.84 178.51 8.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -65.76 161.54 20.6 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.299 -0.864 . . . . 1.0 111.427 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -55.04 -49.26 72.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.083 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -105.0 -39.76 6.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.404 ' OE1' ' CH2' ' A' ' 163' ' ' TRP . 96.1 mt-10 -88.05 138.04 31.8 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.689 -0.405 . . . . 1.0 110.876 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.414 ' H ' HD13 ' A' ' 162' ' ' LEU . 1.8 mp -109.09 112.51 24.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.288 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.404 ' CH2' ' OE1' ' A' ' 161' ' ' GLU . 46.9 m95 -88.04 -36.93 16.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.214 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.0 -171.85 28.64 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 42.1 tp -144.66 131.84 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 1.0 111.585 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.4 tp -105.16 134.18 48.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.03 133.83 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.631 -0.428 . . . . 1.0 111.039 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.5 t -107.8 136.99 46.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.02 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.464 ' O ' ' OG1' ' A' ' 48' ' ' THR . 27.7 m80 -111.71 131.37 55.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.999 0.428 . . . . 1.0 111.668 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.463 ' CD2' ' HG1' ' A' ' 48' ' ' THR . 69.2 m-70 -126.68 130.87 51.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.998 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.418 ' CB ' ' OD2' ' A' ' 49' ' ' ASP . . . -88.64 56.44 3.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.812 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -148.11 136.64 11.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.981 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.3 4.69 5.67 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.866 2.377 . . . . 1.0 111.924 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -64.87 148.39 97.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.895 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.78 165.28 31.82 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.603 2.202 . . . . 1.0 111.897 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 38.4 p90 -86.4 138.46 31.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.425 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 88.3 p -116.8 155.48 28.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.63 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -58.53 -31.78 68.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.676 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -55.81 -40.42 72.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.758 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.47 -38.5 90.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.54 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.5 tp -65.7 -37.71 87.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.547 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -55.34 -37.12 67.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.402 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.2 t -68.84 -52.91 30.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 188' ' ' ALA . 20.8 m -75.14 -36.87 38.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.411 0.523 . . . . 1.0 112.411 -177.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.401 ' O ' ' CG ' ' A' ' 189' ' ' ASP . 53.0 tp60 -50.88 -48.19 60.36 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.7 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.8 -44.33 41.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.963 0.357 . . . . 1.0 111.963 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.1 tp -77.43 -42.44 36.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.906 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -58.24 -39.3 78.74 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.544 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.401 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 86.8 m-20 -59.46 -38.86 81.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.999 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -65.8 -25.74 67.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.115 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.09 -42.29 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.719 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.4 t -58.05 -38.93 77.22 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.1 mt -65.98 -34.77 72.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.209 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -70.89 -39.3 72.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.781 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.6 mm -60.91 -47.53 93.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.199 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.23 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.132 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -70.86 -41.98 70.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.466 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -64.19 -34.49 78.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.73 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -54.83 -25.86 31.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.509 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.35 -34.54 75.46 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.043 -0.263 . . . . 1.0 111.057 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.9 t -45.1 -55.68 5.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.596 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.635 179.703 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.63 HAA1 ' CG1' ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.838 0.351 . . . . 1.0 110.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.97 -29.55 66.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.99 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -78.64 -46.51 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.161 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.448 HD12 HG23 ' A' ' 34' ' ' ILE . 16.0 mm -62.56 -46.2 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.758 0.313 . . . . 1.0 110.908 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.1 mt -58.29 -48.07 81.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.069 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -52.98 -38.72 62.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.23 -29.31 64.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.087 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.4 m -73.44 -47.02 44.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.547 -0.751 . . . . 1.0 112.263 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -65.73 -36.36 77.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 111.941 0.348 . . . . 1.0 111.941 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.75 -44.38 86.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.823 0.344 . . . . 1.0 111.077 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -42.0 98.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.705 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.9 t -59.64 -40.68 82.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.964 -0.294 . . . . 1.0 111.15 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 47' ' ' GLY . 52.1 ttp180 -50.67 -42.59 56.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.8 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.2 78.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.063 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -77.27 -47.01 21.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.549 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.71 -29.88 22.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.502 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.2 22.13 35.29 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.478 -1.049 . . . . 1.0 110.478 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.504 ' OG1' ' CG2' ' A' ' 51' ' ' VAL . 17.7 p -74.74 145.31 43.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.836 0.351 . . . . 1.0 110.193 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -40.77 -43.3 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.654 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -158.55 134.94 9.34 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.031 -0.668 . . . . 1.0 112.578 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.504 ' CG2' ' OG1' ' A' ' 48' ' ' THR . 10.0 t -135.69 129.04 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -140.11 153.94 46.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.449 -0.501 . . . . 1.0 111.872 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.8 t -100.71 136.74 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 30.3 t80 -119.06 107.45 13.51 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.382 -0.527 . . . . 1.0 111.258 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -79.48 127.15 31.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.217 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.493 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 87.5 t80 -90.97 141.31 28.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.971 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.493 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -112.22 150.81 43.07 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 178.009 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -59.91 -23.63 73.3 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.541 2.161 . . . . 1.0 112.494 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -87.88 -12.48 44.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 1.0 110.072 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.21 58.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.605 -0.598 . . . . 1.0 111.605 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -78.31 90.22 4.36 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.931 -0.307 . . . . 1.0 110.631 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.04 151.43 20.76 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -125.48 148.21 48.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.392 . . . . 1.0 111.719 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.01 108.34 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.462 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 96.7 t -106.02 0.03 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.341 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.79 122.79 3.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.052 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -147.78 133.78 19.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.136 0.493 . . . . 1.0 111.809 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.72 141.51 51.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.681 -0.69 . . . . 1.0 109.341 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.528 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 84.6 mtm-85 -138.7 142.81 38.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.74 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -47.43 -28.01 4.49 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.2 -88.91 0.07 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -152.17 52.09 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 1.0 110.509 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -86.22 -45.65 11.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.174 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.3 mt -109.15 146.35 33.7 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.902 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.87 145.84 63.68 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.551 2.168 . . . . 1.0 112.203 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 p -62.18 124.52 21.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.4 mt -98.57 3.48 48.04 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.366 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 tp -66.25 131.45 46.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.213 0.53 . . . . 1.0 112.26 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.17 -15.39 53.95 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.584 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 mt -82.05 153.84 25.94 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.987 -0.285 . . . . 1.0 110.35 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.0 p -107.04 131.29 54.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.686 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.704 ' CE2' HAB1 ' A' ' 203' ' ' CYC . 4.9 m-85 -85.63 154.32 58.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.11 129.6 26.25 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.638 2.225 . . . . 1.0 111.935 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.26 130.05 41.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.739 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.0 -1.11 44.46 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.614 -0.995 . . . . 1.0 110.614 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -53.19 -38.33 62.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mt -78.59 131.55 67.71 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.447 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.81 -165.57 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.438 2.092 . . . . 1.0 112.477 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -107.54 -60.99 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.506 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -57.46 -43.11 83.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.804 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.42 -40.58 85.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -69.04 -41.65 77.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.488 -0.323 . . . . 1.0 111.442 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -60.98 -31.82 71.4 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.8 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.46 ' CD1' HH12 ' A' ' 101' ' ' ARG . 78.1 mt -71.58 -38.02 70.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.227 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.73 -42.08 83.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 1.0 110.018 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 159' ' ' HIS . 77.1 ttt-85 -58.3 -33.09 69.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.798 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.574 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 56.6 mt -98.14 -35.85 10.26 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.584 ' C ' ' NE2' ' A' ' 99' ' ' GLN . . . -118.52 -10.19 10.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.115 1.524 . . . . 1.0 115.115 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.652 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 40.39 82.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.177 -1.009 . . . . 1.0 108.812 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p 175.98 116.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.056 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.471 ' O ' ' CG1' ' A' ' 102' ' ' VAL . 8.0 tpt180 -160.37 143.31 13.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 1.0 110.766 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' A' ' 101' ' ' ARG . 17.4 m -159.78 150.38 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.532 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.421 ' O ' ' OH ' ' A' ' 176' ' ' TYR . 42.9 mt -108.32 136.46 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.098 -0.704 . . . . 1.0 109.098 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.9 t -88.24 158.3 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.215 0.82 . . . . 1.0 113.215 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -48.05 123.95 6.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.904 -1.044 . . . . 1.0 112.193 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.63 -24.72 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.746 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 109' ' ' GLN . 83.9 tt0 -65.27 -47.76 75.59 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.8 -3.49 6.92 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.532 0.682 . . . . 1.0 109.388 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.452 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 36.03 71.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.794 -1.093 . . . . 1.0 113.296 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.7 t -72.44 130.68 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.984 -1.488 . . . . 1.0 106.984 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -118.53 138.57 52.44 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.937 -0.705 . . . . 1.0 111.885 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.62 166.41 26.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.694 -0.684 . . . . 1.0 110.502 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.599 ' C ' ' H ' ' A' ' 115' ' ' GLN . 26.9 pt -127.63 153.21 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.103 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 86.9 p -45.53 -10.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.631 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.599 ' H ' ' C ' ' A' ' 113' ' ' ILE . 64.4 mm-40 -116.27 77.0 7.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.668 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -87.25 -165.27 0.23 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.664 2.243 . . . . 1.0 112.349 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.663 ' H ' ' NH1' ' A' ' 133' ' ' ARG . 97.4 mt-10 -116.49 -99.99 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.443 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.563 ' N ' ' NH2' ' A' ' 133' ' ' ARG . 2.0 t 39.59 93.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.644 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.3 m95 40.65 -93.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.52 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 118' ' ' SER . . . 66.68 -130.3 31.0 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.72 141.18 29.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.738 0.304 . . . . 1.0 110.389 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.7 p -63.63 -24.97 68.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.521 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.75 78.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.745 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -66.93 146.75 54.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.609 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.2 p -70.01 129.51 90.77 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.224 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -80.62 154.98 20.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.565 2.177 . . . . 1.0 112.333 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.521 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 4.0 tp -151.81 -140.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.581 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.521 ' H ' ' CG ' ' A' ' 127' ' ' LEU . . . -59.03 -33.93 76.67 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 49.22 65.32 7.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.584 0.231 . . . . 1.0 110.873 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -87.15 159.7 8.5 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.128 2.552 . . . . 1.0 111.725 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.5 mt -83.74 1.07 44.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.335 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.632 ' O ' ' C ' ' A' ' 133' ' ' ARG . 73.4 mm-40 -59.76 -31.4 69.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.943 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.663 ' NH1' ' H ' ' A' ' 117' ' ' GLU . 4.2 tpp180 15.99 77.91 0.12 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.493 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.86 147.78 17.98 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.829 2.353 . . . . 1.0 111.92 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.1 p -92.56 109.83 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.908 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.669 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 0.7 OUTLIER -45.36 142.31 3.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 140' ' ' VAL . 72.9 Cg_exo -43.87 -47.63 9.81 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.223 2.615 . . . . 1.0 113.988 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.719 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.3 p -35.83 -46.87 0.48 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.734 0.272 . . . . 1.0 111.734 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.719 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 2.1 t60 -82.99 -24.64 32.83 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 137' ' ' PRO . 44.7 t -65.92 -55.01 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.664 -0.414 . . . . 1.0 110.963 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -65.88 -29.25 69.66 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -60.24 -47.35 86.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.666 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.1 mt -73.0 -36.72 67.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.311 -0.625 . . . . 1.0 109.311 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -49.8 -39.68 39.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.597 -1.26 . . . . 1.0 107.597 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -63.69 -28.74 70.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.713 -1.13 . . . . 1.0 109.181 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.5 mmm -85.92 -1.92 57.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.726 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.05 22.01 78.41 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.18 142.32 23.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 1.0 110.966 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.76 -38.17 5.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.932 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.7 t -133.75 125.2 28.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.104 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.2 p -112.91 135.61 53.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.479 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.83 133.89 55.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.296 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.452 ' H ' HG13 ' A' ' 102' ' ' VAL . 2.0 t -122.23 108.76 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.099 0.476 . . . . 1.0 111.792 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.0 t -105.06 114.6 63.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 107.8 -1.185 . . . . 1.0 107.8 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -41.7 134.74 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 123.161 2.574 . . . . 1.0 114.664 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.4 tp -132.4 41.41 3.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.6 ptm -148.92 -172.69 4.17 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.133 0.79 . . . . 1.0 113.133 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.685 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 52.2 t-80 -77.84 178.1 7.67 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.436 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 72.4 m80 -74.84 -54.94 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.051 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -104.01 11.57 35.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.032 0.382 . . . . 1.0 112.032 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.536 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.8 tt0 -146.49 140.18 26.03 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.856 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.443 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 6.9 tt -109.55 116.18 31.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.243 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.536 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 69.0 m95 -92.68 -37.31 12.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.175 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -158.34 -171.72 24.57 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.152 -0.779 . . . . 1.0 111.152 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 16.0 tp -145.14 125.96 14.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 1.0 111.599 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.6 tp -100.58 131.53 46.44 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.17 138.23 41.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.702 -0.399 . . . . 1.0 111.069 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.1 m -110.86 141.76 43.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.96 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -115.57 131.61 56.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.01 0.433 . . . . 1.0 111.572 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -128.01 123.03 33.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.957 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.73 36.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.829 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -164.37 126.11 1.5 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.009 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -42.68 139.55 3.16 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.988 2.459 . . . . 1.0 111.847 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -176.57 97.75 0.24 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.825 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.98 155.64 4.13 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.596 2.197 . . . . 1.0 111.887 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.421 ' OH ' ' O ' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -85.25 133.66 34.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.51 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.2 m -118.31 150.79 38.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.597 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -50.61 -35.97 32.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.663 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.01 -38.24 85.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.729 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.43 -50.79 70.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.526 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.12 -36.07 80.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.569 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -53.67 -37.2 62.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.406 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.6 -54.47 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.743 0.646 . . . . 1.0 112.743 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.3 t -78.04 -40.13 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.451 0.537 . . . . 1.0 112.451 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -46.9 -45.64 20.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.653 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 55.1 mt -74.64 -39.09 62.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.6 tp -76.0 -41.45 51.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.851 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.55 85.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.479 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.27 -37.72 70.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.279 -0.418 . . . . 1.0 109.953 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -71.83 -24.21 61.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.114 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 194' ' ' ALA . 61.4 t -83.18 -47.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.793 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.5 m -51.97 -30.41 24.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.42 -33.29 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.154 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -70.36 -48.36 56.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.811 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.14 -37.07 78.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.132 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.83 -46.13 63.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.093 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -74.1 -35.14 64.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.549 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -61.92 -34.51 76.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.703 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.28 -27.61 47.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.475 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.07 -36.29 74.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.685 0.279 . . . . 1.0 111.054 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.9 m -52.45 -55.8 19.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.589 179.608 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.704 HAB1 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.892 0.377 . . . . 1.0 110.577 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 35.6 p-10 -51.21 -32.62 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 62.8 tt0 -77.07 -48.33 18.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.147 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 34' ' ' ILE . 81.3 mt -60.33 -42.49 90.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 1.0 110.945 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.06 -46.55 82.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.412 . . . . 1.0 111.041 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.533 HH12 ' CD2' ' A' ' 78' ' ' LEU . 51.8 ttt85 -51.95 -38.27 55.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.95 -29.67 65.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.833 -0.622 . . . . 1.0 110.089 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -73.5 -45.07 56.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.557 -0.747 . . . . 1.0 112.21 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.12 -35.6 72.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 111.976 0.362 . . . . 1.0 111.976 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -70.17 -45.48 66.63 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.104 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -63.76 -44.42 93.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.779 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.37 -42.53 87.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.155 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 47' ' ' GLY . 63.7 ttp85 -53.99 -40.76 67.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.851 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.15 -37.28 74.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.03 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -78.29 -43.41 28.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.581 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.7 mt -85.2 -30.4 23.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.512 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 59.28 20.11 49.21 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.509 -1.036 . . . . 1.0 110.509 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 89.8 m -72.93 142.18 47.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.83 0.348 . . . . 1.0 110.224 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -39.89 -54.72 2.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.566 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.529 ' NH2' ' O ' ' A' ' 74' ' ' LEU . 80.6 mtt-85 -152.5 131.89 12.91 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.99 -0.684 . . . . 1.0 112.501 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.64 129.34 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -138.83 156.01 47.67 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.915 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -108.35 136.35 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.63 134.61 47.78 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.366 -0.534 . . . . 1.0 111.311 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -94.01 137.92 32.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.21 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 66.9 t80 -94.29 117.55 30.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 1.0 112.035 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -88.07 140.93 30.89 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.02 -26.77 5.27 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.55 2.167 . . . . 1.0 112.397 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.37 -19.64 38.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.915 0.388 . . . . 1.0 110.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.69 -13.45 38.71 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.556 -0.618 . . . . 1.0 111.556 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -71.92 99.57 2.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.339 . . . . 1.0 110.593 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.62 142.57 16.06 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.626 -0.99 . . . . 1.0 110.626 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.5 p -123.07 145.77 48.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 1.0 111.743 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 t -77.74 106.99 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.09 -2.03 9.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.341 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.86 116.51 3.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.106 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 81.6 tt0 -144.06 132.5 22.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.802 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.35 138.8 52.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.343 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -118.55 137.08 53.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.906 0.384 . . . . 1.0 110.722 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.42 -81.31 0.52 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.849 -0.9 . . . . 1.0 110.849 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.507 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -114.04 50.81 0.75 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.997 -0.841 . . . . 1.0 110.997 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' A' ' 71' ' ' GLY . 15.0 pt-20 31.18 55.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 1.0 110.491 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -84.52 -50.43 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.165 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.529 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 23.8 mt -109.4 153.46 42.76 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.86 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.28 164.71 3.61 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.486 2.124 . . . . 1.0 112.126 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.1 t -87.72 128.58 35.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.878 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.3 mt -101.08 13.48 35.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.39 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.533 ' CD2' HH12 ' A' ' 36' ' ' ARG . 23.9 tp -73.08 128.9 36.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.032 -0.531 . . . . 1.0 112.343 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.9 -8.62 77.37 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.541 -0.754 . . . . 1.0 111.532 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.8 mt -85.73 152.6 22.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.768 0.318 . . . . 1.0 110.31 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.7 t -106.26 133.67 50.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.702 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.638 ' CD2' HAB1 ' A' ' 203' ' ' CYC . 9.4 m-85 -87.59 152.09 51.4 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.68 137.01 56.69 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.61 2.207 . . . . 1.0 111.863 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.46 129.14 38.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.683 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.1 43.53 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.551 -1.019 . . . . 1.0 110.551 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.9 -37.78 66.77 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 88' ' ' PRO . 0.8 OUTLIER -80.08 113.57 39.53 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.394 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 87' ' ' ILE . 86.5 Cg_exo -48.76 -171.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.455 2.103 . . . . 1.0 112.509 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.93 -59.0 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.558 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 20.8 pt-20 -58.24 -42.74 87.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.813 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -66.27 -47.84 72.38 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.971 0.36 . . . . 1.0 111.971 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.519 ' NH2' ' CE2' ' A' ' 56' ' ' PHE . 72.1 ttt180 -52.99 -35.63 59.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.498 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -66.1 -35.95 81.89 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.838 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.69 -37.31 81.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.317 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.595 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 66.9 m-85 -60.73 -55.07 37.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.038 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -51.19 -29.72 14.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.773 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 63.2 mt -99.14 -42.42 7.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.335 1.235 . . . . 1.0 114.335 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.551 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.93 -14.47 10.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.053 1.501 . . . . 1.0 115.053 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.595 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 20.0 mm-40 37.58 81.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.148 -1.021 . . . . 1.0 108.835 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.7 p 176.49 97.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.103 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.475 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 6.6 mmt180 -147.99 146.35 28.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.992 0.425 . . . . 1.0 110.746 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 101' ' ' ARG . 62.8 t -159.79 150.07 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.514 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.5 mt -108.35 136.57 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.03 163.93 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 113.279 0.844 . . . . 1.0 113.279 -176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 21.8 p30 -46.46 119.68 2.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.93 -1.032 . . . . 1.0 112.125 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.7 p -55.18 -20.42 6.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.331 -0.849 . . . . 1.0 110.808 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -65.78 -43.51 88.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.02 -12.86 55.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.529 0.68 . . . . 1.0 109.362 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 45.17 73.44 0.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.782 -1.099 . . . . 1.0 113.284 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.7 p -74.23 129.9 38.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.025 -1.472 . . . . 1.0 107.025 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -118.29 132.86 56.27 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.937 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.467 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -134.65 162.55 31.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.595 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.561 ' C ' ' H ' ' A' ' 115' ' ' GLN . 6.6 pt -125.22 131.03 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.164 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.4 t -55.41 -3.22 0.06 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.62 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.561 ' H ' ' C ' ' A' ' 113' ' ' ILE . 0.7 OUTLIER -57.1 153.15 25.91 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.68 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 115' ' ' GLN . 39.4 Cg_exo -34.48 134.7 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.624 2.216 . . . . 1.0 112.388 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' OE2' ' OE2' ' A' ' 90' ' ' GLU . 23.5 pt-20 -171.23 -0.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.44 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 120' ' ' GLY . 40.8 t -64.31 -90.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.642 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 91.6 m95 53.05 8.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.547 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 118' ' ' SER . . . 44.65 64.83 1.95 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.4 mt -67.96 -7.73 31.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 1.0 110.478 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.8 t -53.27 -18.54 2.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.468 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.12 -43.18 61.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.658 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -151.95 157.4 41.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.506 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.427 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 7.7 p -116.61 87.86 22.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.235 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.88 150.75 12.35 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.606 2.204 . . . . 1.0 112.318 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.9 mt -65.29 -30.47 71.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.578 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.33 -174.54 49.2 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -130.09 120.51 19.26 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.619 0.247 . . . . 1.0 110.863 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -86.39 168.07 8.83 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 123.104 2.536 . . . . 1.0 111.701 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.7 tp -58.13 -32.03 67.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.358 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.49 ' O ' ' CB ' ' A' ' 133' ' ' ARG . 65.3 mt-30 -76.29 126.47 31.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.891 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.677 ' N ' ' HD2' ' A' ' 134' ' ' PRO . 10.4 ttp180 160.84 -52.29 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.585 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 133' ' ' ARG . 11.9 Cg_endo -50.79 160.42 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.706 2.271 . . . . 1.0 111.962 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.428 HG21 HMD2 ' A' ' 203' ' ' CYC . 1.5 p -95.33 114.19 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.947 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -44.0 137.17 3.63 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.467 ' HD3' ' H ' ' A' ' 112' ' ' SER . 54.8 Cg_exo -41.97 -48.52 6.12 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.238 2.625 . . . . 1.0 114.001 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.702 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER -35.96 -45.93 0.44 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.8 0.296 . . . . 1.0 111.8 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.759 ' HE2' ' HHB' ' A' ' 203' ' ' CYC . 8.1 t-80 -82.2 -26.97 32.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' PRO . 48.0 t -63.92 -53.82 39.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.986 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -65.3 -29.1 69.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -58.97 -45.62 90.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.734 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.2 mt -73.23 -41.76 63.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -38.61 56.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.544 -1.28 . . . . 1.0 107.544 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.7 t -63.5 -26.61 68.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.823 -1.081 . . . . 1.0 109.209 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.6 mmm -90.21 3.55 53.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.731 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.25 20.31 79.11 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.08 143.56 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 1.0 110.964 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.59 -19.95 13.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.942 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.5 m -145.87 161.82 39.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 1.0 111.177 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.7 p -147.48 122.55 10.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.49 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 tp -106.27 131.67 53.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.287 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.44 120.38 58.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.126 0.489 . . . . 1.0 111.784 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.555 ' O ' ' CG1' ' A' ' 154' ' ' VAL . 12.6 p -130.76 91.53 36.94 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.829 -1.174 . . . . 1.0 107.829 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.27 152.09 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 123.175 2.583 . . . . 1.0 114.677 -176.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 56.2 mt -126.07 66.64 1.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.829 -1.545 . . . . 1.0 106.829 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.475 ' SD ' ' OE1' ' A' ' 99' ' ' GLN . 2.1 ptt? -146.98 -167.53 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.145 0.795 . . . . 1.0 113.145 -175.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.721 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 59.5 t60 -86.26 -176.0 5.73 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.446 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.721 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 59.3 t-80 -75.32 -55.27 5.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.463 -0.789 . . . . 1.0 112.103 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -105.66 13.72 29.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.014 0.376 . . . . 1.0 112.014 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -144.04 138.91 28.67 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.839 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.1 tt -110.52 116.67 31.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.239 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -92.4 -36.51 13.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.222 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.91 -171.35 27.9 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.6 tp -149.72 133.31 16.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 1.0 111.532 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.3 tp -98.71 135.91 39.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.0 p -139.25 131.68 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.047 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 m -109.11 142.9 39.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.017 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' A' ' 48' ' ' THR . 43.5 m80 -113.16 123.3 49.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.053 0.454 . . . . 1.0 111.69 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.431 ' CE1' ' OG1' ' A' ' 48' ' ' THR . 82.6 m-70 -123.55 115.23 21.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.859 -0.61 . . . . 1.0 109.97 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.12 -16.12 63.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.782 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -94.48 150.15 37.68 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.963 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 174' ' ' ARG . 59.9 Cg_endo -70.83 -2.6 11.2 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.96 2.44 . . . . 1.0 111.825 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 173' ' ' PRO . 0.0 OUTLIER -32.54 98.06 0.12 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.921 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 173' ' ' PRO . 78.2 Cg_exo -50.15 167.68 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.577 2.185 . . . . 1.0 111.933 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.539 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 46.4 p90 -86.75 125.66 34.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.471 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.2 t -115.74 154.1 30.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.681 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -54.34 -31.76 55.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.626 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.81 -39.99 86.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.748 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -63.47 -42.6 98.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.551 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.55 -38.47 87.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.502 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -55.36 -36.4 66.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.899 -0.591 . . . . 1.0 111.394 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.1 -55.93 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.735 0.643 . . . . 1.0 112.735 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 188' ' ' ALA . 26.8 m -74.09 -35.3 40.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.434 0.531 . . . . 1.0 112.434 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -50.28 -45.84 54.68 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.655 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 41.5 mt -79.61 -43.97 21.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.894 0.331 . . . . 1.0 111.894 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 34.2 tp -77.9 -40.53 39.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.835 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -60.67 -41.11 94.42 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.493 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.66 -40.26 87.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.991 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -67.81 -25.81 65.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.149 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 37.0 t -84.13 -45.01 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.78 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.563 ' HG ' ' N ' ' A' ' 193' ' ' ILE . 24.2 p -57.13 -35.33 69.34 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.563 ' N ' ' HG ' ' A' ' 192' ' ' SER . 38.7 mt -67.01 -34.81 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.465 -0.789 . . . . 1.0 109.24 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.93 77.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.819 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.4 mm -59.57 -48.58 86.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.128 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.52 -48.13 57.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.127 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -65.0 -42.77 94.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.466 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.441 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -65.63 -31.87 73.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.706 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.14 -30.97 66.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.464 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 9.7 mp -59.99 -34.17 72.96 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.981 -0.288 . . . . 1.0 111.072 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 87.3 p -55.56 -55.58 30.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.566 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.534 179.896 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.759 ' HHB' ' HE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.868 0.366 . . . . 1.0 110.605 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 33' ' ' GLN . 24.1 p-10 -50.74 -55.48 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.998 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.421 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 63.9 tt0 -52.65 -42.56 64.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.101 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.43 HD13 HG23 ' A' ' 34' ' ' ILE . 18.1 mm -59.64 -50.46 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 1.0 110.966 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 38' ' ' THR . 83.4 mt -58.42 -46.86 85.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.987 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -49.58 -39.68 35.98 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.816 -0.438 . . . . 1.0 109.816 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 -29.4 65.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.073 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 35' ' ' LEU . 24.1 m -74.53 -41.47 60.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 1.0 112.263 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 7.5 p -72.32 -37.82 59.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 111.922 0.341 . . . . 1.0 111.922 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -67.79 -41.61 82.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.783 0.325 . . . . 1.0 111.067 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -67.36 -44.72 78.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.734 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.77 -36.36 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.176 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.558 ' NH2' ' CA ' ' A' ' 70' ' ' GLY . 16.3 tpt85 -59.79 -47.47 85.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 1.0 110.802 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.55 -33.33 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 1.0 111.051 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -74.27 -41.2 61.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.607 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' A' ' 48' ' ' THR . 5.4 mt -87.12 -29.03 22.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.514 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.81 19.19 0.85 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.421 ' N ' ' C ' ' A' ' 46' ' ' LEU . 1.6 p -62.7 -97.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 1.0 110.211 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -155.13 -48.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.613 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -157.16 125.92 5.78 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.089 -0.644 . . . . 1.0 112.644 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 12.6 p -137.03 129.05 43.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.547 -0.908 . . . . 1.0 108.547 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -140.18 159.33 42.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.958 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -99.82 136.25 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.608 -0.886 . . . . 1.0 108.608 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.508 ' CG ' HAB1 ' A' ' 203' ' ' CYC . 74.2 t80 -117.09 108.45 15.73 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.295 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -83.31 126.47 32.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.274 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.621 ' CZ ' ' NH2' ' A' ' 92' ' ' ARG . 77.8 t80 -93.32 137.12 32.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 1.0 112.035 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -108.84 140.85 22.26 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 177.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.88 -27.27 5.57 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.573 2.182 . . . . 1.0 112.442 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.97 -18.19 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 1.0 110.096 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 106.96 -13.85 41.06 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.574 -0.61 . . . . 1.0 111.574 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -78.22 90.39 4.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.765 0.317 . . . . 1.0 110.63 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.48 151.46 20.97 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.635 -0.986 . . . . 1.0 110.635 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.8 p -123.51 146.62 47.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 1.0 111.692 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.4 t -75.81 110.38 10.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.87 2.97 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.339 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.69 122.58 3.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.072 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -144.26 130.16 19.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.109 0.481 . . . . 1.0 111.826 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.62 139.25 52.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.359 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -140.85 145.8 36.69 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.793 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.558 ' CA ' ' NH2' ' A' ' 43' ' ' ARG . . . -47.31 -39.08 13.32 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.864 -0.894 . . . . 1.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.557 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 171.64 -154.27 21.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 72' ' ' GLU . 3.0 pp20? -72.54 20.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 1.0 110.523 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.557 ' H ' ' C ' ' A' ' 71' ' ' GLY . 35.0 mtm180 -76.44 -47.8 21.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.117 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.89 150.36 52.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.92 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.42 157.91 55.4 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.486 2.124 . . . . 1.0 112.155 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.7 p -95.55 132.04 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.918 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.6 17.16 7.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.41 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.44 128.8 37.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.016 -0.538 . . . . 1.0 112.28 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.91 -11.49 64.54 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.536 -0.756 . . . . 1.0 111.577 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.1 mt -82.92 152.05 25.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.914 -0.314 . . . . 1.0 110.341 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.8 m -107.16 134.15 50.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.713 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -84.95 152.19 58.69 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.36 130.66 27.5 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.636 2.224 . . . . 1.0 111.89 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 131.45 46.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.705 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.64 2.13 43.33 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -62.41 -17.02 58.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.573 ' O ' ' O ' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -105.1 103.24 40.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.397 178.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 87' ' ' ILE . 83.1 Cg_exo -49.74 -154.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.407 2.072 . . . . 1.0 112.489 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -109.21 -54.63 2.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.53 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -63.31 -45.04 93.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.78 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.445 ' HB1' HBD2 ' A' ' 203' ' ' CYC . . . -66.4 -48.17 70.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.947 0.351 . . . . 1.0 111.947 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.621 ' NH2' ' CZ ' ' A' ' 56' ' ' PHE . 67.1 ttt180 -56.57 -34.68 67.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.426 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.5 ttt85 -64.25 -35.63 81.45 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.872 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.89 -38.47 91.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.281 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.62 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 40.0 m-85 -60.26 -29.97 69.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.977 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.463 ' C ' HE22 ' A' ' 99' ' ' GLN . 80.0 ttt-85 -84.2 -26.44 28.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.888 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.92 -46.92 6.03 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.434 1.272 . . . . 1.0 114.434 -175.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.526 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.58 -6.05 13.96 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.052 1.501 . . . . 1.0 115.052 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.716 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.7 mm-40 40.5 73.6 0.12 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.191 -1.004 . . . . 1.0 108.821 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 6.2 p 176.1 118.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.993 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.736 HH21 HAD2 ' A' ' 203' ' ' CYC . 30.6 tpt85 -168.66 134.6 1.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 1.0 110.715 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.456 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 4.5 m -149.82 155.28 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.564 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.67 ' CD1' ' HE2' ' A' ' 139' ' ' HIS . 96.9 mt -112.04 134.42 54.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.074 -0.713 . . . . 1.0 109.074 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.01 163.62 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 113.315 0.857 . . . . 1.0 113.315 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 173' ' ' PRO . 49.7 m-20 -45.92 120.11 2.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.986 -1.006 . . . . 1.0 112.156 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.8 -20.62 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.792 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.98 -44.86 83.65 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.16 -13.45 60.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.491 0.662 . . . . 1.0 109.387 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 46.66 72.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.675 -1.148 . . . . 1.0 113.327 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.82 131.98 42.98 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.002 -1.481 . . . . 1.0 107.002 175.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -118.75 134.16 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.003 -0.679 . . . . 1.0 111.904 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.1 164.49 30.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.555 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.42 ' C ' ' H ' ' A' ' 115' ' ' GLN . 16.3 pt -125.12 138.24 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.084 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 53.3 p -79.93 22.47 0.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.666 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 113' ' ' ILE . 15.4 mm100 -120.27 79.25 27.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.632 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.68 151.42 13.07 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.64 2.227 . . . . 1.0 112.395 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.78 -35.7 80.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.405 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 119' ' ' TRP . 31.1 t -173.21 -124.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.684 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.511 ' CE3' ' O ' ' A' ' 120' ' ' GLY . 37.0 t90 -71.69 147.02 47.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.532 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 122' ' ' SER . . . -79.89 179.37 53.25 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.597 ' CD1' HH12 ' A' ' 133' ' ' ARG . 9.5 mp 54.42 5.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 1.0 110.455 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 120' ' ' GLY . 82.6 p -68.07 -22.13 64.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.393 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -63.17 -23.83 67.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.616 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 123' ' ' ALA . 69.4 ttt180 43.91 97.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.631 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.78 150.4 36.11 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.268 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.99 -34.91 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.581 2.187 . . . . 1.0 112.325 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.55 -37.21 85.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.507 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.42 43.01 47.02 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.842 -0.903 . . . . 1.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -133.04 67.95 78.0 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.625 0.25 . . . . 1.0 110.819 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.79 -168.91 0.67 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.102 2.535 . . . . 1.0 111.657 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.7 mt -85.82 -27.15 25.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.364 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -65.36 -36.61 84.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.412 . . . . 1.0 110.873 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.597 HH12 ' CD1' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -61.17 -60.16 11.47 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.568 -178.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 133' ' ' ARG . 33.2 Cg_exo -36.94 148.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.784 2.322 . . . . 1.0 111.951 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.71 147.46 6.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.869 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -92.32 136.13 25.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -41.65 -21.51 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.226 2.618 . . . . 1.0 114.018 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.683 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 4.8 p -71.24 -46.12 61.75 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.751 0.278 . . . . 1.0 111.751 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.779 ' CE1' HAA2 ' A' ' 203' ' ' CYC . 42.1 t60 -84.13 -29.11 26.99 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 1.8 p -62.65 -44.56 99.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.941 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.537 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 83.5 t60 -69.53 -30.3 68.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.738 -0.467 . . . . 1.0 109.738 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -58.2 -43.01 87.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.76 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 146' ' ' MET . 63.6 mt -72.99 -40.11 65.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.279 -0.637 . . . . 1.0 109.279 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -51.01 -39.1 54.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.568 -1.271 . . . . 1.0 107.568 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 m -65.17 -22.94 66.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.783 -1.099 . . . . 1.0 109.203 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.4 mmm -94.52 0.64 55.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.645 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.7 21.11 79.72 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 64.9 t -110.7 142.74 22.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.841 0.353 . . . . 1.0 111.063 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.55 -40.78 5.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.945 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.1 m -131.98 127.14 35.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.217 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.498 ' HG ' ' CD1' ' A' ' 143' ' ' LEU . 0.0 OUTLIER -118.34 129.1 55.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.472 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.02 126.74 54.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.234 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.32 120.49 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 1.0 111.802 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.0 t -128.07 118.04 20.64 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -71.8 145.2 45.39 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.164 2.576 . . . . 1.0 114.721 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.3 mt -121.68 62.27 0.92 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -147.04 -163.31 1.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.099 0.777 . . . . 1.0 113.099 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.584 ' CE1' ' HE1' ' A' ' 163' ' ' TRP . 76.1 m80 -89.06 -178.4 5.68 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.357 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -74.22 -54.09 8.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.054 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.68 11.16 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.03 0.381 . . . . 1.0 112.03 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.5 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.7 tt0 -143.15 136.82 28.59 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.441 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 5.6 tt -111.89 119.64 39.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.044 -0.526 . . . . 1.0 111.259 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.584 ' HE1' ' CE1' ' A' ' 158' ' ' HIS . 82.1 m95 -92.85 -41.07 10.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.265 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.442 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -160.15 -176.31 32.1 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.179 -0.768 . . . . 1.0 111.179 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 97.0 mt -140.09 133.72 30.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 1.0 111.522 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.8 tp -105.23 134.17 48.78 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.33 138.2 40.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.048 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m -114.4 132.25 56.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 1.0 109.98 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -109.77 137.01 48.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.999 0.428 . . . . 1.0 111.676 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -130.04 130.4 44.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.015 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.17 45.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.773 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -144.05 150.74 50.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.07 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.446 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 65.4 Cg_endo -71.51 -12.31 29.22 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.905 2.404 . . . . 1.0 111.92 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -40.97 104.54 0.34 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.904 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.07 168.2 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.532 2.155 . . . . 1.0 111.95 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -97.71 136.46 38.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.518 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.2 m -120.65 152.47 38.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.638 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -51.05 -31.47 18.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.665 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -56.5 -34.86 67.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.731 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -64.3 -43.56 94.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.504 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 9.0 mp -67.76 -35.06 78.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.575 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -54.76 -39.74 68.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.367 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.35 -52.46 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.6 t -71.53 -34.92 54.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.401 0.519 . . . . 1.0 112.401 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -50.42 -46.99 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.646 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 51.2 mt -68.8 -40.1 79.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.914 0.339 . . . . 1.0 111.914 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.3 tp -78.45 -37.71 42.92 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.86 0.319 . . . . 1.0 111.86 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.92 86.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.482 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -63.38 -41.17 98.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.002 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -69.03 -29.11 67.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.085 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.4 -46.15 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.681 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.9 t -53.75 -35.6 61.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.0 mt -64.93 -34.69 72.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.2 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.65 -39.5 80.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.617 -0.72 . . . . 1.0 109.845 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.446 HG21 HD12 ' A' ' 195' ' ' ILE . 49.9 mm -59.55 -47.45 90.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.189 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.17 -46.28 61.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.09 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -66.54 -45.4 79.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.457 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.428 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -64.55 -32.7 74.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.669 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.43 -33.13 70.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.55 -0.296 . . . . 1.0 111.427 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.38 -35.09 76.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.664 0.269 . . . . 1.0 111.077 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 90.5 p -56.91 -55.69 31.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.564 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.551 179.567 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.788 ' HC ' HBA2 ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.882 0.372 . . . . 1.0 110.557 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -77.2 -29.76 54.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.942 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -78.53 -45.76 21.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.084 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 pt -64.8 -39.71 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.968 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.539 ' O ' ' OG1' ' A' ' 38' ' ' THR . 26.7 mt -59.72 -45.49 92.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.005 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -55.59 -34.46 64.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.42 -35.92 71.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.105 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.539 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 82.8 p -70.26 -43.35 70.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.548 -0.751 . . . . 1.0 112.188 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.91 -36.59 76.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 111.911 0.337 . . . . 1.0 111.911 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' A' ' 43' ' ' ARG . 39.6 tp10 -66.31 -46.32 77.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.808 0.337 . . . . 1.0 111.076 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.84 -46.69 86.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.722 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.6 t -52.73 -45.06 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.955 -0.298 . . . . 1.0 111.138 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 47' ' ' GLY . 56.5 ttp180 -49.59 -39.52 35.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.825 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.56 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -76.46 -46.46 26.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.546 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.58 -27.73 25.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.507 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.4 21.49 34.1 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 169' ' ' HIS . 7.3 t -74.11 143.93 45.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 1.0 110.234 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 94.6 m-20 -43.6 -43.89 5.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.662 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' NH1' ' CD1' ' A' ' 74' ' ' LEU . 58.4 mtm-85 -154.98 131.71 10.67 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.078 -0.649 . . . . 1.0 112.56 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.8 128.2 46.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -138.4 154.1 48.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.491 -0.484 . . . . 1.0 111.949 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.5 t -99.63 136.3 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 37.9 t80 -116.75 110.93 19.06 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.324 -0.55 . . . . 1.0 111.307 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.531 ' NH1' ' O ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -84.43 122.6 29.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.266 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.531 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 69.4 t80 -88.78 141.28 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 1.0 112.034 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 60' ' ' GLY . 41.0 m-20 -111.97 140.0 22.95 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -46.03 -30.65 7.55 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.458 2.105 . . . . 1.0 112.46 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -81.17 -19.22 43.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 1.0 110.043 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.84 -11.42 38.17 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.56 -0.616 . . . . 1.0 111.56 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -79.22 90.39 4.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.747 0.308 . . . . 1.0 110.699 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.85 152.09 21.2 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 p -125.69 148.87 48.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 1.0 111.711 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.78 109.3 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 65.1 t -107.87 0.8 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.925 -0.31 . . . . 1.0 111.292 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.34 118.69 2.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.017 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -147.04 133.85 20.09 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.874 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.97 148.36 51.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 1.0 109.388 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.524 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 36.3 ptt180 -141.73 145.38 34.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.797 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -50.34 -37.17 31.34 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -175.1 -167.97 35.04 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.952 -0.859 . . . . 1.0 110.952 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.78 43.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 1.0 110.546 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 71' ' ' GLY . 53.9 mtt-85 -84.05 -46.68 11.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.13 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.454 ' CD1' ' NH1' ' A' ' 50' ' ' ARG . 13.3 mt -123.37 150.85 61.66 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.881 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.57 165.28 31.27 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.532 2.155 . . . . 1.0 112.191 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.9 p -93.33 131.81 38.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.981 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.3 mt -89.78 9.04 28.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.454 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.83 130.46 45.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.989 -0.55 . . . . 1.0 112.263 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.62 -14.88 58.74 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.524 -0.762 . . . . 1.0 111.567 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.3 mt -80.77 150.37 29.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.282 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.2 m -104.59 129.53 52.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.75 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -82.16 128.72 66.74 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -40.26 125.34 1.82 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.663 2.242 . . . . 1.0 111.882 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.07 132.68 52.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.74 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.39 1.6 44.08 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.539 -1.024 . . . . 1.0 110.539 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -56.78 -35.66 68.94 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 mt -88.76 126.95 57.97 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.425 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.83 -155.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.477 2.118 . . . . 1.0 112.503 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -107.76 -68.78 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 1.0 111.557 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -49.44 -46.63 48.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.855 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.99 -45.48 81.43 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.702 HH12 ' NH2' ' A' ' 96' ' ' ARG . 71.8 ttt-85 -59.62 -35.34 74.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.475 -0.33 . . . . 1.0 111.513 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -63.51 -31.14 72.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.792 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.422 ' CD1' HH12 ' A' ' 101' ' ' ARG . 87.0 mt -69.25 -35.76 76.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.248 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.626 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 17.6 m-85 -59.14 -31.14 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.017 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.702 ' NH2' HH12 ' A' ' 92' ' ' ARG . 80.7 mtt180 -83.44 -23.61 32.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.815 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.4 mt -99.18 -47.5 5.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.0 -8.51 13.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -173.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.688 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.5 mm-40 39.21 80.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.16 -1.016 . . . . 1.0 108.817 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 4.2 p 173.69 120.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.037 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.472 HH11 ' HG3' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -169.72 146.58 3.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.011 0.434 . . . . 1.0 110.716 177.08 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 101' ' ' ARG . 54.1 t -159.35 150.24 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.565 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.6 mt -108.06 134.63 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.03 165.11 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 15.4 p30 -45.99 117.89 1.68 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.988 -1.005 . . . . 1.0 112.114 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.81 -21.46 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.326 -0.852 . . . . 1.0 110.769 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.54 -43.22 90.63 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.12 -11.83 44.31 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.502 0.668 . . . . 1.0 109.356 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 45.29 69.26 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.748 -1.115 . . . . 1.0 113.291 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 m -76.29 132.36 39.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 174.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -119.44 139.22 52.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.0 -0.68 . . . . 1.0 111.886 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.422 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -124.4 149.91 46.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.576 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.1 pt -152.98 172.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.146 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.9 p -66.8 154.09 41.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.707 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -139.42 152.15 68.46 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.7 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -83.9 -14.39 7.51 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.657 2.238 . . . . 1.0 112.345 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.7 145.5 23.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.422 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.6 m -66.14 165.39 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 -94.34 155.72 16.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.493 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.93 178.11 45.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.9 tp -108.31 89.32 2.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.759 0.314 . . . . 1.0 110.429 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.9 p -75.05 -14.84 60.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.522 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.15 -33.79 28.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.632 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -51.6 -40.91 60.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.593 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 127' ' ' LEU . 2.1 m -115.12 85.92 13.15 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.205 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -42.92 84.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.605 2.203 . . . . 1.0 112.354 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 125' ' ' VAL . 39.9 tp -143.51 139.54 29.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.602 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.74 13.35 53.69 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.814 -0.914 . . . . 1.0 110.814 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 61.96 76.94 0.37 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.632 0.253 . . . . 1.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -85.8 -16.83 4.3 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.224 2.616 . . . . 1.0 111.698 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.8 tp -56.68 -32.3 65.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.394 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -132.99 129.63 38.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.846 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -126.0 145.69 52.98 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.575 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.15 141.6 20.89 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.741 2.294 . . . . 1.0 111.945 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.431 HG12 HBD2 ' A' ' 203' ' ' CYC . 0.7 OUTLIER -109.38 123.61 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.909 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -41.3 153.48 0.25 Allowed Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -57.08 -21.59 43.1 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.194 2.596 . . . . 1.0 114.038 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.691 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 5.6 p -63.02 -46.57 86.97 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.691 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 16.4 t-80 -81.27 -27.15 35.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.245 0.461 . . . . 1.0 112.245 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.4 -53.61 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.915 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -65.74 -28.17 68.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.536 ' O ' ' OG ' ' A' ' 145' ' ' SER . 78.6 t80 -59.17 -42.98 92.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.7 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 146' ' ' MET . 17.5 mt -73.32 -38.85 65.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -52.12 -39.06 59.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.594 -1.261 . . . . 1.0 107.594 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.536 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 9.9 p -65.14 -20.55 66.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.769 -1.105 . . . . 1.0 109.186 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.538 ' N ' ' O ' ' A' ' 143' ' ' LEU . 81.5 mmm -95.65 2.81 54.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.412 -0.813 . . . . 1.0 110.707 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.81 21.86 78.85 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.88 142.54 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 1.0 111.02 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.38 -21.03 13.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.931 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -147.82 160.63 42.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.155 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 p -148.38 126.37 12.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.469 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.43 128.7 55.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.302 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.82 121.05 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.173 0.511 . . . . 1.0 111.801 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.509 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 3.1 m -126.16 92.99 44.51 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.816 -1.179 . . . . 1.0 107.816 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -44.84 143.86 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.148 2.565 . . . . 1.0 114.672 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 154' ' ' VAL . 10.9 mp -121.91 60.24 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.818 -1.549 . . . . 1.0 106.818 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.3 ptm -147.66 -178.63 6.36 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.139 0.792 . . . . 1.0 113.139 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.621 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 57.7 t-80 -71.08 172.66 8.74 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.289 -0.869 . . . . 1.0 111.368 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.621 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 55.9 t-80 -61.48 -50.59 72.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.326 -0.852 . . . . 1.0 112.039 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -105.36 -37.66 6.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -89.97 136.13 33.23 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.957 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.443 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 6.3 tt -107.39 118.46 36.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.279 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -92.55 -44.17 8.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.205 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -161.53 -176.11 33.28 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.63 138.16 34.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 1.0 111.534 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.5 tp -103.81 134.19 47.53 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.23 140.07 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.699 -0.401 . . . . 1.0 111.089 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.3 m -114.12 137.89 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.994 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.48 ' O ' ' OG1' ' A' ' 48' ' ' THR . 77.5 m-70 -111.46 135.65 51.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.003 0.43 . . . . 1.0 111.611 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -128.27 121.9 30.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.966 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.51 -12.54 60.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.817 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -129.83 148.02 67.81 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.018 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -44.32 146.48 1.93 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.952 2.435 . . . . 1.0 111.821 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -172.82 79.42 0.43 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.03 151.17 12.21 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.569 2.179 . . . . 1.0 111.933 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -99.41 136.16 39.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.482 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.7 m -125.65 172.45 9.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.593 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -50.47 -35.41 28.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.667 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -62.35 -50.11 72.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.682 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -62.34 -37.21 84.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.477 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.7 tp -61.47 -36.2 79.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.561 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -61.33 -30.12 70.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 1.0 111.36 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 74.4 t -71.35 -53.54 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 188' ' ' ALA . 34.7 m -77.94 -36.09 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.398 0.518 . . . . 1.0 112.398 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -54.9 -49.68 70.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.707 0.289 . . . . 1.0 111.631 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 33.4 tp -73.46 -39.73 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 28.3 tp -79.21 -40.15 31.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.418 -0.355 . . . . 1.0 111.813 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.527 ' O ' ' OG ' ' A' ' 192' ' ' SER . . . -55.8 -36.38 67.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.56 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -77.68 -38.8 46.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 1.0 109.97 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.98 -35.99 82.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.127 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -83.65 -40.06 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.722 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.527 ' OG ' ' O ' ' A' ' 188' ' ' ALA . 68.7 m -54.43 -35.8 63.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.1 mt -61.42 -35.67 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.217 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.33 -38.58 78.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.756 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.13 -49.5 83.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.154 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.39 -46.84 65.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.864 -0.607 . . . . 1.0 111.138 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -64.23 -40.58 96.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 1.0 111.518 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.97 67.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.321 -0.399 . . . . 1.0 111.699 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -63.1 -37.91 89.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.495 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 48.6 mt -61.42 -31.77 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.983 -0.287 . . . . 1.0 111.083 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.6 m -54.6 -52.55 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.529 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 31.0 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.521 179.655 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.486 ' HHA' ' O1A' ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.534 ' CD2' ' NH2' ' A' ' 55' ' ' ARG . 39.4 tp . . . . . 0 C--O 1.23 0.028 0 CA-C-O 120.91 0.385 . . . . 1.0 110.594 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 65.5 t0 -79.61 -30.5 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.984 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -79.38 -45.16 20.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.08 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.3 tt -61.52 -39.92 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 1.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.7 mt -61.1 -45.51 94.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.049 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.458 HH12 ' CD2' ' A' ' 78' ' ' LEU . 77.9 mtt-85 -53.75 -38.55 64.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.564 -0.455 . . . . 1.0 109.938 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.92 -29.34 65.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.082 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.5 m -73.08 -44.52 60.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.544 -0.753 . . . . 1.0 112.249 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -69.16 -37.57 76.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.55 -37.23 71.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.796 0.332 . . . . 1.0 111.112 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -67.49 -49.01 65.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.78 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.4 -31.22 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.136 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.8 tmt_? -61.09 -45.83 93.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.811 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.02 72.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.09 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -78.33 -41.35 33.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.58 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.7 mt -85.55 -30.23 23.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.427 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.02 20.07 32.92 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.455 -1.058 . . . . 1.0 110.455 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.6 p -72.59 143.23 48.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.343 . . . . 1.0 110.239 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -39.58 -53.55 2.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.607 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -154.04 130.75 10.76 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.048 -0.661 . . . . 1.0 112.588 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -136.95 128.97 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.582 -0.896 . . . . 1.0 108.582 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -139.73 154.51 47.46 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.532 -0.467 . . . . 1.0 111.932 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.69 137.18 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -132.86 134.25 44.37 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.26 -178.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.534 ' NH2' ' CD2' ' A' ' 31' ' ' LEU . 42.4 ttm-85 -90.61 138.21 31.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.241 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -92.99 117.01 29.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 1.0 112.077 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -84.09 149.85 56.86 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.35 -23.97 72.43 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.517 2.145 . . . . 1.0 112.481 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.66 -16.48 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.0 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.67 -12.36 42.41 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.534 -0.626 . . . . 1.0 111.534 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -75.3 96.11 3.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.784 0.326 . . . . 1.0 110.662 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.15 143.09 16.78 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.7 p -122.21 146.02 47.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 1.0 111.693 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.73 109.47 13.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -108.74 -1.66 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.97 -0.292 . . . . 1.0 111.242 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.68 114.62 2.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.044 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.41 ' C ' ' OE1' ' A' ' 67' ' ' GLU . 1.6 pp20? -145.22 135.29 23.82 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.523 -0.471 . . . . 1.0 111.833 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.39 144.83 51.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.692 -0.685 . . . . 1.0 109.386 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.473 ' NH1' ' C ' ' A' ' 71' ' ' GLY . 34.3 ptt85 -136.55 143.65 43.78 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.746 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -49.17 -41.68 30.86 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -173.31 -167.46 33.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -70.96 39.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.735 0.302 . . . . 1.0 110.515 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.523 ' H ' ' C ' ' A' ' 71' ' ' GLY . 39.2 ttm180 -83.08 -49.72 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.18 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.93 151.18 49.95 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 1.0 109.849 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.66 164.2 35.33 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.522 2.148 . . . . 1.0 112.144 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.538 ' HG ' ' H ' ' A' ' 78' ' ' LEU . 33.3 t -94.88 131.14 41.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.988 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.7 mt -90.26 11.51 20.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.411 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.538 ' H ' ' HG ' ' A' ' 76' ' ' SER . 11.3 tp -63.2 130.19 43.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 1.0 112.288 -177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.99 -12.36 66.33 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.498 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -81.68 150.0 28.24 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.285 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -109.35 137.61 46.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.646 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.745 ' CE2' HAB1 ' A' ' 203' ' ' CYC . 9.3 m-85 -90.45 152.58 45.55 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.495 -0.557 . . . . 1.0 109.495 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.18 140.13 87.42 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.691 2.261 . . . . 1.0 111.816 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.02 126.83 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.709 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.89 -0.52 45.0 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.484 -1.046 . . . . 1.0 110.484 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -57.43 -37.87 73.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.507 ' N ' ' CD1' ' A' ' 87' ' ' ILE . 1.6 mp -70.96 114.34 26.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.429 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.452 ' CG ' ' HD ' ' A' ' 203' ' ' CYC . 99.9 Cg_exo -46.55 173.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.467 2.111 . . . . 1.0 112.481 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.523 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 96.2 mt-10 -104.5 -52.1 2.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.495 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.586 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 3.1 pm0 -68.55 -41.51 79.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.762 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.04 -42.01 90.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.966 0.358 . . . . 1.0 111.966 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -60.44 -36.44 78.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.487 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 75.3 mtt85 -66.58 -41.49 88.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.833 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.9 -39.24 93.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.277 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.662 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 8.4 t80 -64.39 -28.76 69.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.02 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.435 ' C ' HE22 ' A' ' 99' ' ' GLN . 73.4 ttt-85 -81.95 -26.41 34.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.814 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.9 mt -98.18 -43.28 7.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.382 1.253 . . . . 1.0 114.382 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -111.8 -7.39 14.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.996 1.48 . . . . 1.0 114.996 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.665 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.6 mm-40 47.02 82.85 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.239 -0.984 . . . . 1.0 108.769 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 2.6 p 174.13 103.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.048 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.7 mmt-85 -143.87 139.54 29.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 1.0 110.825 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -171.6 147.25 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.539 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.75 138.06 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.95 165.37 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -48.31 119.83 3.23 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.133 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.27 -27.58 32.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.296 -0.866 . . . . 1.0 110.793 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 109' ' ' GLN . 82.7 tt0 -66.67 -42.84 85.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.68 -9.79 4.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.519 0.676 . . . . 1.0 109.395 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.433 ' H ' ' C ' ' A' ' 107' ' ' GLU . 45.1 tt0 45.41 58.42 4.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.704 -1.134 . . . . 1.0 113.28 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.8 p -77.55 134.65 38.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.919 -1.511 . . . . 1.0 106.919 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -123.1 144.64 49.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.952 -0.699 . . . . 1.0 111.903 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.37 156.48 46.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.527 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.9 pt -155.39 177.09 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.193 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 p -59.96 157.2 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.654 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -140.15 153.76 69.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.702 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -36.1 153.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.655 2.237 . . . . 1.0 112.34 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.602 ' H ' ' CD ' ' A' ' 117' ' ' GLU . 4.6 pm0 -48.05 144.15 3.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.43 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 t -159.03 148.32 18.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.631 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -136.27 152.12 50.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.59 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.37 132.19 22.82 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 38.5 mt -85.87 156.11 20.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.75 0.309 . . . . 1.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 124' ' ' ARG . 22.6 m -53.37 -28.08 27.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.484 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 125' ' ' VAL . . . -61.4 0.75 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.649 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.528 ' H ' ' C ' ' A' ' 122' ' ' SER . 78.9 mtm180 62.71 -65.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.566 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 123' ' ' ALA . 7.3 p -127.52 86.48 58.4 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.209 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 128' ' ' GLY . 82.0 Cg_endo -83.93 0.67 9.2 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.621 2.214 . . . . 1.0 112.248 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 tp 66.5 1.52 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.568 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 126' ' ' PRO . . . -54.52 -36.98 59.49 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.93 163.51 48.31 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.553 0.216 . . . . 1.0 110.826 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -87.4 -169.06 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.1 2.534 . . . . 1.0 111.621 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.1 mp -82.21 -2.0 50.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.364 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 58.97 22.76 10.75 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.958 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.558 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 4.0 mtp-105 -43.07 -44.71 11.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.589 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 5.0 Cg_exo -83.97 137.0 7.26 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.71 2.273 . . . . 1.0 111.956 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.494 HG22 HMD3 ' A' ' 203' ' ' CYC . 2.3 p -122.69 134.26 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.861 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.638 ' OD2' HMD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -46.53 151.22 1.05 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 138' ' ' CYS . 36.2 Cg_endo -59.62 -46.93 18.04 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.263 2.642 . . . . 1.0 113.991 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -36.66 -44.84 0.48 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.682 0.253 . . . . 1.0 111.682 -178.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.688 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.6 t60 -83.79 -27.87 28.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.7 t -68.09 -51.0 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.979 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -66.75 -30.86 71.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -58.54 -43.85 89.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.67 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 146' ' ' MET . 13.1 mt -73.28 -37.79 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -50.86 -39.17 53.09 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -64.38 -25.5 68.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.765 -1.107 . . . . 1.0 109.195 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.562 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.2 mmm -90.56 1.95 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.705 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.55 21.57 78.73 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.81 142.47 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.89 0.376 . . . . 1.0 111.062 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.47 -20.39 13.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.908 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -145.62 160.6 41.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.203 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.7 p -147.7 122.08 9.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.411 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.2 mp -108.6 139.81 42.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.293 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.81 118.41 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.128 0.49 . . . . 1.0 111.726 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.8 t -122.5 127.35 25.86 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 95' ' ' PHE . 83.4 Cg_endo -76.33 148.62 30.5 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.135 2.557 . . . . 1.0 114.692 -176.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.63 49.01 2.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.814 -1.551 . . . . 1.0 106.814 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.02 -175.72 4.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -174.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.38 163.09 28.36 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.383 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.526 ' ND1' ' OE1' ' A' ' 160' ' ' GLN . 58.4 t-80 -66.65 -53.99 28.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.37 -0.832 . . . . 1.0 112.023 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.526 ' OE1' ' ND1' ' A' ' 159' ' ' HIS . 12.1 mm100 -99.78 8.81 43.95 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.047 0.388 . . . . 1.0 112.047 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -143.13 134.83 26.57 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.834 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.609 ' N ' ' CD1' ' A' ' 162' ' ' LEU . 1.1 mp -110.41 116.98 32.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.188 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -92.19 -41.01 10.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.263 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.72 -177.95 27.71 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.02 143.71 29.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.897 0.379 . . . . 1.0 111.531 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.18 132.75 54.72 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.8 p -136.08 132.84 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.982 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 21.3 m -107.49 149.44 27.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.074 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -124.87 131.85 53.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.02 0.438 . . . . 1.0 111.648 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.6 113.8 14.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.98 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.45 -15.89 63.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.84 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -96.18 147.43 32.96 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.942 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.86 76.18 2.06 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.98 2.453 . . . . 1.0 111.886 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -113.77 97.76 45.37 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.836 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.75 164.83 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.494 2.129 . . . . 1.0 111.972 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 44.6 p90 -92.0 130.68 37.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.488 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 98.4 p -119.17 157.64 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.607 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -54.79 -34.75 63.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.638 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -57.12 -36.71 70.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.81 -36.59 83.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.499 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 9.4 mp -67.97 -38.13 82.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.53 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -53.58 -40.88 65.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.356 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 88.5 t -70.32 -56.43 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.39 -38.89 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.477 0.547 . . . . 1.0 112.477 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 181' ' ' LEU . 62.9 tt0 -49.98 -49.82 49.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.667 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 31.7 tp -70.16 -40.38 74.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.938 0.347 . . . . 1.0 111.938 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.7 tp -76.44 -38.79 54.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.787 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.46 77.93 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.517 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.68 -39.27 80.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.94 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -65.66 -27.87 68.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.084 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -83.71 -41.8 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.736 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.8 p -56.64 -33.24 66.14 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.4 mt -69.94 -38.23 74.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.213 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.11 76.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.602 -0.727 . . . . 1.0 109.832 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.6 mm -60.59 -46.55 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.162 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.98 -45.64 66.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -67.59 -41.21 84.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.517 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.448 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -66.94 -31.56 72.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.69 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.06 -39.79 93.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.559 -0.291 . . . . 1.0 111.492 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.32 -36.26 83.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.986 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 98.6 p -56.89 -52.92 63.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.784 0.326 . . . . 1.0 110.588 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.568 179.547 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.745 HAB1 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.808 0.337 . . . . 1.0 110.585 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.7 -28.72 56.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.032 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -79.84 -46.49 16.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.128 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 35' ' ' LEU . 3.2 tp -63.8 -43.96 98.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.955 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.494 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 83.6 mt -61.39 -49.26 77.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.015 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 39' ' ' VAL . 60.5 ttp180 -53.84 -37.68 63.86 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 -30.14 66.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.013 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.4 m -73.54 -45.0 56.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.591 -0.731 . . . . 1.0 112.204 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 36' ' ' ARG . 9.1 p -67.39 -34.98 72.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -70.5 -39.33 74.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 1.0 111.098 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -65.54 -50.78 63.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.829 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.23 -28.81 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.683 0.278 . . . . 1.0 111.128 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.3 tmm_? -61.88 -46.4 89.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.865 0.364 . . . . 1.0 110.882 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.15 -33.45 69.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.097 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -79.68 -41.18 27.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.551 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 mt -85.34 -35.42 21.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.453 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 62.31 20.54 61.01 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.521 -1.031 . . . . 1.0 110.521 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -73.42 141.63 46.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.808 0.337 . . . . 1.0 110.173 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' CG ' HH21 ' A' ' 73' ' ' ARG . 92.3 m-20 -39.45 -44.3 1.36 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.622 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -164.76 130.43 2.77 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.025 -0.67 . . . . 1.0 112.57 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.16 129.01 42.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -140.83 154.81 46.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.867 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -98.47 135.04 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 47.5 t80 -115.74 105.36 12.64 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.323 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -76.16 124.81 28.04 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.232 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 86.7 t80 -90.87 142.18 28.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 1.0 112.02 -178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 1.1 m-20 -112.04 151.36 43.53 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 108.617 -0.882 . . . . 1.0 108.617 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.48 -23.65 75.78 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.541 2.161 . . . . 1.0 112.469 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -88.32 -12.12 44.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 1.0 110.045 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.61 -13.85 57.92 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.572 -0.611 . . . . 1.0 111.572 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -78.88 89.83 4.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.855 0.36 . . . . 1.0 110.606 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.47 151.63 21.07 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -125.07 146.39 49.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 1.0 111.679 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.96 108.98 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.5 t -105.79 -1.61 9.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.904 -0.318 . . . . 1.0 111.333 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.03 115.38 2.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.143 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.482 ' CD ' ' NH2' ' A' ' 69' ' ' ARG . 87.7 tt0 -143.14 132.49 23.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.074 0.464 . . . . 1.0 111.856 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.98 147.77 50.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.4 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.482 ' NH2' ' CD ' ' A' ' 67' ' ' GLU . 42.3 mtt85 -141.23 142.33 33.96 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.77 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.98 -31.21 80.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -171.41 -173.66 38.53 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -79.26 40.0 0.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 1.0 110.517 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.55 HH21 ' CG ' ' A' ' 49' ' ' ASP . 22.3 ttp-105 -83.19 -48.64 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.22 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -103.37 149.93 37.48 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.167 -0.47 . . . . 1.0 109.905 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.61 148.58 72.61 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.535 2.157 . . . . 1.0 112.138 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.0 m -76.83 125.2 28.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.907 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.1 mt -103.99 9.75 36.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.323 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.54 132.43 41.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.182 0.515 . . . . 1.0 112.305 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.88 -7.96 75.05 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.624 -0.716 . . . . 1.0 111.521 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.38 154.87 20.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.76 0.314 . . . . 1.0 110.246 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -103.07 129.02 49.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.663 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -82.49 152.06 66.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.57 132.08 31.89 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.617 2.211 . . . . 1.0 111.848 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 128.72 37.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.052 0.454 . . . . 1.0 110.686 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.42 -0.17 40.29 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -59.24 -15.71 17.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.57 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.7 mt -104.14 105.62 49.77 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.696 -0.683 . . . . 1.0 109.465 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 87' ' ' ILE . 92.8 Cg_exo -48.11 -162.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.4 2.067 . . . . 1.0 112.485 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -107.21 -58.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.543 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.55 -42.04 86.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.835 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.84 -48.63 68.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.98 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -59.38 -37.94 79.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.445 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -64.51 -33.31 75.6 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.9 -0.32 . . . . 1.0 110.807 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.49 -38.12 89.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.256 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.601 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 21.0 m-85 -61.45 -48.5 80.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.041 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -51.5 -34.57 36.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.835 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.4 mt -99.07 -38.01 9.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 114.4 1.259 . . . . 1.0 114.4 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.596 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.25 -13.25 11.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 115.105 1.52 . . . . 1.0 115.105 -174.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 21.6 mm-40 34.65 74.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.249 -0.98 . . . . 1.0 108.788 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p 177.17 117.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.122 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.528 HH22 ' CD ' ' A' ' 129' ' ' GLU . 2.0 tpt180 -176.0 145.36 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.922 0.391 . . . . 1.0 110.791 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.0 m -151.22 158.05 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.515 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.7 136.06 44.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 3.4 m -93.03 166.12 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 113.321 0.86 . . . . 1.0 113.321 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 173' ' ' PRO . 57.8 m-20 -46.31 118.42 1.93 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.918 -1.037 . . . . 1.0 112.166 -176.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.05 -22.73 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.789 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -62.56 -44.02 97.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.71 -10.97 31.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.56 0.695 . . . . 1.0 109.351 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 44.12 72.06 0.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.743 -1.117 . . . . 1.0 113.294 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.478 ' OG ' ' CG2' ' A' ' 104' ' ' VAL . 2.0 m -73.74 131.81 41.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.951 -1.499 . . . . 1.0 106.951 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -119.93 137.35 54.09 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.029 -0.668 . . . . 1.0 111.936 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.2 t -135.27 158.72 43.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.482 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.656 ' C ' ' H ' ' A' ' 115' ' ' GLN . 44.9 mm -121.82 133.94 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.15 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.5 m -57.01 5.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.702 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.656 ' H ' ' C ' ' A' ' 113' ' ' ILE . 26.6 mt-30 -116.72 81.3 11.57 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.646 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -83.72 150.26 12.81 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.73 2.287 . . . . 1.0 112.345 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.81 -42.99 99.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.434 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 59.1 p -169.0 176.01 5.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.706 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 120' ' ' GLY . 38.9 p90 -140.13 171.17 14.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.488 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 119' ' ' TRP . . . 55.23 111.98 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 9.2 mp -85.82 126.18 33.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 1.0 110.408 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 124' ' ' ARG . 50.5 m -74.23 -14.95 61.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.512 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -68.91 16.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.675 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.586 ' H ' ' C ' ' A' ' 122' ' ' SER . 18.6 mmm180 41.92 92.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.602 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.25 129.96 23.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.234 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.457 ' HG2' ' H ' ' A' ' 127' ' ' LEU . 87.1 Cg_endo -78.82 -56.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.619 2.212 . . . . 1.0 112.291 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.457 ' H ' ' HG2' ' A' ' 126' ' ' PRO . 8.4 mp -68.9 -18.21 64.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.607 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 97.89 172.14 32.94 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.528 ' CD ' HH22 ' A' ' 101' ' ' ARG . 8.9 pt-20 -52.64 149.9 10.26 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 121.136 -0.226 . . . . 1.0 110.921 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' GLU . 24.7 Cg_exo -33.39 150.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 123.168 2.578 . . . . 1.0 111.661 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.9 mt -70.79 -7.67 46.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.332 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.529 ' O ' ' NE ' ' A' ' 133' ' ' ARG . 90.7 mt-30 -82.64 82.88 7.83 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.91 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 132' ' ' GLN . 5.9 mmp_? -118.8 114.81 35.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.485 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.02 143.1 14.12 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.791 2.327 . . . . 1.0 111.895 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.77 119.0 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.887 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 112' ' ' SER . 18.7 t70 -44.13 137.38 3.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.754 -0.462 . . . . 1.0 109.754 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -37.82 -46.72 2.01 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.141 2.561 . . . . 1.0 114.034 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.684 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -41.31 -45.28 2.95 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.668 0.247 . . . . 1.0 111.668 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.684 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 17.4 t60 -81.86 -28.19 33.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.235 0.458 . . . . 1.0 112.235 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.2 t -66.97 -54.09 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -63.99 -29.36 70.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -57.68 -45.15 85.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.68 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 146' ' ' MET . 16.8 mt -73.02 -38.81 66.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -51.07 -39.7 56.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -63.78 -24.91 67.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.766 -1.106 . . . . 1.0 109.147 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.549 ' N ' ' O ' ' A' ' 143' ' ' LEU . 80.6 mmm -91.08 2.09 56.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.731 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.14 20.69 79.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.21 141.63 22.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 1.0 111.014 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.63 -21.65 13.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.919 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.6 p -146.35 161.29 40.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.166 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 p -146.54 131.93 18.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.449 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -119.51 125.15 48.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.315 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.32 114.14 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.129 0.49 . . . . 1.0 111.754 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.6 t -120.62 93.69 48.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.751 -1.203 . . . . 1.0 107.751 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -44.94 140.24 7.21 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.142 2.562 . . . . 1.0 114.666 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mp -122.04 50.31 1.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.87 -1.53 . . . . 1.0 106.87 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.446 ' CE ' ' O ' ' A' ' 164' ' ' GLY . 0.1 OUTLIER -146.45 -174.18 4.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.118 0.784 . . . . 1.0 113.118 -176.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.712 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 8.2 m-70 -65.37 154.1 39.32 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.305 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -56.23 -46.04 79.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.342 -0.845 . . . . 1.0 112.035 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -103.6 -44.02 5.21 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.049 0.388 . . . . 1.0 112.049 -177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.492 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 88.3 tt0 -84.75 138.03 32.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.895 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.409 ' HG ' ' SD ' ' A' ' 157' ' ' MET . 3.1 tt -105.72 113.85 27.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.324 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.712 ' HE1' ' CD2' ' A' ' 158' ' ' HIS . 68.7 m95 -94.15 -39.95 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.255 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -156.87 -173.4 25.27 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.179 -0.769 . . . . 1.0 111.179 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 tp -141.27 130.0 22.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.857 0.361 . . . . 1.0 111.526 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 56.5 tp -101.96 133.01 47.43 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.4 p -142.2 134.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.059 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.3 p -107.41 146.54 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.016 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -119.73 131.44 55.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.989 0.423 . . . . 1.0 111.634 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.89 113.76 13.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.971 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.83 -17.07 64.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.815 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -83.57 146.79 50.91 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.031 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.446 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 71.2 Cg_endo -72.38 5.99 2.49 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.898 2.399 . . . . 1.0 111.863 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -51.42 131.49 34.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.39 167.12 26.3 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.557 2.172 . . . . 1.0 111.883 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 50.4 p90 -88.95 132.8 34.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.466 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.1 t -117.25 147.22 42.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.565 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -50.96 -34.66 29.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.63 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -55.3 -41.1 71.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.709 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.47 -41.3 98.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.491 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.1 tp -63.82 -38.96 93.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.534 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -54.83 -35.03 63.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.308 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.7 t -70.61 -52.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.805 0.668 . . . . 1.0 112.805 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 t -77.31 -30.97 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -52.67 -49.87 64.38 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.026 -0.27 . . . . 1.0 111.646 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.537 ' N ' ' CD1' ' A' ' 186' ' ' LEU . 7.5 mp -70.71 -37.27 73.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 8.0 tp -77.57 -37.83 49.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.828 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.27 95.81 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.552 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -61.11 -39.29 89.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 1.0 109.958 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -71.99 -29.05 63.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.115 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 194' ' ' ALA . 26.3 t -82.38 -48.78 17.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.712 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 84.2 p -50.66 -27.57 7.23 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 193' ' ' ILE . 47.5 mt -77.51 -32.54 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.2 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -69.47 -47.69 63.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.617 -0.719 . . . . 1.0 109.803 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.1 pp -67.47 -35.53 73.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.134 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.447 ' CB ' ' HE2' ' A' ' 158' ' ' HIS . . . -70.68 -49.7 44.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.15 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.19 -32.36 66.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.496 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.433 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -64.09 -34.25 77.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.701 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -56.26 -29.85 61.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.575 -0.284 . . . . 1.0 111.445 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 9.9 mp -60.13 -33.28 71.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.702 0.287 . . . . 1.0 111.033 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.7 ' HG ' ' H ' ' A' ' 202' ' ' LEU . 63.3 p -52.95 -54.62 32.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.566 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.7 ' H ' ' HG ' ' A' ' 201' ' ' SER . 10.2 mp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.488 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.579 ' O2A' ' HHA' ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.342 . . . . 1.0 110.542 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -48.43 -32.78 8.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.987 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -78.72 -45.56 20.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.065 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.8 mm -64.5 -39.93 87.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.878 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.7 mt -59.83 -45.94 90.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.006 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -57.31 -37.25 72.18 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.45 -28.48 65.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.079 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 m -74.05 -47.24 38.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.526 -0.761 . . . . 1.0 112.244 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.27 -34.52 71.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.949 0.351 . . . . 1.0 111.949 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.48 -49.55 70.95 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.9 -47.24 81.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.766 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.9 t -53.51 -46.49 59.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.989 -0.284 . . . . 1.0 111.165 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 47' ' ' GLY . 15.5 ttt-85 -49.87 -38.48 35.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.771 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.52 75.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -76.8 -44.12 33.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.552 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mt -86.2 -27.58 24.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.502 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.68 22.02 24.01 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.449 -1.061 . . . . 1.0 110.449 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.5 p -74.44 144.18 44.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.884 0.373 . . . . 1.0 110.194 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -42.35 -39.83 2.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.659 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 42.9 ttm180 -162.73 129.08 3.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.038 -0.665 . . . . 1.0 112.574 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.81 130.95 53.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.75 ' NZ ' HAB2 ' A' ' 203' ' ' CYC . 17.4 pttp -141.57 158.64 43.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.073 0.464 . . . . 1.0 111.969 -177.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.7 t -100.48 136.85 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -119.08 104.78 10.78 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.392 -0.523 . . . . 1.0 111.272 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.622 HH22 ' CG2' ' A' ' 195' ' ' ILE . 42.5 mmt-85 -77.3 128.0 33.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.264 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.498 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 78.9 t80 -93.32 139.21 30.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 1.0 112.024 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.498 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 1.6 m-20 -109.03 151.24 41.82 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.658 -0.867 . . . . 1.0 108.658 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.44 -23.93 72.61 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.516 2.144 . . . . 1.0 112.483 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -87.08 -13.26 44.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.64 -11.56 57.91 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.569 -0.613 . . . . 1.0 111.569 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -80.69 90.54 5.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.793 0.33 . . . . 1.0 110.642 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.7 151.43 20.88 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.617 -0.993 . . . . 1.0 110.617 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -124.77 149.01 47.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 1.0 111.679 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.5 t -77.93 109.16 12.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.06 -0.3 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.327 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.39 115.97 2.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.038 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 86.0 tt0 -144.5 132.73 21.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.839 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.3 142.31 50.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.415 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -140.04 144.79 37.06 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.721 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' CA ' HH21 ' A' ' 43' ' ' ARG . . . -60.55 -35.31 88.86 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -172.7 -164.33 27.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.59 25.69 0.33 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.76 0.314 . . . . 1.0 110.536 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 71' ' ' GLY . 74.1 ttt-85 -72.19 -48.0 46.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.117 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.423 ' C ' HH22 ' A' ' 50' ' ' ARG . 15.1 mt -106.65 148.35 36.67 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.879 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.526 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 58.1 Cg_endo -69.59 137.99 37.27 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.49 2.127 . . . . 1.0 112.166 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.1 t -72.44 123.46 23.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.936 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.9 mt -99.02 11.32 39.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.397 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.7 tp -71.43 128.89 37.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.241 0.543 . . . . 1.0 112.261 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.79 -9.44 76.33 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.455 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 mt -85.7 152.06 23.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.307 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.1 p -104.51 132.89 50.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.731 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 9.5 m-85 -87.23 128.15 56.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.557 -0.534 . . . . 1.0 109.557 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -41.28 133.08 3.24 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.675 2.25 . . . . 1.0 111.862 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.36 132.48 49.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.657 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.77 0.58 42.53 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.53 -1.028 . . . . 1.0 110.53 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -54.52 -33.85 60.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.9 mt -90.61 111.71 49.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.361 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' A' ' 87' ' ' ILE . 87.2 Cg_exo -51.89 -157.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.411 2.074 . . . . 1.0 112.467 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 74.8 mm-40 -109.43 -54.59 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.536 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.83 -43.86 97.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.822 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.27 76.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.436 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 51.2 ttt85 -56.06 -35.38 66.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.393 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 75.4 mtt85 -64.22 -34.01 77.12 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.812 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.19 -37.42 87.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.332 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 101' ' ' ARG . 32.2 m-85 -59.88 -30.78 69.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.096 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -79.93 -26.26 40.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.829 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.548 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 82.3 mt -100.65 -44.66 5.76 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.44 1.274 . . . . 1.0 114.44 -175.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.53 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -118.23 -12.45 9.97 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 115.078 1.511 . . . . 1.0 115.078 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.572 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 38.8 79.72 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.166 -1.014 . . . . 1.0 108.827 -178.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.496 ' CG1' ' O ' ' A' ' 100' ' ' VAL . 11.1 p -177.11 102.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.066 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 11.1 mmt180 -148.07 151.18 35.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.923 0.392 . . . . 1.0 110.746 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -169.54 147.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.476 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.679 ' CD1' HAA1 ' A' ' 203' ' ' CYC . 76.8 mt -109.41 134.8 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 m -92.16 164.65 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.331 0.863 . . . . 1.0 113.331 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 18.0 p30 -43.98 117.7 1.27 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.98 -1.009 . . . . 1.0 112.156 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.74 -19.55 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.734 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.28 -43.04 92.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.03 -13.28 62.07 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.56 0.695 . . . . 1.0 109.453 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.542 ' CD ' HH21 ' A' ' 111' ' ' ARG . 55.4 tt0 45.74 72.59 0.21 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.684 -1.143 . . . . 1.0 113.334 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.0 t -73.86 131.66 41.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.542 HH21 ' CD ' ' A' ' 109' ' ' GLN . 93.9 mtt180 -118.99 139.14 52.19 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.943 -0.703 . . . . 1.0 111.886 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.412 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -130.97 152.11 50.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.513 179.199 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.5 pt -152.89 174.24 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.146 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.8 m -65.14 161.43 19.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.599 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -136.6 151.37 72.64 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.655 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -35.07 -69.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.772 2.315 . . . . 1.0 112.281 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -135.2 145.16 47.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.443 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.8 t -156.59 133.23 10.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.617 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -144.09 158.87 43.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.596 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -158.28 127.31 1.86 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.472 ' CG ' ' H ' ' A' ' 122' ' ' SER . 2.7 tp -164.64 -149.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 1.0 110.392 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.472 ' H ' ' CG ' ' A' ' 121' ' ' LEU . 23.0 t -70.44 -34.35 72.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.493 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.33 6.69 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.641 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -56.18 143.29 33.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.55 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 127' ' ' LEU . 2.9 t -127.34 86.27 59.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.229 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -44.22 89.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.655 2.236 . . . . 1.0 112.29 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 125' ' ' VAL . 94.8 mt -136.94 -97.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.527 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -73.92 102.97 1.39 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.842 -0.903 . . . . 1.0 110.842 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.499 ' N ' ' HD3' ' A' ' 130' ' ' PRO . 73.3 tt0 -160.24 57.62 0.97 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.541 0.21 . . . . 1.0 110.862 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 129' ' ' GLU . 41.4 Cg_endo -97.24 -53.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 123.192 2.595 . . . . 1.0 111.64 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.458 ' H ' ' CD ' ' A' ' 130' ' ' PRO . 31.2 mt -63.5 -25.86 68.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.339 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -75.8 -34.71 60.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.012 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.472 ' NH1' ' CD ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -47.08 -56.34 12.42 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.545 -178.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 133' ' ' ARG . 70.2 Cg_exo -42.65 149.62 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.77 2.314 . . . . 1.0 111.956 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.88 116.51 42.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.797 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' A' ' 112' ' ' SER . 10.7 t70 -43.1 136.95 2.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 140' ' ' VAL . 62.3 Cg_exo -42.42 -49.5 6.22 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 123.213 2.609 . . . . 1.0 114.019 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.689 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -36.88 -45.33 0.55 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.645 0.239 . . . . 1.0 111.645 -178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.689 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.5 t60 -81.55 -27.73 34.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.254 0.464 . . . . 1.0 112.254 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 137' ' ' PRO . 40.2 t -65.39 -52.97 45.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.967 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -64.77 -27.62 69.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.528 ' O ' ' OG ' ' A' ' 145' ' ' SER . 76.4 t80 -61.21 -46.45 90.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.678 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 146' ' ' MET . 54.0 mt -73.11 -37.62 66.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -38.69 58.74 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.561 -1.274 . . . . 1.0 107.561 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.528 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 5.7 p -62.82 -20.4 65.01 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.782 -1.099 . . . . 1.0 109.201 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 143' ' ' LEU . 95.4 mmm -95.49 1.21 53.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.774 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.92 24.5 71.79 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.25 140.8 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 1.0 111.014 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.63 -38.12 6.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.934 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.3 m -133.59 125.77 29.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 1.0 111.109 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.8 m -115.42 138.29 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.45 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.5 mt -116.55 139.5 50.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.313 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.44 114.81 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.482 . . . . 1.0 111.818 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.7 t -123.43 91.28 49.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -48.31 144.57 12.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 123.144 2.563 . . . . 1.0 114.705 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.9 mp -121.54 66.87 0.89 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -149.58 -172.92 4.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.129 0.788 . . . . 1.0 113.129 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 54.8 t-80 -77.6 173.89 11.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.413 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 92.9 m-70 -61.73 -52.46 64.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.387 -0.824 . . . . 1.0 112.058 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -104.53 -40.52 6.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.054 0.391 . . . . 1.0 112.054 -177.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE1' ' CD2' ' A' ' 163' ' ' TRP . 7.7 tm-20 -87.81 136.6 32.89 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.691 -0.403 . . . . 1.0 110.93 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER -111.55 116.3 30.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.272 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.533 ' CD2' ' OE1' ' A' ' 161' ' ' GLU . 25.1 m95 -88.67 -33.91 17.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.277 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.82 -173.79 36.19 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.233 -0.747 . . . . 1.0 111.233 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.3 135.41 30.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 1.0 111.495 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.14 136.2 43.38 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.519 ' CG1' ' HZ3' ' A' ' 52' ' ' LYS . 9.5 p -140.36 135.01 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.121 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.5 m -108.93 139.86 43.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.029 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -116.33 133.68 55.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.948 0.404 . . . . 1.0 111.653 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.71 123.16 30.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.94 178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.43 41.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.794 -177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -165.07 148.52 7.3 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.041 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.475 ' O ' ' C ' ' A' ' 174' ' ' ARG . 77.8 Cg_exo -41.42 -75.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.884 2.389 . . . . 1.0 111.897 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.475 ' C ' ' O ' ' A' ' 173' ' ' PRO . 54.3 ttt85 33.65 84.59 0.18 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.875 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.0 162.93 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.541 2.161 . . . . 1.0 111.894 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 51.6 p90 -82.69 125.93 31.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.464 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.0 t -113.6 148.59 35.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.565 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -52.9 -27.01 16.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.631 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -58.14 -43.25 87.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.685 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -64.13 -35.85 82.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.479 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 18.8 tp -60.68 -41.78 95.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.536 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -58.35 -34.94 71.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.342 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 64.0 t -67.84 -53.33 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 188' ' ' ALA . 33.6 m -70.35 -43.71 78.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.395 0.517 . . . . 1.0 112.395 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -43.51 -42.12 4.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.954 -0.299 . . . . 1.0 111.644 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.9 mt -74.97 -44.9 45.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.459 ' O ' ' CG2' ' A' ' 191' ' ' VAL . 57.3 mt -80.55 -39.79 27.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.827 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -58.98 -47.64 84.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.492 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -65.84 -39.64 90.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.002 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -67.69 -29.43 68.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 187' ' ' LEU . 58.6 t -84.08 -45.03 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.714 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.403 ' HG ' ' N ' ' A' ' 193' ' ' ILE . 57.9 p -55.37 -31.38 61.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.403 ' N ' ' HG ' ' A' ' 192' ' ' SER . 52.6 mt -76.73 -34.31 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.234 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.11 -42.4 84.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.82 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.622 ' CG2' HH22 ' A' ' 55' ' ' ARG . 37.4 pt -68.15 -33.72 62.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.163 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.423 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -70.13 -50.71 37.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.14 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -71.67 -36.51 70.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.479 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.66 -35.04 79.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -56.93 -29.58 63.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.472 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 9.2 mp -61.91 -34.15 75.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.682 0.277 . . . . 1.0 111.069 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 35.0 m -49.92 -54.08 22.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.563 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.579 179.695 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.75 HAB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.888 0.375 . . . . 1.0 110.604 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -55.71 -50.93 69.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.978 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.571 HE22 ' NH2' ' A' ' 36' ' ' ARG . 84.7 mm-40 -57.03 -45.54 83.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.077 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.22 -47.15 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 1.0 110.939 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -58.68 -48.41 81.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.048 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.571 ' NH2' HE22 ' A' ' 33' ' ' GLN . 66.3 mtm180 -56.42 -36.32 68.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.442 . . . . 1.0 109.83 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.88 65.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.061 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.2 m -73.29 -47.82 39.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.556 -0.747 . . . . 1.0 112.149 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -65.6 -35.07 74.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.38 -50.93 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 1.0 111.105 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -61.03 -43.36 99.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.784 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.8 t -57.36 -42.57 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.714 0.293 . . . . 1.0 111.166 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 47' ' ' GLY . 62.7 ttp85 -51.29 -40.18 58.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.763 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.41 78.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.041 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -78.38 -45.97 21.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 1.0 111.56 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.87 -31.8 22.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.53 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.93 20.71 27.71 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.6 p -70.92 142.0 51.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 1.0 110.167 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -40.98 -41.28 1.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.633 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.536 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -163.34 128.7 3.08 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.079 -0.648 . . . . 1.0 112.606 -178.582 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.9 130.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -139.98 157.2 46.05 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.441 -0.504 . . . . 1.0 111.903 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.23 136.95 29.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.525 -0.917 . . . . 1.0 108.525 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.473 ' OH ' ' O ' ' A' ' 61' ' ' HIS . 50.1 t80 -130.28 128.96 42.64 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.322 -0.551 . . . . 1.0 111.227 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -94.94 132.43 39.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.18 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -91.33 118.63 30.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -87.79 151.4 49.88 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 108.639 -0.875 . . . . 1.0 108.639 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.76 -20.85 60.84 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.48 2.12 . . . . 1.0 112.444 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -82.77 -17.51 43.92 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.06 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.73 -15.41 37.78 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.549 -0.621 . . . . 1.0 111.549 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.473 ' O ' ' OH ' ' A' ' 54' ' ' TYR . 40.5 m80 -64.14 -104.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.773 0.32 . . . . 1.0 110.632 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.453 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . 103.89 152.97 23.09 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -128.09 147.51 50.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 1.0 111.696 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.66 117.06 27.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.93 4.87 9.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.696 0.284 . . . . 1.0 111.37 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.99 118.58 2.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.104 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 85.8 tt0 -144.37 133.21 22.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 1.0 111.846 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.2 151.5 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.393 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -139.74 142.26 36.82 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.762 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -39.96 -68.96 0.5 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.96 83.84 0.13 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 41.7 38.65 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.746 0.308 . . . . 1.0 110.522 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -82.62 -53.53 5.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.215 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.2 mt -110.27 141.42 23.85 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.888 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.14 165.67 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.479 2.12 . . . . 1.0 112.176 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.8 t -93.38 123.41 36.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.871 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.9 mt -90.59 2.59 55.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.376 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.16 131.12 49.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.179 0.514 . . . . 1.0 112.28 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.67 -13.55 63.89 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.545 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.1 150.93 27.24 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.309 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.5 m -106.14 134.4 49.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.703 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.741 ' CE2' HAB1 ' A' ' 203' ' ' CYC . 8.2 m-85 -88.92 153.04 49.29 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.92 136.16 51.52 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.692 2.262 . . . . 1.0 111.879 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.21 130.56 43.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.708 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.4 -2.43 39.93 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.497 -1.041 . . . . 1.0 110.497 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 20.8 p-10 -54.61 -38.19 66.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 87' ' ' ILE . 14.4 mm -75.08 133.49 75.39 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.42 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.28 -175.21 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.426 2.084 . . . . 1.0 112.526 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -105.46 -51.25 3.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.556 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.43 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 21.5 pt-20 -67.5 -41.97 83.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.843 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.534 ' CB ' HBD2 ' A' ' 203' ' ' CYC . . . -68.16 -42.47 80.01 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.876 0.324 . . . . 1.0 111.876 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -63.83 -41.82 97.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.471 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -60.23 -32.96 71.62 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.879 -0.329 . . . . 1.0 110.847 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.4 mt -71.46 -35.91 71.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.289 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.53 -40.85 96.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.02 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -63.66 -33.57 75.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.81 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.55 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 72.0 mt -97.18 -37.11 10.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 114.389 1.255 . . . . 1.0 114.389 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.563 ' C ' ' NE2' ' A' ' 99' ' ' GLN . . . -118.01 -10.1 10.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.11 1.522 . . . . 1.0 115.11 -175.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.648 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 41.58 79.48 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.114 -1.034 . . . . 1.0 108.864 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.443 ' CG1' ' O ' ' A' ' 100' ' ' VAL . 7.8 p 179.78 107.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.096 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.514 ' NH1' ' O ' ' A' ' 91' ' ' ALA . 8.9 ttm105 -153.27 148.76 27.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.954 0.407 . . . . 1.0 110.803 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 p -167.62 150.26 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.502 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.3 mt -106.91 136.43 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.4 t -88.78 158.64 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 64.5 m-20 -48.37 122.77 5.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.913 -1.039 . . . . 1.0 112.121 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.19 -26.71 26.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.786 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.9 -46.75 83.45 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.79 -12.67 50.29 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.49 0.662 . . . . 1.0 109.359 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 45.86 72.2 0.24 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.767 -1.106 . . . . 1.0 113.275 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 p -73.74 130.53 40.17 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.915 -1.513 . . . . 1.0 106.915 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -118.57 133.99 55.44 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.946 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 t -125.96 145.32 50.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.55 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.492 HG21 ' H ' ' A' ' 114' ' ' SER . 2.4 mt -148.18 169.61 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.201 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.492 ' H ' HG21 ' A' ' 113' ' ' ILE . 22.6 t -53.47 149.22 8.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.658 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 117' ' ' GLU . 3.2 pt20 -139.42 158.85 67.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.632 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -40.9 -13.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.714 2.276 . . . . 1.0 112.344 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 115' ' ' GLN . 69.4 tt0 65.04 113.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.446 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.8 m -140.32 158.26 44.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.673 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.441 ' C ' ' H ' ' A' ' 121' ' ' LEU . 24.0 m-90 -58.59 141.89 50.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.538 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.39 14.03 5.66 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 119' ' ' TRP . 20.5 mt 48.12 65.53 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 1.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 83.1 p -61.64 -23.6 66.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.513 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.93 -45.95 82.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.66 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.2 tpp85 -148.95 144.55 26.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.538 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 127' ' ' LEU . 34.2 m -79.69 147.91 68.09 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.246 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -38.25 -27.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.679 2.253 . . . . 1.0 112.293 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' VAL . 16.6 tp 51.55 81.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.563 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.97 -94.23 0.12 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -131.08 71.9 81.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.592 0.234 . . . . 1.0 110.865 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -85.99 -12.59 5.97 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 123.102 2.535 . . . . 1.0 111.636 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.95 -16.22 61.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.376 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -79.14 89.57 4.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.869 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -124.1 79.91 58.46 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.569 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.99 143.52 13.58 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.729 2.286 . . . . 1.0 111.904 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.501 ' HA ' HMD3 ' A' ' 203' ' ' CYC . 0.5 OUTLIER -103.24 117.9 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.824 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 138' ' ' CYS . 19.4 t70 -43.72 137.8 3.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -39.45 -20.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 123.153 2.569 . . . . 1.0 114.005 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.701 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.1 p -64.91 -46.06 83.28 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.662 0.245 . . . . 1.0 111.662 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.701 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.8 t60 -82.75 -24.53 33.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.85 -52.03 54.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.651 -0.42 . . . . 1.0 110.947 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.9 -29.71 69.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.778 -0.452 . . . . 1.0 109.778 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -58.49 -46.66 86.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.74 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 146' ' ' MET . 11.6 mt -72.73 -38.13 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -51.29 -38.71 54.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -65.04 -25.33 67.78 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.153 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.1 mmm -90.77 0.36 57.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.668 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.87 79.1 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.06 142.19 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.889 0.376 . . . . 1.0 110.969 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.53 -29.31 9.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.912 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.441 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 37.8 m -138.5 155.3 48.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.198 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 p -145.49 126.77 14.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.446 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tp -110.3 134.91 51.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.284 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.422 HG23 HAA1 ' A' ' 203' ' ' CYC . 5.7 t -122.81 120.92 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.182 0.515 . . . . 1.0 111.725 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.2 m -114.81 167.37 9.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -83.27 122.36 3.24 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.187 2.591 . . . . 1.0 114.667 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.3 tp -124.24 35.56 4.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -146.34 177.7 8.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.158 0.799 . . . . 1.0 113.158 -176.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.71 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 40.8 t60 -68.73 -171.51 0.29 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.344 -0.843 . . . . 1.0 111.365 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.71 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 56.1 t-80 -73.68 -54.27 8.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.403 -0.817 . . . . 1.0 112.097 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -104.95 -32.01 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.046 0.387 . . . . 1.0 112.046 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 85.1 tt0 -94.05 141.41 28.57 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.88 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.2 tt -108.15 116.02 31.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.263 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.515 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 77.8 m95 -89.86 -37.64 14.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.266 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.04 -174.69 35.01 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.56 132.61 31.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.807 0.337 . . . . 1.0 111.563 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.5 tp -101.61 133.79 45.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.13 133.25 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.796 -0.361 . . . . 1.0 111.147 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 78.6 p -109.76 139.89 44.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.025 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -113.66 133.34 55.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.026 0.441 . . . . 1.0 111.651 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -130.93 130.85 43.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.597 . . . . 1.0 109.973 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.32 59.02 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.785 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 174' ' ' ARG . 34.9 tp10 -160.14 128.7 2.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.993 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.426 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 90.0 Cg_endo -77.21 22.36 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.922 2.414 . . . . 1.0 111.883 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' A' ' 172' ' ' GLU . 47.9 ttp180 -72.57 126.24 90.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.883 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -46.7 153.01 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.609 2.206 . . . . 1.0 111.882 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -86.24 141.86 28.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.481 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.7 m -118.07 150.24 39.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.598 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -57.74 -29.4 64.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.623 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -56.24 -38.47 71.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.756 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.25 -40.03 94.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.548 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.03 -37.94 89.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.509 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -53.62 -39.36 64.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.917 -0.583 . . . . 1.0 111.382 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.25 -54.33 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.9 -36.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -47.53 -49.22 26.77 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.656 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 33.5 mt -75.19 -38.35 60.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.97 -41.32 51.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.801 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.39 86.96 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.504 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.29 -37.76 70.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.976 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -68.85 -24.73 64.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.118 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.8 t -83.99 -45.35 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.793 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 85.5 p -56.86 -35.25 68.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.0 mt -66.96 -33.95 66.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.426 -0.806 . . . . 1.0 109.185 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.42 -38.35 74.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.778 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.426 HG23 HD13 ' A' ' 195' ' ' ILE . 38.2 mm -59.28 -49.35 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.112 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.454 ' O ' ' CD1' ' A' ' 200' ' ' LEU . . . -71.59 -48.61 47.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.836 -0.62 . . . . 1.0 111.122 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -63.96 -42.9 97.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.496 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.89 -31.11 71.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.673 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -58.29 -31.97 67.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.592 -0.277 . . . . 1.0 111.417 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 196' ' ' ALA . 8.7 mp -60.63 -34.58 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.045 -0.262 . . . . 1.0 111.054 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 31.7 t -55.31 -56.72 16.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.538 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.587 179.829 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.741 HAB1 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.911 0.386 . . . . 1.0 110.574 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.45 -51.07 69.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.964 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -56.64 -47.49 79.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.066 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 34' ' ' ILE . 80.5 mt -62.51 -47.85 91.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.787 0.327 . . . . 1.0 110.974 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.526 ' O ' ' OG1' ' A' ' 38' ' ' THR . 33.9 mt -55.91 -42.42 76.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 1.0 111.056 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.24 -35.29 62.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -34.6 70.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.065 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 64.5 p -73.1 -41.22 64.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.498 -0.774 . . . . 1.0 112.271 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.44 -37.66 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.23 -46.65 79.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.151 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -59.89 -47.92 83.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.78 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 71.0 t -53.58 -38.43 33.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.986 -0.285 . . . . 1.0 111.115 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.541 ' NH1' ' O ' ' A' ' 69' ' ' ARG . 54.1 ttp180 -53.62 -44.11 69.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.339 . . . . 1.0 110.85 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.38 -34.2 70.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.117 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -74.14 -43.92 55.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.549 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.57 -30.12 19.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.421 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.5 20.88 1.12 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.5 p -63.64 -96.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.81 0.338 . . . . 1.0 110.236 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -155.6 -47.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 1.0 111.658 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -154.76 124.23 6.47 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.954 -0.699 . . . . 1.0 112.515 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.8 t -128.35 129.39 69.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.629 ' NZ ' HBB3 ' A' ' 203' ' ' CYC . 19.5 pttp -141.08 149.74 42.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.888 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.8 t -111.84 138.16 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.495 ' CD1' ' C ' ' A' ' 54' ' ' TYR . 2.4 p90 -136.15 139.09 42.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.314 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -93.31 141.38 28.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.294 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.64 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 64.0 t80 -92.69 117.54 30.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 1.0 112.123 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 17.3 p-10 -88.17 150.72 47.83 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.41 -20.11 67.05 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.516 2.144 . . . . 1.0 112.476 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -87.02 -19.82 28.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 1.0 110.096 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.64 -16.07 37.53 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.589 -0.604 . . . . 1.0 111.589 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.547 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 93.7 m-70 -74.25 91.81 2.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 1.0 110.561 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.55 144.36 20.51 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.3 p -122.01 143.47 49.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 1.0 111.666 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.1 t -79.18 110.87 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.27 2.17 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.387 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.94 123.98 4.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.112 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -146.09 132.59 19.73 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.519 -0.472 . . . . 1.0 111.797 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.77 141.53 51.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.381 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.541 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 30.0 ptt180 -143.06 144.21 32.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.724 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.14 -34.81 47.87 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -173.27 -168.64 34.72 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.437 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 77.2 mm-40 -72.35 44.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 1.0 110.49 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 71' ' ' GLY . 56.9 ttm-85 -83.47 -48.85 9.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.141 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.36 149.77 41.54 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.906 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.13 165.19 33.21 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.577 2.185 . . . . 1.0 112.094 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.9 p -88.19 129.4 35.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.952 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.6 mt -98.47 2.57 47.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.364 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tp -62.01 131.35 49.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 1.0 112.337 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.17 -14.03 61.86 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.549 -0.75 . . . . 1.0 111.505 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.3 mt -82.12 151.06 27.15 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.963 -0.295 . . . . 1.0 110.29 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.4 p -104.83 130.55 52.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.657 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.69 ' CE2' HAB1 ' A' ' 203' ' ' CYC . 6.8 m-85 -85.61 153.76 58.58 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.28 135.68 59.53 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.704 2.269 . . . . 1.0 111.897 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.23 126.75 29.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.722 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.3 -0.58 43.64 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.49 -37.13 64.92 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.675 ' H ' ' CD1' ' A' ' 87' ' ' ILE . 0.6 OUTLIER -81.55 113.52 42.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.413 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 87' ' ' ILE . 80.4 Cg_exo -49.47 -171.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.468 2.112 . . . . 1.0 112.474 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 79.3 mm-40 -108.43 -55.85 2.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.553 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -59.88 -42.53 93.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.789 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.99 -51.05 59.91 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.922 0.342 . . . . 1.0 111.922 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.737 ' HE ' HH21 ' A' ' 96' ' ' ARG . 59.3 ttt85 -50.17 -35.44 26.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.504 -0.316 . . . . 1.0 111.427 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 78.5 mtt85 -67.78 -35.16 78.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.798 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.7 mt -58.37 -39.03 78.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.273 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.615 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 92.5 m-85 -61.57 -50.44 72.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.052 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.737 HH21 ' HE ' ' A' ' 92' ' ' ARG . 95.6 mtt180 -54.56 -32.68 58.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.811 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.2 mt -101.39 -44.04 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.428 1.27 . . . . 1.0 114.428 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.12 -15.3 11.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 115.057 1.502 . . . . 1.0 115.057 -173.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 19.9 mm-40 44.16 79.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.205 -0.998 . . . . 1.0 108.849 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -179.36 107.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.074 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.448 ' HE ' ' NE ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -156.15 150.94 26.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 1.0 110.777 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -170.43 148.51 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.498 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.2 mt -109.37 135.13 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.39 165.16 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 113.243 0.831 . . . . 1.0 113.243 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -46.51 119.38 2.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.91 -1.041 . . . . 1.0 112.13 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.75 -22.36 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.737 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.01 -44.68 91.88 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.18 -10.17 29.14 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.494 0.664 . . . . 1.0 109.36 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 45.21 71.42 0.27 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.734 -1.121 . . . . 1.0 113.308 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -73.82 132.7 42.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.979 -1.489 . . . . 1.0 106.979 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -121.5 137.99 54.49 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.882 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.89 155.85 48.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.528 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.0 pt -156.1 177.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.149 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.1 t -54.93 156.33 3.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.623 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.404 ' O ' ' OE1' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -136.34 156.05 76.85 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.716 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 117' ' ' GLU . 86.5 Cg_endo -78.6 93.68 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.616 2.211 . . . . 1.0 112.324 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 116' ' ' PRO . 44.7 tp10 50.82 101.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.409 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.3 m -123.36 146.85 47.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.692 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -104.99 142.6 34.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 122' ' ' SER . . . -58.24 -23.05 52.07 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.0 mt -51.92 -14.04 0.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 1.0 110.394 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 120' ' ' GLY . 15.8 t -53.61 -34.24 57.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.472 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.62 69.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.696 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -57.27 -56.23 24.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.596 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 m -150.45 87.56 4.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.205 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -41.28 127.84 3.08 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.588 2.192 . . . . 1.0 112.268 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.2 tp -58.22 -38.8 77.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.529 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -165.74 -81.79 0.05 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.816 -0.914 . . . . 1.0 110.816 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 132' ' ' GLN . 5.7 mm-40 57.3 66.98 2.69 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.613 0.244 . . . . 1.0 110.865 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -45.33 -41.47 17.4 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 123.136 2.557 . . . . 1.0 111.685 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 19.2 mt -76.56 -9.06 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.377 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 129' ' ' GLU . 73.3 mt-30 63.86 117.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.831 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.448 ' NE ' ' HE ' ' A' ' 101' ' ' ARG . 1.1 mmm180 36.2 76.0 0.47 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.584 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -85.15 136.04 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.793 2.328 . . . . 1.0 111.991 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.97 129.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.915 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.45 ' OD2' HMD1 ' A' ' 203' ' ' CYC . 37.2 m-20 -43.96 134.56 4.0 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -40.35 -46.53 4.32 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.124 2.549 . . . . 1.0 114.007 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 3.8 p -39.33 -45.4 1.43 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.686 0.254 . . . . 1.0 111.686 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.668 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.2 t60 -81.36 -29.34 34.09 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.276 0.473 . . . . 1.0 112.276 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.6 t -65.67 -52.53 49.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.961 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -66.75 -27.67 67.79 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.513 ' O ' ' OG ' ' A' ' 145' ' ' SER . 81.2 t80 -60.21 -45.51 92.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.775 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 146' ' ' MET . 65.1 mt -73.44 -35.82 65.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -52.18 -39.13 59.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.593 -1.262 . . . . 1.0 107.593 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 8.7 p -65.24 -20.63 66.51 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.779 -1.1 . . . . 1.0 109.158 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 143' ' ' LEU . 89.4 mmm -93.83 1.45 56.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.462 -0.79 . . . . 1.0 110.735 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.5 22.21 78.64 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.66 142.35 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 1.0 110.986 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.89 -42.99 4.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.485 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 7.2 t -129.84 125.8 36.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 1.0 111.17 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 m -112.96 135.49 53.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.458 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tp -115.13 136.85 52.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.291 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.24 113.96 39.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.15 0.5 . . . . 1.0 111.753 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.16 110.52 30.91 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.66 149.21 54.56 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.144 2.562 . . . . 1.0 114.671 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 29.6 mt -125.34 68.44 1.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.796 -1.557 . . . . 1.0 106.796 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.4 ptm -148.04 -173.84 4.41 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.619 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 30.7 t-80 -78.26 178.57 7.52 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.321 -0.854 . . . . 1.0 111.373 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 13.0 m-70 -74.13 -55.39 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.309 -0.859 . . . . 1.0 112.122 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -105.0 11.92 32.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -144.29 137.61 27.35 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.922 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.454 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 7.9 tt -112.38 117.42 32.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.258 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -92.19 -34.19 14.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.289 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.77 -167.58 25.55 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.4 mt -152.42 144.69 23.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 1.0 111.592 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.7 tp -114.51 139.18 49.77 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.4 p -140.4 140.6 34.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.999 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 69.5 m -113.53 143.11 45.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.968 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -113.54 131.8 55.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 1.0 111.572 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.666 ' N ' ' ND1' ' A' ' 170' ' ' HIS . 0.0 OUTLIER -124.67 121.19 34.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.844 -0.616 . . . . 1.0 109.961 178.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.0 -16.03 60.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.79 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -107.88 139.0 20.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.012 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 174' ' ' ARG . 72.7 Cg_exo -39.54 -73.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.885 2.39 . . . . 1.0 111.883 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 173' ' ' PRO . 17.0 ttp85 35.41 88.83 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.903 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.87 162.86 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.521 2.148 . . . . 1.0 111.986 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.454 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 50.8 p90 -90.88 131.33 36.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.43 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.1 t -121.21 157.39 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.599 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -53.01 -32.17 45.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.14 -39.38 86.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.731 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.1 -45.29 89.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.429 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.76 -36.29 83.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.581 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -55.41 -39.39 70.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.392 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.4 t -67.85 -55.54 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.82 -46.54 68.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.452 0.538 . . . . 1.0 112.452 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -41.48 -46.31 3.44 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.663 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 15.5 tp -71.6 -42.79 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 46.4 tp -77.2 -40.44 45.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.86 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.19 -37.9 72.86 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.473 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -61.56 -39.75 92.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.33 -0.395 . . . . 1.0 109.982 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -64.98 -28.62 69.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.104 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 20.6 t -84.04 -41.22 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.791 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m -56.7 -36.7 69.95 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 mt -65.46 -38.7 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.445 -0.798 . . . . 1.0 109.221 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.52 83.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.838 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.3 -47.34 92.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.171 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.82 -46.85 62.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.147 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -65.92 -42.54 90.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.508 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.73 -31.83 72.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.679 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.79 -40.14 95.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.521 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 20.5 tp -62.85 -36.58 83.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.67 0.272 . . . . 1.0 111.011 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 38.8 t -50.74 -51.48 49.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.594 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.532 179.654 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.69 HAB1 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.8 tp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.9 0.381 . . . . 1.0 110.551 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 25.0 p-10 -76.83 -28.66 55.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.043 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -77.81 -47.09 19.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.086 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 pt -63.41 -38.58 82.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 1.0 110.964 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -60.84 -49.38 77.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.054 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -53.93 -39.5 65.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.71 -28.92 67.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.073 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.6 m -71.47 -47.46 55.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.445 -0.798 . . . . 1.0 112.196 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.09 -33.27 59.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 111.907 0.336 . . . . 1.0 111.907 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -69.1 -51.36 39.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.829 0.347 . . . . 1.0 111.14 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -61.73 -45.65 93.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.745 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.56 -35.73 68.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.696 0.284 . . . . 1.0 111.169 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.618 ' NH2' ' CA ' ' A' ' 70' ' ' GLY . 15.7 tpt85 -56.51 -42.19 77.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.803 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.97 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.112 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -79.08 -43.2 24.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.624 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.3 mt -86.43 -32.28 20.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.461 -0.336 . . . . 1.0 111.455 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.54 19.28 18.54 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.564 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 67.3 m -69.97 141.21 53.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.859 0.361 . . . . 1.0 110.209 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' THR . 92.3 m-20 -37.16 -45.9 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.578 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.618 ' NH2' ' CE1' ' A' ' 169' ' ' HIS . 19.2 ttp-105 -163.66 126.7 2.62 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.985 -0.686 . . . . 1.0 112.567 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.6 p -133.91 127.83 52.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 176.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' HE3' HAB2 ' A' ' 203' ' ' CYC . 44.0 pttt -140.09 155.65 46.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.14 0.495 . . . . 1.0 111.878 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.96 133.65 40.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -115.01 112.27 22.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.262 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -84.45 127.18 33.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.219 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.442 ' CE2' ' CZ ' ' A' ' 92' ' ' ARG . 71.9 t80 -95.26 134.16 38.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 1.0 112.039 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 60' ' ' GLY . 0.9 OUTLIER -103.86 140.32 20.95 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.34 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.36 -27.83 7.55 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 C-N-CA 122.495 2.13 . . . . 1.0 112.441 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -83.39 -16.22 46.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 1.0 110.089 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 105.56 -13.55 46.9 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.572 -0.611 . . . . 1.0 111.572 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -78.23 90.86 4.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.771 0.319 . . . . 1.0 110.616 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.97 150.8 20.44 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.527 -1.029 . . . . 1.0 110.527 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.4 p -124.85 147.79 48.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.372 . . . . 1.0 111.741 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.82 107.93 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 37.2 t -106.51 -1.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.282 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.64 113.82 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.068 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.4 tt0 -143.74 135.78 26.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.087 0.47 . . . . 1.0 111.758 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.25 131.97 47.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.415 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -124.65 147.21 48.68 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.711 -0.396 . . . . 1.0 110.725 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.618 ' CA ' ' NH2' ' A' ' 43' ' ' ARG . . . -72.25 -134.79 0.18 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.794 -0.922 . . . . 1.0 110.794 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.26 59.12 1.12 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.006 -0.838 . . . . 1.0 111.006 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 41.83 46.73 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.667 0.27 . . . . 1.0 110.486 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 73' ' ' ARG . 2.0 tpm_? -82.73 -48.72 10.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.401 HD12 HH11 ' A' ' 50' ' ' ARG . 42.0 mt -107.38 131.44 21.71 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.862 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.48 145.65 11.73 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.575 2.183 . . . . 1.0 112.111 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 p -72.79 123.34 23.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.978 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 16.8 mt -98.62 13.6 31.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.309 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 23.9 tp -73.14 129.17 37.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.269 0.557 . . . . 1.0 112.209 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.56 -9.94 71.61 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.602 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.8 mt -85.12 153.07 22.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.808 0.337 . . . . 1.0 110.243 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.6 m -105.91 132.54 51.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -85.17 152.0 57.78 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.52 127.52 13.33 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.714 2.276 . . . . 1.0 111.854 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 142.33 57.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.623 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.35 1.18 37.99 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.571 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 20.2 p-10 -50.84 -52.95 36.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 86' ' ' ASP . 1.9 pp -171.42 50.63 0.14 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.437 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 87' ' ' ILE . 4.1 Cg_endo -94.57 -0.84 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.398 2.065 . . . . 1.0 112.531 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -90.67 -82.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.037 -0.528 . . . . 1.0 111.494 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -78.79 -48.23 15.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.772 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.33 74.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.868 0.321 . . . . 1.0 111.868 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.442 ' CZ ' ' CE2' ' A' ' 56' ' ' PHE . 58.5 ttt85 -71.68 -39.95 69.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.421 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -63.1 -43.32 98.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.824 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.407 ' CD1' HH22 ' A' ' 101' ' ' ARG . 76.1 mt -64.72 -41.73 95.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.297 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.431 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 1.2 t80 -55.04 -44.02 74.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.022 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -56.6 -28.58 60.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.803 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.67 ' C ' HE22 ' A' ' 99' ' ' GLN . 75.1 mt -98.24 -39.63 8.76 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -177.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.594 ' N ' ' NE2' ' A' ' 99' ' ' GLN . . . -119.38 -13.12 9.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.994 1.479 . . . . 1.0 114.994 -174.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.69 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 35.67 81.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.192 -1.003 . . . . 1.0 108.858 -178.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.478 ' CG1' ' O ' ' A' ' 100' ' ' VAL . 11.0 p -174.64 108.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.075 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.407 HH22 ' CD1' ' A' ' 94' ' ' LEU . 56.6 mmt-85 -141.87 146.01 35.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 1.0 110.781 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.5 p -171.83 135.93 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.573 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.8 137.0 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.459 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 32.8 m -91.04 165.04 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 17.8 p30 -48.65 119.35 3.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.895 -1.048 . . . . 1.0 112.106 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -53.77 -21.74 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.785 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -65.85 -45.28 82.77 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.9 -16.02 63.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.557 0.694 . . . . 1.0 109.411 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 46.4 72.71 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.757 -1.111 . . . . 1.0 113.314 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.459 ' OG ' ' CG2' ' A' ' 104' ' ' VAL . 1.1 p -73.51 129.01 37.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.97 -1.493 . . . . 1.0 106.97 174.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -116.61 134.9 54.28 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.96 -0.696 . . . . 1.0 111.937 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.96 163.96 31.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.514 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.599 ' C ' ' H ' ' A' ' 115' ' ' GLN . 17.6 pt -126.54 138.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.209 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.0 t -67.1 16.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.631 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.599 ' H ' ' C ' ' A' ' 113' ' ' ILE . 50.6 mt-30 -119.85 79.45 24.24 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.65 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.79 151.26 12.88 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.633 2.222 . . . . 1.0 112.349 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -65.61 -48.3 72.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.464 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 t -175.12 161.05 2.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.713 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.522 ' CE3' ' N ' ' A' ' 120' ' ' GLY . 15.0 t90 -145.42 177.01 9.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.591 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.522 ' N ' ' CE3' ' A' ' 119' ' ' TRP . . . 104.06 -42.38 1.91 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.998 -0.841 . . . . 1.0 110.998 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.479 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 8.9 mp -61.55 -30.37 70.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 1.0 110.436 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.5 p -58.18 -18.55 26.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.481 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.38 -25.03 63.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.711 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -119.22 -34.8 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.505 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.68 113.67 3.2 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.222 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -40.43 138.89 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.546 2.164 . . . . 1.0 112.309 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 tt -152.6 116.56 4.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.584 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.0 30.58 25.5 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.891 -0.883 . . . . 1.0 110.891 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 129' ' ' GLU . 1.9 mp0 50.22 66.09 6.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.574 0.226 . . . . 1.0 110.89 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.64 -34.92 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 123.143 2.562 . . . . 1.0 111.631 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 26.0 tp -58.43 -41.37 84.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.378 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 133' ' ' ARG . 90.6 mt-30 -74.2 -29.35 61.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.929 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 132' ' ' GLN . 12.7 tpt85 34.79 65.72 1.6 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.615 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -49.79 146.6 15.65 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.749 2.299 . . . . 1.0 111.971 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.83 149.31 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.871 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -94.51 156.24 38.75 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -55.39 -29.03 66.36 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.195 2.597 . . . . 1.0 113.974 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.711 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.7 OUTLIER -60.4 -46.25 90.66 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.705 0.261 . . . . 1.0 111.705 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.711 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 4.4 t60 -80.64 -24.16 39.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.271 0.471 . . . . 1.0 112.271 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.33 -54.11 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.944 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -64.9 -28.84 69.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -60.26 -45.85 91.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.776 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 146' ' ' MET . 27.3 mt -73.02 -37.2 67.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -50.98 -39.52 55.63 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.2 m -64.36 -24.47 67.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.746 -1.115 . . . . 1.0 109.204 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.565 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -91.86 -2.92 56.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.437 -0.801 . . . . 1.0 110.684 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.91 20.36 79.74 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.4 t -108.48 143.06 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 1.0 110.933 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.51 -42.74 4.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.948 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.8 m -131.99 124.22 28.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 1.0 111.164 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.2 p -108.73 139.59 43.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.444 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 tp -121.95 125.82 47.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.232 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -119.74 113.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.182 0.515 . . . . 1.0 111.774 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.13 107.09 54.39 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.745 -1.205 . . . . 1.0 107.745 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -40.43 128.18 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.189 2.593 . . . . 1.0 114.681 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 tp -116.49 41.4 2.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.868 -1.53 . . . . 1.0 106.868 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 7.9 ptm -146.92 178.81 8.05 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.665 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 30.4 t-80 -69.04 -176.92 0.94 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.34 -0.846 . . . . 1.0 111.415 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.665 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 96.3 m-70 -68.77 -55.2 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.426 -0.806 . . . . 1.0 112.066 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -104.15 -42.3 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -83.47 129.43 34.98 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.882 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.446 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 6.7 tt -103.68 117.72 35.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.263 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -92.51 -39.78 11.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.244 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.58 -176.28 36.89 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.1 mt -138.24 136.46 36.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.778 0.323 . . . . 1.0 111.55 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.9 tp -105.84 130.95 53.71 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.63 142.14 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.743 -0.383 . . . . 1.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 m -112.59 138.52 49.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.054 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.618 ' CE1' ' NH2' ' A' ' 50' ' ' ARG . 56.1 m80 -106.98 121.6 44.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.977 0.418 . . . . 1.0 111.69 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -122.04 112.51 18.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.991 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.76 -15.09 63.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.884 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -87.51 148.39 44.12 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.3 -2.32 11.5 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.95 2.433 . . . . 1.0 111.88 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -41.59 131.25 2.3 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.878 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.82 167.23 25.67 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.578 2.185 . . . . 1.0 111.977 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 43.7 p90 -79.94 126.7 31.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.505 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.7 t -114.54 147.36 39.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.574 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.504 ' H ' ' CD ' ' A' ' 178' ' ' GLN . 11.1 mp0 -53.75 -32.45 52.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 1.0 110.622 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -62.35 -41.49 98.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.749 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -62.93 -43.79 97.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.465 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.5 mt -65.31 -37.76 88.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.558 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -54.1 -36.15 62.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.397 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.6 -54.47 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.1 -32.37 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -54.19 -50.31 67.34 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.627 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.8 tp -70.14 -38.41 75.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.005 0.372 . . . . 1.0 112.005 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 38.0 tp -77.75 -38.65 46.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.812 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.18 86.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.502 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.86 -40.14 91.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.964 0.411 . . . . 1.0 110.041 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -71.71 -24.44 61.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.146 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.79 -48.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.718 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 82.9 p -55.34 -35.4 65.15 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.4 mt -65.61 -33.83 66.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.215 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.58 -38.49 77.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.776 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.1 mm -60.04 -46.6 94.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.123 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.26 -45.51 69.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.087 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -65.99 -40.71 91.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.495 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.91 70.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.308 -0.405 . . . . 1.0 111.733 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.35 -35.68 78.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.51 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.04 -32.28 71.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -54.37 -53.16 57.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.648 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 10.1 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.559 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.506 ' NA ' ' NE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.887 0.375 . . . . 1.0 110.563 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -74.98 -50.04 17.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.975 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -57.01 -48.12 79.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.066 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 35' ' ' LEU . 18.8 tt -65.93 -43.31 92.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.759 0.314 . . . . 1.0 110.974 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.415 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 30.7 mt -61.37 -46.72 89.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.033 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -59.5 -37.5 78.46 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.66 -29.62 67.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.128 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.8 m -73.5 -48.0 36.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.476 -0.783 . . . . 1.0 112.259 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.14 -33.41 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.01 0.374 . . . . 1.0 112.01 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -65.72 -49.15 69.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.342 . . . . 1.0 111.112 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.92 -38.61 89.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.748 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.05 -44.8 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.169 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 47' ' ' GLY . 61.7 ttp85 -53.71 -39.42 65.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.778 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.57 -37.84 79.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -79.45 -44.0 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.539 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.12 -33.59 22.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 1.0 111.523 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 60.45 19.52 53.61 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.457 -1.057 . . . . 1.0 110.457 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.648 ' HG1' ' HE2' ' A' ' 170' ' ' HIS . 93.9 m -72.27 142.31 48.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.349 . . . . 1.0 110.244 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -39.35 -45.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.625 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -163.72 130.91 3.36 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.046 -0.661 . . . . 1.0 112.545 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.6 p -138.47 128.63 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.685 ' HZ3' HBB1 ' A' ' 203' ' ' CYC . 51.6 pttt -140.35 155.2 46.87 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.897 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.04 136.57 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.449 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 39.7 t80 -126.61 127.31 45.03 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.35 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -92.33 127.58 37.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.196 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 67.2 t80 -89.83 118.49 29.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 1.0 112.03 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 17.5 p-10 -90.04 152.37 46.13 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -59.43 -19.26 50.53 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.524 2.15 . . . . 1.0 112.458 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -82.6 -21.22 35.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.921 0.391 . . . . 1.0 110.04 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.11 -17.24 35.06 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.564 -0.614 . . . . 1.0 111.564 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.444 ' O ' ' OH ' ' A' ' 54' ' ' TYR . 40.9 m80 -63.36 -100.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.603 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . 102.3 154.84 25.54 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 p -126.74 149.57 49.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 1.0 111.726 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.3 t -78.21 111.15 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.796 -0.816 . . . . 1.0 108.796 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.19 -1.04 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.304 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.11 113.23 2.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.025 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 88.4 tt0 -143.12 134.1 25.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.133 0.492 . . . . 1.0 111.816 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.57 139.7 52.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.666 -0.697 . . . . 1.0 109.414 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -135.21 147.72 49.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.861 0.363 . . . . 1.0 110.74 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -51.34 -36.86 38.22 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 168.76 -160.26 33.67 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -65.08 4.31 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.312 . . . . 1.0 110.527 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' A' ' 71' ' ' GLY . 68.0 ttp85 -66.74 -46.8 74.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.165 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.7 mt -118.48 116.84 34.92 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.864 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.28 157.07 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.514 2.143 . . . . 1.0 112.183 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 p -96.61 130.21 43.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.925 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -91.29 13.59 16.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.422 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.9 tp -65.62 130.38 43.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.979 -0.555 . . . . 1.0 112.265 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.46 -10.66 72.55 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.54 -0.754 . . . . 1.0 111.498 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.0 mt -83.82 148.88 26.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.959 -0.296 . . . . 1.0 110.336 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.5 p -105.31 135.58 46.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.655 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.54 ' CE2' HBB2 ' A' ' 203' ' ' CYC . 8.8 m-85 -88.56 151.53 48.2 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.42 138.38 65.25 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.643 2.229 . . . . 1.0 111.863 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.38 128.28 35.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.429 . . . . 1.0 110.7 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.6 -1.6 42.46 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -55.44 -37.42 67.69 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 88' ' ' PRO . 8.5 mm -77.8 113.41 32.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.641 -0.709 . . . . 1.0 109.388 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 87' ' ' ILE . 92.7 Cg_exo -46.8 -176.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.429 2.086 . . . . 1.0 112.48 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.53 -49.34 3.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.502 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.81 -39.33 87.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.868 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB1' HBD2 ' A' ' 203' ' ' CYC . . . -68.01 -51.71 43.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.928 0.344 . . . . 1.0 111.928 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.634 ' NH2' ' CE2' ' A' ' 56' ' ' PHE . 64.0 ttt180 -53.31 -39.62 64.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.465 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -62.8 -33.07 74.44 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.758 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.16 -36.43 74.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.304 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.669 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 11.0 m-85 -59.62 -29.88 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.996 0.427 . . . . 1.0 110.028 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.493 ' C ' HE22 ' A' ' 99' ' ' GLN . 79.6 ttt-85 -83.28 -25.82 31.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.865 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.6 mt -97.42 -45.42 6.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 114.416 1.265 . . . . 1.0 114.416 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.514 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.83 -6.66 12.65 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.702 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 3.0 mm-40 41.24 78.28 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.133 -1.027 . . . . 1.0 108.787 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 99' ' ' GLN . 3.8 p 171.42 116.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.115 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.5 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -169.89 130.59 1.01 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.388 . . . . 1.0 110.808 177.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.5 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 3.5 m -147.02 157.55 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.439 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.6 mt -108.52 132.97 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.6 p -92.54 159.96 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.299 0.851 . . . . 1.0 113.299 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -45.21 119.65 2.13 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.94 -1.027 . . . . 1.0 112.128 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.32 -19.74 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.335 -0.848 . . . . 1.0 110.799 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.17 -46.32 84.54 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.64 -13.55 54.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.492 0.663 . . . . 1.0 109.356 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 44.5 70.37 0.34 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.745 -1.116 . . . . 1.0 113.212 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.6 t -74.97 131.17 40.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.968 -1.493 . . . . 1.0 106.968 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -118.89 134.47 55.15 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.974 -0.69 . . . . 1.0 111.859 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 0.6 OUTLIER -127.01 148.35 50.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.501 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 114' ' ' SER . 2.7 mt -147.91 167.37 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.126 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.474 ' H ' HG22 ' A' ' 113' ' ' ILE . 53.1 p -64.33 161.04 17.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.634 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -135.66 151.99 75.34 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.633 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -36.39 -25.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.573 2.182 . . . . 1.0 112.417 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 115' ' ' GLN . 78.3 mm-40 -128.66 151.43 49.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.428 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.5 p -103.55 -101.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.648 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -51.43 141.58 15.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.517 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 76.99 -169.92 55.07 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 125' ' ' VAL . 69.7 mt 41.5 -95.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 1.0 110.373 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 120' ' ' GLY . 22.7 t -56.68 -39.75 74.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.487 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 124' ' ' ARG . . . -79.69 -2.81 44.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.601 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 123' ' ' ALA . 49.1 ttp180 177.04 75.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.586 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 121' ' ' LEU . 26.2 m -66.61 149.09 98.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.245 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 128' ' ' GLY . 50.9 Cg_exo -37.42 147.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.647 2.231 . . . . 1.0 112.278 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.1 mt 62.48 -76.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.574 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 74.08 161.25 7.47 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.746 -0.942 . . . . 1.0 110.746 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.577 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 1.5 tp10 178.89 -44.78 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.624 0.25 . . . . 1.0 110.852 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.5 Cg_endo -90.49 147.2 4.2 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.182 2.588 . . . . 1.0 111.676 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 133' ' ' ARG . 46.8 mt -93.93 10.22 34.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.358 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -56.52 88.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.852 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 131' ' ' LEU . 92.8 mtt-85 -129.37 82.17 68.47 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.517 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.452 ' O ' ' OG ' ' A' ' 112' ' ' SER . 81.2 Cg_exo -47.01 148.86 3.76 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.717 2.278 . . . . 1.0 111.957 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.471 ' HA ' HMD3 ' A' ' 203' ' ' CYC . 0.5 OUTLIER -98.69 115.2 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.871 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -43.58 139.01 2.79 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -40.51 -44.57 4.4 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 123.255 2.637 . . . . 1.0 114.014 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.738 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.9 p -40.74 -48.6 3.02 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.733 0.272 . . . . 1.0 111.733 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.738 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 15.2 t-80 -81.12 -27.2 35.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.278 0.473 . . . . 1.0 112.278 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.6 t -64.23 -53.21 46.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.636 -0.425 . . . . 1.0 111.023 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -65.7 -29.09 69.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.75 -43.46 94.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 1.0 109.737 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 146' ' ' MET . 9.3 mt -72.7 -39.21 67.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -50.82 -38.82 51.0 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 177.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.1 m -65.88 -24.53 66.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.847 -1.069 . . . . 1.0 109.171 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.8 mmm -92.4 -2.03 56.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.682 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.11 19.65 78.61 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.5 t -106.88 143.92 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 1.0 111.061 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.69 -43.91 3.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.993 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -134.35 121.0 20.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.198 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.3 t -111.99 142.98 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.402 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 tp -116.44 139.52 50.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.267 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.416 HG23 HAA1 ' A' ' 203' ' ' CYC . 1.5 t -128.81 120.35 52.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.167 0.508 . . . . 1.0 111.745 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.1 t -126.09 120.0 23.82 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.63 124.35 9.72 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.243 2.629 . . . . 1.0 114.655 -175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.505 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 8.3 mp -102.37 58.98 0.81 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.846 -1.539 . . . . 1.0 106.846 177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.406 ' N ' ' OG ' ' A' ' 192' ' ' SER . 6.0 ptt? -147.95 -170.15 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.076 0.769 . . . . 1.0 113.076 -176.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.694 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 70.3 t60 -80.52 -179.56 7.24 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.424 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.694 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 60.0 t60 -74.79 -54.06 8.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.392 -0.822 . . . . 1.0 112.093 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -103.66 13.35 33.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.04 0.385 . . . . 1.0 112.04 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -146.39 140.21 26.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.714 -0.395 . . . . 1.0 110.904 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.421 ' H ' HD13 ' A' ' 162' ' ' LEU . 0.8 OUTLIER -112.61 119.68 38.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.267 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -92.43 -35.53 13.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.306 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -163.88 -178.02 37.13 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.208 -0.757 . . . . 1.0 111.208 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 87.5 mt -138.4 133.4 32.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.841 0.353 . . . . 1.0 111.551 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.5 tp -102.33 133.97 46.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.87 135.14 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.089 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.0 m -109.56 139.17 44.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.003 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.429 ' O ' ' CG2' ' A' ' 48' ' ' THR . 48.5 m80 -108.2 119.29 39.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.674 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.648 ' HE2' ' HG1' ' A' ' 48' ' ' THR . 72.9 m80 -120.59 113.83 20.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 1.0 109.952 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.2 -16.08 61.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.841 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.99 138.01 72.82 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.013 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.94 10.82 2.19 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.978 2.452 . . . . 1.0 111.919 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -68.76 148.43 98.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.846 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.2 161.92 41.86 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.512 2.141 . . . . 1.0 111.939 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 44.0 p90 -74.87 133.6 41.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.465 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.8 m -112.51 147.91 35.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.69 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -59.88 -28.39 67.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.616 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -55.51 -44.12 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.693 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.3 -36.46 83.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.473 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.4 tp -62.23 -42.16 99.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.516 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.84 -33.74 64.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 1.0 111.371 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.34 -56.86 11.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 188' ' ' ALA . 13.5 m -78.7 -30.61 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.435 0.531 . . . . 1.0 112.435 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -51.06 -54.19 27.05 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.614 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 24.4 tp -75.14 -39.24 60.6 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.2 tp -76.46 -41.47 47.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.891 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -57.19 -39.8 76.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.519 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -58.29 -39.22 78.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.012 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -66.21 -28.39 68.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.132 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 16.3 t -82.98 -44.57 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.782 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.406 ' OG ' ' N ' ' A' ' 157' ' ' MET . 1.5 t -53.71 -29.64 40.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.671 -0.862 . . . . 1.0 108.671 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.1 mm -77.19 -33.46 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.465 -0.789 . . . . 1.0 109.268 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.69 -47.81 44.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.893 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.53 -37.17 79.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.142 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.01 -47.01 55.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.134 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -71.53 -36.0 70.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.519 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.59 74.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.645 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -59.35 -32.49 70.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.483 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 8.8 mp -61.32 -33.68 74.0 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.025 -0.27 . . . . 1.0 111.029 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -51.52 -53.66 35.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.571 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.543 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.696 ' HHB' ' HE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.867 0.365 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -77.64 -29.34 51.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -77.87 -45.93 22.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.139 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 pt -64.23 -38.66 83.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.46 -0.337 . . . . 1.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 mt -61.17 -50.64 72.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.033 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -53.81 -38.23 64.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.27 -29.96 66.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.043 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.3 m -74.17 -45.32 49.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.509 -0.768 . . . . 1.0 112.269 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.77 -34.53 68.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -67.45 -46.14 73.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.85 0.357 . . . . 1.0 111.173 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -64.42 -41.09 96.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.783 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.19 -43.19 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.1 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 47' ' ' GLY . 66.8 ttp85 -55.03 -41.03 70.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 1.0 110.824 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.23 -36.55 73.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.026 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -79.37 -42.35 25.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.56 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mt -85.39 -32.52 22.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.466 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 61.81 20.31 59.57 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.474 -1.05 . . . . 1.0 110.474 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.447 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 69.7 m -73.1 141.18 47.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 1.0 110.132 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -40.03 -45.1 1.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 1.0 111.634 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.63 ' HE ' ' CE1' ' A' ' 169' ' ' HIS . 56.9 ttp180 -162.68 130.89 3.91 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.06 -0.656 . . . . 1.0 112.596 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.24 129.82 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' HZ2' ' CG1' ' A' ' 167' ' ' VAL . 24.8 pttm -141.69 152.86 44.27 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.912 -177.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.6 t -102.32 134.86 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.563 -0.902 . . . . 1.0 108.563 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.49 ' OH ' ' O ' ' A' ' 61' ' ' HIS . 52.1 t80 -120.89 126.29 49.64 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.299 -0.561 . . . . 1.0 111.293 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 163' ' ' TRP . 18.2 tpt85 -87.23 124.76 33.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.276 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -88.76 119.84 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.326 -0.397 . . . . 1.0 112.023 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.87 151.9 43.98 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.87 -21.84 59.53 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.491 2.127 . . . . 1.0 112.493 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -82.23 -15.59 52.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.378 . . . . 1.0 110.032 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.39 -15.79 49.67 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.489 -0.644 . . . . 1.0 111.489 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.49 ' O ' ' OH ' ' A' ' 54' ' ' TYR . 84.8 m-70 -64.09 -104.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.934 -0.307 . . . . 1.0 110.62 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . 102.61 155.95 25.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 p -127.58 151.07 49.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.935 0.398 . . . . 1.0 111.688 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.82 108.38 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.53 -0.76 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.314 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.09 113.02 2.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.099 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 87.6 tt0 -144.28 132.59 21.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.146 0.498 . . . . 1.0 111.798 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.16 140.97 50.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.413 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ptt-85 -142.91 150.1 39.34 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.02 -121.8 0.01 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.856 -0.898 . . . . 1.0 110.856 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -81.01 -175.94 50.39 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 1.1 pm0 -73.09 45.46 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.777 0.322 . . . . 1.0 110.488 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 71' ' ' GLY . 15.4 tpt180 -84.31 -47.84 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.175 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 23.3 mt -116.64 146.71 38.23 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.168 -0.469 . . . . 1.0 109.878 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.59 163.23 38.92 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.459 2.106 . . . . 1.0 112.218 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.43 ' HG ' ' H ' ' A' ' 78' ' ' LEU . 33.3 t -92.79 130.68 38.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.958 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.85 12.73 29.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.429 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 76' ' ' SER . 18.8 tp -70.89 131.12 43.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.284 0.564 . . . . 1.0 112.261 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.84 -8.8 78.67 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.608 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.01 151.97 22.79 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.325 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.2 p -105.18 134.27 48.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.675 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.639 ' CE2' HAB1 ' A' ' 203' ' ' CYC . 8.6 m-85 -89.65 151.24 45.55 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.94 135.87 36.46 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.681 2.254 . . . . 1.0 111.884 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.12 136.77 56.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.71 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.29 -3.47 40.41 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.528 -1.029 . . . . 1.0 110.528 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -52.35 -40.78 62.39 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.1 mt -80.99 133.23 54.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.445 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.89 -161.97 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.385 2.057 . . . . 1.0 112.513 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.02 -57.99 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.584 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -60.18 -45.76 92.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.8 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.1 -44.61 88.24 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -58.69 -34.99 71.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.459 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -63.71 -34.4 77.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.766 0.317 . . . . 1.0 110.805 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' ALA . 11.9 mt -65.31 -34.16 77.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.297 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.632 ' C ' HE21 ' A' ' 99' ' ' GLN . 17.7 m-85 -64.24 -55.13 23.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.014 0.435 . . . . 1.0 110.01 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 159' ' ' HIS . 79.5 ttt180 -48.04 -33.92 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.843 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 mt -100.69 -37.91 8.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.04 -16.48 11.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -173.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.632 HE21 ' C ' ' A' ' 95' ' ' PHE . 22.4 mm-40 38.06 77.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.205 -0.998 . . . . 1.0 108.826 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.8 p 176.35 113.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.101 -178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -175.31 141.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 1.0 110.737 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.0 161.51 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.542 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.2 mt -104.37 137.5 33.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 t -88.2 157.91 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 113.294 0.85 . . . . 1.0 113.294 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -47.16 121.29 3.65 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.974 -1.012 . . . . 1.0 112.082 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.6 p -57.14 -25.15 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.371 -0.832 . . . . 1.0 110.762 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -64.85 -45.5 85.81 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.93 -11.38 27.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.479 0.657 . . . . 1.0 109.326 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.1 tp60 45.94 70.26 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.801 -1.091 . . . . 1.0 113.308 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -74.43 131.85 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.903 -1.517 . . . . 1.0 106.903 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -120.27 137.12 54.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.023 -0.671 . . . . 1.0 111.931 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.538 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -139.36 162.76 34.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.705 -0.679 . . . . 1.0 110.538 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.568 ' C ' ' H ' ' A' ' 115' ' ' GLN . 30.0 pt -126.15 141.93 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.105 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 81.0 p -52.74 -4.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.692 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.568 ' H ' ' C ' ' A' ' 113' ' ' ILE . 23.6 mt-30 -121.81 76.29 38.06 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.646 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.58 -23.16 3.46 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.657 2.238 . . . . 1.0 112.36 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 55.41 39.94 31.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.418 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.0 m -125.88 143.59 51.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.709 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -144.43 156.07 44.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.601 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -122.1 116.46 3.07 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.982 -0.847 . . . . 1.0 110.982 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.579 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 5.7 mp -90.48 -133.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.72 0.295 . . . . 1.0 110.379 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.2 t -63.68 -51.52 64.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.14 -28.93 62.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.637 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 64.82 153.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.56 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.437 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 7.3 p -114.31 87.64 13.95 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.27 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 128' ' ' GLY . 85.9 Cg_endo -83.06 157.56 15.29 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.556 2.17 . . . . 1.0 112.306 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 129' ' ' GLU . 11.1 mp 42.49 -97.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.556 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 66.49 -67.64 0.16 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 127' ' ' LEU . 8.3 mm-40 -51.49 153.0 4.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 121.174 -0.211 . . . . 1.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.83 -26.28 3.76 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.088 2.525 . . . . 1.0 111.598 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -88.54 2.48 52.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.415 179.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 131' ' ' LEU . 74.2 mt-30 71.21 64.28 0.16 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.853 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 55.03 82.33 0.24 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.577 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.73 144.02 96.81 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.714 2.276 . . . . 1.0 111.958 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.54 126.0 59.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.844 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.538 ' N ' ' OG ' ' A' ' 112' ' ' SER . 26.4 t70 -46.05 131.07 7.26 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 138' ' ' CYS . 59.5 Cg_exo -41.61 -47.11 6.1 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.194 2.596 . . . . 1.0 114.041 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.698 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.8 p -37.35 -46.4 0.76 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.723 0.268 . . . . 1.0 111.723 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.698 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 4.4 t60 -82.29 -30.43 30.58 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.2 t -67.73 -50.9 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.963 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -66.0 -29.18 69.51 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -60.03 -42.13 93.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.714 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' MET . 8.4 mt -73.49 -38.15 65.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -51.92 -39.17 58.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 t -63.69 -24.04 67.62 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.76 -1.109 . . . . 1.0 109.16 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -92.26 4.37 53.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.423 -0.808 . . . . 1.0 110.671 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.06 21.04 79.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.29 142.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 1.0 111.097 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.66 -23.2 12.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.964 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.4 m -141.96 160.52 40.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.202 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.73 121.01 9.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.496 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.7 mp -109.95 132.6 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.258 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.468 HG23 HAA2 ' A' ' 203' ' ' CYC . 16.8 t -123.21 119.4 57.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.175 0.512 . . . . 1.0 111.775 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.6 t -131.65 92.47 30.94 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.79 -1.189 . . . . 1.0 107.79 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.04 150.37 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.203 2.602 . . . . 1.0 114.616 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.538 ' H ' ' HE2' ' A' ' 157' ' ' MET . 33.9 mt -124.88 54.5 1.41 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.868 -1.53 . . . . 1.0 106.868 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.538 ' HE2' ' H ' ' A' ' 156' ' ' LEU . 7.5 ptp -148.56 -167.94 2.96 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.141 0.793 . . . . 1.0 113.141 -175.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.644 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 18.1 m-70 -68.83 163.2 24.77 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.342 -0.845 . . . . 1.0 111.408 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 96' ' ' ARG . 80.1 m80 -70.45 -55.36 9.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.44 -0.8 . . . . 1.0 112.042 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -94.98 11.36 32.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.081 0.401 . . . . 1.0 112.081 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -148.12 140.82 24.6 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.93 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.0 mt -113.52 117.14 30.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.304 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.644 ' HE1' ' CD2' ' A' ' 158' ' ' HIS . 81.8 m95 -89.22 -26.07 21.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.246 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.485 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -163.58 -160.85 11.96 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.177 -0.769 . . . . 1.0 111.177 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 13.3 tp -150.37 124.27 9.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 1.0 111.506 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.3 tp -99.71 129.29 45.82 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.485 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 13.0 p -139.5 134.14 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.077 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.2 p -106.99 141.99 37.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.991 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.63 ' CE1' ' HE ' ' A' ' 50' ' ' ARG . 24.1 m80 -112.75 126.21 55.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.978 0.418 . . . . 1.0 111.689 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -126.12 113.84 17.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.955 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.4 -15.08 63.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.779 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -117.65 151.03 47.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.99 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.48 132.05 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.895 2.397 . . . . 1.0 111.895 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 53.3 ttt85 -157.87 95.02 2.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.895 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.48 161.24 25.39 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.531 2.154 . . . . 1.0 111.916 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 44.0 p90 -91.17 123.79 34.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.441 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 52.3 m -123.75 164.56 18.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.619 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -50.74 -38.38 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.582 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -67.84 -37.45 81.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.756 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -61.46 -49.92 74.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.573 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 185' ' ' GLN . 43.1 mt -64.28 -34.2 77.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.476 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -54.05 -42.13 68.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 88.1 t -69.45 -57.31 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.773 0.656 . . . . 1.0 112.773 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.11 -46.29 45.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.395 0.517 . . . . 1.0 112.395 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.416 ' CB ' ' O ' ' A' ' 181' ' ' LEU . 63.3 tt0 -42.74 -47.74 5.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.59 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.5 tp -72.36 -41.49 66.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.461 -0.336 . . . . 1.0 111.894 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.5 tp -77.11 -41.84 40.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.818 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -55.05 -39.55 69.3 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.506 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -61.66 -38.14 86.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.007 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.14 -30.58 71.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.076 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 13.0 t -83.8 -42.58 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.756 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.0 p -55.16 -32.85 62.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 193' ' ' ILE . 39.5 mt -69.03 -37.34 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.203 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.96 -39.95 83.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.626 -0.715 . . . . 1.0 109.779 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 195' ' ' ILE . 36.5 mm -61.04 -46.48 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.123 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.69 -47.24 60.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.1 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -65.48 -41.51 93.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.0 111.492 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.02 70.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.675 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.17 -40.95 97.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.509 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.52 -35.68 80.17 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.007 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.5 t -52.42 -52.22 55.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 1.0 110.595 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.583 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.65 ' HHA' HBA1 ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.6 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.902 0.382 . . . . 1.0 110.578 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 66.5 t0 -49.05 -34.99 14.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -77.29 -47.44 20.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.069 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.44 -42.44 93.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 1.0 110.977 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -56.87 -45.02 82.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.099 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -53.22 -38.69 63.16 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.56 71.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.055 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -69.08 -45.7 69.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.547 -0.752 . . . . 1.0 112.227 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 p -71.28 -35.26 57.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.995 0.368 . . . . 1.0 111.995 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -70.17 -35.7 74.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.776 0.322 . . . . 1.0 111.06 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -80.46 -53.54 6.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 1.0 111.755 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 9.6 p -55.08 -44.08 72.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.744 0.306 . . . . 1.0 111.118 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HG3' ' H ' ' A' ' 44' ' ' ALA . 2.6 ppt_? -56.21 -41.7 76.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.85 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.505 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.17 -33.91 59.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.022 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -79.61 -36.2 38.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 1.0 111.581 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -85.34 -30.64 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.501 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 59.33 19.29 46.3 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 93.3 m -72.24 140.77 48.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.792 0.33 . . . . 1.0 110.234 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -39.72 -50.43 2.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.623 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.467 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 59.6 ttp180 -157.97 130.56 7.25 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.018 -0.673 . . . . 1.0 112.591 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.95 131.06 36.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -139.62 155.24 47.55 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.9 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.5 t -106.03 138.91 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.23 131.45 28.22 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.323 -0.551 . . . . 1.0 111.284 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -92.74 145.46 24.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.275 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.469 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 85.6 t80 -96.46 122.13 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 1.0 112.04 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -87.73 164.68 33.51 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 178.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.25 -25.83 15.29 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.521 2.147 . . . . 1.0 112.522 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.94 -15.37 54.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 1.0 110.096 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.37 -17.22 37.31 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.514 -0.635 . . . . 1.0 111.514 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -67.21 101.85 0.97 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.909 -0.316 . . . . 1.0 110.592 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.61 134.89 12.64 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.562 -1.015 . . . . 1.0 110.562 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.6 p -122.24 142.23 50.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 1.0 111.665 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.77 120.53 38.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 t -110.41 5.84 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 1.0 111.356 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.08 118.36 3.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.126 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -143.67 135.91 26.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.073 0.463 . . . . 1.0 111.816 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.92 146.96 52.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.434 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -141.15 145.99 36.42 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.755 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.47 -32.81 46.16 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.881 -0.887 . . . . 1.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 176.63 -161.64 29.75 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -73.94 25.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.339 . . . . 1.0 110.523 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' A' ' 71' ' ' GLY . 43.1 mtm180 -77.47 -47.14 20.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.082 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.7 mt -113.04 145.56 33.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 1.0 109.921 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -70.93 160.31 49.77 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.516 2.144 . . . . 1.0 112.148 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.1 p -93.31 128.13 39.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.864 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.9 mt -94.44 6.4 48.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.372 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 tp -61.34 128.83 38.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.3 0.572 . . . . 1.0 112.246 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.45 -13.83 62.81 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.514 -0.767 . . . . 1.0 111.526 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.3 mt -81.29 150.55 28.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.296 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -106.86 133.85 50.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.652 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -87.02 133.28 39.48 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -41.15 132.87 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.633 2.222 . . . . 1.0 111.895 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.91 128.33 35.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 1.0 110.738 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.27 0.63 44.2 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.529 -1.028 . . . . 1.0 110.529 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -58.71 -33.11 69.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.4 mt -78.99 132.8 62.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.69 -0.687 . . . . 1.0 109.49 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.74 -171.99 0.99 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.452 2.102 . . . . 1.0 112.479 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -106.43 -55.07 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.546 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -63.21 -42.27 99.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.813 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.77 -44.32 77.72 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.928 0.344 . . . . 1.0 111.928 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -64.11 -39.64 94.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.47 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -60.6 -32.13 71.26 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.762 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 98' ' ' ALA . 96.5 mt -70.1 -28.14 65.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.905 0.383 . . . . 1.0 110.341 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.653 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 0.8 OUTLIER -65.33 -54.25 31.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.036 178.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.99 -31.69 65.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.878 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.3 mt -99.41 -44.51 6.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 114.357 1.243 . . . . 1.0 114.357 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -113.55 -12.51 12.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.112 1.523 . . . . 1.0 115.112 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.653 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 18.2 mm-40 45.34 86.73 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.198 -1.001 . . . . 1.0 108.75 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.54 99.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.12 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.501 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 9.8 mmp_? -139.49 133.24 30.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.998 0.428 . . . . 1.0 110.737 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 101' ' ' ARG . 71.3 t -161.4 141.81 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.536 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.15 133.65 53.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.89 164.97 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.318 0.858 . . . . 1.0 113.318 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 20.0 p30 -46.89 118.54 2.1 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.003 -0.999 . . . . 1.0 112.098 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.98 -22.2 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.311 -0.859 . . . . 1.0 110.801 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -67.83 -43.56 79.29 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.55 -11.75 12.44 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.525 0.678 . . . . 1.0 109.389 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 45.54 61.45 2.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.779 -1.1 . . . . 1.0 113.335 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 m -76.26 133.23 40.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 175.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -119.82 140.29 51.02 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.926 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.8 135.19 54.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.496 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 114' ' ' SER . 89.3 mt -136.86 165.95 27.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.185 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.485 ' N ' ' CG2' ' A' ' 113' ' ' ILE . 52.2 p -52.28 156.92 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 117' ' ' GLU . 15.3 mm100 -137.86 79.04 34.56 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.647 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -39.0 85.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.709 2.273 . . . . 1.0 112.363 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 115' ' ' GLN . 84.7 tt0 -171.95 134.79 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.458 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.1 p -76.07 157.0 33.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.681 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -153.44 168.51 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.601 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.79 -100.94 0.19 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 124' ' ' ARG . 23.0 mt 54.76 50.79 14.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 1.0 110.394 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -57.23 -28.89 63.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.534 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.85 -31.66 66.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.512 . . . . 1.0 110.657 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 121' ' ' LEU . 75.8 mtp180 -131.96 140.29 48.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.575 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.5 m -75.2 139.24 72.15 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.296 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.15 83.36 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.558 2.172 . . . . 1.0 112.322 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.8 mt -92.68 -0.8 57.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.585 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.81 10.81 73.78 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.829 -0.908 . . . . 1.0 110.829 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -67.86 136.21 92.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.617 0.246 . . . . 1.0 110.913 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -37.05 151.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 123.164 2.576 . . . . 1.0 111.626 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.59 -24.17 67.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.362 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -130.99 135.84 47.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.898 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.493 HH22 ' CD1' ' A' ' 94' ' ' LEU . 17.6 mmm-85 -124.16 94.27 45.58 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.56 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -45.41 145.87 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.674 2.249 . . . . 1.0 111.93 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 p -100.37 119.98 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.811 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.654 ' CG ' HMD2 ' A' ' 203' ' ' CYC . 49.7 p-10 -43.77 134.1 3.85 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.738 -0.468 . . . . 1.0 109.738 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -42.49 -16.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.095 2.53 . . . . 1.0 114.067 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.743 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -71.55 -48.38 48.91 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.713 0.264 . . . . 1.0 111.713 -176.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.743 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 35.7 t-80 -82.97 -28.24 29.91 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.279 0.474 . . . . 1.0 112.279 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 2.6 p -66.45 -43.76 90.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.004 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.523 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 79.2 t60 -69.86 -30.35 67.8 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.522 ' O ' ' OG ' ' A' ' 145' ' ' SER . 76.9 t80 -59.82 -42.21 93.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.76 178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 146' ' ' MET . 29.8 mt -74.36 -36.14 63.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -52.41 -39.32 60.81 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 9.7 p -65.08 -18.91 65.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.786 -1.097 . . . . 1.0 109.16 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.2 mmm -96.15 1.14 52.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.12 22.89 78.62 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.944 -0.863 . . . . 1.0 110.944 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.33 142.98 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 1.0 111.006 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.65 -39.76 5.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.964 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.7 t -135.96 126.44 26.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.199 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.4 m -113.91 140.78 48.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.428 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.96 138.48 53.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.262 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.462 HG22 HAA1 ' A' ' 203' ' ' CYC . 2.8 t -128.3 119.45 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.167 0.508 . . . . 1.0 111.732 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.6 124.52 21.91 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.735 -1.209 . . . . 1.0 107.735 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.97 144.27 42.54 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 123.175 2.584 . . . . 1.0 114.678 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.462 ' H ' ' HE1' ' A' ' 157' ' ' MET . 11.3 mt -125.14 47.46 2.16 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.561 ' CE ' ' O ' ' A' ' 164' ' ' GLY . 4.4 ptp -147.36 -167.38 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.104 0.779 . . . . 1.0 113.104 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.451 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 20.7 m-70 -68.71 159.24 32.58 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.45 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -60.63 -50.11 74.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.414 -0.812 . . . . 1.0 112.107 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -97.74 -42.75 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.06 0.393 . . . . 1.0 112.06 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.473 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 85.2 tt0 -86.27 134.3 33.76 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.87 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 19.1 mt -109.17 115.58 30.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.215 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.473 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 77.8 m95 -88.85 -31.42 18.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.278 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.561 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -169.97 -166.95 29.76 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.229 -0.748 . . . . 1.0 111.229 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.416 ' CD1' ' C ' ' A' ' 164' ' ' GLY . 5.8 mp -148.65 136.37 20.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 1.0 111.506 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.4 tp -98.58 134.92 40.86 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.4 p -138.5 127.41 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.695 -0.402 . . . . 1.0 111.097 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.2 p -104.68 137.13 42.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.064 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.467 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 28.4 m80 -105.07 121.24 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.981 0.419 . . . . 1.0 111.601 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -122.1 113.45 19.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.936 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.46 -14.23 61.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.781 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.74 135.14 74.85 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.06 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.01 -4.54 14.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.905 2.404 . . . . 1.0 111.813 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 174' ' ' ARG . 1.0 OUTLIER -54.73 151.34 15.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.845 -179.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.65 160.96 46.75 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.53 2.153 . . . . 1.0 111.946 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -81.54 136.64 35.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.483 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -113.03 144.83 41.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.64 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -55.86 -29.32 59.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.537 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -55.82 -37.07 68.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.696 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.01 -37.72 88.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.505 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 9.0 mp -65.07 -38.94 92.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.48 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.53 -37.98 68.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.371 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.85 -55.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.737 0.643 . . . . 1.0 112.737 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 188' ' ' ALA . 10.9 p -68.38 -38.69 79.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.394 0.516 . . . . 1.0 112.394 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -52.52 -45.22 66.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.644 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 37.2 tp -65.04 -45.52 85.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 85.1 mt -78.92 -31.55 45.27 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -62.88 -44.46 96.06 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.494 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -62.25 -42.23 99.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.067 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -64.12 -27.34 69.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.095 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.4 t -84.8 -40.86 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.749 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -56.78 -36.11 69.48 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.5 mt -67.58 -38.44 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.228 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -68.02 -40.2 82.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.838 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.457 HG23 HD11 ' A' ' 195' ' ' ILE . 26.1 mm -59.23 -48.19 87.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.051 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.47 -48.75 47.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.031 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.15 -45.77 79.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.525 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -63.42 -32.65 74.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.711 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -57.32 -29.6 64.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.385 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.27 -32.88 73.65 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.058 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.0 t -52.15 -55.85 18.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.551 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.6 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.54 179.439 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.693 ' HHB' ' HE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.806 0.336 . . . . 1.0 110.589 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -53.01 -54.5 34.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.951 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -54.54 -46.95 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.114 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 mm -62.03 -46.99 95.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.826 0.346 . . . . 1.0 110.972 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.2 mt -56.46 -45.14 80.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.08 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -53.59 -38.41 63.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.65 -30.33 66.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.124 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.7 m -73.59 -44.76 56.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.528 -0.76 . . . . 1.0 112.228 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 p -68.56 -35.94 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.96 0.356 . . . . 1.0 111.96 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -67.16 -49.18 65.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 1.0 111.156 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -58.72 -45.26 90.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.683 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.94 -37.32 60.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.686 0.279 . . . . 1.0 111.149 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 47' ' ' GLY . 36.7 ttp180 -52.53 -40.83 62.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.832 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.89 -35.76 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.056 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.11 -46.36 20.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.538 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.6 mt -86.37 -31.59 21.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.494 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.57 22.22 31.22 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.461 -1.056 . . . . 1.0 110.461 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.2 p -74.02 144.96 44.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.332 . . . . 1.0 110.286 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -41.52 -42.01 2.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.617 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.532 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 56.3 ttm-85 -163.26 129.33 3.24 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.123 -0.631 . . . . 1.0 112.636 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.84 130.29 52.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' NZ ' ' HE2' ' A' ' 169' ' ' HIS . 23.5 pttm -140.6 154.97 46.68 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.442 -0.503 . . . . 1.0 111.874 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -109.17 138.76 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.34 133.47 33.01 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.348 -0.541 . . . . 1.0 111.283 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -92.62 145.58 24.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.201 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -95.62 117.73 31.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 1.0 112.089 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.09 149.47 59.02 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.52 -23.15 74.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.58 2.187 . . . . 1.0 112.45 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -86.14 -14.53 43.85 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.057 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.43 -13.13 47.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.469 -0.652 . . . . 1.0 111.469 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -76.0 94.79 3.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.804 0.335 . . . . 1.0 110.608 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.88 143.54 17.61 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -122.18 144.54 48.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.914 0.388 . . . . 1.0 111.638 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -80.51 112.49 18.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.07 3.63 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.276 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.28 119.71 2.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.076 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.532 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 84.8 tt0 -144.84 132.87 21.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.106 0.479 . . . . 1.0 111.847 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.96 148.82 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.336 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.613 ' NH2' ' N ' ' A' ' 76' ' ' SER . 6.8 ptp180 -139.68 142.21 36.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.895 0.379 . . . . 1.0 110.718 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.41 -33.18 86.54 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -171.26 -178.97 42.08 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -73.61 40.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 1.0 110.581 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 71' ' ' GLY . 10.1 tpt180 -83.06 -47.79 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.144 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.36 150.85 43.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.863 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.462 ' C ' ' NH2' ' A' ' 69' ' ' ARG . 58.3 Cg_endo -69.86 160.3 50.19 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.483 2.122 . . . . 1.0 112.131 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.613 ' N ' ' NH2' ' A' ' 69' ' ' ARG . 21.9 t -88.86 129.55 35.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.942 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.6 mt -98.14 10.22 41.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.383 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.08 132.58 45.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.003 -0.544 . . . . 1.0 112.305 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.13 -10.02 67.57 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.527 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.8 mt -85.5 154.11 22.0 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.336 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 p -105.37 130.72 53.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.688 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -84.66 152.67 60.42 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.84 133.94 41.28 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.678 2.252 . . . . 1.0 111.883 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.35 129.14 38.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.67 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.64 0.46 42.91 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -56.42 -35.58 67.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 87' ' ' ILE . 16.7 mm -80.16 132.39 59.91 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.66 -0.7 . . . . 1.0 109.434 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.39 -167.26 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.398 2.065 . . . . 1.0 112.483 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -107.63 -60.06 1.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.505 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 39.6 mp0 -57.95 -44.43 86.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.818 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.88 -44.62 80.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -58.62 -36.26 73.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.477 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -63.81 -32.03 73.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.811 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.1 mt -67.11 -36.36 81.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.295 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.424 ' CE1' ' O1A' ' A' ' 203' ' ' CYC . 24.2 m-85 -57.18 -54.36 47.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.051 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -53.43 -29.81 37.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.838 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.555 ' C ' HE22 ' A' ' 99' ' ' GLN . 75.9 mt -98.97 -41.37 7.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.413 1.264 . . . . 1.0 114.413 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.561 ' N ' ' NE2' ' A' ' 99' ' ' GLN . . . -120.19 -17.09 8.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 115.031 1.493 . . . . 1.0 115.031 -173.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.592 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.2 OUTLIER 45.15 71.45 0.27 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.123 -1.031 . . . . 1.0 108.847 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 2.7 m -164.26 113.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.051 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.44 ' CZ ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -155.68 148.26 23.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.932 0.396 . . . . 1.0 110.774 178.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.13 143.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.505 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.7 mt -108.94 135.62 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.09 164.39 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 113.275 0.843 . . . . 1.0 113.275 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -43.98 117.27 1.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.95 -1.023 . . . . 1.0 112.145 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.88 -20.02 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.79 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -66.9 -42.27 85.76 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.09 -10.39 40.0 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.45 0.643 . . . . 1.0 109.408 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 45.26 70.63 0.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.734 -1.121 . . . . 1.0 113.354 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 p -75.35 134.43 40.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.984 -1.488 . . . . 1.0 106.984 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -122.02 139.78 53.28 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.893 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.28 153.51 48.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.6 pt -154.88 178.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.121 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.7 p -51.49 150.54 3.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.577 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -141.22 153.66 66.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.668 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -36.26 99.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.677 2.251 . . . . 1.0 112.309 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 44.35 -121.89 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.433 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.4 m -129.31 149.6 51.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.65 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -70.51 -61.04 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.589 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.75 -162.77 52.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.5 mt 42.07 73.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 1.0 110.437 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 76.9 p -63.19 -16.42 60.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.511 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.82 -20.46 8.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.736 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -141.96 147.43 36.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.574 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 m -78.78 150.74 76.01 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.289 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.05 152.02 31.13 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.647 2.231 . . . . 1.0 112.32 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' A' ' 127' ' ' LEU . 8.4 mp -88.07 161.06 17.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.575 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.26 59.23 2.07 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -134.72 78.97 54.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.585 0.231 . . . . 1.0 110.843 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -87.1 -46.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.159 2.573 . . . . 1.0 111.652 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.5 mt -79.08 -0.49 31.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.416 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.529 ' O ' ' C ' ' A' ' 133' ' ' ARG . 61.1 mm-40 63.86 114.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.94 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.529 ' C ' ' O ' ' A' ' 132' ' ' GLN . 23.6 ttm105 29.0 77.38 0.3 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.564 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -81.54 141.71 12.6 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.767 2.311 . . . . 1.0 111.95 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.49 124.3 61.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.878 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -43.22 141.97 1.71 Allowed Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -49.18 -13.52 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 123.224 2.616 . . . . 1.0 114.073 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.681 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.4 p -75.59 -44.43 43.1 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.746 0.276 . . . . 1.0 111.746 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.681 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.6 t60 -82.9 -32.86 27.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.226 0.454 . . . . 1.0 112.226 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 4.3 p -68.76 -45.03 81.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.936 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.51 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 35.5 m-70 -68.69 -28.97 67.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -60.83 -41.0 94.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.923 -0.581 . . . . 1.0 109.715 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.6 mt -72.86 -36.49 67.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -52.15 -38.73 58.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -64.44 -23.07 67.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.746 -1.115 . . . . 1.0 109.161 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.529 ' N ' ' O ' ' A' ' 143' ' ' LEU . 97.1 mmm -92.74 2.15 56.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.727 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.84 79.28 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.3 t -111.93 142.03 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 1.0 111.019 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.92 -26.67 11.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.012 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.2 m -136.45 160.83 37.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.166 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.35 127.72 13.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.44 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 tp -114.92 136.31 53.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.292 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.4 119.62 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.132 0.491 . . . . 1.0 111.793 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.62 91.1 41.71 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 107.862 -1.162 . . . . 1.0 107.862 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.22 151.68 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.175 2.584 . . . . 1.0 114.693 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.5 mt -126.05 63.18 1.24 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.832 -1.544 . . . . 1.0 106.832 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 ptm -146.35 179.61 7.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.163 0.801 . . . . 1.0 113.163 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.606 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 46.1 t-80 -68.07 176.24 2.76 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.394 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.606 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 97.8 m-70 -64.54 -51.64 61.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.401 -0.818 . . . . 1.0 112.082 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.68 -37.79 6.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.064 0.394 . . . . 1.0 112.064 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -87.67 136.29 33.01 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.689 -0.405 . . . . 1.0 110.846 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.436 ' H ' HD13 ' A' ' 162' ' ' LEU . 1.2 mp -108.63 112.14 24.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.317 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -88.27 -37.49 16.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.257 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.71 -175.75 36.5 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.17 141.56 30.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 1.0 111.5 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.4 tp -101.07 135.26 42.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.64 129.68 35.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 1.0 111.078 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.2 m -106.77 139.37 41.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.057 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.479 ' HE2' ' NZ ' ' A' ' 52' ' ' LYS . 85.7 m-70 -113.76 132.09 55.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.948 0.404 . . . . 1.0 111.667 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.561 ' CD2' ' N ' ' A' ' 170' ' ' HIS . 1.0 OUTLIER -124.57 125.32 43.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.929 177.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.43 33.63 0.69 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.832 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -161.35 154.38 17.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.029 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.16 112.82 2.18 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.928 2.419 . . . . 1.0 111.84 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -149.16 90.11 4.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.884 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.96 158.42 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.597 2.198 . . . . 1.0 111.905 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 41.6 p90 -84.79 127.27 34.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.487 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.6 p -121.06 162.37 20.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.581 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.59 ' H ' ' CD ' ' A' ' 178' ' ' GLN . 1.7 pm0 -50.33 -30.47 12.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.648 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -61.87 -36.24 80.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.739 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -66.01 -24.43 66.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.486 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.8 mt -81.33 -33.88 32.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.483 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.45 -43.09 99.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.34 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 184' ' ' VAL . 13.1 m -73.41 -49.16 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.708 0.633 . . . . 1.0 112.708 -177.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 183' ' ' VAL . 27.9 m -70.4 -43.87 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.403 0.52 . . . . 1.0 112.403 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -53.28 -43.43 67.46 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.983 -0.287 . . . . 1.0 111.67 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.73 -49.99 59.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.445 ' O ' ' CG2' ' A' ' 191' ' ' VAL . 71.2 mt -79.86 -35.07 38.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.795 -177.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -61.1 -43.38 98.97 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.488 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.58 -42.47 86.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 1.0 109.989 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.63 -28.23 68.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.135 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 187' ' ' LEU . 59.4 t -84.3 -43.71 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.785 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.2 p -57.83 -35.63 71.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.655 -0.868 . . . . 1.0 108.655 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.9 mt -67.84 -35.03 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.207 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.57 76.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.646 -0.707 . . . . 1.0 109.843 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.0 mm -61.38 -47.53 93.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.133 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.8 -48.02 60.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.045 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -65.68 -41.19 92.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.558 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.05 -31.3 72.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.677 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.72 -31.92 68.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.497 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 9.0 mp -60.62 -34.84 74.84 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.932 -0.307 . . . . 1.0 111.095 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.3 m -55.96 -56.14 24.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.58 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.536 179.715 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.454 ' NA ' ' NE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.6 tp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.795 0.331 . . . . 1.0 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -60.52 -51.95 67.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.048 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -55.89 -45.91 78.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.127 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 mm -61.4 -48.4 89.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.771 0.32 . . . . 1.0 110.877 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.02 -47.74 84.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.012 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -52.45 -39.54 61.21 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.622 -0.431 . . . . 1.0 109.846 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.56 -29.09 65.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.137 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.8 m -73.25 -45.32 56.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.477 -0.783 . . . . 1.0 112.312 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 7.8 p -68.45 -35.3 70.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -177.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -70.6 -42.31 71.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.784 0.326 . . . . 1.0 111.094 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.71 -54.67 24.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.77 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -52.45 -39.84 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.171 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -52.76 -41.76 64.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 1.0 110.811 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.3 -38.34 79.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.04 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -75.5 -42.82 51.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.603 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.2 mt -85.6 -26.81 25.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.457 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.76 19.95 16.39 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 91.3 m -73.01 143.39 47.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.832 0.349 . . . . 1.0 110.192 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -39.34 -55.43 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.668 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.617 HH22 ' CG2' ' A' ' 148' ' ' VAL . 61.2 mtm-85 -148.92 131.8 16.12 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.053 -0.659 . . . . 1.0 112.576 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 38.4 t -132.69 127.64 56.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.681 ' NZ ' ' HE2' ' A' ' 169' ' ' HIS . 20.4 pttm -141.4 154.92 45.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.13 0.49 . . . . 1.0 111.939 -178.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.15 135.56 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.626 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -133.76 120.06 20.05 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.243 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -74.04 140.2 45.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.273 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.629 ' CE1' ' NH2' ' A' ' 92' ' ' ARG . 58.9 t80 -92.91 117.21 29.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 1.0 112.048 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 41.2 p-10 -93.59 141.35 23.74 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.83 -14.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.573 2.182 . . . . 1.0 112.517 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 57' ' ' ASP . 96.3 mt-10 -87.97 -33.86 18.27 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.729 -0.389 . . . . 1.0 110.104 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.41 -10.79 39.37 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.514 -0.634 . . . . 1.0 111.514 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.685 ' O ' ' O ' ' A' ' 62' ' ' GLY . 64.2 m80 -66.54 -42.81 86.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.926 -0.31 . . . . 1.0 110.61 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.685 ' O ' ' O ' ' A' ' 61' ' ' HIS . . . 47.97 155.98 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.659 -0.976 . . . . 1.0 110.659 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 p -124.81 146.25 49.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 1.0 111.711 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.95 106.82 4.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.793 -0.818 . . . . 1.0 108.793 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.3 t -106.56 -1.85 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.719 0.295 . . . . 1.0 111.375 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.44 118.04 3.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.103 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -144.43 129.0 18.1 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.566 -0.454 . . . . 1.0 111.865 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.21 145.55 49.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.378 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -142.28 142.7 32.59 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.722 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.6 -36.1 83.85 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -163.63 -179.56 38.07 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -73.47 55.13 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 1.0 110.525 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -86.42 -48.88 8.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.131 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.9 mt -119.09 147.77 43.44 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.867 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.9 138.75 45.34 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.517 2.145 . . . . 1.0 112.131 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.1 m -60.43 130.26 45.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.89 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.7 mt -91.91 7.04 43.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.346 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tp -59.4 129.55 42.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.29 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.55 -12.82 65.73 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.526 -0.761 . . . . 1.0 111.507 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.5 mt -83.11 153.1 25.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.742 0.306 . . . . 1.0 110.327 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.7 p -107.65 135.06 49.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.646 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' CE2' HBB1 ' A' ' 203' ' ' CYC . 7.1 m-85 -87.68 154.46 53.28 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.22 124.92 12.75 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.684 2.256 . . . . 1.0 111.847 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.437 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . -62.44 137.67 58.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.696 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.87 -2.23 38.64 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -54.6 -38.73 67.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 88' ' ' PRO . 6.1 mm -83.65 111.92 35.85 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.433 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 87' ' ' ILE . 87.9 Cg_exo -51.46 -162.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.486 2.124 . . . . 1.0 112.499 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -107.82 -51.56 2.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.572 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.72 -41.32 92.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.768 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.94 79.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.936 0.346 . . . . 1.0 111.936 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.629 ' NH2' ' CE1' ' A' ' 56' ' ' PHE . 63.2 ttt180 -64.04 -39.15 93.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.519 -0.31 . . . . 1.0 111.457 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -62.3 -34.34 76.4 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.777 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.31 -34.7 75.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.266 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.652 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 2.3 t80 -63.54 -26.36 68.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.99 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.652 HH21 ' NE2' ' A' ' 160' ' ' GLN . 52.3 ttt180 -81.54 -28.32 33.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.786 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.9 mt -98.21 -41.21 8.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.36 -8.13 12.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 115.067 1.506 . . . . 1.0 115.067 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.695 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.6 mm-40 41.64 83.31 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.221 -0.991 . . . . 1.0 108.818 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.7 p 174.7 113.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.973 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.49 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 5.0 tpt180 -153.52 139.26 17.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 1.0 110.799 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 101' ' ' ARG . 55.9 t -161.22 145.91 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.547 -178.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 103' ' ' ILE . 65.4 mt -110.18 133.76 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.91 165.86 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 113.322 0.86 . . . . 1.0 113.322 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -45.81 119.72 2.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.964 -1.017 . . . . 1.0 112.139 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.13 -22.11 13.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.221 -0.899 . . . . 1.0 110.792 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -65.6 -44.11 87.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.6 -0.518 . . . . 1.0 109.6 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.93 -11.23 35.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.535 0.683 . . . . 1.0 109.42 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 44.72 71.12 0.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.731 -1.122 . . . . 1.0 113.327 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 p -74.27 132.75 42.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 176.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -118.8 128.96 54.96 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.017 -0.673 . . . . 1.0 111.884 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.478 ' HG ' ' H ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -124.77 152.09 44.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.623 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.1 pt -154.21 177.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.117 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 m -56.14 160.98 2.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.691 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -129.59 152.86 80.4 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.667 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' A' ' 117' ' ' GLU . 72.9 Cg_endo -73.19 -53.67 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.666 2.244 . . . . 1.0 112.351 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 118' ' ' SER . 0.9 OUTLIER -66.88 -40.83 87.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.397 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.515 ' OG ' ' CD2' ' A' ' 119' ' ' TRP . 37.2 t 55.29 156.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.659 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.515 ' CD2' ' OG ' ' A' ' 118' ' ' SER . 2.2 m-90 40.33 -152.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.594 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 70.35 -134.78 24.93 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.4 tp 58.92 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.8 0.333 . . . . 1.0 110.359 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' GLY . 87.0 p -62.18 -29.81 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.494 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.96 95.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.614 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -69.44 -64.28 0.91 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.547 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.19 85.39 51.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.19 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -45.37 154.35 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.556 2.171 . . . . 1.0 112.292 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.3 mt 59.48 59.18 2.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.615 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -150.07 60.94 0.42 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.842 -0.903 . . . . 1.0 110.842 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 129' ' ' GLU . 1.6 pm0 -126.54 76.03 74.11 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.577 0.227 . . . . 1.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -38.09 151.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 123.206 2.604 . . . . 1.0 111.672 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.9 mt -64.24 -14.8 57.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.383 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -79.34 84.86 5.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.895 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.401 HH21 ' CB ' ' A' ' 129' ' ' GLU . 55.0 mtt-85 -120.21 114.62 33.35 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.52 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.13 140.27 13.93 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.713 2.276 . . . . 1.0 112.0 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.3 p -107.91 121.34 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.835 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.667 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 2.8 p-10 -45.13 140.57 3.64 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 138' ' ' CYS . 63.0 Cg_exo -42.63 -50.17 6.03 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.09 2.527 . . . . 1.0 114.047 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.757 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.0 OUTLIER -34.46 -49.26 0.39 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.72 0.267 . . . . 1.0 111.72 -177.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.757 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 20.5 t-80 -81.18 -25.66 36.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.319 0.488 . . . . 1.0 112.319 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 137' ' ' PRO . 42.1 t -65.88 -51.77 57.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.941 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.441 ' O ' ' OG ' ' A' ' 145' ' ' SER . 58.5 t-80 -63.57 -29.6 70.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.06 -44.32 94.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.694 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 146' ' ' MET . 61.8 mt -73.02 -41.54 64.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -50.63 -39.54 50.61 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 141' ' ' HIS . 2.6 m -62.93 -27.19 69.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.784 -1.098 . . . . 1.0 109.19 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.55 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.2 mmm -89.05 -0.46 57.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.7 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.77 21.5 78.48 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.976 -0.85 . . . . 1.0 110.976 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.617 ' CG2' HH22 ' A' ' 50' ' ' ARG . 47.7 t -109.45 142.25 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 1.0 111.035 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.1 -36.82 6.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.011 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 t -138.71 129.4 26.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.136 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.6 m -114.77 137.25 52.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.41 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tp -117.38 137.89 52.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.284 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 102' ' ' VAL . 2.1 t -126.58 113.77 34.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.082 0.468 . . . . 1.0 111.744 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.39 106.94 57.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 107.825 -1.176 . . . . 1.0 107.825 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.33 123.72 2.09 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.16 2.573 . . . . 1.0 114.77 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.4 tp -115.93 45.9 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.5 ptm -148.02 -178.36 6.24 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.091 0.775 . . . . 1.0 113.091 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.657 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 48.6 t-80 -69.3 178.64 2.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.306 -0.861 . . . . 1.0 111.411 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.657 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 83.6 t60 -67.89 -51.62 45.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 1.0 112.044 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.652 ' NE2' HH21 ' A' ' 96' ' ' ARG . 48.9 tt0 -105.17 -38.6 6.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.047 0.388 . . . . 1.0 112.047 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.512 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.7 tt0 -90.69 139.17 30.98 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.841 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.433 ' CD2' ' C ' ' A' ' 162' ' ' LEU . 7.9 tt -107.03 115.39 30.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.357 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.512 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 78.6 m95 -91.75 -41.14 10.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.298 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.79 -173.71 24.75 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.422 ' CD1' ' CZ ' ' A' ' 95' ' ' PHE . 7.2 tp -144.26 128.13 17.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.332 . . . . 1.0 111.558 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.4 tp -98.04 129.06 44.9 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.53 136.7 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.087 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.1 m -111.24 149.65 30.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.053 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.681 ' HE2' ' NZ ' ' A' ' 52' ' ' LYS . 93.1 m-70 -124.6 131.21 53.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.003 0.43 . . . . 1.0 111.603 -177.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.03 114.42 15.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.984 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.94 -15.69 63.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.859 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -112.41 151.27 43.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.993 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.18 92.61 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.891 2.394 . . . . 1.0 111.929 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -120.85 91.27 47.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.901 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.97 152.36 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.533 2.156 . . . . 1.0 111.937 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -109.25 143.53 38.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.444 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.585 ' HG ' ' H ' ' A' ' 178' ' ' GLN . 23.2 t -125.24 171.35 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.607 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.585 ' H ' ' HG ' ' A' ' 177' ' ' SER . 98.2 mm-40 -50.89 -30.38 14.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.616 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -63.22 -39.45 94.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.708 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.54 -44.85 93.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.524 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 9.9 mp -63.92 -36.76 84.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.502 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -54.48 -36.64 64.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.884 -0.598 . . . . 1.0 111.331 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.34 -54.98 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.722 0.638 . . . . 1.0 112.722 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.1 t -77.68 -42.17 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -44.31 -45.28 8.64 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.951 -0.299 . . . . 1.0 111.631 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.535 ' N ' ' CD1' ' A' ' 186' ' ' LEU . 7.4 mp -75.96 -37.79 58.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.92 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.1 tp -77.65 -41.47 38.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.806 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.71 93.49 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.474 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -57.67 -39.6 77.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.294 -0.412 . . . . 1.0 109.924 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -71.8 -24.11 61.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.157 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 73.1 t -82.5 -48.92 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 1.0 109.798 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.454 ' HG ' ' N ' ' A' ' 193' ' ' ILE . 85.8 p -54.25 -34.19 60.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.454 ' N ' ' HG ' ' A' ' 192' ' ' SER . 30.9 mt -65.59 -33.85 66.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.161 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.74 -38.12 79.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.575 -0.738 . . . . 1.0 109.8 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.59 -46.46 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.14 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.03 -46.55 61.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.059 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -66.61 -44.54 81.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.515 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.34 -33.25 75.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.299 -0.409 . . . . 1.0 111.674 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -60.42 -32.87 71.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.578 -0.283 . . . . 1.0 111.498 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.61 -34.92 78.88 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.012 -0.275 . . . . 1.0 111.052 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.7 m -55.53 -54.74 40.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.802 0.334 . . . . 1.0 110.65 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 9.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.539 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.667 HMD2 ' OD1' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.83 0.348 . . . . 1.0 110.562 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' CG ' ' N ' ' A' ' 33' ' ' GLN . 24.1 p-10 -55.63 -54.46 43.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.967 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.404 ' N ' ' CG ' ' A' ' 32' ' ' ASP . 62.9 tt0 -54.35 -44.84 72.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.124 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.694 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -60.91 -52.89 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.955 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.2 mt -58.71 -48.2 81.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.011 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -53.4 -39.41 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.6 -0.44 . . . . 1.0 109.871 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.5 65.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.042 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 42' ' ' VAL . 21.5 m -73.22 -44.59 59.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.529 -0.76 . . . . 1.0 112.197 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.639 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 4.1 p -69.96 -35.79 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.916 0.339 . . . . 1.0 111.916 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.06 -48.92 61.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.753 0.311 . . . . 1.0 111.096 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -66.94 -50.65 61.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.745 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 38' ' ' THR . 83.1 t -58.38 -42.77 84.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.724 0.297 . . . . 1.0 111.169 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -56.21 -43.11 78.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.811 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.76 -33.53 61.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -77.08 -37.93 53.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.608 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -85.78 -27.8 24.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.446 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.93 20.0 24.65 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.458 -1.057 . . . . 1.0 110.458 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.44 ' OG1' HG23 ' A' ' 51' ' ' VAL . 12.5 p -72.11 142.52 49.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.859 0.361 . . . . 1.0 110.217 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -40.39 -47.5 2.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.664 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.53 ' NH1' ' CE1' ' A' ' 169' ' ' HIS . 54.0 ttp85 -154.02 131.29 11.17 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.029 -0.668 . . . . 1.0 112.629 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.44 HG23 ' OG1' ' A' ' 48' ' ' THR . 48.9 t -135.38 127.36 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -140.94 156.07 46.14 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.478 -0.489 . . . . 1.0 111.967 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.8 t -101.08 140.56 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.437 ' O ' ' N ' ' A' ' 165' ' ' LEU . 55.4 t80 -127.19 111.48 14.02 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.364 -0.534 . . . . 1.0 111.209 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -84.39 133.72 34.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -95.77 125.66 40.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 1.0 112.096 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 60' ' ' GLY . 6.2 m-20 -95.14 138.57 21.96 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.79 -29.11 3.32 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.514 2.142 . . . . 1.0 112.453 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -82.82 -19.71 37.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 1.0 110.03 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.56 -10.91 38.94 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.517 -0.633 . . . . 1.0 111.517 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -82.18 88.26 6.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.63 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.06 154.29 23.6 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.5 p -124.97 148.85 48.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.971 0.415 . . . . 1.0 111.646 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.93 107.9 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 65' ' ' VAL . 60.5 t -106.75 0.16 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.779 0.324 . . . . 1.0 111.413 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.639 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.33 120.44 3.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.5 tt0 -145.46 132.51 20.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 1.0 111.846 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.19 142.42 51.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 1.0 109.406 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -143.09 145.47 32.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.907 0.384 . . . . 1.0 110.76 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.07 -35.03 63.07 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -179.9 -164.49 32.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.037 -0.825 . . . . 1.0 111.037 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -72.42 16.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.309 . . . . 1.0 110.486 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 71' ' ' GLY . 61.5 ttm-85 -66.83 -46.66 74.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.15 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.6 mt -115.19 124.61 29.95 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.87 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.24 154.21 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.535 2.157 . . . . 1.0 112.134 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.7 m -90.13 130.39 36.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.934 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.54 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 23.6 mt -98.48 13.56 31.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.437 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 20.4 tp -71.41 130.42 41.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.224 0.535 . . . . 1.0 112.308 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.18 -10.0 70.54 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.496 -0.774 . . . . 1.0 111.581 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 77' ' ' LEU . 65.7 mt -85.14 153.77 22.45 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.327 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 81' ' ' THR . 14.1 t -107.69 133.5 52.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.658 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -85.55 152.26 57.12 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.57 133.82 38.59 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.625 2.216 . . . . 1.0 111.808 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 131.13 45.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.712 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.89 0.64 42.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 50.9 t0 -53.71 -33.92 57.13 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.3 mt -91.44 110.37 42.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.377 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 87' ' ' ILE . 88.7 Cg_exo -51.47 -155.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.437 2.091 . . . . 1.0 112.448 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -107.11 -59.38 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.493 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.89 -40.27 79.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.369 . . . . 1.0 111.875 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.55 38.48 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.969 0.359 . . . . 1.0 111.969 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -53.85 -35.92 62.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.485 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -65.33 -33.42 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.78 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.72 -36.73 78.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.256 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.6 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 23.7 m-85 -58.19 -30.54 66.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.069 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -83.31 -23.93 32.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.824 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.2 mt -97.93 -47.51 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.449 ' O ' HG22 ' A' ' 100' ' ' VAL . . . -114.62 -12.64 12.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.089 1.514 . . . . 1.0 115.089 -173.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.856 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.2 mm100 45.6 61.43 2.62 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.164 -1.014 . . . . 1.0 108.813 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 99' ' ' GLN . 3.9 m -165.71 105.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.075 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.457 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 9.9 mmt180 -148.29 150.36 33.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.418 . . . . 1.0 110.742 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -169.09 146.7 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.522 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.1 mt -107.42 135.07 47.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 105' ' ' ASP . 6.0 p -90.65 160.28 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.227 0.825 . . . . 1.0 113.227 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.489 ' N ' HG22 ' A' ' 104' ' ' VAL . 4.3 p30 -45.52 121.0 2.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.881 -1.054 . . . . 1.0 112.209 -177.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 140' ' ' VAL . 9.4 p -57.2 -22.11 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.816 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -62.53 -49.03 76.94 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.413 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . . . -62.65 -8.47 6.62 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.504 0.669 . . . . 1.0 109.391 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 43.89 72.07 0.21 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.77 -1.105 . . . . 1.0 113.35 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.42 131.9 41.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.905 -1.517 . . . . 1.0 106.905 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -119.77 139.53 52.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.962 -0.695 . . . . 1.0 111.884 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -147.91 167.64 24.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.544 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 113' ' ' ILE . 15.8 pt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.133 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo . . . . . 0 N--CA 1.493 1.466 0 CA-C-O 120.729 0.22 . . . . 1.0 111.908 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.5 t -106.96 128.03 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.829 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.547 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER -44.92 148.36 0.99 Allowed Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.16 -33.95 89.89 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.224 2.616 . . . . 1.0 113.988 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.724 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.8 p -48.32 -47.73 36.61 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.74 0.274 . . . . 1.0 111.74 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.724 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 29.4 t-80 -81.5 -29.38 33.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.274 0.472 . . . . 1.0 112.274 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.414 ' CG1' HG23 ' A' ' 106' ' ' VAL . 98.4 t -64.22 -53.7 40.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.928 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -64.34 -28.02 69.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -59.63 -41.08 89.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.868 -0.606 . . . . 1.0 109.759 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 146' ' ' MET . 12.7 mt -73.52 -39.33 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -51.08 -38.87 54.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.5 m -64.44 -24.72 67.72 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.738 -1.119 . . . . 1.0 109.223 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.58 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.4 mmm -92.0 -1.69 57.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.739 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.6 22.0 77.88 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.03 142.39 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 1.0 111.002 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.54 -39.9 5.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.015 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -133.41 125.38 28.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.118 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 m -119.06 138.37 52.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.449 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -116.27 141.13 48.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.29 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.6 t -126.24 122.65 61.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.157 0.503 . . . . 1.0 111.77 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 154' ' ' VAL . 1.4 p -132.46 93.03 26.14 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.836 -1.172 . . . . 1.0 107.836 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.698 ' C ' HD12 ' A' ' 156' ' ' LEU . 87.1 Cg_exo -48.14 150.21 5.31 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.149 2.566 . . . . 1.0 114.648 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 155' ' ' PRO . 10.9 mp -123.08 64.19 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.571 ' HE3' HE22 ' A' ' 99' ' ' GLN . 6.3 ptt? -149.63 -161.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.138 0.792 . . . . 1.0 113.138 -175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.22 -178.72 5.23 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.315 -0.857 . . . . 1.0 111.397 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -73.8 -55.42 6.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 1.0 112.026 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -103.57 8.6 37.64 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.991 0.367 . . . . 1.0 111.991 -177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -140.6 133.45 29.07 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.877 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.532 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.7 OUTLIER -110.63 119.35 38.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.236 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -93.58 -36.65 12.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.241 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.41 -177.38 37.03 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.7 mp -141.16 138.89 33.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 1.0 111.564 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.512 ' HB2' HD13 ' A' ' 156' ' ' LEU . 6.0 tp -104.98 136.99 43.42 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.24 135.39 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.713 -0.395 . . . . 1.0 111.106 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.5 m -112.04 142.4 44.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.019 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.53 ' CE1' ' NH1' ' A' ' 50' ' ' ARG . 42.3 m80 -114.81 127.42 55.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.029 0.442 . . . . 1.0 111.698 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.533 ' CD2' ' OE2' ' A' ' 172' ' ' GLU . 1.7 t-80 -127.42 121.93 32.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.949 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.47 61.44 5.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.803 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.533 ' OE2' ' CD2' ' A' ' 170' ' ' HIS . 26.3 pt-20 -152.04 142.65 15.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.064 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.39 -0.49 10.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.986 2.457 . . . . 1.0 111.854 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -60.67 147.18 84.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.898 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.15 167.48 25.85 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.545 2.163 . . . . 1.0 111.924 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -86.42 142.44 28.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.42 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.2 m -115.0 150.87 35.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.622 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -60.54 -29.88 69.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.57 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 29.8 mp0 -55.34 -34.33 64.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.769 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -63.66 -37.54 87.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.503 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.56 -37.81 85.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.543 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.5 tm0? -54.49 -39.22 67.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.389 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 83.7 t -67.24 -53.9 28.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 19.2 m -74.58 -29.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -51.61 -45.48 63.22 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.873 -0.331 . . . . 1.0 111.686 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 18.5 tp -76.25 -41.17 49.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.878 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.877 ' O ' HG23 ' A' ' 191' ' ' VAL . 47.5 mt -78.39 -39.71 38.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.816 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.44 -44.45 97.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.472 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -61.53 -38.12 86.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 1.0 109.971 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.43 -26.4 60.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.136 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 187' ' ' LEU . 59.9 t -82.73 -49.61 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.734 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 83.1 p -51.47 -30.27 19.24 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 56.9 mt -76.82 -33.85 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.495 -0.775 . . . . 1.0 109.214 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.61 -45.81 77.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.789 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.404 HD11 ' O ' ' A' ' 156' ' ' LEU . 25.0 pt -63.43 -35.11 71.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.138 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.4 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -69.78 -44.51 69.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 1.0 111.199 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.26 -38.44 75.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 1.0 111.518 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.32 -32.88 74.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.666 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.55 -32.85 70.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.478 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.3 mt -60.68 -32.62 71.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.99 -0.284 . . . . 1.0 111.051 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -53.45 -53.0 57.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.563 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 21.7 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.53 179.594 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.899 0.38 . . . . 1.0 110.59 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -57.29 -52.05 66.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.03 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -55.99 -46.19 78.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.085 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.7 mt -61.61 -53.4 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 1.0 110.91 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.8 mt -53.98 -43.52 70.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.995 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.497 HH12 ' CD2' ' A' ' 78' ' ' LEU . 59.8 ttm-85 -54.02 -35.46 61.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.617 -0.433 . . . . 1.0 109.895 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -36.23 72.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.078 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.8 p -70.83 -42.11 70.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.527 -0.76 . . . . 1.0 112.295 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.708 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p -69.05 -36.52 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.93 0.344 . . . . 1.0 111.93 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -71.6 -40.99 69.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.805 0.336 . . . . 1.0 111.094 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.25 -52.01 65.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.757 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.5 m -56.06 -34.42 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.721 0.296 . . . . 1.0 111.13 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 47' ' ' GLY . 60.9 ttp180 -54.01 -43.08 69.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 1.0 110.81 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.51 76.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.047 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -78.73 -45.63 20.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.611 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.0 mt -86.04 -31.98 21.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.49 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.9 22.6 48.56 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.459 -1.057 . . . . 1.0 110.459 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -73.34 141.99 47.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 1.0 110.229 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -42.12 -43.43 3.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.6 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -158.29 130.53 6.96 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.048 -0.661 . . . . 1.0 112.61 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.48 130.51 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.579 -0.897 . . . . 1.0 108.579 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 166' ' ' LEU . 12.3 pttm -142.08 156.4 45.39 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.453 -0.499 . . . . 1.0 111.871 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 50.6 t -99.99 134.39 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 42.4 t80 -115.59 105.89 13.3 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.335 -0.546 . . . . 1.0 111.306 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -76.68 126.27 30.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.212 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.438 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 68.3 t80 -92.52 136.91 32.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.991 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.438 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 4.8 m-20 -106.57 140.1 20.99 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.31 -28.86 6.22 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.53 2.153 . . . . 1.0 112.45 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -83.31 -17.76 41.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.882 0.373 . . . . 1.0 110.03 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.96 -13.73 41.11 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.574 -0.611 . . . . 1.0 111.574 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -78.15 91.16 4.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.808 0.337 . . . . 1.0 110.613 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.92 152.56 21.06 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.566 -1.014 . . . . 1.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.7 p -125.29 148.17 48.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 1.0 111.727 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -74.41 107.31 4.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.55 -1.58 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.351 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.708 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.94 115.87 3.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.112 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 85.4 tt0 -145.25 131.17 19.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.079 0.466 . . . . 1.0 111.854 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB1' ' HD3' ' A' ' 43' ' ' ARG . . . -130.81 137.47 49.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.409 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -143.33 148.7 36.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.875 0.369 . . . . 1.0 110.718 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.99 -120.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.852 -0.899 . . . . 1.0 110.852 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -78.78 -179.74 51.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.78 43.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 1.0 110.559 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 71' ' ' GLY . 77.6 ttt180 -82.91 -46.72 12.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.177 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 mt -111.68 146.44 34.7 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 1.0 109.84 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.2 160.31 50.01 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.525 2.15 . . . . 1.0 112.132 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 m -89.78 127.42 35.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.941 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 80' ' ' LEU . 28.6 mt -98.28 11.33 38.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.399 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.497 ' CD2' HH12 ' A' ' 36' ' ' ARG . 19.4 tp -72.47 132.76 44.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.012 -0.54 . . . . 1.0 112.306 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.96 -9.72 71.11 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.604 -0.726 . . . . 1.0 111.529 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 77' ' ' LEU . 76.5 mt -86.67 152.96 22.11 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.936 -0.305 . . . . 1.0 110.344 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.6 m -105.26 132.24 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.675 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -86.28 152.25 55.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.45 133.45 37.34 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.653 2.236 . . . . 1.0 111.873 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.78 131.48 46.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.693 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.62 2.12 40.3 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.548 -1.021 . . . . 1.0 110.548 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 54.3 t0 -57.59 -33.46 68.21 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 87' ' ' ILE . 1.6 mp -82.59 127.09 71.8 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.46 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.737 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 89.6 Cg_endo -73.06 -164.86 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.411 2.074 . . . . 1.0 112.54 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -105.87 -58.68 1.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.535 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.19 -45.0 96.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.795 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.06 -40.21 87.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -63.79 -37.77 88.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.424 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -62.05 -36.48 81.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.781 0.324 . . . . 1.0 110.835 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.552 HD12 ' NH2' ' A' ' 101' ' ' ARG . 77.7 mt -69.82 -33.07 71.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.286 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.492 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 2.3 t80 -63.8 -31.42 72.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.003 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -81.87 -27.12 33.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.865 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.85 -42.67 7.85 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 114.356 1.243 . . . . 1.0 114.356 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.74 -6.78 13.84 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -175.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.492 ' OE1' ' O ' ' A' ' 95' ' ' PHE . 1.1 mm100 42.58 75.31 0.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.226 -0.99 . . . . 1.0 108.864 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 100' ' ' VAL . 4.1 p 175.79 115.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.023 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.552 ' NH2' HD12 ' A' ' 94' ' ' LEU . 33.7 ttm-85 -159.18 153.25 23.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 1.0 110.758 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.1 p -168.99 148.07 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.504 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 56.2 mt -105.34 134.79 45.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 105' ' ' ASP . 11.2 t -88.53 158.92 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.25 0.833 . . . . 1.0 113.25 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.7 p30 -49.23 121.0 4.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.937 -1.029 . . . . 1.0 112.151 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.448 HG23 ' CG1' ' A' ' 140' ' ' VAL . 9.1 p -56.09 -22.07 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.342 -0.845 . . . . 1.0 110.784 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -61.79 -50.31 72.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.421 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . . . -64.26 -10.53 24.28 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.465 0.65 . . . . 1.0 109.347 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 44.51 70.74 0.31 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.785 -1.098 . . . . 1.0 113.267 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.55 131.99 42.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.965 -1.495 . . . . 1.0 106.965 175.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -121.13 134.89 55.25 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.967 -0.693 . . . . 1.0 111.937 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -128.61 156.23 43.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.63 -0.713 . . . . 1.0 110.529 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 112' ' ' SER . 21.2 pt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.103 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 N--CA 1.492 1.411 0 CA-C-O 120.727 0.22 . . . . 1.0 111.92 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.482 HG23 ' CG2' ' A' ' 140' ' ' VAL . 3.0 m -105.55 125.54 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.927 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -43.71 130.37 3.99 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.44 ' HD3' ' H ' ' A' ' 112' ' ' SER . 49.4 Cg_exo -40.23 -46.28 4.18 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.178 2.585 . . . . 1.0 114.051 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.3 p -38.85 -45.24 1.14 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.688 0.255 . . . . 1.0 111.688 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.677 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 17.5 t60 -81.19 -28.68 34.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.482 ' CG2' HG23 ' A' ' 135' ' ' VAL . 85.8 t -64.87 -54.96 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.939 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -65.14 -28.7 69.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -59.78 -44.72 93.78 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.774 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.631 HD11 ' NE2' ' A' ' 139' ' ' HIS . 69.5 mt -72.96 -38.08 66.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -50.64 -39.27 50.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -63.87 -26.87 68.81 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.729 -1.123 . . . . 1.0 109.165 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.564 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.5 mmm -88.75 -1.27 58.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.452 -0.794 . . . . 1.0 110.709 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.98 22.01 77.5 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.9 t -111.62 140.75 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.905 0.383 . . . . 1.0 110.968 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.47 -40.54 4.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.0 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.6 m -133.4 122.53 23.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.12 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.446 ' OG ' ' CG2' ' A' ' 167' ' ' VAL . 3.7 t -116.75 133.63 55.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.436 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 tt -112.19 137.19 50.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.273 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.3 120.05 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.157 0.503 . . . . 1.0 111.774 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.03 103.74 47.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -40.38 125.91 2.0 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.197 2.598 . . . . 1.0 114.69 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.485 HD11 ' HB ' ' A' ' 191' ' ' VAL . 10.9 tp -113.59 47.53 1.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.861 -1.533 . . . . 1.0 106.861 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.2 ptm -148.59 -174.75 4.69 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.069 0.766 . . . . 1.0 113.069 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.664 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 42.0 t-80 -75.13 -179.33 4.32 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.311 -0.859 . . . . 1.0 111.38 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.664 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 82.2 t60 -75.16 -55.64 5.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.396 -0.82 . . . . 1.0 112.057 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -104.62 9.48 35.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -139.76 137.15 34.84 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.701 -0.399 . . . . 1.0 110.906 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.847 ' O ' HD23 ' A' ' 162' ' ' LEU . 5.7 tt -110.62 113.93 26.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.068 -0.515 . . . . 1.0 111.303 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -90.79 -35.45 14.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.28 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -163.02 -172.95 31.15 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.39 129.01 26.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 1.0 111.562 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 52' ' ' LYS . 37.6 tp -103.54 129.1 50.69 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.446 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 11.5 p -139.14 139.71 39.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.069 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 84.2 p -110.86 140.33 45.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.049 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -111.71 132.3 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.979 0.418 . . . . 1.0 111.601 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -130.1 121.2 25.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 1.0 109.882 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -81.64 55.79 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.808 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -156.77 149.63 18.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.012 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.78 -11.55 31.03 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.907 2.405 . . . . 1.0 111.914 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -39.33 104.17 0.31 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.862 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.81 167.44 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.585 2.19 . . . . 1.0 111.902 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 49.5 p90 -80.09 129.66 34.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.462 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.5 t -111.93 143.0 43.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.635 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -58.04 -27.74 63.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.664 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -57.55 -38.48 74.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.666 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.86 -38.07 89.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.542 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 56.5 mt -64.18 -40.82 96.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.517 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -53.63 -38.21 63.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.33 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.23 -54.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 188' ' ' ALA . 29.3 m -77.34 -29.8 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.404 0.52 . . . . 1.0 112.404 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 189' ' ' ASP . 58.8 tp60 -50.98 -49.9 59.32 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.98 -0.288 . . . . 1.0 111.631 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.6 tp -76.84 -41.33 44.59 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.8 tp -76.75 -43.43 37.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.806 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -60.09 -40.42 89.53 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.511 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 93.5 m-20 -56.52 -38.37 71.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.018 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -71.23 -24.91 62.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.155 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.485 ' HB ' HD11 ' A' ' 156' ' ' LEU . 93.8 t -82.85 -49.01 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 1.0 109.731 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.6 m -51.4 -29.92 17.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 57.9 mt -75.92 -33.28 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.236 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -67.07 -45.41 77.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.825 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 19.0 pt -63.93 -35.53 73.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.149 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -68.78 -43.37 75.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.135 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -70.94 -38.04 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.553 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.21 -32.08 73.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.725 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.92 -39.13 93.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.475 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 200' ' ' LEU . 23.8 tp -62.93 -35.67 80.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.723 0.297 . . . . 1.0 111.119 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.2 t -54.8 -53.68 52.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.612 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.48 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.814 0.34 . . . . 1.0 110.531 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -60.13 -52.7 64.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.985 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -54.9 -45.98 74.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.087 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 mm -61.01 -48.24 89.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 1.0 110.966 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.628 HD21 HD11 ' A' ' 195' ' ' ILE . 35.5 mt -56.95 -42.78 80.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 1.0 111.03 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -52.91 -35.33 58.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.068 0.461 . . . . 1.0 109.869 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.91 -34.34 71.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.06 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 42' ' ' VAL . 62.4 p -72.28 -40.23 67.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.524 -0.762 . . . . 1.0 112.263 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.654 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.3 p -73.57 -38.76 52.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 111.899 0.333 . . . . 1.0 111.899 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.403 ' N ' HG13 ' A' ' 39' ' ' VAL . 99.5 mt-10 -71.2 -45.46 63.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.772 0.32 . . . . 1.0 111.104 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.85 -47.93 70.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.784 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 38' ' ' THR . 72.0 t -60.39 -39.06 79.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.982 -0.287 . . . . 1.0 111.12 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.4 tmm_? -57.25 -42.9 82.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 1.0 110.823 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.82 -33.59 68.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -78.42 -40.67 35.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.542 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.71 -31.2 22.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.448 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 61.7 21.78 61.09 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 169' ' ' HIS . 5.2 t -73.22 139.48 46.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.35 . . . . 1.0 110.17 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -44.57 -38.68 4.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.609 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.556 HH22 ' H ' ' A' ' 77' ' ' LEU . 53.7 ttt85 -161.53 126.24 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.058 -0.657 . . . . 1.0 112.625 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.23 128.31 29.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HD3' ' HE ' ' A' ' 50' ' ' ARG . 20.7 pttp -140.18 155.66 46.84 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.86 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 66.4 t -106.42 137.49 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.473 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -136.62 127.91 28.21 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.252 -0.579 . . . . 1.0 111.288 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -88.03 144.35 26.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.745 -0.662 . . . . 1.0 110.208 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.595 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 80.4 t80 -95.52 117.79 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 1.0 112.027 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.9 m-20 -85.27 135.85 38.56 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -45.83 -24.06 1.92 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.456 2.104 . . . . 1.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.21 -18.48 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.052 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.88 -13.36 38.11 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.583 -0.607 . . . . 1.0 111.583 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -75.07 92.25 2.62 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.642 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.54 142.54 18.0 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 p -121.39 142.75 49.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 1.0 111.751 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.65 110.94 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.748 -0.834 . . . . 1.0 108.748 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.613 ' O ' HG12 ' A' ' 65' ' ' VAL . 95.5 t -106.59 -0.89 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.942 -0.303 . . . . 1.0 111.372 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.97 120.79 3.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.149 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 68.6 tt0 -142.12 131.78 24.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.06 0.457 . . . . 1.0 111.818 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.95 143.11 50.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.375 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.528 ' NH1' ' OG ' ' A' ' 76' ' ' SER . 32.8 ptt180 -142.88 142.44 31.77 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.743 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.44 -33.01 85.04 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.48 -170.92 36.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 77.6 mm-40 -78.25 38.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 1.0 110.556 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -82.83 -48.11 11.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.148 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.46 149.26 36.85 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.826 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.95 146.69 59.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.532 2.155 . . . . 1.0 112.183 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.528 ' OG ' ' NH1' ' A' ' 69' ' ' ARG . 67.2 m -77.28 121.23 23.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.962 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.556 ' H ' HH22 ' A' ' 50' ' ' ARG . 27.5 mt -100.59 12.12 38.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.416 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.2 tp -73.49 132.68 43.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.307 0.575 . . . . 1.0 112.288 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.86 -10.04 63.89 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.505 -0.771 . . . . 1.0 111.546 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 77' ' ' LEU . 64.0 mt -86.43 155.55 20.52 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.001 -0.28 . . . . 1.0 110.329 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.2 p -103.65 126.37 50.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.67 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -77.86 151.8 79.65 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.55 117.7 4.66 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.648 2.232 . . . . 1.0 111.818 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.01 125.09 11.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.677 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.7 0.13 42.59 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.574 -1.011 . . . . 1.0 110.574 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 2.6 p30 -56.76 -32.64 65.8 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.477 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 3.2 tp -84.25 131.05 51.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.384 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.71 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 71.7 Cg_endo -70.19 -169.48 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.427 2.085 . . . . 1.0 112.487 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -107.1 -44.71 4.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.559 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 42.0 mp0 -69.36 -41.15 76.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.796 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.71 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.35 -44.05 79.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.906 0.336 . . . . 1.0 111.906 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.595 ' NH2' ' CG ' ' A' ' 56' ' ' PHE . 51.6 ttt85 -65.23 -44.09 89.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.472 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -61.05 -34.14 74.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.34 . . . . 1.0 110.879 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.514 ' C ' HH22 ' A' ' 101' ' ' ARG . 47.4 mt -71.18 -38.75 72.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.298 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.609 ' N ' ' NH2' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -58.19 -28.51 64.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.061 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -74.91 -29.87 61.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.87 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.437 ' C ' ' OE1' ' A' ' 99' ' ' GLN . 75.5 mt -97.17 -39.4 9.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.547 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -118.34 -7.19 10.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.051 1.5 . . . . 1.0 115.051 -176.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.547 ' C ' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 38.51 77.4 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.161 -1.015 . . . . 1.0 108.847 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 100' ' ' VAL . 12.9 p 179.32 114.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.108 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.609 ' NH2' ' N ' ' A' ' 95' ' ' PHE . 4.0 tpp180 -156.79 150.84 24.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.954 0.407 . . . . 1.0 110.75 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.32 145.72 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.456 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.7 mt -108.6 131.84 58.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.141 -0.689 . . . . 1.0 109.141 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.1 m -91.66 164.9 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 113.23 0.826 . . . . 1.0 113.23 -176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -48.07 117.24 1.82 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.89 -1.05 . . . . 1.0 112.139 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.44 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.1 p -53.51 -19.34 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.347 -0.842 . . . . 1.0 110.799 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -66.37 -44.69 82.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.97 -4.77 10.43 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.596 0.712 . . . . 1.0 109.414 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 36.6 69.45 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.713 -1.131 . . . . 1.0 113.295 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.3 p -75.22 131.06 40.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.997 -1.482 . . . . 1.0 106.997 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -121.91 142.14 50.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.888 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 t -130.3 122.57 28.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.55 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.191 -178.724 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo . . . . . 0 N--CA 1.492 1.417 0 CA-C-O 120.747 0.228 . . . . 1.0 111.997 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 t -105.84 122.82 59.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.85 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -42.43 152.74 0.33 Allowed Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.746 -0.464 . . . . 1.0 109.746 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -58.89 -34.72 99.21 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.223 2.615 . . . . 1.0 114.068 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.705 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -48.16 -46.31 34.48 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.684 0.253 . . . . 1.0 111.684 -178.494 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.705 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 19.1 t-80 -82.91 -27.75 30.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.272 0.471 . . . . 1.0 112.272 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.44 ' CG1' HG23 ' A' ' 106' ' ' VAL . 86.4 t -65.2 -52.26 55.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.965 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -66.47 -27.87 68.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -60.02 -41.98 93.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.732 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 146' ' ' MET . 8.9 mt -73.03 -37.83 66.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -51.95 -38.24 55.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.9 p -66.85 -20.66 65.97 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.761 -1.109 . . . . 1.0 109.188 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.568 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -95.43 -0.02 52.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.406 -0.816 . . . . 1.0 110.711 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.61 20.68 78.65 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.69 143.96 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 1.0 110.968 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.66 -42.29 4.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.982 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 t -135.35 122.85 22.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.135 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.6 m -110.99 141.91 43.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.503 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.511 HD13 ' CE1' ' A' ' 176' ' ' TYR . 2.4 tp -118.27 136.35 53.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.292 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.7 t -123.14 114.85 43.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.12 0.486 . . . . 1.0 111.772 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.5 t -113.26 131.2 23.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 107.806 -1.183 . . . . 1.0 107.806 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.75 125.45 8.17 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.152 2.568 . . . . 1.0 114.676 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.2 mt -118.52 48.95 1.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -146.14 176.55 9.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.502 ' ND1' ' N ' ' A' ' 159' ' ' HIS . 49.9 t-80 -67.72 171.68 6.16 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.379 -0.828 . . . . 1.0 111.391 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.502 ' N ' ' ND1' ' A' ' 158' ' ' HIS . 73.5 m80 -61.98 -52.82 62.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.039 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -103.79 -39.32 6.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.541 ' OE1' ' CD2' ' A' ' 163' ' ' TRP . 11.0 tm-20 -87.54 133.55 33.76 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.909 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.567 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -107.2 117.52 34.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 1.0 111.301 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.541 ' CD2' ' OE1' ' A' ' 161' ' ' GLU . 54.2 m95 -92.0 -41.04 10.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.231 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.515 ' C ' HD12 ' A' ' 165' ' ' LEU . . . -163.34 -176.86 35.76 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.204 -0.759 . . . . 1.0 111.204 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 164' ' ' GLY . 5.3 mp -143.87 140.19 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 1.0 111.569 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.5 tp -98.97 135.67 40.06 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.8 p -138.59 129.11 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.371 . . . . 1.0 111.051 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.5 t -107.6 150.7 26.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.996 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.442 ' O ' ' OG1' ' A' ' 48' ' ' THR . 91.7 m-70 -127.81 134.84 49.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.961 0.41 . . . . 1.0 111.626 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -132.62 113.93 13.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.015 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.78 -14.24 62.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.857 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -108.04 150.0 39.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.01 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.2 140.59 34.35 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.902 2.401 . . . . 1.0 111.896 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -172.31 129.66 0.62 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.898 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.58 157.81 28.55 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.517 2.144 . . . . 1.0 111.932 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.511 ' CE1' HD13 ' A' ' 152' ' ' LEU . 75.7 m-85 -102.2 139.0 38.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.444 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.496 ' N ' ' OE1' ' A' ' 180' ' ' GLU . 8.7 t -126.94 -177.35 4.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.591 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' A' ' 182' ' ' GLN . 95.0 mt-30 -59.98 -34.1 72.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.657 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -56.17 -36.93 68.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.764 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 177' ' ' SER . 40.5 mp0 -65.15 -24.21 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.497 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.6 tp -80.88 -30.53 35.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.497 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.497 ' NE2' ' N ' ' A' ' 182' ' ' GLN . 0.3 OUTLIER -63.28 -43.36 98.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.32 -178.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.67 HG23 ' N ' ' A' ' 184' ' ' VAL . 22.9 m -73.7 -51.56 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.67 ' N ' HG23 ' A' ' 183' ' ' VAL . 16.9 m -68.57 -46.26 80.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.445 0.535 . . . . 1.0 112.445 -177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.6 ' N ' HG23 ' A' ' 184' ' ' VAL . 52.7 tp60 -53.09 -36.62 60.89 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.664 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.553 ' O ' HD23 ' A' ' 186' ' ' LEU . 1.1 tt -74.55 -53.48 9.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.875 ' O ' HG23 ' A' ' 191' ' ' VAL . 71.0 mt -78.91 -39.27 35.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.883 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 184' ' ' VAL . . . -62.18 -45.52 93.04 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.487 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.415 ' OD2' ' NE2' ' A' ' 185' ' ' GLN . 93.0 m-20 -60.01 -40.19 88.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.069 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -69.21 -23.85 63.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.117 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 187' ' ' LEU . 57.9 t -83.79 -45.58 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.041 -0.527 . . . . 1.0 109.775 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.5 p -57.58 -34.59 69.38 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.677 -0.861 . . . . 1.0 108.677 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.8 mt -69.15 -34.3 62.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.394 -0.821 . . . . 1.0 109.156 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.6 -38.03 77.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.783 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.628 HD11 HD21 ' A' ' 35' ' ' LEU . 4.7 mm -64.24 -40.24 88.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.087 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.36 -49.06 53.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.132 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 8.1 pt20 -69.99 -35.98 74.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.492 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.441 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.49 -33.5 74.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.673 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.75 -33.25 72.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.449 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.79 -30.54 71.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.002 -0.279 . . . . 1.0 111.067 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -51.67 -51.99 51.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.551 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 23.7 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.56 179.495 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.847 0.356 . . . . 1.0 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -79.13 -29.73 43.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.942 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -77.41 -47.72 19.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.11 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.507 HG23 ' N ' ' A' ' 35' ' ' LEU . 2.9 tp -61.61 -41.15 89.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.74 0.305 . . . . 1.0 110.859 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.6 ' O ' ' OG1' ' A' ' 38' ' ' THR . 20.2 mt -57.0 -44.43 82.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.089 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -55.35 -33.95 63.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.1 -33.22 69.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.154 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.6 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 82.8 p -72.15 -40.94 67.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.416 -0.811 . . . . 1.0 112.264 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.684 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 8.5 p -71.33 -37.23 64.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.04 -48.17 66.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 1.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.82 -52.69 59.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.687 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 38' ' ' THR . 77.6 t -53.49 -40.72 42.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.953 -0.299 . . . . 1.0 111.153 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.2 tmm_? -53.28 -39.3 63.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.737 0.303 . . . . 1.0 110.816 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.05 74.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.028 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -77.18 -42.22 38.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.578 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.14 -28.32 24.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.459 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.43 20.65 17.44 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.515 HG23 ' CD2' ' A' ' 170' ' ' HIS . 87.5 m -71.73 142.52 49.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 1.0 110.253 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -41.91 -45.53 3.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.596 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.529 HH21 ' CD ' ' A' ' 67' ' ' GLU . 64.0 ttt-85 -159.87 128.14 4.88 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.022 -0.671 . . . . 1.0 112.572 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.48 131.32 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -140.2 156.47 46.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.478 -0.489 . . . . 1.0 111.918 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 63.9 t -110.8 135.69 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -134.39 125.78 28.23 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.358 -0.537 . . . . 1.0 111.339 -178.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -84.17 143.47 29.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.235 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.609 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 72.7 t80 -95.51 119.23 33.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.065 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.43 149.48 52.06 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -60.93 -23.43 77.16 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.51 2.14 . . . . 1.0 112.456 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.5 -11.87 53.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.924 0.392 . . . . 1.0 110.116 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.69 -15.15 53.07 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.547 -0.621 . . . . 1.0 111.547 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.429 ' NE2' ' HB2' ' A' ' 84' ' ' ALA . 45.5 m80 -73.13 94.98 2.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.759 0.314 . . . . 1.0 110.6 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.6 139.59 16.04 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.1 p -120.64 142.14 49.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.862 0.363 . . . . 1.0 111.756 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 t -79.22 110.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.18 0.71 10.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.886 -0.325 . . . . 1.0 111.306 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.684 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.99 117.97 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.035 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.529 ' CD ' HH21 ' A' ' 50' ' ' ARG . 85.8 tt0 -143.58 132.4 22.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.122 0.487 . . . . 1.0 111.784 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.49 143.14 50.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.393 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -141.59 145.78 35.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.784 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -52.39 -34.09 40.93 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 177.31 -161.61 29.19 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.06 16.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 1.0 110.54 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 71' ' ' GLY . 30.3 ttm180 -65.31 -49.07 70.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.195 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.8 mt -111.82 146.77 35.42 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.887 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.33 159.32 54.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.486 2.124 . . . . 1.0 112.19 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.3 m -95.02 127.95 41.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.915 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 80' ' ' LEU . 28.7 mt -94.95 11.29 32.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.371 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.5 tp -68.0 132.21 46.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 1.0 112.241 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.08 -11.65 66.61 Favored Glycine 0 CA--C 1.523 0.594 0 CA-C-N 115.615 -0.721 . . . . 1.0 111.54 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 77' ' ' LEU . 80.4 mt -83.99 151.62 24.91 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.944 -0.303 . . . . 1.0 110.306 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.7 p -105.25 132.69 51.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.679 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -86.97 130.53 47.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -40.39 138.49 1.31 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.686 2.257 . . . . 1.0 111.864 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.429 ' HB2' ' NE2' ' A' ' 61' ' ' HIS . . . -65.86 125.63 25.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.676 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.32 -1.51 43.4 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -60.54 -33.38 72.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 87' ' ' ILE . 1.5 mp -69.31 130.28 91.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.417 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.59 168.9 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.35 2.033 . . . . 1.0 112.499 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -100.45 -56.04 2.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.572 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -64.59 -41.67 96.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.813 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.84 -44.01 82.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.609 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 42.2 ttt85 -62.42 -41.3 98.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.436 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -62.87 -34.88 78.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.768 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.495 ' C ' HH22 ' A' ' 101' ' ' ARG . 71.2 mt -70.84 -38.21 73.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.225 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.608 ' N ' ' NH2' ' A' ' 101' ' ' ARG . 1.7 t80 -62.03 -20.71 64.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -82.96 -28.38 29.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.824 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.24 -42.65 7.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.07 -8.06 13.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 115.07 1.508 . . . . 1.0 115.07 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 99' ' ' GLN . 0.9 OUTLIER 42.43 81.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.186 -1.005 . . . . 1.0 108.817 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 100' ' ' VAL . 2.8 p 174.41 114.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.985 -0.552 . . . . 1.0 111.101 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.608 ' NH2' ' N ' ' A' ' 95' ' ' PHE . 3.8 tpp180 -155.23 147.02 23.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 1.0 110.714 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 p -170.76 146.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.514 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.591 HD11 ' CD2' ' A' ' 139' ' ' HIS . 67.2 mt -108.65 136.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -93.02 165.79 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.262 0.838 . . . . 1.0 113.262 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -48.07 117.22 1.82 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.899 -1.046 . . . . 1.0 112.109 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.429 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.4 p -58.38 -25.79 28.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.401 -0.818 . . . . 1.0 110.773 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 109' ' ' GLN . 84.5 tt0 -63.78 -44.98 91.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.47 -8.07 1.68 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.457 0.646 . . . . 1.0 109.338 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.544 ' CD ' HH21 ' A' ' 111' ' ' ARG . 6.5 tt0 45.04 60.91 2.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.744 -1.116 . . . . 1.0 113.266 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 t -75.15 133.46 41.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.954 -1.499 . . . . 1.0 106.954 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.544 HH21 ' CD ' ' A' ' 109' ' ' GLN . 80.0 mtt180 -119.57 139.52 52.01 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.038 -0.665 . . . . 1.0 111.9 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.29 163.51 32.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.564 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.9 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.153 179.355 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.492 1.414 0 CA-C-O 120.741 0.225 . . . . 1.0 111.977 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 26.4 t -125.89 140.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.808 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -43.68 138.88 2.92 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -58.48 -32.45 96.44 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.153 2.569 . . . . 1.0 114.005 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.6 p -49.79 -45.18 49.56 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.693 0.257 . . . . 1.0 111.693 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.668 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 6.5 t60 -81.39 -28.6 34.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.229 0.455 . . . . 1.0 112.229 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.429 ' CG1' HG23 ' A' ' 106' ' ' VAL . 60.2 t -68.77 -52.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.668 -0.413 . . . . 1.0 111.017 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -67.07 -24.84 66.01 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -64.56 -39.52 93.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.673 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 146' ' ' MET . 10.4 mt -73.35 -36.01 66.09 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -52.72 -38.22 60.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.625 -1.25 . . . . 1.0 107.625 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.3 p -66.69 -19.47 65.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.728 -1.124 . . . . 1.0 109.199 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.504 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.9 mmm -96.49 3.25 52.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.477 -0.783 . . . . 1.0 110.715 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.7 21.28 77.85 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 150' ' ' SER . 55.2 t -110.54 144.13 19.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.381 . . . . 1.0 110.971 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.95 -17.92 13.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.961 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.409 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 5.6 t -149.83 163.36 38.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.227 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.471 ' OG ' HD12 ' A' ' 103' ' ' ILE . 9.3 p -148.08 125.06 11.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.482 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -109.03 133.01 53.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.318 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.57 116.25 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.11 0.481 . . . . 1.0 111.77 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.11 129.27 25.21 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 107.81 -1.181 . . . . 1.0 107.81 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.479 ' C ' HD12 ' A' ' 156' ' ' LEU . 95.1 Cg_endo -74.21 123.48 8.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.091 2.527 . . . . 1.0 114.685 -175.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.571 HD23 HG11 ' A' ' 191' ' ' VAL . 10.8 mp -116.4 49.3 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.866 -1.531 . . . . 1.0 106.866 177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.498 ' CE ' ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -147.2 179.29 7.74 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.112 0.782 . . . . 1.0 113.112 -176.393 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -67.6 164.58 18.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.286 -0.87 . . . . 1.0 111.434 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -57.89 -50.55 72.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.463 -0.789 . . . . 1.0 112.064 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -103.93 -39.64 6.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -88.28 137.92 31.9 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.863 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.4 OUTLIER -108.93 112.94 25.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.269 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -88.9 -42.56 11.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.195 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.71 -175.71 25.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.428 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 5.1 tp -145.44 134.15 22.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.352 . . . . 1.0 111.517 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.5 tp -101.63 131.33 47.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 167' ' ' VAL . 12.0 p -137.61 131.33 43.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.811 -0.356 . . . . 1.0 111.12 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.9 m -108.59 139.77 42.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.071 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.462 ' O ' ' CG2' ' A' ' 48' ' ' THR . 62.0 m80 -110.43 125.37 53.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.006 0.432 . . . . 1.0 111.636 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.515 ' CD2' HG23 ' A' ' 48' ' ' THR . 57.1 m80 -123.78 114.62 20.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.875 -0.602 . . . . 1.0 109.952 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.36 -14.8 63.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.837 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.89 148.33 34.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.051 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' A' ' 174' ' ' ARG . 80.9 Cg_endo -74.83 -98.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.891 2.394 . . . . 1.0 111.917 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.507 ' O ' ' O ' ' A' ' 173' ' ' PRO . 16.2 mtp-105 56.38 144.94 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.838 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.87 152.0 40.93 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.603 2.202 . . . . 1.0 111.921 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -90.69 146.98 23.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.473 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.434 ' OG ' ' OE1' ' A' ' 180' ' ' GLU . 95.2 p -121.97 156.66 32.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.652 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -60.31 -26.16 66.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.558 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -54.58 -39.55 67.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.765 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.434 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 1.5 mp0 -63.96 -39.39 94.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.525 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.27 -38.84 91.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.429 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -56.21 -37.61 69.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.361 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 73.3 t -67.69 -56.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.667 0.617 . . . . 1.0 112.667 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 188' ' ' ALA . 1.8 t -73.47 -42.7 56.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -43.38 -47.7 6.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.605 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 19.7 tp -70.95 -41.06 71.6 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.919 0.34 . . . . 1.0 111.919 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.636 ' O ' HG23 ' A' ' 191' ' ' VAL . 8.4 tp -77.91 -38.4 45.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.821 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -62.24 -37.97 87.42 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.53 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -61.37 -40.11 93.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.031 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.86 -25.36 63.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.12 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 187' ' ' LEU . 59.2 t -83.25 -45.25 18.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.767 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.6 t -56.67 -37.02 70.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.3 mt -66.83 -33.65 64.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.448 -0.796 . . . . 1.0 109.171 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.9 -38.94 73.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.784 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.4 mm -65.21 -41.56 91.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.154 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.63 -47.96 61.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.115 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.6 pt20 -70.33 -34.52 72.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.532 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -67.52 -32.78 73.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.667 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.14 -34.59 75.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.588 -0.278 . . . . 1.0 111.424 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 41.3 mt -61.09 -33.24 73.04 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.091 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 17.5 m -54.04 -53.19 56.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.796 0.331 . . . . 1.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.624 179.658 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.9 mp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.815 0.341 . . . . 1.0 110.56 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -49.5 -35.25 19.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.993 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -75.4 -46.92 29.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.138 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 38' ' ' THR . 18.1 mm -64.99 -38.79 83.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.544 -0.298 . . . . 1.0 110.962 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.583 ' O ' ' OG1' ' A' ' 38' ' ' THR . 18.9 mt -57.88 -35.83 71.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.005 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -66.37 -33.47 75.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.084 0.468 . . . . 1.0 109.833 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.19 -30.94 67.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.107 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -73.0 -45.33 58.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.505 -0.77 . . . . 1.0 112.241 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.7 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.1 p -65.41 -35.23 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 111.929 0.344 . . . . 1.0 111.929 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.85 -40.1 65.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 1.0 111.071 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.12 -51.63 67.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.749 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.21 -30.6 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.203 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.647 HH22 ' CA ' ' A' ' 70' ' ' GLY . 8.1 tpt180 -55.38 -43.9 75.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.76 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.74 77.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.041 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -80.31 -45.48 17.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.526 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.92 -34.74 20.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.427 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.87 20.04 17.37 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.471 -1.052 . . . . 1.0 110.471 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.541 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 10.1 t -69.15 141.06 54.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.796 0.331 . . . . 1.0 110.23 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD2' ' CB ' ' A' ' 171' ' ' ALA . 84.5 m-20 -38.03 -39.82 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.659 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.436 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 24.3 ttm180 -167.75 131.95 1.77 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.007 -0.677 . . . . 1.0 112.588 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 p -138.81 130.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -139.88 157.55 45.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.131 0.491 . . . . 1.0 111.948 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.5 t -99.88 135.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -118.25 108.46 15.15 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.257 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -83.17 125.08 31.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.236 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.523 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 84.1 t80 -90.68 141.19 29.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 1.0 112.039 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.523 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 7.1 m-20 -112.13 151.05 43.35 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.11 -23.5 69.32 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.512 2.141 . . . . 1.0 112.49 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -87.46 -11.72 48.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.17 -11.63 60.29 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.552 -0.619 . . . . 1.0 111.552 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -80.14 90.74 5.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 1.0 110.627 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.52 151.05 21.12 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.576 -1.009 . . . . 1.0 110.576 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 p -125.44 148.47 48.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 1.0 111.711 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.71 109.26 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.78 0.69 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.366 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.7 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.6 115.72 2.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.066 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 85.5 tt0 -144.98 134.41 23.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.047 0.451 . . . . 1.0 111.834 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.87 132.37 45.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.433 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' C ' HH12 ' A' ' 43' ' ' ARG . 35.6 ptt-85 -134.97 150.94 50.44 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.733 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.647 ' CA ' HH22 ' A' ' 43' ' ' ARG . . . -56.76 -119.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.18 -76.94 1.03 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -169.22 46.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.747 0.308 . . . . 1.0 110.546 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -83.43 -45.99 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.1 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 28.6 mt -108.17 145.46 31.51 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.474 . . . . 1.0 109.874 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.3 139.57 42.16 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.485 2.123 . . . . 1.0 112.17 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.8 m -66.9 124.31 22.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.957 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 80' ' ' LEU . 26.9 mt -100.08 13.11 35.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.334 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.464 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 26.9 tp -71.65 128.36 35.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.284 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.42 -9.86 75.45 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.492 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 77' ' ' LEU . 73.7 mt -84.88 151.6 24.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.757 0.313 . . . . 1.0 110.292 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.9 m -104.07 131.0 51.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.688 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -82.82 152.44 66.08 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.568 -0.53 . . . . 1.0 109.568 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.62 133.5 39.86 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.594 2.196 . . . . 1.0 111.877 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.27 127.88 33.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.681 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.09 2.76 45.26 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.539 -1.024 . . . . 1.0 110.539 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -58.44 -33.66 69.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.77 129.33 52.97 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.429 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.671 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 86.2 Cg_endo -73.89 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.459 2.106 . . . . 1.0 112.484 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -109.95 -59.02 1.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.531 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -58.42 -44.65 89.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.833 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.671 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -66.79 -48.03 70.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -54.72 -35.07 63.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.464 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -64.4 -34.15 77.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.0 mt -63.44 -37.58 87.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.281 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.508 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 56.2 m-85 -63.99 -27.18 68.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.04 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -82.68 -29.36 29.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.77 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.1 mt -98.64 -42.41 7.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 114.416 1.265 . . . . 1.0 114.416 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.539 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.69 -7.87 13.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.019 1.489 . . . . 1.0 115.019 -174.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.539 ' C ' ' O ' ' A' ' 98' ' ' ALA . 1.0 OUTLIER 39.55 74.18 0.1 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.201 -1.0 . . . . 1.0 108.821 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 100' ' ' VAL . 6.8 p 174.27 121.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.059 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.571 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -171.04 147.65 2.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 1.0 110.811 177.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.571 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 21.9 m -157.25 157.63 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.515 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.6 mt -106.06 135.59 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 105' ' ' ASP . 10.7 t -87.12 158.2 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.248 0.833 . . . . 1.0 113.248 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.46 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.0 p-10 -50.67 121.95 6.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.865 -1.061 . . . . 1.0 112.095 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.2 -23.06 12.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.792 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 109' ' ' GLN . 82.1 tt0 -63.15 -49.24 75.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . . . -66.4 -4.56 8.41 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.554 0.692 . . . . 1.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 36.34 72.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.787 -1.097 . . . . 1.0 113.282 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.4 p -72.83 129.75 38.88 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.968 -1.493 . . . . 1.0 106.968 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -118.4 133.18 56.09 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.918 -0.713 . . . . 1.0 111.835 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -125.91 153.47 44.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.556 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 112' ' ' SER . 23.1 pt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.172 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 CA-C-O 120.711 0.213 . . . . 1.0 111.948 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.01 122.74 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.87 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -43.32 151.76 0.43 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.56 -43.46 50.69 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.217 2.612 . . . . 1.0 114.005 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.666 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.3 p -38.97 -44.75 1.11 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.679 0.252 . . . . 1.0 111.679 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.666 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.3 t60 -82.76 -31.78 28.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.249 0.463 . . . . 1.0 112.249 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.64 -52.8 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.639 -0.425 . . . . 1.0 110.982 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -65.79 -29.39 69.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -63.53 -44.86 93.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.707 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 146' ' ' MET . 12.6 mt -73.33 -36.67 66.24 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -48.23 -39.07 20.08 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.507 -1.294 . . . . 1.0 107.507 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.3 m -58.26 -32.64 68.56 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.786 -1.097 . . . . 1.0 109.214 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.574 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.2 mmm -79.1 0.72 26.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.743 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.49 26.07 74.7 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.39 142.28 30.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.976 0.417 . . . . 1.0 110.932 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.54 -26.43 12.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.969 -0.559 . . . . 1.0 111.027 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 p -141.5 127.11 18.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.413 . . . . 1.0 111.137 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.15 131.43 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.47 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 152' ' ' LEU . 8.3 mp -110.49 139.9 45.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.285 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.412 ' CG1' HD11 ' A' ' 165' ' ' LEU . 2.4 t -123.97 116.24 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.113 0.482 . . . . 1.0 111.74 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.561 HG21 HG21 ' A' ' 184' ' ' VAL . 41.1 t -117.94 121.29 31.72 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 107.791 -1.189 . . . . 1.0 107.791 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.452 ' C ' HD12 ' A' ' 156' ' ' LEU . 86.4 Cg_endo -75.54 123.86 7.87 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.247 2.631 . . . . 1.0 114.7 -176.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.452 HD12 ' C ' ' A' ' 155' ' ' PRO . 10.8 mp -111.85 56.15 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.807 -1.553 . . . . 1.0 106.807 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -147.84 178.51 8.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -65.76 161.54 20.6 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.299 -0.864 . . . . 1.0 111.427 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -55.04 -49.26 72.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.083 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -105.0 -39.76 6.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.404 ' OE1' ' CH2' ' A' ' 163' ' ' TRP . 96.1 mt-10 -88.05 138.04 31.8 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.689 -0.405 . . . . 1.0 110.876 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.462 HD12 ' H ' ' A' ' 162' ' ' LEU . 1.8 mp -109.09 112.51 24.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.288 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.404 ' CH2' ' OE1' ' A' ' 161' ' ' GLU . 46.9 m95 -88.04 -36.93 16.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.214 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.0 -171.85 28.64 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.412 HD11 ' CG1' ' A' ' 153' ' ' VAL . 42.1 tp -144.66 131.84 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 1.0 111.585 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.46 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.4 tp -105.16 134.18 48.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.03 133.83 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.631 -0.428 . . . . 1.0 111.039 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.403 ' OG ' HG21 ' A' ' 48' ' ' THR . 28.5 t -107.8 136.99 46.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.02 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.463 ' O ' ' OG1' ' A' ' 48' ' ' THR . 27.7 m80 -111.71 131.37 55.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.999 0.428 . . . . 1.0 111.668 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -126.68 130.87 51.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.998 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.418 ' CB ' ' OD2' ' A' ' 49' ' ' ASP . . . -88.64 56.44 3.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.812 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -148.11 136.64 11.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.981 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.3 4.69 5.67 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.866 2.377 . . . . 1.0 111.924 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -64.87 148.39 97.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.895 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.78 165.28 31.82 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.603 2.202 . . . . 1.0 111.897 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 38.4 p90 -86.4 138.46 31.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.425 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 88.3 p -116.8 155.48 28.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.63 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -58.53 -31.78 68.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.676 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -55.81 -40.42 72.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.758 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.47 -38.5 90.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.54 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.5 tp -65.7 -37.71 87.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.547 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -55.34 -37.12 67.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.402 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.2 t -68.84 -52.91 30.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.561 HG21 HG21 ' A' ' 154' ' ' VAL . 20.8 m -75.14 -36.87 38.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.411 0.523 . . . . 1.0 112.411 -177.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.422 ' N ' HG23 ' A' ' 184' ' ' VAL . 53.0 tp60 -50.88 -48.19 60.36 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.7 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.8 -44.33 41.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.963 0.357 . . . . 1.0 111.963 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 191' ' ' VAL . 43.1 tp -77.43 -42.44 36.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.906 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -58.24 -39.3 78.74 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.544 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.401 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 86.8 m-20 -59.46 -38.86 81.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.999 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -65.8 -25.74 67.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.115 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 187' ' ' LEU . 17.0 t -85.09 -42.29 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.719 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.4 t -58.05 -38.93 77.22 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.1 mt -65.98 -34.77 72.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.209 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -70.89 -39.3 72.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.781 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.441 HD11 HD21 ' A' ' 35' ' ' LEU . 4.6 mm -60.91 -47.53 93.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.199 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.23 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.132 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -70.86 -41.98 70.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.466 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -64.19 -34.49 78.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.73 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -54.83 -25.86 31.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.509 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.35 -34.54 75.46 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.043 -0.263 . . . . 1.0 111.057 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.9 t -45.1 -55.68 5.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.596 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.635 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.838 0.351 . . . . 1.0 110.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.97 -29.55 66.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.99 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -78.64 -46.51 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.161 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 mm -62.56 -46.2 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.758 0.313 . . . . 1.0 110.908 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.1 mt -58.29 -48.07 81.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.069 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -52.98 -38.72 62.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.23 -29.31 64.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.087 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.4 m -73.44 -47.02 44.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.547 -0.751 . . . . 1.0 112.263 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.1 p -65.73 -36.36 77.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 111.941 0.348 . . . . 1.0 111.941 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.75 -44.38 86.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.823 0.344 . . . . 1.0 111.077 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -42.0 98.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.705 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.9 t -59.64 -40.68 82.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.964 -0.294 . . . . 1.0 111.15 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 47' ' ' GLY . 52.1 ttp180 -50.67 -42.59 56.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.8 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.2 78.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.063 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -77.27 -47.01 21.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.549 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.71 -29.88 22.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.502 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.2 22.13 35.29 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.478 -1.049 . . . . 1.0 110.478 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.504 ' OG1' ' CG2' ' A' ' 51' ' ' VAL . 17.7 p -74.74 145.31 43.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.836 0.351 . . . . 1.0 110.193 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -40.77 -43.3 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.654 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.407 HH22 ' HG ' ' A' ' 77' ' ' LEU . 44.7 ttt180 -158.55 134.94 9.34 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.031 -0.668 . . . . 1.0 112.578 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.504 ' CG2' ' OG1' ' A' ' 48' ' ' THR . 10.0 t -135.69 129.04 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -140.11 153.94 46.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.449 -0.501 . . . . 1.0 111.872 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 64.8 t -100.71 136.74 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 30.3 t80 -119.06 107.45 13.51 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.382 -0.527 . . . . 1.0 111.258 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -79.48 127.15 31.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.217 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.493 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 87.5 t80 -90.97 141.31 28.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.971 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.493 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -112.22 150.81 43.07 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 178.009 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -59.91 -23.63 73.3 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.541 2.161 . . . . 1.0 112.494 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -87.88 -12.48 44.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 1.0 110.072 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.21 58.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.605 -0.598 . . . . 1.0 111.605 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -78.31 90.22 4.36 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.931 -0.307 . . . . 1.0 110.631 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.04 151.43 20.76 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -125.48 148.21 48.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.392 . . . . 1.0 111.719 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 78' ' ' LEU . 61.5 t -77.01 108.34 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.624 ' O ' HG12 ' A' ' 65' ' ' VAL . 96.7 t -106.02 0.03 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.341 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.79 122.79 3.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.052 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -147.78 133.78 19.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.136 0.493 . . . . 1.0 111.809 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.72 141.51 51.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.681 -0.69 . . . . 1.0 109.341 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.528 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 84.6 mtm-85 -138.7 142.81 38.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.74 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -47.43 -28.01 4.49 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.2 -88.91 0.07 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -152.17 52.09 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 1.0 110.509 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -86.22 -45.65 11.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.174 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.3 mt -109.15 146.35 33.7 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.902 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.87 145.84 63.68 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.551 2.168 . . . . 1.0 112.203 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 p -62.18 124.52 21.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 80' ' ' LEU . 29.4 mt -98.57 3.48 48.04 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.366 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 64' ' ' VAL . 6.2 tp -66.25 131.45 46.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.213 0.53 . . . . 1.0 112.26 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.17 -15.39 53.95 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.584 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 77' ' ' LEU . 59.0 mt -82.05 153.84 25.94 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.987 -0.285 . . . . 1.0 110.35 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.0 p -107.04 131.29 54.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.686 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -85.63 154.32 58.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.11 129.6 26.25 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.638 2.225 . . . . 1.0 111.935 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.26 130.05 41.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.739 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.0 -1.11 44.46 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.614 -0.995 . . . . 1.0 110.614 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -53.19 -38.33 62.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mt -78.59 131.55 67.71 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.447 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.722 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 91.1 Cg_endo -72.81 -165.57 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.438 2.092 . . . . 1.0 112.477 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -107.54 -60.99 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.506 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -57.46 -43.11 83.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.804 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.722 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.42 -40.58 85.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -69.04 -41.65 77.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.488 -0.323 . . . . 1.0 111.442 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -60.98 -31.82 71.4 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.8 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.477 ' CD1' HH12 ' A' ' 101' ' ' ARG . 78.1 mt -71.58 -38.02 70.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.227 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.73 -42.08 83.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 1.0 110.018 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 159' ' ' HIS . 77.1 ttt-85 -58.3 -33.09 69.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.798 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' C ' ' OE1' ' A' ' 99' ' ' GLN . 56.6 mt -98.14 -35.85 10.26 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -118.52 -10.19 10.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.115 1.524 . . . . 1.0 115.115 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.5 ' N ' ' OE1' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 40.39 82.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.177 -1.009 . . . . 1.0 108.812 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 100' ' ' VAL . 2.8 p 175.98 116.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.056 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.599 ' O ' HG13 ' A' ' 102' ' ' VAL . 8.0 tpt180 -160.37 143.31 13.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 1.0 110.766 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 101' ' ' ARG . 17.4 m -159.78 150.38 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.532 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.421 ' O ' ' OH ' ' A' ' 176' ' ' TYR . 42.9 mt -108.32 136.46 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.098 -0.704 . . . . 1.0 109.098 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 105' ' ' ASP . 30.9 t -88.24 158.3 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.215 0.82 . . . . 1.0 113.215 -175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 104' ' ' VAL . 33.0 m-20 -48.05 123.95 6.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.904 -1.044 . . . . 1.0 112.193 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.511 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.1 p -56.63 -24.72 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.746 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.419 ' C ' ' H ' ' A' ' 109' ' ' GLN . 83.9 tt0 -65.27 -47.76 75.59 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.8 -3.49 6.92 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.532 0.682 . . . . 1.0 109.388 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 36.03 71.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.794 -1.093 . . . . 1.0 113.296 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.7 t -72.44 130.68 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.984 -1.488 . . . . 1.0 106.984 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -118.53 138.57 52.44 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.937 -0.705 . . . . 1.0 111.885 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.423 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.2 OUTLIER -146.62 166.41 26.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.694 -0.684 . . . . 1.0 110.502 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.103 179.074 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 120.692 0.205 . . . . 1.0 111.92 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 135' ' ' VAL . 2.1 p -92.56 109.83 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.908 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.496 ' OD2' ' SG ' ' A' ' 138' ' ' CYS . 0.7 OUTLIER -45.36 142.31 3.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 140' ' ' VAL . 72.9 Cg_exo -43.87 -47.63 9.81 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.223 2.615 . . . . 1.0 113.988 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.719 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.3 p -35.83 -46.87 0.48 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.734 0.272 . . . . 1.0 111.734 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.719 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 2.1 t60 -82.99 -24.64 32.83 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.511 ' CG1' HG23 ' A' ' 106' ' ' VAL . 44.7 t -65.92 -55.01 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.664 -0.414 . . . . 1.0 110.963 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -65.88 -29.25 69.66 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -60.24 -47.35 86.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.666 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.1 mt -73.0 -36.72 67.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.311 -0.625 . . . . 1.0 109.311 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -49.8 -39.68 39.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.597 -1.26 . . . . 1.0 107.597 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -63.69 -28.74 70.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.713 -1.13 . . . . 1.0 109.181 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.5 mmm -85.92 -1.92 57.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.726 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.05 22.01 78.41 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.18 142.32 23.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 1.0 110.966 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.76 -38.17 5.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.932 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.7 t -133.75 125.2 28.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.104 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.2 p -112.91 135.61 53.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.479 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.83 133.89 55.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.296 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.0 t -122.23 108.76 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.099 0.476 . . . . 1.0 111.792 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.433 HG11 HG12 ' A' ' 184' ' ' VAL . 48.0 t -105.06 114.6 63.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 107.8 -1.185 . . . . 1.0 107.8 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -41.7 134.74 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 123.161 2.574 . . . . 1.0 114.664 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.4 tp -132.4 41.41 3.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.6 ptm -148.92 -172.69 4.17 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.133 0.79 . . . . 1.0 113.133 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.655 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 52.2 t-80 -77.84 178.1 7.67 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.436 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.655 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 72.4 m80 -74.84 -54.94 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.051 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -104.01 11.57 35.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.032 0.382 . . . . 1.0 112.032 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.536 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.8 tt0 -146.49 140.18 26.03 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.856 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.729 ' O ' HD23 ' A' ' 162' ' ' LEU . 6.9 tt -109.55 116.18 31.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.243 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.536 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 69.0 m95 -92.68 -37.31 12.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.175 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -158.34 -171.72 24.57 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.152 -0.779 . . . . 1.0 111.152 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 16.0 tp -145.14 125.96 14.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 1.0 111.599 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.421 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.6 tp -100.58 131.53 46.44 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.17 138.23 41.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.702 -0.399 . . . . 1.0 111.069 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.1 m -110.86 141.76 43.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.96 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -115.57 131.61 56.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.01 0.433 . . . . 1.0 111.572 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -128.01 123.03 33.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.957 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.73 36.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.829 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -164.37 126.11 1.5 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.009 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -42.68 139.55 3.16 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.988 2.459 . . . . 1.0 111.847 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -176.57 97.75 0.24 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.825 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.98 155.64 4.13 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.596 2.197 . . . . 1.0 111.887 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.421 ' OH ' ' O ' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -85.25 133.66 34.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.51 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.2 m -118.31 150.79 38.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.597 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -50.61 -35.97 32.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.663 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.01 -38.24 85.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.729 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.43 -50.79 70.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.526 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.12 -36.07 80.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.569 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -53.67 -37.2 62.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.406 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.6 -54.47 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.743 0.646 . . . . 1.0 112.743 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.433 HG12 HG11 ' A' ' 154' ' ' VAL . 3.3 t -78.04 -40.13 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.451 0.537 . . . . 1.0 112.451 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -46.9 -45.64 20.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.653 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 55.1 mt -74.64 -39.09 62.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.6 tp -76.0 -41.45 51.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.851 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -60.71 -38.55 85.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.479 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.27 -37.72 70.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.279 -0.418 . . . . 1.0 109.953 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -71.83 -24.21 61.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.114 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 194' ' ' ALA . 61.4 t -83.18 -47.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.793 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.5 m -51.97 -30.41 24.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.42 -33.29 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.154 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -70.36 -48.36 56.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.811 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 196' ' ' ALA . 1.9 pp -67.14 -37.07 78.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.132 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.463 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -70.83 -46.13 63.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.093 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -74.1 -35.14 64.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.549 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -61.92 -34.51 76.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.703 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.28 -27.61 47.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.475 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.07 -36.29 74.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.685 0.279 . . . . 1.0 111.054 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.9 m -52.45 -55.8 19.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.589 179.608 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.892 0.377 . . . . 1.0 110.577 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 35.6 p-10 -51.21 -32.62 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 62.8 tt0 -77.07 -48.33 18.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.147 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.3 mt -60.33 -42.49 90.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 1.0 110.945 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.06 -46.55 82.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.412 . . . . 1.0 111.041 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.55 HH12 ' CD2' ' A' ' 78' ' ' LEU . 51.8 ttt85 -51.95 -38.27 55.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.95 -29.67 65.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.833 -0.622 . . . . 1.0 110.089 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 42' ' ' VAL . 20.8 m -73.5 -45.07 56.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.557 -0.747 . . . . 1.0 112.21 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.646 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.2 p -68.12 -35.6 72.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 111.976 0.362 . . . . 1.0 111.976 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -70.17 -45.48 66.63 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.104 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -63.76 -44.42 93.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.779 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 38' ' ' THR . 75.4 t -59.37 -42.53 87.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.155 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 47' ' ' GLY . 63.7 ttp85 -53.99 -40.76 67.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.851 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.15 -37.28 74.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.03 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -78.29 -43.41 28.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.581 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.7 mt -85.2 -30.4 23.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.512 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 59.28 20.11 49.21 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.509 -1.036 . . . . 1.0 110.509 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.468 ' CG2' ' CE1' ' A' ' 170' ' ' HIS . 89.8 m -72.93 142.18 47.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.83 0.348 . . . . 1.0 110.224 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -39.89 -54.72 2.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.566 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.529 ' NH2' ' O ' ' A' ' 74' ' ' LEU . 80.6 mtt-85 -152.5 131.89 12.91 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.99 -0.684 . . . . 1.0 112.501 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.64 129.34 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -138.83 156.01 47.67 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.915 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 58.7 t -108.35 136.35 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.63 134.61 47.78 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.366 -0.534 . . . . 1.0 111.311 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -94.01 137.92 32.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.21 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 66.9 t80 -94.29 117.55 30.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 1.0 112.035 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -88.07 140.93 30.89 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.422 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.02 -26.77 5.27 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.55 2.167 . . . . 1.0 112.397 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.37 -19.64 38.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.915 0.388 . . . . 1.0 110.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.69 -13.45 38.71 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.556 -0.618 . . . . 1.0 111.556 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -71.92 99.57 2.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.339 . . . . 1.0 110.593 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.62 142.57 16.06 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.626 -0.99 . . . . 1.0 110.626 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.5 p -123.07 145.77 48.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 1.0 111.743 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 t -77.74 106.99 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.09 -2.03 9.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.341 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.646 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -156.86 116.51 3.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.106 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 81.6 tt0 -144.06 132.5 22.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.802 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.433 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -128.35 138.8 52.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.343 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -118.55 137.08 53.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.906 0.384 . . . . 1.0 110.722 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.42 -81.31 0.52 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.849 -0.9 . . . . 1.0 110.849 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.507 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -114.04 50.81 0.75 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.997 -0.841 . . . . 1.0 110.997 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' A' ' 71' ' ' GLY . 15.0 pt-20 31.18 55.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 1.0 110.491 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -84.52 -50.43 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.165 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.529 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 23.8 mt -109.4 153.46 42.76 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.86 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.28 164.71 3.61 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.486 2.124 . . . . 1.0 112.126 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.1 t -87.72 128.58 35.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.878 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.549 ' HA ' HD12 ' A' ' 80' ' ' LEU . 24.3 mt -101.08 13.48 35.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.39 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.55 ' CD2' HH12 ' A' ' 36' ' ' ARG . 23.9 tp -73.08 128.9 36.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.032 -0.531 . . . . 1.0 112.343 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.9 -8.62 77.37 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.541 -0.754 . . . . 1.0 111.532 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 77' ' ' LEU . 69.8 mt -85.73 152.6 22.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.768 0.318 . . . . 1.0 110.31 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 81' ' ' THR . 11.7 t -106.26 133.67 50.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.702 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.59 152.09 51.4 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.68 137.01 56.69 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.61 2.207 . . . . 1.0 111.863 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.46 129.14 38.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.683 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.1 43.53 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.551 -1.019 . . . . 1.0 110.551 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.9 -37.78 66.77 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.754 ' H ' HD12 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -80.08 113.57 39.53 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.394 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 87' ' ' ILE . 86.5 Cg_exo -48.76 -171.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.455 2.103 . . . . 1.0 112.509 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.93 -59.0 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.558 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 20.8 pt-20 -58.24 -42.74 87.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.813 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -66.27 -47.84 72.38 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.971 0.36 . . . . 1.0 111.971 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.519 ' NH2' ' CE2' ' A' ' 56' ' ' PHE . 72.1 ttt180 -52.99 -35.63 59.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.498 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -66.1 -35.95 81.89 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.838 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.463 HD12 HH21 ' A' ' 101' ' ' ARG . 66.6 mt -60.69 -37.31 81.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.317 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 66.9 m-85 -60.73 -55.07 37.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.038 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -51.19 -29.72 14.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.773 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 63.2 mt -99.14 -42.42 7.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.335 1.235 . . . . 1.0 114.335 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.551 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.93 -14.47 10.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.053 1.501 . . . . 1.0 115.053 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.609 ' NE2' ' SD ' ' A' ' 157' ' ' MET . 14.9 mm100 37.58 81.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.148 -1.021 . . . . 1.0 108.835 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 100' ' ' VAL . 2.7 p 176.49 97.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.103 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.604 ' O ' HG23 ' A' ' 102' ' ' VAL . 6.6 mmt180 -147.99 146.35 28.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.992 0.425 . . . . 1.0 110.746 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 101' ' ' ARG . 62.8 t -159.79 150.07 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.514 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.415 HD12 ' OG ' ' A' ' 151' ' ' SER . 49.5 mt -108.35 136.57 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.03 163.93 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 113.279 0.844 . . . . 1.0 113.279 -176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 21.8 p30 -46.46 119.68 2.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.93 -1.032 . . . . 1.0 112.125 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.472 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.7 p -55.18 -20.42 6.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.331 -0.849 . . . . 1.0 110.808 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -65.78 -43.51 88.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.02 -12.86 55.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.529 0.68 . . . . 1.0 109.362 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.436 ' HG2' ' HE ' ' A' ' 111' ' ' ARG . 40.0 tp60 45.17 73.44 0.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.782 -1.099 . . . . 1.0 113.284 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.463 ' OG ' HG12 ' A' ' 135' ' ' VAL . 9.7 p -74.23 129.9 38.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.025 -1.472 . . . . 1.0 107.025 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.436 ' HE ' ' HG2' ' A' ' 109' ' ' GLN . 96.1 mtt180 -118.29 132.86 56.27 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.937 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.518 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -134.65 162.55 31.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.595 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.6 pt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.164 179.45 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo . . . . . 0 N--CA 1.493 1.452 0 CA-C-O 120.763 0.234 . . . . 1.0 111.962 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.463 HG12 ' OG ' ' A' ' 110' ' ' SER . 1.5 p -95.33 114.19 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.947 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -44.0 137.17 3.63 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.518 ' HD3' ' H ' ' A' ' 112' ' ' SER . 54.8 Cg_exo -41.97 -48.52 6.12 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.238 2.625 . . . . 1.0 114.001 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.702 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER -35.96 -45.93 0.44 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.8 0.296 . . . . 1.0 111.8 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.702 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 8.1 t-80 -82.2 -26.97 32.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.472 ' CG1' HG23 ' A' ' 106' ' ' VAL . 48.0 t -63.92 -53.82 39.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.986 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -65.3 -29.1 69.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -58.97 -45.62 90.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.734 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.2 mt -73.23 -41.76 63.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -38.61 56.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.544 -1.28 . . . . 1.0 107.544 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.7 t -63.5 -26.61 68.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.823 -1.081 . . . . 1.0 109.209 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.6 mmm -90.21 3.55 53.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.731 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.25 20.31 79.11 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.08 143.56 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 1.0 110.964 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.59 -19.95 13.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.942 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.5 m -145.87 161.82 39.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 1.0 111.177 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.415 ' OG ' HD12 ' A' ' 103' ' ' ILE . 1.7 p -147.48 122.55 10.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.49 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 tp -106.27 131.67 53.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.287 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.535 HG11 HD21 ' A' ' 165' ' ' LEU . 3.5 t -124.44 120.38 58.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.126 0.489 . . . . 1.0 111.784 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.814 ' O ' HG13 ' A' ' 154' ' ' VAL . 12.6 p -130.76 91.53 36.94 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.829 -1.174 . . . . 1.0 107.829 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.468 ' HB2' ' NE2' ' A' ' 99' ' ' GLN . 84.4 Cg_exo -47.27 152.09 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 123.175 2.583 . . . . 1.0 114.677 -176.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 56.2 mt -126.07 66.64 1.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.829 -1.545 . . . . 1.0 106.829 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.609 ' SD ' ' NE2' ' A' ' 99' ' ' GLN . 2.1 ptt? -146.98 -167.53 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.145 0.795 . . . . 1.0 113.145 -175.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.697 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 18.2 t-80 -86.26 -176.0 5.73 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.446 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.697 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 59.3 t-80 -75.32 -55.27 5.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.463 -0.789 . . . . 1.0 112.103 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -105.66 13.72 29.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.014 0.376 . . . . 1.0 112.014 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -144.04 138.91 28.67 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.839 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 162' ' ' LEU . 9.1 tt -110.52 116.67 31.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.239 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -92.4 -36.51 13.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.222 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.91 -171.35 27.9 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.535 HD21 HG11 ' A' ' 153' ' ' VAL . 7.6 tp -149.72 133.31 16.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 1.0 111.532 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.434 ' CD1' HG22 ' A' ' 53' ' ' VAL . 8.3 tp -98.71 135.91 39.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 167' ' ' VAL . 11.0 p -139.25 131.68 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.047 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 m -109.11 142.9 39.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.017 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' A' ' 48' ' ' THR . 43.5 m80 -113.16 123.3 49.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.053 0.454 . . . . 1.0 111.69 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.468 ' CE1' ' CG2' ' A' ' 48' ' ' THR . 56.2 m80 -123.55 115.23 21.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.859 -0.61 . . . . 1.0 109.97 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.12 -16.12 63.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.782 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -94.48 150.15 37.68 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.963 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 174' ' ' ARG . 59.9 Cg_endo -70.83 -2.6 11.2 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.96 2.44 . . . . 1.0 111.825 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 173' ' ' PRO . 0.0 OUTLIER -32.54 98.06 0.12 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.921 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 173' ' ' PRO . 78.2 Cg_exo -50.15 167.68 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.577 2.185 . . . . 1.0 111.933 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.539 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 46.4 p90 -86.75 125.66 34.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.471 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.2 t -115.74 154.1 30.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.681 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -54.34 -31.76 55.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.626 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.81 -39.99 86.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.748 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -63.47 -42.6 98.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.551 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.55 -38.47 87.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.502 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -55.36 -36.4 66.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.899 -0.591 . . . . 1.0 111.394 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.1 -55.93 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.735 0.643 . . . . 1.0 112.735 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 188' ' ' ALA . 26.8 m -74.09 -35.3 40.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.434 0.531 . . . . 1.0 112.434 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -50.28 -45.84 54.68 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.655 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 41.5 mt -79.61 -43.97 21.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.894 0.331 . . . . 1.0 111.894 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.72 ' O ' HG23 ' A' ' 191' ' ' VAL . 34.2 tp -77.9 -40.53 39.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.835 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -60.67 -41.11 94.42 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.493 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.66 -40.26 87.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.991 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -67.81 -25.81 65.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.149 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 187' ' ' LEU . 37.0 t -84.13 -45.01 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.78 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.2 p -57.13 -35.33 69.34 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.01 -34.81 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.465 -0.789 . . . . 1.0 109.24 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.93 77.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.819 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.4 mm -59.57 -48.58 86.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.128 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.52 -48.13 57.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.127 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -65.0 -42.77 94.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.466 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.63 -31.87 73.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.706 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.14 -30.97 66.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.464 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.7 mp -59.99 -34.17 72.96 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.981 -0.288 . . . . 1.0 111.072 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.3 p -55.56 -55.58 30.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.566 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.534 179.896 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 31' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.868 0.366 . . . . 1.0 110.605 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 33' ' ' GLN . 24.1 p-10 -50.74 -55.48 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.998 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.408 ' N ' ' CG ' ' A' ' 32' ' ' ASP . 63.9 tt0 -52.65 -42.56 64.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.101 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.1 mm -59.64 -50.46 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 1.0 110.966 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.46 HD11 HD22 ' A' ' 31' ' ' LEU . 83.4 mt -58.42 -46.86 85.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.987 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -49.58 -39.68 35.98 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.816 -0.438 . . . . 1.0 109.816 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 -29.4 65.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.073 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 35' ' ' LEU . 24.1 m -74.53 -41.47 60.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 1.0 112.263 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.648 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.5 p -72.32 -37.82 59.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 111.922 0.341 . . . . 1.0 111.922 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -67.79 -41.61 82.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.783 0.325 . . . . 1.0 111.067 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -67.36 -44.72 78.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.734 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 38' ' ' THR . 69.3 t -61.77 -36.36 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.176 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.558 ' NH2' ' CA ' ' A' ' 70' ' ' GLY . 16.3 tpt85 -59.79 -47.47 85.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 1.0 110.802 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.55 -33.33 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 1.0 111.051 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -74.27 -41.2 61.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.607 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' A' ' 48' ' ' THR . 5.4 mt -87.12 -29.03 22.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.514 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.81 19.19 0.85 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.421 ' N ' ' C ' ' A' ' 46' ' ' LEU . 1.6 p -62.7 -97.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 1.0 110.211 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -155.13 -48.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.613 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -157.16 125.92 5.78 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.089 -0.644 . . . . 1.0 112.644 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 12.6 p -137.03 129.05 43.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.547 -0.908 . . . . 1.0 108.547 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -140.18 159.33 42.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.958 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -99.82 136.25 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.608 -0.886 . . . . 1.0 108.608 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 74.2 t80 -117.09 108.45 15.73 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.295 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -83.31 126.47 32.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.274 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.621 ' CZ ' ' NH2' ' A' ' 92' ' ' ARG . 77.8 t80 -93.32 137.12 32.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 1.0 112.035 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.84 140.85 22.26 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.88 -27.27 5.57 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.573 2.182 . . . . 1.0 112.442 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.97 -18.19 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 1.0 110.096 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.96 -13.85 41.06 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.574 -0.61 . . . . 1.0 111.574 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -78.22 90.39 4.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.765 0.317 . . . . 1.0 110.63 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.48 151.46 20.97 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.635 -0.986 . . . . 1.0 110.635 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.8 p -123.51 146.62 47.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 1.0 111.692 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 77' ' ' LEU . 39.4 t -75.81 110.38 10.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.87 2.97 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.339 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.648 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.69 122.58 3.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.072 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -144.26 130.16 19.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.109 0.481 . . . . 1.0 111.826 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.62 139.25 52.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.359 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -140.85 145.8 36.69 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.793 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.558 ' CA ' ' NH2' ' A' ' 43' ' ' ARG . . . -47.31 -39.08 13.32 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.864 -0.894 . . . . 1.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 171.64 -154.27 21.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' O ' ' OE1' ' A' ' 72' ' ' GLU . 3.0 pp20? -72.54 20.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 1.0 110.523 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 71' ' ' GLY . 35.0 mtm180 -76.44 -47.8 21.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.117 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.89 150.36 52.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.92 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.42 157.91 55.4 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.486 2.124 . . . . 1.0 112.155 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.7 p -95.55 132.04 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.918 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.545 ' HA ' HD12 ' A' ' 80' ' ' LEU . 22.7 mt -90.6 17.16 7.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.41 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.44 128.8 37.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.016 -0.538 . . . . 1.0 112.28 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.91 -11.49 64.54 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.536 -0.756 . . . . 1.0 111.577 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 77' ' ' LEU . 72.1 mt -82.92 152.05 25.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.914 -0.314 . . . . 1.0 110.341 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.8 m -107.16 134.15 50.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.713 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -84.95 152.19 58.69 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.36 130.66 27.5 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.636 2.224 . . . . 1.0 111.89 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 131.45 46.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.705 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.64 2.13 43.33 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -62.41 -17.02 58.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.573 ' O ' ' O ' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -105.1 103.24 40.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.397 178.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 87' ' ' ILE . 83.1 Cg_exo -49.74 -154.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.407 2.072 . . . . 1.0 112.489 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -109.21 -54.63 2.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.53 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -63.31 -45.04 93.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.78 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.4 -48.17 70.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.947 0.351 . . . . 1.0 111.947 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.621 ' NH2' ' CZ ' ' A' ' 56' ' ' PHE . 67.1 ttt180 -56.57 -34.68 67.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.426 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.5 ttt85 -64.25 -35.63 81.45 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.872 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.89 -38.47 91.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.281 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.477 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 40.0 m-85 -60.26 -29.97 69.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.977 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -84.2 -26.44 28.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.888 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.92 -46.92 6.03 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.434 1.272 . . . . 1.0 114.434 -175.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.526 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.58 -6.05 13.96 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.052 1.501 . . . . 1.0 115.052 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.526 ' C ' ' O ' ' A' ' 98' ' ' ALA . 1.0 OUTLIER 40.5 73.6 0.12 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.191 -1.004 . . . . 1.0 108.821 179.594 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 100' ' ' VAL . 6.2 p 176.1 118.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.993 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.456 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 30.6 tpt85 -168.66 134.6 1.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 1.0 110.715 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.456 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 4.5 m -149.82 155.28 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.564 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.525 ' CD1' ' NE2' ' A' ' 139' ' ' HIS . 96.9 mt -112.04 134.42 54.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.074 -0.713 . . . . 1.0 109.074 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.01 163.62 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 113.315 0.857 . . . . 1.0 113.315 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 173' ' ' PRO . 49.7 m-20 -45.92 120.11 2.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.986 -1.006 . . . . 1.0 112.156 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.8 -20.62 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.792 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.98 -44.86 83.65 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.16 -13.45 60.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.491 0.662 . . . . 1.0 109.387 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 46.66 72.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.675 -1.148 . . . . 1.0 113.327 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.82 131.98 42.98 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.002 -1.481 . . . . 1.0 107.002 175.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -118.75 134.16 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.003 -0.679 . . . . 1.0 111.904 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.1 164.49 30.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.555 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.3 pt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.084 179.676 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo . . . . . 0 N--CA 1.492 1.405 0 CA-C-O 120.708 0.212 . . . . 1.0 111.951 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.71 147.46 6.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.869 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -92.32 136.13 25.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -41.65 -21.51 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.226 2.618 . . . . 1.0 114.018 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.683 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 4.8 p -71.24 -46.12 61.75 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.751 0.278 . . . . 1.0 111.751 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.683 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 42.1 t60 -84.13 -29.11 26.99 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 1.8 p -62.65 -44.56 99.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.941 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.537 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 83.5 t60 -69.53 -30.3 68.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.738 -0.467 . . . . 1.0 109.738 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -58.2 -43.01 87.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.76 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.676 HD11 ' NE2' ' A' ' 139' ' ' HIS . 63.6 mt -72.99 -40.11 65.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.279 -0.637 . . . . 1.0 109.279 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -51.01 -39.1 54.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.568 -1.271 . . . . 1.0 107.568 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 m -65.17 -22.94 66.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.783 -1.099 . . . . 1.0 109.203 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.4 mmm -94.52 0.64 55.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.645 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.7 21.11 79.72 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 64.9 t -110.7 142.74 22.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.841 0.353 . . . . 1.0 111.063 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.55 -40.78 5.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.945 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.1 m -131.98 127.14 35.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.217 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.34 129.1 55.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.472 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.02 126.74 54.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.234 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.32 120.49 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 1.0 111.802 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.0 t -128.07 118.04 20.64 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -71.8 145.2 45.39 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.164 2.576 . . . . 1.0 114.721 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.3 mt -121.68 62.27 0.92 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.487 ' HE3' HE22 ' A' ' 99' ' ' GLN . 8.0 ptt? -147.04 -163.31 1.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.099 0.777 . . . . 1.0 113.099 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.625 ' CE1' ' HE1' ' A' ' 163' ' ' TRP . 76.1 m80 -89.06 -178.4 5.68 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.357 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -74.22 -54.09 8.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.054 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -104.68 11.16 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.03 0.381 . . . . 1.0 112.03 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.5 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.7 tt0 -143.15 136.82 28.59 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.74 ' O ' HD23 ' A' ' 162' ' ' LEU . 5.6 tt -111.89 119.64 39.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.044 -0.526 . . . . 1.0 111.259 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.625 ' HE1' ' CE1' ' A' ' 158' ' ' HIS . 82.1 m95 -92.85 -41.07 10.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.265 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.442 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -160.15 -176.31 32.1 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.179 -0.768 . . . . 1.0 111.179 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.527 HD21 HD11 ' A' ' 162' ' ' LEU . 97.0 mt -140.09 133.72 30.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 1.0 111.522 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.8 tp -105.23 134.17 48.78 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.33 138.2 40.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.048 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m -114.4 132.25 56.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 1.0 109.98 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -109.77 137.01 48.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.999 0.428 . . . . 1.0 111.676 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -130.04 130.4 44.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.015 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.17 45.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.773 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -144.05 150.74 50.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.07 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.446 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 65.4 Cg_endo -71.51 -12.31 29.22 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.905 2.404 . . . . 1.0 111.92 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -40.97 104.54 0.34 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.904 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.07 168.2 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.532 2.155 . . . . 1.0 111.95 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -97.71 136.46 38.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.518 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.2 m -120.65 152.47 38.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.638 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -51.05 -31.47 18.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.665 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -56.5 -34.86 67.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.731 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -64.3 -43.56 94.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.504 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.0 mp -67.76 -35.06 78.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.575 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.463 ' NE2' HD11 ' A' ' 186' ' ' LEU . 23.1 tm0? -54.76 -39.74 68.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.367 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.35 -52.46 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.6 t -71.53 -34.92 54.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.401 0.519 . . . . 1.0 112.401 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -50.42 -46.99 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.646 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.463 HD11 ' NE2' ' A' ' 182' ' ' GLN . 51.2 mt -68.8 -40.1 79.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.914 0.339 . . . . 1.0 111.914 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.727 ' O ' HG23 ' A' ' 191' ' ' VAL . 6.3 tp -78.45 -37.71 42.92 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.86 0.319 . . . . 1.0 111.86 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.92 86.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.482 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -63.38 -41.17 98.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.002 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -69.03 -29.11 67.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.085 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 187' ' ' LEU . 49.0 t -82.4 -46.15 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.681 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.9 t -53.75 -35.6 61.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.0 mt -64.93 -34.69 72.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.2 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.65 -39.5 80.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.617 -0.72 . . . . 1.0 109.845 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.9 mm -59.55 -47.45 90.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.189 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.465 ' HB2' ' CE1' ' A' ' 158' ' ' HIS . . . -71.17 -46.28 61.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.09 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -66.54 -45.4 79.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.457 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.55 -32.7 74.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.669 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.43 -33.13 70.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.55 -0.296 . . . . 1.0 111.427 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.38 -35.09 76.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.664 0.269 . . . . 1.0 111.077 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 90.5 p -56.91 -55.69 31.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.564 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.551 179.567 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.882 0.372 . . . . 1.0 110.557 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -77.2 -29.76 54.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.942 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -78.53 -45.76 21.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.084 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 38' ' ' THR . 10.2 pt -64.8 -39.71 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.968 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.434 ' O ' ' OG1' ' A' ' 38' ' ' THR . 26.7 mt -59.72 -45.49 92.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.005 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -55.59 -34.46 64.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.42 -35.92 71.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.105 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 34' ' ' ILE . 82.8 p -70.26 -43.35 70.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.548 -0.751 . . . . 1.0 112.188 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.649 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.0 p -67.91 -36.59 76.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 111.911 0.337 . . . . 1.0 111.911 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' A' ' 43' ' ' ARG . 39.6 tp10 -66.31 -46.32 77.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.808 0.337 . . . . 1.0 111.076 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.84 -46.69 86.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.722 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 38' ' ' THR . 75.6 t -52.73 -45.06 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.955 -0.298 . . . . 1.0 111.138 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 47' ' ' GLY . 56.5 ttp180 -49.59 -39.52 35.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.825 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.56 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -76.46 -46.46 26.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.546 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.58 -27.73 25.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.507 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.4 21.49 34.1 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 169' ' ' HIS . 7.3 t -74.11 143.93 45.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 1.0 110.234 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 94.6 m-20 -43.6 -43.89 5.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.662 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' NH1' ' CD1' ' A' ' 74' ' ' LEU . 58.4 mtm-85 -154.98 131.71 10.67 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.078 -0.649 . . . . 1.0 112.56 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 51' ' ' VAL . 12.0 p -135.8 128.2 46.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -138.4 154.1 48.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.491 -0.484 . . . . 1.0 111.949 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 86.5 t -99.63 136.3 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 37.9 t80 -116.75 110.93 19.06 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.324 -0.55 . . . . 1.0 111.307 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.531 ' NH1' ' O ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -84.43 122.6 29.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.266 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.531 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 69.4 t80 -88.78 141.28 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 1.0 112.034 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.466 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 41.0 m-20 -111.97 140.0 22.95 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -46.03 -30.65 7.55 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.458 2.105 . . . . 1.0 112.46 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -81.17 -19.22 43.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 1.0 110.043 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.42 38.17 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.56 -0.616 . . . . 1.0 111.56 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -79.22 90.39 4.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.747 0.308 . . . . 1.0 110.699 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.85 152.09 21.2 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 p -125.69 148.87 48.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 1.0 111.711 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.78 109.3 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.623 ' O ' HG12 ' A' ' 65' ' ' VAL . 65.1 t -107.87 0.8 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.925 -0.31 . . . . 1.0 111.292 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.649 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.34 118.69 2.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.017 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -147.04 133.85 20.09 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.874 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.97 148.36 51.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 1.0 109.388 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.524 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 36.3 ptt180 -141.73 145.38 34.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.797 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -50.34 -37.17 31.34 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -175.1 -167.97 35.04 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.952 -0.859 . . . . 1.0 110.952 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.78 43.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 1.0 110.546 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 71' ' ' GLY . 53.9 mtt-85 -84.05 -46.68 11.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.13 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.454 ' CD1' ' NH1' ' A' ' 50' ' ' ARG . 13.3 mt -123.37 150.85 61.66 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.881 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.57 165.28 31.27 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.532 2.155 . . . . 1.0 112.191 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.9 p -93.33 131.81 38.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.981 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 80' ' ' LEU . 26.3 mt -89.78 9.04 28.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.454 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.83 130.46 45.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.989 -0.55 . . . . 1.0 112.263 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.62 -14.88 58.74 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.524 -0.762 . . . . 1.0 111.567 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 77' ' ' LEU . 77.3 mt -80.77 150.37 29.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.282 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.2 m -104.59 129.53 52.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.75 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -82.16 128.72 66.74 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -40.26 125.34 1.82 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.663 2.242 . . . . 1.0 111.882 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.07 132.68 52.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.74 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.39 1.6 44.08 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.539 -1.024 . . . . 1.0 110.539 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -56.78 -35.66 68.94 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 mt -88.76 126.95 57.97 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.425 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.664 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 85.6 Cg_endo -73.83 -155.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.477 2.118 . . . . 1.0 112.503 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -107.76 -68.78 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 1.0 111.557 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.671 ' CD ' ' H ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -49.44 -46.63 48.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.855 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.664 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -65.99 -45.48 81.43 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.719 HH12 ' NH2' ' A' ' 96' ' ' ARG . 71.8 ttt-85 -59.62 -35.34 74.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.475 -0.33 . . . . 1.0 111.513 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -63.51 -31.14 72.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.792 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.432 ' CD1' HH12 ' A' ' 101' ' ' ARG . 87.0 mt -69.25 -35.76 76.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.248 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.608 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 17.6 m-85 -59.14 -31.14 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.017 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.719 ' NH2' HH12 ' A' ' 92' ' ' ARG . 80.7 mtt180 -83.44 -23.61 32.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.815 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.4 mt -99.18 -47.5 5.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.0 -8.51 13.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -173.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.608 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 0.8 OUTLIER 39.21 80.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.16 -1.016 . . . . 1.0 108.817 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 100' ' ' VAL . 4.2 p 173.69 120.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.037 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -169.72 146.58 3.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.011 0.434 . . . . 1.0 110.716 177.08 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 101' ' ' ARG . 54.1 t -159.35 150.24 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.565 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.6 mt -108.06 134.63 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.03 165.11 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 15.4 p30 -45.99 117.89 1.68 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.988 -1.005 . . . . 1.0 112.114 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.81 -21.46 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.326 -0.852 . . . . 1.0 110.769 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.54 -43.22 90.63 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.12 -11.83 44.31 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.502 0.668 . . . . 1.0 109.356 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 45.29 69.26 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.748 -1.115 . . . . 1.0 113.291 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 m -76.29 132.36 39.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 174.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -119.44 139.22 52.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.0 -0.68 . . . . 1.0 111.886 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.422 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -124.4 149.91 46.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.576 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.146 178.955 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 120.675 0.198 . . . . 1.0 111.945 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' A' ' 140' ' ' VAL . 0.7 OUTLIER -109.38 123.61 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.909 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -41.3 153.48 0.25 Allowed Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -57.08 -21.59 43.1 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.194 2.596 . . . . 1.0 114.038 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.691 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 5.6 p -63.02 -46.57 86.97 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.691 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 16.4 t-80 -81.27 -27.15 35.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.245 0.461 . . . . 1.0 112.245 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' A' ' 135' ' ' VAL . 71.1 t -65.4 -53.61 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.915 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -65.74 -28.17 68.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -59.17 -42.98 92.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.7 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 146' ' ' MET . 17.5 mt -73.32 -38.85 65.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -52.12 -39.06 59.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.594 -1.261 . . . . 1.0 107.594 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.9 p -65.14 -20.55 66.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.769 -1.105 . . . . 1.0 109.186 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 143' ' ' LEU . 81.5 mmm -95.65 2.81 54.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.412 -0.813 . . . . 1.0 110.707 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.81 21.86 78.85 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.88 142.54 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 1.0 111.02 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.38 -21.03 13.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.931 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -147.82 160.63 42.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.155 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 p -148.38 126.37 12.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.469 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.43 128.7 55.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.302 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.82 121.05 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.173 0.511 . . . . 1.0 111.801 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.509 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 3.1 m -126.16 92.99 44.51 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.816 -1.179 . . . . 1.0 107.816 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.645 ' C ' HD12 ' A' ' 156' ' ' LEU . 90.4 Cg_exo -44.84 143.86 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.148 2.565 . . . . 1.0 114.672 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 155' ' ' PRO . 10.9 mp -121.91 60.24 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.818 -1.549 . . . . 1.0 106.818 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.585 ' HE1' HE22 ' A' ' 99' ' ' GLN . 2.3 ptm -147.66 -178.63 6.36 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.139 0.792 . . . . 1.0 113.139 -175.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.606 ' CG ' ' N ' ' A' ' 159' ' ' HIS . 57.7 t-80 -71.08 172.66 8.74 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.289 -0.869 . . . . 1.0 111.368 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.606 ' N ' ' CG ' ' A' ' 158' ' ' HIS . 55.9 t-80 -61.48 -50.59 72.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.326 -0.852 . . . . 1.0 112.039 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -105.36 -37.66 6.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -89.97 136.13 33.23 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.957 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.722 ' O ' HD23 ' A' ' 162' ' ' LEU . 6.3 tt -107.39 118.46 36.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.279 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -92.55 -44.17 8.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.205 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -161.53 -176.11 33.28 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.63 138.16 34.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 1.0 111.534 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.437 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.5 tp -103.81 134.19 47.53 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.23 140.07 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.699 -0.401 . . . . 1.0 111.089 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.3 m -114.12 137.89 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.994 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.48 ' O ' ' OG1' ' A' ' 48' ' ' THR . 77.5 m-70 -111.46 135.65 51.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.003 0.43 . . . . 1.0 111.611 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -128.27 121.9 30.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.966 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.51 -12.54 60.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.817 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -129.83 148.02 67.81 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.018 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -44.32 146.48 1.93 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.952 2.435 . . . . 1.0 111.821 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -172.82 79.42 0.43 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.03 151.17 12.21 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.569 2.179 . . . . 1.0 111.933 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -99.41 136.16 39.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.482 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.7 m -125.65 172.45 9.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.593 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -50.47 -35.41 28.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.667 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -62.35 -50.11 72.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.682 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -62.34 -37.21 84.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.477 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.7 tp -61.47 -36.2 79.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.561 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -61.33 -30.12 70.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 1.0 111.36 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 74.4 t -71.35 -53.54 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 188' ' ' ALA . 34.7 m -77.94 -36.09 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.398 0.518 . . . . 1.0 112.398 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -54.9 -49.68 70.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.707 0.289 . . . . 1.0 111.631 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 33.4 tp -73.46 -39.73 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 187' ' ' LEU . 28.3 tp -79.21 -40.15 31.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.418 -0.355 . . . . 1.0 111.813 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.454 ' O ' ' OG ' ' A' ' 192' ' ' SER . . . -55.8 -36.38 67.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.56 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -77.68 -38.8 46.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 1.0 109.97 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.98 -35.99 82.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.127 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 192' ' ' SER . 7.6 p -83.65 -40.06 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.722 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.459 ' N ' HG13 ' A' ' 191' ' ' VAL . 68.7 m -54.43 -35.8 63.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.1 mt -61.42 -35.67 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.217 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.33 -38.58 78.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.756 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.13 -49.5 83.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.154 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.39 -46.84 65.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.864 -0.607 . . . . 1.0 111.138 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -64.23 -40.58 96.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 1.0 111.518 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.97 67.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.321 -0.399 . . . . 1.0 111.699 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -63.1 -37.91 89.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.495 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 48.6 mt -61.42 -31.77 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.983 -0.287 . . . . 1.0 111.083 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.6 m -54.6 -52.55 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.529 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 202' ' ' LEU . 31.0 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.521 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.534 ' CD2' ' NH2' ' A' ' 55' ' ' ARG . 39.4 tp . . . . . 0 C--O 1.23 0.028 0 CA-C-O 120.91 0.385 . . . . 1.0 110.594 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 65.5 t0 -79.61 -30.5 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.984 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -79.38 -45.16 20.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.08 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 35' ' ' LEU . 21.3 tt -61.52 -39.92 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 1.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.493 ' N ' HG23 ' A' ' 34' ' ' ILE . 58.7 mt -61.1 -45.51 94.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.049 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.477 HH12 ' CD2' ' A' ' 78' ' ' LEU . 77.9 mtt-85 -53.75 -38.55 64.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.564 -0.455 . . . . 1.0 109.938 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.92 -29.34 65.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.082 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.419 ' O ' HG13 ' A' ' 42' ' ' VAL . 25.5 m -73.08 -44.52 60.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.544 -0.753 . . . . 1.0 112.249 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.689 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 5.9 p -69.16 -37.57 76.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.55 -37.23 71.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.796 0.332 . . . . 1.0 111.112 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -67.49 -49.01 65.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.78 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 38' ' ' THR . 28.4 m -64.4 -31.22 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.136 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.8 tmt_? -61.09 -45.83 93.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.811 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.02 72.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.09 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -78.33 -41.35 33.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.58 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.7 mt -85.55 -30.23 23.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.427 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.02 20.07 32.92 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.455 -1.058 . . . . 1.0 110.455 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.6 p -72.59 143.23 48.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.343 . . . . 1.0 110.239 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -39.58 -53.55 2.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.607 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -154.04 130.75 10.76 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.048 -0.661 . . . . 1.0 112.588 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -136.95 128.97 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.582 -0.896 . . . . 1.0 108.582 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -139.73 154.51 47.46 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.532 -0.467 . . . . 1.0 111.932 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 59.0 t -109.69 137.18 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -132.86 134.25 44.37 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.26 -178.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.534 ' NH2' ' CD2' ' A' ' 31' ' ' LEU . 42.4 ttm-85 -90.61 138.21 31.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.241 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -92.99 117.01 29.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 1.0 112.077 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -84.09 149.85 56.86 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.35 -23.97 72.43 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.517 2.145 . . . . 1.0 112.481 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.66 -16.48 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.0 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.67 -12.36 42.41 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.534 -0.626 . . . . 1.0 111.534 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -75.3 96.11 3.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.784 0.326 . . . . 1.0 110.662 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.15 143.09 16.78 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.7 p -122.21 146.02 47.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 1.0 111.693 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.73 109.47 13.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 65' ' ' VAL . 20.5 t -108.74 -1.66 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.97 -0.292 . . . . 1.0 111.242 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.689 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.68 114.62 2.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.044 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.41 ' C ' ' OE1' ' A' ' 67' ' ' GLU . 1.6 pp20? -145.22 135.29 23.82 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.523 -0.471 . . . . 1.0 111.833 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.39 144.83 51.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.692 -0.685 . . . . 1.0 109.386 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.473 ' NH1' ' C ' ' A' ' 71' ' ' GLY . 34.3 ptt85 -136.55 143.65 43.78 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.746 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -49.17 -41.68 30.86 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -173.31 -167.46 33.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -70.96 39.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.735 0.302 . . . . 1.0 110.515 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 71' ' ' GLY . 39.2 ttm180 -83.08 -49.72 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.18 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.93 151.18 49.95 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 1.0 109.849 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.66 164.2 35.33 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.522 2.148 . . . . 1.0 112.144 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -94.88 131.14 41.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.988 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.492 ' HA ' HD12 ' A' ' 80' ' ' LEU . 43.7 mt -90.26 11.51 20.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.411 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' CD2' HH12 ' A' ' 36' ' ' ARG . 11.3 tp -63.2 130.19 43.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 1.0 112.288 -177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.99 -12.36 66.33 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.498 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 77' ' ' LEU . 79.6 mt -81.68 150.0 28.24 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.285 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -109.35 137.61 46.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.646 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -90.45 152.58 45.55 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.495 -0.557 . . . . 1.0 109.495 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.18 140.13 87.42 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.691 2.261 . . . . 1.0 111.816 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.02 126.83 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.709 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.89 -0.52 45.0 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.484 -1.046 . . . . 1.0 110.484 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -57.43 -37.87 73.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.604 HD12 ' N ' ' A' ' 87' ' ' ILE . 1.6 mp -70.96 114.34 26.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.429 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 99.9 Cg_exo -46.55 173.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.467 2.111 . . . . 1.0 112.481 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.523 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 96.2 mt-10 -104.5 -52.1 2.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.495 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 90' ' ' GLU . 3.1 pm0 -68.55 -41.51 79.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.762 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 88' ' ' PRO . . . -66.04 -42.01 90.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.966 0.358 . . . . 1.0 111.966 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.501 ' NH2' HD13 ' A' ' 162' ' ' LEU . 67.0 ttt-85 -60.44 -36.44 78.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.487 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 75.3 mtt85 -66.58 -41.49 88.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.833 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.543 HD12 ' NH2' ' A' ' 101' ' ' ARG . 86.3 mt -64.9 -39.24 93.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.277 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.51 ' CE2' HD11 ' A' ' 165' ' ' LEU . 8.4 t80 -64.39 -28.76 69.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.02 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -81.95 -26.41 34.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.814 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.9 mt -98.18 -43.28 7.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.382 1.253 . . . . 1.0 114.382 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -111.8 -7.39 14.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.996 1.48 . . . . 1.0 114.996 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.509 ' OE1' ' O ' ' A' ' 95' ' ' PHE . 1.4 mm100 47.02 82.85 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.239 -0.984 . . . . 1.0 108.769 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 100' ' ' VAL . 2.6 p 174.13 103.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.048 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.543 ' NH2' HD12 ' A' ' 94' ' ' LEU . 7.7 mmt-85 -143.87 139.54 29.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 1.0 110.825 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -171.6 147.25 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.539 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.603 HD11 ' CD2' ' A' ' 139' ' ' HIS . 71.0 mt -108.75 138.06 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.95 165.37 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -48.31 119.83 3.23 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.133 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.423 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.9 p -58.27 -27.58 32.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.296 -0.866 . . . . 1.0 110.793 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -66.67 -42.84 85.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.68 -9.79 4.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.519 0.676 . . . . 1.0 109.395 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 45.41 58.42 4.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.704 -1.134 . . . . 1.0 113.28 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.8 p -77.55 134.65 38.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.919 -1.511 . . . . 1.0 106.919 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -123.1 144.64 49.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.952 -0.699 . . . . 1.0 111.903 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -132.37 156.48 46.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.527 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 112' ' ' SER . 24.9 pt . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.193 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo . . . . . 0 N--CA 1.492 1.428 0 CA-C-O 120.76 0.233 . . . . 1.0 111.956 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.55 HG13 ' CG2' ' A' ' 140' ' ' VAL . 2.3 p -122.69 134.26 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.861 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.465 ' OD2' ' SG ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -46.53 151.22 1.05 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 138' ' ' CYS . 36.2 Cg_endo -59.62 -46.93 18.04 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.263 2.642 . . . . 1.0 113.991 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -36.66 -44.84 0.48 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.682 0.253 . . . . 1.0 111.682 -178.151 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.688 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.6 t60 -83.79 -27.87 28.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.55 ' CG2' HG13 ' A' ' 135' ' ' VAL . 91.7 t -68.09 -51.0 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.979 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -66.75 -30.86 71.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -58.54 -43.85 89.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.67 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 146' ' ' MET . 13.1 mt -73.28 -37.79 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -50.86 -39.17 53.09 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -64.38 -25.5 68.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.765 -1.107 . . . . 1.0 109.195 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.562 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.2 mmm -90.56 1.95 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.705 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.55 21.57 78.73 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.81 142.47 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.89 0.376 . . . . 1.0 111.062 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.47 -20.39 13.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.908 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -145.62 160.6 41.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.203 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.479 ' OG ' HD12 ' A' ' 103' ' ' ILE . 3.7 p -147.7 122.08 9.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.411 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.2 mp -108.6 139.81 42.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.293 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.81 118.41 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.128 0.49 . . . . 1.0 111.726 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.8 t -122.5 127.35 25.86 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.427 ' HB3' ' CE2' ' A' ' 95' ' ' PHE . 83.4 Cg_endo -76.33 148.62 30.5 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.135 2.557 . . . . 1.0 114.692 -176.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -136.63 49.01 2.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.814 -1.551 . . . . 1.0 106.814 177.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.02 -175.72 4.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -174.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.38 163.09 28.36 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.383 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.526 ' ND1' ' OE1' ' A' ' 160' ' ' GLN . 58.4 t-80 -66.65 -53.99 28.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.37 -0.832 . . . . 1.0 112.023 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.526 ' OE1' ' ND1' ' A' ' 159' ' ' HIS . 12.1 mm100 -99.78 8.81 43.95 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.047 0.388 . . . . 1.0 112.047 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -143.13 134.83 26.57 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.834 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 162' ' ' LEU . 1.1 mp -110.41 116.98 32.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.188 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -92.19 -41.01 10.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.263 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.607 ' O ' HD12 ' A' ' 165' ' ' LEU . . . -153.72 -177.95 27.71 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 164' ' ' GLY . 0.7 OUTLIER -146.02 143.71 29.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.897 0.379 . . . . 1.0 111.531 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.538 ' HB2' HD11 ' A' ' 156' ' ' LEU . 8.8 tp -112.18 132.75 54.72 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 167' ' ' VAL . 14.8 p -136.08 132.84 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.982 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 21.3 m -107.49 149.44 27.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.074 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -124.87 131.85 53.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.02 0.438 . . . . 1.0 111.648 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.6 113.8 14.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.98 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.45 -15.89 63.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.84 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -96.18 147.43 32.96 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.942 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.86 76.18 2.06 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.98 2.453 . . . . 1.0 111.886 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -113.77 97.76 45.37 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.836 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.75 164.83 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.494 2.129 . . . . 1.0 111.972 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 44.6 p90 -92.0 130.68 37.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.488 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 98.4 p -119.17 157.64 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.607 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -54.79 -34.75 63.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.638 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -57.12 -36.71 70.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.81 -36.59 83.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.499 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.4 mp -67.97 -38.13 82.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.53 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -53.58 -40.88 65.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.356 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 88.5 t -70.32 -56.43 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.39 -38.89 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.477 0.547 . . . . 1.0 112.477 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 181' ' ' LEU . 62.9 tt0 -49.98 -49.82 49.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.667 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 31.7 tp -70.16 -40.38 74.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.938 0.347 . . . . 1.0 111.938 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 187' ' ' LEU . 44.7 tp -76.44 -38.79 54.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.787 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.46 77.93 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.517 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.68 -39.27 80.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.94 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -65.66 -27.87 68.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.084 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -83.71 -41.8 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.736 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.8 p -56.64 -33.24 66.14 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.4 mt -69.94 -38.23 74.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.213 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.11 76.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.602 -0.727 . . . . 1.0 109.832 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.6 mm -60.59 -46.55 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.162 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.98 -45.64 66.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -67.59 -41.21 84.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.517 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.56 72.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.69 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.06 -39.79 93.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.559 -0.291 . . . . 1.0 111.492 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.32 -36.26 83.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.986 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 98.6 p -56.89 -52.92 63.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.784 0.326 . . . . 1.0 110.588 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.568 179.547 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.808 0.337 . . . . 1.0 110.585 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.7 -28.72 56.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.032 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -79.84 -46.49 16.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.128 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.566 HG23 ' N ' ' A' ' 35' ' ' LEU . 3.2 tp -63.8 -43.96 98.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.955 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.566 ' N ' HG23 ' A' ' 34' ' ' ILE . 83.6 mt -61.39 -49.26 77.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.015 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -53.84 -37.68 63.86 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 -30.14 66.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.013 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.4 m -73.54 -45.0 56.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.591 -0.731 . . . . 1.0 112.204 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.672 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.1 p -67.39 -34.98 72.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -70.5 -39.33 74.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 1.0 111.098 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -65.54 -50.78 63.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.829 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.23 -28.81 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.683 0.278 . . . . 1.0 111.128 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.3 tmm_? -61.88 -46.4 89.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.865 0.364 . . . . 1.0 110.882 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.15 -33.45 69.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.097 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -79.68 -41.18 27.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.551 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 mt -85.34 -35.42 21.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.453 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 62.31 20.54 61.01 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.521 -1.031 . . . . 1.0 110.521 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -73.42 141.63 46.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.808 0.337 . . . . 1.0 110.173 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.563 ' CG ' HH21 ' A' ' 73' ' ' ARG . 92.3 m-20 -39.45 -44.3 1.36 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.622 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -164.76 130.43 2.77 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.025 -0.67 . . . . 1.0 112.57 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.16 129.01 42.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.464 ' O ' HD12 ' A' ' 166' ' ' LEU . 51.6 pttt -140.83 154.81 46.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.867 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 58.1 t -98.47 135.04 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 176.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 47.5 t80 -115.74 105.36 12.64 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.323 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -76.16 124.81 28.04 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.232 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 86.7 t80 -90.87 142.18 28.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 1.0 112.02 -178.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 1.1 m-20 -112.04 151.36 43.53 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 108.617 -0.882 . . . . 1.0 108.617 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.48 -23.65 75.78 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.541 2.161 . . . . 1.0 112.469 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -88.32 -12.12 44.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 1.0 110.045 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.61 -13.85 57.92 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.572 -0.611 . . . . 1.0 111.572 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -78.88 89.83 4.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.855 0.36 . . . . 1.0 110.606 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.47 151.63 21.07 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -125.07 146.39 49.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 1.0 111.679 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.96 108.98 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 65' ' ' VAL . 52.5 t -105.79 -1.61 9.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.904 -0.318 . . . . 1.0 111.333 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.672 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.03 115.38 2.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.143 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.482 ' CD ' ' NH2' ' A' ' 69' ' ' ARG . 87.7 tt0 -143.14 132.49 23.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.074 0.464 . . . . 1.0 111.856 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.98 147.77 50.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.4 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.482 ' NH2' ' CD ' ' A' ' 67' ' ' GLU . 42.3 mtt85 -141.23 142.33 33.96 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.77 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.98 -31.21 80.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.41 -173.66 38.53 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -79.26 40.0 0.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 1.0 110.517 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.563 HH21 ' CG ' ' A' ' 49' ' ' ASP . 22.3 ttp-105 -83.19 -48.64 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.22 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -103.37 149.93 37.48 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.167 -0.47 . . . . 1.0 109.905 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.61 148.58 72.61 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.535 2.157 . . . . 1.0 112.138 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.0 m -76.83 125.2 28.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.907 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 80' ' ' LEU . 25.1 mt -103.99 9.75 36.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.323 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.54 132.43 41.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.182 0.515 . . . . 1.0 112.305 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.88 -7.96 75.05 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.624 -0.716 . . . . 1.0 111.521 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 77' ' ' LEU . 63.4 mt -88.38 154.87 20.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.76 0.314 . . . . 1.0 110.246 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -103.07 129.02 49.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.663 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -82.49 152.06 66.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.57 132.08 31.89 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.617 2.211 . . . . 1.0 111.848 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 128.72 37.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.052 0.454 . . . . 1.0 110.686 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.42 -0.17 40.29 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -59.24 -15.71 17.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.57 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.7 mt -104.14 105.62 49.77 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.696 -0.683 . . . . 1.0 109.465 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 87' ' ' ILE . 92.8 Cg_exo -48.11 -162.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.4 2.067 . . . . 1.0 112.485 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -107.21 -58.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.543 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.55 -42.04 86.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.835 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.84 -48.63 68.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.98 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -59.38 -37.94 79.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.445 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -64.51 -33.31 75.6 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.9 -0.32 . . . . 1.0 110.807 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.446 HD13 ' NH1' ' A' ' 101' ' ' ARG . 92.3 mt -64.49 -38.12 89.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.256 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.467 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 21.0 m-85 -61.45 -48.5 80.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.041 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -51.5 -34.57 36.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.835 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.4 mt -99.07 -38.01 9.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 114.4 1.259 . . . . 1.0 114.4 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.596 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.25 -13.25 11.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 115.105 1.52 . . . . 1.0 115.105 -174.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.596 ' C ' ' O ' ' A' ' 98' ' ' ALA . 15.3 mm100 34.65 74.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.249 -0.98 . . . . 1.0 108.788 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 100' ' ' VAL . 7.6 p 177.17 117.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.122 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.446 ' NH1' HD13 ' A' ' 94' ' ' LEU . 2.0 tpt180 -176.0 145.36 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.922 0.391 . . . . 1.0 110.791 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.0 m -151.22 158.05 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.515 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.7 136.06 44.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 3.4 m -93.03 166.12 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 113.321 0.86 . . . . 1.0 113.321 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 173' ' ' PRO . 57.8 m-20 -46.31 118.42 1.93 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.918 -1.037 . . . . 1.0 112.166 -176.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.466 HG23 ' CG1' ' A' ' 140' ' ' VAL . 9.9 p -56.05 -22.73 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.789 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -62.56 -44.02 97.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.71 -10.97 31.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.56 0.695 . . . . 1.0 109.351 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 44.12 72.06 0.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.743 -1.117 . . . . 1.0 113.294 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.478 ' OG ' ' CG2' ' A' ' 104' ' ' VAL . 2.0 m -73.74 131.81 41.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.951 -1.499 . . . . 1.0 106.951 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -119.93 137.35 54.09 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.029 -0.668 . . . . 1.0 111.936 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.2 t -135.27 158.72 43.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.482 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 113' ' ' ILE . 44.9 mm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.15 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo . . . . . 0 N--CA 1.492 1.409 0 CA-C-O 120.747 0.228 . . . . 1.0 111.895 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.518 HG23 ' CG2' ' A' ' 140' ' ' VAL . 1.5 m -104.77 119.0 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.887 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 112' ' ' SER . 18.7 t70 -44.13 137.38 3.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.754 -0.462 . . . . 1.0 109.754 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -37.82 -46.72 2.01 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.141 2.561 . . . . 1.0 114.034 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.684 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -41.31 -45.28 2.95 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.668 0.247 . . . . 1.0 111.668 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.684 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 17.4 t60 -81.86 -28.19 33.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.235 0.458 . . . . 1.0 112.235 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.518 ' CG2' HG23 ' A' ' 135' ' ' VAL . 85.2 t -66.97 -54.09 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.963 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -63.99 -29.36 70.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -57.68 -45.15 85.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.68 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 146' ' ' MET . 16.8 mt -73.02 -38.81 66.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -51.07 -39.7 56.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -63.78 -24.91 67.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.766 -1.106 . . . . 1.0 109.147 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.549 ' N ' ' O ' ' A' ' 143' ' ' LEU . 80.6 mmm -91.08 2.09 56.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.731 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.14 20.69 79.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.21 141.63 22.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 1.0 111.014 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.63 -21.65 13.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.919 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.6 p -146.35 161.29 40.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.166 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 p -146.54 131.93 18.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.449 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -119.51 125.15 48.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.315 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 166' ' ' LEU . 2.8 t -113.32 114.14 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.129 0.49 . . . . 1.0 111.754 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.6 t -120.62 93.69 48.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.751 -1.203 . . . . 1.0 107.751 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HB3' ' NE2' ' A' ' 99' ' ' GLN . 90.2 Cg_exo -44.94 140.24 7.21 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.142 2.562 . . . . 1.0 114.666 -176.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.473 HD23 HG11 ' A' ' 191' ' ' VAL . 6.6 mp -122.04 50.31 1.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.87 -1.53 . . . . 1.0 106.87 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.446 ' CE ' ' O ' ' A' ' 164' ' ' GLY . 0.1 OUTLIER -146.45 -174.18 4.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.118 0.784 . . . . 1.0 113.118 -176.136 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.745 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 8.2 m-70 -65.37 154.1 39.32 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.305 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -56.23 -46.04 79.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.342 -0.845 . . . . 1.0 112.035 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -103.6 -44.02 5.21 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.049 0.388 . . . . 1.0 112.049 -177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.492 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 88.3 tt0 -84.75 138.03 32.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.895 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.412 ' HG ' ' SD ' ' A' ' 157' ' ' MET . 3.1 tt -105.72 113.85 27.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.324 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.745 ' HE1' ' CD2' ' A' ' 158' ' ' HIS . 68.7 m95 -94.15 -39.95 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.255 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -156.87 -173.4 25.27 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.179 -0.769 . . . . 1.0 111.179 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 95' ' ' PHE . 11.4 tp -141.27 130.0 22.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.857 0.361 . . . . 1.0 111.526 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.579 ' O ' HG13 ' A' ' 153' ' ' VAL . 56.5 tp -101.96 133.01 47.43 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.4 p -142.2 134.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.059 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.3 p -107.41 146.54 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.016 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -119.73 131.44 55.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.989 0.423 . . . . 1.0 111.634 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.89 113.76 13.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.971 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.83 -17.07 64.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.815 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -83.57 146.79 50.91 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.031 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.446 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 71.2 Cg_endo -72.38 5.99 2.49 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.898 2.399 . . . . 1.0 111.863 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -51.42 131.49 34.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.39 167.12 26.3 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.557 2.172 . . . . 1.0 111.883 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 50.4 p90 -88.95 132.8 34.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.466 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.1 t -117.25 147.22 42.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.565 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -50.96 -34.66 29.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.63 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -55.3 -41.1 71.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.709 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.47 -41.3 98.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.491 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.1 tp -63.82 -38.96 93.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.534 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -54.83 -35.03 63.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.308 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.7 t -70.61 -52.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.805 0.668 . . . . 1.0 112.805 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 t -77.31 -30.97 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -52.67 -49.87 64.38 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.026 -0.27 . . . . 1.0 111.646 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 186' ' ' LEU . 7.5 mp -70.71 -37.27 73.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.876 ' O ' HG23 ' A' ' 191' ' ' VAL . 8.0 tp -77.57 -37.83 49.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.828 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.27 95.81 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.552 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -61.11 -39.29 89.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 1.0 109.958 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -71.99 -29.05 63.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.115 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 187' ' ' LEU . 26.3 t -82.38 -48.78 17.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.712 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 84.2 p -50.66 -27.57 7.23 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.5 mt -77.51 -32.54 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.2 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -69.47 -47.69 63.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.617 -0.719 . . . . 1.0 109.803 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.1 pp -67.47 -35.53 73.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.134 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.46 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -70.68 -49.7 44.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.15 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.19 -32.36 66.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.496 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.09 -34.25 77.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.701 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -56.26 -29.85 61.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.575 -0.284 . . . . 1.0 111.445 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.593 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.9 mp -60.13 -33.28 71.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.702 0.287 . . . . 1.0 111.033 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 63.3 p -52.95 -54.62 32.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.566 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.2 mp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.488 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.342 . . . . 1.0 110.542 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -48.43 -32.78 8.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.987 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -78.72 -45.56 20.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.065 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.8 mm -64.5 -39.93 87.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.878 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.7 mt -59.83 -45.94 90.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.006 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -57.31 -37.25 72.18 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.45 -28.48 65.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.079 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 42' ' ' VAL . 23.7 m -74.05 -47.24 38.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.526 -0.761 . . . . 1.0 112.244 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.673 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p -65.27 -34.52 71.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.949 0.351 . . . . 1.0 111.949 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.48 -49.55 70.95 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.9 -47.24 81.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.766 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 38' ' ' THR . 68.9 t -53.51 -46.49 59.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.989 -0.284 . . . . 1.0 111.165 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 47' ' ' GLY . 15.5 ttt-85 -49.87 -38.48 35.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.771 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.52 75.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -76.8 -44.12 33.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.552 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mt -86.2 -27.58 24.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.502 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.68 22.02 24.01 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.449 -1.061 . . . . 1.0 110.449 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.5 p -74.44 144.18 44.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.884 0.373 . . . . 1.0 110.194 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -42.35 -39.83 2.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.659 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 42.9 ttm180 -162.73 129.08 3.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.038 -0.665 . . . . 1.0 112.574 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.81 130.95 53.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.472 ' HZ2' ' CG1' ' A' ' 167' ' ' VAL . 17.4 pttp -141.57 158.64 43.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.073 0.464 . . . . 1.0 111.969 -177.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 62.7 t -100.48 136.85 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 177.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -119.08 104.78 10.78 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.392 -0.523 . . . . 1.0 111.272 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.638 HH22 ' CG2' ' A' ' 195' ' ' ILE . 42.5 mmt-85 -77.3 128.0 33.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.264 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.498 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 78.9 t80 -93.32 139.21 30.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 1.0 112.024 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.498 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 1.6 m-20 -109.03 151.24 41.82 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.658 -0.867 . . . . 1.0 108.658 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.44 -23.93 72.61 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.516 2.144 . . . . 1.0 112.483 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -87.08 -13.26 44.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.64 -11.56 57.91 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.569 -0.613 . . . . 1.0 111.569 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -80.69 90.54 5.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.793 0.33 . . . . 1.0 110.642 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.7 151.43 20.88 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.617 -0.993 . . . . 1.0 110.617 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -124.77 149.01 47.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 1.0 111.679 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.5 t -77.93 109.16 12.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.0 t -107.06 -0.3 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.327 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.673 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.39 115.97 2.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.038 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 86.0 tt0 -144.5 132.73 21.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.839 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.3 142.31 50.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.415 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -140.04 144.79 37.06 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.721 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.441 ' CA ' HH21 ' A' ' 43' ' ' ARG . . . -60.55 -35.31 88.86 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -172.7 -164.33 27.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.59 25.69 0.33 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.76 0.314 . . . . 1.0 110.536 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -72.19 -48.0 46.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.117 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.432 ' C ' HH22 ' A' ' 50' ' ' ARG . 15.1 mt -106.65 148.35 36.67 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.879 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.526 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 58.1 Cg_endo -69.59 137.99 37.27 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.49 2.127 . . . . 1.0 112.166 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.1 t -72.44 123.46 23.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.936 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HA ' HD12 ' A' ' 80' ' ' LEU . 19.9 mt -99.02 11.32 39.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.397 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.7 tp -71.43 128.89 37.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.241 0.543 . . . . 1.0 112.261 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.79 -9.44 76.33 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.455 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 77' ' ' LEU . 60.8 mt -85.7 152.06 23.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.307 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.1 p -104.51 132.89 50.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.731 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -87.23 128.15 56.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.557 -0.534 . . . . 1.0 109.557 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -41.28 133.08 3.24 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.675 2.25 . . . . 1.0 111.862 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.36 132.48 49.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.657 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.77 0.58 42.53 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.53 -1.028 . . . . 1.0 110.53 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -54.52 -33.85 60.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.9 mt -90.61 111.71 49.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.361 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' A' ' 87' ' ' ILE . 87.2 Cg_exo -51.89 -157.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.411 2.074 . . . . 1.0 112.467 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 74.8 mm-40 -109.43 -54.59 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.536 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.83 -43.86 97.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.822 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.27 76.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.436 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 51.2 ttt85 -56.06 -35.38 66.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.393 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 75.4 mtt85 -64.22 -34.01 77.12 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.812 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.407 HD12 ' NH2' ' A' ' 101' ' ' ARG . 12.8 mt -65.19 -37.42 87.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.332 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE2' ' HG3' ' A' ' 101' ' ' ARG . 32.2 m-85 -59.88 -30.78 69.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.096 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -79.93 -26.26 40.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.829 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.407 ' C ' ' OE1' ' A' ' 99' ' ' GLN . 82.3 mt -100.65 -44.66 5.76 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.44 1.274 . . . . 1.0 114.44 -175.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.53 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -118.23 -12.45 9.97 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 115.078 1.511 . . . . 1.0 115.078 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.53 ' C ' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 38.8 79.72 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.166 -1.014 . . . . 1.0 108.827 -178.481 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 100' ' ' VAL . 11.1 p -177.11 102.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.066 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.435 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 11.1 mmt180 -148.07 151.18 35.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.923 0.392 . . . . 1.0 110.746 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -169.54 147.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.476 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.41 HG23 HG11 ' A' ' 135' ' ' VAL . 76.8 mt -109.41 134.8 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 m -92.16 164.65 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.331 0.863 . . . . 1.0 113.331 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 18.0 p30 -43.98 117.7 1.27 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.98 -1.009 . . . . 1.0 112.156 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.74 -19.55 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.734 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.28 -43.04 92.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.03 -13.28 62.07 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.56 0.695 . . . . 1.0 109.453 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.556 ' CD ' HH21 ' A' ' 111' ' ' ARG . 55.4 tt0 45.74 72.59 0.21 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.684 -1.143 . . . . 1.0 113.334 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.0 t -73.86 131.66 41.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.556 HH21 ' CD ' ' A' ' 109' ' ' GLN . 93.9 mtt180 -118.99 139.14 52.19 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.943 -0.703 . . . . 1.0 111.886 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.416 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.2 OUTLIER -130.97 152.11 50.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.513 179.199 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.5 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.146 179.665 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 120.642 0.184 . . . . 1.0 111.956 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.41 HG11 HG23 ' A' ' 103' ' ' ILE . 1.6 p -98.88 116.51 42.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.797 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' A' ' 112' ' ' SER . 10.7 t70 -43.1 136.95 2.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD3' ' H ' ' A' ' 112' ' ' SER . 62.3 Cg_exo -42.42 -49.5 6.22 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 123.213 2.609 . . . . 1.0 114.019 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.689 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -36.88 -45.33 0.55 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.645 0.239 . . . . 1.0 111.645 -178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.689 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.5 t60 -81.55 -27.73 34.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.254 0.464 . . . . 1.0 112.254 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 137' ' ' PRO . 40.2 t -65.39 -52.97 45.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.967 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -64.77 -27.62 69.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.419 ' O ' ' OG ' ' A' ' 145' ' ' SER . 76.4 t80 -61.21 -46.45 90.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.678 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 146' ' ' MET . 54.0 mt -73.11 -37.62 66.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -38.69 58.74 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.561 -1.274 . . . . 1.0 107.561 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 5.7 p -62.82 -20.4 65.01 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.782 -1.099 . . . . 1.0 109.201 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 143' ' ' LEU . 95.4 mmm -95.49 1.21 53.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.774 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.92 24.5 71.79 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.25 140.8 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 1.0 111.014 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.63 -38.12 6.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.934 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.3 m -133.59 125.77 29.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 1.0 111.109 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.8 m -115.42 138.29 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.45 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.5 mt -116.55 139.5 50.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.313 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.44 114.81 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.482 . . . . 1.0 111.818 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 184' ' ' VAL . 95.7 t -123.43 91.28 49.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.477 ' O ' HD12 ' A' ' 156' ' ' LEU . 85.7 Cg_exo -48.31 144.57 12.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 123.144 2.563 . . . . 1.0 114.705 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.481 HD23 ' CG1' ' A' ' 191' ' ' VAL . 7.9 mp -121.54 66.87 0.89 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -149.58 -172.92 4.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.129 0.788 . . . . 1.0 113.129 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.584 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 54.8 t-80 -77.6 173.89 11.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.413 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.584 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 92.9 m-70 -61.73 -52.46 64.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.387 -0.824 . . . . 1.0 112.058 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -104.53 -40.52 6.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.054 0.391 . . . . 1.0 112.054 -177.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE1' ' CD2' ' A' ' 163' ' ' TRP . 7.7 tm-20 -87.81 136.6 32.89 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.691 -0.403 . . . . 1.0 110.93 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.536 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.4 OUTLIER -111.55 116.3 30.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.272 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.533 ' CD2' ' OE1' ' A' ' 161' ' ' GLU . 25.1 m95 -88.67 -33.91 17.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.277 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.82 -173.79 36.19 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.233 -0.747 . . . . 1.0 111.233 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.3 135.41 30.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 1.0 111.495 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.14 136.2 43.38 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.472 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 9.5 p -140.36 135.01 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.121 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.5 m -108.93 139.86 43.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.029 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -116.33 133.68 55.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.948 0.404 . . . . 1.0 111.653 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.71 123.16 30.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.94 178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.43 41.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.794 -177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -165.07 148.52 7.3 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.041 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.475 ' O ' ' C ' ' A' ' 174' ' ' ARG . 77.8 Cg_exo -41.42 -75.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.884 2.389 . . . . 1.0 111.897 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.475 ' C ' ' O ' ' A' ' 173' ' ' PRO . 54.3 ttt85 33.65 84.59 0.18 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.875 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.0 162.93 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.541 2.161 . . . . 1.0 111.894 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.533 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 51.6 p90 -82.69 125.93 31.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.464 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.0 t -113.6 148.59 35.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.565 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -52.9 -27.01 16.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.631 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -58.14 -43.25 87.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.685 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -64.13 -35.85 82.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.479 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 18.8 tp -60.68 -41.78 95.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.536 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -58.35 -34.94 71.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.342 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 64.0 t -67.84 -53.33 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 185' ' ' GLN . 33.6 m -70.35 -43.71 78.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.395 0.517 . . . . 1.0 112.395 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 184' ' ' VAL . 65.8 mm-40 -43.51 -42.12 4.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.954 -0.299 . . . . 1.0 111.644 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.9 mt -74.97 -44.9 45.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.889 ' O ' HG23 ' A' ' 191' ' ' VAL . 57.3 mt -80.55 -39.79 27.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.827 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.64 84.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.492 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -65.84 -39.64 90.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.002 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -67.69 -29.43 68.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 187' ' ' LEU . 58.6 t -84.08 -45.03 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.714 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 57.9 p -55.37 -31.38 61.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 52.6 mt -76.73 -34.31 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.234 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.11 -42.4 84.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.82 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.638 ' CG2' HH22 ' A' ' 55' ' ' ARG . 37.4 pt -68.15 -33.72 62.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.163 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -70.13 -50.71 37.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.14 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -71.67 -36.51 70.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.479 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.66 -35.04 79.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -56.93 -29.58 63.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.472 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.622 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.2 mp -61.91 -34.15 75.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.682 0.277 . . . . 1.0 111.069 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 35.0 m -49.92 -54.08 22.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.563 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.579 179.695 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.888 0.375 . . . . 1.0 110.604 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -55.71 -50.93 69.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.978 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.596 HE22 ' NH2' ' A' ' 36' ' ' ARG . 84.7 mm-40 -57.03 -45.54 83.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.077 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.22 -47.15 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 1.0 110.939 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -58.68 -48.41 81.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.048 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.596 ' NH2' HE22 ' A' ' 33' ' ' GLN . 66.3 mtm180 -56.42 -36.32 68.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.442 . . . . 1.0 109.83 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.88 65.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.061 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 42' ' ' VAL . 27.2 m -73.29 -47.82 39.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.556 -0.747 . . . . 1.0 112.149 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.676 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.3 p -65.6 -35.07 74.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.38 -50.93 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 1.0 111.105 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -61.03 -43.36 99.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.784 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 38' ' ' THR . 79.8 t -57.36 -42.57 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.714 0.293 . . . . 1.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 47' ' ' GLY . 62.7 ttp85 -51.29 -40.18 58.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.763 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.41 78.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.041 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -78.38 -45.97 21.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 1.0 111.56 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.87 -31.8 22.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.53 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.93 20.71 27.71 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.6 p -70.92 142.0 51.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 1.0 110.167 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -40.98 -41.28 1.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.633 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.536 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -163.34 128.7 3.08 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.079 -0.648 . . . . 1.0 112.606 -178.582 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.9 130.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -139.98 157.2 46.05 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.441 -0.504 . . . . 1.0 111.903 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.8 t -100.23 136.95 29.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.525 -0.917 . . . . 1.0 108.525 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 50.1 t80 -130.28 128.96 42.64 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.322 -0.551 . . . . 1.0 111.227 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -94.94 132.43 39.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.18 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -91.33 118.63 30.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -87.79 151.4 49.88 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 108.639 -0.875 . . . . 1.0 108.639 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.76 -20.85 60.84 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.48 2.12 . . . . 1.0 112.444 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -82.77 -17.51 43.92 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.06 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.73 -15.41 37.78 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.549 -0.621 . . . . 1.0 111.549 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 40.5 m80 -64.14 -104.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.773 0.32 . . . . 1.0 110.632 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.453 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . 103.89 152.97 23.09 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -128.09 147.51 50.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 1.0 111.696 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.458 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.5 p -81.66 117.06 27.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.93 4.87 9.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.696 0.284 . . . . 1.0 111.37 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.676 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.99 118.58 2.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.104 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 85.8 tt0 -144.37 133.21 22.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 1.0 111.846 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.2 151.5 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.393 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -139.74 142.26 36.82 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.762 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -39.96 -68.96 0.5 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.96 83.84 0.13 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 41.7 38.65 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.746 0.308 . . . . 1.0 110.522 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -82.62 -53.53 5.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.215 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.2 mt -110.27 141.42 23.85 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.888 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.14 165.67 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.479 2.12 . . . . 1.0 112.176 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.8 t -93.38 123.41 36.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.871 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.508 ' HA ' HD12 ' A' ' 80' ' ' LEU . 20.9 mt -90.59 2.59 55.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.376 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.16 131.12 49.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.179 0.514 . . . . 1.0 112.28 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.67 -13.55 63.89 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.545 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 77' ' ' LEU . 78.0 mt -82.1 150.93 27.24 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.309 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.5 m -106.14 134.4 49.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.703 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.92 153.04 49.29 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.92 136.16 51.52 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.692 2.262 . . . . 1.0 111.879 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.465 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . . . -67.21 130.56 43.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.708 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.4 -2.43 39.93 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.497 -1.041 . . . . 1.0 110.497 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 20.8 p-10 -54.61 -38.19 66.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.4 mm -75.08 133.49 75.39 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.42 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.736 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 98.9 Cg_endo -72.28 -175.21 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.426 2.084 . . . . 1.0 112.526 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -105.46 -51.25 3.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.556 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.43 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 21.5 pt-20 -67.5 -41.97 83.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.843 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.736 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -68.16 -42.47 80.01 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.876 0.324 . . . . 1.0 111.876 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.604 HH22 HD22 ' A' ' 162' ' ' LEU . 61.0 ttt85 -63.83 -41.82 97.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.471 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -60.23 -32.96 71.62 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.879 -0.329 . . . . 1.0 110.847 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HB2' HH22 ' A' ' 101' ' ' ARG . 96.4 mt -71.46 -35.91 71.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.289 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.53 -40.85 96.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.02 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -63.66 -33.57 75.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.81 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.406 ' C ' ' OE1' ' A' ' 99' ' ' GLN . 72.0 mt -97.18 -37.11 10.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 114.389 1.255 . . . . 1.0 114.389 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -118.01 -10.1 10.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.11 1.522 . . . . 1.0 115.11 -175.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.497 ' N ' ' OE1' ' A' ' 99' ' ' GLN . 0.2 OUTLIER 41.58 79.48 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.114 -1.034 . . . . 1.0 108.864 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 100' ' ' VAL . 7.8 p 179.78 107.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.096 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.514 ' NH1' ' O ' ' A' ' 91' ' ' ALA . 8.9 ttm105 -153.27 148.76 27.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.954 0.407 . . . . 1.0 110.803 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 p -167.62 150.26 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.502 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.3 mt -106.91 136.43 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 105' ' ' ASP . 22.4 t -88.78 158.64 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -176.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.502 ' N ' HG12 ' A' ' 104' ' ' VAL . 64.5 m-20 -48.37 122.77 5.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.913 -1.039 . . . . 1.0 112.121 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.19 -26.71 26.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.786 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.9 -46.75 83.45 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.79 -12.67 50.29 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.49 0.662 . . . . 1.0 109.359 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 45.86 72.2 0.24 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.767 -1.106 . . . . 1.0 113.275 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 p -73.74 130.53 40.17 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.915 -1.513 . . . . 1.0 106.915 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -118.57 133.99 55.44 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.946 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 t -125.96 145.32 50.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.55 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.201 179.777 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 120.723 0.218 . . . . 1.0 111.904 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.562 HG23 ' CG2' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -103.24 117.9 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.824 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 138' ' ' CYS . 19.4 t70 -43.72 137.8 3.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -39.45 -20.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 123.153 2.569 . . . . 1.0 114.005 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.701 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.1 p -64.91 -46.06 83.28 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.662 0.245 . . . . 1.0 111.662 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.701 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.8 t60 -82.75 -24.53 33.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.562 ' CG2' HG23 ' A' ' 135' ' ' VAL . 72.0 t -65.85 -52.03 54.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.651 -0.42 . . . . 1.0 110.947 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.9 -29.71 69.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.778 -0.452 . . . . 1.0 109.778 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -58.49 -46.66 86.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.74 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 146' ' ' MET . 11.6 mt -72.73 -38.13 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -51.29 -38.71 54.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -65.04 -25.33 67.78 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.153 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.1 mmm -90.77 0.36 57.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.668 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.87 79.1 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.06 142.19 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.889 0.376 . . . . 1.0 110.969 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.53 -29.31 9.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.912 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.441 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 37.8 m -138.5 155.3 48.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.198 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 p -145.49 126.77 14.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.446 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tp -110.3 134.91 51.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.284 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 166' ' ' LEU . 5.7 t -122.81 120.92 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.182 0.515 . . . . 1.0 111.725 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 184' ' ' VAL . 1.2 m -114.81 167.37 9.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -83.27 122.36 3.24 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.187 2.591 . . . . 1.0 114.667 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.3 tp -124.24 35.56 4.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -146.34 177.7 8.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.158 0.799 . . . . 1.0 113.158 -176.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.677 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 11.3 t-80 -68.73 -171.51 0.29 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.344 -0.843 . . . . 1.0 111.365 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.677 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 56.1 t-80 -73.68 -54.27 8.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.403 -0.817 . . . . 1.0 112.097 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -104.95 -32.01 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.046 0.387 . . . . 1.0 112.046 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 85.1 tt0 -94.05 141.41 28.57 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.88 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.604 HD22 HH22 ' A' ' 92' ' ' ARG . 7.2 tt -108.15 116.02 31.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.263 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.515 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 77.8 m95 -89.86 -37.64 14.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.266 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.04 -174.69 35.01 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.56 132.61 31.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.807 0.337 . . . . 1.0 111.563 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.481 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.5 tp -101.61 133.79 45.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 167' ' ' VAL . 11.7 p -140.13 133.25 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.796 -0.361 . . . . 1.0 111.147 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 78.6 p -109.76 139.89 44.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.025 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -113.66 133.34 55.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.026 0.441 . . . . 1.0 111.651 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -130.93 130.85 43.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.597 . . . . 1.0 109.973 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.32 59.02 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.785 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -160.14 128.7 2.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.993 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.426 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 90.0 Cg_endo -77.21 22.36 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.922 2.414 . . . . 1.0 111.883 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -72.57 126.24 90.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.883 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -46.7 153.01 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.609 2.206 . . . . 1.0 111.882 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -86.24 141.86 28.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.481 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.7 m -118.07 150.24 39.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.598 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -57.74 -29.4 64.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.623 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -56.24 -38.47 71.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.756 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.25 -40.03 94.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.548 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.03 -37.94 89.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.509 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -53.62 -39.36 64.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.917 -0.583 . . . . 1.0 111.382 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.25 -54.33 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.592 HG21 HG11 ' A' ' 154' ' ' VAL . 7.3 p -78.9 -36.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -47.53 -49.22 26.77 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.656 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 33.5 mt -75.19 -38.35 60.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.97 -41.32 51.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.801 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.39 86.96 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.504 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.29 -37.76 70.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.976 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -68.85 -24.73 64.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.118 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.8 t -83.99 -45.35 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.793 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 85.5 p -56.86 -35.25 68.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.0 mt -66.96 -33.95 66.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.426 -0.806 . . . . 1.0 109.185 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.42 -38.35 74.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.778 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 195' ' ' ILE . 38.2 mm -59.28 -49.35 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.112 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.454 ' O ' ' CD1' ' A' ' 200' ' ' LEU . . . -71.59 -48.61 47.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.836 -0.62 . . . . 1.0 111.122 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -63.96 -42.9 97.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.496 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.89 -31.11 71.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.673 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -58.29 -31.97 67.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.592 -0.277 . . . . 1.0 111.417 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.7 mp -60.63 -34.58 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.045 -0.262 . . . . 1.0 111.054 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 31.7 t -55.31 -56.72 16.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.538 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.587 179.829 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.911 0.386 . . . . 1.0 110.574 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.45 -51.07 69.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.964 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -56.64 -47.49 79.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.066 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.51 -47.85 91.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.787 0.327 . . . . 1.0 110.974 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.9 mt -55.91 -42.42 76.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 1.0 111.056 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.24 -35.29 62.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -34.6 70.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.065 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 42' ' ' VAL . 64.5 p -73.1 -41.22 64.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.498 -0.774 . . . . 1.0 112.271 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.607 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 8.2 p -70.44 -37.66 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.23 -46.65 79.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.151 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -59.89 -47.92 83.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.78 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 38' ' ' THR . 71.0 t -53.58 -38.43 33.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.986 -0.285 . . . . 1.0 111.115 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.541 ' NH1' ' O ' ' A' ' 69' ' ' ARG . 54.1 ttp180 -53.62 -44.11 69.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.339 . . . . 1.0 110.85 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.38 -34.2 70.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.117 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -74.14 -43.92 55.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.549 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.57 -30.12 19.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.421 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.5 20.88 1.12 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.534 HG21 ' CD2' ' A' ' 170' ' ' HIS . 5.5 p -63.64 -96.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.81 0.338 . . . . 1.0 110.236 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -155.6 -47.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 1.0 111.658 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -154.76 124.23 6.47 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.954 -0.699 . . . . 1.0 112.515 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.8 t -128.35 129.39 69.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -141.08 149.74 42.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.888 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 23.8 t -111.84 138.16 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.495 ' CD1' ' C ' ' A' ' 54' ' ' TYR . 2.4 p90 -136.15 139.09 42.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.314 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -93.31 141.38 28.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.294 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.64 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 64.0 t80 -92.69 117.54 30.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 1.0 112.123 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 17.3 p-10 -88.17 150.72 47.83 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.41 -20.11 67.05 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.516 2.144 . . . . 1.0 112.476 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -87.02 -19.82 28.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 1.0 110.096 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.64 -16.07 37.53 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.589 -0.604 . . . . 1.0 111.589 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.547 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 93.7 m-70 -74.25 91.81 2.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 1.0 110.561 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.55 144.36 20.51 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.3 p -122.01 143.47 49.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 1.0 111.666 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.481 ' O ' HD12 ' A' ' 78' ' ' LEU . 61.1 t -79.18 110.87 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.27 2.17 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.387 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.607 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.94 123.98 4.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.112 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -146.09 132.59 19.73 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.519 -0.472 . . . . 1.0 111.797 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.77 141.53 51.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.381 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.541 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 30.0 ptt180 -143.06 144.21 32.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.724 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.14 -34.81 47.87 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -173.27 -168.64 34.72 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.437 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 77.2 mm-40 -72.35 44.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 1.0 110.49 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 71' ' ' GLY . 56.9 ttm-85 -83.47 -48.85 9.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.141 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.36 149.77 41.54 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.906 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.13 165.19 33.21 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.577 2.185 . . . . 1.0 112.094 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.9 p -88.19 129.4 35.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.952 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.512 ' HA ' HD12 ' A' ' 80' ' ' LEU . 25.6 mt -98.47 2.57 47.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.364 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 64' ' ' VAL . 6.0 tp -62.01 131.35 49.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 1.0 112.337 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.17 -14.03 61.86 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.549 -0.75 . . . . 1.0 111.505 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 77' ' ' LEU . 68.3 mt -82.12 151.06 27.15 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.963 -0.295 . . . . 1.0 110.29 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.4 p -104.83 130.55 52.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.657 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -85.61 153.76 58.58 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.28 135.68 59.53 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.704 2.269 . . . . 1.0 111.897 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.23 126.75 29.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.722 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.3 -0.58 43.64 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.49 -37.13 64.92 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.061 ' H ' HD12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -81.55 113.52 42.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.413 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 87' ' ' ILE . 80.4 Cg_exo -49.47 -171.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.468 2.112 . . . . 1.0 112.474 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 79.3 mm-40 -108.43 -55.85 2.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.553 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -59.88 -42.53 93.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.789 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.99 -51.05 59.91 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.922 0.342 . . . . 1.0 111.922 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.783 ' HE ' HH21 ' A' ' 96' ' ' ARG . 59.3 ttt85 -50.17 -35.44 26.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.504 -0.316 . . . . 1.0 111.427 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 78.5 mtt85 -67.78 -35.16 78.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.798 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.7 mt -58.37 -39.03 78.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.273 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.615 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 92.5 m-85 -61.57 -50.44 72.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.052 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.783 HH21 ' HE ' ' A' ' 92' ' ' ARG . 95.6 mtt180 -54.56 -32.68 58.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.811 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.2 mt -101.39 -44.04 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.428 1.27 . . . . 1.0 114.428 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.12 -15.3 11.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 115.057 1.502 . . . . 1.0 115.057 -173.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 19.9 mm-40 44.16 79.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.205 -0.998 . . . . 1.0 108.849 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 100' ' ' VAL . 7.6 p -179.36 107.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.074 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -156.15 150.94 26.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 1.0 110.777 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -170.43 148.51 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.498 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.2 mt -109.37 135.13 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.39 165.16 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 113.243 0.831 . . . . 1.0 113.243 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -46.51 119.38 2.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.91 -1.041 . . . . 1.0 112.13 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.427 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.6 p -56.75 -22.36 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.737 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.01 -44.68 91.88 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.18 -10.17 29.14 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.494 0.664 . . . . 1.0 109.36 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 45.21 71.42 0.27 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.734 -1.121 . . . . 1.0 113.308 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -73.82 132.7 42.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.979 -1.489 . . . . 1.0 106.979 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -121.5 137.99 54.49 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.882 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -132.89 155.85 48.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.528 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 112' ' ' SER . 25.0 pt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.149 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.493 1.446 0 CA-C-O 120.671 0.196 . . . . 1.0 111.991 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.582 HG23 ' CG2' ' A' ' 140' ' ' VAL . 2.9 m -110.97 129.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.915 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -43.96 134.56 4.0 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -40.35 -46.53 4.32 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.124 2.549 . . . . 1.0 114.007 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 3.8 p -39.33 -45.4 1.43 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.686 0.254 . . . . 1.0 111.686 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.668 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.2 t60 -81.36 -29.34 34.09 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.276 0.473 . . . . 1.0 112.276 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.582 ' CG2' HG23 ' A' ' 135' ' ' VAL . 98.6 t -65.67 -52.53 49.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.961 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -66.75 -27.67 67.79 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -60.21 -45.51 92.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.775 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 146' ' ' MET . 65.1 mt -73.44 -35.82 65.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -52.18 -39.13 59.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.593 -1.262 . . . . 1.0 107.593 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 p -65.24 -20.63 66.51 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.779 -1.1 . . . . 1.0 109.158 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 143' ' ' LEU . 89.4 mmm -93.83 1.45 56.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.462 -0.79 . . . . 1.0 110.735 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.5 22.21 78.64 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.66 142.35 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 1.0 110.986 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.89 -42.99 4.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.484 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 7.2 t -129.84 125.8 36.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 1.0 111.17 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 m -112.96 135.49 53.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.458 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tp -115.13 136.85 52.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.291 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.24 113.96 39.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.15 0.5 . . . . 1.0 111.753 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.16 110.52 30.91 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.66 149.21 54.56 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.144 2.562 . . . . 1.0 114.671 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.48 ' CD2' ' HB1' ' A' ' 188' ' ' ALA . 29.6 mt -125.34 68.44 1.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.796 -1.557 . . . . 1.0 106.796 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.4 ptm -148.04 -173.84 4.41 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.594 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 30.7 t-80 -78.26 178.57 7.52 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.321 -0.854 . . . . 1.0 111.373 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.594 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 13.0 m-70 -74.13 -55.39 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.309 -0.859 . . . . 1.0 112.122 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -105.0 11.92 32.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -144.29 137.61 27.35 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.922 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.715 HD22 ' NH2' ' A' ' 92' ' ' ARG . 7.9 tt -112.38 117.42 32.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.258 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -92.19 -34.19 14.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.289 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.77 -167.58 25.55 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.445 HD21 ' CD2' ' A' ' 95' ' ' PHE . 1.4 mt -152.42 144.69 23.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 1.0 111.592 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 167' ' ' VAL . 2.7 tp -114.51 139.18 49.77 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.58 ' N ' HD12 ' A' ' 166' ' ' LEU . 8.4 p -140.4 140.6 34.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 69.5 m -113.53 143.11 45.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.968 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -113.54 131.8 55.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 1.0 111.572 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.666 ' ND1' ' N ' ' A' ' 170' ' ' HIS . 0.0 OUTLIER -124.67 121.19 34.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.844 -0.616 . . . . 1.0 109.961 178.327 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.0 -16.03 60.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.79 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -107.88 139.0 20.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.012 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 174' ' ' ARG . 72.7 Cg_exo -39.54 -73.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.885 2.39 . . . . 1.0 111.883 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 173' ' ' PRO . 17.0 ttp85 35.41 88.83 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.903 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.87 162.86 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.521 2.148 . . . . 1.0 111.986 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.454 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 50.8 p90 -90.88 131.33 36.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.43 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.1 t -121.21 157.39 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.599 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -53.01 -32.17 45.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.14 -39.38 86.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.731 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.1 -45.29 89.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.429 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.76 -36.29 83.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.581 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -55.41 -39.39 70.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.392 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.4 t -67.85 -55.54 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.545 HG12 ' HB2' ' A' ' 188' ' ' ALA . 3.4 t -70.82 -46.54 68.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.452 0.538 . . . . 1.0 112.452 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -41.48 -46.31 3.44 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.663 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 15.5 tp -71.6 -42.79 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 191' ' ' VAL . 46.4 tp -77.2 -40.44 45.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.86 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.545 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -57.19 -37.9 72.86 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.473 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -61.56 -39.75 92.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.33 -0.395 . . . . 1.0 109.982 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -64.98 -28.62 69.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.104 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 187' ' ' LEU . 20.6 t -84.04 -41.22 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.791 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m -56.7 -36.7 69.95 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 mt -65.46 -38.7 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.445 -0.798 . . . . 1.0 109.221 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.52 83.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.838 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.3 -47.34 92.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.171 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.82 -46.85 62.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.147 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.92 -42.54 90.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.508 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.73 -31.83 72.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.679 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.79 -40.14 95.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.521 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 200' ' ' LEU . 20.5 tp -62.85 -36.58 83.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.67 0.272 . . . . 1.0 111.011 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 38.8 t -50.74 -51.48 49.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.594 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.532 179.654 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.8 tp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.9 0.381 . . . . 1.0 110.551 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 25.0 p-10 -76.83 -28.66 55.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.043 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -77.81 -47.09 19.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.086 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 pt -63.41 -38.58 82.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 1.0 110.964 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -60.84 -49.38 77.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.054 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -53.93 -39.5 65.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.71 -28.92 67.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.073 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.443 ' O ' HG23 ' A' ' 42' ' ' VAL . 11.6 m -71.47 -47.46 55.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.445 -0.798 . . . . 1.0 112.196 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.687 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 3.4 p -68.09 -33.27 59.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 111.907 0.336 . . . . 1.0 111.907 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -69.1 -51.36 39.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.829 0.347 . . . . 1.0 111.14 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -61.73 -45.65 93.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.745 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 38' ' ' THR . 84.6 t -61.56 -35.73 68.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.696 0.284 . . . . 1.0 111.169 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.618 ' NH2' ' CA ' ' A' ' 70' ' ' GLY . 15.7 tpt85 -56.51 -42.19 77.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.803 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.97 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.112 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -79.08 -43.2 24.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.624 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.3 mt -86.43 -32.28 20.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.461 -0.336 . . . . 1.0 111.455 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.54 19.28 18.54 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.564 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 67.3 m -69.97 141.21 53.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.859 0.361 . . . . 1.0 110.209 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' THR . 92.3 m-20 -37.16 -45.9 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.578 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.618 ' NH2' ' CE1' ' A' ' 169' ' ' HIS . 19.2 ttp-105 -163.66 126.7 2.62 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.985 -0.686 . . . . 1.0 112.567 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 51' ' ' VAL . 10.6 p -133.91 127.83 52.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 176.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -140.09 155.65 46.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.14 0.495 . . . . 1.0 111.878 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 62.0 t -98.96 133.65 40.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 176.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -115.01 112.27 22.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.262 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -84.45 127.18 33.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.219 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.442 ' CE2' ' CZ ' ' A' ' 92' ' ' ARG . 71.9 t80 -95.26 134.16 38.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 1.0 112.039 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.86 140.32 20.95 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.36 -27.83 7.55 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 C-N-CA 122.495 2.13 . . . . 1.0 112.441 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -83.39 -16.22 46.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 1.0 110.089 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.56 -13.55 46.9 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.572 -0.611 . . . . 1.0 111.572 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -78.23 90.86 4.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.771 0.319 . . . . 1.0 110.616 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.97 150.8 20.44 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.527 -1.029 . . . . 1.0 110.527 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.4 p -124.85 147.79 48.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.372 . . . . 1.0 111.741 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 77' ' ' LEU . 22.1 t -75.82 107.93 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 65' ' ' VAL . 37.2 t -106.51 -1.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.282 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.687 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.64 113.82 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.068 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.4 tt0 -143.74 135.78 26.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.087 0.47 . . . . 1.0 111.758 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.25 131.97 47.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.415 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -124.65 147.21 48.68 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.711 -0.396 . . . . 1.0 110.725 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.618 ' CA ' ' NH2' ' A' ' 43' ' ' ARG . . . -72.25 -134.79 0.18 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.794 -0.922 . . . . 1.0 110.794 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.26 59.12 1.12 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.006 -0.838 . . . . 1.0 111.006 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 41.83 46.73 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.667 0.27 . . . . 1.0 110.486 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 73' ' ' ARG . 2.0 tpm_? -82.73 -48.72 10.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.401 HD13 ' NH1' ' A' ' 50' ' ' ARG . 42.0 mt -107.38 131.44 21.71 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.862 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.48 145.65 11.73 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.575 2.183 . . . . 1.0 112.111 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 p -72.79 123.34 23.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.978 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 80' ' ' LEU . 16.8 mt -98.62 13.6 31.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.309 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 23.9 tp -73.14 129.17 37.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.269 0.557 . . . . 1.0 112.209 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.56 -9.94 71.61 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.602 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 77' ' ' LEU . 68.8 mt -85.12 153.07 22.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.808 0.337 . . . . 1.0 110.243 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.6 m -105.91 132.54 51.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -85.17 152.0 57.78 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.52 127.52 13.33 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.714 2.276 . . . . 1.0 111.854 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 142.33 57.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.623 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.35 1.18 37.99 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.938 ' O ' HG23 ' A' ' 87' ' ' ILE . 20.2 p-10 -50.84 -52.95 36.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.938 HG23 ' O ' ' A' ' 86' ' ' ASP . 1.9 pp -171.42 50.63 0.14 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.437 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 87' ' ' ILE . 4.1 Cg_endo -94.57 -0.84 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.398 2.065 . . . . 1.0 112.531 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -90.67 -82.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.037 -0.528 . . . . 1.0 111.494 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -78.79 -48.23 15.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.772 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.33 74.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.868 0.321 . . . . 1.0 111.868 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.917 HH12 HD22 ' A' ' 162' ' ' LEU . 58.5 ttt85 -71.68 -39.95 69.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.421 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -63.1 -43.32 98.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.824 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.493 HD12 ' NH2' ' A' ' 101' ' ' ARG . 76.1 mt -64.72 -41.73 95.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.297 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.407 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 1.2 t80 -55.04 -44.02 74.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.022 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -56.6 -28.58 60.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.803 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.1 mt -98.24 -39.63 8.76 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.568 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -119.38 -13.12 9.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.994 1.479 . . . . 1.0 114.994 -174.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.568 ' C ' ' O ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER 35.67 81.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.192 -1.003 . . . . 1.0 108.858 -178.512 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 100' ' ' VAL . 11.0 p -174.64 108.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.075 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.493 ' NH2' HD12 ' A' ' 94' ' ' LEU . 56.6 mmt-85 -141.87 146.01 35.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 1.0 110.781 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.5 p -171.83 135.93 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.573 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.8 137.0 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.459 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 32.8 m -91.04 165.04 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 17.8 p30 -48.65 119.35 3.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.895 -1.048 . . . . 1.0 112.106 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 140' ' ' VAL . 9.3 p -53.77 -21.74 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.785 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -65.85 -45.28 82.77 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.404 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . . . -65.9 -16.02 63.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.557 0.694 . . . . 1.0 109.411 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 46.4 72.71 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.757 -1.111 . . . . 1.0 113.314 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.459 ' OG ' ' CG2' ' A' ' 104' ' ' VAL . 1.1 p -73.51 129.01 37.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.97 -1.493 . . . . 1.0 106.97 174.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -116.61 134.9 54.28 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.96 -0.696 . . . . 1.0 111.937 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.96 163.96 31.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.514 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 pt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.209 178.838 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo . . . . . 0 N--CA 1.491 1.38 0 CA-C-O 120.743 0.226 . . . . 1.0 111.971 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.83 149.31 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.871 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -94.51 156.24 38.75 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -55.39 -29.03 66.36 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.195 2.597 . . . . 1.0 113.974 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.711 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.7 OUTLIER -60.4 -46.25 90.66 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.705 0.261 . . . . 1.0 111.705 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.711 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 4.4 t60 -80.64 -24.16 39.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.271 0.471 . . . . 1.0 112.271 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 106' ' ' VAL . 63.3 t -66.33 -54.11 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.944 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -64.9 -28.84 69.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -60.26 -45.85 91.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.776 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 146' ' ' MET . 27.3 mt -73.02 -37.2 67.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -50.98 -39.52 55.63 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.2 m -64.36 -24.47 67.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.746 -1.115 . . . . 1.0 109.204 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.565 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -91.86 -2.92 56.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.437 -0.801 . . . . 1.0 110.684 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.91 20.36 79.74 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.4 t -108.48 143.06 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 1.0 110.933 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.51 -42.74 4.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.948 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.8 m -131.99 124.22 28.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 1.0 111.164 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.2 p -108.73 139.59 43.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.444 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 tp -121.95 125.82 47.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.232 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -119.74 113.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.182 0.515 . . . . 1.0 111.774 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.13 107.09 54.39 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.745 -1.205 . . . . 1.0 107.745 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -40.43 128.18 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.189 2.593 . . . . 1.0 114.681 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.54 HD11 ' CG1' ' A' ' 191' ' ' VAL . 13.7 tp -116.49 41.4 2.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.868 -1.53 . . . . 1.0 106.868 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 7.9 ptm -146.92 178.81 8.05 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 30.4 t-80 -69.04 -176.92 0.94 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.34 -0.846 . . . . 1.0 111.415 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.641 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 96.3 m-70 -68.77 -55.2 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.426 -0.806 . . . . 1.0 112.066 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -104.15 -42.3 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -83.47 129.43 34.98 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.882 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.917 HD22 HH12 ' A' ' 92' ' ' ARG . 6.7 tt -103.68 117.72 35.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.263 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -92.51 -39.78 11.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.244 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.58 -176.28 36.89 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.1 mt -138.24 136.46 36.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.778 0.323 . . . . 1.0 111.55 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.425 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.9 tp -105.84 130.95 53.71 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.63 142.14 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.743 -0.383 . . . . 1.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 m -112.59 138.52 49.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.054 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.618 ' CE1' ' NH2' ' A' ' 50' ' ' ARG . 56.1 m80 -106.98 121.6 44.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.977 0.418 . . . . 1.0 111.69 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -122.04 112.51 18.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.991 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.76 -15.09 63.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.884 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -87.51 148.39 44.12 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.3 -2.32 11.5 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.95 2.433 . . . . 1.0 111.88 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -41.59 131.25 2.3 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.878 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.82 167.23 25.67 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.578 2.185 . . . . 1.0 111.977 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 43.7 p90 -79.94 126.7 31.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.505 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.7 t -114.54 147.36 39.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.574 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.583 ' CD ' ' H ' ' A' ' 178' ' ' GLN . 11.1 mp0 -53.75 -32.45 52.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 1.0 110.622 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -62.35 -41.49 98.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.749 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -62.93 -43.79 97.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.465 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.5 mt -65.31 -37.76 88.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.558 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -54.1 -36.15 62.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.397 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.6 -54.47 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.1 -32.37 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -54.19 -50.31 67.34 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.627 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.8 tp -70.14 -38.41 75.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.005 0.372 . . . . 1.0 112.005 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 191' ' ' VAL . 38.0 tp -77.75 -38.65 46.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.812 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.18 86.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.502 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.86 -40.14 91.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.964 0.411 . . . . 1.0 110.041 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -71.71 -24.44 61.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.146 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 187' ' ' LEU . 87.5 t -82.79 -48.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.718 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 82.9 p -55.34 -35.4 65.15 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.4 mt -65.61 -33.83 66.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.215 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.58 -38.49 77.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.776 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.1 mm -60.04 -46.6 94.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.123 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.26 -45.51 69.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.087 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -65.99 -40.71 91.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.495 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.91 70.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.308 -0.405 . . . . 1.0 111.733 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.35 -35.68 78.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.51 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.04 -32.28 71.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -54.37 -53.16 57.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.648 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.1 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.559 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.887 0.375 . . . . 1.0 110.563 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -74.98 -50.04 17.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.975 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -57.01 -48.12 79.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.066 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 35' ' ' LEU . 18.8 tt -65.93 -43.31 92.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.759 0.314 . . . . 1.0 110.974 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.549 ' N ' HG23 ' A' ' 34' ' ' ILE . 30.7 mt -61.37 -46.72 89.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.033 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -59.5 -37.5 78.46 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.66 -29.62 67.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.128 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 42' ' ' VAL . 45.8 m -73.5 -48.0 36.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.476 -0.783 . . . . 1.0 112.259 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.654 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.0 p -65.14 -33.41 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.01 0.374 . . . . 1.0 112.01 -178.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -65.72 -49.15 69.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.342 . . . . 1.0 111.112 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.92 -38.61 89.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.748 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 38' ' ' THR . 86.0 t -61.05 -44.8 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.169 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 47' ' ' GLY . 61.7 ttp85 -53.71 -39.42 65.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.778 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.57 -37.84 79.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -79.45 -44.0 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.539 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.12 -33.59 22.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 1.0 111.523 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 60.45 19.52 53.61 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.457 -1.057 . . . . 1.0 110.457 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.515 HG23 ' CD2' ' A' ' 170' ' ' HIS . 93.9 m -72.27 142.31 48.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.349 . . . . 1.0 110.244 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -39.35 -45.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.625 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -163.72 130.91 3.36 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.046 -0.661 . . . . 1.0 112.545 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 51' ' ' VAL . 10.6 p -138.47 128.63 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 176.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -140.35 155.2 46.87 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.897 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.9 t -100.04 136.57 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 176.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.449 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 39.7 t80 -126.61 127.31 45.03 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.35 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.468 ' NE ' HG21 ' A' ' 65' ' ' VAL . 57.4 mtm180 -92.33 127.58 37.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.196 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 67.2 t80 -89.83 118.49 29.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 1.0 112.03 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 17.5 p-10 -90.04 152.37 46.13 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -59.43 -19.26 50.53 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.524 2.15 . . . . 1.0 112.458 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -82.6 -21.22 35.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.921 0.391 . . . . 1.0 110.04 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.11 -17.24 35.06 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.564 -0.614 . . . . 1.0 111.564 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' A' ' 84' ' ' ALA . 40.9 m80 -63.36 -100.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.603 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . 102.3 154.84 25.54 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 p -126.74 149.57 49.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 1.0 111.726 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.3 t -78.21 111.15 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.796 -0.816 . . . . 1.0 108.796 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 65' ' ' VAL . 58.3 t -107.19 -1.04 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.304 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.11 113.23 2.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.025 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 88.4 tt0 -143.12 134.1 25.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.133 0.492 . . . . 1.0 111.816 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.57 139.7 52.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.666 -0.697 . . . . 1.0 109.414 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -135.21 147.72 49.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.861 0.363 . . . . 1.0 110.74 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -51.34 -36.86 38.22 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 168.76 -160.26 33.67 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -65.08 4.31 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.312 . . . . 1.0 110.527 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 71' ' ' GLY . 68.0 ttp85 -66.74 -46.8 74.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.165 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.45 HD11 ' NH2' ' A' ' 73' ' ' ARG . 34.7 mt -118.48 116.84 34.92 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.864 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.28 157.07 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.514 2.143 . . . . 1.0 112.183 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 p -96.61 130.21 43.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.925 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 80' ' ' LEU . 44.4 mt -91.29 13.59 16.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.422 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.9 tp -65.62 130.38 43.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.979 -0.555 . . . . 1.0 112.265 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.46 -10.66 72.55 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.54 -0.754 . . . . 1.0 111.498 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 77' ' ' LEU . 76.0 mt -83.82 148.88 26.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.959 -0.296 . . . . 1.0 110.336 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.5 p -105.31 135.58 46.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.655 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -88.56 151.53 48.2 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.42 138.38 65.25 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.643 2.229 . . . . 1.0 111.863 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 61' ' ' HIS . . . -66.38 128.28 35.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.429 . . . . 1.0 110.7 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.6 -1.6 42.46 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -55.44 -37.42 67.69 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 88' ' ' PRO . 8.5 mm -77.8 113.41 32.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.641 -0.709 . . . . 1.0 109.388 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 87' ' ' ILE . 92.7 Cg_exo -46.8 -176.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.429 2.086 . . . . 1.0 112.48 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.53 -49.34 3.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.502 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.81 -39.33 87.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.868 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.01 -51.71 43.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.928 0.344 . . . . 1.0 111.928 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.634 ' NH2' ' CE2' ' A' ' 56' ' ' PHE . 64.0 ttt180 -53.31 -39.62 64.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.465 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -62.8 -33.07 74.44 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.758 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.16 -36.43 74.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.304 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.507 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 11.0 m-85 -59.62 -29.88 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.996 0.427 . . . . 1.0 110.028 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -83.28 -25.82 31.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.865 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.6 mt -97.42 -45.42 6.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 114.416 1.265 . . . . 1.0 114.416 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.514 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.83 -6.66 12.65 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.514 ' C ' ' O ' ' A' ' 98' ' ' ALA . 1.1 mm100 41.24 78.28 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.133 -1.027 . . . . 1.0 108.787 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 100' ' ' VAL . 3.8 p 171.42 116.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.115 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.5 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -169.89 130.59 1.01 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.388 . . . . 1.0 110.808 177.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.5 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 3.5 m -147.02 157.55 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.439 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.6 mt -108.52 132.97 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 105' ' ' ASP . 5.6 p -92.54 159.96 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.299 0.851 . . . . 1.0 113.299 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 104' ' ' VAL . 2.2 p30 -45.21 119.65 2.13 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.94 -1.027 . . . . 1.0 112.128 -177.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.458 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.9 p -53.32 -19.74 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.335 -0.848 . . . . 1.0 110.799 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.17 -46.32 84.54 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.404 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . . . -64.64 -13.55 54.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.492 0.663 . . . . 1.0 109.356 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 44.5 70.37 0.34 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.745 -1.116 . . . . 1.0 113.212 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.6 t -74.97 131.17 40.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.968 -1.493 . . . . 1.0 106.968 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -118.89 134.47 55.15 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.974 -0.69 . . . . 1.0 111.859 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.01 148.35 50.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.501 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.126 179.819 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo . . . . . 0 N--CA 1.492 1.436 0 CA-C-O 120.686 0.202 . . . . 1.0 111.957 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.69 115.2 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.871 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -43.58 139.01 2.79 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -40.51 -44.57 4.4 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 123.255 2.637 . . . . 1.0 114.014 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.738 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.9 p -40.74 -48.6 3.02 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.733 0.272 . . . . 1.0 111.733 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.738 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 15.2 t-80 -81.12 -27.2 35.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.278 0.473 . . . . 1.0 112.278 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.458 ' CG1' HG23 ' A' ' 106' ' ' VAL . 43.6 t -64.23 -53.21 46.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.636 -0.425 . . . . 1.0 111.023 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -65.7 -29.09 69.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.75 -43.46 94.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 1.0 109.737 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 146' ' ' MET . 9.3 mt -72.7 -39.21 67.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -50.82 -38.82 51.0 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 177.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.1 m -65.88 -24.53 66.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.847 -1.069 . . . . 1.0 109.171 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.8 mmm -92.4 -2.03 56.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.682 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.11 19.65 78.61 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.5 t -106.88 143.92 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 1.0 111.061 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.69 -43.91 3.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.993 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -134.35 121.0 20.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.198 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.3 t -111.99 142.98 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.402 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 tp -116.44 139.52 50.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.267 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.81 120.35 52.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.167 0.508 . . . . 1.0 111.745 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.1 t -126.09 120.0 23.82 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.49 ' C ' HD12 ' A' ' 156' ' ' LEU . 98.6 Cg_endo -72.63 124.35 9.72 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.243 2.629 . . . . 1.0 114.655 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 156' ' ' LEU . 8.3 mp -102.37 58.98 0.81 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.846 -1.539 . . . . 1.0 106.846 177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.406 ' N ' ' OG ' ' A' ' 192' ' ' SER . 6.0 ptt? -147.95 -170.15 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.076 0.769 . . . . 1.0 113.076 -176.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.676 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 26.5 t-80 -80.52 -179.56 7.24 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.424 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.676 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 60.0 t60 -74.79 -54.06 8.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.392 -0.822 . . . . 1.0 112.093 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -103.66 13.35 33.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.04 0.385 . . . . 1.0 112.04 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -146.39 140.21 26.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.714 -0.395 . . . . 1.0 110.904 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.487 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -112.61 119.68 38.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.267 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -92.43 -35.53 13.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.306 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -163.88 -178.02 37.13 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.208 -0.757 . . . . 1.0 111.208 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' TYR . 87.5 mt -138.4 133.4 32.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.841 0.353 . . . . 1.0 111.551 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.5 tp -102.33 133.97 46.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.87 135.14 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.089 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.0 m -109.56 139.17 44.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.003 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.429 ' O ' ' CG2' ' A' ' 48' ' ' THR . 48.5 m80 -108.2 119.29 39.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.674 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.515 ' CD2' HG23 ' A' ' 48' ' ' THR . 72.9 m80 -120.59 113.83 20.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 1.0 109.952 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.2 -16.08 61.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.841 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.99 138.01 72.82 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.013 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.94 10.82 2.19 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.978 2.452 . . . . 1.0 111.919 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -68.76 148.43 98.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.846 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.2 161.92 41.86 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.512 2.141 . . . . 1.0 111.939 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 44.0 p90 -74.87 133.6 41.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.465 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.8 m -112.51 147.91 35.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.69 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -59.88 -28.39 67.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.616 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -55.51 -44.12 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.693 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.3 -36.46 83.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.473 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.4 tp -62.23 -42.16 99.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.516 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.84 -33.74 64.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 1.0 111.371 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.34 -56.86 11.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 188' ' ' ALA . 13.5 m -78.7 -30.61 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.435 0.531 . . . . 1.0 112.435 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -51.06 -54.19 27.05 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.614 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 24.4 tp -75.14 -39.24 60.6 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 191' ' ' VAL . 6.2 tp -76.46 -41.47 47.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.891 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -57.19 -39.8 76.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.519 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -58.29 -39.22 78.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.012 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -66.21 -28.39 68.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.132 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 187' ' ' LEU . 16.3 t -82.98 -44.57 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.782 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.406 ' OG ' ' N ' ' A' ' 157' ' ' MET . 1.5 t -53.71 -29.64 40.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.671 -0.862 . . . . 1.0 108.671 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.1 mm -77.19 -33.46 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.465 -0.789 . . . . 1.0 109.268 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.69 -47.81 44.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.893 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.1 pp -65.53 -37.17 79.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.142 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -72.01 -47.01 55.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.134 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -71.53 -36.0 70.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.519 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.59 74.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.645 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -59.35 -32.49 70.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.483 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.668 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.8 mp -61.32 -33.68 74.0 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.025 -0.27 . . . . 1.0 111.029 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -51.52 -53.66 35.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.571 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.543 179.563 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.867 0.365 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -77.64 -29.34 51.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -77.87 -45.93 22.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.139 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 34' ' ' ILE . 12.3 pt -64.23 -38.66 83.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.46 -0.337 . . . . 1.0 110.884 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 40.3 mt -61.17 -50.64 72.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.033 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -53.81 -38.23 64.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.27 -29.96 66.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.043 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 42' ' ' VAL . 28.3 m -74.17 -45.32 49.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.509 -0.768 . . . . 1.0 112.269 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.629 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.9 p -67.77 -34.53 68.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -67.45 -46.14 73.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.85 0.357 . . . . 1.0 111.173 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -64.42 -41.09 96.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.783 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 38' ' ' THR . 79.6 t -61.19 -43.19 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.1 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLY . 66.8 ttp85 -55.03 -41.03 70.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 1.0 110.824 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.23 -36.55 73.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.026 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -79.37 -42.35 25.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.56 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mt -85.39 -32.52 22.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.466 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 61.81 20.31 59.57 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.474 -1.05 . . . . 1.0 110.474 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.447 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 69.7 m -73.1 141.18 47.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 1.0 110.132 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -40.03 -45.1 1.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 1.0 111.634 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.667 ' HE ' ' CE1' ' A' ' 169' ' ' HIS . 56.9 ttp180 -162.68 130.89 3.91 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.06 -0.656 . . . . 1.0 112.596 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.24 129.82 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' HZ1' HG11 ' A' ' 167' ' ' VAL . 24.8 pttm -141.69 152.86 44.27 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.912 -177.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.6 t -102.32 134.86 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.563 -0.902 . . . . 1.0 108.563 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.488 ' OH ' ' O ' ' A' ' 61' ' ' HIS . 52.1 t80 -120.89 126.29 49.64 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.299 -0.561 . . . . 1.0 111.293 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 163' ' ' TRP . 18.2 tpt85 -87.23 124.76 33.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.276 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -88.76 119.84 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.326 -0.397 . . . . 1.0 112.023 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.87 151.9 43.98 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.87 -21.84 59.53 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.491 2.127 . . . . 1.0 112.493 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -82.23 -15.59 52.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.378 . . . . 1.0 110.032 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.39 -15.79 49.67 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.489 -0.644 . . . . 1.0 111.489 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.488 ' O ' ' OH ' ' A' ' 54' ' ' TYR . 84.8 m-70 -64.09 -104.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.934 -0.307 . . . . 1.0 110.62 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.462 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . 102.61 155.95 25.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 p -127.58 151.07 49.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.935 0.398 . . . . 1.0 111.688 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.82 108.38 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.53 -0.76 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.314 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.629 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -160.09 113.02 2.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.099 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 87.6 tt0 -144.28 132.59 21.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.146 0.498 . . . . 1.0 111.798 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -131.16 140.97 50.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.413 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ptt-85 -142.91 150.1 39.34 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.02 -121.8 0.01 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.856 -0.898 . . . . 1.0 110.856 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -81.01 -175.94 50.39 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.1 pm0 -73.09 45.46 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.777 0.322 . . . . 1.0 110.488 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 71' ' ' GLY . 15.4 tpt180 -84.31 -47.84 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.175 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 23.3 mt -116.64 146.71 38.23 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.168 -0.469 . . . . 1.0 109.878 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.59 163.23 38.92 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.459 2.106 . . . . 1.0 112.218 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -92.79 130.68 38.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.958 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 80' ' ' LEU . 29.7 mt -95.85 12.73 29.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.429 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.406 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 18.8 tp -70.89 131.12 43.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.284 0.564 . . . . 1.0 112.261 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.84 -8.8 78.67 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.608 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 77' ' ' LEU . 74.6 mt -87.01 151.97 22.79 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.325 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.2 p -105.18 134.27 48.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.675 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -89.65 151.24 45.55 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.94 135.87 36.46 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.681 2.254 . . . . 1.0 111.884 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . . . -66.12 136.77 56.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.71 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.29 -3.47 40.41 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.528 -1.029 . . . . 1.0 110.528 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -52.35 -40.78 62.39 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.1 mt -80.99 133.23 54.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.445 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.719 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 85.9 Cg_endo -74.89 -161.97 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.385 2.057 . . . . 1.0 112.513 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.02 -57.99 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.584 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -60.18 -45.76 92.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.8 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.719 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -65.1 -44.61 88.24 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -58.69 -34.99 71.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.459 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -63.71 -34.4 77.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.766 0.317 . . . . 1.0 110.805 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' ALA . 11.9 mt -65.31 -34.16 77.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.297 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.404 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 17.7 m-85 -64.24 -55.13 23.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.014 0.435 . . . . 1.0 110.01 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 159' ' ' HIS . 79.5 ttt180 -48.04 -33.92 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.843 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 mt -100.69 -37.91 8.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.04 -16.48 11.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -173.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.547 ' NE2' ' CB ' ' A' ' 155' ' ' PRO . 15.0 mm100 38.06 77.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.205 -0.998 . . . . 1.0 108.826 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 100' ' ' VAL . 3.8 p 176.35 113.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.101 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -175.31 141.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 1.0 110.737 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.0 161.51 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.542 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.436 HD11 ' NE2' ' A' ' 139' ' ' HIS . 20.2 mt -104.37 137.5 33.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 105' ' ' ASP . 14.7 t -88.2 157.91 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 113.294 0.85 . . . . 1.0 113.294 -176.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.462 ' N ' HG12 ' A' ' 104' ' ' VAL . 78.6 m-20 -47.16 121.29 3.65 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.974 -1.012 . . . . 1.0 112.082 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.6 p -57.14 -25.15 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.371 -0.832 . . . . 1.0 110.762 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -64.85 -45.5 85.81 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.93 -11.38 27.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.479 0.657 . . . . 1.0 109.326 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.1 tp60 45.94 70.26 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.801 -1.091 . . . . 1.0 113.308 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -74.43 131.85 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.903 -1.517 . . . . 1.0 106.903 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -120.27 137.12 54.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.023 -0.671 . . . . 1.0 111.931 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.538 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -139.36 162.76 34.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.705 -0.679 . . . . 1.0 110.538 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.0 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.105 179.088 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 N--CA 1.491 1.378 0 CA-C-O 120.698 0.207 . . . . 1.0 111.958 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.54 126.0 59.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.844 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.538 ' N ' ' OG ' ' A' ' 112' ' ' SER . 26.4 t70 -46.05 131.07 7.26 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.442 ' HD3' ' H ' ' A' ' 112' ' ' SER . 59.5 Cg_exo -41.61 -47.11 6.1 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.194 2.596 . . . . 1.0 114.041 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.698 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.8 p -37.35 -46.4 0.76 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.723 0.268 . . . . 1.0 111.723 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.698 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 4.4 t60 -82.29 -30.43 30.58 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.2 t -67.73 -50.9 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.963 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -66.0 -29.18 69.51 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -60.03 -42.13 93.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.714 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' MET . 8.4 mt -73.49 -38.15 65.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -51.92 -39.17 58.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 t -63.69 -24.04 67.62 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.76 -1.109 . . . . 1.0 109.16 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -92.26 4.37 53.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.423 -0.808 . . . . 1.0 110.671 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.06 21.04 79.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.29 142.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 1.0 111.097 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.66 -23.2 12.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.964 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.4 m -141.96 160.52 40.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.202 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.73 121.01 9.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.496 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.7 mp -109.95 132.6 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.258 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 166' ' ' LEU . 16.8 t -123.21 119.4 57.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.175 0.512 . . . . 1.0 111.775 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.6 t -131.65 92.47 30.94 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.79 -1.189 . . . . 1.0 107.79 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.547 ' CB ' ' NE2' ' A' ' 99' ' ' GLN . 83.4 Cg_exo -47.04 150.37 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.203 2.602 . . . . 1.0 114.616 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.575 ' H ' ' HE2' ' A' ' 157' ' ' MET . 33.9 mt -124.88 54.5 1.41 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.868 -1.53 . . . . 1.0 106.868 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.575 ' HE2' ' H ' ' A' ' 156' ' ' LEU . 7.5 ptp -148.56 -167.94 2.96 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.141 0.793 . . . . 1.0 113.141 -175.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.437 ' HE1' ' CB ' ' A' ' 196' ' ' ALA . 30.7 m80 -68.83 163.2 24.77 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.342 -0.845 . . . . 1.0 111.408 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 96' ' ' ARG . 80.1 m80 -70.45 -55.36 9.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.44 -0.8 . . . . 1.0 112.042 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -94.98 11.36 32.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.081 0.401 . . . . 1.0 112.081 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -148.12 140.82 24.6 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.93 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.0 mt -113.52 117.14 30.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.304 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.529 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 81.8 m95 -89.22 -26.07 21.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.246 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.485 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -163.58 -160.85 11.96 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.177 -0.769 . . . . 1.0 111.177 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 13.3 tp -150.37 124.27 9.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 1.0 111.506 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.499 ' O ' HG13 ' A' ' 153' ' ' VAL . 7.3 tp -99.71 129.29 45.82 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.468 HG11 ' HZ1' ' A' ' 52' ' ' LYS . 13.0 p -139.5 134.14 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.077 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.2 p -106.99 141.99 37.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.991 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.667 ' CE1' ' HE ' ' A' ' 50' ' ' ARG . 24.1 m80 -112.75 126.21 55.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.978 0.418 . . . . 1.0 111.689 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -126.12 113.84 17.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.955 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.4 -15.08 63.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.779 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -117.65 151.03 47.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.99 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.48 132.05 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.895 2.397 . . . . 1.0 111.895 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 53.3 ttt85 -157.87 95.02 2.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.895 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.48 161.24 25.39 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.531 2.154 . . . . 1.0 111.916 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 44.0 p90 -91.17 123.79 34.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.441 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 52.3 m -123.75 164.56 18.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.619 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -50.74 -38.38 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.582 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -67.84 -37.45 81.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.756 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -61.46 -49.92 74.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.573 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 185' ' ' GLN . 43.1 mt -64.28 -34.2 77.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.476 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -54.05 -42.13 68.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 88.1 t -69.45 -57.31 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.773 0.656 . . . . 1.0 112.773 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 188' ' ' ALA . 35.3 t -74.11 -46.29 45.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.395 0.517 . . . . 1.0 112.395 -177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.416 ' CB ' ' O ' ' A' ' 181' ' ' LEU . 63.3 tt0 -42.74 -47.74 5.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.59 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.5 tp -72.36 -41.49 66.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.461 -0.336 . . . . 1.0 111.894 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 191' ' ' VAL . 40.5 tp -77.11 -41.84 40.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.818 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.571 ' HB1' ' CD2' ' A' ' 156' ' ' LEU . . . -55.05 -39.55 69.3 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.506 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -61.66 -38.14 86.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.007 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.14 -30.58 71.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.076 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 187' ' ' LEU . 13.0 t -83.8 -42.58 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.756 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.0 p -55.16 -32.85 62.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.5 mt -69.03 -37.34 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.203 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.96 -39.95 83.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.626 -0.715 . . . . 1.0 109.779 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.435 ' HA ' HD13 ' A' ' 195' ' ' ILE . 36.5 mm -61.04 -46.48 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.123 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.437 ' CB ' ' HE1' ' A' ' 158' ' ' HIS . . . -70.69 -47.24 60.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.1 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -65.48 -41.51 93.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.0 111.492 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.02 70.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.675 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.17 -40.95 97.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.509 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.52 -35.68 80.17 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.007 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.5 t -52.42 -52.22 55.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 1.0 110.595 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.583 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.6 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.902 0.382 . . . . 1.0 110.578 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 66.5 t0 -49.05 -34.99 14.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -77.29 -47.44 20.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.069 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.44 -42.44 93.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 1.0 110.977 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -56.87 -45.02 82.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.099 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -53.22 -38.69 63.16 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.56 71.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.055 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -69.08 -45.7 69.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.547 -0.752 . . . . 1.0 112.227 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.688 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.6 p -71.28 -35.26 57.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.995 0.368 . . . . 1.0 111.995 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 43' ' ' ARG . 43.4 tp10 -70.17 -35.7 74.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.776 0.322 . . . . 1.0 111.06 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -80.46 -53.54 6.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 1.0 111.755 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.55 HG13 ' N ' ' A' ' 43' ' ' ARG . 9.6 p -55.08 -44.08 72.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.744 0.306 . . . . 1.0 111.118 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.55 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.6 ppt_? -56.21 -41.7 76.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.85 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.465 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.17 -33.91 59.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.022 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -79.61 -36.2 38.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 1.0 111.581 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -85.34 -30.64 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.501 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 59.33 19.29 46.3 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 93.3 m -72.24 140.77 48.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.792 0.33 . . . . 1.0 110.234 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -39.72 -50.43 2.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.623 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.467 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 59.6 ttp180 -157.97 130.56 7.25 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.018 -0.673 . . . . 1.0 112.591 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.95 131.06 36.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -139.62 155.24 47.55 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.9 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 89.5 t -106.03 138.91 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 177.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.59 ' CE2' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -139.23 131.45 28.22 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.323 -0.551 . . . . 1.0 111.284 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -92.74 145.46 24.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.275 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.469 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 85.6 t80 -96.46 122.13 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 1.0 112.04 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -87.73 164.68 33.51 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 178.317 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.25 -25.83 15.29 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.521 2.147 . . . . 1.0 112.522 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.94 -15.37 54.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 1.0 110.096 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.37 -17.22 37.31 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.514 -0.635 . . . . 1.0 111.514 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -67.21 101.85 0.97 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.909 -0.316 . . . . 1.0 110.592 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.61 134.89 12.64 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.562 -1.015 . . . . 1.0 110.562 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.6 p -122.24 142.23 50.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 1.0 111.665 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.4 p -89.77 120.53 38.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 65' ' ' VAL . 10.9 t -110.41 5.84 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 1.0 111.356 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.08 118.36 3.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.126 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -143.67 135.91 26.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.073 0.463 . . . . 1.0 111.816 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.92 146.96 52.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.434 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -141.15 145.99 36.42 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.755 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.47 -32.81 46.16 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.881 -0.887 . . . . 1.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 176.63 -161.64 29.75 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -73.94 25.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.339 . . . . 1.0 110.523 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.507 ' H ' ' C ' ' A' ' 71' ' ' GLY . 43.1 mtm180 -77.47 -47.14 20.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.082 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.7 mt -113.04 145.56 33.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 1.0 109.921 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -70.93 160.31 49.77 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.516 2.144 . . . . 1.0 112.148 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.1 p -93.31 128.13 39.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.864 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.537 ' HA ' HD12 ' A' ' 80' ' ' LEU . 18.9 mt -94.44 6.4 48.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.372 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 tp -61.34 128.83 38.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.3 0.572 . . . . 1.0 112.246 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.45 -13.83 62.81 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.514 -0.767 . . . . 1.0 111.526 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 77' ' ' LEU . 76.3 mt -81.29 150.55 28.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.296 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -106.86 133.85 50.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.652 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -87.02 133.28 39.48 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -41.15 132.87 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.633 2.222 . . . . 1.0 111.895 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.91 128.33 35.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 1.0 110.738 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.27 0.63 44.2 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.529 -1.028 . . . . 1.0 110.529 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -58.71 -33.11 69.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.457 HD11 ' OH ' ' A' ' 54' ' ' TYR . 8.4 mt -78.99 132.8 62.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.69 -0.687 . . . . 1.0 109.49 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.716 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 91.0 Cg_endo -73.74 -171.99 0.99 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.452 2.102 . . . . 1.0 112.479 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -106.43 -55.07 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.546 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -63.21 -42.27 99.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.813 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.716 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.77 -44.32 77.72 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.928 0.344 . . . . 1.0 111.928 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -64.11 -39.64 94.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.47 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -60.6 -32.13 71.26 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.762 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 98' ' ' ALA . 96.5 mt -70.1 -28.14 65.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.905 0.383 . . . . 1.0 110.341 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.653 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 0.8 OUTLIER -65.33 -54.25 31.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.036 178.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.99 -31.69 65.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.878 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.3 mt -99.41 -44.51 6.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 114.357 1.243 . . . . 1.0 114.357 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -113.55 -12.51 12.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.112 1.523 . . . . 1.0 115.112 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.653 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 18.2 mm-40 45.34 86.73 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.198 -1.001 . . . . 1.0 108.75 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 100' ' ' VAL . 2.5 p 177.54 99.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.12 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 102' ' ' VAL . 9.8 mmp_? -139.49 133.24 30.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.998 0.428 . . . . 1.0 110.737 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 101' ' ' ARG . 71.3 t -161.4 141.81 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.536 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.15 133.65 53.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.515 HG21 ' OG ' ' A' ' 110' ' ' SER . 5.0 m -91.89 164.97 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.318 0.858 . . . . 1.0 113.318 -176.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 20.0 p30 -46.89 118.54 2.1 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.003 -0.999 . . . . 1.0 112.098 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.98 -22.2 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.311 -0.859 . . . . 1.0 110.801 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -67.83 -43.56 79.29 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.55 -11.75 12.44 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.525 0.678 . . . . 1.0 109.389 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 45.54 61.45 2.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.779 -1.1 . . . . 1.0 113.335 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.515 ' OG ' HG21 ' A' ' 104' ' ' VAL . 13.2 m -76.26 133.23 40.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 175.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -119.82 140.29 51.02 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.926 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.8 135.19 54.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.496 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.185 179.432 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo . . . . . 0 N--CA 1.492 1.41 0 CA-C-O 120.759 0.233 . . . . 1.0 111.93 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 p -100.37 119.98 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.811 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.475 ' OD2' ' SG ' ' A' ' 138' ' ' CYS . 49.7 p-10 -43.77 134.1 3.85 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.738 -0.468 . . . . 1.0 109.738 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -42.49 -16.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.095 2.53 . . . . 1.0 114.067 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.743 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -71.55 -48.38 48.91 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.713 0.264 . . . . 1.0 111.713 -176.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.743 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 35.7 t-80 -82.97 -28.24 29.91 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.279 0.474 . . . . 1.0 112.279 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 2.6 p -66.45 -43.76 90.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.004 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.523 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 79.2 t60 -69.86 -30.35 67.8 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -59.82 -42.21 93.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.76 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 146' ' ' MET . 29.8 mt -74.36 -36.14 63.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -52.41 -39.32 60.81 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.7 p -65.08 -18.91 65.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.786 -1.097 . . . . 1.0 109.16 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.2 mmm -96.15 1.14 52.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.12 22.89 78.62 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.944 -0.863 . . . . 1.0 110.944 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.33 142.98 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 1.0 111.006 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.65 -39.76 5.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.964 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.7 t -135.96 126.44 26.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.199 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.4 m -113.91 140.78 48.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.428 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.96 138.48 53.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.262 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -128.3 119.45 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.167 0.508 . . . . 1.0 111.732 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.6 124.52 21.91 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.735 -1.209 . . . . 1.0 107.735 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.47 ' O ' HD23 ' A' ' 156' ' ' LEU . 85.4 Cg_endo -71.97 144.27 42.54 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 123.175 2.584 . . . . 1.0 114.678 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.571 ' CD2' ' HB1' ' A' ' 188' ' ' ALA . 11.3 mt -125.14 47.46 2.16 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.561 ' CE ' ' O ' ' A' ' 164' ' ' GLY . 4.4 ptp -147.36 -167.38 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.104 0.779 . . . . 1.0 113.104 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -68.71 159.24 32.58 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.45 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -60.63 -50.11 74.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.414 -0.812 . . . . 1.0 112.107 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -97.74 -42.75 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.06 0.393 . . . . 1.0 112.06 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.473 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 85.2 tt0 -86.27 134.3 33.76 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.87 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 19.1 mt -109.17 115.58 30.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.215 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.473 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 77.8 m95 -88.85 -31.42 18.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.278 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.813 ' C ' HD12 ' A' ' 165' ' ' LEU . . . -169.97 -166.95 29.76 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.229 -0.748 . . . . 1.0 111.229 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.813 HD12 ' C ' ' A' ' 164' ' ' GLY . 5.8 mp -148.65 136.37 20.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 1.0 111.506 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.4 tp -98.58 134.92 40.86 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 167' ' ' VAL . 8.4 p -138.5 127.41 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.695 -0.402 . . . . 1.0 111.097 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.2 p -104.68 137.13 42.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.064 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.467 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 28.4 m80 -105.07 121.24 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.981 0.419 . . . . 1.0 111.601 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -122.1 113.45 19.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.936 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.46 -14.23 61.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.781 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.74 135.14 74.85 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.06 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.01 -4.54 14.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.905 2.404 . . . . 1.0 111.813 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 174' ' ' ARG . 1.0 OUTLIER -54.73 151.34 15.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.845 -179.488 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.65 160.96 46.75 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.53 2.153 . . . . 1.0 111.946 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -81.54 136.64 35.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.483 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -113.03 144.83 41.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.64 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -55.86 -29.32 59.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.537 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -55.82 -37.07 68.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.696 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.01 -37.72 88.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.505 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.0 mp -65.07 -38.94 92.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.48 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.53 -37.98 68.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.371 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.85 -55.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.737 0.643 . . . . 1.0 112.737 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 185' ' ' GLN . 10.9 p -68.38 -38.69 79.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.394 0.516 . . . . 1.0 112.394 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.457 ' N ' HG13 ' A' ' 184' ' ' VAL . 83.7 mt-30 -52.52 -45.22 66.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.644 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 37.2 tp -65.04 -45.52 85.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.873 ' O ' HG23 ' A' ' 191' ' ' VAL . 85.1 mt -78.92 -31.55 45.27 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.571 ' HB1' ' CD2' ' A' ' 156' ' ' LEU . . . -62.88 -44.46 96.06 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.494 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -62.25 -42.23 99.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.067 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -64.12 -27.34 69.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.095 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 187' ' ' LEU . 45.4 t -84.8 -40.86 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.749 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -56.78 -36.11 69.48 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.5 mt -67.58 -38.44 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.228 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -68.02 -40.2 82.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.838 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 195' ' ' ILE . 26.1 mm -59.23 -48.19 87.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.051 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.47 -48.75 47.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.031 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -66.15 -45.77 79.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.525 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -63.42 -32.65 74.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.711 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -57.32 -29.6 64.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.385 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 200' ' ' LEU . 10.0 mp -62.27 -32.88 73.65 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.058 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.0 t -52.15 -55.85 18.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.551 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.6 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.54 179.439 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.806 0.336 . . . . 1.0 110.589 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -53.01 -54.5 34.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.951 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -54.54 -46.95 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.114 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 mm -62.03 -46.99 95.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.826 0.346 . . . . 1.0 110.972 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 34.2 mt -56.46 -45.14 80.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.08 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -53.59 -38.41 63.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.65 -30.33 66.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.124 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 42' ' ' VAL . 24.7 m -73.59 -44.76 56.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.528 -0.76 . . . . 1.0 112.228 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.71 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.4 p -68.56 -35.94 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.96 0.356 . . . . 1.0 111.96 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -67.16 -49.18 65.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 1.0 111.156 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -58.72 -45.26 90.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.683 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 38' ' ' THR . 73.9 t -57.94 -37.32 60.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.686 0.279 . . . . 1.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 47' ' ' GLY . 36.7 ttp180 -52.53 -40.83 62.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.832 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.89 -35.76 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.056 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.11 -46.36 20.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.538 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.6 mt -86.37 -31.59 21.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.494 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.57 22.22 31.22 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.461 -1.056 . . . . 1.0 110.461 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.2 p -74.02 144.96 44.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.332 . . . . 1.0 110.286 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -41.52 -42.01 2.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.617 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.532 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 56.3 ttm-85 -163.26 129.33 3.24 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.123 -0.631 . . . . 1.0 112.636 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.84 130.29 52.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.469 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 23.5 pttm -140.6 154.97 46.68 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.442 -0.503 . . . . 1.0 111.874 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 95.1 t -109.17 138.76 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.496 ' CE2' HD13 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -138.34 133.47 33.01 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.348 -0.541 . . . . 1.0 111.283 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -92.62 145.58 24.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.201 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -95.62 117.73 31.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 1.0 112.089 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.09 149.47 59.02 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.52 -23.15 74.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.58 2.187 . . . . 1.0 112.45 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -86.14 -14.53 43.85 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.057 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.43 -13.13 47.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.469 -0.652 . . . . 1.0 111.469 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -76.0 94.79 3.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.804 0.335 . . . . 1.0 110.608 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.88 143.54 17.61 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -122.18 144.54 48.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.914 0.388 . . . . 1.0 111.638 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -80.51 112.49 18.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.07 3.63 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.276 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.71 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -160.28 119.71 2.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.076 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.532 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 84.8 tt0 -144.84 132.87 21.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.106 0.479 . . . . 1.0 111.847 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.96 148.82 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.336 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.613 ' NH2' ' N ' ' A' ' 76' ' ' SER . 6.8 ptp180 -139.68 142.21 36.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.895 0.379 . . . . 1.0 110.718 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.41 -33.18 86.54 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -171.26 -178.97 42.08 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -73.61 40.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 1.0 110.581 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 71' ' ' GLY . 10.1 tpt180 -83.06 -47.79 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.144 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.402 ' HB2' HH21 ' A' ' 50' ' ' ARG . 13.6 mt -113.36 150.85 43.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.863 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.462 ' C ' ' NH2' ' A' ' 69' ' ' ARG . 58.3 Cg_endo -69.86 160.3 50.19 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.483 2.122 . . . . 1.0 112.131 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.613 ' N ' ' NH2' ' A' ' 69' ' ' ARG . 21.9 t -88.86 129.55 35.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.942 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 80' ' ' LEU . 22.6 mt -98.14 10.22 41.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.383 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.08 132.58 45.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.003 -0.544 . . . . 1.0 112.305 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.13 -10.02 67.57 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.527 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 77' ' ' LEU . 46.8 mt -85.5 154.11 22.0 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.336 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 p -105.37 130.72 53.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.688 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -84.66 152.67 60.42 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.84 133.94 41.28 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.678 2.252 . . . . 1.0 111.883 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.35 129.14 38.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.67 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.64 0.46 42.91 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -56.42 -35.58 67.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.7 mm -80.16 132.39 59.91 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.66 -0.7 . . . . 1.0 109.434 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.685 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 86.7 Cg_endo -74.39 -167.26 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.398 2.065 . . . . 1.0 112.483 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -107.63 -60.06 1.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.505 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 90' ' ' GLU . 39.6 mp0 -57.95 -44.43 86.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.818 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.685 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -66.88 -44.62 80.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -58.62 -36.26 73.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.477 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -63.81 -32.03 73.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.811 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.1 mt -67.11 -36.36 81.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.295 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -57.18 -54.36 47.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.051 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -53.43 -29.81 37.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.838 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.97 -41.37 7.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.413 1.264 . . . . 1.0 114.413 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -120.19 -17.09 8.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 115.031 1.493 . . . . 1.0 115.031 -173.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.793 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.2 OUTLIER 45.15 71.45 0.27 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.123 -1.031 . . . . 1.0 108.847 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 99' ' ' GLN . 2.7 m -164.26 113.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.051 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.452 ' HE ' ' CA ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -155.68 148.26 23.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.932 0.396 . . . . 1.0 110.774 178.197 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.13 143.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.505 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.7 mt -108.94 135.62 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.09 164.39 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 113.275 0.843 . . . . 1.0 113.275 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -43.98 117.27 1.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.95 -1.023 . . . . 1.0 112.145 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.88 -20.02 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.79 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -66.9 -42.27 85.76 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.09 -10.39 40.0 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.45 0.643 . . . . 1.0 109.408 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 45.26 70.63 0.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.734 -1.121 . . . . 1.0 113.354 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 p -75.35 134.43 40.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.984 -1.488 . . . . 1.0 106.984 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -122.02 139.78 53.28 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.893 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.456 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -130.28 153.51 48.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.571 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 112' ' ' SER . 28.6 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.121 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.492 1.403 0 CA-C-O 120.712 0.213 . . . . 1.0 111.95 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.49 124.3 61.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.878 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' HA ' ' H ' ' A' ' 112' ' ' SER . 12.5 t70 -43.22 141.97 1.71 Allowed Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.422 ' HA ' HG12 ' A' ' 140' ' ' VAL . 13.2 Cg_endo -49.18 -13.52 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 123.224 2.616 . . . . 1.0 114.073 -177.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.681 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.4 p -75.59 -44.43 43.1 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.746 0.276 . . . . 1.0 111.746 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.681 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.6 t60 -82.9 -32.86 27.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.226 0.454 . . . . 1.0 112.226 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 141' ' ' HIS . 4.3 p -68.76 -45.03 81.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.936 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.534 ' N ' HG13 ' A' ' 140' ' ' VAL . 35.5 m-70 -68.69 -28.97 67.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -60.83 -41.0 94.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.923 -0.581 . . . . 1.0 109.715 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.6 mt -72.86 -36.49 67.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -52.15 -38.73 58.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -64.44 -23.07 67.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.746 -1.115 . . . . 1.0 109.161 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 143' ' ' LEU . 97.1 mmm -92.74 2.15 56.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.727 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.84 79.28 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.3 t -111.93 142.03 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 1.0 111.019 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.92 -26.67 11.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.012 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.2 m -136.45 160.83 37.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.166 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.35 127.72 13.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.44 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 tp -114.92 136.31 53.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.292 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.4 119.62 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.132 0.491 . . . . 1.0 111.793 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.5 HG21 HG21 ' A' ' 184' ' ' VAL . 45.7 t -129.62 91.1 41.71 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 107.862 -1.162 . . . . 1.0 107.862 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.22 151.68 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.175 2.584 . . . . 1.0 114.693 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.5 mt -126.05 63.18 1.24 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.832 -1.544 . . . . 1.0 106.832 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 ptm -146.35 179.61 7.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.163 0.801 . . . . 1.0 113.163 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.582 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 46.1 t-80 -68.07 176.24 2.76 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.394 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.582 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 97.8 m-70 -64.54 -51.64 61.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.401 -0.818 . . . . 1.0 112.082 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.68 -37.79 6.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.064 0.394 . . . . 1.0 112.064 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -87.67 136.29 33.01 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.689 -0.405 . . . . 1.0 110.846 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.498 HD12 ' H ' ' A' ' 162' ' ' LEU . 1.2 mp -108.63 112.14 24.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.317 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -88.27 -37.49 16.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.257 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.571 ' C ' HD12 ' A' ' 165' ' ' LEU . . . -165.71 -175.75 36.5 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 164' ' ' GLY . 5.3 mp -144.17 141.56 30.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 1.0 111.5 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.4 tp -101.07 135.26 42.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 167' ' ' VAL . 12.4 p -138.64 129.68 35.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 1.0 111.078 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.2 m -106.77 139.37 41.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.057 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.469 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 85.7 m-70 -113.76 132.09 55.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.948 0.404 . . . . 1.0 111.667 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.57 125.32 43.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.929 177.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.43 33.63 0.69 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.832 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -161.35 154.38 17.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.029 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.16 112.82 2.18 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.928 2.419 . . . . 1.0 111.84 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -149.16 90.11 4.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.884 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.96 158.42 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.597 2.198 . . . . 1.0 111.905 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.496 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 41.6 p90 -84.79 127.27 34.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.487 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.6 p -121.06 162.37 20.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.581 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.666 ' CD ' ' H ' ' A' ' 178' ' ' GLN . 1.7 pm0 -50.33 -30.47 12.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.648 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -61.87 -36.24 80.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.739 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 184' ' ' VAL . 78.3 mm-40 -66.01 -24.43 66.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.486 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.8 mt -81.33 -33.88 32.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.483 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.45 -43.09 99.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.34 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.638 HG23 ' N ' ' A' ' 184' ' ' VAL . 13.1 m -73.41 -49.16 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.708 0.633 . . . . 1.0 112.708 -177.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.638 ' N ' HG23 ' A' ' 183' ' ' VAL . 27.9 m -70.4 -43.87 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.403 0.52 . . . . 1.0 112.403 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.538 ' N ' HG23 ' A' ' 184' ' ' VAL . 88.5 mt-30 -53.28 -43.43 67.46 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.983 -0.287 . . . . 1.0 111.67 -178.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.73 -49.99 59.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.84 ' O ' HG23 ' A' ' 191' ' ' VAL . 71.2 mt -79.86 -35.07 38.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.795 -177.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 184' ' ' VAL . . . -61.1 -43.38 98.97 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.488 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.58 -42.47 86.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 1.0 109.989 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.63 -28.23 68.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.135 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 187' ' ' LEU . 59.4 t -84.3 -43.71 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.785 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.2 p -57.83 -35.63 71.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.655 -0.868 . . . . 1.0 108.655 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.9 mt -67.84 -35.03 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.207 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.57 76.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.646 -0.707 . . . . 1.0 109.843 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.424 HD11 HD21 ' A' ' 35' ' ' LEU . 5.0 mm -61.38 -47.53 93.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.133 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.8 -48.02 60.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.045 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.68 -41.19 92.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.558 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.05 -31.3 72.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.677 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.72 -31.92 68.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.497 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.628 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.0 mp -60.62 -34.84 74.84 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.932 -0.307 . . . . 1.0 111.095 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.3 m -55.96 -56.14 24.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.58 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.536 179.715 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.6 tp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.795 0.331 . . . . 1.0 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -60.52 -51.95 67.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.048 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -55.89 -45.91 78.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.127 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 mm -61.4 -48.4 89.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.771 0.32 . . . . 1.0 110.877 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.02 -47.74 84.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.012 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -52.45 -39.54 61.21 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.622 -0.431 . . . . 1.0 109.846 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.56 -29.09 65.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.137 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 42' ' ' VAL . 16.8 m -73.25 -45.32 56.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.477 -0.783 . . . . 1.0 112.312 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.705 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.8 p -68.45 -35.3 70.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -177.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -70.6 -42.31 71.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.784 0.326 . . . . 1.0 111.094 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.71 -54.67 24.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.77 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG23 ' N ' ' A' ' 43' ' ' ARG . 34.2 m -52.45 -39.84 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.171 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -52.76 -41.76 64.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 1.0 110.811 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.3 -38.34 79.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.04 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -75.5 -42.82 51.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.603 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.2 mt -85.6 -26.81 25.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.457 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.76 19.95 16.39 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 169' ' ' HIS . 91.3 m -73.01 143.39 47.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.832 0.349 . . . . 1.0 110.192 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -39.34 -55.43 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.668 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.635 HH22 ' CG2' ' A' ' 148' ' ' VAL . 61.2 mtm-85 -148.92 131.8 16.12 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.053 -0.659 . . . . 1.0 112.576 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 38.4 t -132.69 127.64 56.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.503 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 20.4 pttm -141.4 154.92 45.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.13 0.49 . . . . 1.0 111.939 -178.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 61.6 t -115.15 135.56 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.626 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -133.76 120.06 20.05 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.243 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -74.04 140.2 45.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.273 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.629 ' CE1' ' NH2' ' A' ' 92' ' ' ARG . 58.9 t80 -92.91 117.21 29.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 1.0 112.048 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 41.2 p-10 -93.59 141.35 23.74 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.83 -14.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.573 2.182 . . . . 1.0 112.517 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 57' ' ' ASP . 96.3 mt-10 -87.97 -33.86 18.27 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.729 -0.389 . . . . 1.0 110.104 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.41 -10.79 39.37 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.514 -0.634 . . . . 1.0 111.514 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.685 ' O ' ' O ' ' A' ' 62' ' ' GLY . 64.2 m80 -66.54 -42.81 86.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.926 -0.31 . . . . 1.0 110.61 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.685 ' O ' ' O ' ' A' ' 61' ' ' HIS . . . 47.97 155.98 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.659 -0.976 . . . . 1.0 110.659 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 p -124.81 146.25 49.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 1.0 111.711 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.95 106.82 4.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.793 -0.818 . . . . 1.0 108.793 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 65' ' ' VAL . 57.3 t -106.56 -1.85 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.719 0.295 . . . . 1.0 111.375 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.44 118.04 3.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.103 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -144.43 129.0 18.1 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.566 -0.454 . . . . 1.0 111.865 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.21 145.55 49.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.378 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -142.28 142.7 32.59 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.722 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.6 -36.1 83.85 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -163.63 -179.56 38.07 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -73.47 55.13 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 1.0 110.525 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -86.42 -48.88 8.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.131 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.449 HD12 ' CZ ' ' A' ' 50' ' ' ARG . 66.9 mt -119.09 147.77 43.44 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.867 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.9 138.75 45.34 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.517 2.145 . . . . 1.0 112.131 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.1 m -60.43 130.26 45.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.89 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 80' ' ' LEU . 25.7 mt -91.91 7.04 43.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.346 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tp -59.4 129.55 42.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.29 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.55 -12.82 65.73 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.526 -0.761 . . . . 1.0 111.507 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 77' ' ' LEU . 73.5 mt -83.11 153.1 25.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.742 0.306 . . . . 1.0 110.327 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.7 p -107.65 135.06 49.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.646 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -87.68 154.46 53.28 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.22 124.92 12.75 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.684 2.256 . . . . 1.0 111.847 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.59 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . . . -62.44 137.67 58.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.696 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.87 -2.23 38.64 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -54.6 -38.73 67.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 88' ' ' PRO . 6.1 mm -83.65 111.92 35.85 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.433 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 87' ' ' ILE . 87.9 Cg_exo -51.46 -162.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.486 2.124 . . . . 1.0 112.499 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -107.82 -51.56 2.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.572 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.72 -41.32 92.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.768 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.94 79.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.936 0.346 . . . . 1.0 111.936 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.629 ' NH2' ' CE1' ' A' ' 56' ' ' PHE . 63.2 ttt180 -64.04 -39.15 93.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.519 -0.31 . . . . 1.0 111.457 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -62.3 -34.34 76.4 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.777 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.31 -34.7 75.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.266 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.543 ' CZ ' HD11 ' A' ' 165' ' ' LEU . 2.3 t80 -63.54 -26.36 68.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.99 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.493 HH21 ' CD ' ' A' ' 160' ' ' GLN . 52.3 ttt180 -81.54 -28.32 33.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.786 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.9 mt -98.21 -41.21 8.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.36 -8.13 12.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 115.067 1.506 . . . . 1.0 115.067 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.513 ' OE1' ' O ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER 41.64 83.31 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.221 -0.991 . . . . 1.0 108.818 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 100' ' ' VAL . 2.7 p 174.7 113.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.973 -178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.634 ' O ' HG23 ' A' ' 102' ' ' VAL . 5.0 tpt180 -153.52 139.26 17.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 1.0 110.799 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 101' ' ' ARG . 55.9 t -161.22 145.91 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.547 -178.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.414 HG23 HG11 ' A' ' 135' ' ' VAL . 65.4 mt -110.18 133.76 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.91 165.86 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 113.322 0.86 . . . . 1.0 113.322 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -45.81 119.72 2.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.964 -1.017 . . . . 1.0 112.139 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.478 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.4 p -56.13 -22.11 13.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.221 -0.899 . . . . 1.0 110.792 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -65.6 -44.11 87.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.6 -0.518 . . . . 1.0 109.6 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.93 -11.23 35.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.535 0.683 . . . . 1.0 109.42 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 44.72 71.12 0.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.731 -1.122 . . . . 1.0 113.327 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 p -74.27 132.75 42.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 176.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -118.8 128.96 54.96 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.017 -0.673 . . . . 1.0 111.884 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.77 152.09 44.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.623 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.1 pt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.117 179.373 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 N--CA 1.493 1.453 0 CA-C-O 120.757 0.232 . . . . 1.0 112.0 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.414 HG11 HG23 ' A' ' 103' ' ' ILE . 1.3 p -107.91 121.34 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.835 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 136' ' ' ASP . 2.8 p-10 -45.13 140.57 3.64 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 138' ' ' CYS . 63.0 Cg_exo -42.63 -50.17 6.03 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.09 2.527 . . . . 1.0 114.047 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.757 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.0 OUTLIER -34.46 -49.26 0.39 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.72 0.267 . . . . 1.0 111.72 -177.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.757 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 20.5 t-80 -81.18 -25.66 36.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.319 0.488 . . . . 1.0 112.319 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.478 ' CG1' HG23 ' A' ' 106' ' ' VAL . 42.1 t -65.88 -51.77 57.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.941 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.417 ' O ' ' OG ' ' A' ' 145' ' ' SER . 58.5 t-80 -63.57 -29.6 70.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.06 -44.32 94.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.694 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 146' ' ' MET . 61.8 mt -73.02 -41.54 64.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -50.63 -39.54 50.61 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 141' ' ' HIS . 2.6 m -62.93 -27.19 69.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.784 -1.098 . . . . 1.0 109.19 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.55 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.2 mmm -89.05 -0.46 57.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.7 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.77 21.5 78.48 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.976 -0.85 . . . . 1.0 110.976 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.635 ' CG2' HH22 ' A' ' 50' ' ' ARG . 47.7 t -109.45 142.25 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 1.0 111.035 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.1 -36.82 6.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.011 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 t -138.71 129.4 26.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.136 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.6 m -114.77 137.25 52.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.41 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tp -117.38 137.89 52.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.284 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 166' ' ' LEU . 2.1 t -126.58 113.77 34.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.082 0.468 . . . . 1.0 111.744 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.495 HG11 ' CG1' ' A' ' 184' ' ' VAL . 40.9 t -111.39 106.94 57.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 107.825 -1.176 . . . . 1.0 107.825 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.33 123.72 2.09 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.16 2.573 . . . . 1.0 114.77 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.434 HD11 ' HB ' ' A' ' 191' ' ' VAL . 9.4 tp -115.93 45.9 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.5 ptm -148.02 -178.36 6.24 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.091 0.775 . . . . 1.0 113.091 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.637 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 48.6 t-80 -69.3 178.64 2.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.306 -0.861 . . . . 1.0 111.411 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.637 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 83.6 t60 -67.89 -51.62 45.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 1.0 112.044 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.493 ' CD ' HH21 ' A' ' 96' ' ' ARG . 16.5 tt0 -105.17 -38.6 6.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.047 0.388 . . . . 1.0 112.047 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.512 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.7 tt0 -90.69 139.17 30.98 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.841 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.68 HD23 ' C ' ' A' ' 162' ' ' LEU . 7.9 tt -107.03 115.39 30.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.357 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.512 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 78.6 m95 -91.75 -41.14 10.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.298 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.79 -173.71 24.75 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.543 HD11 ' CZ ' ' A' ' 95' ' ' PHE . 7.2 tp -144.26 128.13 17.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.332 . . . . 1.0 111.558 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 153' ' ' VAL . 9.4 tp -98.04 129.06 44.9 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 177.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.53 136.7 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.087 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.1 m -111.24 149.65 30.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.053 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.562 ' HD1' HG11 ' A' ' 148' ' ' VAL . 93.1 m-70 -124.6 131.21 53.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.003 0.43 . . . . 1.0 111.603 -177.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.03 114.42 15.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.984 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.94 -15.69 63.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.859 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -112.41 151.27 43.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.993 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.18 92.61 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.891 2.394 . . . . 1.0 111.929 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -120.85 91.27 47.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.901 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.97 152.36 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.533 2.156 . . . . 1.0 111.937 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -109.25 143.53 38.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.444 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.2 t -125.24 171.35 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.607 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -50.89 -30.38 14.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.616 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -63.22 -39.45 94.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.708 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.54 -44.85 93.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.524 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.9 mp -63.92 -36.76 84.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.502 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -54.48 -36.64 64.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.884 -0.598 . . . . 1.0 111.331 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.34 -54.98 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.722 0.638 . . . . 1.0 112.722 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.496 HG12 ' HB2' ' A' ' 188' ' ' ALA . 5.1 t -77.68 -42.17 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -44.31 -45.28 8.64 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.951 -0.299 . . . . 1.0 111.631 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 186' ' ' LEU . 7.4 mp -75.96 -37.79 58.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.92 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 191' ' ' VAL . 6.1 tp -77.65 -41.47 38.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.806 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.496 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -62.13 -39.71 93.49 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.474 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -57.67 -39.6 77.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.294 -0.412 . . . . 1.0 109.924 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -71.8 -24.11 61.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.157 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 187' ' ' LEU . 73.1 t -82.5 -48.92 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 1.0 109.798 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 85.8 p -54.25 -34.19 60.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.9 mt -65.59 -33.85 66.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.161 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 191' ' ' VAL . . . -68.74 -38.12 79.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.575 -0.738 . . . . 1.0 109.8 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.59 -46.46 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.14 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.03 -46.55 61.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.059 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -66.61 -44.54 81.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.515 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.34 -33.25 75.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.299 -0.409 . . . . 1.0 111.674 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -60.42 -32.87 71.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.578 -0.283 . . . . 1.0 111.498 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.61 -34.92 78.88 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.012 -0.275 . . . . 1.0 111.052 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.7 m -55.53 -54.74 40.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.802 0.334 . . . . 1.0 110.65 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.539 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.83 0.348 . . . . 1.0 110.562 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' CG ' ' N ' ' A' ' 33' ' ' GLN . 24.1 p-10 -55.63 -54.46 43.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.967 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.404 ' N ' ' CG ' ' A' ' 32' ' ' ASP . 62.9 tt0 -54.35 -44.84 72.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.124 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.694 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -60.91 -52.89 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.955 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.2 mt -58.71 -48.2 81.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.011 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -53.4 -39.41 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.6 -0.44 . . . . 1.0 109.871 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.5 65.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.042 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 42' ' ' VAL . 21.5 m -73.22 -44.59 59.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.529 -0.76 . . . . 1.0 112.197 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.639 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 4.1 p -69.96 -35.79 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.916 0.339 . . . . 1.0 111.916 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.06 -48.92 61.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.753 0.311 . . . . 1.0 111.096 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -66.94 -50.65 61.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.745 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 38' ' ' THR . 83.1 t -58.38 -42.77 84.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.724 0.297 . . . . 1.0 111.169 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -56.21 -43.11 78.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.811 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.76 -33.53 61.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -77.08 -37.93 53.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.608 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -85.78 -27.8 24.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.446 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.93 20.0 24.65 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.458 -1.057 . . . . 1.0 110.458 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.44 ' OG1' HG23 ' A' ' 51' ' ' VAL . 12.5 p -72.11 142.52 49.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.859 0.361 . . . . 1.0 110.217 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -40.39 -47.5 2.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.664 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.53 ' NH1' ' CE1' ' A' ' 169' ' ' HIS . 54.0 ttp85 -154.02 131.29 11.17 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.029 -0.668 . . . . 1.0 112.629 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.44 HG23 ' OG1' ' A' ' 48' ' ' THR . 48.9 t -135.38 127.36 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HE3' HAB1 ' A' ' 203' ' ' CYC . 58.2 pttt -140.94 156.07 46.14 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.478 -0.489 . . . . 1.0 111.967 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.8 t -101.08 140.56 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.437 ' O ' ' N ' ' A' ' 165' ' ' LEU . 55.4 t80 -127.19 111.48 14.02 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.364 -0.534 . . . . 1.0 111.209 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -84.39 133.72 34.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -95.77 125.66 40.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 1.0 112.096 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 60' ' ' GLY . 6.2 m-20 -95.14 138.57 21.96 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.79 -29.11 3.32 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.514 2.142 . . . . 1.0 112.453 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -82.82 -19.71 37.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 1.0 110.03 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.56 -10.91 38.94 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.517 -0.633 . . . . 1.0 111.517 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -82.18 88.26 6.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.63 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.06 154.29 23.6 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.5 p -124.97 148.85 48.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.971 0.415 . . . . 1.0 111.646 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.93 107.9 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 65' ' ' VAL . 60.5 t -106.75 0.16 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.779 0.324 . . . . 1.0 111.413 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.639 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.33 120.44 3.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.5 tt0 -145.46 132.51 20.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 1.0 111.846 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.19 142.42 51.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 1.0 109.406 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -143.09 145.47 32.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.907 0.384 . . . . 1.0 110.76 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.07 -35.03 63.07 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -179.9 -164.49 32.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.037 -0.825 . . . . 1.0 111.037 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -72.42 16.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.309 . . . . 1.0 110.486 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 71' ' ' GLY . 61.5 ttm-85 -66.83 -46.66 74.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.15 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.6 mt -115.19 124.61 29.95 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.87 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.24 154.21 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.535 2.157 . . . . 1.0 112.134 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.7 m -90.13 130.39 36.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.934 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.54 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 23.6 mt -98.48 13.56 31.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.437 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 20.4 tp -71.41 130.42 41.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.224 0.535 . . . . 1.0 112.308 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.18 -10.0 70.54 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.496 -0.774 . . . . 1.0 111.581 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 77' ' ' LEU . 65.7 mt -85.14 153.77 22.45 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.327 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 81' ' ' THR . 14.1 t -107.69 133.5 52.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.658 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.558 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 7.4 m-85 -85.55 152.26 57.12 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.57 133.82 38.59 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.625 2.216 . . . . 1.0 111.808 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 131.13 45.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.712 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.89 0.64 42.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 50.9 t0 -53.71 -33.92 57.13 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.3 mt -91.44 110.37 42.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.377 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 87' ' ' ILE . 88.7 Cg_exo -51.47 -155.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.437 2.091 . . . . 1.0 112.448 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -107.11 -59.38 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.493 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.89 -40.27 79.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.369 . . . . 1.0 111.875 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.553 ' HB2' HBD1 ' A' ' 203' ' ' CYC . . . -68.95 -51.55 38.48 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.969 0.359 . . . . 1.0 111.969 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -53.85 -35.92 62.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.485 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -65.33 -33.42 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.78 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.72 -36.73 78.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.256 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.6 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 23.7 m-85 -58.19 -30.54 66.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.069 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -83.31 -23.93 32.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.824 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.2 mt -97.93 -47.51 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.449 ' O ' HG22 ' A' ' 100' ' ' VAL . . . -114.62 -12.64 12.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.089 1.514 . . . . 1.0 115.089 -173.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.856 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.2 mm100 45.6 61.43 2.62 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.164 -1.014 . . . . 1.0 108.813 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 99' ' ' GLN . 3.9 m -165.71 105.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.075 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.457 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 9.9 mmt180 -148.29 150.36 33.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.418 . . . . 1.0 110.742 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -169.09 146.7 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.522 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.499 ' CG1' HBA2 ' A' ' 203' ' ' CYC . 27.1 mt -107.42 135.07 47.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 105' ' ' ASP . 6.0 p -90.65 160.28 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.227 0.825 . . . . 1.0 113.227 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.489 ' N ' HG22 ' A' ' 104' ' ' VAL . 4.3 p30 -45.52 121.0 2.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.881 -1.054 . . . . 1.0 112.209 -177.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 140' ' ' VAL . 9.4 p -57.2 -22.11 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.816 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -62.53 -49.03 76.94 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.413 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . . . -62.65 -8.47 6.62 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.504 0.669 . . . . 1.0 109.391 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 43.89 72.07 0.21 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.77 -1.105 . . . . 1.0 113.35 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.42 131.9 41.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.905 -1.517 . . . . 1.0 106.905 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -119.77 139.53 52.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.962 -0.695 . . . . 1.0 111.884 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -147.91 167.64 24.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.544 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.525 ' C ' ' H ' ' A' ' 115' ' ' GLN . 15.8 pt -125.24 138.48 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.133 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.2 m -72.87 25.74 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.64 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.525 ' H ' ' C ' ' A' ' 113' ' ' ILE . 83.1 mm-40 -115.16 82.35 8.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.631 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -84.66 160.35 12.37 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.626 2.217 . . . . 1.0 112.336 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 118' ' ' SER . 84.5 tt0 -100.63 115.58 30.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.492 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 117' ' ' GLU . 4.5 m 39.93 -164.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.638 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.647 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 63.8 t-105 -141.97 170.18 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.543 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.647 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . -80.51 165.6 48.4 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 38.0 mt -90.48 170.23 10.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.715 0.293 . . . . 1.0 110.423 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.1 m -53.68 -42.69 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.478 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.32 84.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.711 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -83.04 141.05 32.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.56 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 125' ' ' VAL . 7.6 p -130.54 85.51 55.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.201 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -48.73 131.49 24.52 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.616 2.21 . . . . 1.0 112.335 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.9 mt -132.32 76.21 1.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 40.39 87.98 0.01 OUTLIER Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.839 -0.904 . . . . 1.0 110.839 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.476 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 1.4 tt0 -48.53 -48.11 68.53 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.548 0.213 . . . . 1.0 110.859 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 40.2 Cg_endo -94.49 158.18 1.97 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.11 2.54 . . . . 1.0 111.671 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.7 mt -82.82 -15.71 50.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.32 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.63 ' O ' ' C ' ' A' ' 133' ' ' ARG . 93.4 mt-30 -91.09 -8.59 48.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.931 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.63 ' C ' ' O ' ' A' ' 132' ' ' GLN . 85.5 mtt180 17.83 68.58 0.22 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.582 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.28 141.77 96.64 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.777 2.318 . . . . 1.0 111.908 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.5 t -106.96 128.03 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.829 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.651 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -44.92 148.36 0.99 Allowed Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.16 -33.95 89.89 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.224 2.616 . . . . 1.0 113.988 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.724 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.8 p -48.32 -47.73 36.61 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.74 0.274 . . . . 1.0 111.74 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.724 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 29.4 t-80 -81.5 -29.38 33.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.274 0.472 . . . . 1.0 112.274 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.414 ' CG1' HG23 ' A' ' 106' ' ' VAL . 98.4 t -64.22 -53.7 40.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.928 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -64.34 -28.02 69.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -59.63 -41.08 89.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.868 -0.606 . . . . 1.0 109.759 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 146' ' ' MET . 12.7 mt -73.52 -39.33 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -51.08 -38.87 54.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.5 m -64.44 -24.72 67.72 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.738 -1.119 . . . . 1.0 109.223 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.58 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.4 mmm -92.0 -1.69 57.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.739 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.6 22.0 77.88 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.03 142.39 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 1.0 111.002 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.54 -39.9 5.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.015 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -133.41 125.38 28.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.118 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 m -119.06 138.37 52.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.449 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -116.27 141.13 48.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.29 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.693 HG21 HAA2 ' A' ' 203' ' ' CYC . 1.6 t -126.24 122.65 61.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.157 0.503 . . . . 1.0 111.77 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 154' ' ' VAL . 1.4 p -132.46 93.03 26.14 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.836 -1.172 . . . . 1.0 107.836 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.698 ' C ' HD12 ' A' ' 156' ' ' LEU . 87.1 Cg_exo -48.14 150.21 5.31 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.149 2.566 . . . . 1.0 114.648 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 155' ' ' PRO . 10.9 mp -123.08 64.19 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.571 ' HE3' HE22 ' A' ' 99' ' ' GLN . 6.3 ptt? -149.63 -161.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.138 0.792 . . . . 1.0 113.138 -175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.22 -178.72 5.23 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.315 -0.857 . . . . 1.0 111.397 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -73.8 -55.42 6.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 1.0 112.026 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -103.57 8.6 37.64 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.991 0.367 . . . . 1.0 111.991 -177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -140.6 133.45 29.07 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.877 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.532 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.7 OUTLIER -110.63 119.35 38.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.236 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -93.58 -36.65 12.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.241 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.41 -177.38 37.03 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.7 mp -141.16 138.89 33.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 1.0 111.564 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.512 ' HB2' HD13 ' A' ' 156' ' ' LEU . 6.0 tp -104.98 136.99 43.42 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.24 135.39 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.713 -0.395 . . . . 1.0 111.106 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.5 m -112.04 142.4 44.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.019 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.53 ' CE1' ' NH1' ' A' ' 50' ' ' ARG . 42.3 m80 -114.81 127.42 55.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.029 0.442 . . . . 1.0 111.698 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.533 ' CD2' ' OE2' ' A' ' 172' ' ' GLU . 1.7 t-80 -127.42 121.93 32.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.949 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.47 61.44 5.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.803 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.533 ' OE2' ' CD2' ' A' ' 170' ' ' HIS . 26.3 pt-20 -152.04 142.65 15.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.064 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.39 -0.49 10.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.986 2.457 . . . . 1.0 111.854 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -60.67 147.18 84.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.898 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.15 167.48 25.85 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.545 2.163 . . . . 1.0 111.924 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -86.42 142.44 28.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.42 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.2 m -115.0 150.87 35.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.622 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -60.54 -29.88 69.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.57 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 29.8 mp0 -55.34 -34.33 64.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.769 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -63.66 -37.54 87.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.503 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.56 -37.81 85.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.543 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.5 tm0? -54.49 -39.22 67.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.389 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 83.7 t -67.24 -53.9 28.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 19.2 m -74.58 -29.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -51.61 -45.48 63.22 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.873 -0.331 . . . . 1.0 111.686 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 18.5 tp -76.25 -41.17 49.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.878 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.877 ' O ' HG23 ' A' ' 191' ' ' VAL . 47.5 mt -78.39 -39.71 38.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.816 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.44 -44.45 97.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.472 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -61.53 -38.12 86.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 1.0 109.971 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.43 -26.4 60.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.136 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 187' ' ' LEU . 59.9 t -82.73 -49.61 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.734 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 83.1 p -51.47 -30.27 19.24 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 56.9 mt -76.82 -33.85 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.495 -0.775 . . . . 1.0 109.214 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.61 -45.81 77.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.789 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.404 HD11 ' O ' ' A' ' 156' ' ' LEU . 25.0 pt -63.43 -35.11 71.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.138 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.4 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -69.78 -44.51 69.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 1.0 111.199 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.26 -38.44 75.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 1.0 111.518 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.32 -32.88 74.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.666 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.55 -32.85 70.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.478 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.3 mt -60.68 -32.62 71.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.99 -0.284 . . . . 1.0 111.051 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -53.45 -53.0 57.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.563 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 21.7 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.53 179.594 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.693 HAA2 HG21 ' A' ' 153' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.899 0.38 . . . . 1.0 110.59 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -57.29 -52.05 66.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.03 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -55.99 -46.19 78.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.085 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.7 mt -61.61 -53.4 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 1.0 110.91 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.8 mt -53.98 -43.52 70.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.995 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.497 HH12 ' CD2' ' A' ' 78' ' ' LEU . 59.8 ttm-85 -54.02 -35.46 61.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.617 -0.433 . . . . 1.0 109.895 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -36.23 72.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.078 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.8 p -70.83 -42.11 70.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.527 -0.76 . . . . 1.0 112.295 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.708 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p -69.05 -36.52 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.93 0.344 . . . . 1.0 111.93 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -71.6 -40.99 69.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.805 0.336 . . . . 1.0 111.094 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.25 -52.01 65.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.757 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.5 m -56.06 -34.42 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.721 0.296 . . . . 1.0 111.13 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 47' ' ' GLY . 60.9 ttp180 -54.01 -43.08 69.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 1.0 110.81 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.51 76.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.047 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -78.73 -45.63 20.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.611 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.0 mt -86.04 -31.98 21.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.49 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.9 22.6 48.56 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.459 -1.057 . . . . 1.0 110.459 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -73.34 141.99 47.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 1.0 110.229 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -42.12 -43.43 3.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.6 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -158.29 130.53 6.96 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.048 -0.661 . . . . 1.0 112.61 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.48 130.51 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.579 -0.897 . . . . 1.0 108.579 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 166' ' ' LEU . 12.3 pttm -142.08 156.4 45.39 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.453 -0.499 . . . . 1.0 111.871 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 50.6 t -99.99 134.39 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 42.4 t80 -115.59 105.89 13.3 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.335 -0.546 . . . . 1.0 111.306 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -76.68 126.27 30.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.212 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.438 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 68.3 t80 -92.52 136.91 32.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.991 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.438 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 4.8 m-20 -106.57 140.1 20.99 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.31 -28.86 6.22 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.53 2.153 . . . . 1.0 112.45 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -83.31 -17.76 41.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.882 0.373 . . . . 1.0 110.03 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.96 -13.73 41.11 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.574 -0.611 . . . . 1.0 111.574 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -78.15 91.16 4.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.808 0.337 . . . . 1.0 110.613 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.92 152.56 21.06 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.566 -1.014 . . . . 1.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.7 p -125.29 148.17 48.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 1.0 111.727 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -74.41 107.31 4.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.55 -1.58 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.351 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.708 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.94 115.87 3.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.112 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 85.4 tt0 -145.25 131.17 19.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.079 0.466 . . . . 1.0 111.854 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB1' ' HD3' ' A' ' 43' ' ' ARG . . . -130.81 137.47 49.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.409 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -143.33 148.7 36.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.875 0.369 . . . . 1.0 110.718 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.99 -120.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.852 -0.899 . . . . 1.0 110.852 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -78.78 -179.74 51.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.78 43.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 1.0 110.559 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 71' ' ' GLY . 77.6 ttt180 -82.91 -46.72 12.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.177 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 mt -111.68 146.44 34.7 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 1.0 109.84 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.2 160.31 50.01 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.525 2.15 . . . . 1.0 112.132 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 m -89.78 127.42 35.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.941 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 80' ' ' LEU . 28.6 mt -98.28 11.33 38.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.399 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.497 ' CD2' HH12 ' A' ' 36' ' ' ARG . 19.4 tp -72.47 132.76 44.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.012 -0.54 . . . . 1.0 112.306 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.96 -9.72 71.11 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.604 -0.726 . . . . 1.0 111.529 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 77' ' ' LEU . 76.5 mt -86.67 152.96 22.11 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.936 -0.305 . . . . 1.0 110.344 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.6 m -105.26 132.24 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.675 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 7.4 m-85 -86.28 152.25 55.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.45 133.45 37.34 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.653 2.236 . . . . 1.0 111.873 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.78 131.48 46.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.693 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.62 2.12 40.3 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.548 -1.021 . . . . 1.0 110.548 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 54.3 t0 -57.59 -33.46 68.21 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 87' ' ' ILE . 1.6 mp -82.59 127.09 71.8 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.46 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.737 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 89.6 Cg_endo -73.06 -164.86 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.411 2.074 . . . . 1.0 112.54 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -105.87 -58.68 1.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.535 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.19 -45.0 96.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.795 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.06 -40.21 87.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -63.79 -37.77 88.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.424 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -62.05 -36.48 81.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.781 0.324 . . . . 1.0 110.835 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.552 HD12 ' NH2' ' A' ' 101' ' ' ARG . 77.7 mt -69.82 -33.07 71.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.286 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.492 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 2.3 t80 -63.8 -31.42 72.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.003 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -81.87 -27.12 33.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.865 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.85 -42.67 7.85 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 114.356 1.243 . . . . 1.0 114.356 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.74 -6.78 13.84 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -175.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.492 ' OE1' ' O ' ' A' ' 95' ' ' PHE . 1.1 mm100 42.58 75.31 0.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.226 -0.99 . . . . 1.0 108.864 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 100' ' ' VAL . 4.1 p 175.79 115.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.023 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.574 ' HD3' HAA2 ' A' ' 203' ' ' CYC . 33.7 ttm-85 -159.18 153.25 23.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 1.0 110.758 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.1 p -168.99 148.07 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.504 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 56.2 mt -105.34 134.79 45.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 105' ' ' ASP . 11.2 t -88.53 158.92 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.25 0.833 . . . . 1.0 113.25 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.7 p30 -49.23 121.0 4.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.937 -1.029 . . . . 1.0 112.151 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.448 HG23 ' CG1' ' A' ' 140' ' ' VAL . 9.1 p -56.09 -22.07 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.342 -0.845 . . . . 1.0 110.784 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -61.79 -50.31 72.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.421 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . . . -64.26 -10.53 24.28 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.465 0.65 . . . . 1.0 109.347 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 44.51 70.74 0.31 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.785 -1.098 . . . . 1.0 113.267 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.55 131.99 42.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.965 -1.495 . . . . 1.0 106.965 175.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -121.13 134.89 55.25 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.967 -0.693 . . . . 1.0 111.937 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -128.61 156.23 43.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.63 -0.713 . . . . 1.0 110.529 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 112' ' ' SER . 21.2 pt -156.83 -179.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.103 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.9 p -59.91 154.01 19.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.685 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -137.9 152.3 71.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.698 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.46 -20.91 10.6 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.727 2.285 . . . . 1.0 112.416 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -122.29 158.2 30.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.357 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.3 m -121.02 148.64 43.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.671 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -86.45 -99.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.522 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.44 169.41 45.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.81 -37.9 88.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 1.0 110.416 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.9 p -57.54 -33.85 68.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.522 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 124' ' ' ARG . . . -71.77 -30.82 65.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.662 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 123' ' ' ALA . 70.2 mtt180 76.32 -178.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.505 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.571 ' O ' ' O ' ' A' ' 126' ' ' PRO . 10.7 t -146.92 86.77 6.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.242 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 125' ' ' VAL . 78.9 Cg_exo -50.5 -131.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.653 2.235 . . . . 1.0 112.239 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.6 mt -56.91 -31.94 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.579 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 117.44 129.01 4.12 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -70.66 149.45 95.35 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.57 0.224 . . . . 1.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -85.98 10.25 3.74 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.177 2.584 . . . . 1.0 111.635 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.8 mp -75.74 -17.42 59.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.336 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 64.77 5.99 3.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.942 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 60.13 71.61 0.85 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.555 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.7 155.23 70.83 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.758 2.305 . . . . 1.0 111.92 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.618 HG12 HBD2 ' A' ' 203' ' ' CYC . 3.0 m -105.55 125.54 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.927 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -43.71 130.37 3.99 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.44 ' HD3' ' H ' ' A' ' 112' ' ' SER . 49.4 Cg_exo -40.23 -46.28 4.18 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.178 2.585 . . . . 1.0 114.051 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.3 p -38.85 -45.24 1.14 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.688 0.255 . . . . 1.0 111.688 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.677 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 17.5 t60 -81.19 -28.68 34.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.482 ' CG2' HG23 ' A' ' 135' ' ' VAL . 85.8 t -64.87 -54.96 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.939 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -65.14 -28.7 69.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -59.78 -44.72 93.78 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.774 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.631 HD11 ' NE2' ' A' ' 139' ' ' HIS . 69.5 mt -72.96 -38.08 66.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -50.64 -39.27 50.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -63.87 -26.87 68.81 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.729 -1.123 . . . . 1.0 109.165 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.564 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.5 mmm -88.75 -1.27 58.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.452 -0.794 . . . . 1.0 110.709 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.98 22.01 77.5 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.9 t -111.62 140.75 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.905 0.383 . . . . 1.0 110.968 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.47 -40.54 4.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.0 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.6 m -133.4 122.53 23.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.12 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.446 ' OG ' ' CG2' ' A' ' 167' ' ' VAL . 3.7 t -116.75 133.63 55.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.436 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 tt -112.19 137.19 50.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.273 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.418 HG21 HAA1 ' A' ' 203' ' ' CYC . 2.1 t -122.3 120.05 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.157 0.503 . . . . 1.0 111.774 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.03 103.74 47.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -40.38 125.91 2.0 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.197 2.598 . . . . 1.0 114.69 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.485 HD11 ' HB ' ' A' ' 191' ' ' VAL . 10.9 tp -113.59 47.53 1.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.861 -1.533 . . . . 1.0 106.861 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.2 ptm -148.59 -174.75 4.69 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.069 0.766 . . . . 1.0 113.069 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.664 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 42.0 t-80 -75.13 -179.33 4.32 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.311 -0.859 . . . . 1.0 111.38 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.664 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 82.2 t60 -75.16 -55.64 5.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.396 -0.82 . . . . 1.0 112.057 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -104.62 9.48 35.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -139.76 137.15 34.84 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.701 -0.399 . . . . 1.0 110.906 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.847 ' O ' HD23 ' A' ' 162' ' ' LEU . 5.7 tt -110.62 113.93 26.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.068 -0.515 . . . . 1.0 111.303 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -90.79 -35.45 14.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.28 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -163.02 -172.95 31.15 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.39 129.01 26.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 1.0 111.562 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 52' ' ' LYS . 37.6 tp -103.54 129.1 50.69 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.446 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 11.5 p -139.14 139.71 39.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.069 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 84.2 p -110.86 140.33 45.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.049 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -111.71 132.3 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.979 0.418 . . . . 1.0 111.601 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -130.1 121.2 25.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 1.0 109.882 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -81.64 55.79 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.808 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -156.77 149.63 18.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.012 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.78 -11.55 31.03 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.907 2.405 . . . . 1.0 111.914 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -39.33 104.17 0.31 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.862 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.81 167.44 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.585 2.19 . . . . 1.0 111.902 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 49.5 p90 -80.09 129.66 34.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.462 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.5 t -111.93 143.0 43.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.635 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -58.04 -27.74 63.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.664 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -57.55 -38.48 74.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.666 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.86 -38.07 89.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.542 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 56.5 mt -64.18 -40.82 96.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.517 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -53.63 -38.21 63.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.33 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.23 -54.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 188' ' ' ALA . 29.3 m -77.34 -29.8 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.404 0.52 . . . . 1.0 112.404 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 189' ' ' ASP . 58.8 tp60 -50.98 -49.9 59.32 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.98 -0.288 . . . . 1.0 111.631 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.6 tp -76.84 -41.33 44.59 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.8 tp -76.75 -43.43 37.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.806 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -60.09 -40.42 89.53 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.511 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 93.5 m-20 -56.52 -38.37 71.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.018 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -71.23 -24.91 62.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.155 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.485 ' HB ' HD11 ' A' ' 156' ' ' LEU . 93.8 t -82.85 -49.01 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 1.0 109.731 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.6 m -51.4 -29.92 17.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 57.9 mt -75.92 -33.28 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.236 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -67.07 -45.41 77.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.825 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 19.0 pt -63.93 -35.53 73.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.149 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -68.78 -43.37 75.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.135 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -70.94 -38.04 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.553 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.21 -32.08 73.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.725 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.92 -39.13 93.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.475 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 200' ' ' LEU . 23.8 tp -62.93 -35.67 80.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.723 0.297 . . . . 1.0 111.119 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.2 t -54.8 -53.68 52.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.612 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.48 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.618 HBD2 HG12 ' A' ' 135' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.814 0.34 . . . . 1.0 110.531 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -60.13 -52.7 64.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.985 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -54.9 -45.98 74.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.087 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 mm -61.01 -48.24 89.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 1.0 110.966 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.628 HD21 HD11 ' A' ' 195' ' ' ILE . 35.5 mt -56.95 -42.78 80.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 1.0 111.03 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -52.91 -35.33 58.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.068 0.461 . . . . 1.0 109.869 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.91 -34.34 71.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.06 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 42' ' ' VAL . 62.4 p -72.28 -40.23 67.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.524 -0.762 . . . . 1.0 112.263 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.654 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.3 p -73.57 -38.76 52.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 111.899 0.333 . . . . 1.0 111.899 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.403 ' N ' HG13 ' A' ' 39' ' ' VAL . 99.5 mt-10 -71.2 -45.46 63.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.772 0.32 . . . . 1.0 111.104 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.85 -47.93 70.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.784 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 38' ' ' THR . 72.0 t -60.39 -39.06 79.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.982 -0.287 . . . . 1.0 111.12 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.4 tmm_? -57.25 -42.9 82.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 1.0 110.823 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.82 -33.59 68.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -78.42 -40.67 35.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.542 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.71 -31.2 22.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.448 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 61.7 21.78 61.09 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 169' ' ' HIS . 5.2 t -73.22 139.48 46.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.35 . . . . 1.0 110.17 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -44.57 -38.68 4.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.609 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.556 HH22 ' H ' ' A' ' 77' ' ' LEU . 53.7 ttt85 -161.53 126.24 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.058 -0.657 . . . . 1.0 112.625 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.23 128.31 29.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.563 ' NZ ' HAB1 ' A' ' 203' ' ' CYC . 20.7 pttp -140.18 155.66 46.84 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.86 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 66.4 t -106.42 137.49 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.473 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -136.62 127.91 28.21 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.252 -0.579 . . . . 1.0 111.288 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -88.03 144.35 26.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.745 -0.662 . . . . 1.0 110.208 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.595 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 80.4 t80 -95.52 117.79 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 1.0 112.027 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.9 m-20 -85.27 135.85 38.56 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -45.83 -24.06 1.92 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.456 2.104 . . . . 1.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.21 -18.48 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.052 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.88 -13.36 38.11 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.583 -0.607 . . . . 1.0 111.583 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -75.07 92.25 2.62 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.642 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.54 142.54 18.0 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 p -121.39 142.75 49.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 1.0 111.751 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.65 110.94 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.748 -0.834 . . . . 1.0 108.748 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.613 ' O ' HG12 ' A' ' 65' ' ' VAL . 95.5 t -106.59 -0.89 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.942 -0.303 . . . . 1.0 111.372 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.97 120.79 3.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.149 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 68.6 tt0 -142.12 131.78 24.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.06 0.457 . . . . 1.0 111.818 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.95 143.11 50.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.375 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.528 ' NH1' ' OG ' ' A' ' 76' ' ' SER . 32.8 ptt180 -142.88 142.44 31.77 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.743 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.44 -33.01 85.04 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.48 -170.92 36.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 77.6 mm-40 -78.25 38.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 1.0 110.556 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -82.83 -48.11 11.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.148 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.46 149.26 36.85 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.826 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.95 146.69 59.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.532 2.155 . . . . 1.0 112.183 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.528 ' OG ' ' NH1' ' A' ' 69' ' ' ARG . 67.2 m -77.28 121.23 23.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.962 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.556 ' H ' HH22 ' A' ' 50' ' ' ARG . 27.5 mt -100.59 12.12 38.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.416 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.2 tp -73.49 132.68 43.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.307 0.575 . . . . 1.0 112.288 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.86 -10.04 63.89 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.505 -0.771 . . . . 1.0 111.546 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 77' ' ' LEU . 64.0 mt -86.43 155.55 20.52 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.001 -0.28 . . . . 1.0 110.329 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.2 p -103.65 126.37 50.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.67 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 6.6 m-85 -77.86 151.8 79.65 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.55 117.7 4.66 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.648 2.232 . . . . 1.0 111.818 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.01 125.09 11.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.677 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.7 0.13 42.59 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.574 -1.011 . . . . 1.0 110.574 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 2.6 p30 -56.76 -32.64 65.8 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.477 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 3.2 tp -84.25 131.05 51.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.384 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.71 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 71.7 Cg_endo -70.19 -169.48 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.427 2.085 . . . . 1.0 112.487 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -107.1 -44.71 4.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.559 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 42.0 mp0 -69.36 -41.15 76.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.796 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.72 ' HB2' HAD2 ' A' ' 203' ' ' CYC . . . -67.35 -44.05 79.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.906 0.336 . . . . 1.0 111.906 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.595 ' NH2' ' CG ' ' A' ' 56' ' ' PHE . 51.6 ttt85 -65.23 -44.09 89.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.472 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -61.05 -34.14 74.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.34 . . . . 1.0 110.879 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.514 ' C ' HH22 ' A' ' 101' ' ' ARG . 47.4 mt -71.18 -38.75 72.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.298 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.609 ' N ' ' NH2' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -58.19 -28.51 64.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.061 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -74.91 -29.87 61.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.87 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.437 ' C ' ' OE1' ' A' ' 99' ' ' GLN . 75.5 mt -97.17 -39.4 9.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.547 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -118.34 -7.19 10.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.051 1.5 . . . . 1.0 115.051 -176.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.547 ' C ' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 38.51 77.4 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.161 -1.015 . . . . 1.0 108.847 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 100' ' ' VAL . 12.9 p 179.32 114.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.108 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.609 ' NH2' ' N ' ' A' ' 95' ' ' PHE . 4.0 tpp180 -156.79 150.84 24.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.954 0.407 . . . . 1.0 110.75 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.32 145.72 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.456 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.7 mt -108.6 131.84 58.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.141 -0.689 . . . . 1.0 109.141 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.1 m -91.66 164.9 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 113.23 0.826 . . . . 1.0 113.23 -176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -48.07 117.24 1.82 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.89 -1.05 . . . . 1.0 112.139 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.44 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.1 p -53.51 -19.34 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.347 -0.842 . . . . 1.0 110.799 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -66.37 -44.69 82.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.97 -4.77 10.43 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.596 0.712 . . . . 1.0 109.414 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 36.6 69.45 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.713 -1.131 . . . . 1.0 113.295 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.3 p -75.22 131.06 40.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.997 -1.482 . . . . 1.0 106.997 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -121.91 142.14 50.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.888 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 t -130.3 122.57 28.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.55 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.797 ' O ' ' N ' ' A' ' 115' ' ' GLN . 69.3 mt -129.79 174.13 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.191 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.722 ' N ' HG22 ' A' ' 113' ' ' ILE . 29.3 t 38.48 -77.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.654 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.797 ' N ' ' O ' ' A' ' 113' ' ' ILE . 53.1 tp60 -54.23 107.49 0.87 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.639 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -92.6 -43.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.638 2.225 . . . . 1.0 112.372 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -96.6 169.55 9.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.418 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.406 ' CB ' ' NH1' ' A' ' 133' ' ' ARG . 95.8 p -130.11 160.4 33.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.646 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -57.88 120.1 7.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.511 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.43 92.12 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 124' ' ' ARG . 33.7 mt -87.92 139.73 30.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 1.0 110.357 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 t -60.94 -37.12 81.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.45 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.85 90.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.708 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 121' ' ' LEU . 10.4 tpp85 -139.43 144.75 38.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.56 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.29 84.81 23.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.18 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.59 153.94 1.97 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.671 2.247 . . . . 1.0 112.288 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.651 HD12 ' N ' ' A' ' 127' ' ' LEU . 9.0 mp -57.76 -19.77 30.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.58 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.67 74.79 0.01 OUTLIER Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.786 -0.925 . . . . 1.0 110.786 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 127' ' ' LEU . 42.4 mt-10 -143.78 74.74 16.45 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.559 0.219 . . . . 1.0 110.877 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -86.88 163.37 8.97 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 123.099 2.533 . . . . 1.0 111.679 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 48.8 mt -76.36 -5.87 49.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.361 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -85.52 88.33 7.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.939 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.406 ' NH1' ' CB ' ' A' ' 118' ' ' SER . 22.1 mmt180 -124.33 80.35 59.64 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.506 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.87 138.94 20.3 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.691 2.261 . . . . 1.0 111.997 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 t -105.84 122.82 59.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.85 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -42.43 152.74 0.33 Allowed Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.746 -0.464 . . . . 1.0 109.746 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -58.89 -34.72 99.21 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.223 2.615 . . . . 1.0 114.068 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.705 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -48.16 -46.31 34.48 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.684 0.253 . . . . 1.0 111.684 -178.494 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.705 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 19.1 t-80 -82.91 -27.75 30.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.272 0.471 . . . . 1.0 112.272 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.44 ' CG1' HG23 ' A' ' 106' ' ' VAL . 86.4 t -65.2 -52.26 55.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.965 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -66.47 -27.87 68.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -60.02 -41.98 93.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.732 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 146' ' ' MET . 8.9 mt -73.03 -37.83 66.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -51.95 -38.24 55.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.9 p -66.85 -20.66 65.97 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.761 -1.109 . . . . 1.0 109.188 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.568 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -95.43 -0.02 52.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.406 -0.816 . . . . 1.0 110.711 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.61 20.68 78.65 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.69 143.96 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 1.0 110.968 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.66 -42.29 4.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.982 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 t -135.35 122.85 22.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.135 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.6 m -110.99 141.91 43.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.503 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.511 HD13 ' CE1' ' A' ' 176' ' ' TYR . 2.4 tp -118.27 136.35 53.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.292 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.7 t -123.14 114.85 43.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.12 0.486 . . . . 1.0 111.772 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.5 t -113.26 131.2 23.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 107.806 -1.183 . . . . 1.0 107.806 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.75 125.45 8.17 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.152 2.568 . . . . 1.0 114.676 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.2 mt -118.52 48.95 1.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -146.14 176.55 9.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.502 ' ND1' ' N ' ' A' ' 159' ' ' HIS . 49.9 t-80 -67.72 171.68 6.16 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.379 -0.828 . . . . 1.0 111.391 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.502 ' N ' ' ND1' ' A' ' 158' ' ' HIS . 73.5 m80 -61.98 -52.82 62.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.039 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -103.79 -39.32 6.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.541 ' OE1' ' CD2' ' A' ' 163' ' ' TRP . 11.0 tm-20 -87.54 133.55 33.76 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.909 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.567 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -107.2 117.52 34.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 1.0 111.301 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.541 ' CD2' ' OE1' ' A' ' 161' ' ' GLU . 54.2 m95 -92.0 -41.04 10.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.231 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.515 ' C ' HD12 ' A' ' 165' ' ' LEU . . . -163.34 -176.86 35.76 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.204 -0.759 . . . . 1.0 111.204 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 164' ' ' GLY . 5.3 mp -143.87 140.19 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 1.0 111.569 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.5 tp -98.97 135.67 40.06 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.8 p -138.59 129.11 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.371 . . . . 1.0 111.051 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.5 t -107.6 150.7 26.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.996 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.442 ' O ' ' OG1' ' A' ' 48' ' ' THR . 91.7 m-70 -127.81 134.84 49.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.961 0.41 . . . . 1.0 111.626 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -132.62 113.93 13.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.015 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.78 -14.24 62.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.857 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -108.04 150.0 39.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.01 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.2 140.59 34.35 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.902 2.401 . . . . 1.0 111.896 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -172.31 129.66 0.62 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.898 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.58 157.81 28.55 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.517 2.144 . . . . 1.0 111.932 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.511 ' CE1' HD13 ' A' ' 152' ' ' LEU . 75.7 m-85 -102.2 139.0 38.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.444 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.496 ' N ' ' OE1' ' A' ' 180' ' ' GLU . 8.7 t -126.94 -177.35 4.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.591 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' A' ' 182' ' ' GLN . 95.0 mt-30 -59.98 -34.1 72.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.657 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -56.17 -36.93 68.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.764 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 177' ' ' SER . 40.5 mp0 -65.15 -24.21 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.497 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.6 tp -80.88 -30.53 35.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.497 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.497 ' NE2' ' N ' ' A' ' 182' ' ' GLN . 0.3 OUTLIER -63.28 -43.36 98.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.32 -178.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.67 HG23 ' N ' ' A' ' 184' ' ' VAL . 22.9 m -73.7 -51.56 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.67 ' N ' HG23 ' A' ' 183' ' ' VAL . 16.9 m -68.57 -46.26 80.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.445 0.535 . . . . 1.0 112.445 -177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.6 ' N ' HG23 ' A' ' 184' ' ' VAL . 52.7 tp60 -53.09 -36.62 60.89 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.664 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.553 ' O ' HD23 ' A' ' 186' ' ' LEU . 1.1 tt -74.55 -53.48 9.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.875 ' O ' HG23 ' A' ' 191' ' ' VAL . 71.0 mt -78.91 -39.27 35.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.883 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 184' ' ' VAL . . . -62.18 -45.52 93.04 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.487 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.415 ' OD2' ' NE2' ' A' ' 185' ' ' GLN . 93.0 m-20 -60.01 -40.19 88.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.069 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -69.21 -23.85 63.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.117 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 187' ' ' LEU . 57.9 t -83.79 -45.58 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.041 -0.527 . . . . 1.0 109.775 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.5 p -57.58 -34.59 69.38 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.677 -0.861 . . . . 1.0 108.677 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.8 mt -69.15 -34.3 62.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.394 -0.821 . . . . 1.0 109.156 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.6 -38.03 77.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.783 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.628 HD11 HD21 ' A' ' 35' ' ' LEU . 4.7 mm -64.24 -40.24 88.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.087 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.36 -49.06 53.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.132 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 8.1 pt20 -69.99 -35.98 74.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.492 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.441 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.49 -33.5 74.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.673 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.75 -33.25 72.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.449 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.79 -30.54 71.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.002 -0.279 . . . . 1.0 111.067 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -51.67 -51.99 51.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.551 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 23.7 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.56 179.495 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.72 HAD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.847 0.356 . . . . 1.0 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -79.13 -29.73 43.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.942 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -77.41 -47.72 19.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.11 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.507 HG23 ' N ' ' A' ' 35' ' ' LEU . 2.9 tp -61.61 -41.15 89.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.74 0.305 . . . . 1.0 110.859 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.6 ' O ' ' OG1' ' A' ' 38' ' ' THR . 20.2 mt -57.0 -44.43 82.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.089 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -55.35 -33.95 63.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.1 -33.22 69.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.154 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.6 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 82.8 p -72.15 -40.94 67.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.416 -0.811 . . . . 1.0 112.264 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.684 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 8.5 p -71.33 -37.23 64.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.04 -48.17 66.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 1.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.82 -52.69 59.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.687 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 38' ' ' THR . 77.6 t -53.49 -40.72 42.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.953 -0.299 . . . . 1.0 111.153 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.2 tmm_? -53.28 -39.3 63.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.737 0.303 . . . . 1.0 110.816 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.05 74.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.028 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -77.18 -42.22 38.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.578 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.14 -28.32 24.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.459 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.43 20.65 17.44 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.515 HG23 ' CD2' ' A' ' 170' ' ' HIS . 87.5 m -71.73 142.52 49.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 1.0 110.253 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -41.91 -45.53 3.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.596 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.529 HH21 ' CD ' ' A' ' 67' ' ' GLU . 64.0 ttt-85 -159.87 128.14 4.88 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.022 -0.671 . . . . 1.0 112.572 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.48 131.32 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.661 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 56.4 pttt -140.2 156.47 46.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.478 -0.489 . . . . 1.0 111.918 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 63.9 t -110.8 135.69 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -134.39 125.78 28.23 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.358 -0.537 . . . . 1.0 111.339 -178.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -84.17 143.47 29.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.235 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.609 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 72.7 t80 -95.51 119.23 33.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.065 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.43 149.48 52.06 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -60.93 -23.43 77.16 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.51 2.14 . . . . 1.0 112.456 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.5 -11.87 53.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.924 0.392 . . . . 1.0 110.116 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.69 -15.15 53.07 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.547 -0.621 . . . . 1.0 111.547 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.429 ' NE2' ' HB2' ' A' ' 84' ' ' ALA . 45.5 m80 -73.13 94.98 2.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.759 0.314 . . . . 1.0 110.6 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.6 139.59 16.04 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.1 p -120.64 142.14 49.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.862 0.363 . . . . 1.0 111.756 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 t -79.22 110.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.18 0.71 10.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.886 -0.325 . . . . 1.0 111.306 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.684 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.99 117.97 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.035 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.529 ' CD ' HH21 ' A' ' 50' ' ' ARG . 85.8 tt0 -143.58 132.4 22.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.122 0.487 . . . . 1.0 111.784 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.49 143.14 50.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.393 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -141.59 145.78 35.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.784 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -52.39 -34.09 40.93 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 177.31 -161.61 29.19 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.06 16.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 1.0 110.54 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 71' ' ' GLY . 30.3 ttm180 -65.31 -49.07 70.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.195 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.8 mt -111.82 146.77 35.42 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.887 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.33 159.32 54.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.486 2.124 . . . . 1.0 112.19 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.3 m -95.02 127.95 41.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.915 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 80' ' ' LEU . 28.7 mt -94.95 11.29 32.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.371 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.5 tp -68.0 132.21 46.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 1.0 112.241 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.08 -11.65 66.61 Favored Glycine 0 CA--C 1.523 0.594 0 CA-C-N 115.615 -0.721 . . . . 1.0 111.54 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 77' ' ' LEU . 80.4 mt -83.99 151.62 24.91 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.944 -0.303 . . . . 1.0 110.306 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.7 p -105.25 132.69 51.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.679 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.755 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 9.2 m-85 -86.97 130.53 47.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -40.39 138.49 1.31 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.686 2.257 . . . . 1.0 111.864 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.429 ' HB2' ' NE2' ' A' ' 61' ' ' HIS . . . -65.86 125.63 25.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.676 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.32 -1.51 43.4 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -60.54 -33.38 72.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 87' ' ' ILE . 1.5 mp -69.31 130.28 91.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.417 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.59 168.9 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.35 2.033 . . . . 1.0 112.499 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -100.45 -56.04 2.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.572 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -64.59 -41.67 96.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.813 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.929 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -66.84 -44.01 82.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.609 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 42.2 ttt85 -62.42 -41.3 98.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.436 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -62.87 -34.88 78.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.768 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.495 ' C ' HH22 ' A' ' 101' ' ' ARG . 71.2 mt -70.84 -38.21 73.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.225 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.608 ' N ' ' NH2' ' A' ' 101' ' ' ARG . 1.7 t80 -62.03 -20.71 64.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -82.96 -28.38 29.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.824 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.24 -42.65 7.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.07 -8.06 13.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 115.07 1.508 . . . . 1.0 115.07 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 99' ' ' GLN . 0.9 OUTLIER 42.43 81.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.186 -1.005 . . . . 1.0 108.817 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 100' ' ' VAL . 2.8 p 174.41 114.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.985 -0.552 . . . . 1.0 111.101 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.608 ' NH2' ' N ' ' A' ' 95' ' ' PHE . 3.8 tpp180 -155.23 147.02 23.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 1.0 110.714 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 p -170.76 146.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.514 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.591 HD11 ' CD2' ' A' ' 139' ' ' HIS . 67.2 mt -108.65 136.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.608 HG11 ' H ' ' A' ' 133' ' ' ARG . 3.2 m -93.02 165.79 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.262 0.838 . . . . 1.0 113.262 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -48.07 117.22 1.82 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.899 -1.046 . . . . 1.0 112.109 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.429 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.4 p -58.38 -25.79 28.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.401 -0.818 . . . . 1.0 110.773 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 109' ' ' GLN . 84.5 tt0 -63.78 -44.98 91.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.47 -8.07 1.68 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.457 0.646 . . . . 1.0 109.338 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.544 ' CD ' HH21 ' A' ' 111' ' ' ARG . 6.5 tt0 45.04 60.91 2.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.744 -1.116 . . . . 1.0 113.266 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 t -75.15 133.46 41.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.954 -1.499 . . . . 1.0 106.954 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.544 HH21 ' CD ' ' A' ' 109' ' ' GLN . 80.0 mtt180 -119.57 139.52 52.01 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.038 -0.665 . . . . 1.0 111.9 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.29 163.51 32.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.564 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.9 pt -127.31 140.96 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.153 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.489 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 28.6 p -80.47 15.22 1.71 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.644 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 116' ' ' PRO . 65.0 mt-30 -64.51 151.67 91.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.598 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' GLN . 33.9 Cg_exo -34.0 -64.96 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.655 2.237 . . . . 1.0 112.365 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 118' ' ' SER . 72.4 tt0 41.58 61.24 1.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.405 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 117' ' ' GLU . 51.6 p 50.39 176.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.668 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -118.55 144.27 46.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.548 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 72.21 179.34 33.61 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.6 mt -102.47 89.58 3.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 1.0 110.423 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.0 p -66.6 -32.3 73.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.481 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.75 -23.37 64.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.71 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.51 ' NH2' ' O ' ' A' ' 125' ' ' VAL . 2.1 tpm_? 51.45 83.28 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.55 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.51 ' O ' ' NH2' ' A' ' 124' ' ' ARG . 1.6 m -68.38 143.46 95.56 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.23 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -80.96 4.6 6.84 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.577 2.185 . . . . 1.0 112.322 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.0 mp 55.59 26.15 8.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.571 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.73 -130.33 1.2 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.524 ' CD ' ' NE2' ' A' ' 178' ' ' GLN . 10.7 mp0 -127.23 78.17 74.73 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.655 0.264 . . . . 1.0 110.875 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -87.35 -175.52 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.136 2.557 . . . . 1.0 111.654 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.8 mt -50.87 -61.21 2.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.339 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 179.5 153.74 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.956 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.608 ' H ' HG11 ' A' ' 104' ' ' VAL . 73.4 mtp180 -97.6 111.35 58.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.585 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.06 138.33 12.82 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.774 2.316 . . . . 1.0 111.977 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 26.4 t -125.89 140.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.808 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 114' ' ' SER . 3.7 t70 -43.68 138.88 2.92 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -58.48 -32.45 96.44 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.153 2.569 . . . . 1.0 114.005 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.6 p -49.79 -45.18 49.56 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.693 0.257 . . . . 1.0 111.693 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.668 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 6.5 t60 -81.39 -28.6 34.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.229 0.455 . . . . 1.0 112.229 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.429 ' CG1' HG23 ' A' ' 106' ' ' VAL . 60.2 t -68.77 -52.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.668 -0.413 . . . . 1.0 111.017 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -67.07 -24.84 66.01 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -64.56 -39.52 93.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.673 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 146' ' ' MET . 10.4 mt -73.35 -36.01 66.09 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -52.72 -38.22 60.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.625 -1.25 . . . . 1.0 107.625 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.3 p -66.69 -19.47 65.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.728 -1.124 . . . . 1.0 109.199 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.504 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.9 mmm -96.49 3.25 52.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.477 -0.783 . . . . 1.0 110.715 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.7 21.28 77.85 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 150' ' ' SER . 55.2 t -110.54 144.13 19.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.381 . . . . 1.0 110.971 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.95 -17.92 13.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.961 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.409 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 5.6 t -149.83 163.36 38.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.227 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.471 ' OG ' HD12 ' A' ' 103' ' ' ILE . 9.3 p -148.08 125.06 11.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.482 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -109.03 133.01 53.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.318 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.578 HG21 HAA1 ' A' ' 203' ' ' CYC . 3.7 t -123.57 116.25 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.11 0.481 . . . . 1.0 111.77 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.11 129.27 25.21 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 107.81 -1.181 . . . . 1.0 107.81 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.479 ' C ' HD12 ' A' ' 156' ' ' LEU . 95.1 Cg_endo -74.21 123.48 8.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.091 2.527 . . . . 1.0 114.685 -175.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.571 HD23 HG11 ' A' ' 191' ' ' VAL . 10.8 mp -116.4 49.3 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.866 -1.531 . . . . 1.0 106.866 177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.498 ' CE ' ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -147.2 179.29 7.74 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.112 0.782 . . . . 1.0 113.112 -176.393 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -67.6 164.58 18.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.286 -0.87 . . . . 1.0 111.434 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -57.89 -50.55 72.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.463 -0.789 . . . . 1.0 112.064 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -103.93 -39.64 6.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -88.28 137.92 31.9 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.863 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.4 OUTLIER -108.93 112.94 25.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.269 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -88.9 -42.56 11.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.195 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.71 -175.71 25.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.428 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 5.1 tp -145.44 134.15 22.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.352 . . . . 1.0 111.517 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.5 tp -101.63 131.33 47.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 167' ' ' VAL . 12.0 p -137.61 131.33 43.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.811 -0.356 . . . . 1.0 111.12 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.9 m -108.59 139.77 42.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.071 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.462 ' O ' ' CG2' ' A' ' 48' ' ' THR . 62.0 m80 -110.43 125.37 53.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.006 0.432 . . . . 1.0 111.636 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.515 ' CD2' HG23 ' A' ' 48' ' ' THR . 57.1 m80 -123.78 114.62 20.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.875 -0.602 . . . . 1.0 109.952 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.36 -14.8 63.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.837 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.89 148.33 34.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.051 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' A' ' 174' ' ' ARG . 80.9 Cg_endo -74.83 -98.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.891 2.394 . . . . 1.0 111.917 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.507 ' O ' ' O ' ' A' ' 173' ' ' PRO . 16.2 mtp-105 56.38 144.94 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.838 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.87 152.0 40.93 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.603 2.202 . . . . 1.0 111.921 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -90.69 146.98 23.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.473 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.434 ' OG ' ' OE1' ' A' ' 180' ' ' GLU . 95.2 p -121.97 156.66 32.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.652 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.524 ' NE2' ' CD ' ' A' ' 129' ' ' GLU . 22.4 mp0 -60.31 -26.16 66.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.558 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -54.58 -39.55 67.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.765 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.434 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 1.5 mp0 -63.96 -39.39 94.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.525 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.27 -38.84 91.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.429 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -56.21 -37.61 69.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.361 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 73.3 t -67.69 -56.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.667 0.617 . . . . 1.0 112.667 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 188' ' ' ALA . 1.8 t -73.47 -42.7 56.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -43.38 -47.7 6.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.605 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 19.7 tp -70.95 -41.06 71.6 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.919 0.34 . . . . 1.0 111.919 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.636 ' O ' HG23 ' A' ' 191' ' ' VAL . 8.4 tp -77.91 -38.4 45.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.821 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -62.24 -37.97 87.42 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.53 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -61.37 -40.11 93.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.031 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.86 -25.36 63.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.12 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 187' ' ' LEU . 59.2 t -83.25 -45.25 18.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.767 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.6 t -56.67 -37.02 70.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.3 mt -66.83 -33.65 64.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.448 -0.796 . . . . 1.0 109.171 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.9 -38.94 73.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.784 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.4 mm -65.21 -41.56 91.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.154 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.63 -47.96 61.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.115 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.6 pt20 -70.33 -34.52 72.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.532 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -67.52 -32.78 73.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.667 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.14 -34.59 75.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.588 -0.278 . . . . 1.0 111.424 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 41.3 mt -61.09 -33.24 73.04 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.091 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 17.5 m -54.04 -53.19 56.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.796 0.331 . . . . 1.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.624 179.658 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.929 HBD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.9 mp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.815 0.341 . . . . 1.0 110.56 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -49.5 -35.25 19.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.993 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -75.4 -46.92 29.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.138 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 38' ' ' THR . 18.1 mm -64.99 -38.79 83.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.544 -0.298 . . . . 1.0 110.962 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.583 ' O ' ' OG1' ' A' ' 38' ' ' THR . 18.9 mt -57.88 -35.83 71.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.005 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -66.37 -33.47 75.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.084 0.468 . . . . 1.0 109.833 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.19 -30.94 67.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.107 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -73.0 -45.33 58.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.505 -0.77 . . . . 1.0 112.241 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.7 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.1 p -65.41 -35.23 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 111.929 0.344 . . . . 1.0 111.929 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.85 -40.1 65.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 1.0 111.071 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.12 -51.63 67.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.749 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.21 -30.6 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.203 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.647 HH22 ' CA ' ' A' ' 70' ' ' GLY . 8.1 tpt180 -55.38 -43.9 75.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.76 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.74 77.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.041 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -80.31 -45.48 17.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.526 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.92 -34.74 20.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.427 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.87 20.04 17.37 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.471 -1.052 . . . . 1.0 110.471 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.541 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 10.1 t -69.15 141.06 54.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.796 0.331 . . . . 1.0 110.23 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD2' ' CB ' ' A' ' 171' ' ' ALA . 84.5 m-20 -38.03 -39.82 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.659 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.436 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 24.3 ttm180 -167.75 131.95 1.77 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.007 -0.677 . . . . 1.0 112.588 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 p -138.81 130.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -139.88 157.55 45.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.131 0.491 . . . . 1.0 111.948 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.5 t -99.88 135.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -118.25 108.46 15.15 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.257 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -83.17 125.08 31.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.236 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.523 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 84.1 t80 -90.68 141.19 29.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 1.0 112.039 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.523 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 7.1 m-20 -112.13 151.05 43.35 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.11 -23.5 69.32 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.512 2.141 . . . . 1.0 112.49 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -87.46 -11.72 48.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.17 -11.63 60.29 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.552 -0.619 . . . . 1.0 111.552 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -80.14 90.74 5.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 1.0 110.627 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.52 151.05 21.12 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.576 -1.009 . . . . 1.0 110.576 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 p -125.44 148.47 48.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 1.0 111.711 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.71 109.26 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.78 0.69 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.366 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.7 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.6 115.72 2.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.066 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 85.5 tt0 -144.98 134.41 23.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.047 0.451 . . . . 1.0 111.834 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.87 132.37 45.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.433 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' C ' HH12 ' A' ' 43' ' ' ARG . 35.6 ptt-85 -134.97 150.94 50.44 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.733 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.647 ' CA ' HH22 ' A' ' 43' ' ' ARG . . . -56.76 -119.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.18 -76.94 1.03 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -169.22 46.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.747 0.308 . . . . 1.0 110.546 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -83.43 -45.99 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.1 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 28.6 mt -108.17 145.46 31.51 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.474 . . . . 1.0 109.874 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.3 139.57 42.16 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.485 2.123 . . . . 1.0 112.17 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.8 m -66.9 124.31 22.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.957 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 80' ' ' LEU . 26.9 mt -100.08 13.11 35.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.334 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.464 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 26.9 tp -71.65 128.36 35.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.284 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.42 -9.86 75.45 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.492 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 77' ' ' LEU . 73.7 mt -84.88 151.6 24.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.757 0.313 . . . . 1.0 110.292 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.9 m -104.07 131.0 51.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.688 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 6.1 m-85 -82.82 152.44 66.08 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.568 -0.53 . . . . 1.0 109.568 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.62 133.5 39.86 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.594 2.196 . . . . 1.0 111.877 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.27 127.88 33.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.681 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.09 2.76 45.26 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.539 -1.024 . . . . 1.0 110.539 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -58.44 -33.66 69.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.77 129.33 52.97 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.429 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.671 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 86.2 Cg_endo -73.89 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.459 2.106 . . . . 1.0 112.484 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -109.95 -59.02 1.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.531 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -58.42 -44.65 89.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.833 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.897 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -66.79 -48.03 70.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -54.72 -35.07 63.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.464 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -64.4 -34.15 77.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.0 mt -63.44 -37.58 87.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.281 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.508 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 56.2 m-85 -63.99 -27.18 68.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.04 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -82.68 -29.36 29.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.77 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.1 mt -98.64 -42.41 7.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 114.416 1.265 . . . . 1.0 114.416 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.539 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.69 -7.87 13.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.019 1.489 . . . . 1.0 115.019 -174.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.539 ' C ' ' O ' ' A' ' 98' ' ' ALA . 1.0 OUTLIER 39.55 74.18 0.1 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.201 -1.0 . . . . 1.0 108.821 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 100' ' ' VAL . 6.8 p 174.27 121.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.059 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.571 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -171.04 147.65 2.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 1.0 110.811 177.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.571 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 21.9 m -157.25 157.63 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.515 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.754 HD11 HAA1 ' A' ' 203' ' ' CYC . 49.6 mt -106.06 135.59 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 105' ' ' ASP . 10.7 t -87.12 158.2 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.248 0.833 . . . . 1.0 113.248 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.46 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.0 p-10 -50.67 121.95 6.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.865 -1.061 . . . . 1.0 112.095 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.2 -23.06 12.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.792 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 109' ' ' GLN . 82.1 tt0 -63.15 -49.24 75.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . . . -66.4 -4.56 8.41 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.554 0.692 . . . . 1.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 36.34 72.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.787 -1.097 . . . . 1.0 113.282 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.4 p -72.83 129.75 38.88 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.968 -1.493 . . . . 1.0 106.968 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -118.4 133.18 56.09 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.918 -0.713 . . . . 1.0 111.835 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -125.91 153.47 44.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.556 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 112' ' ' SER . 23.1 pt -156.0 175.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.172 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.7 m -58.28 150.83 20.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.663 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -139.57 153.02 70.02 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.635 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.18 -12.15 19.3 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.709 2.273 . . . . 1.0 112.401 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -171.51 134.83 0.87 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.396 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.9 m -165.43 -23.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.635 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 81.3 t90 -68.85 137.42 53.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.507 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 72.31 -102.15 1.14 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.4 tp 47.39 93.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.332 . . . . 1.0 110.374 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 26.7 t -58.64 -34.13 70.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.489 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 124' ' ' ARG . . . -59.75 -52.11 66.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.681 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.51 ' HE ' ' H ' ' A' ' 125' ' ' VAL . 18.1 ttp180 80.54 -142.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.549 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.51 ' H ' ' HE ' ' A' ' 124' ' ' ARG . 3.2 m -115.82 83.65 11.98 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.186 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -86.86 -6.31 7.65 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.582 2.188 . . . . 1.0 112.309 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.24 146.27 39.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.567 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -76.43 161.19 51.46 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.754 -0.938 . . . . 1.0 110.754 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 42.24 62.6 7.67 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 121.144 -0.223 . . . . 1.0 110.823 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -86.61 160.78 9.34 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.197 2.598 . . . . 1.0 111.649 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.9 mt -73.22 -0.16 13.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.374 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 57.79 53.89 6.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.955 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? 64.11 89.87 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.593 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.37 146.31 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.733 2.289 . . . . 1.0 111.948 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.01 122.74 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.87 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -43.32 151.76 0.43 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.56 -43.46 50.69 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.217 2.612 . . . . 1.0 114.005 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.666 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.3 p -38.97 -44.75 1.11 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.679 0.252 . . . . 1.0 111.679 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.666 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.3 t60 -82.76 -31.78 28.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.249 0.463 . . . . 1.0 112.249 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.64 -52.8 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.639 -0.425 . . . . 1.0 110.982 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -65.79 -29.39 69.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -63.53 -44.86 93.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.707 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 146' ' ' MET . 12.6 mt -73.33 -36.67 66.24 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -48.23 -39.07 20.08 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.507 -1.294 . . . . 1.0 107.507 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.3 m -58.26 -32.64 68.56 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.786 -1.097 . . . . 1.0 109.214 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.574 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.2 mmm -79.1 0.72 26.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.743 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.49 26.07 74.7 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.39 142.28 30.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.976 0.417 . . . . 1.0 110.932 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.54 -26.43 12.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.969 -0.559 . . . . 1.0 111.027 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 p -141.5 127.11 18.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.413 . . . . 1.0 111.137 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.15 131.43 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.47 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 152' ' ' LEU . 8.3 mp -110.49 139.9 45.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.285 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.492 HG21 HMA3 ' A' ' 203' ' ' CYC . 2.4 t -123.97 116.24 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.113 0.482 . . . . 1.0 111.74 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.561 HG21 HG21 ' A' ' 184' ' ' VAL . 41.1 t -117.94 121.29 31.72 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 107.791 -1.189 . . . . 1.0 107.791 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.452 ' C ' HD12 ' A' ' 156' ' ' LEU . 86.4 Cg_endo -75.54 123.86 7.87 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.247 2.631 . . . . 1.0 114.7 -176.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.452 HD12 ' C ' ' A' ' 155' ' ' PRO . 10.8 mp -111.85 56.15 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.807 -1.553 . . . . 1.0 106.807 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -147.84 178.51 8.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -65.76 161.54 20.6 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.299 -0.864 . . . . 1.0 111.427 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -55.04 -49.26 72.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.083 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -105.0 -39.76 6.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.404 ' OE1' ' CH2' ' A' ' 163' ' ' TRP . 96.1 mt-10 -88.05 138.04 31.8 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.689 -0.405 . . . . 1.0 110.876 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.462 HD12 ' H ' ' A' ' 162' ' ' LEU . 1.8 mp -109.09 112.51 24.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.288 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.404 ' CH2' ' OE1' ' A' ' 161' ' ' GLU . 46.9 m95 -88.04 -36.93 16.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.214 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.0 -171.85 28.64 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.412 HD11 ' CG1' ' A' ' 153' ' ' VAL . 42.1 tp -144.66 131.84 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 1.0 111.585 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.46 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.4 tp -105.16 134.18 48.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.03 133.83 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.631 -0.428 . . . . 1.0 111.039 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.403 ' OG ' HG21 ' A' ' 48' ' ' THR . 28.5 t -107.8 136.99 46.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.02 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.463 ' O ' ' OG1' ' A' ' 48' ' ' THR . 27.7 m80 -111.71 131.37 55.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.999 0.428 . . . . 1.0 111.668 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -126.68 130.87 51.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.998 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.418 ' CB ' ' OD2' ' A' ' 49' ' ' ASP . . . -88.64 56.44 3.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.812 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -148.11 136.64 11.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.981 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.3 4.69 5.67 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.866 2.377 . . . . 1.0 111.924 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -64.87 148.39 97.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.895 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.78 165.28 31.82 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.603 2.202 . . . . 1.0 111.897 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 38.4 p90 -86.4 138.46 31.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.425 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 88.3 p -116.8 155.48 28.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.63 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -58.53 -31.78 68.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.676 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -55.81 -40.42 72.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.758 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.47 -38.5 90.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.54 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.5 tp -65.7 -37.71 87.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.547 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -55.34 -37.12 67.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.402 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.2 t -68.84 -52.91 30.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.561 HG21 HG21 ' A' ' 154' ' ' VAL . 20.8 m -75.14 -36.87 38.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.411 0.523 . . . . 1.0 112.411 -177.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.422 ' N ' HG23 ' A' ' 184' ' ' VAL . 53.0 tp60 -50.88 -48.19 60.36 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.7 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.8 -44.33 41.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.963 0.357 . . . . 1.0 111.963 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 191' ' ' VAL . 43.1 tp -77.43 -42.44 36.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.906 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -58.24 -39.3 78.74 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.544 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.401 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 86.8 m-20 -59.46 -38.86 81.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.999 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -65.8 -25.74 67.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.115 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 187' ' ' LEU . 17.0 t -85.09 -42.29 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.719 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.4 t -58.05 -38.93 77.22 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.1 mt -65.98 -34.77 72.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.209 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -70.89 -39.3 72.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.781 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.441 HD11 HD21 ' A' ' 35' ' ' LEU . 4.6 mm -60.91 -47.53 93.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.199 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.23 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.132 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -70.86 -41.98 70.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.466 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -64.19 -34.49 78.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.73 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -54.83 -25.86 31.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.509 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.35 -34.54 75.46 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.043 -0.263 . . . . 1.0 111.057 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.9 t -45.1 -55.68 5.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.596 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.635 179.703 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.897 HBD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.838 0.351 . . . . 1.0 110.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.97 -29.55 66.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.99 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -78.64 -46.51 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.161 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 mm -62.56 -46.2 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.758 0.313 . . . . 1.0 110.908 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.1 mt -58.29 -48.07 81.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.069 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -52.98 -38.72 62.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.23 -29.31 64.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.087 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.4 m -73.44 -47.02 44.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.547 -0.751 . . . . 1.0 112.263 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.1 p -65.73 -36.36 77.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 111.941 0.348 . . . . 1.0 111.941 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.75 -44.38 86.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.823 0.344 . . . . 1.0 111.077 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -42.0 98.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.705 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.9 t -59.64 -40.68 82.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.964 -0.294 . . . . 1.0 111.15 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 47' ' ' GLY . 52.1 ttp180 -50.67 -42.59 56.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.8 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.2 78.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.063 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -77.27 -47.01 21.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.549 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.71 -29.88 22.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.502 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.2 22.13 35.29 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.478 -1.049 . . . . 1.0 110.478 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.504 ' OG1' ' CG2' ' A' ' 51' ' ' VAL . 17.7 p -74.74 145.31 43.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.836 0.351 . . . . 1.0 110.193 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -40.77 -43.3 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.654 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.407 HH22 ' HG ' ' A' ' 77' ' ' LEU . 44.7 ttt180 -158.55 134.94 9.34 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.031 -0.668 . . . . 1.0 112.578 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.504 ' CG2' ' OG1' ' A' ' 48' ' ' THR . 10.0 t -135.69 129.04 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -140.11 153.94 46.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.449 -0.501 . . . . 1.0 111.872 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 64.8 t -100.71 136.74 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 30.3 t80 -119.06 107.45 13.51 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.382 -0.527 . . . . 1.0 111.258 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -79.48 127.15 31.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.217 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.493 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 87.5 t80 -90.97 141.31 28.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.971 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.493 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -112.22 150.81 43.07 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 178.009 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -59.91 -23.63 73.3 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.541 2.161 . . . . 1.0 112.494 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -87.88 -12.48 44.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 1.0 110.072 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.21 58.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.605 -0.598 . . . . 1.0 111.605 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -78.31 90.22 4.36 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.931 -0.307 . . . . 1.0 110.631 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.04 151.43 20.76 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -125.48 148.21 48.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.392 . . . . 1.0 111.719 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 78' ' ' LEU . 61.5 t -77.01 108.34 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.624 ' O ' HG12 ' A' ' 65' ' ' VAL . 96.7 t -106.02 0.03 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.341 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.79 122.79 3.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.052 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -147.78 133.78 19.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.136 0.493 . . . . 1.0 111.809 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.72 141.51 51.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.681 -0.69 . . . . 1.0 109.341 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.528 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 84.6 mtm-85 -138.7 142.81 38.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.74 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -47.43 -28.01 4.49 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.2 -88.91 0.07 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -152.17 52.09 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 1.0 110.509 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -86.22 -45.65 11.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.174 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.3 mt -109.15 146.35 33.7 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.902 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.87 145.84 63.68 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.551 2.168 . . . . 1.0 112.203 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 p -62.18 124.52 21.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 80' ' ' LEU . 29.4 mt -98.57 3.48 48.04 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.366 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 64' ' ' VAL . 6.2 tp -66.25 131.45 46.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.213 0.53 . . . . 1.0 112.26 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.17 -15.39 53.95 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.584 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 77' ' ' LEU . 59.0 mt -82.05 153.84 25.94 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.987 -0.285 . . . . 1.0 110.35 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.0 p -107.04 131.29 54.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.686 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.779 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 4.9 m-85 -85.63 154.32 58.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.11 129.6 26.25 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.638 2.225 . . . . 1.0 111.935 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.26 130.05 41.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.739 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.0 -1.11 44.46 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.614 -0.995 . . . . 1.0 110.614 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -53.19 -38.33 62.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mt -78.59 131.55 67.71 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.447 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.722 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 91.1 Cg_endo -72.81 -165.57 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.438 2.092 . . . . 1.0 112.477 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -107.54 -60.99 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.506 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -57.46 -43.11 83.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.804 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.722 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.42 -40.58 85.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -69.04 -41.65 77.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.488 -0.323 . . . . 1.0 111.442 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -60.98 -31.82 71.4 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.8 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.477 ' CD1' HH12 ' A' ' 101' ' ' ARG . 78.1 mt -71.58 -38.02 70.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.227 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.73 -42.08 83.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 1.0 110.018 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 159' ' ' HIS . 77.1 ttt-85 -58.3 -33.09 69.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.798 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' C ' ' OE1' ' A' ' 99' ' ' GLN . 56.6 mt -98.14 -35.85 10.26 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -118.52 -10.19 10.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.115 1.524 . . . . 1.0 115.115 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.5 ' N ' ' OE1' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 40.39 82.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.177 -1.009 . . . . 1.0 108.812 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 100' ' ' VAL . 2.8 p 175.98 116.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.056 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.599 ' O ' HG13 ' A' ' 102' ' ' VAL . 8.0 tpt180 -160.37 143.31 13.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 1.0 110.766 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 101' ' ' ARG . 17.4 m -159.78 150.38 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.532 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.421 ' O ' ' OH ' ' A' ' 176' ' ' TYR . 42.9 mt -108.32 136.46 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.098 -0.704 . . . . 1.0 109.098 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 105' ' ' ASP . 30.9 t -88.24 158.3 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.215 0.82 . . . . 1.0 113.215 -175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 104' ' ' VAL . 33.0 m-20 -48.05 123.95 6.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.904 -1.044 . . . . 1.0 112.193 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.511 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.1 p -56.63 -24.72 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.746 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.419 ' C ' ' H ' ' A' ' 109' ' ' GLN . 83.9 tt0 -65.27 -47.76 75.59 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.8 -3.49 6.92 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.532 0.682 . . . . 1.0 109.388 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 36.03 71.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.794 -1.093 . . . . 1.0 113.296 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.7 t -72.44 130.68 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.984 -1.488 . . . . 1.0 106.984 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -118.53 138.57 52.44 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.937 -0.705 . . . . 1.0 111.885 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.423 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.2 OUTLIER -146.62 166.41 26.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.694 -0.684 . . . . 1.0 110.502 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' GLN . 26.9 pt -127.63 153.21 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.103 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 86.9 p -45.53 -10.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.631 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.585 ' N ' ' O ' ' A' ' 113' ' ' ILE . 18.6 mm100 -116.27 77.0 7.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.668 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -87.25 -165.27 0.23 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.664 2.243 . . . . 1.0 112.349 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.72 ' H ' ' NH1' ' A' ' 133' ' ' ARG . 97.4 mt-10 -116.49 -99.99 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.443 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.563 ' N ' ' NH2' ' A' ' 133' ' ' ARG . 2.0 t 39.59 93.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.644 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.3 m95 40.65 -93.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.52 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 118' ' ' SER . . . 66.68 -130.3 31.0 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.72 141.18 29.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.738 0.304 . . . . 1.0 110.389 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.7 p -63.63 -24.97 68.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.521 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.75 78.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.745 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -66.93 146.75 54.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.609 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 125' ' ' VAL . 10.2 p -70.01 129.51 90.77 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.224 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -80.62 154.98 20.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.565 2.177 . . . . 1.0 112.333 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.488 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 4.0 tp -151.81 -140.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.581 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.488 ' H ' ' CG ' ' A' ' 127' ' ' LEU . . . -59.03 -33.93 76.67 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 49.22 65.32 7.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.584 0.231 . . . . 1.0 110.873 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -87.15 159.7 8.5 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.128 2.552 . . . . 1.0 111.725 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.5 mt -83.74 1.07 44.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.335 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.632 ' O ' ' C ' ' A' ' 133' ' ' ARG . 73.4 mm-40 -59.76 -31.4 69.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.943 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.72 ' NH1' ' H ' ' A' ' 117' ' ' GLU . 4.2 tpp180 15.99 77.91 0.12 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.493 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.86 147.78 17.98 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.829 2.353 . . . . 1.0 111.92 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 135' ' ' VAL . 2.1 p -92.56 109.83 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.908 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.504 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 0.7 OUTLIER -45.36 142.31 3.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 140' ' ' VAL . 72.9 Cg_exo -43.87 -47.63 9.81 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.223 2.615 . . . . 1.0 113.988 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.719 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.3 p -35.83 -46.87 0.48 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.734 0.272 . . . . 1.0 111.734 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.719 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 2.1 t60 -82.99 -24.64 32.83 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.511 ' CG1' HG23 ' A' ' 106' ' ' VAL . 44.7 t -65.92 -55.01 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.664 -0.414 . . . . 1.0 110.963 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -65.88 -29.25 69.66 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -60.24 -47.35 86.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.666 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.1 mt -73.0 -36.72 67.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.311 -0.625 . . . . 1.0 109.311 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -49.8 -39.68 39.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.597 -1.26 . . . . 1.0 107.597 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -63.69 -28.74 70.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.713 -1.13 . . . . 1.0 109.181 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.5 mmm -85.92 -1.92 57.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.726 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.05 22.01 78.41 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.18 142.32 23.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 1.0 110.966 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.76 -38.17 5.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.932 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.7 t -133.75 125.2 28.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.104 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.2 p -112.91 135.61 53.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.479 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.83 133.89 55.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.296 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.508 HG21 HAA1 ' A' ' 203' ' ' CYC . 2.0 t -122.23 108.76 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.099 0.476 . . . . 1.0 111.792 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.433 HG11 HG12 ' A' ' 184' ' ' VAL . 48.0 t -105.06 114.6 63.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 107.8 -1.185 . . . . 1.0 107.8 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -41.7 134.74 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 123.161 2.574 . . . . 1.0 114.664 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.4 tp -132.4 41.41 3.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.6 ptm -148.92 -172.69 4.17 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.133 0.79 . . . . 1.0 113.133 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.655 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 52.2 t-80 -77.84 178.1 7.67 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.436 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.655 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 72.4 m80 -74.84 -54.94 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.051 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -104.01 11.57 35.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.032 0.382 . . . . 1.0 112.032 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.536 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.8 tt0 -146.49 140.18 26.03 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.856 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.729 ' O ' HD23 ' A' ' 162' ' ' LEU . 6.9 tt -109.55 116.18 31.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.243 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.536 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 69.0 m95 -92.68 -37.31 12.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.175 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -158.34 -171.72 24.57 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.152 -0.779 . . . . 1.0 111.152 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.412 HD21 HBA2 ' A' ' 203' ' ' CYC . 16.0 tp -145.14 125.96 14.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 1.0 111.599 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.421 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.6 tp -100.58 131.53 46.44 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.17 138.23 41.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.702 -0.399 . . . . 1.0 111.069 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.1 m -110.86 141.76 43.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.96 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -115.57 131.61 56.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.01 0.433 . . . . 1.0 111.572 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -128.01 123.03 33.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.957 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.73 36.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.829 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -164.37 126.11 1.5 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.009 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -42.68 139.55 3.16 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.988 2.459 . . . . 1.0 111.847 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -176.57 97.75 0.24 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.825 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.98 155.64 4.13 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.596 2.197 . . . . 1.0 111.887 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.421 ' OH ' ' O ' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -85.25 133.66 34.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.51 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.2 m -118.31 150.79 38.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.597 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -50.61 -35.97 32.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.663 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.01 -38.24 85.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.729 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.43 -50.79 70.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.526 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.12 -36.07 80.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.569 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -53.67 -37.2 62.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.406 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.6 -54.47 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.743 0.646 . . . . 1.0 112.743 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.433 HG12 HG11 ' A' ' 154' ' ' VAL . 3.3 t -78.04 -40.13 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.451 0.537 . . . . 1.0 112.451 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -46.9 -45.64 20.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.653 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 55.1 mt -74.64 -39.09 62.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.6 tp -76.0 -41.45 51.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.851 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -60.71 -38.55 85.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.479 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.27 -37.72 70.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.279 -0.418 . . . . 1.0 109.953 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -71.83 -24.21 61.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.114 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 194' ' ' ALA . 61.4 t -83.18 -47.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.793 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.5 m -51.97 -30.41 24.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.42 -33.29 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.154 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -70.36 -48.36 56.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.811 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 196' ' ' ALA . 1.9 pp -67.14 -37.07 78.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.132 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.463 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -70.83 -46.13 63.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.093 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -74.1 -35.14 64.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.549 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -61.92 -34.51 76.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.703 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.28 -27.61 47.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.475 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.07 -36.29 74.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.685 0.279 . . . . 1.0 111.054 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.9 m -52.45 -55.8 19.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.589 179.608 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.779 HAB2 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.892 0.377 . . . . 1.0 110.577 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 35.6 p-10 -51.21 -32.62 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 62.8 tt0 -77.07 -48.33 18.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.147 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.3 mt -60.33 -42.49 90.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 1.0 110.945 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.06 -46.55 82.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.412 . . . . 1.0 111.041 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.55 HH12 ' CD2' ' A' ' 78' ' ' LEU . 51.8 ttt85 -51.95 -38.27 55.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.95 -29.67 65.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.833 -0.622 . . . . 1.0 110.089 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 42' ' ' VAL . 20.8 m -73.5 -45.07 56.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.557 -0.747 . . . . 1.0 112.21 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.646 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.2 p -68.12 -35.6 72.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 111.976 0.362 . . . . 1.0 111.976 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -70.17 -45.48 66.63 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.104 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -63.76 -44.42 93.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.779 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 38' ' ' THR . 75.4 t -59.37 -42.53 87.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.155 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 47' ' ' GLY . 63.7 ttp85 -53.99 -40.76 67.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.851 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.15 -37.28 74.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.03 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -78.29 -43.41 28.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.581 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.7 mt -85.2 -30.4 23.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.512 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 59.28 20.11 49.21 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.509 -1.036 . . . . 1.0 110.509 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.468 ' CG2' ' CE1' ' A' ' 170' ' ' HIS . 89.8 m -72.93 142.18 47.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.83 0.348 . . . . 1.0 110.224 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -39.89 -54.72 2.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.566 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.529 ' NH2' ' O ' ' A' ' 74' ' ' LEU . 80.6 mtt-85 -152.5 131.89 12.91 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.99 -0.684 . . . . 1.0 112.501 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.64 129.34 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -138.83 156.01 47.67 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.915 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 58.7 t -108.35 136.35 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.63 134.61 47.78 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.366 -0.534 . . . . 1.0 111.311 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -94.01 137.92 32.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.21 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 66.9 t80 -94.29 117.55 30.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 1.0 112.035 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -88.07 140.93 30.89 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.422 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.02 -26.77 5.27 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.55 2.167 . . . . 1.0 112.397 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.37 -19.64 38.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.915 0.388 . . . . 1.0 110.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.69 -13.45 38.71 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.556 -0.618 . . . . 1.0 111.556 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -71.92 99.57 2.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.339 . . . . 1.0 110.593 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.62 142.57 16.06 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.626 -0.99 . . . . 1.0 110.626 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.5 p -123.07 145.77 48.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 1.0 111.743 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 t -77.74 106.99 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.09 -2.03 9.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.341 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.646 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -156.86 116.51 3.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.106 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 81.6 tt0 -144.06 132.5 22.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.802 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.433 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -128.35 138.8 52.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.343 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -118.55 137.08 53.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.906 0.384 . . . . 1.0 110.722 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.42 -81.31 0.52 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.849 -0.9 . . . . 1.0 110.849 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.507 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -114.04 50.81 0.75 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.997 -0.841 . . . . 1.0 110.997 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' A' ' 71' ' ' GLY . 15.0 pt-20 31.18 55.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 1.0 110.491 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -84.52 -50.43 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.165 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.529 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 23.8 mt -109.4 153.46 42.76 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.86 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.28 164.71 3.61 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.486 2.124 . . . . 1.0 112.126 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.1 t -87.72 128.58 35.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.878 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.549 ' HA ' HD12 ' A' ' 80' ' ' LEU . 24.3 mt -101.08 13.48 35.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.39 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.55 ' CD2' HH12 ' A' ' 36' ' ' ARG . 23.9 tp -73.08 128.9 36.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.032 -0.531 . . . . 1.0 112.343 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.9 -8.62 77.37 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.541 -0.754 . . . . 1.0 111.532 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 77' ' ' LEU . 69.8 mt -85.73 152.6 22.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.768 0.318 . . . . 1.0 110.31 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 81' ' ' THR . 11.7 t -106.26 133.67 50.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.702 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.711 ' CD2' HAB2 ' A' ' 203' ' ' CYC . 9.4 m-85 -87.59 152.09 51.4 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.68 137.01 56.69 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.61 2.207 . . . . 1.0 111.863 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.46 129.14 38.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.683 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.1 43.53 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.551 -1.019 . . . . 1.0 110.551 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.9 -37.78 66.77 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.754 ' H ' HD12 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -80.08 113.57 39.53 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.394 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 87' ' ' ILE . 86.5 Cg_exo -48.76 -171.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.455 2.103 . . . . 1.0 112.509 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.93 -59.0 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.558 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 20.8 pt-20 -58.24 -42.74 87.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.813 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -66.27 -47.84 72.38 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.971 0.36 . . . . 1.0 111.971 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.519 ' NH2' ' CE2' ' A' ' 56' ' ' PHE . 72.1 ttt180 -52.99 -35.63 59.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.498 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -66.1 -35.95 81.89 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.838 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.463 HD12 HH21 ' A' ' 101' ' ' ARG . 66.6 mt -60.69 -37.31 81.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.317 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 66.9 m-85 -60.73 -55.07 37.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.038 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -51.19 -29.72 14.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.773 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 63.2 mt -99.14 -42.42 7.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.335 1.235 . . . . 1.0 114.335 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.551 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.93 -14.47 10.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.053 1.501 . . . . 1.0 115.053 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.609 ' NE2' ' SD ' ' A' ' 157' ' ' MET . 14.9 mm100 37.58 81.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.148 -1.021 . . . . 1.0 108.835 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 100' ' ' VAL . 2.7 p 176.49 97.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.103 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.604 ' O ' HG23 ' A' ' 102' ' ' VAL . 6.6 mmt180 -147.99 146.35 28.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.992 0.425 . . . . 1.0 110.746 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 101' ' ' ARG . 62.8 t -159.79 150.07 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.514 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.415 HD12 ' OG ' ' A' ' 151' ' ' SER . 49.5 mt -108.35 136.57 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.03 163.93 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 113.279 0.844 . . . . 1.0 113.279 -176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 21.8 p30 -46.46 119.68 2.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.93 -1.032 . . . . 1.0 112.125 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.472 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.7 p -55.18 -20.42 6.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.331 -0.849 . . . . 1.0 110.808 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -65.78 -43.51 88.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.02 -12.86 55.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.529 0.68 . . . . 1.0 109.362 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.436 ' HG2' ' HE ' ' A' ' 111' ' ' ARG . 40.0 tp60 45.17 73.44 0.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.782 -1.099 . . . . 1.0 113.284 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.463 ' OG ' HG12 ' A' ' 135' ' ' VAL . 9.7 p -74.23 129.9 38.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.025 -1.472 . . . . 1.0 107.025 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.436 ' HE ' ' HG2' ' A' ' 109' ' ' GLN . 96.1 mtt180 -118.29 132.86 56.27 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.937 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.518 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -134.65 162.55 31.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.595 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.541 ' C ' ' H ' ' A' ' 115' ' ' GLN . 6.6 pt -125.22 131.03 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.164 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.4 t -55.41 -3.22 0.06 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.62 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.541 ' H ' ' C ' ' A' ' 113' ' ' ILE . 0.7 OUTLIER -57.1 153.15 25.91 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.68 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 115' ' ' GLN . 39.4 Cg_exo -34.48 134.7 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.624 2.216 . . . . 1.0 112.388 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' OE2' ' OE2' ' A' ' 90' ' ' GLU . 23.5 pt-20 -171.23 -0.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.44 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 120' ' ' GLY . 40.8 t -64.31 -90.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.642 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 91.6 m95 53.05 8.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.547 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 118' ' ' SER . . . 44.65 64.83 1.95 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.4 mt -67.96 -7.73 31.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 1.0 110.478 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.8 t -53.27 -18.54 2.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.468 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.12 -43.18 61.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.658 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -151.95 157.4 41.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.506 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 125' ' ' VAL . 7.7 p -116.61 87.86 22.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.235 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.88 150.75 12.35 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.606 2.204 . . . . 1.0 112.318 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.9 mt -65.29 -30.47 71.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.578 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.33 -174.54 49.2 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -130.09 120.51 19.26 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.619 0.247 . . . . 1.0 110.863 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -86.39 168.07 8.83 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 123.104 2.536 . . . . 1.0 111.701 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.7 tp -58.13 -32.03 67.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.358 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.49 ' O ' ' CB ' ' A' ' 133' ' ' ARG . 65.3 mt-30 -76.29 126.47 31.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.891 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.709 ' N ' ' HD2' ' A' ' 134' ' ' PRO . 10.4 ttp180 160.84 -52.29 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.585 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 133' ' ' ARG . 11.9 Cg_endo -50.79 160.42 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.706 2.271 . . . . 1.0 111.962 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.463 HG12 ' OG ' ' A' ' 110' ' ' SER . 1.5 p -95.33 114.19 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.947 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -44.0 137.17 3.63 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.518 ' HD3' ' H ' ' A' ' 112' ' ' SER . 54.8 Cg_exo -41.97 -48.52 6.12 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.238 2.625 . . . . 1.0 114.001 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.702 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER -35.96 -45.93 0.44 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.8 0.296 . . . . 1.0 111.8 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.715 ' NE2' ' HHB' ' A' ' 203' ' ' CYC . 8.1 t-80 -82.2 -26.97 32.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.472 ' CG1' HG23 ' A' ' 106' ' ' VAL . 48.0 t -63.92 -53.82 39.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.986 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -65.3 -29.1 69.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -58.97 -45.62 90.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.734 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.2 mt -73.23 -41.76 63.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -38.61 56.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.544 -1.28 . . . . 1.0 107.544 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.7 t -63.5 -26.61 68.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.823 -1.081 . . . . 1.0 109.209 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.6 mmm -90.21 3.55 53.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.731 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.25 20.31 79.11 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.08 143.56 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 1.0 110.964 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.59 -19.95 13.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.942 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.5 m -145.87 161.82 39.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 1.0 111.177 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.415 ' OG ' HD12 ' A' ' 103' ' ' ILE . 1.7 p -147.48 122.55 10.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.49 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 tp -106.27 131.67 53.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.287 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.535 HG11 HD21 ' A' ' 165' ' ' LEU . 3.5 t -124.44 120.38 58.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.126 0.489 . . . . 1.0 111.784 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.814 ' O ' HG13 ' A' ' 154' ' ' VAL . 12.6 p -130.76 91.53 36.94 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.829 -1.174 . . . . 1.0 107.829 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.468 ' HB2' ' NE2' ' A' ' 99' ' ' GLN . 84.4 Cg_exo -47.27 152.09 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 123.175 2.583 . . . . 1.0 114.677 -176.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 56.2 mt -126.07 66.64 1.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.829 -1.545 . . . . 1.0 106.829 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.609 ' SD ' ' NE2' ' A' ' 99' ' ' GLN . 2.1 ptt? -146.98 -167.53 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.145 0.795 . . . . 1.0 113.145 -175.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.697 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 18.2 t-80 -86.26 -176.0 5.73 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.446 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.697 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 59.3 t-80 -75.32 -55.27 5.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.463 -0.789 . . . . 1.0 112.103 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -105.66 13.72 29.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.014 0.376 . . . . 1.0 112.014 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -144.04 138.91 28.67 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.839 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 162' ' ' LEU . 9.1 tt -110.52 116.67 31.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.239 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -92.4 -36.51 13.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.222 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.91 -171.35 27.9 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.535 HD21 HG11 ' A' ' 153' ' ' VAL . 7.6 tp -149.72 133.31 16.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 1.0 111.532 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.434 ' CD1' HG22 ' A' ' 53' ' ' VAL . 8.3 tp -98.71 135.91 39.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 167' ' ' VAL . 11.0 p -139.25 131.68 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.047 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 m -109.11 142.9 39.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.017 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' A' ' 48' ' ' THR . 43.5 m80 -113.16 123.3 49.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.053 0.454 . . . . 1.0 111.69 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.468 ' CE1' ' CG2' ' A' ' 48' ' ' THR . 56.2 m80 -123.55 115.23 21.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.859 -0.61 . . . . 1.0 109.97 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.12 -16.12 63.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.782 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -94.48 150.15 37.68 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.963 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 174' ' ' ARG . 59.9 Cg_endo -70.83 -2.6 11.2 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.96 2.44 . . . . 1.0 111.825 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 173' ' ' PRO . 0.0 OUTLIER -32.54 98.06 0.12 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.921 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 173' ' ' PRO . 78.2 Cg_exo -50.15 167.68 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.577 2.185 . . . . 1.0 111.933 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.539 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 46.4 p90 -86.75 125.66 34.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.471 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.2 t -115.74 154.1 30.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.681 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -54.34 -31.76 55.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.626 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.81 -39.99 86.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.748 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -63.47 -42.6 98.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.551 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.55 -38.47 87.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.502 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -55.36 -36.4 66.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.899 -0.591 . . . . 1.0 111.394 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.1 -55.93 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.735 0.643 . . . . 1.0 112.735 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 188' ' ' ALA . 26.8 m -74.09 -35.3 40.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.434 0.531 . . . . 1.0 112.434 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -50.28 -45.84 54.68 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.655 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 41.5 mt -79.61 -43.97 21.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.894 0.331 . . . . 1.0 111.894 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.72 ' O ' HG23 ' A' ' 191' ' ' VAL . 34.2 tp -77.9 -40.53 39.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.835 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -60.67 -41.11 94.42 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.493 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.66 -40.26 87.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.991 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -67.81 -25.81 65.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.149 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 187' ' ' LEU . 37.0 t -84.13 -45.01 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.78 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.2 p -57.13 -35.33 69.34 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.01 -34.81 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.465 -0.789 . . . . 1.0 109.24 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.93 77.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.819 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.4 mm -59.57 -48.58 86.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.128 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.52 -48.13 57.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.127 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -65.0 -42.77 94.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.466 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.63 -31.87 73.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.706 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.14 -30.97 66.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.464 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.7 mp -59.99 -34.17 72.96 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.981 -0.288 . . . . 1.0 111.072 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.3 p -55.56 -55.58 30.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.566 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.534 179.896 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.715 ' HHB' ' NE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 31' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.868 0.366 . . . . 1.0 110.605 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 33' ' ' GLN . 24.1 p-10 -50.74 -55.48 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.998 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.408 ' N ' ' CG ' ' A' ' 32' ' ' ASP . 63.9 tt0 -52.65 -42.56 64.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.101 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.1 mm -59.64 -50.46 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 1.0 110.966 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.46 HD11 HD22 ' A' ' 31' ' ' LEU . 83.4 mt -58.42 -46.86 85.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.987 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -49.58 -39.68 35.98 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.816 -0.438 . . . . 1.0 109.816 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 -29.4 65.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.073 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 35' ' ' LEU . 24.1 m -74.53 -41.47 60.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 1.0 112.263 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.648 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.5 p -72.32 -37.82 59.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 111.922 0.341 . . . . 1.0 111.922 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -67.79 -41.61 82.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.783 0.325 . . . . 1.0 111.067 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -67.36 -44.72 78.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.734 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 38' ' ' THR . 69.3 t -61.77 -36.36 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.176 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.558 ' NH2' ' CA ' ' A' ' 70' ' ' GLY . 16.3 tpt85 -59.79 -47.47 85.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 1.0 110.802 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.55 -33.33 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 1.0 111.051 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -74.27 -41.2 61.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.607 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' A' ' 48' ' ' THR . 5.4 mt -87.12 -29.03 22.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.514 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.81 19.19 0.85 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.421 ' N ' ' C ' ' A' ' 46' ' ' LEU . 1.6 p -62.7 -97.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 1.0 110.211 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -155.13 -48.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.613 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -157.16 125.92 5.78 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.089 -0.644 . . . . 1.0 112.644 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 12.6 p -137.03 129.05 43.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.547 -0.908 . . . . 1.0 108.547 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -140.18 159.33 42.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.958 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -99.82 136.25 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.608 -0.886 . . . . 1.0 108.608 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.566 ' CG ' HAB2 ' A' ' 203' ' ' CYC . 74.2 t80 -117.09 108.45 15.73 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.295 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -83.31 126.47 32.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.274 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.621 ' CZ ' ' NH2' ' A' ' 92' ' ' ARG . 77.8 t80 -93.32 137.12 32.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 1.0 112.035 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.84 140.85 22.26 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.88 -27.27 5.57 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.573 2.182 . . . . 1.0 112.442 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.97 -18.19 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 1.0 110.096 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.96 -13.85 41.06 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.574 -0.61 . . . . 1.0 111.574 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -78.22 90.39 4.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.765 0.317 . . . . 1.0 110.63 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.48 151.46 20.97 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.635 -0.986 . . . . 1.0 110.635 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.8 p -123.51 146.62 47.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 1.0 111.692 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 77' ' ' LEU . 39.4 t -75.81 110.38 10.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.87 2.97 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.339 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.648 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.69 122.58 3.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.072 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -144.26 130.16 19.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.109 0.481 . . . . 1.0 111.826 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.62 139.25 52.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.359 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -140.85 145.8 36.69 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.793 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.558 ' CA ' ' NH2' ' A' ' 43' ' ' ARG . . . -47.31 -39.08 13.32 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.864 -0.894 . . . . 1.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 171.64 -154.27 21.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' O ' ' OE1' ' A' ' 72' ' ' GLU . 3.0 pp20? -72.54 20.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 1.0 110.523 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 71' ' ' GLY . 35.0 mtm180 -76.44 -47.8 21.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.117 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.89 150.36 52.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.92 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.42 157.91 55.4 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.486 2.124 . . . . 1.0 112.155 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.7 p -95.55 132.04 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.918 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.545 ' HA ' HD12 ' A' ' 80' ' ' LEU . 22.7 mt -90.6 17.16 7.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.41 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.44 128.8 37.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.016 -0.538 . . . . 1.0 112.28 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.91 -11.49 64.54 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.536 -0.756 . . . . 1.0 111.577 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 77' ' ' LEU . 72.1 mt -82.92 152.05 25.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.914 -0.314 . . . . 1.0 110.341 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.8 m -107.16 134.15 50.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.713 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CD2' HBB2 ' A' ' 203' ' ' CYC . 5.3 m-85 -84.95 152.19 58.69 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.36 130.66 27.5 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.636 2.224 . . . . 1.0 111.89 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 131.45 46.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.705 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.64 2.13 43.33 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -62.41 -17.02 58.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.573 ' O ' ' O ' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -105.1 103.24 40.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.397 178.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 87' ' ' ILE . 83.1 Cg_exo -49.74 -154.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.407 2.072 . . . . 1.0 112.489 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -109.21 -54.63 2.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.53 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -63.31 -45.04 93.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.78 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.765 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -66.4 -48.17 70.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.947 0.351 . . . . 1.0 111.947 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.621 ' NH2' ' CZ ' ' A' ' 56' ' ' PHE . 67.1 ttt180 -56.57 -34.68 67.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.426 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.5 ttt85 -64.25 -35.63 81.45 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.872 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.89 -38.47 91.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.281 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 40.0 m-85 -60.26 -29.97 69.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.977 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -84.2 -26.44 28.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.888 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.92 -46.92 6.03 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.434 1.272 . . . . 1.0 114.434 -175.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.526 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.58 -6.05 13.96 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.052 1.501 . . . . 1.0 115.052 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.526 ' C ' ' O ' ' A' ' 98' ' ' ALA . 1.0 OUTLIER 40.5 73.6 0.12 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.191 -1.004 . . . . 1.0 108.821 179.594 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 100' ' ' VAL . 6.2 p 176.1 118.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.993 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.837 HH21 HAD2 ' A' ' 203' ' ' CYC . 30.6 tpt85 -168.66 134.6 1.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 1.0 110.715 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.456 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 4.5 m -149.82 155.28 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.564 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.655 HD11 HMA3 ' A' ' 203' ' ' CYC . 96.9 mt -112.04 134.42 54.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.074 -0.713 . . . . 1.0 109.074 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.01 163.62 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 113.315 0.857 . . . . 1.0 113.315 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 173' ' ' PRO . 49.7 m-20 -45.92 120.11 2.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.986 -1.006 . . . . 1.0 112.156 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.8 -20.62 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.792 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.98 -44.86 83.65 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.16 -13.45 60.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.491 0.662 . . . . 1.0 109.387 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 46.66 72.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.675 -1.148 . . . . 1.0 113.327 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.82 131.98 42.98 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.002 -1.481 . . . . 1.0 107.002 175.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -118.75 134.16 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.003 -0.679 . . . . 1.0 111.904 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.1 164.49 30.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.555 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.3 pt -125.12 138.24 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.084 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 53.3 p -79.93 22.47 0.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.666 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -120.27 79.25 27.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.632 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.68 151.42 13.07 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.64 2.227 . . . . 1.0 112.395 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.78 -35.7 80.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.405 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 119' ' ' TRP . 31.1 t -173.21 -124.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.684 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.511 ' CE3' ' O ' ' A' ' 120' ' ' GLY . 37.0 t90 -71.69 147.02 47.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.532 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 122' ' ' SER . . . -79.89 179.37 53.25 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 121' ' ' LEU . 9.5 mp 54.42 5.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 1.0 110.455 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 120' ' ' GLY . 82.6 p -68.07 -22.13 64.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.393 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -63.17 -23.83 67.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.616 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 123' ' ' ALA . 69.4 ttt180 43.91 97.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.631 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.78 150.4 36.11 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.268 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.99 -34.91 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.581 2.187 . . . . 1.0 112.325 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.55 -37.21 85.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.507 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.42 43.01 47.02 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.842 -0.903 . . . . 1.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -133.04 67.95 78.0 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.625 0.25 . . . . 1.0 110.819 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.79 -168.91 0.67 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.102 2.535 . . . . 1.0 111.657 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.7 mt -85.82 -27.15 25.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.364 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -65.36 -36.61 84.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.412 . . . . 1.0 110.873 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.61 HH12 ' CD1' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -61.17 -60.16 11.47 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.568 -178.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 133' ' ' ARG . 33.2 Cg_exo -36.94 148.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.784 2.322 . . . . 1.0 111.951 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.71 147.46 6.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.869 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -92.32 136.13 25.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -41.65 -21.51 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.226 2.618 . . . . 1.0 114.018 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.683 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 4.8 p -71.24 -46.12 61.75 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.751 0.278 . . . . 1.0 111.751 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.852 ' CE1' HAA2 ' A' ' 203' ' ' CYC . 42.1 t60 -84.13 -29.11 26.99 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 1.8 p -62.65 -44.56 99.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.941 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.537 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 83.5 t60 -69.53 -30.3 68.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.738 -0.467 . . . . 1.0 109.738 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -58.2 -43.01 87.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.76 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.676 HD11 ' NE2' ' A' ' 139' ' ' HIS . 63.6 mt -72.99 -40.11 65.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.279 -0.637 . . . . 1.0 109.279 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -51.01 -39.1 54.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.568 -1.271 . . . . 1.0 107.568 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 m -65.17 -22.94 66.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.783 -1.099 . . . . 1.0 109.203 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.4 mmm -94.52 0.64 55.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.645 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.7 21.11 79.72 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 64.9 t -110.7 142.74 22.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.841 0.353 . . . . 1.0 111.063 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.55 -40.78 5.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.945 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.1 m -131.98 127.14 35.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.217 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.34 129.1 55.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.472 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.02 126.74 54.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.234 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.32 120.49 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 1.0 111.802 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.0 t -128.07 118.04 20.64 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -71.8 145.2 45.39 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.164 2.576 . . . . 1.0 114.721 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.3 mt -121.68 62.27 0.92 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.487 ' HE3' HE22 ' A' ' 99' ' ' GLN . 8.0 ptt? -147.04 -163.31 1.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.099 0.777 . . . . 1.0 113.099 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.625 ' CE1' ' HE1' ' A' ' 163' ' ' TRP . 76.1 m80 -89.06 -178.4 5.68 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.357 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -74.22 -54.09 8.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.054 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -104.68 11.16 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.03 0.381 . . . . 1.0 112.03 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.5 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.7 tt0 -143.15 136.82 28.59 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.74 ' O ' HD23 ' A' ' 162' ' ' LEU . 5.6 tt -111.89 119.64 39.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.044 -0.526 . . . . 1.0 111.259 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.625 ' HE1' ' CE1' ' A' ' 158' ' ' HIS . 82.1 m95 -92.85 -41.07 10.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.265 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.442 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -160.15 -176.31 32.1 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.179 -0.768 . . . . 1.0 111.179 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.527 HD21 HD11 ' A' ' 162' ' ' LEU . 97.0 mt -140.09 133.72 30.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 1.0 111.522 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.8 tp -105.23 134.17 48.78 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.33 138.2 40.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.048 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m -114.4 132.25 56.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 1.0 109.98 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -109.77 137.01 48.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.999 0.428 . . . . 1.0 111.676 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -130.04 130.4 44.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.015 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.17 45.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.773 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -144.05 150.74 50.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.07 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.446 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 65.4 Cg_endo -71.51 -12.31 29.22 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.905 2.404 . . . . 1.0 111.92 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -40.97 104.54 0.34 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.904 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.07 168.2 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.532 2.155 . . . . 1.0 111.95 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -97.71 136.46 38.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.518 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.2 m -120.65 152.47 38.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.638 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -51.05 -31.47 18.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.665 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -56.5 -34.86 67.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.731 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -64.3 -43.56 94.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.504 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.0 mp -67.76 -35.06 78.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.575 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.463 ' NE2' HD11 ' A' ' 186' ' ' LEU . 23.1 tm0? -54.76 -39.74 68.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.367 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.35 -52.46 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.6 t -71.53 -34.92 54.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.401 0.519 . . . . 1.0 112.401 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -50.42 -46.99 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.646 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.463 HD11 ' NE2' ' A' ' 182' ' ' GLN . 51.2 mt -68.8 -40.1 79.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.914 0.339 . . . . 1.0 111.914 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.727 ' O ' HG23 ' A' ' 191' ' ' VAL . 6.3 tp -78.45 -37.71 42.92 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.86 0.319 . . . . 1.0 111.86 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.92 86.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.482 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -63.38 -41.17 98.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.002 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -69.03 -29.11 67.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.085 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 187' ' ' LEU . 49.0 t -82.4 -46.15 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.681 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.9 t -53.75 -35.6 61.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.0 mt -64.93 -34.69 72.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.2 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.65 -39.5 80.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.617 -0.72 . . . . 1.0 109.845 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.9 mm -59.55 -47.45 90.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.189 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.465 ' HB2' ' CE1' ' A' ' 158' ' ' HIS . . . -71.17 -46.28 61.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.09 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -66.54 -45.4 79.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.457 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.55 -32.7 74.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.669 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.43 -33.13 70.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.55 -0.296 . . . . 1.0 111.427 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.38 -35.09 76.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.664 0.269 . . . . 1.0 111.077 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 90.5 p -56.91 -55.69 31.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.564 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.551 179.567 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.852 HAA2 ' CE1' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.882 0.372 . . . . 1.0 110.557 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -77.2 -29.76 54.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.942 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -78.53 -45.76 21.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.084 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 38' ' ' THR . 10.2 pt -64.8 -39.71 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.968 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.434 ' O ' ' OG1' ' A' ' 38' ' ' THR . 26.7 mt -59.72 -45.49 92.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.005 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -55.59 -34.46 64.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.42 -35.92 71.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.105 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 34' ' ' ILE . 82.8 p -70.26 -43.35 70.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.548 -0.751 . . . . 1.0 112.188 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.649 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.0 p -67.91 -36.59 76.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 111.911 0.337 . . . . 1.0 111.911 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' A' ' 43' ' ' ARG . 39.6 tp10 -66.31 -46.32 77.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.808 0.337 . . . . 1.0 111.076 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.84 -46.69 86.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.722 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 38' ' ' THR . 75.6 t -52.73 -45.06 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.955 -0.298 . . . . 1.0 111.138 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 47' ' ' GLY . 56.5 ttp180 -49.59 -39.52 35.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.825 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.56 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -76.46 -46.46 26.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.546 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.58 -27.73 25.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.507 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.4 21.49 34.1 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 169' ' ' HIS . 7.3 t -74.11 143.93 45.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 1.0 110.234 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 94.6 m-20 -43.6 -43.89 5.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.662 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' NH1' ' CD1' ' A' ' 74' ' ' LEU . 58.4 mtm-85 -154.98 131.71 10.67 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.078 -0.649 . . . . 1.0 112.56 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 51' ' ' VAL . 12.0 p -135.8 128.2 46.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -138.4 154.1 48.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.491 -0.484 . . . . 1.0 111.949 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 86.5 t -99.63 136.3 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 37.9 t80 -116.75 110.93 19.06 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.324 -0.55 . . . . 1.0 111.307 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.531 ' NH1' ' O ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -84.43 122.6 29.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.266 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.531 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 69.4 t80 -88.78 141.28 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 1.0 112.034 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.466 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 41.0 m-20 -111.97 140.0 22.95 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -46.03 -30.65 7.55 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.458 2.105 . . . . 1.0 112.46 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -81.17 -19.22 43.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 1.0 110.043 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.42 38.17 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.56 -0.616 . . . . 1.0 111.56 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -79.22 90.39 4.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.747 0.308 . . . . 1.0 110.699 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.85 152.09 21.2 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 p -125.69 148.87 48.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 1.0 111.711 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.78 109.3 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.623 ' O ' HG12 ' A' ' 65' ' ' VAL . 65.1 t -107.87 0.8 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.925 -0.31 . . . . 1.0 111.292 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.649 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.34 118.69 2.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.017 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -147.04 133.85 20.09 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.874 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.97 148.36 51.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 1.0 109.388 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.524 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 36.3 ptt180 -141.73 145.38 34.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.797 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -50.34 -37.17 31.34 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -175.1 -167.97 35.04 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.952 -0.859 . . . . 1.0 110.952 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.78 43.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 1.0 110.546 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 71' ' ' GLY . 53.9 mtt-85 -84.05 -46.68 11.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.13 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.454 ' CD1' ' NH1' ' A' ' 50' ' ' ARG . 13.3 mt -123.37 150.85 61.66 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.881 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.57 165.28 31.27 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.532 2.155 . . . . 1.0 112.191 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.9 p -93.33 131.81 38.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.981 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 80' ' ' LEU . 26.3 mt -89.78 9.04 28.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.454 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.83 130.46 45.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.989 -0.55 . . . . 1.0 112.263 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.62 -14.88 58.74 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.524 -0.762 . . . . 1.0 111.567 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 77' ' ' LEU . 77.3 mt -80.77 150.37 29.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.282 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.2 m -104.59 129.53 52.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.75 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.558 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 6.7 m-85 -82.16 128.72 66.74 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -40.26 125.34 1.82 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.663 2.242 . . . . 1.0 111.882 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.07 132.68 52.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.74 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.39 1.6 44.08 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.539 -1.024 . . . . 1.0 110.539 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -56.78 -35.66 68.94 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 mt -88.76 126.95 57.97 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.425 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.664 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 85.6 Cg_endo -73.83 -155.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.477 2.118 . . . . 1.0 112.503 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -107.76 -68.78 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 1.0 111.557 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.671 ' CD ' ' H ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -49.44 -46.63 48.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.855 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.664 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -65.99 -45.48 81.43 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.719 HH12 ' NH2' ' A' ' 96' ' ' ARG . 71.8 ttt-85 -59.62 -35.34 74.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.475 -0.33 . . . . 1.0 111.513 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.434 ' HD3' ' HE1' ' A' ' 119' ' ' TRP . 56.6 ttt85 -63.51 -31.14 72.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.792 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.432 ' CD1' HH12 ' A' ' 101' ' ' ARG . 87.0 mt -69.25 -35.76 76.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.248 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.608 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 17.6 m-85 -59.14 -31.14 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.017 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.719 ' NH2' HH12 ' A' ' 92' ' ' ARG . 80.7 mtt180 -83.44 -23.61 32.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.815 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.4 mt -99.18 -47.5 5.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.0 -8.51 13.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -173.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.608 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 0.8 OUTLIER 39.21 80.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.16 -1.016 . . . . 1.0 108.817 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 100' ' ' VAL . 4.2 p 173.69 120.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.037 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -169.72 146.58 3.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.011 0.434 . . . . 1.0 110.716 177.08 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 101' ' ' ARG . 54.1 t -159.35 150.24 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.565 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.6 mt -108.06 134.63 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.03 165.11 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 15.4 p30 -45.99 117.89 1.68 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.988 -1.005 . . . . 1.0 112.114 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.81 -21.46 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.326 -0.852 . . . . 1.0 110.769 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.54 -43.22 90.63 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.12 -11.83 44.31 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.502 0.668 . . . . 1.0 109.356 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 45.29 69.26 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.748 -1.115 . . . . 1.0 113.291 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 m -76.29 132.36 39.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 174.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -119.44 139.22 52.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.0 -0.68 . . . . 1.0 111.886 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.422 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -124.4 149.91 46.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.576 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.1 pt -152.98 172.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.146 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.9 p -66.8 154.09 41.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.707 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -139.42 152.15 68.46 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.7 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -83.9 -14.39 7.51 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.657 2.238 . . . . 1.0 112.345 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.7 145.5 23.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.422 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.6 m -66.14 165.39 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.434 ' HE1' ' HD3' ' A' ' 93' ' ' ARG . 43.0 t-105 -94.34 155.72 16.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.493 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.93 178.11 45.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.9 tp -108.31 89.32 2.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.759 0.314 . . . . 1.0 110.429 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.9 p -75.05 -14.84 60.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.522 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.15 -33.79 28.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.632 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -51.6 -40.91 60.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.593 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 127' ' ' LEU . 2.1 m -115.12 85.92 13.15 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.205 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -42.92 84.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.605 2.203 . . . . 1.0 112.354 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 125' ' ' VAL . 39.9 tp -143.51 139.54 29.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.602 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.74 13.35 53.69 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.814 -0.914 . . . . 1.0 110.814 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 61.96 76.94 0.37 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.632 0.253 . . . . 1.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -85.8 -16.83 4.3 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.224 2.616 . . . . 1.0 111.698 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.8 tp -56.68 -32.3 65.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.394 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -132.99 129.63 38.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.846 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -126.0 145.69 52.98 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.575 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.15 141.6 20.89 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.741 2.294 . . . . 1.0 111.945 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.709 HG12 HBD2 ' A' ' 203' ' ' CYC . 0.7 OUTLIER -109.38 123.61 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.909 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -41.3 153.48 0.25 Allowed Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -57.08 -21.59 43.1 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.194 2.596 . . . . 1.0 114.038 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.691 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 5.6 p -63.02 -46.57 86.97 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.691 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 16.4 t-80 -81.27 -27.15 35.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.245 0.461 . . . . 1.0 112.245 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' A' ' 135' ' ' VAL . 71.1 t -65.4 -53.61 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.915 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -65.74 -28.17 68.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -59.17 -42.98 92.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.7 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 146' ' ' MET . 17.5 mt -73.32 -38.85 65.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -52.12 -39.06 59.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.594 -1.261 . . . . 1.0 107.594 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.9 p -65.14 -20.55 66.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.769 -1.105 . . . . 1.0 109.186 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 143' ' ' LEU . 81.5 mmm -95.65 2.81 54.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.412 -0.813 . . . . 1.0 110.707 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.81 21.86 78.85 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.88 142.54 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 1.0 111.02 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.38 -21.03 13.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.931 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -147.82 160.63 42.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.155 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 p -148.38 126.37 12.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.469 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.43 128.7 55.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.302 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.82 121.05 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.173 0.511 . . . . 1.0 111.801 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.509 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 3.1 m -126.16 92.99 44.51 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.816 -1.179 . . . . 1.0 107.816 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.645 ' C ' HD12 ' A' ' 156' ' ' LEU . 90.4 Cg_exo -44.84 143.86 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.148 2.565 . . . . 1.0 114.672 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 155' ' ' PRO . 10.9 mp -121.91 60.24 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.818 -1.549 . . . . 1.0 106.818 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.585 ' HE1' HE22 ' A' ' 99' ' ' GLN . 2.3 ptm -147.66 -178.63 6.36 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.139 0.792 . . . . 1.0 113.139 -175.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.606 ' CG ' ' N ' ' A' ' 159' ' ' HIS . 57.7 t-80 -71.08 172.66 8.74 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.289 -0.869 . . . . 1.0 111.368 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.606 ' N ' ' CG ' ' A' ' 158' ' ' HIS . 55.9 t-80 -61.48 -50.59 72.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.326 -0.852 . . . . 1.0 112.039 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -105.36 -37.66 6.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -89.97 136.13 33.23 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.957 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.722 ' O ' HD23 ' A' ' 162' ' ' LEU . 6.3 tt -107.39 118.46 36.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.279 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -92.55 -44.17 8.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.205 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -161.53 -176.11 33.28 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.63 138.16 34.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 1.0 111.534 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.437 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.5 tp -103.81 134.19 47.53 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.23 140.07 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.699 -0.401 . . . . 1.0 111.089 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.3 m -114.12 137.89 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.994 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.48 ' O ' ' OG1' ' A' ' 48' ' ' THR . 77.5 m-70 -111.46 135.65 51.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.003 0.43 . . . . 1.0 111.611 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -128.27 121.9 30.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.966 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.51 -12.54 60.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.817 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -129.83 148.02 67.81 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.018 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -44.32 146.48 1.93 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.952 2.435 . . . . 1.0 111.821 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -172.82 79.42 0.43 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.03 151.17 12.21 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.569 2.179 . . . . 1.0 111.933 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -99.41 136.16 39.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.482 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.7 m -125.65 172.45 9.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.593 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -50.47 -35.41 28.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.667 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -62.35 -50.11 72.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.682 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -62.34 -37.21 84.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.477 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.7 tp -61.47 -36.2 79.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.561 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -61.33 -30.12 70.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 1.0 111.36 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 74.4 t -71.35 -53.54 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 188' ' ' ALA . 34.7 m -77.94 -36.09 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.398 0.518 . . . . 1.0 112.398 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -54.9 -49.68 70.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.707 0.289 . . . . 1.0 111.631 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 33.4 tp -73.46 -39.73 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 187' ' ' LEU . 28.3 tp -79.21 -40.15 31.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.418 -0.355 . . . . 1.0 111.813 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.454 ' O ' ' OG ' ' A' ' 192' ' ' SER . . . -55.8 -36.38 67.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.56 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -77.68 -38.8 46.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 1.0 109.97 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.98 -35.99 82.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.127 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 192' ' ' SER . 7.6 p -83.65 -40.06 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.722 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.459 ' N ' HG13 ' A' ' 191' ' ' VAL . 68.7 m -54.43 -35.8 63.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.1 mt -61.42 -35.67 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.217 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.33 -38.58 78.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.756 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.13 -49.5 83.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.154 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.39 -46.84 65.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.864 -0.607 . . . . 1.0 111.138 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -64.23 -40.58 96.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 1.0 111.518 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.97 67.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.321 -0.399 . . . . 1.0 111.699 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -63.1 -37.91 89.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.495 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 48.6 mt -61.42 -31.77 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.983 -0.287 . . . . 1.0 111.083 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.6 m -54.6 -52.55 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.529 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 202' ' ' LEU . 31.0 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.521 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.709 HBD2 HG12 ' A' ' 135' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.534 ' CD2' ' NH2' ' A' ' 55' ' ' ARG . 39.4 tp . . . . . 0 C--O 1.23 0.028 0 CA-C-O 120.91 0.385 . . . . 1.0 110.594 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 65.5 t0 -79.61 -30.5 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.984 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -79.38 -45.16 20.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.08 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 35' ' ' LEU . 21.3 tt -61.52 -39.92 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 1.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.493 ' N ' HG23 ' A' ' 34' ' ' ILE . 58.7 mt -61.1 -45.51 94.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.049 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.477 HH12 ' CD2' ' A' ' 78' ' ' LEU . 77.9 mtt-85 -53.75 -38.55 64.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.564 -0.455 . . . . 1.0 109.938 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.92 -29.34 65.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.082 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.419 ' O ' HG13 ' A' ' 42' ' ' VAL . 25.5 m -73.08 -44.52 60.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.544 -0.753 . . . . 1.0 112.249 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.689 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 5.9 p -69.16 -37.57 76.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.55 -37.23 71.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.796 0.332 . . . . 1.0 111.112 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -67.49 -49.01 65.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.78 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 38' ' ' THR . 28.4 m -64.4 -31.22 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.136 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.8 tmt_? -61.09 -45.83 93.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.811 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.02 72.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.09 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -78.33 -41.35 33.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.58 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.7 mt -85.55 -30.23 23.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.427 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.02 20.07 32.92 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.455 -1.058 . . . . 1.0 110.455 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.6 p -72.59 143.23 48.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.343 . . . . 1.0 110.239 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -39.58 -53.55 2.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.607 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -154.04 130.75 10.76 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.048 -0.661 . . . . 1.0 112.588 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -136.95 128.97 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.582 -0.896 . . . . 1.0 108.582 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.576 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 51.4 pttt -139.73 154.51 47.46 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.532 -0.467 . . . . 1.0 111.932 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 59.0 t -109.69 137.18 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -132.86 134.25 44.37 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.26 -178.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.534 ' NH2' ' CD2' ' A' ' 31' ' ' LEU . 42.4 ttm-85 -90.61 138.21 31.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.241 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -92.99 117.01 29.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 1.0 112.077 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -84.09 149.85 56.86 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.35 -23.97 72.43 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.517 2.145 . . . . 1.0 112.481 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.66 -16.48 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.0 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.67 -12.36 42.41 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.534 -0.626 . . . . 1.0 111.534 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -75.3 96.11 3.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.784 0.326 . . . . 1.0 110.662 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.15 143.09 16.78 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.7 p -122.21 146.02 47.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 1.0 111.693 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.73 109.47 13.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 65' ' ' VAL . 20.5 t -108.74 -1.66 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.97 -0.292 . . . . 1.0 111.242 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.689 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.68 114.62 2.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.044 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.41 ' C ' ' OE1' ' A' ' 67' ' ' GLU . 1.6 pp20? -145.22 135.29 23.82 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.523 -0.471 . . . . 1.0 111.833 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.39 144.83 51.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.692 -0.685 . . . . 1.0 109.386 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.473 ' NH1' ' C ' ' A' ' 71' ' ' GLY . 34.3 ptt85 -136.55 143.65 43.78 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.746 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -49.17 -41.68 30.86 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -173.31 -167.46 33.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -70.96 39.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.735 0.302 . . . . 1.0 110.515 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 71' ' ' GLY . 39.2 ttm180 -83.08 -49.72 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.18 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.93 151.18 49.95 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 1.0 109.849 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.66 164.2 35.33 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.522 2.148 . . . . 1.0 112.144 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -94.88 131.14 41.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.988 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.492 ' HA ' HD12 ' A' ' 80' ' ' LEU . 43.7 mt -90.26 11.51 20.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.411 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' CD2' HH12 ' A' ' 36' ' ' ARG . 11.3 tp -63.2 130.19 43.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 1.0 112.288 -177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.99 -12.36 66.33 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.498 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 77' ' ' LEU . 79.6 mt -81.68 150.0 28.24 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.285 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -109.35 137.61 46.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.646 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.831 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 9.3 m-85 -90.45 152.58 45.55 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.495 -0.557 . . . . 1.0 109.495 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.18 140.13 87.42 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.691 2.261 . . . . 1.0 111.816 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.02 126.83 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.709 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.89 -0.52 45.0 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.484 -1.046 . . . . 1.0 110.484 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -57.43 -37.87 73.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.604 HD12 ' N ' ' A' ' 87' ' ' ILE . 1.6 mp -70.96 114.34 26.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.429 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 99.9 Cg_exo -46.55 173.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.467 2.111 . . . . 1.0 112.481 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.523 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 96.2 mt-10 -104.5 -52.1 2.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.495 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 90' ' ' GLU . 3.1 pm0 -68.55 -41.51 79.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.762 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.555 ' HB2' ' CBD' ' A' ' 203' ' ' CYC . . . -66.04 -42.01 90.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.966 0.358 . . . . 1.0 111.966 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.501 ' NH2' HD13 ' A' ' 162' ' ' LEU . 67.0 ttt-85 -60.44 -36.44 78.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.487 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 75.3 mtt85 -66.58 -41.49 88.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.833 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.543 HD12 ' NH2' ' A' ' 101' ' ' ARG . 86.3 mt -64.9 -39.24 93.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.277 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.51 ' CE2' HD11 ' A' ' 165' ' ' LEU . 8.4 t80 -64.39 -28.76 69.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.02 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -81.95 -26.41 34.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.814 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.9 mt -98.18 -43.28 7.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.382 1.253 . . . . 1.0 114.382 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -111.8 -7.39 14.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.996 1.48 . . . . 1.0 114.996 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.509 ' OE1' ' O ' ' A' ' 95' ' ' PHE . 1.4 mm100 47.02 82.85 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.239 -0.984 . . . . 1.0 108.769 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 100' ' ' VAL . 2.6 p 174.13 103.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.048 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.543 ' NH2' HD12 ' A' ' 94' ' ' LEU . 7.7 mmt-85 -143.87 139.54 29.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 1.0 110.825 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -171.6 147.25 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.539 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.603 HD11 ' CD2' ' A' ' 139' ' ' HIS . 71.0 mt -108.75 138.06 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.95 165.37 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -48.31 119.83 3.23 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.133 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.423 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.9 p -58.27 -27.58 32.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.296 -0.866 . . . . 1.0 110.793 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -66.67 -42.84 85.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.68 -9.79 4.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.519 0.676 . . . . 1.0 109.395 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 45.41 58.42 4.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.704 -1.134 . . . . 1.0 113.28 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.8 p -77.55 134.65 38.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.919 -1.511 . . . . 1.0 106.919 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -123.1 144.64 49.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.952 -0.699 . . . . 1.0 111.903 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -132.37 156.48 46.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.527 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 112' ' ' SER . 24.9 pt -155.39 177.09 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.193 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 p -59.96 157.2 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.654 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -140.15 153.76 69.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.702 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -36.1 153.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.655 2.237 . . . . 1.0 112.34 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 4.6 pm0 -48.05 144.15 3.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.43 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 t -159.03 148.32 18.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.631 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -136.27 152.12 50.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.59 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.37 132.19 22.82 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 38.5 mt -85.87 156.11 20.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.75 0.309 . . . . 1.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 124' ' ' ARG . 22.6 m -53.37 -28.08 27.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.484 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 125' ' ' VAL . . . -61.4 0.75 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.649 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' A' ' 122' ' ' SER . 78.9 mtm180 62.71 -65.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.566 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 125' ' ' VAL . 7.3 p -127.52 86.48 58.4 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.209 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -83.93 0.67 9.2 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.621 2.214 . . . . 1.0 112.248 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 tp 66.5 1.52 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.568 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.52 -36.98 59.49 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.93 163.51 48.31 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.553 0.216 . . . . 1.0 110.826 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -87.4 -169.06 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.1 2.534 . . . . 1.0 111.621 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 131' ' ' LEU . 11.1 mp -82.21 -2.0 50.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.364 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 58.97 22.76 10.75 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.958 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.558 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 4.0 mtp-105 -43.07 -44.71 11.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.589 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 5.0 Cg_exo -83.97 137.0 7.26 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.71 2.273 . . . . 1.0 111.956 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.55 HG13 ' CG2' ' A' ' 140' ' ' VAL . 2.3 p -122.69 134.26 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.861 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.64 ' OD2' HMD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -46.53 151.22 1.05 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 138' ' ' CYS . 36.2 Cg_endo -59.62 -46.93 18.04 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.263 2.642 . . . . 1.0 113.991 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -36.66 -44.84 0.48 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.682 0.253 . . . . 1.0 111.682 -178.151 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.688 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.6 t60 -83.79 -27.87 28.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.55 ' CG2' HG13 ' A' ' 135' ' ' VAL . 91.7 t -68.09 -51.0 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.979 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -66.75 -30.86 71.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -58.54 -43.85 89.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.67 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 146' ' ' MET . 13.1 mt -73.28 -37.79 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -50.86 -39.17 53.09 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -64.38 -25.5 68.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.765 -1.107 . . . . 1.0 109.195 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.562 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.2 mmm -90.56 1.95 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.705 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.55 21.57 78.73 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.81 142.47 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.89 0.376 . . . . 1.0 111.062 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.47 -20.39 13.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.908 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -145.62 160.6 41.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.203 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.479 ' OG ' HD12 ' A' ' 103' ' ' ILE . 3.7 p -147.7 122.08 9.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.411 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.2 mp -108.6 139.81 42.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.293 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.44 HG21 HAA1 ' A' ' 203' ' ' CYC . 9.8 t -128.81 118.41 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.128 0.49 . . . . 1.0 111.726 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.8 t -122.5 127.35 25.86 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.427 ' HB3' ' CE2' ' A' ' 95' ' ' PHE . 83.4 Cg_endo -76.33 148.62 30.5 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.135 2.557 . . . . 1.0 114.692 -176.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -136.63 49.01 2.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.814 -1.551 . . . . 1.0 106.814 177.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.02 -175.72 4.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -174.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.38 163.09 28.36 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.383 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.526 ' ND1' ' OE1' ' A' ' 160' ' ' GLN . 58.4 t-80 -66.65 -53.99 28.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.37 -0.832 . . . . 1.0 112.023 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.526 ' OE1' ' ND1' ' A' ' 159' ' ' HIS . 12.1 mm100 -99.78 8.81 43.95 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.047 0.388 . . . . 1.0 112.047 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -143.13 134.83 26.57 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.834 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 162' ' ' LEU . 1.1 mp -110.41 116.98 32.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.188 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -92.19 -41.01 10.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.263 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.607 ' O ' HD12 ' A' ' 165' ' ' LEU . . . -153.72 -177.95 27.71 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 164' ' ' GLY . 0.7 OUTLIER -146.02 143.71 29.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.897 0.379 . . . . 1.0 111.531 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.538 ' HB2' HD11 ' A' ' 156' ' ' LEU . 8.8 tp -112.18 132.75 54.72 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 167' ' ' VAL . 14.8 p -136.08 132.84 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.982 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 21.3 m -107.49 149.44 27.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.074 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -124.87 131.85 53.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.02 0.438 . . . . 1.0 111.648 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.6 113.8 14.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.98 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.45 -15.89 63.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.84 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -96.18 147.43 32.96 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.942 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.86 76.18 2.06 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.98 2.453 . . . . 1.0 111.886 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -113.77 97.76 45.37 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.836 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.75 164.83 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.494 2.129 . . . . 1.0 111.972 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 44.6 p90 -92.0 130.68 37.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.488 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 98.4 p -119.17 157.64 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.607 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -54.79 -34.75 63.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.638 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -57.12 -36.71 70.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.81 -36.59 83.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.499 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.4 mp -67.97 -38.13 82.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.53 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -53.58 -40.88 65.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.356 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 88.5 t -70.32 -56.43 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.39 -38.89 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.477 0.547 . . . . 1.0 112.477 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 181' ' ' LEU . 62.9 tt0 -49.98 -49.82 49.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.667 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 31.7 tp -70.16 -40.38 74.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.938 0.347 . . . . 1.0 111.938 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 187' ' ' LEU . 44.7 tp -76.44 -38.79 54.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.787 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.46 77.93 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.517 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.68 -39.27 80.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.94 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -65.66 -27.87 68.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.084 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -83.71 -41.8 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.736 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.8 p -56.64 -33.24 66.14 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.4 mt -69.94 -38.23 74.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.213 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.11 76.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.602 -0.727 . . . . 1.0 109.832 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.6 mm -60.59 -46.55 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.162 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.98 -45.64 66.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -67.59 -41.21 84.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.517 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.56 72.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.69 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.06 -39.79 93.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.559 -0.291 . . . . 1.0 111.492 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.32 -36.26 83.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.986 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 98.6 p -56.89 -52.92 63.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.784 0.326 . . . . 1.0 110.588 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.568 179.547 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.831 HAB2 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.808 0.337 . . . . 1.0 110.585 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.7 -28.72 56.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.032 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -79.84 -46.49 16.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.128 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.566 HG23 ' N ' ' A' ' 35' ' ' LEU . 3.2 tp -63.8 -43.96 98.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.955 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.566 ' N ' HG23 ' A' ' 34' ' ' ILE . 83.6 mt -61.39 -49.26 77.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.015 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -53.84 -37.68 63.86 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 -30.14 66.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.013 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.4 m -73.54 -45.0 56.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.591 -0.731 . . . . 1.0 112.204 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.672 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.1 p -67.39 -34.98 72.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -70.5 -39.33 74.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 1.0 111.098 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -65.54 -50.78 63.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.829 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.23 -28.81 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.683 0.278 . . . . 1.0 111.128 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.3 tmm_? -61.88 -46.4 89.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.865 0.364 . . . . 1.0 110.882 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.15 -33.45 69.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.097 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -79.68 -41.18 27.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.551 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 mt -85.34 -35.42 21.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.453 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 62.31 20.54 61.01 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.521 -1.031 . . . . 1.0 110.521 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -73.42 141.63 46.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.808 0.337 . . . . 1.0 110.173 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' CG ' HH21 ' A' ' 73' ' ' ARG . 92.3 m-20 -39.45 -44.3 1.36 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.622 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -164.76 130.43 2.77 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.025 -0.67 . . . . 1.0 112.57 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.16 129.01 42.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.464 ' O ' HD12 ' A' ' 166' ' ' LEU . 51.6 pttt -140.83 154.81 46.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.867 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 58.1 t -98.47 135.04 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 176.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 47.5 t80 -115.74 105.36 12.64 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.323 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -76.16 124.81 28.04 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.232 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 86.7 t80 -90.87 142.18 28.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 1.0 112.02 -178.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 1.1 m-20 -112.04 151.36 43.53 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 108.617 -0.882 . . . . 1.0 108.617 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.48 -23.65 75.78 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.541 2.161 . . . . 1.0 112.469 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -88.32 -12.12 44.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 1.0 110.045 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.61 -13.85 57.92 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.572 -0.611 . . . . 1.0 111.572 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -78.88 89.83 4.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.855 0.36 . . . . 1.0 110.606 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.47 151.63 21.07 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -125.07 146.39 49.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 1.0 111.679 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.96 108.98 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 65' ' ' VAL . 52.5 t -105.79 -1.61 9.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.904 -0.318 . . . . 1.0 111.333 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.672 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.03 115.38 2.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.143 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.482 ' CD ' ' NH2' ' A' ' 69' ' ' ARG . 87.7 tt0 -143.14 132.49 23.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.074 0.464 . . . . 1.0 111.856 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.98 147.77 50.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.4 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.482 ' NH2' ' CD ' ' A' ' 67' ' ' GLU . 42.3 mtt85 -141.23 142.33 33.96 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.77 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.98 -31.21 80.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.41 -173.66 38.53 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -79.26 40.0 0.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 1.0 110.517 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.563 HH21 ' CG ' ' A' ' 49' ' ' ASP . 22.3 ttp-105 -83.19 -48.64 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.22 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -103.37 149.93 37.48 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.167 -0.47 . . . . 1.0 109.905 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.61 148.58 72.61 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.535 2.157 . . . . 1.0 112.138 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.0 m -76.83 125.2 28.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.907 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 80' ' ' LEU . 25.1 mt -103.99 9.75 36.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.323 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.54 132.43 41.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.182 0.515 . . . . 1.0 112.305 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.88 -7.96 75.05 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.624 -0.716 . . . . 1.0 111.521 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 77' ' ' LEU . 63.4 mt -88.38 154.87 20.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.76 0.314 . . . . 1.0 110.246 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -103.07 129.02 49.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.663 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.561 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 6.3 m-85 -82.49 152.06 66.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.57 132.08 31.89 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.617 2.211 . . . . 1.0 111.848 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 128.72 37.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.052 0.454 . . . . 1.0 110.686 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.42 -0.17 40.29 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -59.24 -15.71 17.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.57 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.7 mt -104.14 105.62 49.77 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.696 -0.683 . . . . 1.0 109.465 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 87' ' ' ILE . 92.8 Cg_exo -48.11 -162.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.4 2.067 . . . . 1.0 112.485 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -107.21 -58.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.543 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.55 -42.04 86.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.835 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.84 -48.63 68.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.98 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -59.38 -37.94 79.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.445 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -64.51 -33.31 75.6 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.9 -0.32 . . . . 1.0 110.807 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.446 HD13 ' NH1' ' A' ' 101' ' ' ARG . 92.3 mt -64.49 -38.12 89.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.256 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.467 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 21.0 m-85 -61.45 -48.5 80.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.041 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -51.5 -34.57 36.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.835 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.4 mt -99.07 -38.01 9.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 114.4 1.259 . . . . 1.0 114.4 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.596 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.25 -13.25 11.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 115.105 1.52 . . . . 1.0 115.105 -174.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.596 ' C ' ' O ' ' A' ' 98' ' ' ALA . 15.3 mm100 34.65 74.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.249 -0.98 . . . . 1.0 108.788 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 100' ' ' VAL . 7.6 p 177.17 117.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.122 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.545 HH22 ' CD ' ' A' ' 129' ' ' GLU . 2.0 tpt180 -176.0 145.36 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.922 0.391 . . . . 1.0 110.791 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.0 m -151.22 158.05 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.515 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.7 136.06 44.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 3.4 m -93.03 166.12 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 113.321 0.86 . . . . 1.0 113.321 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 173' ' ' PRO . 57.8 m-20 -46.31 118.42 1.93 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.918 -1.037 . . . . 1.0 112.166 -176.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.466 HG23 ' CG1' ' A' ' 140' ' ' VAL . 9.9 p -56.05 -22.73 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.789 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -62.56 -44.02 97.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.71 -10.97 31.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.56 0.695 . . . . 1.0 109.351 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 44.12 72.06 0.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.743 -1.117 . . . . 1.0 113.294 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.478 ' OG ' ' CG2' ' A' ' 104' ' ' VAL . 2.0 m -73.74 131.81 41.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.951 -1.499 . . . . 1.0 106.951 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -119.93 137.35 54.09 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.029 -0.668 . . . . 1.0 111.936 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.2 t -135.27 158.72 43.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.482 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.627 ' C ' ' H ' ' A' ' 115' ' ' GLN . 44.9 mm -121.82 133.94 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.15 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.5 m -57.01 5.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.702 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.627 ' H ' ' C ' ' A' ' 113' ' ' ILE . 88.6 mt-30 -116.72 81.3 11.57 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.646 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -83.72 150.26 12.81 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.73 2.287 . . . . 1.0 112.345 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.81 -42.99 99.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.434 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 59.1 p -169.0 176.01 5.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.706 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 120' ' ' GLY . 38.9 p90 -140.13 171.17 14.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.488 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 119' ' ' TRP . . . 55.23 111.98 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.648 HD12 ' N ' ' A' ' 121' ' ' LEU . 9.2 mp -85.82 126.18 33.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 1.0 110.408 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.548 ' C ' ' H ' ' A' ' 124' ' ' ARG . 50.5 m -74.23 -14.95 61.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.512 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -68.91 16.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.675 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' A' ' 122' ' ' SER . 18.6 mmm180 41.92 92.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.602 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 128' ' ' GLY . 4.1 t -110.25 129.96 23.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.234 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.438 ' HG2' ' H ' ' A' ' 127' ' ' LEU . 87.1 Cg_endo -78.82 -56.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.619 2.212 . . . . 1.0 112.291 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.438 ' H ' ' HG2' ' A' ' 126' ' ' PRO . 8.4 mp -68.9 -18.21 64.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.607 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.415 ' H ' HG12 ' A' ' 125' ' ' VAL . . . 97.89 172.14 32.94 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.545 ' CD ' HH22 ' A' ' 101' ' ' ARG . 8.9 pt-20 -52.64 149.9 10.26 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 121.136 -0.226 . . . . 1.0 110.921 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' GLU . 24.7 Cg_exo -33.39 150.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 123.168 2.578 . . . . 1.0 111.661 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.9 mt -70.79 -7.67 46.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.332 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.529 ' O ' ' NE ' ' A' ' 133' ' ' ARG . 90.7 mt-30 -82.64 82.88 7.83 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.91 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 132' ' ' GLN . 5.9 mmp_? -118.8 114.81 35.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.485 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.02 143.1 14.12 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.791 2.327 . . . . 1.0 111.895 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.518 HG23 ' CG2' ' A' ' 140' ' ' VAL . 1.5 m -104.77 119.0 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.887 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 112' ' ' SER . 18.7 t70 -44.13 137.38 3.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.754 -0.462 . . . . 1.0 109.754 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -37.82 -46.72 2.01 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.141 2.561 . . . . 1.0 114.034 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.684 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -41.31 -45.28 2.95 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.668 0.247 . . . . 1.0 111.668 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.684 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 17.4 t60 -81.86 -28.19 33.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.235 0.458 . . . . 1.0 112.235 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.518 ' CG2' HG23 ' A' ' 135' ' ' VAL . 85.2 t -66.97 -54.09 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.963 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -63.99 -29.36 70.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -57.68 -45.15 85.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.68 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 146' ' ' MET . 16.8 mt -73.02 -38.81 66.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -51.07 -39.7 56.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -63.78 -24.91 67.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.766 -1.106 . . . . 1.0 109.147 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.549 ' N ' ' O ' ' A' ' 143' ' ' LEU . 80.6 mmm -91.08 2.09 56.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.731 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.14 20.69 79.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.21 141.63 22.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 1.0 111.014 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.63 -21.65 13.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.919 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.6 p -146.35 161.29 40.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.166 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 p -146.54 131.93 18.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.449 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -119.51 125.15 48.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.315 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 166' ' ' LEU . 2.8 t -113.32 114.14 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.129 0.49 . . . . 1.0 111.754 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.6 t -120.62 93.69 48.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.751 -1.203 . . . . 1.0 107.751 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HB3' ' NE2' ' A' ' 99' ' ' GLN . 90.2 Cg_exo -44.94 140.24 7.21 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.142 2.562 . . . . 1.0 114.666 -176.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.473 HD23 HG11 ' A' ' 191' ' ' VAL . 6.6 mp -122.04 50.31 1.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.87 -1.53 . . . . 1.0 106.87 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.446 ' CE ' ' O ' ' A' ' 164' ' ' GLY . 0.1 OUTLIER -146.45 -174.18 4.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.118 0.784 . . . . 1.0 113.118 -176.136 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.745 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 8.2 m-70 -65.37 154.1 39.32 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.305 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -56.23 -46.04 79.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.342 -0.845 . . . . 1.0 112.035 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -103.6 -44.02 5.21 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.049 0.388 . . . . 1.0 112.049 -177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.492 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 88.3 tt0 -84.75 138.03 32.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.895 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.412 ' HG ' ' SD ' ' A' ' 157' ' ' MET . 3.1 tt -105.72 113.85 27.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.324 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.745 ' HE1' ' CD2' ' A' ' 158' ' ' HIS . 68.7 m95 -94.15 -39.95 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.255 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -156.87 -173.4 25.27 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.179 -0.769 . . . . 1.0 111.179 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 95' ' ' PHE . 11.4 tp -141.27 130.0 22.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.857 0.361 . . . . 1.0 111.526 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.579 ' O ' HG13 ' A' ' 153' ' ' VAL . 56.5 tp -101.96 133.01 47.43 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.4 p -142.2 134.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.059 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.3 p -107.41 146.54 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.016 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -119.73 131.44 55.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.989 0.423 . . . . 1.0 111.634 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.89 113.76 13.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.971 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.83 -17.07 64.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.815 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -83.57 146.79 50.91 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.031 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.446 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 71.2 Cg_endo -72.38 5.99 2.49 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.898 2.399 . . . . 1.0 111.863 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -51.42 131.49 34.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.39 167.12 26.3 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.557 2.172 . . . . 1.0 111.883 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 50.4 p90 -88.95 132.8 34.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.466 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.1 t -117.25 147.22 42.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.565 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -50.96 -34.66 29.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.63 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -55.3 -41.1 71.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.709 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.47 -41.3 98.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.491 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.1 tp -63.82 -38.96 93.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.534 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -54.83 -35.03 63.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.308 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.7 t -70.61 -52.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.805 0.668 . . . . 1.0 112.805 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 t -77.31 -30.97 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -52.67 -49.87 64.38 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.026 -0.27 . . . . 1.0 111.646 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 186' ' ' LEU . 7.5 mp -70.71 -37.27 73.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.876 ' O ' HG23 ' A' ' 191' ' ' VAL . 8.0 tp -77.57 -37.83 49.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.828 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.27 95.81 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.552 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -61.11 -39.29 89.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 1.0 109.958 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -71.99 -29.05 63.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.115 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 187' ' ' LEU . 26.3 t -82.38 -48.78 17.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.712 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 84.2 p -50.66 -27.57 7.23 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.5 mt -77.51 -32.54 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.2 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -69.47 -47.69 63.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.617 -0.719 . . . . 1.0 109.803 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.1 pp -67.47 -35.53 73.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.134 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.46 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -70.68 -49.7 44.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.15 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.19 -32.36 66.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.496 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.09 -34.25 77.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.701 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -56.26 -29.85 61.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.575 -0.284 . . . . 1.0 111.445 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.593 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.9 mp -60.13 -33.28 71.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.702 0.287 . . . . 1.0 111.033 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 63.3 p -52.95 -54.62 32.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.566 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.2 mp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.488 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.661 ' O2A' ' HHA' ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.342 . . . . 1.0 110.542 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -48.43 -32.78 8.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.987 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -78.72 -45.56 20.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.065 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.8 mm -64.5 -39.93 87.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.878 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.7 mt -59.83 -45.94 90.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.006 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -57.31 -37.25 72.18 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.45 -28.48 65.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.079 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 42' ' ' VAL . 23.7 m -74.05 -47.24 38.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.526 -0.761 . . . . 1.0 112.244 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.673 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p -65.27 -34.52 71.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.949 0.351 . . . . 1.0 111.949 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.48 -49.55 70.95 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.9 -47.24 81.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.766 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 38' ' ' THR . 68.9 t -53.51 -46.49 59.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.989 -0.284 . . . . 1.0 111.165 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 47' ' ' GLY . 15.5 ttt-85 -49.87 -38.48 35.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.771 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.52 75.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -76.8 -44.12 33.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.552 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mt -86.2 -27.58 24.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.502 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.68 22.02 24.01 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.449 -1.061 . . . . 1.0 110.449 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.5 p -74.44 144.18 44.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.884 0.373 . . . . 1.0 110.194 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -42.35 -39.83 2.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.659 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 42.9 ttm180 -162.73 129.08 3.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.038 -0.665 . . . . 1.0 112.574 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.81 130.95 53.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.828 ' NZ ' HAB1 ' A' ' 203' ' ' CYC . 17.4 pttp -141.57 158.64 43.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.073 0.464 . . . . 1.0 111.969 -177.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 62.7 t -100.48 136.85 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 177.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -119.08 104.78 10.78 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.392 -0.523 . . . . 1.0 111.272 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.638 HH22 ' CG2' ' A' ' 195' ' ' ILE . 42.5 mmt-85 -77.3 128.0 33.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.264 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.498 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 78.9 t80 -93.32 139.21 30.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 1.0 112.024 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.498 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 1.6 m-20 -109.03 151.24 41.82 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.658 -0.867 . . . . 1.0 108.658 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.44 -23.93 72.61 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.516 2.144 . . . . 1.0 112.483 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -87.08 -13.26 44.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.64 -11.56 57.91 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.569 -0.613 . . . . 1.0 111.569 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -80.69 90.54 5.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.793 0.33 . . . . 1.0 110.642 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.7 151.43 20.88 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.617 -0.993 . . . . 1.0 110.617 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -124.77 149.01 47.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 1.0 111.679 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.5 t -77.93 109.16 12.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.0 t -107.06 -0.3 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.327 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.673 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.39 115.97 2.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.038 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 86.0 tt0 -144.5 132.73 21.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.839 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.3 142.31 50.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.415 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -140.04 144.79 37.06 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.721 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.441 ' CA ' HH21 ' A' ' 43' ' ' ARG . . . -60.55 -35.31 88.86 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -172.7 -164.33 27.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.59 25.69 0.33 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.76 0.314 . . . . 1.0 110.536 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -72.19 -48.0 46.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.117 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.432 ' C ' HH22 ' A' ' 50' ' ' ARG . 15.1 mt -106.65 148.35 36.67 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.879 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.526 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 58.1 Cg_endo -69.59 137.99 37.27 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.49 2.127 . . . . 1.0 112.166 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.1 t -72.44 123.46 23.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.936 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HA ' HD12 ' A' ' 80' ' ' LEU . 19.9 mt -99.02 11.32 39.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.397 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.7 tp -71.43 128.89 37.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.241 0.543 . . . . 1.0 112.261 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.79 -9.44 76.33 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.455 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 77' ' ' LEU . 60.8 mt -85.7 152.06 23.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.307 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.1 p -104.51 132.89 50.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.731 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.635 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 9.5 m-85 -87.23 128.15 56.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.557 -0.534 . . . . 1.0 109.557 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -41.28 133.08 3.24 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.675 2.25 . . . . 1.0 111.862 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.36 132.48 49.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.657 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.77 0.58 42.53 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.53 -1.028 . . . . 1.0 110.53 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -54.52 -33.85 60.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.9 mt -90.61 111.71 49.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.361 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' A' ' 87' ' ' ILE . 87.2 Cg_exo -51.89 -157.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.411 2.074 . . . . 1.0 112.467 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 74.8 mm-40 -109.43 -54.59 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.536 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.83 -43.86 97.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.822 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.27 76.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.436 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 51.2 ttt85 -56.06 -35.38 66.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.393 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 75.4 mtt85 -64.22 -34.01 77.12 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.812 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.407 HD12 ' NH2' ' A' ' 101' ' ' ARG . 12.8 mt -65.19 -37.42 87.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.332 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE2' ' HG3' ' A' ' 101' ' ' ARG . 32.2 m-85 -59.88 -30.78 69.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.096 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -79.93 -26.26 40.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.829 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.407 ' C ' ' OE1' ' A' ' 99' ' ' GLN . 82.3 mt -100.65 -44.66 5.76 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.44 1.274 . . . . 1.0 114.44 -175.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.53 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -118.23 -12.45 9.97 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 115.078 1.511 . . . . 1.0 115.078 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.53 ' C ' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 38.8 79.72 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.166 -1.014 . . . . 1.0 108.827 -178.481 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 100' ' ' VAL . 11.1 p -177.11 102.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.066 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.435 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 11.1 mmt180 -148.07 151.18 35.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.923 0.392 . . . . 1.0 110.746 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -169.54 147.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.476 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.894 HD11 HAA1 ' A' ' 203' ' ' CYC . 76.8 mt -109.41 134.8 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 m -92.16 164.65 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.331 0.863 . . . . 1.0 113.331 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 18.0 p30 -43.98 117.7 1.27 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.98 -1.009 . . . . 1.0 112.156 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.74 -19.55 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.734 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.28 -43.04 92.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.03 -13.28 62.07 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.56 0.695 . . . . 1.0 109.453 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.556 ' CD ' HH21 ' A' ' 111' ' ' ARG . 55.4 tt0 45.74 72.59 0.21 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.684 -1.143 . . . . 1.0 113.334 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.0 t -73.86 131.66 41.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.556 HH21 ' CD ' ' A' ' 109' ' ' GLN . 93.9 mtt180 -118.99 139.14 52.19 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.943 -0.703 . . . . 1.0 111.886 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.416 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.2 OUTLIER -130.97 152.11 50.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.513 179.199 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.5 pt -152.89 174.24 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.146 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.8 m -65.14 161.43 19.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.599 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -136.6 151.37 72.64 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.655 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -35.07 -69.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.772 2.315 . . . . 1.0 112.281 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -135.2 145.16 47.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.443 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.8 t -156.59 133.23 10.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.617 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -144.09 158.87 43.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.596 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -158.28 127.31 1.86 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.462 ' CG ' ' H ' ' A' ' 122' ' ' SER . 2.7 tp -164.64 -149.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 1.0 110.392 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.462 ' H ' ' CG ' ' A' ' 121' ' ' LEU . 23.0 t -70.44 -34.35 72.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.493 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.33 6.69 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.641 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HB2' ' H ' ' A' ' 121' ' ' LEU . 55.8 ttt85 -56.18 143.29 33.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.55 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 127' ' ' LEU . 2.9 t -127.34 86.27 59.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.229 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -44.22 89.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.655 2.236 . . . . 1.0 112.29 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 125' ' ' VAL . 94.8 mt -136.94 -97.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.527 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -73.92 102.97 1.39 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.842 -0.903 . . . . 1.0 110.842 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.498 ' N ' ' HD3' ' A' ' 130' ' ' PRO . 73.3 tt0 -160.24 57.62 0.97 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.541 0.21 . . . . 1.0 110.862 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 129' ' ' GLU . 41.4 Cg_endo -97.24 -53.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 123.192 2.595 . . . . 1.0 111.64 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.421 ' H ' ' CD ' ' A' ' 130' ' ' PRO . 31.2 mt -63.5 -25.86 68.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.339 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -75.8 -34.71 60.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.012 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.472 ' NH1' ' CD ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -47.08 -56.34 12.42 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.545 -178.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 133' ' ' ARG . 70.2 Cg_exo -42.65 149.62 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.77 2.314 . . . . 1.0 111.956 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.41 HG11 HG23 ' A' ' 103' ' ' ILE . 1.6 p -98.88 116.51 42.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.797 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' A' ' 112' ' ' SER . 10.7 t70 -43.1 136.95 2.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD3' ' H ' ' A' ' 112' ' ' SER . 62.3 Cg_exo -42.42 -49.5 6.22 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 123.213 2.609 . . . . 1.0 114.019 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.689 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -36.88 -45.33 0.55 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.645 0.239 . . . . 1.0 111.645 -178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.689 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.5 t60 -81.55 -27.73 34.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.254 0.464 . . . . 1.0 112.254 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 137' ' ' PRO . 40.2 t -65.39 -52.97 45.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.967 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -64.77 -27.62 69.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.419 ' O ' ' OG ' ' A' ' 145' ' ' SER . 76.4 t80 -61.21 -46.45 90.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.678 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 146' ' ' MET . 54.0 mt -73.11 -37.62 66.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -38.69 58.74 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.561 -1.274 . . . . 1.0 107.561 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 5.7 p -62.82 -20.4 65.01 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.782 -1.099 . . . . 1.0 109.201 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 143' ' ' LEU . 95.4 mmm -95.49 1.21 53.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.774 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.92 24.5 71.79 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.25 140.8 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 1.0 111.014 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.63 -38.12 6.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.934 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.3 m -133.59 125.77 29.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 1.0 111.109 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.8 m -115.42 138.29 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.45 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.5 mt -116.55 139.5 50.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.313 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.467 HG21 HMA3 ' A' ' 203' ' ' CYC . 3.0 t -125.44 114.81 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.482 . . . . 1.0 111.818 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 184' ' ' VAL . 95.7 t -123.43 91.28 49.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.477 ' O ' HD12 ' A' ' 156' ' ' LEU . 85.7 Cg_exo -48.31 144.57 12.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 123.144 2.563 . . . . 1.0 114.705 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.481 HD23 ' CG1' ' A' ' 191' ' ' VAL . 7.9 mp -121.54 66.87 0.89 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -149.58 -172.92 4.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.129 0.788 . . . . 1.0 113.129 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.584 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 54.8 t-80 -77.6 173.89 11.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.413 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.584 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 92.9 m-70 -61.73 -52.46 64.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.387 -0.824 . . . . 1.0 112.058 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -104.53 -40.52 6.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.054 0.391 . . . . 1.0 112.054 -177.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE1' ' CD2' ' A' ' 163' ' ' TRP . 7.7 tm-20 -87.81 136.6 32.89 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.691 -0.403 . . . . 1.0 110.93 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.536 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.4 OUTLIER -111.55 116.3 30.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.272 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.533 ' CD2' ' OE1' ' A' ' 161' ' ' GLU . 25.1 m95 -88.67 -33.91 17.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.277 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.82 -173.79 36.19 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.233 -0.747 . . . . 1.0 111.233 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.3 135.41 30.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 1.0 111.495 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.14 136.2 43.38 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.461 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 9.5 p -140.36 135.01 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.121 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.5 m -108.93 139.86 43.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.029 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -116.33 133.68 55.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.948 0.404 . . . . 1.0 111.653 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.71 123.16 30.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.94 178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.43 41.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.794 -177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -165.07 148.52 7.3 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.041 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.475 ' O ' ' C ' ' A' ' 174' ' ' ARG . 77.8 Cg_exo -41.42 -75.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.884 2.389 . . . . 1.0 111.897 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.475 ' C ' ' O ' ' A' ' 173' ' ' PRO . 54.3 ttt85 33.65 84.59 0.18 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.875 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.0 162.93 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.541 2.161 . . . . 1.0 111.894 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.533 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 51.6 p90 -82.69 125.93 31.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.464 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.0 t -113.6 148.59 35.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.565 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -52.9 -27.01 16.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.631 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -58.14 -43.25 87.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.685 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -64.13 -35.85 82.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.479 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 18.8 tp -60.68 -41.78 95.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.536 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -58.35 -34.94 71.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.342 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 64.0 t -67.84 -53.33 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 185' ' ' GLN . 33.6 m -70.35 -43.71 78.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.395 0.517 . . . . 1.0 112.395 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 184' ' ' VAL . 65.8 mm-40 -43.51 -42.12 4.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.954 -0.299 . . . . 1.0 111.644 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.9 mt -74.97 -44.9 45.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.889 ' O ' HG23 ' A' ' 191' ' ' VAL . 57.3 mt -80.55 -39.79 27.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.827 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.64 84.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.492 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -65.84 -39.64 90.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.002 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -67.69 -29.43 68.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 187' ' ' LEU . 58.6 t -84.08 -45.03 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.714 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 57.9 p -55.37 -31.38 61.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 52.6 mt -76.73 -34.31 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.234 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.11 -42.4 84.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.82 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.638 ' CG2' HH22 ' A' ' 55' ' ' ARG . 37.4 pt -68.15 -33.72 62.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.163 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -70.13 -50.71 37.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.14 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -71.67 -36.51 70.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.479 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.66 -35.04 79.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -56.93 -29.58 63.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.472 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.622 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.2 mp -61.91 -34.15 75.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.682 0.277 . . . . 1.0 111.069 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 35.0 m -49.92 -54.08 22.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.563 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.579 179.695 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.894 HAA1 HD11 ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.888 0.375 . . . . 1.0 110.604 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -55.71 -50.93 69.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.978 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.596 HE22 ' NH2' ' A' ' 36' ' ' ARG . 84.7 mm-40 -57.03 -45.54 83.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.077 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.22 -47.15 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 1.0 110.939 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -58.68 -48.41 81.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.048 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.596 ' NH2' HE22 ' A' ' 33' ' ' GLN . 66.3 mtm180 -56.42 -36.32 68.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.442 . . . . 1.0 109.83 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.88 65.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.061 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 42' ' ' VAL . 27.2 m -73.29 -47.82 39.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.556 -0.747 . . . . 1.0 112.149 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.676 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.3 p -65.6 -35.07 74.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.38 -50.93 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 1.0 111.105 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -61.03 -43.36 99.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.784 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 38' ' ' THR . 79.8 t -57.36 -42.57 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.714 0.293 . . . . 1.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 47' ' ' GLY . 62.7 ttp85 -51.29 -40.18 58.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.763 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.41 78.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.041 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -78.38 -45.97 21.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 1.0 111.56 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.87 -31.8 22.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.53 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.93 20.71 27.71 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.6 p -70.92 142.0 51.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 1.0 110.167 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -40.98 -41.28 1.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.633 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.536 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -163.34 128.7 3.08 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.079 -0.648 . . . . 1.0 112.606 -178.582 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.9 130.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.538 ' CE ' HBB2 ' A' ' 203' ' ' CYC . 25.4 pttm -139.98 157.2 46.05 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.441 -0.504 . . . . 1.0 111.903 -178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.8 t -100.23 136.95 29.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.525 -0.917 . . . . 1.0 108.525 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 50.1 t80 -130.28 128.96 42.64 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.322 -0.551 . . . . 1.0 111.227 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -94.94 132.43 39.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.18 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -91.33 118.63 30.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -87.79 151.4 49.88 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 108.639 -0.875 . . . . 1.0 108.639 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.76 -20.85 60.84 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.48 2.12 . . . . 1.0 112.444 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -82.77 -17.51 43.92 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.06 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.73 -15.41 37.78 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.549 -0.621 . . . . 1.0 111.549 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 40.5 m80 -64.14 -104.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.773 0.32 . . . . 1.0 110.632 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.453 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . 103.89 152.97 23.09 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -128.09 147.51 50.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 1.0 111.696 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.458 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.5 p -81.66 117.06 27.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.93 4.87 9.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.696 0.284 . . . . 1.0 111.37 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.676 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.99 118.58 2.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.104 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 85.8 tt0 -144.37 133.21 22.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 1.0 111.846 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.2 151.5 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.393 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -139.74 142.26 36.82 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.762 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -39.96 -68.96 0.5 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.96 83.84 0.13 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 41.7 38.65 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.746 0.308 . . . . 1.0 110.522 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -82.62 -53.53 5.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.215 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.2 mt -110.27 141.42 23.85 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.888 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.14 165.67 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.479 2.12 . . . . 1.0 112.176 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.8 t -93.38 123.41 36.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.871 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.508 ' HA ' HD12 ' A' ' 80' ' ' LEU . 20.9 mt -90.59 2.59 55.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.376 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.16 131.12 49.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.179 0.514 . . . . 1.0 112.28 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.67 -13.55 63.89 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.545 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 77' ' ' LEU . 78.0 mt -82.1 150.93 27.24 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.309 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.5 m -106.14 134.4 49.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.703 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.824 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 8.2 m-85 -88.92 153.04 49.29 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.92 136.16 51.52 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.692 2.262 . . . . 1.0 111.879 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.465 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . . . -67.21 130.56 43.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.708 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.4 -2.43 39.93 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.497 -1.041 . . . . 1.0 110.497 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 20.8 p-10 -54.61 -38.19 66.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.4 mm -75.08 133.49 75.39 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.42 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.736 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 98.9 Cg_endo -72.28 -175.21 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.426 2.084 . . . . 1.0 112.526 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -105.46 -51.25 3.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.556 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.43 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 21.5 pt-20 -67.5 -41.97 83.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.843 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 1.013 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -68.16 -42.47 80.01 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.876 0.324 . . . . 1.0 111.876 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.604 HH22 HD22 ' A' ' 162' ' ' LEU . 61.0 ttt85 -63.83 -41.82 97.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.471 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -60.23 -32.96 71.62 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.879 -0.329 . . . . 1.0 110.847 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HB2' HH22 ' A' ' 101' ' ' ARG . 96.4 mt -71.46 -35.91 71.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.289 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.53 -40.85 96.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.02 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -63.66 -33.57 75.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.81 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.406 ' C ' ' OE1' ' A' ' 99' ' ' GLN . 72.0 mt -97.18 -37.11 10.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 114.389 1.255 . . . . 1.0 114.389 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -118.01 -10.1 10.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.11 1.522 . . . . 1.0 115.11 -175.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.497 ' N ' ' OE1' ' A' ' 99' ' ' GLN . 0.2 OUTLIER 41.58 79.48 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.114 -1.034 . . . . 1.0 108.864 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 100' ' ' VAL . 7.8 p 179.78 107.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.096 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.575 ' HD3' HAA2 ' A' ' 203' ' ' CYC . 8.9 ttm105 -153.27 148.76 27.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.954 0.407 . . . . 1.0 110.803 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 p -167.62 150.26 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.502 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.3 mt -106.91 136.43 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 105' ' ' ASP . 22.4 t -88.78 158.64 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -176.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.502 ' N ' HG12 ' A' ' 104' ' ' VAL . 64.5 m-20 -48.37 122.77 5.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.913 -1.039 . . . . 1.0 112.121 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.19 -26.71 26.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.786 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.9 -46.75 83.45 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.79 -12.67 50.29 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.49 0.662 . . . . 1.0 109.359 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 45.86 72.2 0.24 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.767 -1.106 . . . . 1.0 113.275 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 p -73.74 130.53 40.17 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.915 -1.513 . . . . 1.0 106.915 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -118.57 133.99 55.44 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.946 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 t -125.96 145.32 50.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.55 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 114' ' ' SER . 2.4 mt -148.18 169.61 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.201 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.475 ' H ' HG22 ' A' ' 113' ' ' ILE . 22.6 t -53.47 149.22 8.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.658 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 117' ' ' GLU . 3.2 pt20 -139.42 158.85 67.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.632 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -40.9 -13.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.714 2.276 . . . . 1.0 112.344 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 115' ' ' GLN . 69.4 tt0 65.04 113.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.446 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.8 m -140.32 158.26 44.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.673 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -58.59 141.89 50.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.538 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.39 14.03 5.66 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.5 mt 48.12 65.53 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 1.0 110.446 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 83.1 p -61.64 -23.6 66.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.513 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.93 -45.95 82.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.66 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.2 tpp85 -148.95 144.55 26.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.538 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 127' ' ' LEU . 34.2 m -79.69 147.91 68.09 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.246 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -38.25 -27.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.679 2.253 . . . . 1.0 112.293 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' VAL . 16.6 tp 51.55 81.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.563 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.97 -94.23 0.12 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -131.08 71.9 81.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.592 0.234 . . . . 1.0 110.865 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -85.99 -12.59 5.97 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 123.102 2.535 . . . . 1.0 111.636 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.95 -16.22 61.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.376 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -79.14 89.57 4.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.869 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -124.1 79.91 58.46 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.569 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.99 143.52 13.58 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.729 2.286 . . . . 1.0 111.904 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.562 HG23 ' CG2' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -103.24 117.9 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.824 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 138' ' ' CYS . 19.4 t70 -43.72 137.8 3.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -39.45 -20.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 123.153 2.569 . . . . 1.0 114.005 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.701 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.1 p -64.91 -46.06 83.28 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.662 0.245 . . . . 1.0 111.662 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.701 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.8 t60 -82.75 -24.53 33.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.562 ' CG2' HG23 ' A' ' 135' ' ' VAL . 72.0 t -65.85 -52.03 54.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.651 -0.42 . . . . 1.0 110.947 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.9 -29.71 69.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.778 -0.452 . . . . 1.0 109.778 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -58.49 -46.66 86.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.74 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 146' ' ' MET . 11.6 mt -72.73 -38.13 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -51.29 -38.71 54.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -65.04 -25.33 67.78 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.153 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.1 mmm -90.77 0.36 57.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.668 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.87 79.1 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.06 142.19 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.889 0.376 . . . . 1.0 110.969 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.53 -29.31 9.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.912 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.441 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 37.8 m -138.5 155.3 48.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.198 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 p -145.49 126.77 14.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.446 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tp -110.3 134.91 51.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.284 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.523 HG21 HAA1 ' A' ' 203' ' ' CYC . 5.7 t -122.81 120.92 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.182 0.515 . . . . 1.0 111.725 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 184' ' ' VAL . 1.2 m -114.81 167.37 9.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -83.27 122.36 3.24 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.187 2.591 . . . . 1.0 114.667 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.3 tp -124.24 35.56 4.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -146.34 177.7 8.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.158 0.799 . . . . 1.0 113.158 -176.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.677 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 11.3 t-80 -68.73 -171.51 0.29 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.344 -0.843 . . . . 1.0 111.365 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.677 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 56.1 t-80 -73.68 -54.27 8.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.403 -0.817 . . . . 1.0 112.097 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -104.95 -32.01 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.046 0.387 . . . . 1.0 112.046 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 85.1 tt0 -94.05 141.41 28.57 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.88 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.604 HD22 HH22 ' A' ' 92' ' ' ARG . 7.2 tt -108.15 116.02 31.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.263 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.515 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 77.8 m95 -89.86 -37.64 14.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.266 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.04 -174.69 35.01 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.56 132.61 31.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.807 0.337 . . . . 1.0 111.563 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.5 tp -101.61 133.79 45.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 167' ' ' VAL . 11.7 p -140.13 133.25 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.796 -0.361 . . . . 1.0 111.147 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 78.6 p -109.76 139.89 44.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.025 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -113.66 133.34 55.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.026 0.441 . . . . 1.0 111.651 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -130.93 130.85 43.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.597 . . . . 1.0 109.973 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.32 59.02 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.785 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -160.14 128.7 2.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.993 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.426 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 90.0 Cg_endo -77.21 22.36 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.922 2.414 . . . . 1.0 111.883 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -72.57 126.24 90.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.883 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -46.7 153.01 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.609 2.206 . . . . 1.0 111.882 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -86.24 141.86 28.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.481 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.7 m -118.07 150.24 39.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.598 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -57.74 -29.4 64.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.623 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -56.24 -38.47 71.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.756 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.25 -40.03 94.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.548 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.03 -37.94 89.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.509 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -53.62 -39.36 64.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.917 -0.583 . . . . 1.0 111.382 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.25 -54.33 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.592 HG21 HG11 ' A' ' 154' ' ' VAL . 7.3 p -78.9 -36.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -47.53 -49.22 26.77 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.656 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 33.5 mt -75.19 -38.35 60.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.97 -41.32 51.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.801 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.39 86.96 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.504 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.29 -37.76 70.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.976 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -68.85 -24.73 64.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.118 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.8 t -83.99 -45.35 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.793 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 85.5 p -56.86 -35.25 68.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.0 mt -66.96 -33.95 66.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.426 -0.806 . . . . 1.0 109.185 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.42 -38.35 74.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.778 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 195' ' ' ILE . 38.2 mm -59.28 -49.35 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.112 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.454 ' O ' ' CD1' ' A' ' 200' ' ' LEU . . . -71.59 -48.61 47.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.836 -0.62 . . . . 1.0 111.122 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -63.96 -42.9 97.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.496 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.89 -31.11 71.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.673 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -58.29 -31.97 67.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.592 -0.277 . . . . 1.0 111.417 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.7 mp -60.63 -34.58 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.045 -0.262 . . . . 1.0 111.054 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 31.7 t -55.31 -56.72 16.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.538 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.587 179.829 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 1.013 HBD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.911 0.386 . . . . 1.0 110.574 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.45 -51.07 69.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.964 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -56.64 -47.49 79.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.066 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.51 -47.85 91.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.787 0.327 . . . . 1.0 110.974 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.9 mt -55.91 -42.42 76.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 1.0 111.056 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.24 -35.29 62.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -34.6 70.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.065 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 42' ' ' VAL . 64.5 p -73.1 -41.22 64.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.498 -0.774 . . . . 1.0 112.271 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.607 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 8.2 p -70.44 -37.66 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.23 -46.65 79.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.151 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -59.89 -47.92 83.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.78 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 38' ' ' THR . 71.0 t -53.58 -38.43 33.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.986 -0.285 . . . . 1.0 111.115 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.541 ' NH1' ' O ' ' A' ' 69' ' ' ARG . 54.1 ttp180 -53.62 -44.11 69.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.339 . . . . 1.0 110.85 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.38 -34.2 70.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.117 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -74.14 -43.92 55.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.549 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.57 -30.12 19.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.421 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.5 20.88 1.12 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.534 HG21 ' CD2' ' A' ' 170' ' ' HIS . 5.5 p -63.64 -96.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.81 0.338 . . . . 1.0 110.236 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -155.6 -47.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 1.0 111.658 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -154.76 124.23 6.47 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.954 -0.699 . . . . 1.0 112.515 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.8 t -128.35 129.39 69.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.431 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 19.5 pttp -141.08 149.74 42.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.888 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 23.8 t -111.84 138.16 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.495 ' CD1' ' C ' ' A' ' 54' ' ' TYR . 2.4 p90 -136.15 139.09 42.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.314 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -93.31 141.38 28.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.294 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.64 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 64.0 t80 -92.69 117.54 30.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 1.0 112.123 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 17.3 p-10 -88.17 150.72 47.83 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.41 -20.11 67.05 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.516 2.144 . . . . 1.0 112.476 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -87.02 -19.82 28.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 1.0 110.096 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.64 -16.07 37.53 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.589 -0.604 . . . . 1.0 111.589 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.547 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 93.7 m-70 -74.25 91.81 2.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 1.0 110.561 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.55 144.36 20.51 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.3 p -122.01 143.47 49.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 1.0 111.666 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.481 ' O ' HD12 ' A' ' 78' ' ' LEU . 61.1 t -79.18 110.87 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.27 2.17 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.387 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.607 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.94 123.98 4.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.112 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -146.09 132.59 19.73 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.519 -0.472 . . . . 1.0 111.797 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.77 141.53 51.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.381 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.541 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 30.0 ptt180 -143.06 144.21 32.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.724 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.14 -34.81 47.87 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -173.27 -168.64 34.72 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.437 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 77.2 mm-40 -72.35 44.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 1.0 110.49 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 71' ' ' GLY . 56.9 ttm-85 -83.47 -48.85 9.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.141 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.36 149.77 41.54 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.906 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.13 165.19 33.21 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.577 2.185 . . . . 1.0 112.094 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.9 p -88.19 129.4 35.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.952 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.512 ' HA ' HD12 ' A' ' 80' ' ' LEU . 25.6 mt -98.47 2.57 47.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.364 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 64' ' ' VAL . 6.0 tp -62.01 131.35 49.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 1.0 112.337 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.17 -14.03 61.86 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.549 -0.75 . . . . 1.0 111.505 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 77' ' ' LEU . 68.3 mt -82.12 151.06 27.15 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.963 -0.295 . . . . 1.0 110.29 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.4 p -104.83 130.55 52.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.657 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.763 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 6.8 m-85 -85.61 153.76 58.58 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.28 135.68 59.53 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.704 2.269 . . . . 1.0 111.897 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.23 126.75 29.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.722 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.3 -0.58 43.64 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.49 -37.13 64.92 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.061 ' H ' HD12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -81.55 113.52 42.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.413 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 87' ' ' ILE . 80.4 Cg_exo -49.47 -171.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.468 2.112 . . . . 1.0 112.474 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 79.3 mm-40 -108.43 -55.85 2.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.553 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -59.88 -42.53 93.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.789 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.893 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -66.99 -51.05 59.91 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.922 0.342 . . . . 1.0 111.922 -178.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.783 ' HE ' HH21 ' A' ' 96' ' ' ARG . 59.3 ttt85 -50.17 -35.44 26.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.504 -0.316 . . . . 1.0 111.427 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 78.5 mtt85 -67.78 -35.16 78.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.798 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.7 mt -58.37 -39.03 78.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.273 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.615 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 92.5 m-85 -61.57 -50.44 72.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.052 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.783 HH21 ' HE ' ' A' ' 92' ' ' ARG . 95.6 mtt180 -54.56 -32.68 58.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.811 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.2 mt -101.39 -44.04 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.428 1.27 . . . . 1.0 114.428 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.12 -15.3 11.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 115.057 1.502 . . . . 1.0 115.057 -173.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 19.9 mm-40 44.16 79.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.205 -0.998 . . . . 1.0 108.849 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 100' ' ' VAL . 7.6 p -179.36 107.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.074 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.48 ' HE ' ' NE ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -156.15 150.94 26.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 1.0 110.777 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -170.43 148.51 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.498 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.2 mt -109.37 135.13 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.39 165.16 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 113.243 0.831 . . . . 1.0 113.243 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -46.51 119.38 2.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.91 -1.041 . . . . 1.0 112.13 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.427 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.6 p -56.75 -22.36 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.737 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.01 -44.68 91.88 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.18 -10.17 29.14 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.494 0.664 . . . . 1.0 109.36 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 45.21 71.42 0.27 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.734 -1.121 . . . . 1.0 113.308 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -73.82 132.7 42.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.979 -1.489 . . . . 1.0 106.979 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.548 ' NH1' HD11 ' A' ' 131' ' ' LEU . 36.6 ptt-85 -121.5 137.99 54.49 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.882 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -132.89 155.85 48.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.528 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 112' ' ' SER . 25.0 pt -156.1 177.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.149 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.1 t -54.93 156.33 3.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.623 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.404 ' O ' ' OE1' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -136.34 156.05 76.85 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.716 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 117' ' ' GLU . 86.5 Cg_endo -78.6 93.68 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.616 2.211 . . . . 1.0 112.324 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 116' ' ' PRO . 44.7 tp10 50.82 101.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.409 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.3 m -123.36 146.85 47.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.692 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -104.99 142.6 34.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.405 ' C ' ' N ' ' A' ' 122' ' ' SER . . . -58.24 -23.05 52.07 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.0 mt -51.92 -14.04 0.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 1.0 110.394 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 120' ' ' GLY . 15.8 t -53.61 -34.24 57.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.472 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.62 69.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.696 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -57.27 -56.23 24.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.596 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 m -150.45 87.56 4.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.205 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -41.28 127.84 3.08 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.588 2.192 . . . . 1.0 112.268 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.2 tp -58.22 -38.8 77.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.529 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -165.74 -81.79 0.05 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.816 -0.914 . . . . 1.0 110.816 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 132' ' ' GLN . 5.7 mm-40 57.3 66.98 2.69 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.613 0.244 . . . . 1.0 110.865 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -45.33 -41.47 17.4 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 123.136 2.557 . . . . 1.0 111.685 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.548 HD11 ' NH1' ' A' ' 111' ' ' ARG . 19.2 mt -76.56 -9.06 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.377 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 133' ' ' ARG . 73.3 mt-30 63.86 117.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.831 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.48 ' NE ' ' HE ' ' A' ' 101' ' ' ARG . 1.1 mmm180 36.2 76.0 0.47 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.584 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -85.15 136.04 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.793 2.328 . . . . 1.0 111.991 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.582 HG23 ' CG2' ' A' ' 140' ' ' VAL . 2.9 m -110.97 129.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.915 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.549 ' OD2' HMD3 ' A' ' 203' ' ' CYC . 37.2 m-20 -43.96 134.56 4.0 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -40.35 -46.53 4.32 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.124 2.549 . . . . 1.0 114.007 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 3.8 p -39.33 -45.4 1.43 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.686 0.254 . . . . 1.0 111.686 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.668 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.2 t60 -81.36 -29.34 34.09 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.276 0.473 . . . . 1.0 112.276 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.582 ' CG2' HG23 ' A' ' 135' ' ' VAL . 98.6 t -65.67 -52.53 49.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.961 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -66.75 -27.67 67.79 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -60.21 -45.51 92.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.775 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 146' ' ' MET . 65.1 mt -73.44 -35.82 65.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -52.18 -39.13 59.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.593 -1.262 . . . . 1.0 107.593 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 p -65.24 -20.63 66.51 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.779 -1.1 . . . . 1.0 109.158 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 143' ' ' LEU . 89.4 mmm -93.83 1.45 56.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.462 -0.79 . . . . 1.0 110.735 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.5 22.21 78.64 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.66 142.35 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 1.0 110.986 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.89 -42.99 4.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.484 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 7.2 t -129.84 125.8 36.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 1.0 111.17 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 m -112.96 135.49 53.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.458 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tp -115.13 136.85 52.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.291 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.24 113.96 39.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.15 0.5 . . . . 1.0 111.753 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.16 110.52 30.91 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.66 149.21 54.56 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.144 2.562 . . . . 1.0 114.671 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.48 ' CD2' ' HB1' ' A' ' 188' ' ' ALA . 29.6 mt -125.34 68.44 1.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.796 -1.557 . . . . 1.0 106.796 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.4 ptm -148.04 -173.84 4.41 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.594 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 30.7 t-80 -78.26 178.57 7.52 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.321 -0.854 . . . . 1.0 111.373 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.594 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 13.0 m-70 -74.13 -55.39 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.309 -0.859 . . . . 1.0 112.122 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -105.0 11.92 32.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -144.29 137.61 27.35 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.922 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.715 HD22 ' NH2' ' A' ' 92' ' ' ARG . 7.9 tt -112.38 117.42 32.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.258 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -92.19 -34.19 14.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.289 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.77 -167.58 25.55 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.445 HD21 ' CD2' ' A' ' 95' ' ' PHE . 1.4 mt -152.42 144.69 23.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 1.0 111.592 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 167' ' ' VAL . 2.7 tp -114.51 139.18 49.77 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.58 ' N ' HD12 ' A' ' 166' ' ' LEU . 8.4 p -140.4 140.6 34.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 69.5 m -113.53 143.11 45.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.968 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -113.54 131.8 55.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 1.0 111.572 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.666 ' ND1' ' N ' ' A' ' 170' ' ' HIS . 0.0 OUTLIER -124.67 121.19 34.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.844 -0.616 . . . . 1.0 109.961 178.327 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.0 -16.03 60.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.79 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -107.88 139.0 20.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.012 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 174' ' ' ARG . 72.7 Cg_exo -39.54 -73.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.885 2.39 . . . . 1.0 111.883 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 173' ' ' PRO . 17.0 ttp85 35.41 88.83 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.903 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.87 162.86 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.521 2.148 . . . . 1.0 111.986 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.454 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 50.8 p90 -90.88 131.33 36.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.43 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.1 t -121.21 157.39 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.599 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -53.01 -32.17 45.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.14 -39.38 86.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.731 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.1 -45.29 89.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.429 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.76 -36.29 83.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.581 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -55.41 -39.39 70.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.392 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.4 t -67.85 -55.54 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.545 HG12 ' HB2' ' A' ' 188' ' ' ALA . 3.4 t -70.82 -46.54 68.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.452 0.538 . . . . 1.0 112.452 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -41.48 -46.31 3.44 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.663 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 15.5 tp -71.6 -42.79 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 191' ' ' VAL . 46.4 tp -77.2 -40.44 45.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.86 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.545 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -57.19 -37.9 72.86 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.473 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -61.56 -39.75 92.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.33 -0.395 . . . . 1.0 109.982 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -64.98 -28.62 69.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.104 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 187' ' ' LEU . 20.6 t -84.04 -41.22 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.791 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m -56.7 -36.7 69.95 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 mt -65.46 -38.7 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.445 -0.798 . . . . 1.0 109.221 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.52 83.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.838 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.3 -47.34 92.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.171 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.82 -46.85 62.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.147 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.92 -42.54 90.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.508 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.73 -31.83 72.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.679 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.79 -40.14 95.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.521 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 200' ' ' LEU . 20.5 tp -62.85 -36.58 83.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.67 0.272 . . . . 1.0 111.011 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 38.8 t -50.74 -51.48 49.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.594 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.532 179.654 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.893 HBD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.8 tp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.9 0.381 . . . . 1.0 110.551 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 25.0 p-10 -76.83 -28.66 55.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.043 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -77.81 -47.09 19.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.086 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 pt -63.41 -38.58 82.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 1.0 110.964 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -60.84 -49.38 77.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.054 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -53.93 -39.5 65.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.71 -28.92 67.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.073 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.443 ' O ' HG23 ' A' ' 42' ' ' VAL . 11.6 m -71.47 -47.46 55.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.445 -0.798 . . . . 1.0 112.196 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.687 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 3.4 p -68.09 -33.27 59.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 111.907 0.336 . . . . 1.0 111.907 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -69.1 -51.36 39.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.829 0.347 . . . . 1.0 111.14 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -61.73 -45.65 93.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.745 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 38' ' ' THR . 84.6 t -61.56 -35.73 68.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.696 0.284 . . . . 1.0 111.169 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.618 ' NH2' ' CA ' ' A' ' 70' ' ' GLY . 15.7 tpt85 -56.51 -42.19 77.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.803 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.97 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.112 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -79.08 -43.2 24.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.624 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.3 mt -86.43 -32.28 20.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.461 -0.336 . . . . 1.0 111.455 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.54 19.28 18.54 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.564 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 67.3 m -69.97 141.21 53.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.859 0.361 . . . . 1.0 110.209 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' THR . 92.3 m-20 -37.16 -45.9 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.578 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.618 ' NH2' ' CE1' ' A' ' 169' ' ' HIS . 19.2 ttp-105 -163.66 126.7 2.62 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.985 -0.686 . . . . 1.0 112.567 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 51' ' ' VAL . 10.6 p -133.91 127.83 52.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 176.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.555 ' HE3' HAB1 ' A' ' 203' ' ' CYC . 44.0 pttt -140.09 155.65 46.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.14 0.495 . . . . 1.0 111.878 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 62.0 t -98.96 133.65 40.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 176.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -115.01 112.27 22.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.262 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -84.45 127.18 33.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.219 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.442 ' CE2' ' CZ ' ' A' ' 92' ' ' ARG . 71.9 t80 -95.26 134.16 38.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 1.0 112.039 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.86 140.32 20.95 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.36 -27.83 7.55 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 C-N-CA 122.495 2.13 . . . . 1.0 112.441 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -83.39 -16.22 46.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 1.0 110.089 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.56 -13.55 46.9 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.572 -0.611 . . . . 1.0 111.572 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -78.23 90.86 4.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.771 0.319 . . . . 1.0 110.616 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.97 150.8 20.44 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.527 -1.029 . . . . 1.0 110.527 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.4 p -124.85 147.79 48.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.372 . . . . 1.0 111.741 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 77' ' ' LEU . 22.1 t -75.82 107.93 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 65' ' ' VAL . 37.2 t -106.51 -1.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.282 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.687 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.64 113.82 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.068 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.4 tt0 -143.74 135.78 26.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.087 0.47 . . . . 1.0 111.758 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.25 131.97 47.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.415 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -124.65 147.21 48.68 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.711 -0.396 . . . . 1.0 110.725 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.618 ' CA ' ' NH2' ' A' ' 43' ' ' ARG . . . -72.25 -134.79 0.18 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.794 -0.922 . . . . 1.0 110.794 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.26 59.12 1.12 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.006 -0.838 . . . . 1.0 111.006 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 41.83 46.73 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.667 0.27 . . . . 1.0 110.486 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 73' ' ' ARG . 2.0 tpm_? -82.73 -48.72 10.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.401 HD13 ' NH1' ' A' ' 50' ' ' ARG . 42.0 mt -107.38 131.44 21.71 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.862 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.48 145.65 11.73 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.575 2.183 . . . . 1.0 112.111 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 p -72.79 123.34 23.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.978 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 80' ' ' LEU . 16.8 mt -98.62 13.6 31.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.309 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 23.9 tp -73.14 129.17 37.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.269 0.557 . . . . 1.0 112.209 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.56 -9.94 71.61 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.602 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 77' ' ' LEU . 68.8 mt -85.12 153.07 22.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.808 0.337 . . . . 1.0 110.243 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.6 m -105.91 132.54 51.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.703 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 8.1 m-85 -85.17 152.0 57.78 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.52 127.52 13.33 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.714 2.276 . . . . 1.0 111.854 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 142.33 57.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.623 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.35 1.18 37.99 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.938 ' O ' HG23 ' A' ' 87' ' ' ILE . 20.2 p-10 -50.84 -52.95 36.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.938 HG23 ' O ' ' A' ' 86' ' ' ASP . 1.9 pp -171.42 50.63 0.14 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.437 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 87' ' ' ILE . 4.1 Cg_endo -94.57 -0.84 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.398 2.065 . . . . 1.0 112.531 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -90.67 -82.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.037 -0.528 . . . . 1.0 111.494 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -78.79 -48.23 15.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.772 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.415 ' HB2' ' O1D' ' A' ' 203' ' ' CYC . . . -59.82 -35.33 74.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.868 0.321 . . . . 1.0 111.868 -176.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.917 HH12 HD22 ' A' ' 162' ' ' LEU . 58.5 ttt85 -71.68 -39.95 69.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.421 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -63.1 -43.32 98.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.824 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.493 HD12 ' NH2' ' A' ' 101' ' ' ARG . 76.1 mt -64.72 -41.73 95.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.297 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.407 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 1.2 t80 -55.04 -44.02 74.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.022 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -56.6 -28.58 60.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.803 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.1 mt -98.24 -39.63 8.76 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.568 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -119.38 -13.12 9.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.994 1.479 . . . . 1.0 114.994 -174.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.568 ' C ' ' O ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER 35.67 81.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.192 -1.003 . . . . 1.0 108.858 -178.512 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 100' ' ' VAL . 11.0 p -174.64 108.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.075 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.495 ' HD2' HAA2 ' A' ' 203' ' ' CYC . 56.6 mmt-85 -141.87 146.01 35.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 1.0 110.781 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.5 p -171.83 135.93 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.573 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.8 137.0 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.459 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 32.8 m -91.04 165.04 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 17.8 p30 -48.65 119.35 3.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.895 -1.048 . . . . 1.0 112.106 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 140' ' ' VAL . 9.3 p -53.77 -21.74 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.785 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -65.85 -45.28 82.77 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.404 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . . . -65.9 -16.02 63.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.557 0.694 . . . . 1.0 109.411 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 46.4 72.71 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.757 -1.111 . . . . 1.0 113.314 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.459 ' OG ' ' CG2' ' A' ' 104' ' ' VAL . 1.1 p -73.51 129.01 37.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.97 -1.493 . . . . 1.0 106.97 174.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -116.61 134.9 54.28 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.96 -0.696 . . . . 1.0 111.937 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.96 163.96 31.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.514 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.574 ' C ' ' H ' ' A' ' 115' ' ' GLN . 17.6 pt -126.54 138.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.209 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.0 t -67.1 16.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.631 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.574 ' H ' ' C ' ' A' ' 113' ' ' ILE . 50.6 mt-30 -119.85 79.45 24.24 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.65 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.79 151.26 12.88 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.633 2.222 . . . . 1.0 112.349 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -65.61 -48.3 72.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.464 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 t -175.12 161.05 2.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.713 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.522 ' CE3' ' N ' ' A' ' 120' ' ' GLY . 15.0 t90 -145.42 177.01 9.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.591 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.522 ' N ' ' CE3' ' A' ' 119' ' ' TRP . . . 104.06 -42.38 1.91 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.998 -0.841 . . . . 1.0 110.998 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 121' ' ' LEU . 8.9 mp -61.55 -30.37 70.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 1.0 110.436 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.5 p -58.18 -18.55 26.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.481 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.38 -25.03 63.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.711 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -119.22 -34.8 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.505 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 125' ' ' VAL . 7.6 p -150.68 113.67 3.2 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.222 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -40.43 138.89 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.546 2.164 . . . . 1.0 112.309 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 128' ' ' GLY . 2.8 tt -152.6 116.56 4.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.584 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.626 ' N ' HD23 ' A' ' 127' ' ' LEU . . . 85.0 30.58 25.5 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.891 -0.883 . . . . 1.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 129' ' ' GLU . 1.9 mp0 50.22 66.09 6.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.574 0.226 . . . . 1.0 110.89 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.64 -34.92 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 123.143 2.562 . . . . 1.0 111.631 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 26.0 tp -58.43 -41.37 84.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.378 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 133' ' ' ARG . 90.6 mt-30 -74.2 -29.35 61.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.929 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 132' ' ' GLN . 12.7 tpt85 34.79 65.72 1.6 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.615 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -49.79 146.6 15.65 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.749 2.299 . . . . 1.0 111.971 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.83 149.31 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.871 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -94.51 156.24 38.75 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -55.39 -29.03 66.36 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.195 2.597 . . . . 1.0 113.974 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.711 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.7 OUTLIER -60.4 -46.25 90.66 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.705 0.261 . . . . 1.0 111.705 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.711 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 4.4 t60 -80.64 -24.16 39.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.271 0.471 . . . . 1.0 112.271 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 106' ' ' VAL . 63.3 t -66.33 -54.11 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.944 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -64.9 -28.84 69.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -60.26 -45.85 91.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.776 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 146' ' ' MET . 27.3 mt -73.02 -37.2 67.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -50.98 -39.52 55.63 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.2 m -64.36 -24.47 67.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.746 -1.115 . . . . 1.0 109.204 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.565 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -91.86 -2.92 56.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.437 -0.801 . . . . 1.0 110.684 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.91 20.36 79.74 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.4 t -108.48 143.06 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 1.0 110.933 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.51 -42.74 4.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.948 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.8 m -131.99 124.22 28.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 1.0 111.164 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.2 p -108.73 139.59 43.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.444 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 tp -121.95 125.82 47.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.232 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.424 HG21 HAA1 ' A' ' 203' ' ' CYC . 2.5 t -119.74 113.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.182 0.515 . . . . 1.0 111.774 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.13 107.09 54.39 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.745 -1.205 . . . . 1.0 107.745 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -40.43 128.18 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.189 2.593 . . . . 1.0 114.681 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.54 HD11 ' CG1' ' A' ' 191' ' ' VAL . 13.7 tp -116.49 41.4 2.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.868 -1.53 . . . . 1.0 106.868 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 7.9 ptm -146.92 178.81 8.05 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 30.4 t-80 -69.04 -176.92 0.94 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.34 -0.846 . . . . 1.0 111.415 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.641 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 96.3 m-70 -68.77 -55.2 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.426 -0.806 . . . . 1.0 112.066 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -104.15 -42.3 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -83.47 129.43 34.98 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.882 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.917 HD22 HH12 ' A' ' 92' ' ' ARG . 6.7 tt -103.68 117.72 35.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.263 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -92.51 -39.78 11.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.244 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.58 -176.28 36.89 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.1 mt -138.24 136.46 36.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.778 0.323 . . . . 1.0 111.55 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.425 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.9 tp -105.84 130.95 53.71 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.63 142.14 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.743 -0.383 . . . . 1.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 m -112.59 138.52 49.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.054 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.618 ' CE1' ' NH2' ' A' ' 50' ' ' ARG . 56.1 m80 -106.98 121.6 44.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.977 0.418 . . . . 1.0 111.69 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -122.04 112.51 18.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.991 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.76 -15.09 63.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.884 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -87.51 148.39 44.12 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.3 -2.32 11.5 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.95 2.433 . . . . 1.0 111.88 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -41.59 131.25 2.3 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.878 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.82 167.23 25.67 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.578 2.185 . . . . 1.0 111.977 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 43.7 p90 -79.94 126.7 31.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.505 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.7 t -114.54 147.36 39.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.574 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.583 ' CD ' ' H ' ' A' ' 178' ' ' GLN . 11.1 mp0 -53.75 -32.45 52.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 1.0 110.622 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -62.35 -41.49 98.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.749 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -62.93 -43.79 97.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.465 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.5 mt -65.31 -37.76 88.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.558 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -54.1 -36.15 62.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.397 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.6 -54.47 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.1 -32.37 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -54.19 -50.31 67.34 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.627 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.8 tp -70.14 -38.41 75.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.005 0.372 . . . . 1.0 112.005 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 191' ' ' VAL . 38.0 tp -77.75 -38.65 46.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.812 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.18 86.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.502 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.86 -40.14 91.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.964 0.411 . . . . 1.0 110.041 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -71.71 -24.44 61.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.146 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 187' ' ' LEU . 87.5 t -82.79 -48.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.718 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 82.9 p -55.34 -35.4 65.15 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.4 mt -65.61 -33.83 66.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.215 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.58 -38.49 77.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.776 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.1 mm -60.04 -46.6 94.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.123 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.26 -45.51 69.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.087 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -65.99 -40.71 91.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.495 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.91 70.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.308 -0.405 . . . . 1.0 111.733 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.35 -35.68 78.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.51 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.04 -32.28 71.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -54.37 -53.16 57.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.648 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.1 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.559 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.703 HBB3 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.887 0.375 . . . . 1.0 110.563 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -74.98 -50.04 17.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.975 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -57.01 -48.12 79.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.066 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 35' ' ' LEU . 18.8 tt -65.93 -43.31 92.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.759 0.314 . . . . 1.0 110.974 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.549 ' N ' HG23 ' A' ' 34' ' ' ILE . 30.7 mt -61.37 -46.72 89.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.033 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -59.5 -37.5 78.46 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.66 -29.62 67.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.128 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 42' ' ' VAL . 45.8 m -73.5 -48.0 36.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.476 -0.783 . . . . 1.0 112.259 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.654 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.0 p -65.14 -33.41 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.01 0.374 . . . . 1.0 112.01 -178.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -65.72 -49.15 69.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.342 . . . . 1.0 111.112 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.92 -38.61 89.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.748 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 38' ' ' THR . 86.0 t -61.05 -44.8 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.169 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 47' ' ' GLY . 61.7 ttp85 -53.71 -39.42 65.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.778 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.57 -37.84 79.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -79.45 -44.0 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.539 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.12 -33.59 22.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 1.0 111.523 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 60.45 19.52 53.61 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.457 -1.057 . . . . 1.0 110.457 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.515 HG23 ' CD2' ' A' ' 170' ' ' HIS . 93.9 m -72.27 142.31 48.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.349 . . . . 1.0 110.244 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -39.35 -45.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.625 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -163.72 130.91 3.36 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.046 -0.661 . . . . 1.0 112.545 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 51' ' ' VAL . 10.6 p -138.47 128.63 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 176.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -140.35 155.2 46.87 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.897 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.9 t -100.04 136.57 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 176.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.449 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 39.7 t80 -126.61 127.31 45.03 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.35 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.468 ' NE ' HG21 ' A' ' 65' ' ' VAL . 57.4 mtm180 -92.33 127.58 37.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.196 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 67.2 t80 -89.83 118.49 29.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 1.0 112.03 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 17.5 p-10 -90.04 152.37 46.13 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -59.43 -19.26 50.53 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.524 2.15 . . . . 1.0 112.458 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -82.6 -21.22 35.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.921 0.391 . . . . 1.0 110.04 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.11 -17.24 35.06 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.564 -0.614 . . . . 1.0 111.564 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' A' ' 84' ' ' ALA . 40.9 m80 -63.36 -100.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.603 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . 102.3 154.84 25.54 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 p -126.74 149.57 49.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 1.0 111.726 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.3 t -78.21 111.15 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.796 -0.816 . . . . 1.0 108.796 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 65' ' ' VAL . 58.3 t -107.19 -1.04 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.304 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.11 113.23 2.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.025 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 88.4 tt0 -143.12 134.1 25.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.133 0.492 . . . . 1.0 111.816 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.57 139.7 52.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.666 -0.697 . . . . 1.0 109.414 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -135.21 147.72 49.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.861 0.363 . . . . 1.0 110.74 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -51.34 -36.86 38.22 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 168.76 -160.26 33.67 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -65.08 4.31 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.312 . . . . 1.0 110.527 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 71' ' ' GLY . 68.0 ttp85 -66.74 -46.8 74.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.165 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.45 HD11 ' NH2' ' A' ' 73' ' ' ARG . 34.7 mt -118.48 116.84 34.92 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.864 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.28 157.07 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.514 2.143 . . . . 1.0 112.183 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 p -96.61 130.21 43.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.925 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 80' ' ' LEU . 44.4 mt -91.29 13.59 16.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.422 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.9 tp -65.62 130.38 43.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.979 -0.555 . . . . 1.0 112.265 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.46 -10.66 72.55 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.54 -0.754 . . . . 1.0 111.498 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 77' ' ' LEU . 76.0 mt -83.82 148.88 26.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.959 -0.296 . . . . 1.0 110.336 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.5 p -105.31 135.58 46.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.655 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.416 ' CD2' HBB2 ' A' ' 203' ' ' CYC . 8.8 m-85 -88.56 151.53 48.2 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.42 138.38 65.25 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.643 2.229 . . . . 1.0 111.863 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 61' ' ' HIS . . . -66.38 128.28 35.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.429 . . . . 1.0 110.7 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.6 -1.6 42.46 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -55.44 -37.42 67.69 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 88' ' ' PRO . 8.5 mm -77.8 113.41 32.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.641 -0.709 . . . . 1.0 109.388 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 87' ' ' ILE . 92.7 Cg_exo -46.8 -176.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.429 2.086 . . . . 1.0 112.48 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.53 -49.34 3.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.502 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 123' ' ' ALA . 88.2 tt0 -66.81 -39.33 87.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.868 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.883 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -68.01 -51.71 43.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.928 0.344 . . . . 1.0 111.928 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.634 ' NH2' ' CE2' ' A' ' 56' ' ' PHE . 64.0 ttt180 -53.31 -39.62 64.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.465 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -62.8 -33.07 74.44 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.758 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.16 -36.43 74.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.304 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.507 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 11.0 m-85 -59.62 -29.88 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.996 0.427 . . . . 1.0 110.028 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -83.28 -25.82 31.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.865 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.6 mt -97.42 -45.42 6.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 114.416 1.265 . . . . 1.0 114.416 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.514 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.83 -6.66 12.65 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.514 ' C ' ' O ' ' A' ' 98' ' ' ALA . 1.1 mm100 41.24 78.28 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.133 -1.027 . . . . 1.0 108.787 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 100' ' ' VAL . 3.8 p 171.42 116.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.115 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.5 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -169.89 130.59 1.01 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.388 . . . . 1.0 110.808 177.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.5 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 3.5 m -147.02 157.55 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.439 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.6 mt -108.52 132.97 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 105' ' ' ASP . 5.6 p -92.54 159.96 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.299 0.851 . . . . 1.0 113.299 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 104' ' ' VAL . 2.2 p30 -45.21 119.65 2.13 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.94 -1.027 . . . . 1.0 112.128 -177.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.458 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.9 p -53.32 -19.74 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.335 -0.848 . . . . 1.0 110.799 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.17 -46.32 84.54 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.404 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . . . -64.64 -13.55 54.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.492 0.663 . . . . 1.0 109.356 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 44.5 70.37 0.34 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.745 -1.116 . . . . 1.0 113.212 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.6 t -74.97 131.17 40.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.968 -1.493 . . . . 1.0 106.968 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -118.89 134.47 55.15 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.974 -0.69 . . . . 1.0 111.859 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.01 148.35 50.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.501 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.503 ' O ' ' NE2' ' A' ' 115' ' ' GLN . 2.7 mt -147.91 167.37 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.126 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.443 ' H ' HG22 ' A' ' 113' ' ' ILE . 53.1 p -64.33 161.04 17.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.634 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 117' ' ' GLU . 4.3 mp0 -135.66 151.99 75.34 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.633 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -36.39 -25.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.573 2.182 . . . . 1.0 112.417 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 115' ' ' GLN . 78.3 mm-40 -128.66 151.43 49.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.428 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.5 p -103.55 -101.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.648 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -51.43 141.58 15.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.517 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 76.99 -169.92 55.07 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 125' ' ' VAL . 69.7 mt 41.5 -95.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 1.0 110.373 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 120' ' ' GLY . 22.7 t -56.68 -39.75 74.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.487 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 124' ' ' ARG . . . -79.69 -2.81 44.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.601 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 123' ' ' ALA . 49.1 ttp180 177.04 75.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.586 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 121' ' ' LEU . 26.2 m -66.61 149.09 98.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.245 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 128' ' ' GLY . 50.9 Cg_exo -37.42 147.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.647 2.231 . . . . 1.0 112.278 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.1 mt 62.48 -76.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.574 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 74.08 161.25 7.47 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.746 -0.942 . . . . 1.0 110.746 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.617 ' H ' ' HD2' ' A' ' 130' ' ' PRO . 1.5 tp10 178.89 -44.78 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.624 0.25 . . . . 1.0 110.852 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.617 ' HD2' ' H ' ' A' ' 129' ' ' GLU . 44.5 Cg_endo -90.49 147.2 4.2 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.182 2.588 . . . . 1.0 111.676 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 133' ' ' ARG . 46.8 mt -93.93 10.22 34.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.358 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -56.52 88.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.852 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 131' ' ' LEU . 92.8 mtt-85 -129.37 82.17 68.47 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.517 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.01 148.86 3.76 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.717 2.278 . . . . 1.0 111.957 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.402 ' HA ' HMD1 ' A' ' 203' ' ' CYC . 0.5 OUTLIER -98.69 115.2 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.871 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.492 ' OD2' HMD3 ' A' ' 203' ' ' CYC . 6.7 m-20 -43.58 139.01 2.79 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -40.51 -44.57 4.4 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 123.255 2.637 . . . . 1.0 114.014 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.738 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.9 p -40.74 -48.6 3.02 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.733 0.272 . . . . 1.0 111.733 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.738 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 15.2 t-80 -81.12 -27.2 35.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.278 0.473 . . . . 1.0 112.278 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.458 ' CG1' HG23 ' A' ' 106' ' ' VAL . 43.6 t -64.23 -53.21 46.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.636 -0.425 . . . . 1.0 111.023 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -65.7 -29.09 69.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.75 -43.46 94.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 1.0 109.737 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 146' ' ' MET . 9.3 mt -72.7 -39.21 67.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -50.82 -38.82 51.0 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 177.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.1 m -65.88 -24.53 66.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.847 -1.069 . . . . 1.0 109.171 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.8 mmm -92.4 -2.03 56.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.682 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.11 19.65 78.61 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.5 t -106.88 143.92 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 1.0 111.061 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.69 -43.91 3.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.993 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -134.35 121.0 20.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.198 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.3 t -111.99 142.98 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.402 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 tp -116.44 139.52 50.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.267 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.5 HG21 HAA1 ' A' ' 203' ' ' CYC . 1.5 t -128.81 120.35 52.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.167 0.508 . . . . 1.0 111.745 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.1 t -126.09 120.0 23.82 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.49 ' C ' HD12 ' A' ' 156' ' ' LEU . 98.6 Cg_endo -72.63 124.35 9.72 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.243 2.629 . . . . 1.0 114.655 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 156' ' ' LEU . 8.3 mp -102.37 58.98 0.81 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.846 -1.539 . . . . 1.0 106.846 177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.406 ' N ' ' OG ' ' A' ' 192' ' ' SER . 6.0 ptt? -147.95 -170.15 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.076 0.769 . . . . 1.0 113.076 -176.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.676 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 26.5 t-80 -80.52 -179.56 7.24 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.424 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.676 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 60.0 t60 -74.79 -54.06 8.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.392 -0.822 . . . . 1.0 112.093 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -103.66 13.35 33.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.04 0.385 . . . . 1.0 112.04 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -146.39 140.21 26.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.714 -0.395 . . . . 1.0 110.904 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.487 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -112.61 119.68 38.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.267 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -92.43 -35.53 13.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.306 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -163.88 -178.02 37.13 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.208 -0.757 . . . . 1.0 111.208 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' TYR . 87.5 mt -138.4 133.4 32.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.841 0.353 . . . . 1.0 111.551 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.5 tp -102.33 133.97 46.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.87 135.14 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.089 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.0 m -109.56 139.17 44.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.003 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.429 ' O ' ' CG2' ' A' ' 48' ' ' THR . 48.5 m80 -108.2 119.29 39.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.674 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.515 ' CD2' HG23 ' A' ' 48' ' ' THR . 72.9 m80 -120.59 113.83 20.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 1.0 109.952 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.2 -16.08 61.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.841 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.99 138.01 72.82 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.013 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.94 10.82 2.19 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.978 2.452 . . . . 1.0 111.919 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -68.76 148.43 98.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.846 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.2 161.92 41.86 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.512 2.141 . . . . 1.0 111.939 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 44.0 p90 -74.87 133.6 41.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.465 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.8 m -112.51 147.91 35.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.69 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -59.88 -28.39 67.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.616 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -55.51 -44.12 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.693 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.3 -36.46 83.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.473 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.4 tp -62.23 -42.16 99.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.516 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.84 -33.74 64.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 1.0 111.371 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.34 -56.86 11.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 188' ' ' ALA . 13.5 m -78.7 -30.61 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.435 0.531 . . . . 1.0 112.435 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -51.06 -54.19 27.05 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.614 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 24.4 tp -75.14 -39.24 60.6 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 191' ' ' VAL . 6.2 tp -76.46 -41.47 47.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.891 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -57.19 -39.8 76.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.519 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -58.29 -39.22 78.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.012 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -66.21 -28.39 68.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.132 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 187' ' ' LEU . 16.3 t -82.98 -44.57 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.782 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.406 ' OG ' ' N ' ' A' ' 157' ' ' MET . 1.5 t -53.71 -29.64 40.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.671 -0.862 . . . . 1.0 108.671 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.1 mm -77.19 -33.46 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.465 -0.789 . . . . 1.0 109.268 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.69 -47.81 44.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.893 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.1 pp -65.53 -37.17 79.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.142 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -72.01 -47.01 55.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.134 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -71.53 -36.0 70.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.519 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.59 74.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.645 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -59.35 -32.49 70.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.483 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.668 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.8 mp -61.32 -33.68 74.0 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.025 -0.27 . . . . 1.0 111.029 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -51.52 -53.66 35.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.571 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.543 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.883 HBD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.867 0.365 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -77.64 -29.34 51.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -77.87 -45.93 22.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.139 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 34' ' ' ILE . 12.3 pt -64.23 -38.66 83.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.46 -0.337 . . . . 1.0 110.884 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 40.3 mt -61.17 -50.64 72.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.033 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -53.81 -38.23 64.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.27 -29.96 66.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.043 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 42' ' ' VAL . 28.3 m -74.17 -45.32 49.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.509 -0.768 . . . . 1.0 112.269 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.629 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.9 p -67.77 -34.53 68.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -67.45 -46.14 73.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.85 0.357 . . . . 1.0 111.173 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -64.42 -41.09 96.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.783 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 38' ' ' THR . 79.6 t -61.19 -43.19 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.1 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLY . 66.8 ttp85 -55.03 -41.03 70.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 1.0 110.824 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.23 -36.55 73.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.026 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -79.37 -42.35 25.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.56 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mt -85.39 -32.52 22.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.466 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 61.81 20.31 59.57 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.474 -1.05 . . . . 1.0 110.474 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.447 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 69.7 m -73.1 141.18 47.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 1.0 110.132 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -40.03 -45.1 1.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 1.0 111.634 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.667 ' HE ' ' CE1' ' A' ' 169' ' ' HIS . 56.9 ttp180 -162.68 130.89 3.91 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.06 -0.656 . . . . 1.0 112.596 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.24 129.82 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' HZ1' HG11 ' A' ' 167' ' ' VAL . 24.8 pttm -141.69 152.86 44.27 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.912 -177.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.6 t -102.32 134.86 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.563 -0.902 . . . . 1.0 108.563 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.488 ' OH ' ' O ' ' A' ' 61' ' ' HIS . 52.1 t80 -120.89 126.29 49.64 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.299 -0.561 . . . . 1.0 111.293 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 163' ' ' TRP . 18.2 tpt85 -87.23 124.76 33.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.276 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -88.76 119.84 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.326 -0.397 . . . . 1.0 112.023 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.87 151.9 43.98 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.87 -21.84 59.53 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.491 2.127 . . . . 1.0 112.493 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -82.23 -15.59 52.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.378 . . . . 1.0 110.032 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.39 -15.79 49.67 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.489 -0.644 . . . . 1.0 111.489 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.488 ' O ' ' OH ' ' A' ' 54' ' ' TYR . 84.8 m-70 -64.09 -104.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.934 -0.307 . . . . 1.0 110.62 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . 102.61 155.95 25.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 p -127.58 151.07 49.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.935 0.398 . . . . 1.0 111.688 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.82 108.38 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.53 -0.76 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.314 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.629 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -160.09 113.02 2.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.099 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 87.6 tt0 -144.28 132.59 21.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.146 0.498 . . . . 1.0 111.798 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -131.16 140.97 50.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.413 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ptt-85 -142.91 150.1 39.34 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.02 -121.8 0.01 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.856 -0.898 . . . . 1.0 110.856 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -81.01 -175.94 50.39 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.1 pm0 -73.09 45.46 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.777 0.322 . . . . 1.0 110.488 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 71' ' ' GLY . 15.4 tpt180 -84.31 -47.84 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.175 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 23.3 mt -116.64 146.71 38.23 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.168 -0.469 . . . . 1.0 109.878 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.59 163.23 38.92 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.459 2.106 . . . . 1.0 112.218 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -92.79 130.68 38.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.958 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 80' ' ' LEU . 29.7 mt -95.85 12.73 29.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.429 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 18.8 tp -70.89 131.12 43.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.284 0.564 . . . . 1.0 112.261 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.84 -8.8 78.67 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.608 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 77' ' ' LEU . 74.6 mt -87.01 151.97 22.79 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.325 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.2 p -105.18 134.27 48.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.675 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.717 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 8.6 m-85 -89.65 151.24 45.55 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.94 135.87 36.46 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.681 2.254 . . . . 1.0 111.884 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . . . -66.12 136.77 56.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.71 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.29 -3.47 40.41 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.528 -1.029 . . . . 1.0 110.528 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -52.35 -40.78 62.39 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.1 mt -80.99 133.23 54.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.445 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.719 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 85.9 Cg_endo -74.89 -161.97 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.385 2.057 . . . . 1.0 112.513 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.02 -57.99 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.584 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -60.18 -45.76 92.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.8 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.719 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -65.1 -44.61 88.24 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -58.69 -34.99 71.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.459 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -63.71 -34.4 77.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.766 0.317 . . . . 1.0 110.805 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' ALA . 11.9 mt -65.31 -34.16 77.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.297 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.404 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 17.7 m-85 -64.24 -55.13 23.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.014 0.435 . . . . 1.0 110.01 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 159' ' ' HIS . 79.5 ttt180 -48.04 -33.92 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.843 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 mt -100.69 -37.91 8.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.04 -16.48 11.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -173.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.547 ' NE2' ' CB ' ' A' ' 155' ' ' PRO . 15.0 mm100 38.06 77.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.205 -0.998 . . . . 1.0 108.826 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 100' ' ' VAL . 3.8 p 176.35 113.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.101 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -175.31 141.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 1.0 110.737 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.0 161.51 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.542 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.436 HD11 ' NE2' ' A' ' 139' ' ' HIS . 20.2 mt -104.37 137.5 33.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 105' ' ' ASP . 14.7 t -88.2 157.91 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 113.294 0.85 . . . . 1.0 113.294 -176.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.462 ' N ' HG12 ' A' ' 104' ' ' VAL . 78.6 m-20 -47.16 121.29 3.65 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.974 -1.012 . . . . 1.0 112.082 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.6 p -57.14 -25.15 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.371 -0.832 . . . . 1.0 110.762 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -64.85 -45.5 85.81 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.93 -11.38 27.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.479 0.657 . . . . 1.0 109.326 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.1 tp60 45.94 70.26 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.801 -1.091 . . . . 1.0 113.308 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -74.43 131.85 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.903 -1.517 . . . . 1.0 106.903 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -120.27 137.12 54.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.023 -0.671 . . . . 1.0 111.931 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.538 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -139.36 162.76 34.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.705 -0.679 . . . . 1.0 110.538 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.535 ' C ' ' H ' ' A' ' 115' ' ' GLN . 30.0 pt -126.15 141.93 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.105 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 81.0 p -52.74 -4.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.692 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 113' ' ' ILE . 23.6 mt-30 -121.81 76.29 38.06 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.646 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.58 -23.16 3.46 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.657 2.238 . . . . 1.0 112.36 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 55.41 39.94 31.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.418 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.0 m -125.88 143.59 51.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.709 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -144.43 156.07 44.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.601 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -122.1 116.46 3.07 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.982 -0.847 . . . . 1.0 110.982 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.805 HD12 ' N ' ' A' ' 121' ' ' LEU . 5.7 mp -90.48 -133.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.72 0.295 . . . . 1.0 110.379 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.2 t -63.68 -51.52 64.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.14 -28.93 62.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.637 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 64.82 153.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.56 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.691 ' O ' HG13 ' A' ' 125' ' ' VAL . 7.3 p -114.31 87.64 13.95 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.27 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 128' ' ' GLY . 85.9 Cg_endo -83.06 157.56 15.29 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.556 2.17 . . . . 1.0 112.306 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 127' ' ' LEU . 11.1 mp 42.49 -97.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.556 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 66.49 -67.64 0.16 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 127' ' ' LEU . 8.3 mm-40 -51.49 153.0 4.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 121.174 -0.211 . . . . 1.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.83 -26.28 3.76 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.088 2.525 . . . . 1.0 111.598 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -88.54 2.48 52.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.415 179.673 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 131' ' ' LEU . 74.2 mt-30 71.21 64.28 0.16 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.853 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 129' ' ' GLU . 90.2 mtm180 55.03 82.33 0.24 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.577 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.73 144.02 96.81 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.714 2.276 . . . . 1.0 111.958 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.54 126.0 59.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.844 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.538 ' N ' ' OG ' ' A' ' 112' ' ' SER . 26.4 t70 -46.05 131.07 7.26 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.442 ' HD3' ' H ' ' A' ' 112' ' ' SER . 59.5 Cg_exo -41.61 -47.11 6.1 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.194 2.596 . . . . 1.0 114.041 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.698 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.8 p -37.35 -46.4 0.76 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.723 0.268 . . . . 1.0 111.723 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.698 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 4.4 t60 -82.29 -30.43 30.58 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.2 t -67.73 -50.9 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.963 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -66.0 -29.18 69.51 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -60.03 -42.13 93.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.714 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' MET . 8.4 mt -73.49 -38.15 65.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -51.92 -39.17 58.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 t -63.69 -24.04 67.62 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.76 -1.109 . . . . 1.0 109.16 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -92.26 4.37 53.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.423 -0.808 . . . . 1.0 110.671 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.06 21.04 79.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.29 142.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 1.0 111.097 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.66 -23.2 12.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.964 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.4 m -141.96 160.52 40.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.202 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.73 121.01 9.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.496 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.7 mp -109.95 132.6 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.258 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.548 HG21 HAA2 ' A' ' 203' ' ' CYC . 16.8 t -123.21 119.4 57.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.175 0.512 . . . . 1.0 111.775 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.6 t -131.65 92.47 30.94 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.79 -1.189 . . . . 1.0 107.79 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.547 ' CB ' ' NE2' ' A' ' 99' ' ' GLN . 83.4 Cg_exo -47.04 150.37 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.203 2.602 . . . . 1.0 114.616 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.575 ' H ' ' HE2' ' A' ' 157' ' ' MET . 33.9 mt -124.88 54.5 1.41 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.868 -1.53 . . . . 1.0 106.868 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.575 ' HE2' ' H ' ' A' ' 156' ' ' LEU . 7.5 ptp -148.56 -167.94 2.96 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.141 0.793 . . . . 1.0 113.141 -175.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.437 ' HE1' ' CB ' ' A' ' 196' ' ' ALA . 30.7 m80 -68.83 163.2 24.77 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.342 -0.845 . . . . 1.0 111.408 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 96' ' ' ARG . 80.1 m80 -70.45 -55.36 9.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.44 -0.8 . . . . 1.0 112.042 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -94.98 11.36 32.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.081 0.401 . . . . 1.0 112.081 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -148.12 140.82 24.6 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.93 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.0 mt -113.52 117.14 30.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.304 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.529 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 81.8 m95 -89.22 -26.07 21.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.246 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.485 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -163.58 -160.85 11.96 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.177 -0.769 . . . . 1.0 111.177 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 13.3 tp -150.37 124.27 9.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 1.0 111.506 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.499 ' O ' HG13 ' A' ' 153' ' ' VAL . 7.3 tp -99.71 129.29 45.82 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.468 HG11 ' HZ1' ' A' ' 52' ' ' LYS . 13.0 p -139.5 134.14 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.077 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.2 p -106.99 141.99 37.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.991 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.667 ' CE1' ' HE ' ' A' ' 50' ' ' ARG . 24.1 m80 -112.75 126.21 55.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.978 0.418 . . . . 1.0 111.689 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -126.12 113.84 17.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.955 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.4 -15.08 63.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.779 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -117.65 151.03 47.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.99 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.48 132.05 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.895 2.397 . . . . 1.0 111.895 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 53.3 ttt85 -157.87 95.02 2.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.895 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.48 161.24 25.39 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.531 2.154 . . . . 1.0 111.916 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 44.0 p90 -91.17 123.79 34.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.441 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 52.3 m -123.75 164.56 18.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.619 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -50.74 -38.38 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.582 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -67.84 -37.45 81.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.756 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -61.46 -49.92 74.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.573 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 185' ' ' GLN . 43.1 mt -64.28 -34.2 77.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.476 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -54.05 -42.13 68.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 88.1 t -69.45 -57.31 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.773 0.656 . . . . 1.0 112.773 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 188' ' ' ALA . 35.3 t -74.11 -46.29 45.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.395 0.517 . . . . 1.0 112.395 -177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.416 ' CB ' ' O ' ' A' ' 181' ' ' LEU . 63.3 tt0 -42.74 -47.74 5.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.59 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.5 tp -72.36 -41.49 66.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.461 -0.336 . . . . 1.0 111.894 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 191' ' ' VAL . 40.5 tp -77.11 -41.84 40.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.818 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.571 ' HB1' ' CD2' ' A' ' 156' ' ' LEU . . . -55.05 -39.55 69.3 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.506 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -61.66 -38.14 86.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.007 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.14 -30.58 71.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.076 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 187' ' ' LEU . 13.0 t -83.8 -42.58 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.756 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.0 p -55.16 -32.85 62.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.5 mt -69.03 -37.34 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.203 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.96 -39.95 83.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.626 -0.715 . . . . 1.0 109.779 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.435 ' HA ' HD13 ' A' ' 195' ' ' ILE . 36.5 mm -61.04 -46.48 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.123 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.437 ' CB ' ' HE1' ' A' ' 158' ' ' HIS . . . -70.69 -47.24 60.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.1 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -65.48 -41.51 93.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.0 111.492 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.02 70.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.675 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.17 -40.95 97.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.509 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.52 -35.68 80.17 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.007 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.5 t -52.42 -52.22 55.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 1.0 110.595 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.583 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.788 HBA1 ' HHA' ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.6 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.902 0.382 . . . . 1.0 110.578 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 66.5 t0 -49.05 -34.99 14.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -77.29 -47.44 20.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.069 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.44 -42.44 93.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 1.0 110.977 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -56.87 -45.02 82.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.099 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -53.22 -38.69 63.16 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.56 71.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.055 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -69.08 -45.7 69.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.547 -0.752 . . . . 1.0 112.227 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.688 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.6 p -71.28 -35.26 57.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.995 0.368 . . . . 1.0 111.995 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 43' ' ' ARG . 43.4 tp10 -70.17 -35.7 74.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.776 0.322 . . . . 1.0 111.06 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -80.46 -53.54 6.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 1.0 111.755 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.55 HG13 ' N ' ' A' ' 43' ' ' ARG . 9.6 p -55.08 -44.08 72.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.744 0.306 . . . . 1.0 111.118 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.55 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.6 ppt_? -56.21 -41.7 76.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.85 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.17 -33.91 59.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.022 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -79.61 -36.2 38.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 1.0 111.581 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -85.34 -30.64 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.501 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 59.33 19.29 46.3 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 93.3 m -72.24 140.77 48.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.792 0.33 . . . . 1.0 110.234 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -39.72 -50.43 2.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.623 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.467 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 59.6 ttp180 -157.97 130.56 7.25 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.018 -0.673 . . . . 1.0 112.591 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.95 131.06 36.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -139.62 155.24 47.55 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.9 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 89.5 t -106.03 138.91 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 177.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.59 ' CE2' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -139.23 131.45 28.22 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.323 -0.551 . . . . 1.0 111.284 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -92.74 145.46 24.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.275 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.469 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 85.6 t80 -96.46 122.13 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 1.0 112.04 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -87.73 164.68 33.51 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 178.317 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.25 -25.83 15.29 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.521 2.147 . . . . 1.0 112.522 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.94 -15.37 54.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 1.0 110.096 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.37 -17.22 37.31 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.514 -0.635 . . . . 1.0 111.514 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -67.21 101.85 0.97 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.909 -0.316 . . . . 1.0 110.592 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.61 134.89 12.64 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.562 -1.015 . . . . 1.0 110.562 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.6 p -122.24 142.23 50.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 1.0 111.665 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.4 p -89.77 120.53 38.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 65' ' ' VAL . 10.9 t -110.41 5.84 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 1.0 111.356 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.08 118.36 3.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.126 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -143.67 135.91 26.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.073 0.463 . . . . 1.0 111.816 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.92 146.96 52.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.434 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -141.15 145.99 36.42 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.755 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.47 -32.81 46.16 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.881 -0.887 . . . . 1.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 176.63 -161.64 29.75 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -73.94 25.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.339 . . . . 1.0 110.523 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.507 ' H ' ' C ' ' A' ' 71' ' ' GLY . 43.1 mtm180 -77.47 -47.14 20.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.082 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.7 mt -113.04 145.56 33.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 1.0 109.921 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -70.93 160.31 49.77 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.516 2.144 . . . . 1.0 112.148 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.1 p -93.31 128.13 39.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.864 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.537 ' HA ' HD12 ' A' ' 80' ' ' LEU . 18.9 mt -94.44 6.4 48.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.372 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 tp -61.34 128.83 38.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.3 0.572 . . . . 1.0 112.246 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.45 -13.83 62.81 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.514 -0.767 . . . . 1.0 111.526 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 77' ' ' LEU . 76.3 mt -81.29 150.55 28.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.296 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -106.86 133.85 50.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.652 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.585 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 9.9 m-85 -87.02 133.28 39.48 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -41.15 132.87 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.633 2.222 . . . . 1.0 111.895 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.91 128.33 35.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 1.0 110.738 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.27 0.63 44.2 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.529 -1.028 . . . . 1.0 110.529 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -58.71 -33.11 69.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.457 HD11 ' OH ' ' A' ' 54' ' ' TYR . 8.4 mt -78.99 132.8 62.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.69 -0.687 . . . . 1.0 109.49 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.716 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 91.0 Cg_endo -73.74 -171.99 0.99 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.452 2.102 . . . . 1.0 112.479 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -106.43 -55.07 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.546 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -63.21 -42.27 99.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.813 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.716 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.77 -44.32 77.72 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.928 0.344 . . . . 1.0 111.928 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -64.11 -39.64 94.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.47 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -60.6 -32.13 71.26 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.762 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.564 HD11 HH22 ' A' ' 133' ' ' ARG . 96.5 mt -70.1 -28.14 65.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.905 0.383 . . . . 1.0 110.341 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.653 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 0.8 OUTLIER -65.33 -54.25 31.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.036 178.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.99 -31.69 65.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.878 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.3 mt -99.41 -44.51 6.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 114.357 1.243 . . . . 1.0 114.357 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -113.55 -12.51 12.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.112 1.523 . . . . 1.0 115.112 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.653 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 18.2 mm-40 45.34 86.73 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.198 -1.001 . . . . 1.0 108.75 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 100' ' ' VAL . 2.5 p 177.54 99.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.12 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 102' ' ' VAL . 9.8 mmp_? -139.49 133.24 30.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.998 0.428 . . . . 1.0 110.737 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 101' ' ' ARG . 71.3 t -161.4 141.81 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.536 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.15 133.65 53.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.515 HG21 ' OG ' ' A' ' 110' ' ' SER . 5.0 m -91.89 164.97 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.318 0.858 . . . . 1.0 113.318 -176.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 20.0 p30 -46.89 118.54 2.1 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.003 -0.999 . . . . 1.0 112.098 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.98 -22.2 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.311 -0.859 . . . . 1.0 110.801 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -67.83 -43.56 79.29 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.55 -11.75 12.44 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.525 0.678 . . . . 1.0 109.389 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 45.54 61.45 2.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.779 -1.1 . . . . 1.0 113.335 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.515 ' OG ' HG21 ' A' ' 104' ' ' VAL . 13.2 m -76.26 133.23 40.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 175.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -119.82 140.29 51.02 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.926 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.8 135.19 54.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.496 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 114' ' ' SER . 89.3 mt -136.86 165.95 27.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.185 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.614 ' N ' HG22 ' A' ' 113' ' ' ILE . 52.2 p -52.28 156.92 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 117' ' ' GLU . 81.6 mm-40 -137.86 79.04 34.56 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.647 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -39.0 85.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.709 2.273 . . . . 1.0 112.363 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 115' ' ' GLN . 84.7 tt0 -171.95 134.79 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.458 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.1 p -76.07 157.0 33.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.681 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -153.44 168.51 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.601 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.79 -100.94 0.19 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 124' ' ' ARG . 23.0 mt 54.76 50.79 14.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 1.0 110.394 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -57.23 -28.89 63.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.534 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.85 -31.66 66.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.512 . . . . 1.0 110.657 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 121' ' ' LEU . 75.8 mtp180 -131.96 140.29 48.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.575 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 125' ' ' VAL . 5.5 m -75.2 139.24 72.15 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.296 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.15 83.36 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.558 2.172 . . . . 1.0 112.322 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.8 mt -92.68 -0.8 57.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.585 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.81 10.81 73.78 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.829 -0.908 . . . . 1.0 110.829 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -67.86 136.21 92.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.617 0.246 . . . . 1.0 110.913 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -37.05 151.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 123.164 2.576 . . . . 1.0 111.626 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.59 -24.17 67.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.362 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -130.99 135.84 47.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.898 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.564 HH22 HD11 ' A' ' 94' ' ' LEU . 17.6 mmm-85 -124.16 94.27 45.58 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.56 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -45.41 145.87 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.674 2.249 . . . . 1.0 111.93 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 p -100.37 119.98 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.811 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.743 ' CG ' HMD2 ' A' ' 203' ' ' CYC . 49.7 p-10 -43.77 134.1 3.85 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.738 -0.468 . . . . 1.0 109.738 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -42.49 -16.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.095 2.53 . . . . 1.0 114.067 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.743 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -71.55 -48.38 48.91 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.713 0.264 . . . . 1.0 111.713 -176.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.743 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 35.7 t-80 -82.97 -28.24 29.91 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.279 0.474 . . . . 1.0 112.279 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 2.6 p -66.45 -43.76 90.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.004 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.523 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 79.2 t60 -69.86 -30.35 67.8 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -59.82 -42.21 93.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.76 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 146' ' ' MET . 29.8 mt -74.36 -36.14 63.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -52.41 -39.32 60.81 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.7 p -65.08 -18.91 65.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.786 -1.097 . . . . 1.0 109.16 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.2 mmm -96.15 1.14 52.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.12 22.89 78.62 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.944 -0.863 . . . . 1.0 110.944 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.33 142.98 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 1.0 111.006 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.65 -39.76 5.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.964 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.7 t -135.96 126.44 26.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.199 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.4 m -113.91 140.78 48.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.428 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.96 138.48 53.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.262 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.568 HG21 HAA1 ' A' ' 203' ' ' CYC . 2.8 t -128.3 119.45 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.167 0.508 . . . . 1.0 111.732 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.6 124.52 21.91 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.735 -1.209 . . . . 1.0 107.735 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.47 ' O ' HD23 ' A' ' 156' ' ' LEU . 85.4 Cg_endo -71.97 144.27 42.54 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 123.175 2.584 . . . . 1.0 114.678 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.571 ' CD2' ' HB1' ' A' ' 188' ' ' ALA . 11.3 mt -125.14 47.46 2.16 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.561 ' CE ' ' O ' ' A' ' 164' ' ' GLY . 4.4 ptp -147.36 -167.38 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.104 0.779 . . . . 1.0 113.104 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -68.71 159.24 32.58 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.45 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -60.63 -50.11 74.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.414 -0.812 . . . . 1.0 112.107 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -97.74 -42.75 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.06 0.393 . . . . 1.0 112.06 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.473 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 85.2 tt0 -86.27 134.3 33.76 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.87 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 19.1 mt -109.17 115.58 30.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.215 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.473 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 77.8 m95 -88.85 -31.42 18.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.278 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.813 ' C ' HD12 ' A' ' 165' ' ' LEU . . . -169.97 -166.95 29.76 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.229 -0.748 . . . . 1.0 111.229 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.813 HD12 ' C ' ' A' ' 164' ' ' GLY . 5.8 mp -148.65 136.37 20.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 1.0 111.506 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.4 tp -98.58 134.92 40.86 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 167' ' ' VAL . 8.4 p -138.5 127.41 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.695 -0.402 . . . . 1.0 111.097 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.2 p -104.68 137.13 42.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.064 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.467 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 28.4 m80 -105.07 121.24 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.981 0.419 . . . . 1.0 111.601 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -122.1 113.45 19.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.936 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.46 -14.23 61.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.781 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.74 135.14 74.85 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.06 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.01 -4.54 14.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.905 2.404 . . . . 1.0 111.813 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 174' ' ' ARG . 1.0 OUTLIER -54.73 151.34 15.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.845 -179.488 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.65 160.96 46.75 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.53 2.153 . . . . 1.0 111.946 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -81.54 136.64 35.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.483 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -113.03 144.83 41.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.64 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -55.86 -29.32 59.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.537 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -55.82 -37.07 68.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.696 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.01 -37.72 88.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.505 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.0 mp -65.07 -38.94 92.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.48 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.53 -37.98 68.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.371 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.85 -55.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.737 0.643 . . . . 1.0 112.737 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 185' ' ' GLN . 10.9 p -68.38 -38.69 79.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.394 0.516 . . . . 1.0 112.394 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.457 ' N ' HG13 ' A' ' 184' ' ' VAL . 83.7 mt-30 -52.52 -45.22 66.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.644 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 37.2 tp -65.04 -45.52 85.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.873 ' O ' HG23 ' A' ' 191' ' ' VAL . 85.1 mt -78.92 -31.55 45.27 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.571 ' HB1' ' CD2' ' A' ' 156' ' ' LEU . . . -62.88 -44.46 96.06 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.494 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -62.25 -42.23 99.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.067 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -64.12 -27.34 69.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.095 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 187' ' ' LEU . 45.4 t -84.8 -40.86 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.749 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -56.78 -36.11 69.48 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.5 mt -67.58 -38.44 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.228 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -68.02 -40.2 82.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.838 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 195' ' ' ILE . 26.1 mm -59.23 -48.19 87.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.051 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.47 -48.75 47.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.031 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -66.15 -45.77 79.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.525 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -63.42 -32.65 74.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.711 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -57.32 -29.6 64.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.385 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 200' ' ' LEU . 10.0 mp -62.27 -32.88 73.65 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.058 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.0 t -52.15 -55.85 18.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.551 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.6 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.54 179.439 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.743 HMD2 ' CG ' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.806 0.336 . . . . 1.0 110.589 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -53.01 -54.5 34.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.951 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -54.54 -46.95 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.114 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 mm -62.03 -46.99 95.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.826 0.346 . . . . 1.0 110.972 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 34.2 mt -56.46 -45.14 80.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.08 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -53.59 -38.41 63.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.65 -30.33 66.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.124 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 42' ' ' VAL . 24.7 m -73.59 -44.76 56.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.528 -0.76 . . . . 1.0 112.228 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.71 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.4 p -68.56 -35.94 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.96 0.356 . . . . 1.0 111.96 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -67.16 -49.18 65.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 1.0 111.156 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -58.72 -45.26 90.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.683 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 38' ' ' THR . 73.9 t -57.94 -37.32 60.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.686 0.279 . . . . 1.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 47' ' ' GLY . 36.7 ttp180 -52.53 -40.83 62.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.832 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.89 -35.76 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.056 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.11 -46.36 20.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.538 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.6 mt -86.37 -31.59 21.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.494 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.57 22.22 31.22 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.461 -1.056 . . . . 1.0 110.461 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.2 p -74.02 144.96 44.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.332 . . . . 1.0 110.286 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -41.52 -42.01 2.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.617 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.532 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 56.3 ttm-85 -163.26 129.33 3.24 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.123 -0.631 . . . . 1.0 112.636 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.84 130.29 52.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.499 ' HE2' HAB1 ' A' ' 203' ' ' CYC . 23.5 pttm -140.6 154.97 46.68 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.442 -0.503 . . . . 1.0 111.874 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 95.1 t -109.17 138.76 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.496 ' CE2' HD13 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -138.34 133.47 33.01 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.348 -0.541 . . . . 1.0 111.283 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -92.62 145.58 24.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.201 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -95.62 117.73 31.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 1.0 112.089 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.09 149.47 59.02 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.52 -23.15 74.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.58 2.187 . . . . 1.0 112.45 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -86.14 -14.53 43.85 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.057 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.43 -13.13 47.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.469 -0.652 . . . . 1.0 111.469 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -76.0 94.79 3.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.804 0.335 . . . . 1.0 110.608 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.88 143.54 17.61 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -122.18 144.54 48.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.914 0.388 . . . . 1.0 111.638 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -80.51 112.49 18.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.07 3.63 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.276 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.71 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -160.28 119.71 2.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.076 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.532 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 84.8 tt0 -144.84 132.87 21.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.106 0.479 . . . . 1.0 111.847 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.96 148.82 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.336 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.613 ' NH2' ' N ' ' A' ' 76' ' ' SER . 6.8 ptp180 -139.68 142.21 36.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.895 0.379 . . . . 1.0 110.718 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.41 -33.18 86.54 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -171.26 -178.97 42.08 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -73.61 40.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 1.0 110.581 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 71' ' ' GLY . 10.1 tpt180 -83.06 -47.79 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.144 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.402 ' HB2' HH21 ' A' ' 50' ' ' ARG . 13.6 mt -113.36 150.85 43.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.863 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.462 ' C ' ' NH2' ' A' ' 69' ' ' ARG . 58.3 Cg_endo -69.86 160.3 50.19 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.483 2.122 . . . . 1.0 112.131 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.613 ' N ' ' NH2' ' A' ' 69' ' ' ARG . 21.9 t -88.86 129.55 35.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.942 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 80' ' ' LEU . 22.6 mt -98.14 10.22 41.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.383 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.08 132.58 45.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.003 -0.544 . . . . 1.0 112.305 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.13 -10.02 67.57 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.527 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 77' ' ' LEU . 46.8 mt -85.5 154.11 22.0 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.336 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 p -105.37 130.72 53.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.688 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.738 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 8.1 m-85 -84.66 152.67 60.42 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.84 133.94 41.28 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.678 2.252 . . . . 1.0 111.883 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.35 129.14 38.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.67 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.64 0.46 42.91 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -56.42 -35.58 67.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.7 mm -80.16 132.39 59.91 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.66 -0.7 . . . . 1.0 109.434 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.685 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 86.7 Cg_endo -74.39 -167.26 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.398 2.065 . . . . 1.0 112.483 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -107.63 -60.06 1.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.505 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 90' ' ' GLU . 39.6 mp0 -57.95 -44.43 86.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.818 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.685 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -66.88 -44.62 80.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -58.62 -36.26 73.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.477 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -63.81 -32.03 73.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.811 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.1 mt -67.11 -36.36 81.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.295 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.439 ' CZ ' HBA2 ' A' ' 203' ' ' CYC . 24.2 m-85 -57.18 -54.36 47.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.051 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -53.43 -29.81 37.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.838 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.97 -41.37 7.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.413 1.264 . . . . 1.0 114.413 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -120.19 -17.09 8.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 115.031 1.493 . . . . 1.0 115.031 -173.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.793 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.2 OUTLIER 45.15 71.45 0.27 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.123 -1.031 . . . . 1.0 108.847 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 99' ' ' GLN . 2.7 m -164.26 113.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.051 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.474 ' CZ ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -155.68 148.26 23.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.932 0.396 . . . . 1.0 110.774 178.197 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.13 143.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.505 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.7 mt -108.94 135.62 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.09 164.39 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 113.275 0.843 . . . . 1.0 113.275 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -43.98 117.27 1.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.95 -1.023 . . . . 1.0 112.145 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.88 -20.02 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.79 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -66.9 -42.27 85.76 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.09 -10.39 40.0 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.45 0.643 . . . . 1.0 109.408 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 45.26 70.63 0.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.734 -1.121 . . . . 1.0 113.354 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 p -75.35 134.43 40.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.984 -1.488 . . . . 1.0 106.984 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -122.02 139.78 53.28 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.893 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.456 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -130.28 153.51 48.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.571 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 112' ' ' SER . 28.6 pt -154.88 178.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.121 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.7 p -51.49 150.54 3.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.577 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -141.22 153.66 66.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.668 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -36.26 99.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.677 2.251 . . . . 1.0 112.309 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 44.35 -121.89 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.433 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.4 m -129.31 149.6 51.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.65 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -70.51 -61.04 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.589 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.75 -162.77 52.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.5 mt 42.07 73.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 1.0 110.437 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 76.9 p -63.19 -16.42 60.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.511 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.82 -20.46 8.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.736 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -141.96 147.43 36.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.574 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 125' ' ' VAL . 4.2 m -78.78 150.74 76.01 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.289 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.05 152.02 31.13 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.647 2.231 . . . . 1.0 112.32 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 127' ' ' LEU . 8.4 mp -88.07 161.06 17.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.575 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.26 59.23 2.07 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -134.72 78.97 54.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.585 0.231 . . . . 1.0 110.843 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -87.1 -46.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.159 2.573 . . . . 1.0 111.652 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.5 mt -79.08 -0.49 31.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.416 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.529 ' O ' ' C ' ' A' ' 133' ' ' ARG . 61.1 mm-40 63.86 114.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.94 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.529 ' C ' ' O ' ' A' ' 132' ' ' GLN . 23.6 ttm105 29.0 77.38 0.3 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.564 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -81.54 141.71 12.6 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.767 2.311 . . . . 1.0 111.95 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.458 HG12 HBD2 ' A' ' 203' ' ' CYC . 2.7 m -106.49 124.3 61.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.878 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' HA ' ' H ' ' A' ' 112' ' ' SER . 12.5 t70 -43.22 141.97 1.71 Allowed Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.422 ' HA ' HG12 ' A' ' 140' ' ' VAL . 13.2 Cg_endo -49.18 -13.52 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 123.224 2.616 . . . . 1.0 114.073 -177.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.681 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.4 p -75.59 -44.43 43.1 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.746 0.276 . . . . 1.0 111.746 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.681 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.6 t60 -82.9 -32.86 27.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.226 0.454 . . . . 1.0 112.226 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 141' ' ' HIS . 4.3 p -68.76 -45.03 81.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.936 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.534 ' N ' HG13 ' A' ' 140' ' ' VAL . 35.5 m-70 -68.69 -28.97 67.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -60.83 -41.0 94.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.923 -0.581 . . . . 1.0 109.715 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.6 mt -72.86 -36.49 67.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -52.15 -38.73 58.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -64.44 -23.07 67.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.746 -1.115 . . . . 1.0 109.161 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 143' ' ' LEU . 97.1 mmm -92.74 2.15 56.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.727 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.84 79.28 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.3 t -111.93 142.03 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 1.0 111.019 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.92 -26.67 11.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.012 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.2 m -136.45 160.83 37.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.166 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.35 127.72 13.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.44 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 tp -114.92 136.31 53.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.292 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.4 119.62 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.132 0.491 . . . . 1.0 111.793 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.5 HG21 HG21 ' A' ' 184' ' ' VAL . 45.7 t -129.62 91.1 41.71 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 107.862 -1.162 . . . . 1.0 107.862 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.22 151.68 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.175 2.584 . . . . 1.0 114.693 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.5 mt -126.05 63.18 1.24 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.832 -1.544 . . . . 1.0 106.832 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 ptm -146.35 179.61 7.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.163 0.801 . . . . 1.0 113.163 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.582 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 46.1 t-80 -68.07 176.24 2.76 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.394 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.582 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 97.8 m-70 -64.54 -51.64 61.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.401 -0.818 . . . . 1.0 112.082 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.68 -37.79 6.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.064 0.394 . . . . 1.0 112.064 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -87.67 136.29 33.01 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.689 -0.405 . . . . 1.0 110.846 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.498 HD12 ' H ' ' A' ' 162' ' ' LEU . 1.2 mp -108.63 112.14 24.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.317 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -88.27 -37.49 16.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.257 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.571 ' C ' HD12 ' A' ' 165' ' ' LEU . . . -165.71 -175.75 36.5 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 164' ' ' GLY . 5.3 mp -144.17 141.56 30.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 1.0 111.5 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.4 tp -101.07 135.26 42.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 167' ' ' VAL . 12.4 p -138.64 129.68 35.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 1.0 111.078 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.2 m -106.77 139.37 41.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.057 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.469 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 85.7 m-70 -113.76 132.09 55.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.948 0.404 . . . . 1.0 111.667 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.57 125.32 43.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.929 177.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.43 33.63 0.69 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.832 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -161.35 154.38 17.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.029 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.16 112.82 2.18 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.928 2.419 . . . . 1.0 111.84 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -149.16 90.11 4.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.884 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.96 158.42 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.597 2.198 . . . . 1.0 111.905 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.496 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 41.6 p90 -84.79 127.27 34.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.487 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.6 p -121.06 162.37 20.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.581 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.666 ' CD ' ' H ' ' A' ' 178' ' ' GLN . 1.7 pm0 -50.33 -30.47 12.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.648 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -61.87 -36.24 80.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.739 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 184' ' ' VAL . 78.3 mm-40 -66.01 -24.43 66.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.486 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.8 mt -81.33 -33.88 32.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.483 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.45 -43.09 99.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.34 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.638 HG23 ' N ' ' A' ' 184' ' ' VAL . 13.1 m -73.41 -49.16 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.708 0.633 . . . . 1.0 112.708 -177.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.638 ' N ' HG23 ' A' ' 183' ' ' VAL . 27.9 m -70.4 -43.87 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.403 0.52 . . . . 1.0 112.403 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.538 ' N ' HG23 ' A' ' 184' ' ' VAL . 88.5 mt-30 -53.28 -43.43 67.46 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.983 -0.287 . . . . 1.0 111.67 -178.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.73 -49.99 59.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.84 ' O ' HG23 ' A' ' 191' ' ' VAL . 71.2 mt -79.86 -35.07 38.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.795 -177.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 184' ' ' VAL . . . -61.1 -43.38 98.97 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.488 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.58 -42.47 86.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 1.0 109.989 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.63 -28.23 68.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.135 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 187' ' ' LEU . 59.4 t -84.3 -43.71 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.785 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.2 p -57.83 -35.63 71.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.655 -0.868 . . . . 1.0 108.655 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.9 mt -67.84 -35.03 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.207 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.57 76.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.646 -0.707 . . . . 1.0 109.843 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.424 HD11 HD21 ' A' ' 35' ' ' LEU . 5.0 mm -61.38 -47.53 93.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.133 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.8 -48.02 60.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.045 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.68 -41.19 92.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.558 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.05 -31.3 72.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.677 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.72 -31.92 68.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.497 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.628 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.0 mp -60.62 -34.84 74.84 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.932 -0.307 . . . . 1.0 111.095 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.3 m -55.96 -56.14 24.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.58 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.536 179.715 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.738 HBB3 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.6 tp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.795 0.331 . . . . 1.0 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -60.52 -51.95 67.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.048 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -55.89 -45.91 78.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.127 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 mm -61.4 -48.4 89.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.771 0.32 . . . . 1.0 110.877 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.02 -47.74 84.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.012 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -52.45 -39.54 61.21 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.622 -0.431 . . . . 1.0 109.846 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.56 -29.09 65.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.137 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 42' ' ' VAL . 16.8 m -73.25 -45.32 56.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.477 -0.783 . . . . 1.0 112.312 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.705 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.8 p -68.45 -35.3 70.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -177.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -70.6 -42.31 71.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.784 0.326 . . . . 1.0 111.094 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.71 -54.67 24.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.77 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG23 ' N ' ' A' ' 43' ' ' ARG . 34.2 m -52.45 -39.84 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.171 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -52.76 -41.76 64.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 1.0 110.811 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.3 -38.34 79.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.04 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -75.5 -42.82 51.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.603 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.2 mt -85.6 -26.81 25.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.457 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.76 19.95 16.39 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 169' ' ' HIS . 91.3 m -73.01 143.39 47.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.832 0.349 . . . . 1.0 110.192 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -39.34 -55.43 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.668 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.635 HH22 ' CG2' ' A' ' 148' ' ' VAL . 61.2 mtm-85 -148.92 131.8 16.12 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.053 -0.659 . . . . 1.0 112.576 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 38.4 t -132.69 127.64 56.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.521 ' HE2' HAB1 ' A' ' 203' ' ' CYC . 20.4 pttm -141.4 154.92 45.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.13 0.49 . . . . 1.0 111.939 -178.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 61.6 t -115.15 135.56 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.626 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -133.76 120.06 20.05 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.243 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -74.04 140.2 45.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.273 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.629 ' CE1' ' NH2' ' A' ' 92' ' ' ARG . 58.9 t80 -92.91 117.21 29.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 1.0 112.048 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 41.2 p-10 -93.59 141.35 23.74 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.83 -14.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.573 2.182 . . . . 1.0 112.517 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 57' ' ' ASP . 96.3 mt-10 -87.97 -33.86 18.27 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.729 -0.389 . . . . 1.0 110.104 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.41 -10.79 39.37 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.514 -0.634 . . . . 1.0 111.514 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.685 ' O ' ' O ' ' A' ' 62' ' ' GLY . 64.2 m80 -66.54 -42.81 86.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.926 -0.31 . . . . 1.0 110.61 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.685 ' O ' ' O ' ' A' ' 61' ' ' HIS . . . 47.97 155.98 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.659 -0.976 . . . . 1.0 110.659 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 p -124.81 146.25 49.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 1.0 111.711 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.95 106.82 4.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.793 -0.818 . . . . 1.0 108.793 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 65' ' ' VAL . 57.3 t -106.56 -1.85 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.719 0.295 . . . . 1.0 111.375 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.44 118.04 3.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.103 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -144.43 129.0 18.1 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.566 -0.454 . . . . 1.0 111.865 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.21 145.55 49.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.378 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -142.28 142.7 32.59 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.722 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.6 -36.1 83.85 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -163.63 -179.56 38.07 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -73.47 55.13 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 1.0 110.525 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -86.42 -48.88 8.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.131 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.449 HD12 ' CZ ' ' A' ' 50' ' ' ARG . 66.9 mt -119.09 147.77 43.44 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.867 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.9 138.75 45.34 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.517 2.145 . . . . 1.0 112.131 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.1 m -60.43 130.26 45.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.89 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 80' ' ' LEU . 25.7 mt -91.91 7.04 43.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.346 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tp -59.4 129.55 42.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.29 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.55 -12.82 65.73 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.526 -0.761 . . . . 1.0 111.507 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 77' ' ' LEU . 73.5 mt -83.11 153.1 25.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.742 0.306 . . . . 1.0 110.327 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.7 p -107.65 135.06 49.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.646 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.655 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 7.1 m-85 -87.68 154.46 53.28 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.22 124.92 12.75 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.684 2.256 . . . . 1.0 111.847 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.59 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . . . -62.44 137.67 58.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.696 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.87 -2.23 38.64 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -54.6 -38.73 67.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 88' ' ' PRO . 6.1 mm -83.65 111.92 35.85 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.433 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 87' ' ' ILE . 87.9 Cg_exo -51.46 -162.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.486 2.124 . . . . 1.0 112.499 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -107.82 -51.56 2.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.572 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.72 -41.32 92.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.768 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.94 79.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.936 0.346 . . . . 1.0 111.936 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.629 ' NH2' ' CE1' ' A' ' 56' ' ' PHE . 63.2 ttt180 -64.04 -39.15 93.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.519 -0.31 . . . . 1.0 111.457 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -62.3 -34.34 76.4 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.777 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.31 -34.7 75.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.266 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.543 ' CZ ' HD11 ' A' ' 165' ' ' LEU . 2.3 t80 -63.54 -26.36 68.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.99 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.493 HH21 ' CD ' ' A' ' 160' ' ' GLN . 52.3 ttt180 -81.54 -28.32 33.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.786 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.9 mt -98.21 -41.21 8.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.36 -8.13 12.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 115.067 1.506 . . . . 1.0 115.067 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.513 ' OE1' ' O ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER 41.64 83.31 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.221 -0.991 . . . . 1.0 108.818 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 100' ' ' VAL . 2.7 p 174.7 113.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.973 -178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.634 ' O ' HG23 ' A' ' 102' ' ' VAL . 5.0 tpt180 -153.52 139.26 17.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 1.0 110.799 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 101' ' ' ARG . 55.9 t -161.22 145.91 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.547 -178.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.414 HG23 HG11 ' A' ' 135' ' ' VAL . 65.4 mt -110.18 133.76 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.91 165.86 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 113.322 0.86 . . . . 1.0 113.322 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -45.81 119.72 2.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.964 -1.017 . . . . 1.0 112.139 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.478 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.4 p -56.13 -22.11 13.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.221 -0.899 . . . . 1.0 110.792 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -65.6 -44.11 87.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.6 -0.518 . . . . 1.0 109.6 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.93 -11.23 35.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.535 0.683 . . . . 1.0 109.42 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 44.72 71.12 0.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.731 -1.122 . . . . 1.0 113.327 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 p -74.27 132.75 42.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 176.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -118.8 128.96 54.96 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.017 -0.673 . . . . 1.0 111.884 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.77 152.09 44.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.623 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.1 pt -154.21 177.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.117 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 m -56.14 160.98 2.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.691 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -129.59 152.86 80.4 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.667 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.19 -53.67 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.666 2.244 . . . . 1.0 112.351 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 118' ' ' SER . 0.9 OUTLIER -66.88 -40.83 87.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.397 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.508 ' OG ' ' CD2' ' A' ' 119' ' ' TRP . 37.2 t 55.29 156.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.659 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.508 ' CD2' ' OG ' ' A' ' 118' ' ' SER . 2.2 m-90 40.33 -152.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.594 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 70.35 -134.78 24.93 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.4 tp 58.92 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.8 0.333 . . . . 1.0 110.359 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' GLY . 87.0 p -62.18 -29.81 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.494 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.96 95.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.614 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -69.44 -64.28 0.91 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.547 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.19 85.39 51.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.19 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -45.37 154.35 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.556 2.171 . . . . 1.0 112.292 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.3 mt 59.48 59.18 2.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.615 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -150.07 60.94 0.42 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.842 -0.903 . . . . 1.0 110.842 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 129' ' ' GLU . 1.6 pm0 -126.54 76.03 74.11 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.577 0.227 . . . . 1.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -38.09 151.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 123.206 2.604 . . . . 1.0 111.672 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.9 mt -64.24 -14.8 57.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.383 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -79.34 84.86 5.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.895 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.417 HH21 ' CB ' ' A' ' 129' ' ' GLU . 55.0 mtt-85 -120.21 114.62 33.35 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.52 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.13 140.27 13.93 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.713 2.276 . . . . 1.0 112.0 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.414 HG11 HG23 ' A' ' 103' ' ' ILE . 1.3 p -107.91 121.34 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.835 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.648 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 2.8 p-10 -45.13 140.57 3.64 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 138' ' ' CYS . 63.0 Cg_exo -42.63 -50.17 6.03 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.09 2.527 . . . . 1.0 114.047 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.757 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.0 OUTLIER -34.46 -49.26 0.39 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.72 0.267 . . . . 1.0 111.72 -177.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.757 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 20.5 t-80 -81.18 -25.66 36.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.319 0.488 . . . . 1.0 112.319 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.478 ' CG1' HG23 ' A' ' 106' ' ' VAL . 42.1 t -65.88 -51.77 57.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.941 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.417 ' O ' ' OG ' ' A' ' 145' ' ' SER . 58.5 t-80 -63.57 -29.6 70.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.06 -44.32 94.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.694 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 146' ' ' MET . 61.8 mt -73.02 -41.54 64.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -50.63 -39.54 50.61 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 141' ' ' HIS . 2.6 m -62.93 -27.19 69.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.784 -1.098 . . . . 1.0 109.19 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.55 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.2 mmm -89.05 -0.46 57.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.7 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.77 21.5 78.48 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.976 -0.85 . . . . 1.0 110.976 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.635 ' CG2' HH22 ' A' ' 50' ' ' ARG . 47.7 t -109.45 142.25 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 1.0 111.035 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.1 -36.82 6.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.011 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 t -138.71 129.4 26.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.136 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.6 m -114.77 137.25 52.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.41 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tp -117.38 137.89 52.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.284 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 166' ' ' LEU . 2.1 t -126.58 113.77 34.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.082 0.468 . . . . 1.0 111.744 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.495 HG11 ' CG1' ' A' ' 184' ' ' VAL . 40.9 t -111.39 106.94 57.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 107.825 -1.176 . . . . 1.0 107.825 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.33 123.72 2.09 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.16 2.573 . . . . 1.0 114.77 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.434 HD11 ' HB ' ' A' ' 191' ' ' VAL . 9.4 tp -115.93 45.9 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.5 ptm -148.02 -178.36 6.24 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.091 0.775 . . . . 1.0 113.091 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.637 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 48.6 t-80 -69.3 178.64 2.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.306 -0.861 . . . . 1.0 111.411 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.637 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 83.6 t60 -67.89 -51.62 45.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 1.0 112.044 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.493 ' CD ' HH21 ' A' ' 96' ' ' ARG . 16.5 tt0 -105.17 -38.6 6.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.047 0.388 . . . . 1.0 112.047 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.512 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.7 tt0 -90.69 139.17 30.98 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.841 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.68 HD23 ' C ' ' A' ' 162' ' ' LEU . 7.9 tt -107.03 115.39 30.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.357 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.512 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 78.6 m95 -91.75 -41.14 10.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.298 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.79 -173.71 24.75 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.543 HD11 ' CZ ' ' A' ' 95' ' ' PHE . 7.2 tp -144.26 128.13 17.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.332 . . . . 1.0 111.558 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 153' ' ' VAL . 9.4 tp -98.04 129.06 44.9 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 177.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.53 136.7 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.087 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.1 m -111.24 149.65 30.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.053 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.562 ' HD1' HG11 ' A' ' 148' ' ' VAL . 93.1 m-70 -124.6 131.21 53.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.003 0.43 . . . . 1.0 111.603 -177.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.03 114.42 15.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.984 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.94 -15.69 63.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.859 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -112.41 151.27 43.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.993 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.18 92.61 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.891 2.394 . . . . 1.0 111.929 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -120.85 91.27 47.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.901 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.97 152.36 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.533 2.156 . . . . 1.0 111.937 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -109.25 143.53 38.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.444 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.2 t -125.24 171.35 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.607 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -50.89 -30.38 14.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.616 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -63.22 -39.45 94.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.708 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.54 -44.85 93.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.524 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.9 mp -63.92 -36.76 84.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.502 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -54.48 -36.64 64.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.884 -0.598 . . . . 1.0 111.331 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.34 -54.98 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.722 0.638 . . . . 1.0 112.722 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.496 HG12 ' HB2' ' A' ' 188' ' ' ALA . 5.1 t -77.68 -42.17 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -44.31 -45.28 8.64 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.951 -0.299 . . . . 1.0 111.631 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 186' ' ' LEU . 7.4 mp -75.96 -37.79 58.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.92 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 191' ' ' VAL . 6.1 tp -77.65 -41.47 38.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.806 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.496 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -62.13 -39.71 93.49 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.474 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -57.67 -39.6 77.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.294 -0.412 . . . . 1.0 109.924 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -71.8 -24.11 61.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.157 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 187' ' ' LEU . 73.1 t -82.5 -48.92 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 1.0 109.798 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 85.8 p -54.25 -34.19 60.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.9 mt -65.59 -33.85 66.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.161 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 191' ' ' VAL . . . -68.74 -38.12 79.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.575 -0.738 . . . . 1.0 109.8 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.59 -46.46 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.14 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.03 -46.55 61.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.059 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -66.61 -44.54 81.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.515 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.34 -33.25 75.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.299 -0.409 . . . . 1.0 111.674 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -60.42 -32.87 71.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.578 -0.283 . . . . 1.0 111.498 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.61 -34.92 78.88 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.012 -0.275 . . . . 1.0 111.052 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.7 m -55.53 -54.74 40.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.802 0.334 . . . . 1.0 110.65 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.539 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.655 HBB3 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.83 0.348 . . . . 1.0 110.562 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' CG ' ' N ' ' A' ' 33' ' ' GLN . 24.1 p-10 -55.63 -54.46 43.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.967 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.404 ' N ' ' CG ' ' A' ' 32' ' ' ASP . 62.9 tt0 -54.35 -44.84 72.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.124 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.694 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -60.91 -52.89 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.955 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.2 mt -58.71 -48.2 81.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.011 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -53.4 -39.41 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.6 -0.44 . . . . 1.0 109.871 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.5 65.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.042 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 42' ' ' VAL . 21.5 m -73.22 -44.59 59.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.529 -0.76 . . . . 1.0 112.197 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.639 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 4.1 p -69.96 -35.79 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.916 0.339 . . . . 1.0 111.916 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.06 -48.92 61.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.753 0.311 . . . . 1.0 111.096 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -66.94 -50.65 61.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.745 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 38' ' ' THR . 83.1 t -58.38 -42.77 84.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.724 0.297 . . . . 1.0 111.169 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -56.21 -43.11 78.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.811 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.76 -33.53 61.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -77.08 -37.93 53.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.608 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -85.78 -27.8 24.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.446 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.93 20.0 24.65 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.458 -1.057 . . . . 1.0 110.458 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.44 ' OG1' HG23 ' A' ' 51' ' ' VAL . 12.5 p -72.11 142.52 49.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.859 0.361 . . . . 1.0 110.217 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -40.39 -47.5 2.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.664 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.53 ' NH1' ' CE1' ' A' ' 169' ' ' HIS . 54.0 ttp85 -154.02 131.29 11.17 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.029 -0.668 . . . . 1.0 112.629 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.44 HG23 ' OG1' ' A' ' 48' ' ' THR . 48.9 t -135.38 127.36 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -140.94 156.07 46.14 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.478 -0.489 . . . . 1.0 111.967 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.8 t -101.08 140.56 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.437 ' O ' ' N ' ' A' ' 165' ' ' LEU . 55.4 t80 -127.19 111.48 14.02 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.364 -0.534 . . . . 1.0 111.209 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -84.39 133.72 34.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -95.77 125.66 40.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 1.0 112.096 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 60' ' ' GLY . 6.2 m-20 -95.14 138.57 21.96 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.79 -29.11 3.32 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.514 2.142 . . . . 1.0 112.453 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -82.82 -19.71 37.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 1.0 110.03 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.56 -10.91 38.94 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.517 -0.633 . . . . 1.0 111.517 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -82.18 88.26 6.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.63 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.06 154.29 23.6 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.5 p -124.97 148.85 48.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.971 0.415 . . . . 1.0 111.646 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.93 107.9 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 65' ' ' VAL . 60.5 t -106.75 0.16 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.779 0.324 . . . . 1.0 111.413 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.639 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.33 120.44 3.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.5 tt0 -145.46 132.51 20.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 1.0 111.846 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.19 142.42 51.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 1.0 109.406 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -143.09 145.47 32.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.907 0.384 . . . . 1.0 110.76 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.07 -35.03 63.07 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -179.9 -164.49 32.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.037 -0.825 . . . . 1.0 111.037 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -72.42 16.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.309 . . . . 1.0 110.486 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 71' ' ' GLY . 61.5 ttm-85 -66.83 -46.66 74.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.15 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.6 mt -115.19 124.61 29.95 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.87 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.24 154.21 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.535 2.157 . . . . 1.0 112.134 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.7 m -90.13 130.39 36.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.934 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.54 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 23.6 mt -98.48 13.56 31.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.437 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 20.4 tp -71.41 130.42 41.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.224 0.535 . . . . 1.0 112.308 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.18 -10.0 70.54 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.496 -0.774 . . . . 1.0 111.581 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 77' ' ' LEU . 65.7 mt -85.14 153.77 22.45 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.327 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 81' ' ' THR . 14.1 t -107.69 133.5 52.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.658 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -85.55 152.26 57.12 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.57 133.82 38.59 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.625 2.216 . . . . 1.0 111.808 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 131.13 45.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.712 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.89 0.64 42.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 50.9 t0 -53.71 -33.92 57.13 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.3 mt -91.44 110.37 42.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.377 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 87' ' ' ILE . 88.7 Cg_exo -51.47 -155.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.437 2.091 . . . . 1.0 112.448 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -107.11 -59.38 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.493 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.89 -40.27 79.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.369 . . . . 1.0 111.875 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.55 38.48 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.969 0.359 . . . . 1.0 111.969 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -53.85 -35.92 62.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.485 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -65.33 -33.42 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.78 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.72 -36.73 78.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.256 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.647 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 23.7 m-85 -58.19 -30.54 66.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.069 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -83.31 -23.93 32.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.824 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.2 mt -97.93 -47.51 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.56 ' N ' HE21 ' A' ' 99' ' ' GLN . . . -114.62 -12.64 12.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.089 1.514 . . . . 1.0 115.089 -173.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.856 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.0 mm-40 45.6 61.43 2.62 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.164 -1.014 . . . . 1.0 108.813 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 99' ' ' GLN . 3.9 m -165.71 105.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.075 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.457 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 9.9 mmt180 -148.29 150.36 33.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.418 . . . . 1.0 110.742 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -169.09 146.7 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.522 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.1 mt -107.42 135.07 47.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 105' ' ' ASP . 6.0 p -90.65 160.28 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.227 0.825 . . . . 1.0 113.227 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.489 ' N ' HG22 ' A' ' 104' ' ' VAL . 4.3 p30 -45.52 121.0 2.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.881 -1.054 . . . . 1.0 112.209 -177.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 140' ' ' VAL . 9.4 p -57.2 -22.11 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.816 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -62.53 -49.03 76.94 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.413 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . . . -62.65 -8.47 6.62 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.504 0.669 . . . . 1.0 109.391 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 43.89 72.07 0.21 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.77 -1.105 . . . . 1.0 113.35 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.42 131.9 41.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.905 -1.517 . . . . 1.0 106.905 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -119.77 139.53 52.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.962 -0.695 . . . . 1.0 111.884 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -147.91 167.64 24.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.544 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 113' ' ' ILE . 15.8 pt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.133 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo . . . . . 0 N--CA 1.493 1.466 0 CA-C-O 120.729 0.22 . . . . 1.0 111.908 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.5 t -106.96 128.03 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.829 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.547 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER -44.92 148.36 0.99 Allowed Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.16 -33.95 89.89 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.224 2.616 . . . . 1.0 113.988 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.724 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.8 p -48.32 -47.73 36.61 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.74 0.274 . . . . 1.0 111.74 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.724 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 29.4 t-80 -81.5 -29.38 33.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.274 0.472 . . . . 1.0 112.274 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.414 ' CG1' HG23 ' A' ' 106' ' ' VAL . 98.4 t -64.22 -53.7 40.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.928 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -64.34 -28.02 69.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -59.63 -41.08 89.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.868 -0.606 . . . . 1.0 109.759 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 146' ' ' MET . 12.7 mt -73.52 -39.33 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -51.08 -38.87 54.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.5 m -64.44 -24.72 67.72 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.738 -1.119 . . . . 1.0 109.223 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.58 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.4 mmm -92.0 -1.69 57.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.739 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.6 22.0 77.88 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.03 142.39 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 1.0 111.002 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.54 -39.9 5.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.015 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -133.41 125.38 28.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.118 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 m -119.06 138.37 52.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.449 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -116.27 141.13 48.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.29 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.6 t -126.24 122.65 61.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.157 0.503 . . . . 1.0 111.77 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 154' ' ' VAL . 1.4 p -132.46 93.03 26.14 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.836 -1.172 . . . . 1.0 107.836 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.698 ' C ' HD12 ' A' ' 156' ' ' LEU . 87.1 Cg_exo -48.14 150.21 5.31 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.149 2.566 . . . . 1.0 114.648 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 155' ' ' PRO . 10.9 mp -123.08 64.19 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -149.63 -161.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.138 0.792 . . . . 1.0 113.138 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.22 -178.72 5.23 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.315 -0.857 . . . . 1.0 111.397 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -73.8 -55.42 6.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 1.0 112.026 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -103.57 8.6 37.64 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.991 0.367 . . . . 1.0 111.991 -177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -140.6 133.45 29.07 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.877 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.532 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.7 OUTLIER -110.63 119.35 38.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.236 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -93.58 -36.65 12.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.241 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.41 -177.38 37.03 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.7 mp -141.16 138.89 33.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 1.0 111.564 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.512 ' HB2' HD13 ' A' ' 156' ' ' LEU . 6.0 tp -104.98 136.99 43.42 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.24 135.39 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.713 -0.395 . . . . 1.0 111.106 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.5 m -112.04 142.4 44.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.019 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.53 ' CE1' ' NH1' ' A' ' 50' ' ' ARG . 42.3 m80 -114.81 127.42 55.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.029 0.442 . . . . 1.0 111.698 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.533 ' CD2' ' OE2' ' A' ' 172' ' ' GLU . 1.7 t-80 -127.42 121.93 32.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.949 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.47 61.44 5.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.803 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.533 ' OE2' ' CD2' ' A' ' 170' ' ' HIS . 26.3 pt-20 -152.04 142.65 15.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.064 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.39 -0.49 10.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.986 2.457 . . . . 1.0 111.854 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -60.67 147.18 84.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.898 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.15 167.48 25.85 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.545 2.163 . . . . 1.0 111.924 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -86.42 142.44 28.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.42 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.2 m -115.0 150.87 35.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.622 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -60.54 -29.88 69.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.57 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 29.8 mp0 -55.34 -34.33 64.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.769 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -63.66 -37.54 87.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.503 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.56 -37.81 85.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.543 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.5 tm0? -54.49 -39.22 67.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.389 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 83.7 t -67.24 -53.9 28.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 19.2 m -74.58 -29.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -51.61 -45.48 63.22 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.873 -0.331 . . . . 1.0 111.686 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 18.5 tp -76.25 -41.17 49.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.878 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.877 ' O ' HG23 ' A' ' 191' ' ' VAL . 47.5 mt -78.39 -39.71 38.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.816 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.44 -44.45 97.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.472 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -61.53 -38.12 86.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 1.0 109.971 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.43 -26.4 60.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.136 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 187' ' ' LEU . 59.9 t -82.73 -49.61 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.734 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 83.1 p -51.47 -30.27 19.24 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 56.9 mt -76.82 -33.85 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.495 -0.775 . . . . 1.0 109.214 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.61 -45.81 77.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.789 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.404 HD11 ' O ' ' A' ' 156' ' ' LEU . 25.0 pt -63.43 -35.11 71.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.138 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.4 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -69.78 -44.51 69.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 1.0 111.199 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.26 -38.44 75.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 1.0 111.518 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.32 -32.88 74.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.666 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.55 -32.85 70.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.478 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.3 mt -60.68 -32.62 71.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.99 -0.284 . . . . 1.0 111.051 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -53.45 -53.0 57.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.563 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 21.7 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.53 179.594 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.899 0.38 . . . . 1.0 110.59 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -57.29 -52.05 66.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.03 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -55.99 -46.19 78.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.085 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.7 mt -61.61 -53.4 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 1.0 110.91 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.8 mt -53.98 -43.52 70.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.995 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.497 HH12 ' CD2' ' A' ' 78' ' ' LEU . 59.8 ttm-85 -54.02 -35.46 61.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.617 -0.433 . . . . 1.0 109.895 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -36.23 72.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.078 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.8 p -70.83 -42.11 70.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.527 -0.76 . . . . 1.0 112.295 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.708 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p -69.05 -36.52 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.93 0.344 . . . . 1.0 111.93 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -71.6 -40.99 69.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.805 0.336 . . . . 1.0 111.094 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.25 -52.01 65.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.757 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.5 m -56.06 -34.42 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.721 0.296 . . . . 1.0 111.13 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 47' ' ' GLY . 60.9 ttp180 -54.01 -43.08 69.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 1.0 110.81 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.51 76.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.047 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -78.73 -45.63 20.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.611 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.0 mt -86.04 -31.98 21.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.49 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.9 22.6 48.56 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.459 -1.057 . . . . 1.0 110.459 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -73.34 141.99 47.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 1.0 110.229 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -42.12 -43.43 3.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.6 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -158.29 130.53 6.96 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.048 -0.661 . . . . 1.0 112.61 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.48 130.51 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.579 -0.897 . . . . 1.0 108.579 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 166' ' ' LEU . 12.3 pttm -142.08 156.4 45.39 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.453 -0.499 . . . . 1.0 111.871 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 50.6 t -99.99 134.39 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 42.4 t80 -115.59 105.89 13.3 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.335 -0.546 . . . . 1.0 111.306 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -76.68 126.27 30.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.212 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.438 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 68.3 t80 -92.52 136.91 32.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.991 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.438 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 4.8 m-20 -106.57 140.1 20.99 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.31 -28.86 6.22 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.53 2.153 . . . . 1.0 112.45 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -83.31 -17.76 41.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.882 0.373 . . . . 1.0 110.03 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.96 -13.73 41.11 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.574 -0.611 . . . . 1.0 111.574 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -78.15 91.16 4.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.808 0.337 . . . . 1.0 110.613 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.92 152.56 21.06 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.566 -1.014 . . . . 1.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.7 p -125.29 148.17 48.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 1.0 111.727 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -74.41 107.31 4.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.55 -1.58 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.351 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.708 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.94 115.87 3.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.112 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 85.4 tt0 -145.25 131.17 19.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.079 0.466 . . . . 1.0 111.854 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB1' ' HD3' ' A' ' 43' ' ' ARG . . . -130.81 137.47 49.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.409 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -143.33 148.7 36.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.875 0.369 . . . . 1.0 110.718 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.99 -120.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.852 -0.899 . . . . 1.0 110.852 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -78.78 -179.74 51.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.78 43.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 1.0 110.559 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 71' ' ' GLY . 77.6 ttt180 -82.91 -46.72 12.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.177 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 mt -111.68 146.44 34.7 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 1.0 109.84 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.2 160.31 50.01 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.525 2.15 . . . . 1.0 112.132 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 m -89.78 127.42 35.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.941 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 80' ' ' LEU . 28.6 mt -98.28 11.33 38.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.399 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.497 ' CD2' HH12 ' A' ' 36' ' ' ARG . 19.4 tp -72.47 132.76 44.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.012 -0.54 . . . . 1.0 112.306 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.96 -9.72 71.11 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.604 -0.726 . . . . 1.0 111.529 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 77' ' ' LEU . 76.5 mt -86.67 152.96 22.11 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.936 -0.305 . . . . 1.0 110.344 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.6 m -105.26 132.24 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.675 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -86.28 152.25 55.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.45 133.45 37.34 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.653 2.236 . . . . 1.0 111.873 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.78 131.48 46.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.693 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.62 2.12 40.3 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.548 -1.021 . . . . 1.0 110.548 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 54.3 t0 -57.59 -33.46 68.21 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 87' ' ' ILE . 1.6 mp -82.59 127.09 71.8 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.46 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.737 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 89.6 Cg_endo -73.06 -164.86 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.411 2.074 . . . . 1.0 112.54 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -105.87 -58.68 1.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.535 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.19 -45.0 96.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.795 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.06 -40.21 87.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -63.79 -37.77 88.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.424 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -62.05 -36.48 81.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.781 0.324 . . . . 1.0 110.835 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.552 HD12 ' NH2' ' A' ' 101' ' ' ARG . 77.7 mt -69.82 -33.07 71.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.286 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.642 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 2.3 t80 -63.8 -31.42 72.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.003 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.487 ' C ' HE22 ' A' ' 99' ' ' GLN . 74.6 ttt180 -81.87 -27.12 33.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.865 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.85 -42.67 7.85 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 114.356 1.243 . . . . 1.0 114.356 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.74 -6.78 13.84 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -175.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.755 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.4 mm-40 42.58 75.31 0.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.226 -0.99 . . . . 1.0 108.864 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 100' ' ' VAL . 4.1 p 175.79 115.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.023 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.552 ' NH2' HD12 ' A' ' 94' ' ' LEU . 33.7 ttm-85 -159.18 153.25 23.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 1.0 110.758 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.1 p -168.99 148.07 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.504 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 56.2 mt -105.34 134.79 45.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 105' ' ' ASP . 11.2 t -88.53 158.92 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.25 0.833 . . . . 1.0 113.25 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.7 p30 -49.23 121.0 4.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.937 -1.029 . . . . 1.0 112.151 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.448 HG23 ' CG1' ' A' ' 140' ' ' VAL . 9.1 p -56.09 -22.07 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.342 -0.845 . . . . 1.0 110.784 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -61.79 -50.31 72.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.421 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . . . -64.26 -10.53 24.28 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.465 0.65 . . . . 1.0 109.347 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 44.51 70.74 0.31 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.785 -1.098 . . . . 1.0 113.267 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.55 131.99 42.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.965 -1.495 . . . . 1.0 106.965 175.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -121.13 134.89 55.25 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.967 -0.693 . . . . 1.0 111.937 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -128.61 156.23 43.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.63 -0.713 . . . . 1.0 110.529 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 112' ' ' SER . 21.2 pt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.103 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 N--CA 1.492 1.411 0 CA-C-O 120.727 0.22 . . . . 1.0 111.92 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.482 HG23 ' CG2' ' A' ' 140' ' ' VAL . 3.0 m -105.55 125.54 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.927 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -43.71 130.37 3.99 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.44 ' HD3' ' H ' ' A' ' 112' ' ' SER . 49.4 Cg_exo -40.23 -46.28 4.18 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.178 2.585 . . . . 1.0 114.051 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.3 p -38.85 -45.24 1.14 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.688 0.255 . . . . 1.0 111.688 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.677 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 17.5 t60 -81.19 -28.68 34.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.482 ' CG2' HG23 ' A' ' 135' ' ' VAL . 85.8 t -64.87 -54.96 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.939 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -65.14 -28.7 69.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -59.78 -44.72 93.78 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.774 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.631 HD11 ' NE2' ' A' ' 139' ' ' HIS . 69.5 mt -72.96 -38.08 66.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -50.64 -39.27 50.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -63.87 -26.87 68.81 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.729 -1.123 . . . . 1.0 109.165 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.564 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.5 mmm -88.75 -1.27 58.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.452 -0.794 . . . . 1.0 110.709 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.98 22.01 77.5 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.9 t -111.62 140.75 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.905 0.383 . . . . 1.0 110.968 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.47 -40.54 4.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.0 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.6 m -133.4 122.53 23.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.12 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.446 ' OG ' ' CG2' ' A' ' 167' ' ' VAL . 3.7 t -116.75 133.63 55.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.436 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 tt -112.19 137.19 50.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.273 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.3 120.05 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.157 0.503 . . . . 1.0 111.774 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.03 103.74 47.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -40.38 125.91 2.0 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.197 2.598 . . . . 1.0 114.69 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.485 HD11 ' HB ' ' A' ' 191' ' ' VAL . 10.9 tp -113.59 47.53 1.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.861 -1.533 . . . . 1.0 106.861 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.2 ptm -148.59 -174.75 4.69 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.069 0.766 . . . . 1.0 113.069 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.664 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 42.0 t-80 -75.13 -179.33 4.32 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.311 -0.859 . . . . 1.0 111.38 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.664 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 82.2 t60 -75.16 -55.64 5.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.396 -0.82 . . . . 1.0 112.057 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -104.62 9.48 35.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -139.76 137.15 34.84 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.701 -0.399 . . . . 1.0 110.906 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 162' ' ' LEU . 5.7 tt -110.62 113.93 26.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.068 -0.515 . . . . 1.0 111.303 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -90.79 -35.45 14.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.28 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -163.02 -172.95 31.15 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.39 129.01 26.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 1.0 111.562 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 52' ' ' LYS . 37.6 tp -103.54 129.1 50.69 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.446 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 11.5 p -139.14 139.71 39.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.069 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 84.2 p -110.86 140.33 45.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.049 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -111.71 132.3 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.979 0.418 . . . . 1.0 111.601 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -130.1 121.2 25.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 1.0 109.882 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -81.64 55.79 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.808 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -156.77 149.63 18.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.012 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.78 -11.55 31.03 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.907 2.405 . . . . 1.0 111.914 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -39.33 104.17 0.31 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.862 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.81 167.44 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.585 2.19 . . . . 1.0 111.902 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 49.5 p90 -80.09 129.66 34.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.462 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.5 t -111.93 143.0 43.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.635 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -58.04 -27.74 63.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.664 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -57.55 -38.48 74.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.666 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.86 -38.07 89.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.542 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 56.5 mt -64.18 -40.82 96.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.517 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -53.63 -38.21 63.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.33 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.23 -54.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 188' ' ' ALA . 29.3 m -77.34 -29.8 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.404 0.52 . . . . 1.0 112.404 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 189' ' ' ASP . 58.8 tp60 -50.98 -49.9 59.32 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.98 -0.288 . . . . 1.0 111.631 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.6 tp -76.84 -41.33 44.59 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.8 tp -76.75 -43.43 37.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.806 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -60.09 -40.42 89.53 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.511 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 93.5 m-20 -56.52 -38.37 71.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.018 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -71.23 -24.91 62.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.155 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.485 ' HB ' HD11 ' A' ' 156' ' ' LEU . 93.8 t -82.85 -49.01 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 1.0 109.731 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.6 m -51.4 -29.92 17.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 57.9 mt -75.92 -33.28 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.236 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -67.07 -45.41 77.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.825 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 19.0 pt -63.93 -35.53 73.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.149 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -68.78 -43.37 75.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.135 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -70.94 -38.04 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.553 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.21 -32.08 73.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.725 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.92 -39.13 93.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.475 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 200' ' ' LEU . 23.8 tp -62.93 -35.67 80.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.723 0.297 . . . . 1.0 111.119 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.2 t -54.8 -53.68 52.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.612 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.48 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.814 0.34 . . . . 1.0 110.531 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -60.13 -52.7 64.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.985 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -54.9 -45.98 74.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.087 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 mm -61.01 -48.24 89.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 1.0 110.966 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.628 HD21 HD11 ' A' ' 195' ' ' ILE . 35.5 mt -56.95 -42.78 80.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 1.0 111.03 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -52.91 -35.33 58.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.068 0.461 . . . . 1.0 109.869 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.91 -34.34 71.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.06 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 42' ' ' VAL . 62.4 p -72.28 -40.23 67.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.524 -0.762 . . . . 1.0 112.263 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.654 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.3 p -73.57 -38.76 52.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 111.899 0.333 . . . . 1.0 111.899 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.403 ' N ' HG13 ' A' ' 39' ' ' VAL . 99.5 mt-10 -71.2 -45.46 63.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.772 0.32 . . . . 1.0 111.104 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.85 -47.93 70.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.784 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 38' ' ' THR . 72.0 t -60.39 -39.06 79.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.982 -0.287 . . . . 1.0 111.12 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.4 tmm_? -57.25 -42.9 82.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 1.0 110.823 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.82 -33.59 68.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -78.42 -40.67 35.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.542 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.71 -31.2 22.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.448 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 61.7 21.78 61.09 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 169' ' ' HIS . 5.2 t -73.22 139.48 46.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.35 . . . . 1.0 110.17 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -44.57 -38.68 4.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.609 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.556 HH22 ' H ' ' A' ' 77' ' ' LEU . 53.7 ttt85 -161.53 126.24 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.058 -0.657 . . . . 1.0 112.625 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.23 128.31 29.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HD3' ' HE ' ' A' ' 50' ' ' ARG . 20.7 pttp -140.18 155.66 46.84 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.86 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 66.4 t -106.42 137.49 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.473 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -136.62 127.91 28.21 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.252 -0.579 . . . . 1.0 111.288 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -88.03 144.35 26.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.745 -0.662 . . . . 1.0 110.208 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.595 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 80.4 t80 -95.52 117.79 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 1.0 112.027 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.9 m-20 -85.27 135.85 38.56 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -45.83 -24.06 1.92 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.456 2.104 . . . . 1.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.21 -18.48 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.052 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.88 -13.36 38.11 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.583 -0.607 . . . . 1.0 111.583 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -75.07 92.25 2.62 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.642 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.54 142.54 18.0 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 p -121.39 142.75 49.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 1.0 111.751 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.65 110.94 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.748 -0.834 . . . . 1.0 108.748 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.613 ' O ' HG12 ' A' ' 65' ' ' VAL . 95.5 t -106.59 -0.89 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.942 -0.303 . . . . 1.0 111.372 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.97 120.79 3.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.149 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 68.6 tt0 -142.12 131.78 24.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.06 0.457 . . . . 1.0 111.818 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.95 143.11 50.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.375 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.528 ' NH1' ' OG ' ' A' ' 76' ' ' SER . 32.8 ptt180 -142.88 142.44 31.77 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.743 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.44 -33.01 85.04 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.48 -170.92 36.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 77.6 mm-40 -78.25 38.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 1.0 110.556 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -82.83 -48.11 11.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.148 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.46 149.26 36.85 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.826 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.95 146.69 59.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.532 2.155 . . . . 1.0 112.183 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.528 ' OG ' ' NH1' ' A' ' 69' ' ' ARG . 67.2 m -77.28 121.23 23.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.962 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.556 ' H ' HH22 ' A' ' 50' ' ' ARG . 27.5 mt -100.59 12.12 38.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.416 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.2 tp -73.49 132.68 43.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.307 0.575 . . . . 1.0 112.288 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.86 -10.04 63.89 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.505 -0.771 . . . . 1.0 111.546 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 77' ' ' LEU . 64.0 mt -86.43 155.55 20.52 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.001 -0.28 . . . . 1.0 110.329 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.2 p -103.65 126.37 50.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.67 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -77.86 151.8 79.65 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.55 117.7 4.66 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.648 2.232 . . . . 1.0 111.818 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.01 125.09 11.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.677 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.7 0.13 42.59 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.574 -1.011 . . . . 1.0 110.574 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 2.6 p30 -56.76 -32.64 65.8 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.477 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 3.2 tp -84.25 131.05 51.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.384 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.71 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 71.7 Cg_endo -70.19 -169.48 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.427 2.085 . . . . 1.0 112.487 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -107.1 -44.71 4.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.559 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 42.0 mp0 -69.36 -41.15 76.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.796 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.71 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.35 -44.05 79.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.906 0.336 . . . . 1.0 111.906 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.595 ' NH2' ' CG ' ' A' ' 56' ' ' PHE . 51.6 ttt85 -65.23 -44.09 89.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.472 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -61.05 -34.14 74.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.34 . . . . 1.0 110.879 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.514 ' C ' HH22 ' A' ' 101' ' ' ARG . 47.4 mt -71.18 -38.75 72.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.298 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.609 ' N ' ' NH2' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -58.19 -28.51 64.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.061 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -74.91 -29.87 61.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.87 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.587 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 75.5 mt -97.17 -39.4 9.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.573 ' C ' ' NE2' ' A' ' 99' ' ' GLN . . . -118.34 -7.19 10.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.051 1.5 . . . . 1.0 115.051 -176.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.632 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER 38.51 77.4 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.161 -1.015 . . . . 1.0 108.847 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 100' ' ' VAL . 12.9 p 179.32 114.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.108 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.609 ' NH2' ' N ' ' A' ' 95' ' ' PHE . 4.0 tpp180 -156.79 150.84 24.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.954 0.407 . . . . 1.0 110.75 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.32 145.72 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.456 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.7 mt -108.6 131.84 58.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.141 -0.689 . . . . 1.0 109.141 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.1 m -91.66 164.9 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 113.23 0.826 . . . . 1.0 113.23 -176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -48.07 117.24 1.82 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.89 -1.05 . . . . 1.0 112.139 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.44 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.1 p -53.51 -19.34 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.347 -0.842 . . . . 1.0 110.799 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -66.37 -44.69 82.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.97 -4.77 10.43 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.596 0.712 . . . . 1.0 109.414 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 36.6 69.45 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.713 -1.131 . . . . 1.0 113.295 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.3 p -75.22 131.06 40.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.997 -1.482 . . . . 1.0 106.997 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -121.91 142.14 50.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.888 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 t -130.3 122.57 28.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.55 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.191 -178.724 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo . . . . . 0 N--CA 1.492 1.417 0 CA-C-O 120.747 0.228 . . . . 1.0 111.997 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 t -105.84 122.82 59.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.85 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -42.43 152.74 0.33 Allowed Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.746 -0.464 . . . . 1.0 109.746 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -58.89 -34.72 99.21 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.223 2.615 . . . . 1.0 114.068 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.705 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -48.16 -46.31 34.48 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.684 0.253 . . . . 1.0 111.684 -178.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.705 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 19.1 t-80 -82.91 -27.75 30.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.272 0.471 . . . . 1.0 112.272 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.44 ' CG1' HG23 ' A' ' 106' ' ' VAL . 86.4 t -65.2 -52.26 55.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.965 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -66.47 -27.87 68.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -60.02 -41.98 93.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.732 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 146' ' ' MET . 8.9 mt -73.03 -37.83 66.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -51.95 -38.24 55.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.9 p -66.85 -20.66 65.97 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.761 -1.109 . . . . 1.0 109.188 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.568 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -95.43 -0.02 52.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.406 -0.816 . . . . 1.0 110.711 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.61 20.68 78.65 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.69 143.96 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 1.0 110.968 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.66 -42.29 4.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.982 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 t -135.35 122.85 22.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.135 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.6 m -110.99 141.91 43.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.503 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.511 HD13 ' CE1' ' A' ' 176' ' ' TYR . 2.4 tp -118.27 136.35 53.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.292 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.7 t -123.14 114.85 43.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.12 0.486 . . . . 1.0 111.772 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.5 t -113.26 131.2 23.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 107.806 -1.183 . . . . 1.0 107.806 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.75 125.45 8.17 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.152 2.568 . . . . 1.0 114.676 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.2 mt -118.52 48.95 1.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -146.14 176.55 9.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.502 ' ND1' ' N ' ' A' ' 159' ' ' HIS . 49.9 t-80 -67.72 171.68 6.16 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.379 -0.828 . . . . 1.0 111.391 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.502 ' N ' ' ND1' ' A' ' 158' ' ' HIS . 73.5 m80 -61.98 -52.82 62.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.039 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -103.79 -39.32 6.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.541 ' OE1' ' CD2' ' A' ' 163' ' ' TRP . 11.0 tm-20 -87.54 133.55 33.76 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.909 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.567 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.6 OUTLIER -107.2 117.52 34.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 1.0 111.301 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.541 ' CD2' ' OE1' ' A' ' 161' ' ' GLU . 54.2 m95 -92.0 -41.04 10.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.231 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.515 ' C ' HD12 ' A' ' 165' ' ' LEU . . . -163.34 -176.86 35.76 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.204 -0.759 . . . . 1.0 111.204 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 164' ' ' GLY . 5.3 mp -143.87 140.19 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 1.0 111.569 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.5 tp -98.97 135.67 40.06 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 167' ' ' VAL . 10.8 p -138.59 129.11 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.371 . . . . 1.0 111.051 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.5 t -107.6 150.7 26.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.996 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.442 ' O ' ' OG1' ' A' ' 48' ' ' THR . 91.7 m-70 -127.81 134.84 49.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.961 0.41 . . . . 1.0 111.626 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -132.62 113.93 13.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.015 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.78 -14.24 62.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.857 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -108.04 150.0 39.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.01 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.2 140.59 34.35 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.902 2.401 . . . . 1.0 111.896 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -172.31 129.66 0.62 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.898 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.58 157.81 28.55 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.517 2.144 . . . . 1.0 111.932 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.511 ' CE1' HD13 ' A' ' 152' ' ' LEU . 75.7 m-85 -102.2 139.0 38.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.444 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.496 ' N ' ' OE1' ' A' ' 180' ' ' GLU . 8.7 t -126.94 -177.35 4.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.591 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' A' ' 182' ' ' GLN . 95.0 mt-30 -59.98 -34.1 72.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.657 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -56.17 -36.93 68.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.764 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 177' ' ' SER . 40.5 mp0 -65.15 -24.21 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.497 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.6 tp -80.88 -30.53 35.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.497 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.497 ' NE2' ' N ' ' A' ' 182' ' ' GLN . 0.3 OUTLIER -63.28 -43.36 98.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.32 -178.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.67 HG23 ' N ' ' A' ' 184' ' ' VAL . 22.9 m -73.7 -51.56 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.67 ' N ' HG23 ' A' ' 183' ' ' VAL . 16.9 m -68.57 -46.26 80.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.445 0.535 . . . . 1.0 112.445 -177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.6 ' N ' HG23 ' A' ' 184' ' ' VAL . 52.7 tp60 -53.09 -36.62 60.89 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.664 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 186' ' ' LEU . 1.1 tt -74.55 -53.48 9.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.875 ' O ' HG23 ' A' ' 191' ' ' VAL . 71.0 mt -78.91 -39.27 35.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.883 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 184' ' ' VAL . . . -62.18 -45.52 93.04 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.487 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.415 ' OD2' ' NE2' ' A' ' 185' ' ' GLN . 93.0 m-20 -60.01 -40.19 88.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.069 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -69.21 -23.85 63.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.117 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 187' ' ' LEU . 57.9 t -83.79 -45.58 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.041 -0.527 . . . . 1.0 109.775 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.5 p -57.58 -34.59 69.38 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.677 -0.861 . . . . 1.0 108.677 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.8 mt -69.15 -34.3 62.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.394 -0.821 . . . . 1.0 109.156 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.6 -38.03 77.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.783 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.628 HD11 HD21 ' A' ' 35' ' ' LEU . 4.7 mm -64.24 -40.24 88.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.087 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.36 -49.06 53.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.132 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -69.99 -35.98 74.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.492 -178.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.441 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.49 -33.5 74.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.673 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.75 -33.25 72.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.449 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.79 -30.54 71.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.002 -0.279 . . . . 1.0 111.067 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -51.67 -51.99 51.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.551 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 23.7 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.56 179.495 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.847 0.356 . . . . 1.0 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -79.13 -29.73 43.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.942 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -77.41 -47.72 19.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.11 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.507 HG23 ' N ' ' A' ' 35' ' ' LEU . 2.9 tp -61.61 -41.15 89.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.74 0.305 . . . . 1.0 110.859 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.6 ' O ' ' OG1' ' A' ' 38' ' ' THR . 20.2 mt -57.0 -44.43 82.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.089 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -55.35 -33.95 63.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.1 -33.22 69.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.154 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.6 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 82.8 p -72.15 -40.94 67.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.416 -0.811 . . . . 1.0 112.264 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.684 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 8.5 p -71.33 -37.23 64.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.04 -48.17 66.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 1.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.82 -52.69 59.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.687 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 38' ' ' THR . 77.6 t -53.49 -40.72 42.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.953 -0.299 . . . . 1.0 111.153 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.2 tmm_? -53.28 -39.3 63.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.737 0.303 . . . . 1.0 110.816 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.05 74.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.028 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -77.18 -42.22 38.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.578 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.14 -28.32 24.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.459 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.43 20.65 17.44 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.655 HG23 ' CE1' ' A' ' 170' ' ' HIS . 87.5 m -71.73 142.52 49.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 1.0 110.253 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -41.91 -45.53 3.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.596 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.529 HH21 ' CD ' ' A' ' 67' ' ' GLU . 64.0 ttt-85 -159.87 128.14 4.88 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.022 -0.671 . . . . 1.0 112.572 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.48 131.32 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -140.2 156.47 46.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.478 -0.489 . . . . 1.0 111.918 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 63.9 t -110.8 135.69 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -134.39 125.78 28.23 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.358 -0.537 . . . . 1.0 111.339 -178.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -84.17 143.47 29.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.235 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.609 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 72.7 t80 -95.51 119.23 33.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.065 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.43 149.48 52.06 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -60.93 -23.43 77.16 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.51 2.14 . . . . 1.0 112.456 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.5 -11.87 53.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.924 0.392 . . . . 1.0 110.116 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.69 -15.15 53.07 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.547 -0.621 . . . . 1.0 111.547 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.429 ' NE2' ' HB2' ' A' ' 84' ' ' ALA . 45.5 m80 -73.13 94.98 2.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.759 0.314 . . . . 1.0 110.6 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.6 139.59 16.04 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.1 p -120.64 142.14 49.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.862 0.363 . . . . 1.0 111.756 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 t -79.22 110.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.18 0.71 10.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.886 -0.325 . . . . 1.0 111.306 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.684 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.99 117.97 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.035 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.529 ' CD ' HH21 ' A' ' 50' ' ' ARG . 85.8 tt0 -143.58 132.4 22.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.122 0.487 . . . . 1.0 111.784 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.49 143.14 50.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.393 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -141.59 145.78 35.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.784 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -52.39 -34.09 40.93 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 177.31 -161.61 29.19 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.06 16.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 1.0 110.54 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 71' ' ' GLY . 30.3 ttm180 -65.31 -49.07 70.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.195 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.8 mt -111.82 146.77 35.42 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.887 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.33 159.32 54.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.486 2.124 . . . . 1.0 112.19 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.3 m -95.02 127.95 41.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.915 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 80' ' ' LEU . 28.7 mt -94.95 11.29 32.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.371 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.5 tp -68.0 132.21 46.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 1.0 112.241 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.08 -11.65 66.61 Favored Glycine 0 CA--C 1.523 0.594 0 CA-C-N 115.615 -0.721 . . . . 1.0 111.54 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 77' ' ' LEU . 80.4 mt -83.99 151.62 24.91 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.944 -0.303 . . . . 1.0 110.306 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.7 p -105.25 132.69 51.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.679 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -86.97 130.53 47.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -40.39 138.49 1.31 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.686 2.257 . . . . 1.0 111.864 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.429 ' HB2' ' NE2' ' A' ' 61' ' ' HIS . . . -65.86 125.63 25.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.676 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.32 -1.51 43.4 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -60.54 -33.38 72.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 87' ' ' ILE . 1.5 mp -69.31 130.28 91.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.417 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.59 168.9 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.35 2.033 . . . . 1.0 112.499 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -100.45 -56.04 2.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.572 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -64.59 -41.67 96.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.813 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.84 -44.01 82.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.609 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 42.2 ttt85 -62.42 -41.3 98.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.436 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -62.87 -34.88 78.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.768 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.495 ' C ' HH22 ' A' ' 101' ' ' ARG . 71.2 mt -70.84 -38.21 73.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.225 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.657 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 1.7 t80 -62.03 -20.71 64.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.58 ' C ' HE22 ' A' ' 99' ' ' GLN . 38.2 ttt180 -82.96 -28.38 29.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.824 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.24 -42.65 7.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.499 ' N ' HE21 ' A' ' 99' ' ' GLN . . . -114.07 -8.06 13.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 115.07 1.508 . . . . 1.0 115.07 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.741 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.4 mm-40 42.43 81.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.186 -1.005 . . . . 1.0 108.817 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.8 p 174.41 114.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.985 -0.552 . . . . 1.0 111.101 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.608 ' NH2' ' N ' ' A' ' 95' ' ' PHE . 3.8 tpp180 -155.23 147.02 23.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 1.0 110.714 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 p -170.76 146.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.514 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.591 HD11 ' CD2' ' A' ' 139' ' ' HIS . 67.2 mt -108.65 136.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -93.02 165.79 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.262 0.838 . . . . 1.0 113.262 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -48.07 117.22 1.82 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.899 -1.046 . . . . 1.0 112.109 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.429 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.4 p -58.38 -25.79 28.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.401 -0.818 . . . . 1.0 110.773 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 109' ' ' GLN . 84.5 tt0 -63.78 -44.98 91.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.47 -8.07 1.68 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.457 0.646 . . . . 1.0 109.338 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.646 ' NE2' HH21 ' A' ' 111' ' ' ARG . 45.9 tt0 45.04 60.91 2.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.744 -1.116 . . . . 1.0 113.266 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 t -75.15 133.46 41.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.954 -1.499 . . . . 1.0 106.954 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.646 HH21 ' NE2' ' A' ' 109' ' ' GLN . 80.0 mtt180 -119.57 139.52 52.01 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.038 -0.665 . . . . 1.0 111.9 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.29 163.51 32.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.564 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.9 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.153 179.355 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.492 1.414 0 CA-C-O 120.741 0.225 . . . . 1.0 111.977 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 26.4 t -125.89 140.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.808 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -43.68 138.88 2.92 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -58.48 -32.45 96.44 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.153 2.569 . . . . 1.0 114.005 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.6 p -49.79 -45.18 49.56 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.693 0.257 . . . . 1.0 111.693 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.668 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 6.5 t60 -81.39 -28.6 34.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.229 0.455 . . . . 1.0 112.229 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.429 ' CG1' HG23 ' A' ' 106' ' ' VAL . 60.2 t -68.77 -52.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.668 -0.413 . . . . 1.0 111.017 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -67.07 -24.84 66.01 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -64.56 -39.52 93.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.673 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 146' ' ' MET . 10.4 mt -73.35 -36.01 66.09 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -52.72 -38.22 60.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.625 -1.25 . . . . 1.0 107.625 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.3 p -66.69 -19.47 65.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.728 -1.124 . . . . 1.0 109.199 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.504 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.9 mmm -96.49 3.25 52.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.477 -0.783 . . . . 1.0 110.715 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.7 21.28 77.85 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 150' ' ' SER . 55.2 t -110.54 144.13 19.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.381 . . . . 1.0 110.971 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.95 -17.92 13.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.961 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.409 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 5.6 t -149.83 163.36 38.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.227 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.471 ' OG ' HD12 ' A' ' 103' ' ' ILE . 9.3 p -148.08 125.06 11.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.482 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -109.03 133.01 53.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.318 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.57 116.25 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.11 0.481 . . . . 1.0 111.77 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.11 129.27 25.21 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 107.81 -1.181 . . . . 1.0 107.81 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.479 ' C ' HD12 ' A' ' 156' ' ' LEU . 95.1 Cg_endo -74.21 123.48 8.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.091 2.527 . . . . 1.0 114.685 -175.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.571 HD23 HG11 ' A' ' 191' ' ' VAL . 10.8 mp -116.4 49.3 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.866 -1.531 . . . . 1.0 106.866 177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -147.2 179.29 7.74 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.112 0.782 . . . . 1.0 113.112 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -67.6 164.58 18.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.286 -0.87 . . . . 1.0 111.434 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -57.89 -50.55 72.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.463 -0.789 . . . . 1.0 112.064 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -103.93 -39.64 6.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -88.28 137.92 31.9 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.863 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.61 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER -108.93 112.94 25.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.269 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -88.9 -42.56 11.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.195 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.71 -175.71 25.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.428 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 5.1 tp -145.44 134.15 22.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.352 . . . . 1.0 111.517 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.5 tp -101.63 131.33 47.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 167' ' ' VAL . 12.0 p -137.61 131.33 43.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.811 -0.356 . . . . 1.0 111.12 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.9 m -108.59 139.77 42.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.071 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.462 ' O ' ' CG2' ' A' ' 48' ' ' THR . 62.0 m80 -110.43 125.37 53.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.006 0.432 . . . . 1.0 111.636 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.655 ' CE1' HG23 ' A' ' 48' ' ' THR . 88.8 m-70 -123.78 114.62 20.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.875 -0.602 . . . . 1.0 109.952 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.36 -14.8 63.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.837 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.89 148.33 34.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.051 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' A' ' 174' ' ' ARG . 80.9 Cg_endo -74.83 -98.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.891 2.394 . . . . 1.0 111.917 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.507 ' O ' ' O ' ' A' ' 173' ' ' PRO . 16.2 mtp-105 56.38 144.94 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.838 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.87 152.0 40.93 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.603 2.202 . . . . 1.0 111.921 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -90.69 146.98 23.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.473 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.434 ' OG ' ' OE1' ' A' ' 180' ' ' GLU . 95.2 p -121.97 156.66 32.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.652 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.832 ' NE2' ' H ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -60.31 -26.16 66.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.558 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -54.58 -39.55 67.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.765 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.434 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 1.5 mp0 -63.96 -39.39 94.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.525 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.27 -38.84 91.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.429 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -56.21 -37.61 69.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.361 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 73.3 t -67.69 -56.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.667 0.617 . . . . 1.0 112.667 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 188' ' ' ALA . 1.8 t -73.47 -42.7 56.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -43.38 -47.7 6.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.605 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 19.7 tp -70.95 -41.06 71.6 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.919 0.34 . . . . 1.0 111.919 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.636 ' O ' HG23 ' A' ' 191' ' ' VAL . 8.4 tp -77.91 -38.4 45.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.821 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -62.24 -37.97 87.42 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.53 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -61.37 -40.11 93.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.031 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.86 -25.36 63.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.12 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 187' ' ' LEU . 59.2 t -83.25 -45.25 18.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.767 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.6 t -56.67 -37.02 70.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.3 mt -66.83 -33.65 64.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.448 -0.796 . . . . 1.0 109.171 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.9 -38.94 73.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.784 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.4 mm -65.21 -41.56 91.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.154 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.63 -47.96 61.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.115 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 0.5 OUTLIER -70.33 -34.52 72.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.532 -178.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -67.52 -32.78 73.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.667 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.14 -34.59 75.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.588 -0.278 . . . . 1.0 111.424 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 41.3 mt -61.09 -33.24 73.04 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.091 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 17.5 m -54.04 -53.19 56.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.796 0.331 . . . . 1.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.624 179.658 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.815 0.341 . . . . 1.0 110.56 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -49.5 -35.25 19.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.993 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -75.4 -46.92 29.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.138 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 38' ' ' THR . 18.1 mm -64.99 -38.79 83.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.544 -0.298 . . . . 1.0 110.962 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.583 ' O ' ' OG1' ' A' ' 38' ' ' THR . 18.9 mt -57.88 -35.83 71.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.005 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -66.37 -33.47 75.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.084 0.468 . . . . 1.0 109.833 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.19 -30.94 67.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.107 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -73.0 -45.33 58.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.505 -0.77 . . . . 1.0 112.241 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.7 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.1 p -65.41 -35.23 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 111.929 0.344 . . . . 1.0 111.929 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.85 -40.1 65.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 1.0 111.071 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.12 -51.63 67.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.749 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.21 -30.6 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.203 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.647 HH22 ' CA ' ' A' ' 70' ' ' GLY . 8.1 tpt180 -55.38 -43.9 75.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.76 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.74 77.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.041 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -80.31 -45.48 17.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.526 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.92 -34.74 20.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.427 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.87 20.04 17.37 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.471 -1.052 . . . . 1.0 110.471 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.541 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 10.1 t -69.15 141.06 54.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.796 0.331 . . . . 1.0 110.23 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD2' ' CB ' ' A' ' 171' ' ' ALA . 84.5 m-20 -38.03 -39.82 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.659 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.436 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 24.3 ttm180 -167.75 131.95 1.77 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.007 -0.677 . . . . 1.0 112.588 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 p -138.81 130.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -139.88 157.55 45.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.131 0.491 . . . . 1.0 111.948 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.5 t -99.88 135.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -118.25 108.46 15.15 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.257 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -83.17 125.08 31.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.236 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.523 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 84.1 t80 -90.68 141.19 29.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 1.0 112.039 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.523 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 7.1 m-20 -112.13 151.05 43.35 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.11 -23.5 69.32 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.512 2.141 . . . . 1.0 112.49 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -87.46 -11.72 48.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.17 -11.63 60.29 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.552 -0.619 . . . . 1.0 111.552 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -80.14 90.74 5.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 1.0 110.627 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.52 151.05 21.12 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.576 -1.009 . . . . 1.0 110.576 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 p -125.44 148.47 48.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 1.0 111.711 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.71 109.26 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.78 0.69 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.366 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.7 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.6 115.72 2.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.066 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 85.5 tt0 -144.98 134.41 23.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.047 0.451 . . . . 1.0 111.834 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.87 132.37 45.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.433 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' C ' HH12 ' A' ' 43' ' ' ARG . 35.6 ptt-85 -134.97 150.94 50.44 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.733 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.647 ' CA ' HH22 ' A' ' 43' ' ' ARG . . . -56.76 -119.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.18 -76.94 1.03 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -169.22 46.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.747 0.308 . . . . 1.0 110.546 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -83.43 -45.99 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.1 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 28.6 mt -108.17 145.46 31.51 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.474 . . . . 1.0 109.874 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.3 139.57 42.16 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.485 2.123 . . . . 1.0 112.17 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.8 m -66.9 124.31 22.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.957 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 80' ' ' LEU . 26.9 mt -100.08 13.11 35.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.334 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.464 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 26.9 tp -71.65 128.36 35.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.284 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.42 -9.86 75.45 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.492 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 77' ' ' LEU . 73.7 mt -84.88 151.6 24.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.757 0.313 . . . . 1.0 110.292 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.9 m -104.07 131.0 51.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.688 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -82.82 152.44 66.08 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.568 -0.53 . . . . 1.0 109.568 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.62 133.5 39.86 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.594 2.196 . . . . 1.0 111.877 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.27 127.88 33.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.681 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.09 2.76 45.26 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.539 -1.024 . . . . 1.0 110.539 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -58.44 -33.66 69.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.77 129.33 52.97 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.429 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.671 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 86.2 Cg_endo -73.89 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.459 2.106 . . . . 1.0 112.484 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -109.95 -59.02 1.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.531 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -58.42 -44.65 89.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.833 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.671 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -66.79 -48.03 70.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -54.72 -35.07 63.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.464 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -64.4 -34.15 77.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.0 mt -63.44 -37.58 87.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.281 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.66 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 56.2 m-85 -63.99 -27.18 68.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.04 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.549 ' C ' HE22 ' A' ' 99' ' ' GLN . 65.9 ttt180 -82.68 -29.36 29.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.77 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.1 mt -98.64 -42.41 7.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 114.416 1.265 . . . . 1.0 114.416 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.539 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.69 -7.87 13.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.019 1.489 . . . . 1.0 115.019 -174.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.76 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.7 mm-40 39.55 74.18 0.1 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.201 -1.0 . . . . 1.0 108.821 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 100' ' ' VAL . 6.8 p 174.27 121.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.059 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.571 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -171.04 147.65 2.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 1.0 110.811 177.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.571 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 21.9 m -157.25 157.63 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.515 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.6 mt -106.06 135.59 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 105' ' ' ASP . 10.7 t -87.12 158.2 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.248 0.833 . . . . 1.0 113.248 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.46 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.0 p-10 -50.67 121.95 6.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.865 -1.061 . . . . 1.0 112.095 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.2 -23.06 12.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.792 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 109' ' ' GLN . 82.1 tt0 -63.15 -49.24 75.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . . . -66.4 -4.56 8.41 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.554 0.692 . . . . 1.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 36.34 72.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.787 -1.097 . . . . 1.0 113.282 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.4 p -72.83 129.75 38.88 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.968 -1.493 . . . . 1.0 106.968 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -118.4 133.18 56.09 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.918 -0.713 . . . . 1.0 111.835 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -125.91 153.47 44.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.556 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 112' ' ' SER . 23.1 pt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.172 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 CA-C-O 120.711 0.213 . . . . 1.0 111.948 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.01 122.74 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.87 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -43.32 151.76 0.43 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.56 -43.46 50.69 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.217 2.612 . . . . 1.0 114.005 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.666 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.3 p -38.97 -44.75 1.11 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.679 0.252 . . . . 1.0 111.679 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.666 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.3 t60 -82.76 -31.78 28.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.249 0.463 . . . . 1.0 112.249 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.64 -52.8 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.639 -0.425 . . . . 1.0 110.982 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -65.79 -29.39 69.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -63.53 -44.86 93.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.707 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 146' ' ' MET . 12.6 mt -73.33 -36.67 66.24 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -48.23 -39.07 20.08 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.507 -1.294 . . . . 1.0 107.507 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.3 m -58.26 -32.64 68.56 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.786 -1.097 . . . . 1.0 109.214 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.574 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.2 mmm -79.1 0.72 26.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.743 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.49 26.07 74.7 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.39 142.28 30.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.976 0.417 . . . . 1.0 110.932 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.54 -26.43 12.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.969 -0.559 . . . . 1.0 111.027 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 p -141.5 127.11 18.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.413 . . . . 1.0 111.137 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.15 131.43 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.47 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 152' ' ' LEU . 8.3 mp -110.49 139.9 45.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.285 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.412 ' CG1' HD11 ' A' ' 165' ' ' LEU . 2.4 t -123.97 116.24 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.113 0.482 . . . . 1.0 111.74 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.561 HG21 HG21 ' A' ' 184' ' ' VAL . 41.1 t -117.94 121.29 31.72 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 107.791 -1.189 . . . . 1.0 107.791 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.452 ' C ' HD12 ' A' ' 156' ' ' LEU . 86.4 Cg_endo -75.54 123.86 7.87 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.247 2.631 . . . . 1.0 114.7 -176.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.452 HD12 ' C ' ' A' ' 155' ' ' PRO . 10.8 mp -111.85 56.15 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.807 -1.553 . . . . 1.0 106.807 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -147.84 178.51 8.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -65.76 161.54 20.6 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.299 -0.864 . . . . 1.0 111.427 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -55.04 -49.26 72.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.083 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -105.0 -39.76 6.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.404 ' OE1' ' CH2' ' A' ' 163' ' ' TRP . 96.1 mt-10 -88.05 138.04 31.8 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.689 -0.405 . . . . 1.0 110.876 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 162' ' ' LEU . 1.8 mp -109.09 112.51 24.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.288 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.404 ' CH2' ' OE1' ' A' ' 161' ' ' GLU . 46.9 m95 -88.04 -36.93 16.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.214 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.0 -171.85 28.64 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.412 HD11 ' CG1' ' A' ' 153' ' ' VAL . 42.1 tp -144.66 131.84 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 1.0 111.585 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.46 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.4 tp -105.16 134.18 48.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.03 133.83 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.631 -0.428 . . . . 1.0 111.039 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.403 ' OG ' HG21 ' A' ' 48' ' ' THR . 28.5 t -107.8 136.99 46.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.02 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.463 ' O ' ' OG1' ' A' ' 48' ' ' THR . 27.7 m80 -111.71 131.37 55.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.999 0.428 . . . . 1.0 111.668 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -126.68 130.87 51.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.998 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.418 ' CB ' ' OD2' ' A' ' 49' ' ' ASP . . . -88.64 56.44 3.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.812 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -148.11 136.64 11.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.981 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.3 4.69 5.67 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.866 2.377 . . . . 1.0 111.924 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -64.87 148.39 97.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.895 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.78 165.28 31.82 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.603 2.202 . . . . 1.0 111.897 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 38.4 p90 -86.4 138.46 31.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.425 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 88.3 p -116.8 155.48 28.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.63 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.523 ' NE2' HD23 ' A' ' 181' ' ' LEU . 62.5 tp60 -58.53 -31.78 68.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.676 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -55.81 -40.42 72.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.758 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.47 -38.5 90.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.54 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.523 HD23 ' NE2' ' A' ' 178' ' ' GLN . 15.5 tp -65.7 -37.71 87.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.547 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -55.34 -37.12 67.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.402 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.2 t -68.84 -52.91 30.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.561 HG21 HG21 ' A' ' 154' ' ' VAL . 20.8 m -75.14 -36.87 38.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.411 0.523 . . . . 1.0 112.411 -177.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.422 ' N ' HG23 ' A' ' 184' ' ' VAL . 53.0 tp60 -50.88 -48.19 60.36 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.7 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.8 -44.33 41.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.963 0.357 . . . . 1.0 111.963 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 191' ' ' VAL . 43.1 tp -77.43 -42.44 36.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.906 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 184' ' ' VAL . . . -58.24 -39.3 78.74 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.544 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.401 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 86.8 m-20 -59.46 -38.86 81.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.999 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -65.8 -25.74 67.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.115 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 187' ' ' LEU . 17.0 t -85.09 -42.29 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.719 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.4 t -58.05 -38.93 77.22 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.1 mt -65.98 -34.77 72.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.209 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -70.89 -39.3 72.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.781 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.441 HD11 HD21 ' A' ' 35' ' ' LEU . 4.6 mm -60.91 -47.53 93.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.199 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.23 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.132 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -70.86 -41.98 70.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.466 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -64.19 -34.49 78.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.73 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -54.83 -25.86 31.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.509 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.35 -34.54 75.46 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.043 -0.263 . . . . 1.0 111.057 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.9 t -45.1 -55.68 5.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.596 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.635 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.838 0.351 . . . . 1.0 110.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.97 -29.55 66.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.99 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -78.64 -46.51 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.161 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 mm -62.56 -46.2 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.758 0.313 . . . . 1.0 110.908 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.1 mt -58.29 -48.07 81.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.069 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -52.98 -38.72 62.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.23 -29.31 64.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.087 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.4 m -73.44 -47.02 44.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.547 -0.751 . . . . 1.0 112.263 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.1 p -65.73 -36.36 77.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 111.941 0.348 . . . . 1.0 111.941 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.75 -44.38 86.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.823 0.344 . . . . 1.0 111.077 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -42.0 98.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.705 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.9 t -59.64 -40.68 82.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.964 -0.294 . . . . 1.0 111.15 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 47' ' ' GLY . 52.1 ttp180 -50.67 -42.59 56.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.8 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.2 78.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.063 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -77.27 -47.01 21.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.549 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.71 -29.88 22.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.502 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.2 22.13 35.29 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.478 -1.049 . . . . 1.0 110.478 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.504 ' OG1' ' CG2' ' A' ' 51' ' ' VAL . 17.7 p -74.74 145.31 43.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.836 0.351 . . . . 1.0 110.193 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -40.77 -43.3 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.654 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.407 HH22 ' HG ' ' A' ' 77' ' ' LEU . 44.7 ttt180 -158.55 134.94 9.34 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.031 -0.668 . . . . 1.0 112.578 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.504 ' CG2' ' OG1' ' A' ' 48' ' ' THR . 10.0 t -135.69 129.04 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -140.11 153.94 46.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.449 -0.501 . . . . 1.0 111.872 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 64.8 t -100.71 136.74 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 30.3 t80 -119.06 107.45 13.51 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.382 -0.527 . . . . 1.0 111.258 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -79.48 127.15 31.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.217 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.493 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 87.5 t80 -90.97 141.31 28.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.971 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.493 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -112.22 150.81 43.07 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 178.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -59.91 -23.63 73.3 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.541 2.161 . . . . 1.0 112.494 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -87.88 -12.48 44.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 1.0 110.072 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.21 58.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.605 -0.598 . . . . 1.0 111.605 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -78.31 90.22 4.36 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.931 -0.307 . . . . 1.0 110.631 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.04 151.43 20.76 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -125.48 148.21 48.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.392 . . . . 1.0 111.719 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 78' ' ' LEU . 61.5 t -77.01 108.34 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.624 ' O ' HG12 ' A' ' 65' ' ' VAL . 96.7 t -106.02 0.03 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.341 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.79 122.79 3.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.052 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -147.78 133.78 19.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.136 0.493 . . . . 1.0 111.809 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.72 141.51 51.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.681 -0.69 . . . . 1.0 109.341 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.528 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 84.6 mtm-85 -138.7 142.81 38.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.74 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -47.43 -28.01 4.49 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.2 -88.91 0.07 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -152.17 52.09 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 1.0 110.509 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -86.22 -45.65 11.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.174 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.3 mt -109.15 146.35 33.7 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.902 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.87 145.84 63.68 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.551 2.168 . . . . 1.0 112.203 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 p -62.18 124.52 21.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 80' ' ' LEU . 29.4 mt -98.57 3.48 48.04 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.366 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 64' ' ' VAL . 6.2 tp -66.25 131.45 46.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.213 0.53 . . . . 1.0 112.26 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.17 -15.39 53.95 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.584 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 77' ' ' LEU . 59.0 mt -82.05 153.84 25.94 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.987 -0.285 . . . . 1.0 110.35 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.0 p -107.04 131.29 54.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.686 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -85.63 154.32 58.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.11 129.6 26.25 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.638 2.225 . . . . 1.0 111.935 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.26 130.05 41.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.739 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.0 -1.11 44.46 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.614 -0.995 . . . . 1.0 110.614 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -53.19 -38.33 62.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mt -78.59 131.55 67.71 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.447 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.722 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 91.1 Cg_endo -72.81 -165.57 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.438 2.092 . . . . 1.0 112.477 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -107.54 -60.99 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.506 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -57.46 -43.11 83.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.804 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.722 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.42 -40.58 85.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -69.04 -41.65 77.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.488 -0.323 . . . . 1.0 111.442 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -60.98 -31.82 71.4 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.8 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.477 ' CD1' HH12 ' A' ' 101' ' ' ARG . 78.1 mt -71.58 -38.02 70.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.227 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.73 -42.08 83.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 1.0 110.018 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 159' ' ' HIS . 77.1 ttt-85 -58.3 -33.09 69.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.798 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.574 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 56.6 mt -98.14 -35.85 10.26 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.584 ' C ' ' NE2' ' A' ' 99' ' ' GLN . . . -118.52 -10.19 10.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.115 1.524 . . . . 1.0 115.115 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.652 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 40.39 82.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.177 -1.009 . . . . 1.0 108.812 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.8 p 175.98 116.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.056 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.599 ' O ' HG13 ' A' ' 102' ' ' VAL . 8.0 tpt180 -160.37 143.31 13.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 1.0 110.766 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 101' ' ' ARG . 17.4 m -159.78 150.38 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.532 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.421 ' O ' ' OH ' ' A' ' 176' ' ' TYR . 42.9 mt -108.32 136.46 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.098 -0.704 . . . . 1.0 109.098 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 105' ' ' ASP . 30.9 t -88.24 158.3 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.215 0.82 . . . . 1.0 113.215 -175.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 104' ' ' VAL . 33.0 m-20 -48.05 123.95 6.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.904 -1.044 . . . . 1.0 112.193 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.511 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.1 p -56.63 -24.72 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.746 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.419 ' C ' ' H ' ' A' ' 109' ' ' GLN . 83.9 tt0 -65.27 -47.76 75.59 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.8 -3.49 6.92 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.532 0.682 . . . . 1.0 109.388 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 36.03 71.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.794 -1.093 . . . . 1.0 113.296 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.7 t -72.44 130.68 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.984 -1.488 . . . . 1.0 106.984 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -118.53 138.57 52.44 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.937 -0.705 . . . . 1.0 111.885 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.423 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.2 OUTLIER -146.62 166.41 26.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.694 -0.684 . . . . 1.0 110.502 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.103 179.074 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 120.692 0.205 . . . . 1.0 111.92 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 135' ' ' VAL . 2.1 p -92.56 109.83 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.908 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.496 ' OD2' ' SG ' ' A' ' 138' ' ' CYS . 0.7 OUTLIER -45.36 142.31 3.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 140' ' ' VAL . 72.9 Cg_exo -43.87 -47.63 9.81 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.223 2.615 . . . . 1.0 113.988 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.719 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.3 p -35.83 -46.87 0.48 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.734 0.272 . . . . 1.0 111.734 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.719 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 2.1 t60 -82.99 -24.64 32.83 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.511 ' CG1' HG23 ' A' ' 106' ' ' VAL . 44.7 t -65.92 -55.01 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.664 -0.414 . . . . 1.0 110.963 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -65.88 -29.25 69.66 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -60.24 -47.35 86.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.666 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.1 mt -73.0 -36.72 67.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.311 -0.625 . . . . 1.0 109.311 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -49.8 -39.68 39.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.597 -1.26 . . . . 1.0 107.597 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -63.69 -28.74 70.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.713 -1.13 . . . . 1.0 109.181 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.5 mmm -85.92 -1.92 57.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.726 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.05 22.01 78.41 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.18 142.32 23.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 1.0 110.966 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.76 -38.17 5.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.932 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.7 t -133.75 125.2 28.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.104 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.2 p -112.91 135.61 53.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.479 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.83 133.89 55.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.296 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.0 t -122.23 108.76 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.099 0.476 . . . . 1.0 111.792 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.433 HG11 HG12 ' A' ' 184' ' ' VAL . 48.0 t -105.06 114.6 63.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 107.8 -1.185 . . . . 1.0 107.8 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -41.7 134.74 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 123.161 2.574 . . . . 1.0 114.664 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.4 tp -132.4 41.41 3.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.6 ptm -148.92 -172.69 4.17 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.133 0.79 . . . . 1.0 113.133 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.655 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 52.2 t-80 -77.84 178.1 7.67 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.436 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.655 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 72.4 m80 -74.84 -54.94 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.051 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -104.01 11.57 35.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.032 0.382 . . . . 1.0 112.032 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.536 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.8 tt0 -146.49 140.18 26.03 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.856 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.729 HD23 ' O ' ' A' ' 162' ' ' LEU . 6.9 tt -109.55 116.18 31.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.243 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.536 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 69.0 m95 -92.68 -37.31 12.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.175 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -158.34 -171.72 24.57 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.152 -0.779 . . . . 1.0 111.152 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 16.0 tp -145.14 125.96 14.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 1.0 111.599 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.421 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.6 tp -100.58 131.53 46.44 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.17 138.23 41.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.702 -0.399 . . . . 1.0 111.069 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.1 m -110.86 141.76 43.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.96 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -115.57 131.61 56.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.01 0.433 . . . . 1.0 111.572 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -128.01 123.03 33.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.957 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.73 36.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.829 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -164.37 126.11 1.5 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.009 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -42.68 139.55 3.16 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.988 2.459 . . . . 1.0 111.847 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -176.57 97.75 0.24 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.825 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.98 155.64 4.13 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.596 2.197 . . . . 1.0 111.887 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.421 ' OH ' ' O ' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -85.25 133.66 34.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.51 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.2 m -118.31 150.79 38.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.597 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -50.61 -35.97 32.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.663 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.01 -38.24 85.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.729 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.43 -50.79 70.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.526 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.12 -36.07 80.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.569 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.548 HE21 HD11 ' A' ' 186' ' ' LEU . 61.9 tp60 -53.67 -37.2 62.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.406 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.6 -54.47 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.743 0.646 . . . . 1.0 112.743 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.433 HG12 HG11 ' A' ' 154' ' ' VAL . 3.3 t -78.04 -40.13 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.451 0.537 . . . . 1.0 112.451 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -46.9 -45.64 20.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.653 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.548 HD11 HE21 ' A' ' 182' ' ' GLN . 55.1 mt -74.64 -39.09 62.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.6 tp -76.0 -41.45 51.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.851 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -60.71 -38.55 85.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.479 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.27 -37.72 70.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.279 -0.418 . . . . 1.0 109.953 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -71.83 -24.21 61.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.114 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 194' ' ' ALA . 61.4 t -83.18 -47.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.793 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.5 m -51.97 -30.41 24.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.42 -33.29 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.154 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -70.36 -48.36 56.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.811 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 196' ' ' ALA . 1.9 pp -67.14 -37.07 78.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.132 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.463 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -70.83 -46.13 63.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.093 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -74.1 -35.14 64.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.549 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -61.92 -34.51 76.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.703 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.28 -27.61 47.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.475 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.07 -36.29 74.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.685 0.279 . . . . 1.0 111.054 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.9 m -52.45 -55.8 19.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.589 179.608 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.892 0.377 . . . . 1.0 110.577 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 35.6 p-10 -51.21 -32.62 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 62.8 tt0 -77.07 -48.33 18.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.147 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.3 mt -60.33 -42.49 90.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 1.0 110.945 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.06 -46.55 82.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.412 . . . . 1.0 111.041 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.55 HH12 ' CD2' ' A' ' 78' ' ' LEU . 51.8 ttt85 -51.95 -38.27 55.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.95 -29.67 65.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.833 -0.622 . . . . 1.0 110.089 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 42' ' ' VAL . 20.8 m -73.5 -45.07 56.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.557 -0.747 . . . . 1.0 112.21 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.646 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.2 p -68.12 -35.6 72.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 111.976 0.362 . . . . 1.0 111.976 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -70.17 -45.48 66.63 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.104 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -63.76 -44.42 93.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.779 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 38' ' ' THR . 75.4 t -59.37 -42.53 87.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.155 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 47' ' ' GLY . 63.7 ttp85 -53.99 -40.76 67.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.851 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.15 -37.28 74.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.03 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -78.29 -43.41 28.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.581 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.7 mt -85.2 -30.4 23.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.512 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 59.28 20.11 49.21 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.509 -1.036 . . . . 1.0 110.509 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.613 HG23 ' CE1' ' A' ' 170' ' ' HIS . 89.8 m -72.93 142.18 47.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.83 0.348 . . . . 1.0 110.224 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -39.89 -54.72 2.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.566 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.529 ' NH2' ' O ' ' A' ' 74' ' ' LEU . 80.6 mtt-85 -152.5 131.89 12.91 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.99 -0.684 . . . . 1.0 112.501 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.64 129.34 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -138.83 156.01 47.67 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.915 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 58.7 t -108.35 136.35 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.63 134.61 47.78 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.366 -0.534 . . . . 1.0 111.311 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -94.01 137.92 32.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.21 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 66.9 t80 -94.29 117.55 30.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 1.0 112.035 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -88.07 140.93 30.89 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.02 -26.77 5.27 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.55 2.167 . . . . 1.0 112.397 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.37 -19.64 38.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.915 0.388 . . . . 1.0 110.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.69 -13.45 38.71 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.556 -0.618 . . . . 1.0 111.556 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -71.92 99.57 2.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.339 . . . . 1.0 110.593 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.62 142.57 16.06 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.626 -0.99 . . . . 1.0 110.626 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.5 p -123.07 145.77 48.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 1.0 111.743 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 t -77.74 106.99 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.09 -2.03 9.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.341 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.646 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -156.86 116.51 3.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.106 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 81.6 tt0 -144.06 132.5 22.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.802 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.433 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -128.35 138.8 52.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.343 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -118.55 137.08 53.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.906 0.384 . . . . 1.0 110.722 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.42 -81.31 0.52 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.849 -0.9 . . . . 1.0 110.849 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.507 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -114.04 50.81 0.75 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.997 -0.841 . . . . 1.0 110.997 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' A' ' 71' ' ' GLY . 15.0 pt-20 31.18 55.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 1.0 110.491 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -84.52 -50.43 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.165 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.529 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 23.8 mt -109.4 153.46 42.76 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.86 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.28 164.71 3.61 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.486 2.124 . . . . 1.0 112.126 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.1 t -87.72 128.58 35.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.878 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.549 ' HA ' HD12 ' A' ' 80' ' ' LEU . 24.3 mt -101.08 13.48 35.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.39 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.55 ' CD2' HH12 ' A' ' 36' ' ' ARG . 23.9 tp -73.08 128.9 36.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.032 -0.531 . . . . 1.0 112.343 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.9 -8.62 77.37 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.541 -0.754 . . . . 1.0 111.532 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 77' ' ' LEU . 69.8 mt -85.73 152.6 22.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.768 0.318 . . . . 1.0 110.31 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 81' ' ' THR . 11.7 t -106.26 133.67 50.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.702 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.59 152.09 51.4 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.68 137.01 56.69 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.61 2.207 . . . . 1.0 111.863 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.46 129.14 38.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.683 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.1 43.53 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.551 -1.019 . . . . 1.0 110.551 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.9 -37.78 66.77 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.754 ' H ' HD12 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -80.08 113.57 39.53 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.394 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 87' ' ' ILE . 86.5 Cg_exo -48.76 -171.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.455 2.103 . . . . 1.0 112.509 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.93 -59.0 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.558 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 20.8 pt-20 -58.24 -42.74 87.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.813 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -66.27 -47.84 72.38 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.971 0.36 . . . . 1.0 111.971 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.519 ' NH2' ' CE2' ' A' ' 56' ' ' PHE . 72.1 ttt180 -52.99 -35.63 59.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.498 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -66.1 -35.95 81.89 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.838 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.463 HD12 HH21 ' A' ' 101' ' ' ARG . 66.6 mt -60.69 -37.31 81.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.317 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.609 ' C ' HE21 ' A' ' 99' ' ' GLN . 66.9 m-85 -60.73 -55.07 37.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.038 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -51.19 -29.72 14.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.773 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 63.2 mt -99.14 -42.42 7.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.335 1.235 . . . . 1.0 114.335 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.551 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.93 -14.47 10.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.053 1.501 . . . . 1.0 115.053 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.609 HE21 ' C ' ' A' ' 95' ' ' PHE . 20.0 mm-40 37.58 81.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.148 -1.021 . . . . 1.0 108.835 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.7 p 176.49 97.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.103 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.604 ' O ' HG23 ' A' ' 102' ' ' VAL . 6.6 mmt180 -147.99 146.35 28.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.992 0.425 . . . . 1.0 110.746 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 101' ' ' ARG . 62.8 t -159.79 150.07 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.514 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.415 HD12 ' OG ' ' A' ' 151' ' ' SER . 49.5 mt -108.35 136.57 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.03 163.93 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 113.279 0.844 . . . . 1.0 113.279 -176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 21.8 p30 -46.46 119.68 2.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.93 -1.032 . . . . 1.0 112.125 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.472 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.7 p -55.18 -20.42 6.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.331 -0.849 . . . . 1.0 110.808 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -65.78 -43.51 88.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.02 -12.86 55.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.529 0.68 . . . . 1.0 109.362 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.436 ' HG2' ' HE ' ' A' ' 111' ' ' ARG . 40.0 tp60 45.17 73.44 0.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.782 -1.099 . . . . 1.0 113.284 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.463 ' OG ' HG12 ' A' ' 135' ' ' VAL . 9.7 p -74.23 129.9 38.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.025 -1.472 . . . . 1.0 107.025 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.436 ' HE ' ' HG2' ' A' ' 109' ' ' GLN . 96.1 mtt180 -118.29 132.86 56.27 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.937 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.518 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -134.65 162.55 31.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.595 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.6 pt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.164 179.45 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo . . . . . 0 N--CA 1.493 1.452 0 CA-C-O 120.763 0.234 . . . . 1.0 111.962 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.463 HG12 ' OG ' ' A' ' 110' ' ' SER . 1.5 p -95.33 114.19 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.947 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -44.0 137.17 3.63 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.518 ' HD3' ' H ' ' A' ' 112' ' ' SER . 54.8 Cg_exo -41.97 -48.52 6.12 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.238 2.625 . . . . 1.0 114.001 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.702 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER -35.96 -45.93 0.44 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.8 0.296 . . . . 1.0 111.8 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.702 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 8.1 t-80 -82.2 -26.97 32.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.472 ' CG1' HG23 ' A' ' 106' ' ' VAL . 48.0 t -63.92 -53.82 39.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.986 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -65.3 -29.1 69.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -58.97 -45.62 90.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.734 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.2 mt -73.23 -41.76 63.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -38.61 56.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.544 -1.28 . . . . 1.0 107.544 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.7 t -63.5 -26.61 68.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.823 -1.081 . . . . 1.0 109.209 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.6 mmm -90.21 3.55 53.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.731 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.25 20.31 79.11 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.08 143.56 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 1.0 110.964 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.59 -19.95 13.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.942 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.5 m -145.87 161.82 39.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 1.0 111.177 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.415 ' OG ' HD12 ' A' ' 103' ' ' ILE . 1.7 p -147.48 122.55 10.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.49 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 tp -106.27 131.67 53.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.287 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.535 HG11 HD21 ' A' ' 165' ' ' LEU . 3.5 t -124.44 120.38 58.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.126 0.489 . . . . 1.0 111.784 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.814 HG13 ' O ' ' A' ' 154' ' ' VAL . 12.6 p -130.76 91.53 36.94 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.829 -1.174 . . . . 1.0 107.829 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.27 152.09 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 123.175 2.583 . . . . 1.0 114.677 -176.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 56.2 mt -126.07 66.64 1.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.829 -1.545 . . . . 1.0 106.829 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.475 ' SD ' ' OE1' ' A' ' 99' ' ' GLN . 2.1 ptt? -146.98 -167.53 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.145 0.795 . . . . 1.0 113.145 -175.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.697 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 59.5 t60 -86.26 -176.0 5.73 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.446 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.697 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 59.3 t-80 -75.32 -55.27 5.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.463 -0.789 . . . . 1.0 112.103 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -105.66 13.72 29.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.014 0.376 . . . . 1.0 112.014 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -144.04 138.91 28.67 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.839 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 162' ' ' LEU . 9.1 tt -110.52 116.67 31.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.239 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -92.4 -36.51 13.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.222 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.91 -171.35 27.9 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.535 HD21 HG11 ' A' ' 153' ' ' VAL . 7.6 tp -149.72 133.31 16.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 1.0 111.532 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.434 ' CD1' HG22 ' A' ' 53' ' ' VAL . 8.3 tp -98.71 135.91 39.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 167' ' ' VAL . 11.0 p -139.25 131.68 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.047 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 m -109.11 142.9 39.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.017 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' A' ' 48' ' ' THR . 43.5 m80 -113.16 123.3 49.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.053 0.454 . . . . 1.0 111.69 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.613 ' CE1' HG23 ' A' ' 48' ' ' THR . 82.6 m-70 -123.55 115.23 21.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.859 -0.61 . . . . 1.0 109.97 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.12 -16.12 63.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.782 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -94.48 150.15 37.68 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.963 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 174' ' ' ARG . 59.9 Cg_endo -70.83 -2.6 11.2 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.96 2.44 . . . . 1.0 111.825 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 173' ' ' PRO . 0.0 OUTLIER -32.54 98.06 0.12 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.921 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 173' ' ' PRO . 78.2 Cg_exo -50.15 167.68 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.577 2.185 . . . . 1.0 111.933 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.539 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 46.4 p90 -86.75 125.66 34.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.471 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.2 t -115.74 154.1 30.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.681 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -54.34 -31.76 55.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.626 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.81 -39.99 86.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.748 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -63.47 -42.6 98.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.551 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.55 -38.47 87.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.502 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -55.36 -36.4 66.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.899 -0.591 . . . . 1.0 111.394 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.1 -55.93 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.735 0.643 . . . . 1.0 112.735 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 188' ' ' ALA . 26.8 m -74.09 -35.3 40.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.434 0.531 . . . . 1.0 112.434 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -50.28 -45.84 54.68 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.655 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 41.5 mt -79.61 -43.97 21.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.894 0.331 . . . . 1.0 111.894 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.72 ' O ' HG23 ' A' ' 191' ' ' VAL . 34.2 tp -77.9 -40.53 39.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.835 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -60.67 -41.11 94.42 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.493 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.66 -40.26 87.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.991 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -67.81 -25.81 65.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.149 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 187' ' ' LEU . 37.0 t -84.13 -45.01 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.78 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.2 p -57.13 -35.33 69.34 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.01 -34.81 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.465 -0.789 . . . . 1.0 109.24 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.93 77.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.819 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.4 mm -59.57 -48.58 86.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.128 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.52 -48.13 57.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.127 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -65.0 -42.77 94.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.466 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.63 -31.87 73.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.706 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.14 -30.97 66.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.464 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.7 mp -59.99 -34.17 72.96 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.981 -0.288 . . . . 1.0 111.072 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.3 p -55.56 -55.58 30.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.566 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.534 179.896 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.868 0.366 . . . . 1.0 110.605 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 33' ' ' GLN . 24.1 p-10 -50.74 -55.48 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.998 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.408 ' N ' ' CG ' ' A' ' 32' ' ' ASP . 63.9 tt0 -52.65 -42.56 64.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.101 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.1 mm -59.64 -50.46 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 1.0 110.966 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.46 HD11 HD22 ' A' ' 31' ' ' LEU . 83.4 mt -58.42 -46.86 85.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.987 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -49.58 -39.68 35.98 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.816 -0.438 . . . . 1.0 109.816 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 -29.4 65.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.073 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 35' ' ' LEU . 24.1 m -74.53 -41.47 60.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 1.0 112.263 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.648 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.5 p -72.32 -37.82 59.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 111.922 0.341 . . . . 1.0 111.922 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -67.79 -41.61 82.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.783 0.325 . . . . 1.0 111.067 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -67.36 -44.72 78.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.734 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 38' ' ' THR . 69.3 t -61.77 -36.36 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.176 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.558 ' NH2' ' CA ' ' A' ' 70' ' ' GLY . 16.3 tpt85 -59.79 -47.47 85.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 1.0 110.802 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.55 -33.33 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 1.0 111.051 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -74.27 -41.2 61.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.607 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' A' ' 48' ' ' THR . 5.4 mt -87.12 -29.03 22.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.514 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.81 19.19 0.85 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.421 ' N ' ' C ' ' A' ' 46' ' ' LEU . 1.6 p -62.7 -97.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 1.0 110.211 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -155.13 -48.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.613 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -157.16 125.92 5.78 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.089 -0.644 . . . . 1.0 112.644 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 12.6 p -137.03 129.05 43.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.547 -0.908 . . . . 1.0 108.547 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -140.18 159.33 42.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.958 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -99.82 136.25 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.608 -0.886 . . . . 1.0 108.608 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 74.2 t80 -117.09 108.45 15.73 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.295 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -83.31 126.47 32.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.274 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.621 ' CZ ' ' NH2' ' A' ' 92' ' ' ARG . 77.8 t80 -93.32 137.12 32.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 1.0 112.035 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.84 140.85 22.26 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.88 -27.27 5.57 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.573 2.182 . . . . 1.0 112.442 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.97 -18.19 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 1.0 110.096 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.96 -13.85 41.06 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.574 -0.61 . . . . 1.0 111.574 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -78.22 90.39 4.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.765 0.317 . . . . 1.0 110.63 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.48 151.46 20.97 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.635 -0.986 . . . . 1.0 110.635 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.8 p -123.51 146.62 47.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 1.0 111.692 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 77' ' ' LEU . 39.4 t -75.81 110.38 10.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.87 2.97 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.339 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.648 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.69 122.58 3.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.072 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -144.26 130.16 19.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.109 0.481 . . . . 1.0 111.826 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.62 139.25 52.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.359 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -140.85 145.8 36.69 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.793 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.558 ' CA ' ' NH2' ' A' ' 43' ' ' ARG . . . -47.31 -39.08 13.32 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.864 -0.894 . . . . 1.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 171.64 -154.27 21.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 72' ' ' GLU . 3.0 pp20? -72.54 20.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 1.0 110.523 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 71' ' ' GLY . 35.0 mtm180 -76.44 -47.8 21.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.117 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.89 150.36 52.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.92 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.42 157.91 55.4 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.486 2.124 . . . . 1.0 112.155 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.7 p -95.55 132.04 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.918 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.545 ' HA ' HD12 ' A' ' 80' ' ' LEU . 22.7 mt -90.6 17.16 7.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.41 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.44 128.8 37.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.016 -0.538 . . . . 1.0 112.28 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.91 -11.49 64.54 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.536 -0.756 . . . . 1.0 111.577 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 77' ' ' LEU . 72.1 mt -82.92 152.05 25.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.914 -0.314 . . . . 1.0 110.341 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.8 m -107.16 134.15 50.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.713 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -84.95 152.19 58.69 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.36 130.66 27.5 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.636 2.224 . . . . 1.0 111.89 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 131.45 46.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.705 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.64 2.13 43.33 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -62.41 -17.02 58.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.573 ' O ' ' O ' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -105.1 103.24 40.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.397 178.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 87' ' ' ILE . 83.1 Cg_exo -49.74 -154.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.407 2.072 . . . . 1.0 112.489 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -109.21 -54.63 2.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.53 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -63.31 -45.04 93.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.78 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.4 -48.17 70.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.947 0.351 . . . . 1.0 111.947 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.621 ' NH2' ' CZ ' ' A' ' 56' ' ' PHE . 67.1 ttt180 -56.57 -34.68 67.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.426 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.5 ttt85 -64.25 -35.63 81.45 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.872 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.89 -38.47 91.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.281 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.614 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 40.0 m-85 -60.26 -29.97 69.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.977 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.489 ' C ' HE22 ' A' ' 99' ' ' GLN . 80.0 ttt-85 -84.2 -26.44 28.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.888 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.92 -46.92 6.03 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.434 1.272 . . . . 1.0 114.434 -175.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.526 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.58 -6.05 13.96 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.052 1.501 . . . . 1.0 115.052 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.769 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.7 mm-40 40.5 73.6 0.12 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.191 -1.004 . . . . 1.0 108.821 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 100' ' ' VAL . 6.2 p 176.1 118.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.993 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.456 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 30.6 tpt85 -168.66 134.6 1.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 1.0 110.715 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.456 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 4.5 m -149.82 155.28 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.564 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.525 ' CD1' ' NE2' ' A' ' 139' ' ' HIS . 96.9 mt -112.04 134.42 54.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.074 -0.713 . . . . 1.0 109.074 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.01 163.62 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 113.315 0.857 . . . . 1.0 113.315 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 173' ' ' PRO . 49.7 m-20 -45.92 120.11 2.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.986 -1.006 . . . . 1.0 112.156 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.8 -20.62 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.792 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.98 -44.86 83.65 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.16 -13.45 60.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.491 0.662 . . . . 1.0 109.387 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 46.66 72.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.675 -1.148 . . . . 1.0 113.327 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.82 131.98 42.98 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.002 -1.481 . . . . 1.0 107.002 175.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -118.75 134.16 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.003 -0.679 . . . . 1.0 111.904 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.1 164.49 30.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.555 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.3 pt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.084 179.676 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo . . . . . 0 N--CA 1.492 1.405 0 CA-C-O 120.708 0.212 . . . . 1.0 111.951 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.71 147.46 6.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.869 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -92.32 136.13 25.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -41.65 -21.51 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.226 2.618 . . . . 1.0 114.018 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.683 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 4.8 p -71.24 -46.12 61.75 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.751 0.278 . . . . 1.0 111.751 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.683 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 42.1 t60 -84.13 -29.11 26.99 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 1.8 p -62.65 -44.56 99.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.941 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.537 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 83.5 t60 -69.53 -30.3 68.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.738 -0.467 . . . . 1.0 109.738 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -58.2 -43.01 87.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.76 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.676 HD11 ' NE2' ' A' ' 139' ' ' HIS . 63.6 mt -72.99 -40.11 65.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.279 -0.637 . . . . 1.0 109.279 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -51.01 -39.1 54.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.568 -1.271 . . . . 1.0 107.568 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 m -65.17 -22.94 66.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.783 -1.099 . . . . 1.0 109.203 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.4 mmm -94.52 0.64 55.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.645 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.7 21.11 79.72 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 64.9 t -110.7 142.74 22.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.841 0.353 . . . . 1.0 111.063 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.55 -40.78 5.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.945 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.1 m -131.98 127.14 35.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.217 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.34 129.1 55.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.472 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.02 126.74 54.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.234 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.32 120.49 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 1.0 111.802 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.0 t -128.07 118.04 20.64 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -71.8 145.2 45.39 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.164 2.576 . . . . 1.0 114.721 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.3 mt -121.68 62.27 0.92 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -147.04 -163.31 1.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.099 0.777 . . . . 1.0 113.099 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.625 ' CE1' ' HE1' ' A' ' 163' ' ' TRP . 76.1 m80 -89.06 -178.4 5.68 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.357 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -74.22 -54.09 8.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.054 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.68 11.16 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.03 0.381 . . . . 1.0 112.03 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.5 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.7 tt0 -143.15 136.82 28.59 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 162' ' ' LEU . 5.6 tt -111.89 119.64 39.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.044 -0.526 . . . . 1.0 111.259 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.625 ' HE1' ' CE1' ' A' ' 158' ' ' HIS . 82.1 m95 -92.85 -41.07 10.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.265 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.442 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -160.15 -176.31 32.1 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.179 -0.768 . . . . 1.0 111.179 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.527 HD21 HD11 ' A' ' 162' ' ' LEU . 97.0 mt -140.09 133.72 30.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 1.0 111.522 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.8 tp -105.23 134.17 48.78 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.33 138.2 40.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.048 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m -114.4 132.25 56.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 1.0 109.98 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -109.77 137.01 48.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.999 0.428 . . . . 1.0 111.676 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -130.04 130.4 44.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.015 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.17 45.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.773 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -144.05 150.74 50.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.07 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.446 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 65.4 Cg_endo -71.51 -12.31 29.22 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.905 2.404 . . . . 1.0 111.92 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -40.97 104.54 0.34 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.904 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.07 168.2 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.532 2.155 . . . . 1.0 111.95 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -97.71 136.46 38.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.518 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.2 m -120.65 152.47 38.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.638 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -51.05 -31.47 18.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.665 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -56.5 -34.86 67.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.731 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -64.3 -43.56 94.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.504 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.0 mp -67.76 -35.06 78.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.575 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.463 ' NE2' HD11 ' A' ' 186' ' ' LEU . 23.1 tm0? -54.76 -39.74 68.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.367 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.35 -52.46 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.6 t -71.53 -34.92 54.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.401 0.519 . . . . 1.0 112.401 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -50.42 -46.99 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.646 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.463 HD11 ' NE2' ' A' ' 182' ' ' GLN . 51.2 mt -68.8 -40.1 79.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.914 0.339 . . . . 1.0 111.914 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.727 ' O ' HG23 ' A' ' 191' ' ' VAL . 6.3 tp -78.45 -37.71 42.92 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.86 0.319 . . . . 1.0 111.86 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.92 86.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.482 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -63.38 -41.17 98.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.002 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -69.03 -29.11 67.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.085 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 187' ' ' LEU . 49.0 t -82.4 -46.15 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.681 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.9 t -53.75 -35.6 61.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.0 mt -64.93 -34.69 72.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.2 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.65 -39.5 80.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.617 -0.72 . . . . 1.0 109.845 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.9 mm -59.55 -47.45 90.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.189 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.465 ' HB2' ' CE1' ' A' ' 158' ' ' HIS . . . -71.17 -46.28 61.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.09 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -66.54 -45.4 79.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.457 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.55 -32.7 74.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.669 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.43 -33.13 70.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.55 -0.296 . . . . 1.0 111.427 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.38 -35.09 76.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.664 0.269 . . . . 1.0 111.077 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 90.5 p -56.91 -55.69 31.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.564 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.551 179.567 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.882 0.372 . . . . 1.0 110.557 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -77.2 -29.76 54.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.942 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -78.53 -45.76 21.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.084 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 38' ' ' THR . 10.2 pt -64.8 -39.71 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.968 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.434 ' O ' ' OG1' ' A' ' 38' ' ' THR . 26.7 mt -59.72 -45.49 92.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.005 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -55.59 -34.46 64.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.42 -35.92 71.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.105 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 34' ' ' ILE . 82.8 p -70.26 -43.35 70.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.548 -0.751 . . . . 1.0 112.188 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.649 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.0 p -67.91 -36.59 76.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 111.911 0.337 . . . . 1.0 111.911 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' A' ' 43' ' ' ARG . 39.6 tp10 -66.31 -46.32 77.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.808 0.337 . . . . 1.0 111.076 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.84 -46.69 86.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.722 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 38' ' ' THR . 75.6 t -52.73 -45.06 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.955 -0.298 . . . . 1.0 111.138 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 47' ' ' GLY . 56.5 ttp180 -49.59 -39.52 35.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.825 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.56 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -76.46 -46.46 26.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.546 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.58 -27.73 25.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.507 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.4 21.49 34.1 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 169' ' ' HIS . 7.3 t -74.11 143.93 45.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 1.0 110.234 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 94.6 m-20 -43.6 -43.89 5.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.662 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' NH1' ' CD1' ' A' ' 74' ' ' LEU . 58.4 mtm-85 -154.98 131.71 10.67 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.078 -0.649 . . . . 1.0 112.56 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 51' ' ' VAL . 12.0 p -135.8 128.2 46.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -138.4 154.1 48.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.491 -0.484 . . . . 1.0 111.949 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 86.5 t -99.63 136.3 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 37.9 t80 -116.75 110.93 19.06 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.324 -0.55 . . . . 1.0 111.307 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.531 ' NH1' ' O ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -84.43 122.6 29.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.266 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.531 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 69.4 t80 -88.78 141.28 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 1.0 112.034 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.466 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 41.0 m-20 -111.97 140.0 22.95 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -46.03 -30.65 7.55 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.458 2.105 . . . . 1.0 112.46 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -81.17 -19.22 43.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 1.0 110.043 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.42 38.17 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.56 -0.616 . . . . 1.0 111.56 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -79.22 90.39 4.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.747 0.308 . . . . 1.0 110.699 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.85 152.09 21.2 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 p -125.69 148.87 48.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 1.0 111.711 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.78 109.3 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.623 ' O ' HG12 ' A' ' 65' ' ' VAL . 65.1 t -107.87 0.8 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.925 -0.31 . . . . 1.0 111.292 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.649 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.34 118.69 2.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.017 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -147.04 133.85 20.09 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.874 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.97 148.36 51.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 1.0 109.388 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.524 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 36.3 ptt180 -141.73 145.38 34.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.797 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -50.34 -37.17 31.34 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -175.1 -167.97 35.04 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.952 -0.859 . . . . 1.0 110.952 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.78 43.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 1.0 110.546 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 71' ' ' GLY . 53.9 mtt-85 -84.05 -46.68 11.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.13 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.454 ' CD1' ' NH1' ' A' ' 50' ' ' ARG . 13.3 mt -123.37 150.85 61.66 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.881 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.57 165.28 31.27 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.532 2.155 . . . . 1.0 112.191 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.9 p -93.33 131.81 38.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.981 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 80' ' ' LEU . 26.3 mt -89.78 9.04 28.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.454 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.83 130.46 45.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.989 -0.55 . . . . 1.0 112.263 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.62 -14.88 58.74 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.524 -0.762 . . . . 1.0 111.567 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 77' ' ' LEU . 77.3 mt -80.77 150.37 29.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.282 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.2 m -104.59 129.53 52.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.75 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -82.16 128.72 66.74 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -40.26 125.34 1.82 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.663 2.242 . . . . 1.0 111.882 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.07 132.68 52.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.74 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.39 1.6 44.08 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.539 -1.024 . . . . 1.0 110.539 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -56.78 -35.66 68.94 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 mt -88.76 126.95 57.97 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.425 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.664 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 85.6 Cg_endo -73.83 -155.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.477 2.118 . . . . 1.0 112.503 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -107.76 -68.78 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 1.0 111.557 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.671 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -49.44 -46.63 48.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.855 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.664 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -65.99 -45.48 81.43 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.719 HH12 ' NH2' ' A' ' 96' ' ' ARG . 71.8 ttt-85 -59.62 -35.34 74.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.475 -0.33 . . . . 1.0 111.513 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -63.51 -31.14 72.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.792 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.432 ' CD1' HH12 ' A' ' 101' ' ' ARG . 87.0 mt -69.25 -35.76 76.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.248 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.626 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 17.6 m-85 -59.14 -31.14 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.017 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.719 ' NH2' HH12 ' A' ' 92' ' ' ARG . 80.7 mtt180 -83.44 -23.61 32.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.815 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.4 mt -99.18 -47.5 5.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.0 -8.51 13.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -173.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.727 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.5 mm-40 39.21 80.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.16 -1.016 . . . . 1.0 108.817 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 100' ' ' VAL . 4.2 p 173.69 120.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.037 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -169.72 146.58 3.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.011 0.434 . . . . 1.0 110.716 177.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 101' ' ' ARG . 54.1 t -159.35 150.24 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.565 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.6 mt -108.06 134.63 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.03 165.11 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 15.4 p30 -45.99 117.89 1.68 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.988 -1.005 . . . . 1.0 112.114 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.81 -21.46 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.326 -0.852 . . . . 1.0 110.769 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.54 -43.22 90.63 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.12 -11.83 44.31 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.502 0.668 . . . . 1.0 109.356 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 45.29 69.26 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.748 -1.115 . . . . 1.0 113.291 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 m -76.29 132.36 39.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 174.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -119.44 139.22 52.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.0 -0.68 . . . . 1.0 111.886 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.422 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -124.4 149.91 46.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.576 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.146 178.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 120.675 0.198 . . . . 1.0 111.945 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' A' ' 140' ' ' VAL . 0.7 OUTLIER -109.38 123.61 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.909 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -41.3 153.48 0.25 Allowed Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -57.08 -21.59 43.1 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.194 2.596 . . . . 1.0 114.038 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.691 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 5.6 p -63.02 -46.57 86.97 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.691 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 16.4 t-80 -81.27 -27.15 35.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.245 0.461 . . . . 1.0 112.245 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' A' ' 135' ' ' VAL . 71.1 t -65.4 -53.61 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.915 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -65.74 -28.17 68.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -59.17 -42.98 92.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.7 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 146' ' ' MET . 17.5 mt -73.32 -38.85 65.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -52.12 -39.06 59.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.594 -1.261 . . . . 1.0 107.594 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.9 p -65.14 -20.55 66.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.769 -1.105 . . . . 1.0 109.186 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 143' ' ' LEU . 81.5 mmm -95.65 2.81 54.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.412 -0.813 . . . . 1.0 110.707 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.81 21.86 78.85 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.88 142.54 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 1.0 111.02 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.38 -21.03 13.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.931 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -147.82 160.63 42.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.155 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 p -148.38 126.37 12.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.469 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.43 128.7 55.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.302 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.82 121.05 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.173 0.511 . . . . 1.0 111.801 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.509 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 3.1 m -126.16 92.99 44.51 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.816 -1.179 . . . . 1.0 107.816 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.645 ' C ' HD12 ' A' ' 156' ' ' LEU . 90.4 Cg_exo -44.84 143.86 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.148 2.565 . . . . 1.0 114.672 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 155' ' ' PRO . 10.9 mp -121.91 60.24 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.818 -1.549 . . . . 1.0 106.818 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.3 ptm -147.66 -178.63 6.36 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.139 0.792 . . . . 1.0 113.139 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.606 ' CG ' ' N ' ' A' ' 159' ' ' HIS . 57.7 t-80 -71.08 172.66 8.74 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.289 -0.869 . . . . 1.0 111.368 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.606 ' N ' ' CG ' ' A' ' 158' ' ' HIS . 55.9 t-80 -61.48 -50.59 72.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.326 -0.852 . . . . 1.0 112.039 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -105.36 -37.66 6.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -89.97 136.13 33.23 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.957 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.722 HD23 ' O ' ' A' ' 162' ' ' LEU . 6.3 tt -107.39 118.46 36.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.279 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -92.55 -44.17 8.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.205 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -161.53 -176.11 33.28 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.63 138.16 34.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 1.0 111.534 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.437 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.5 tp -103.81 134.19 47.53 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.23 140.07 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.699 -0.401 . . . . 1.0 111.089 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.3 m -114.12 137.89 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.994 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.48 ' O ' ' OG1' ' A' ' 48' ' ' THR . 77.5 m-70 -111.46 135.65 51.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.003 0.43 . . . . 1.0 111.611 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -128.27 121.9 30.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.966 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.51 -12.54 60.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.817 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -129.83 148.02 67.81 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.018 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -44.32 146.48 1.93 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.952 2.435 . . . . 1.0 111.821 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -172.82 79.42 0.43 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.03 151.17 12.21 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.569 2.179 . . . . 1.0 111.933 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -99.41 136.16 39.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.482 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.7 m -125.65 172.45 9.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.593 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -50.47 -35.41 28.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.667 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -62.35 -50.11 72.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.682 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -62.34 -37.21 84.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.477 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.7 tp -61.47 -36.2 79.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.561 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -61.33 -30.12 70.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 1.0 111.36 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 74.4 t -71.35 -53.54 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 188' ' ' ALA . 34.7 m -77.94 -36.09 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.398 0.518 . . . . 1.0 112.398 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -54.9 -49.68 70.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.707 0.289 . . . . 1.0 111.631 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 33.4 tp -73.46 -39.73 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 187' ' ' LEU . 28.3 tp -79.21 -40.15 31.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.418 -0.355 . . . . 1.0 111.813 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.454 ' O ' ' OG ' ' A' ' 192' ' ' SER . . . -55.8 -36.38 67.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.56 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -77.68 -38.8 46.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 1.0 109.97 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.98 -35.99 82.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.127 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 192' ' ' SER . 7.6 p -83.65 -40.06 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.722 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.459 ' N ' HG13 ' A' ' 191' ' ' VAL . 68.7 m -54.43 -35.8 63.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.1 mt -61.42 -35.67 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.217 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.33 -38.58 78.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.756 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.13 -49.5 83.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.154 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.39 -46.84 65.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.864 -0.607 . . . . 1.0 111.138 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -64.23 -40.58 96.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 1.0 111.518 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.97 67.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.321 -0.399 . . . . 1.0 111.699 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -63.1 -37.91 89.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.495 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 48.6 mt -61.42 -31.77 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.983 -0.287 . . . . 1.0 111.083 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.6 m -54.6 -52.55 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.529 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 202' ' ' LEU . 31.0 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.521 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.534 ' CD2' ' NH2' ' A' ' 55' ' ' ARG . 39.4 tp . . . . . 0 C--O 1.23 0.028 0 CA-C-O 120.91 0.385 . . . . 1.0 110.594 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 65.5 t0 -79.61 -30.5 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.984 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -79.38 -45.16 20.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.08 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 35' ' ' LEU . 21.3 tt -61.52 -39.92 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 1.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.493 ' N ' HG23 ' A' ' 34' ' ' ILE . 58.7 mt -61.1 -45.51 94.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.049 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.477 HH12 ' CD2' ' A' ' 78' ' ' LEU . 77.9 mtt-85 -53.75 -38.55 64.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.564 -0.455 . . . . 1.0 109.938 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.92 -29.34 65.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.082 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.419 ' O ' HG13 ' A' ' 42' ' ' VAL . 25.5 m -73.08 -44.52 60.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.544 -0.753 . . . . 1.0 112.249 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.689 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 5.9 p -69.16 -37.57 76.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.55 -37.23 71.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.796 0.332 . . . . 1.0 111.112 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -67.49 -49.01 65.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.78 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 38' ' ' THR . 28.4 m -64.4 -31.22 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.136 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.8 tmt_? -61.09 -45.83 93.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.811 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.02 72.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.09 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -78.33 -41.35 33.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.58 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.7 mt -85.55 -30.23 23.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.427 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.02 20.07 32.92 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.455 -1.058 . . . . 1.0 110.455 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.6 p -72.59 143.23 48.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.343 . . . . 1.0 110.239 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -39.58 -53.55 2.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.607 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -154.04 130.75 10.76 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.048 -0.661 . . . . 1.0 112.588 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -136.95 128.97 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.582 -0.896 . . . . 1.0 108.582 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -139.73 154.51 47.46 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.532 -0.467 . . . . 1.0 111.932 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 59.0 t -109.69 137.18 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -132.86 134.25 44.37 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.26 -178.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.534 ' NH2' ' CD2' ' A' ' 31' ' ' LEU . 42.4 ttm-85 -90.61 138.21 31.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.241 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -92.99 117.01 29.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 1.0 112.077 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -84.09 149.85 56.86 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.35 -23.97 72.43 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.517 2.145 . . . . 1.0 112.481 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.66 -16.48 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.0 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.67 -12.36 42.41 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.534 -0.626 . . . . 1.0 111.534 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -75.3 96.11 3.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.784 0.326 . . . . 1.0 110.662 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.15 143.09 16.78 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.7 p -122.21 146.02 47.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 1.0 111.693 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.73 109.47 13.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 65' ' ' VAL . 20.5 t -108.74 -1.66 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.97 -0.292 . . . . 1.0 111.242 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.689 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.68 114.62 2.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.044 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.41 ' C ' ' OE1' ' A' ' 67' ' ' GLU . 1.6 pp20? -145.22 135.29 23.82 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.523 -0.471 . . . . 1.0 111.833 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.39 144.83 51.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.692 -0.685 . . . . 1.0 109.386 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.473 ' NH1' ' C ' ' A' ' 71' ' ' GLY . 34.3 ptt85 -136.55 143.65 43.78 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.746 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -49.17 -41.68 30.86 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -173.31 -167.46 33.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -70.96 39.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.735 0.302 . . . . 1.0 110.515 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 71' ' ' GLY . 39.2 ttm180 -83.08 -49.72 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.18 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.93 151.18 49.95 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 1.0 109.849 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.66 164.2 35.33 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.522 2.148 . . . . 1.0 112.144 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -94.88 131.14 41.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.988 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.492 ' HA ' HD12 ' A' ' 80' ' ' LEU . 43.7 mt -90.26 11.51 20.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.411 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' CD2' HH12 ' A' ' 36' ' ' ARG . 11.3 tp -63.2 130.19 43.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 1.0 112.288 -177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.99 -12.36 66.33 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.498 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 77' ' ' LEU . 79.6 mt -81.68 150.0 28.24 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.285 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -109.35 137.61 46.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.646 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -90.45 152.58 45.55 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.495 -0.557 . . . . 1.0 109.495 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.18 140.13 87.42 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.691 2.261 . . . . 1.0 111.816 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.02 126.83 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.709 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.89 -0.52 45.0 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.484 -1.046 . . . . 1.0 110.484 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -57.43 -37.87 73.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 87' ' ' ILE . 1.6 mp -70.96 114.34 26.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.429 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 99.9 Cg_exo -46.55 173.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.467 2.111 . . . . 1.0 112.481 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.523 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 96.2 mt-10 -104.5 -52.1 2.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.495 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.648 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 3.1 pm0 -68.55 -41.51 79.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.762 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 88' ' ' PRO . . . -66.04 -42.01 90.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.966 0.358 . . . . 1.0 111.966 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.501 ' NH2' HD13 ' A' ' 162' ' ' LEU . 67.0 ttt-85 -60.44 -36.44 78.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.487 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 75.3 mtt85 -66.58 -41.49 88.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.833 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.543 HD12 ' NH2' ' A' ' 101' ' ' ARG . 86.3 mt -64.9 -39.24 93.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.277 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.662 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 8.4 t80 -64.39 -28.76 69.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.02 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.457 ' C ' HE22 ' A' ' 99' ' ' GLN . 73.4 ttt-85 -81.95 -26.41 34.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.814 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.9 mt -98.18 -43.28 7.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.382 1.253 . . . . 1.0 114.382 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -111.8 -7.39 14.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.996 1.48 . . . . 1.0 114.996 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.713 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.6 mm-40 47.02 82.85 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.239 -0.984 . . . . 1.0 108.769 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.6 p 174.13 103.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.048 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.543 ' NH2' HD12 ' A' ' 94' ' ' LEU . 7.7 mmt-85 -143.87 139.54 29.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 1.0 110.825 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -171.6 147.25 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.539 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.603 HD11 ' CD2' ' A' ' 139' ' ' HIS . 71.0 mt -108.75 138.06 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.95 165.37 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -48.31 119.83 3.23 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.133 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.423 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.9 p -58.27 -27.58 32.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.296 -0.866 . . . . 1.0 110.793 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -66.67 -42.84 85.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.68 -9.79 4.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.519 0.676 . . . . 1.0 109.395 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 45.41 58.42 4.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.704 -1.134 . . . . 1.0 113.28 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.8 p -77.55 134.65 38.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.919 -1.511 . . . . 1.0 106.919 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -123.1 144.64 49.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.952 -0.699 . . . . 1.0 111.903 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -132.37 156.48 46.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.527 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 112' ' ' SER . 24.9 pt . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.193 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo . . . . . 0 N--CA 1.492 1.428 0 CA-C-O 120.76 0.233 . . . . 1.0 111.956 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.55 HG13 ' CG2' ' A' ' 140' ' ' VAL . 2.3 p -122.69 134.26 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.861 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.465 ' OD2' ' SG ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -46.53 151.22 1.05 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 138' ' ' CYS . 36.2 Cg_endo -59.62 -46.93 18.04 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.263 2.642 . . . . 1.0 113.991 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -36.66 -44.84 0.48 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.682 0.253 . . . . 1.0 111.682 -178.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.688 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.6 t60 -83.79 -27.87 28.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.55 ' CG2' HG13 ' A' ' 135' ' ' VAL . 91.7 t -68.09 -51.0 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.979 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -66.75 -30.86 71.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -58.54 -43.85 89.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.67 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 146' ' ' MET . 13.1 mt -73.28 -37.79 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -50.86 -39.17 53.09 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -64.38 -25.5 68.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.765 -1.107 . . . . 1.0 109.195 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.562 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.2 mmm -90.56 1.95 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.705 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.55 21.57 78.73 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.81 142.47 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.89 0.376 . . . . 1.0 111.062 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.47 -20.39 13.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.908 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -145.62 160.6 41.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.203 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.479 ' OG ' HD12 ' A' ' 103' ' ' ILE . 3.7 p -147.7 122.08 9.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.411 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.2 mp -108.6 139.81 42.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.293 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.81 118.41 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.128 0.49 . . . . 1.0 111.726 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.8 t -122.5 127.35 25.86 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.427 ' HB3' ' CE2' ' A' ' 95' ' ' PHE . 83.4 Cg_endo -76.33 148.62 30.5 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.135 2.557 . . . . 1.0 114.692 -176.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -136.63 49.01 2.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.814 -1.551 . . . . 1.0 106.814 177.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.02 -175.72 4.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -174.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.38 163.09 28.36 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.383 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.526 ' ND1' ' OE1' ' A' ' 160' ' ' GLN . 58.4 t-80 -66.65 -53.99 28.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.37 -0.832 . . . . 1.0 112.023 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.526 ' OE1' ' ND1' ' A' ' 159' ' ' HIS . 12.1 mm100 -99.78 8.81 43.95 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.047 0.388 . . . . 1.0 112.047 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -143.13 134.83 26.57 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.834 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 162' ' ' LEU . 1.1 mp -110.41 116.98 32.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.188 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -92.19 -41.01 10.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.263 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.607 ' O ' HD12 ' A' ' 165' ' ' LEU . . . -153.72 -177.95 27.71 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 164' ' ' GLY . 0.7 OUTLIER -146.02 143.71 29.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.897 0.379 . . . . 1.0 111.531 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.538 ' HB2' HD11 ' A' ' 156' ' ' LEU . 8.8 tp -112.18 132.75 54.72 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 167' ' ' VAL . 14.8 p -136.08 132.84 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.982 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 21.3 m -107.49 149.44 27.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.074 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -124.87 131.85 53.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.02 0.438 . . . . 1.0 111.648 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.6 113.8 14.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.98 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.45 -15.89 63.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.84 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -96.18 147.43 32.96 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.942 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.86 76.18 2.06 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.98 2.453 . . . . 1.0 111.886 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -113.77 97.76 45.37 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.836 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.75 164.83 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.494 2.129 . . . . 1.0 111.972 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 44.6 p90 -92.0 130.68 37.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.488 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 98.4 p -119.17 157.64 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.607 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -54.79 -34.75 63.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.638 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -57.12 -36.71 70.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.81 -36.59 83.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.499 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.4 mp -67.97 -38.13 82.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.53 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -53.58 -40.88 65.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.356 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 88.5 t -70.32 -56.43 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.39 -38.89 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.477 0.547 . . . . 1.0 112.477 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 181' ' ' LEU . 62.9 tt0 -49.98 -49.82 49.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.667 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 31.7 tp -70.16 -40.38 74.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.938 0.347 . . . . 1.0 111.938 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 187' ' ' LEU . 44.7 tp -76.44 -38.79 54.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.787 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.46 77.93 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.517 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.68 -39.27 80.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.94 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -65.66 -27.87 68.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.084 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -83.71 -41.8 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.736 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.8 p -56.64 -33.24 66.14 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.4 mt -69.94 -38.23 74.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.213 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.11 76.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.602 -0.727 . . . . 1.0 109.832 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.6 mm -60.59 -46.55 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.162 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.98 -45.64 66.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -67.59 -41.21 84.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.517 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.56 72.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.69 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.06 -39.79 93.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.559 -0.291 . . . . 1.0 111.492 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.32 -36.26 83.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.986 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 98.6 p -56.89 -52.92 63.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.784 0.326 . . . . 1.0 110.588 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.568 179.547 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.808 0.337 . . . . 1.0 110.585 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.7 -28.72 56.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.032 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -79.84 -46.49 16.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.128 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.566 HG23 ' N ' ' A' ' 35' ' ' LEU . 3.2 tp -63.8 -43.96 98.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.955 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.566 ' N ' HG23 ' A' ' 34' ' ' ILE . 83.6 mt -61.39 -49.26 77.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.015 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -53.84 -37.68 63.86 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 -30.14 66.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.013 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.4 m -73.54 -45.0 56.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.591 -0.731 . . . . 1.0 112.204 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.672 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.1 p -67.39 -34.98 72.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -70.5 -39.33 74.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 1.0 111.098 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -65.54 -50.78 63.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.829 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.23 -28.81 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.683 0.278 . . . . 1.0 111.128 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.3 tmm_? -61.88 -46.4 89.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.865 0.364 . . . . 1.0 110.882 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.15 -33.45 69.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.097 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -79.68 -41.18 27.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.551 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 mt -85.34 -35.42 21.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.453 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 62.31 20.54 61.01 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.521 -1.031 . . . . 1.0 110.521 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -73.42 141.63 46.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.808 0.337 . . . . 1.0 110.173 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.563 ' CG ' HH21 ' A' ' 73' ' ' ARG . 92.3 m-20 -39.45 -44.3 1.36 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.622 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -164.76 130.43 2.77 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.025 -0.67 . . . . 1.0 112.57 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.16 129.01 42.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.464 ' O ' HD12 ' A' ' 166' ' ' LEU . 51.6 pttt -140.83 154.81 46.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.867 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 58.1 t -98.47 135.04 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 176.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 47.5 t80 -115.74 105.36 12.64 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.323 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -76.16 124.81 28.04 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.232 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 86.7 t80 -90.87 142.18 28.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 1.0 112.02 -178.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 1.1 m-20 -112.04 151.36 43.53 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 108.617 -0.882 . . . . 1.0 108.617 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.48 -23.65 75.78 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.541 2.161 . . . . 1.0 112.469 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -88.32 -12.12 44.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 1.0 110.045 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.61 -13.85 57.92 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.572 -0.611 . . . . 1.0 111.572 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -78.88 89.83 4.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.855 0.36 . . . . 1.0 110.606 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.47 151.63 21.07 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -125.07 146.39 49.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 1.0 111.679 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.96 108.98 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 65' ' ' VAL . 52.5 t -105.79 -1.61 9.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.904 -0.318 . . . . 1.0 111.333 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.672 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.03 115.38 2.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.143 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.482 ' CD ' ' NH2' ' A' ' 69' ' ' ARG . 87.7 tt0 -143.14 132.49 23.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.074 0.464 . . . . 1.0 111.856 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.98 147.77 50.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.4 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.482 ' NH2' ' CD ' ' A' ' 67' ' ' GLU . 42.3 mtt85 -141.23 142.33 33.96 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.77 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.98 -31.21 80.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.41 -173.66 38.53 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -79.26 40.0 0.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 1.0 110.517 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.563 HH21 ' CG ' ' A' ' 49' ' ' ASP . 22.3 ttp-105 -83.19 -48.64 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.22 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -103.37 149.93 37.48 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.167 -0.47 . . . . 1.0 109.905 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.61 148.58 72.61 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.535 2.157 . . . . 1.0 112.138 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.0 m -76.83 125.2 28.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.907 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 80' ' ' LEU . 25.1 mt -103.99 9.75 36.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.323 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.54 132.43 41.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.182 0.515 . . . . 1.0 112.305 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.88 -7.96 75.05 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.624 -0.716 . . . . 1.0 111.521 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 77' ' ' LEU . 63.4 mt -88.38 154.87 20.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.76 0.314 . . . . 1.0 110.246 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -103.07 129.02 49.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.663 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -82.49 152.06 66.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.57 132.08 31.89 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.617 2.211 . . . . 1.0 111.848 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 128.72 37.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.052 0.454 . . . . 1.0 110.686 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.42 -0.17 40.29 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -59.24 -15.71 17.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.57 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.7 mt -104.14 105.62 49.77 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.696 -0.683 . . . . 1.0 109.465 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 87' ' ' ILE . 92.8 Cg_exo -48.11 -162.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.4 2.067 . . . . 1.0 112.485 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -107.21 -58.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.543 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.55 -42.04 86.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.835 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.84 -48.63 68.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.98 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -59.38 -37.94 79.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.445 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -64.51 -33.31 75.6 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.9 -0.32 . . . . 1.0 110.807 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.446 HD13 ' NH1' ' A' ' 101' ' ' ARG . 92.3 mt -64.49 -38.12 89.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.256 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.601 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 21.0 m-85 -61.45 -48.5 80.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.041 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -51.5 -34.57 36.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.835 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.4 mt -99.07 -38.01 9.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 114.4 1.259 . . . . 1.0 114.4 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.596 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.25 -13.25 11.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 115.105 1.52 . . . . 1.0 115.105 -174.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 21.6 mm-40 34.65 74.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.249 -0.98 . . . . 1.0 108.788 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.566 ' O ' HG13 ' A' ' 100' ' ' VAL . 7.6 p 177.17 117.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.122 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.446 ' NH1' HD13 ' A' ' 94' ' ' LEU . 2.0 tpt180 -176.0 145.36 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.922 0.391 . . . . 1.0 110.791 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.0 m -151.22 158.05 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.515 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.7 136.06 44.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 3.4 m -93.03 166.12 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 113.321 0.86 . . . . 1.0 113.321 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 173' ' ' PRO . 57.8 m-20 -46.31 118.42 1.93 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.918 -1.037 . . . . 1.0 112.166 -176.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.466 HG23 ' CG1' ' A' ' 140' ' ' VAL . 9.9 p -56.05 -22.73 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.789 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -62.56 -44.02 97.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.71 -10.97 31.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.56 0.695 . . . . 1.0 109.351 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 44.12 72.06 0.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.743 -1.117 . . . . 1.0 113.294 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.478 ' OG ' ' CG2' ' A' ' 104' ' ' VAL . 2.0 m -73.74 131.81 41.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.951 -1.499 . . . . 1.0 106.951 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -119.93 137.35 54.09 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.029 -0.668 . . . . 1.0 111.936 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.2 t -135.27 158.72 43.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.482 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 113' ' ' ILE . 44.9 mm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.15 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo . . . . . 0 N--CA 1.492 1.409 0 CA-C-O 120.747 0.228 . . . . 1.0 111.895 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.518 HG23 ' CG2' ' A' ' 140' ' ' VAL . 1.5 m -104.77 119.0 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.887 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 112' ' ' SER . 18.7 t70 -44.13 137.38 3.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.754 -0.462 . . . . 1.0 109.754 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -37.82 -46.72 2.01 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.141 2.561 . . . . 1.0 114.034 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.684 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -41.31 -45.28 2.95 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.668 0.247 . . . . 1.0 111.668 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.684 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 17.4 t60 -81.86 -28.19 33.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.235 0.458 . . . . 1.0 112.235 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.518 ' CG2' HG23 ' A' ' 135' ' ' VAL . 85.2 t -66.97 -54.09 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.963 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -63.99 -29.36 70.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -57.68 -45.15 85.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.68 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 146' ' ' MET . 16.8 mt -73.02 -38.81 66.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -51.07 -39.7 56.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -63.78 -24.91 67.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.766 -1.106 . . . . 1.0 109.147 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.549 ' N ' ' O ' ' A' ' 143' ' ' LEU . 80.6 mmm -91.08 2.09 56.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.731 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.14 20.69 79.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.21 141.63 22.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 1.0 111.014 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.63 -21.65 13.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.919 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.6 p -146.35 161.29 40.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.166 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 p -146.54 131.93 18.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.449 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -119.51 125.15 48.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.315 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 166' ' ' LEU . 2.8 t -113.32 114.14 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.129 0.49 . . . . 1.0 111.754 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.6 t -120.62 93.69 48.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.751 -1.203 . . . . 1.0 107.751 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -44.94 140.24 7.21 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.142 2.562 . . . . 1.0 114.666 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.473 HD23 HG11 ' A' ' 191' ' ' VAL . 6.6 mp -122.04 50.31 1.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.87 -1.53 . . . . 1.0 106.87 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.446 ' CE ' ' O ' ' A' ' 164' ' ' GLY . 0.1 OUTLIER -146.45 -174.18 4.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.118 0.784 . . . . 1.0 113.118 -176.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.745 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 8.2 m-70 -65.37 154.1 39.32 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.305 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -56.23 -46.04 79.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.342 -0.845 . . . . 1.0 112.035 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -103.6 -44.02 5.21 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.049 0.388 . . . . 1.0 112.049 -177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.492 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 88.3 tt0 -84.75 138.03 32.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.895 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.412 ' HG ' ' SD ' ' A' ' 157' ' ' MET . 3.1 tt -105.72 113.85 27.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.324 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.745 ' HE1' ' CD2' ' A' ' 158' ' ' HIS . 68.7 m95 -94.15 -39.95 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.255 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -156.87 -173.4 25.27 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.179 -0.769 . . . . 1.0 111.179 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 95' ' ' PHE . 11.4 tp -141.27 130.0 22.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.857 0.361 . . . . 1.0 111.526 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.579 ' O ' HG13 ' A' ' 153' ' ' VAL . 56.5 tp -101.96 133.01 47.43 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.4 p -142.2 134.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.059 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.3 p -107.41 146.54 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.016 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -119.73 131.44 55.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.989 0.423 . . . . 1.0 111.634 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.89 113.76 13.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.971 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.83 -17.07 64.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.815 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -83.57 146.79 50.91 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.031 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.446 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 71.2 Cg_endo -72.38 5.99 2.49 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.898 2.399 . . . . 1.0 111.863 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -51.42 131.49 34.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.39 167.12 26.3 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.557 2.172 . . . . 1.0 111.883 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 50.4 p90 -88.95 132.8 34.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.466 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.1 t -117.25 147.22 42.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.565 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -50.96 -34.66 29.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.63 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -55.3 -41.1 71.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.709 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.47 -41.3 98.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.491 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.1 tp -63.82 -38.96 93.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.534 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -54.83 -35.03 63.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.308 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.7 t -70.61 -52.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.805 0.668 . . . . 1.0 112.805 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 t -77.31 -30.97 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -52.67 -49.87 64.38 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.026 -0.27 . . . . 1.0 111.646 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 186' ' ' LEU . 7.5 mp -70.71 -37.27 73.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.876 ' O ' HG23 ' A' ' 191' ' ' VAL . 8.0 tp -77.57 -37.83 49.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.828 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.27 95.81 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.552 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -61.11 -39.29 89.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 1.0 109.958 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -71.99 -29.05 63.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.115 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 187' ' ' LEU . 26.3 t -82.38 -48.78 17.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.712 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 84.2 p -50.66 -27.57 7.23 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.5 mt -77.51 -32.54 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.2 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -69.47 -47.69 63.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.617 -0.719 . . . . 1.0 109.803 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.1 pp -67.47 -35.53 73.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.134 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.46 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -70.68 -49.7 44.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.15 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.19 -32.36 66.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.496 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.09 -34.25 77.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.701 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -56.26 -29.85 61.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.575 -0.284 . . . . 1.0 111.445 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.593 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.9 mp -60.13 -33.28 71.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.702 0.287 . . . . 1.0 111.033 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 63.3 p -52.95 -54.62 32.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.566 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.2 mp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.488 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.342 . . . . 1.0 110.542 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -48.43 -32.78 8.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.987 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -78.72 -45.56 20.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.065 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.8 mm -64.5 -39.93 87.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.878 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.7 mt -59.83 -45.94 90.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.006 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -57.31 -37.25 72.18 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.45 -28.48 65.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.079 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 42' ' ' VAL . 23.7 m -74.05 -47.24 38.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.526 -0.761 . . . . 1.0 112.244 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.673 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p -65.27 -34.52 71.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.949 0.351 . . . . 1.0 111.949 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.48 -49.55 70.95 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.9 -47.24 81.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.766 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 38' ' ' THR . 68.9 t -53.51 -46.49 59.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.989 -0.284 . . . . 1.0 111.165 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 47' ' ' GLY . 15.5 ttt-85 -49.87 -38.48 35.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.771 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.52 75.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -76.8 -44.12 33.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.552 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mt -86.2 -27.58 24.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.502 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.68 22.02 24.01 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.449 -1.061 . . . . 1.0 110.449 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.5 p -74.44 144.18 44.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.884 0.373 . . . . 1.0 110.194 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -42.35 -39.83 2.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.659 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 42.9 ttm180 -162.73 129.08 3.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.038 -0.665 . . . . 1.0 112.574 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.81 130.95 53.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.472 ' HZ2' ' CG1' ' A' ' 167' ' ' VAL . 17.4 pttp -141.57 158.64 43.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.073 0.464 . . . . 1.0 111.969 -177.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 62.7 t -100.48 136.85 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 177.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -119.08 104.78 10.78 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.392 -0.523 . . . . 1.0 111.272 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.638 HH22 ' CG2' ' A' ' 195' ' ' ILE . 42.5 mmt-85 -77.3 128.0 33.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.264 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.498 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 78.9 t80 -93.32 139.21 30.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 1.0 112.024 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.498 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 1.6 m-20 -109.03 151.24 41.82 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.658 -0.867 . . . . 1.0 108.658 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.44 -23.93 72.61 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.516 2.144 . . . . 1.0 112.483 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -87.08 -13.26 44.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.64 -11.56 57.91 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.569 -0.613 . . . . 1.0 111.569 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -80.69 90.54 5.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.793 0.33 . . . . 1.0 110.642 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.7 151.43 20.88 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.617 -0.993 . . . . 1.0 110.617 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -124.77 149.01 47.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 1.0 111.679 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.5 t -77.93 109.16 12.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.0 t -107.06 -0.3 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.327 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.673 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.39 115.97 2.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.038 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 86.0 tt0 -144.5 132.73 21.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.839 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.3 142.31 50.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.415 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -140.04 144.79 37.06 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.721 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.441 ' CA ' HH21 ' A' ' 43' ' ' ARG . . . -60.55 -35.31 88.86 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -172.7 -164.33 27.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.59 25.69 0.33 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.76 0.314 . . . . 1.0 110.536 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -72.19 -48.0 46.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.117 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.432 ' C ' HH22 ' A' ' 50' ' ' ARG . 15.1 mt -106.65 148.35 36.67 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.879 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.526 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 58.1 Cg_endo -69.59 137.99 37.27 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.49 2.127 . . . . 1.0 112.166 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.1 t -72.44 123.46 23.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.936 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HA ' HD12 ' A' ' 80' ' ' LEU . 19.9 mt -99.02 11.32 39.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.397 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.7 tp -71.43 128.89 37.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.241 0.543 . . . . 1.0 112.261 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.79 -9.44 76.33 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.455 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 77' ' ' LEU . 60.8 mt -85.7 152.06 23.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.307 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.1 p -104.51 132.89 50.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.731 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -87.23 128.15 56.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.557 -0.534 . . . . 1.0 109.557 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -41.28 133.08 3.24 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.675 2.25 . . . . 1.0 111.862 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.36 132.48 49.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.657 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.77 0.58 42.53 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.53 -1.028 . . . . 1.0 110.53 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -54.52 -33.85 60.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.9 mt -90.61 111.71 49.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.361 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' A' ' 87' ' ' ILE . 87.2 Cg_exo -51.89 -157.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.411 2.074 . . . . 1.0 112.467 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 74.8 mm-40 -109.43 -54.59 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.536 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.83 -43.86 97.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.822 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.27 76.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.436 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 51.2 ttt85 -56.06 -35.38 66.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.393 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 75.4 mtt85 -64.22 -34.01 77.12 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.812 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.407 HD12 ' NH2' ' A' ' 101' ' ' ARG . 12.8 mt -65.19 -37.42 87.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.332 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE2' ' HG3' ' A' ' 101' ' ' ARG . 32.2 m-85 -59.88 -30.78 69.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.096 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -79.93 -26.26 40.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.829 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.548 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 82.3 mt -100.65 -44.66 5.76 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.44 1.274 . . . . 1.0 114.44 -175.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.53 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -118.23 -12.45 9.97 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 115.078 1.511 . . . . 1.0 115.078 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.572 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 38.8 79.72 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.166 -1.014 . . . . 1.0 108.827 -178.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.751 ' O ' HG13 ' A' ' 100' ' ' VAL . 11.1 p -177.11 102.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.066 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.435 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 11.1 mmt180 -148.07 151.18 35.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.923 0.392 . . . . 1.0 110.746 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -169.54 147.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.476 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.41 HG23 HG11 ' A' ' 135' ' ' VAL . 76.8 mt -109.41 134.8 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 m -92.16 164.65 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.331 0.863 . . . . 1.0 113.331 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 18.0 p30 -43.98 117.7 1.27 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.98 -1.009 . . . . 1.0 112.156 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.74 -19.55 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.734 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.28 -43.04 92.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.03 -13.28 62.07 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.56 0.695 . . . . 1.0 109.453 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.556 ' CD ' HH21 ' A' ' 111' ' ' ARG . 55.4 tt0 45.74 72.59 0.21 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.684 -1.143 . . . . 1.0 113.334 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.0 t -73.86 131.66 41.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.556 HH21 ' CD ' ' A' ' 109' ' ' GLN . 93.9 mtt180 -118.99 139.14 52.19 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.943 -0.703 . . . . 1.0 111.886 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.416 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.2 OUTLIER -130.97 152.11 50.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.513 179.199 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.5 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.146 179.665 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 120.642 0.184 . . . . 1.0 111.956 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.41 HG11 HG23 ' A' ' 103' ' ' ILE . 1.6 p -98.88 116.51 42.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.797 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' A' ' 112' ' ' SER . 10.7 t70 -43.1 136.95 2.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD3' ' H ' ' A' ' 112' ' ' SER . 62.3 Cg_exo -42.42 -49.5 6.22 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 123.213 2.609 . . . . 1.0 114.019 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.689 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -36.88 -45.33 0.55 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.645 0.239 . . . . 1.0 111.645 -178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.689 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.5 t60 -81.55 -27.73 34.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.254 0.464 . . . . 1.0 112.254 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 137' ' ' PRO . 40.2 t -65.39 -52.97 45.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.967 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -64.77 -27.62 69.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.419 ' O ' ' OG ' ' A' ' 145' ' ' SER . 76.4 t80 -61.21 -46.45 90.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.678 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 146' ' ' MET . 54.0 mt -73.11 -37.62 66.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -38.69 58.74 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.561 -1.274 . . . . 1.0 107.561 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 5.7 p -62.82 -20.4 65.01 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.782 -1.099 . . . . 1.0 109.201 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 143' ' ' LEU . 95.4 mmm -95.49 1.21 53.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.774 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.92 24.5 71.79 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.25 140.8 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 1.0 111.014 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.63 -38.12 6.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.934 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.3 m -133.59 125.77 29.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 1.0 111.109 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.8 m -115.42 138.29 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.45 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.5 mt -116.55 139.5 50.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.313 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.44 114.81 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.482 . . . . 1.0 111.818 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 184' ' ' VAL . 95.7 t -123.43 91.28 49.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.477 ' O ' HD12 ' A' ' 156' ' ' LEU . 85.7 Cg_exo -48.31 144.57 12.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 123.144 2.563 . . . . 1.0 114.705 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.481 HD23 ' CG1' ' A' ' 191' ' ' VAL . 7.9 mp -121.54 66.87 0.89 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -149.58 -172.92 4.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.129 0.788 . . . . 1.0 113.129 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.584 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 54.8 t-80 -77.6 173.89 11.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.413 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.584 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 92.9 m-70 -61.73 -52.46 64.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.387 -0.824 . . . . 1.0 112.058 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -104.53 -40.52 6.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.054 0.391 . . . . 1.0 112.054 -177.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE1' ' CD2' ' A' ' 163' ' ' TRP . 7.7 tm-20 -87.81 136.6 32.89 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.691 -0.403 . . . . 1.0 110.93 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.536 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER -111.55 116.3 30.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.272 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.533 ' CD2' ' OE1' ' A' ' 161' ' ' GLU . 25.1 m95 -88.67 -33.91 17.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.277 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.82 -173.79 36.19 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.233 -0.747 . . . . 1.0 111.233 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.3 135.41 30.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 1.0 111.495 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.14 136.2 43.38 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.472 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 9.5 p -140.36 135.01 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.121 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.5 m -108.93 139.86 43.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.029 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -116.33 133.68 55.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.948 0.404 . . . . 1.0 111.653 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.71 123.16 30.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.94 178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.43 41.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.794 -177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -165.07 148.52 7.3 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.041 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.475 ' O ' ' C ' ' A' ' 174' ' ' ARG . 77.8 Cg_exo -41.42 -75.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.884 2.389 . . . . 1.0 111.897 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.475 ' C ' ' O ' ' A' ' 173' ' ' PRO . 54.3 ttt85 33.65 84.59 0.18 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.875 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.0 162.93 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.541 2.161 . . . . 1.0 111.894 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 51.6 p90 -82.69 125.93 31.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.464 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.0 t -113.6 148.59 35.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.565 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -52.9 -27.01 16.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.631 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -58.14 -43.25 87.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.685 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -64.13 -35.85 82.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.479 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 18.8 tp -60.68 -41.78 95.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.536 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -58.35 -34.94 71.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.342 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 64.0 t -67.84 -53.33 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 185' ' ' GLN . 33.6 m -70.35 -43.71 78.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.395 0.517 . . . . 1.0 112.395 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 184' ' ' VAL . 65.8 mm-40 -43.51 -42.12 4.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.954 -0.299 . . . . 1.0 111.644 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.9 mt -74.97 -44.9 45.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.889 ' O ' HG23 ' A' ' 191' ' ' VAL . 57.3 mt -80.55 -39.79 27.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.827 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.64 84.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.492 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -65.84 -39.64 90.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.002 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -67.69 -29.43 68.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 187' ' ' LEU . 58.6 t -84.08 -45.03 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.714 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 57.9 p -55.37 -31.38 61.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 52.6 mt -76.73 -34.31 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.234 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.11 -42.4 84.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.82 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.638 ' CG2' HH22 ' A' ' 55' ' ' ARG . 37.4 pt -68.15 -33.72 62.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.163 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -70.13 -50.71 37.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.14 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -71.67 -36.51 70.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.479 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.66 -35.04 79.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -56.93 -29.58 63.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.472 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.622 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.2 mp -61.91 -34.15 75.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.682 0.277 . . . . 1.0 111.069 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 35.0 m -49.92 -54.08 22.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.563 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.579 179.695 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.888 0.375 . . . . 1.0 110.604 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -55.71 -50.93 69.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.978 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.596 HE22 ' NH2' ' A' ' 36' ' ' ARG . 84.7 mm-40 -57.03 -45.54 83.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.077 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.22 -47.15 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 1.0 110.939 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -58.68 -48.41 81.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.048 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.596 ' NH2' HE22 ' A' ' 33' ' ' GLN . 66.3 mtm180 -56.42 -36.32 68.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.442 . . . . 1.0 109.83 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.88 65.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.061 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 42' ' ' VAL . 27.2 m -73.29 -47.82 39.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.556 -0.747 . . . . 1.0 112.149 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.676 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.3 p -65.6 -35.07 74.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.38 -50.93 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 1.0 111.105 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -61.03 -43.36 99.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.784 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 38' ' ' THR . 79.8 t -57.36 -42.57 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.714 0.293 . . . . 1.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 47' ' ' GLY . 62.7 ttp85 -51.29 -40.18 58.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.763 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.41 78.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.041 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -78.38 -45.97 21.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 1.0 111.56 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.87 -31.8 22.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.53 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.93 20.71 27.71 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.6 p -70.92 142.0 51.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 1.0 110.167 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -40.98 -41.28 1.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.633 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.536 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -163.34 128.7 3.08 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.079 -0.648 . . . . 1.0 112.606 -178.582 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.9 130.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -139.98 157.2 46.05 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.441 -0.504 . . . . 1.0 111.903 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.8 t -100.23 136.95 29.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.525 -0.917 . . . . 1.0 108.525 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 50.1 t80 -130.28 128.96 42.64 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.322 -0.551 . . . . 1.0 111.227 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -94.94 132.43 39.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.18 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -91.33 118.63 30.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -87.79 151.4 49.88 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 108.639 -0.875 . . . . 1.0 108.639 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.76 -20.85 60.84 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.48 2.12 . . . . 1.0 112.444 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -82.77 -17.51 43.92 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.06 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.73 -15.41 37.78 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.549 -0.621 . . . . 1.0 111.549 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 40.5 m80 -64.14 -104.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.773 0.32 . . . . 1.0 110.632 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.453 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . 103.89 152.97 23.09 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -128.09 147.51 50.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 1.0 111.696 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.458 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.5 p -81.66 117.06 27.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.93 4.87 9.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.696 0.284 . . . . 1.0 111.37 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.676 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.99 118.58 2.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.104 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 85.8 tt0 -144.37 133.21 22.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 1.0 111.846 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.2 151.5 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.393 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -139.74 142.26 36.82 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.762 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -39.96 -68.96 0.5 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.96 83.84 0.13 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 41.7 38.65 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.746 0.308 . . . . 1.0 110.522 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -82.62 -53.53 5.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.215 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.2 mt -110.27 141.42 23.85 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.888 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.14 165.67 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.479 2.12 . . . . 1.0 112.176 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.8 t -93.38 123.41 36.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.871 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.508 ' HA ' HD12 ' A' ' 80' ' ' LEU . 20.9 mt -90.59 2.59 55.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.376 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.16 131.12 49.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.179 0.514 . . . . 1.0 112.28 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.67 -13.55 63.89 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.545 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 77' ' ' LEU . 78.0 mt -82.1 150.93 27.24 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.309 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.5 m -106.14 134.4 49.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.703 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.92 153.04 49.29 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.92 136.16 51.52 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.692 2.262 . . . . 1.0 111.879 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.465 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . . . -67.21 130.56 43.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.708 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.4 -2.43 39.93 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.497 -1.041 . . . . 1.0 110.497 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 20.8 p-10 -54.61 -38.19 66.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.4 mm -75.08 133.49 75.39 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.42 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.736 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 98.9 Cg_endo -72.28 -175.21 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.426 2.084 . . . . 1.0 112.526 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -105.46 -51.25 3.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.556 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.43 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 21.5 pt-20 -67.5 -41.97 83.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.843 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.736 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -68.16 -42.47 80.01 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.876 0.324 . . . . 1.0 111.876 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.604 HH22 HD22 ' A' ' 162' ' ' LEU . 61.0 ttt85 -63.83 -41.82 97.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.471 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -60.23 -32.96 71.62 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.879 -0.329 . . . . 1.0 110.847 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HB2' HH22 ' A' ' 101' ' ' ARG . 96.4 mt -71.46 -35.91 71.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.289 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.53 -40.85 96.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.02 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -63.66 -33.57 75.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.81 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.553 ' C ' HE22 ' A' ' 99' ' ' GLN . 72.0 mt -97.18 -37.11 10.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 114.389 1.255 . . . . 1.0 114.389 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.563 ' C ' ' NE2' ' A' ' 99' ' ' GLN . . . -118.01 -10.1 10.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.11 1.522 . . . . 1.0 115.11 -175.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.648 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 41.58 79.48 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.114 -1.034 . . . . 1.0 108.864 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 100' ' ' VAL . 7.8 p 179.78 107.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.096 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.514 ' NH1' ' O ' ' A' ' 91' ' ' ALA . 8.9 ttm105 -153.27 148.76 27.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.954 0.407 . . . . 1.0 110.803 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 p -167.62 150.26 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.502 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.3 mt -106.91 136.43 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 105' ' ' ASP . 22.4 t -88.78 158.64 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -176.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.502 ' N ' HG12 ' A' ' 104' ' ' VAL . 64.5 m-20 -48.37 122.77 5.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.913 -1.039 . . . . 1.0 112.121 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.19 -26.71 26.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.786 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.9 -46.75 83.45 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.79 -12.67 50.29 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.49 0.662 . . . . 1.0 109.359 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 45.86 72.2 0.24 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.767 -1.106 . . . . 1.0 113.275 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 p -73.74 130.53 40.17 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.915 -1.513 . . . . 1.0 106.915 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -118.57 133.99 55.44 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.946 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 t -125.96 145.32 50.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.55 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.201 179.777 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 120.723 0.218 . . . . 1.0 111.904 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.562 HG23 ' CG2' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -103.24 117.9 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.824 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 138' ' ' CYS . 19.4 t70 -43.72 137.8 3.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -39.45 -20.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 123.153 2.569 . . . . 1.0 114.005 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.701 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.1 p -64.91 -46.06 83.28 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.662 0.245 . . . . 1.0 111.662 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.701 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.8 t60 -82.75 -24.53 33.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.562 ' CG2' HG23 ' A' ' 135' ' ' VAL . 72.0 t -65.85 -52.03 54.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.651 -0.42 . . . . 1.0 110.947 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.9 -29.71 69.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.778 -0.452 . . . . 1.0 109.778 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -58.49 -46.66 86.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.74 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 146' ' ' MET . 11.6 mt -72.73 -38.13 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -51.29 -38.71 54.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -65.04 -25.33 67.78 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.153 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.1 mmm -90.77 0.36 57.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.668 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.87 79.1 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.06 142.19 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.889 0.376 . . . . 1.0 110.969 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.53 -29.31 9.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.912 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.441 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 37.8 m -138.5 155.3 48.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.198 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 p -145.49 126.77 14.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.446 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tp -110.3 134.91 51.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.284 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 166' ' ' LEU . 5.7 t -122.81 120.92 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.182 0.515 . . . . 1.0 111.725 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 184' ' ' VAL . 1.2 m -114.81 167.37 9.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -83.27 122.36 3.24 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.187 2.591 . . . . 1.0 114.667 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.3 tp -124.24 35.56 4.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -146.34 177.7 8.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.158 0.799 . . . . 1.0 113.158 -176.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.677 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 40.8 t60 -68.73 -171.51 0.29 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.344 -0.843 . . . . 1.0 111.365 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.677 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 56.1 t-80 -73.68 -54.27 8.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.403 -0.817 . . . . 1.0 112.097 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -104.95 -32.01 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.046 0.387 . . . . 1.0 112.046 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 85.1 tt0 -94.05 141.41 28.57 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.88 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.604 HD22 HH22 ' A' ' 92' ' ' ARG . 7.2 tt -108.15 116.02 31.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.263 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.515 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 77.8 m95 -89.86 -37.64 14.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.266 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.04 -174.69 35.01 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.56 132.61 31.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.807 0.337 . . . . 1.0 111.563 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.481 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.5 tp -101.61 133.79 45.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 167' ' ' VAL . 11.7 p -140.13 133.25 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.796 -0.361 . . . . 1.0 111.147 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 78.6 p -109.76 139.89 44.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.025 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -113.66 133.34 55.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.026 0.441 . . . . 1.0 111.651 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -130.93 130.85 43.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.597 . . . . 1.0 109.973 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.32 59.02 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.785 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -160.14 128.7 2.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.993 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.426 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 90.0 Cg_endo -77.21 22.36 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.922 2.414 . . . . 1.0 111.883 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -72.57 126.24 90.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.883 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -46.7 153.01 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.609 2.206 . . . . 1.0 111.882 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -86.24 141.86 28.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.481 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.7 m -118.07 150.24 39.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.598 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -57.74 -29.4 64.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.623 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -56.24 -38.47 71.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.756 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.25 -40.03 94.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.548 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.03 -37.94 89.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.509 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -53.62 -39.36 64.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.917 -0.583 . . . . 1.0 111.382 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.25 -54.33 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.592 HG21 HG11 ' A' ' 154' ' ' VAL . 7.3 p -78.9 -36.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -47.53 -49.22 26.77 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.656 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 33.5 mt -75.19 -38.35 60.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.97 -41.32 51.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.801 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.39 86.96 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.504 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.29 -37.76 70.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.976 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -68.85 -24.73 64.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.118 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.8 t -83.99 -45.35 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.793 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 85.5 p -56.86 -35.25 68.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.0 mt -66.96 -33.95 66.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.426 -0.806 . . . . 1.0 109.185 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.42 -38.35 74.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.778 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 195' ' ' ILE . 38.2 mm -59.28 -49.35 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.112 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.454 ' O ' ' CD1' ' A' ' 200' ' ' LEU . . . -71.59 -48.61 47.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.836 -0.62 . . . . 1.0 111.122 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -63.96 -42.9 97.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.496 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.89 -31.11 71.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.673 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -58.29 -31.97 67.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.592 -0.277 . . . . 1.0 111.417 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.7 mp -60.63 -34.58 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.045 -0.262 . . . . 1.0 111.054 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 31.7 t -55.31 -56.72 16.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.538 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.587 179.829 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.911 0.386 . . . . 1.0 110.574 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.45 -51.07 69.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.964 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -56.64 -47.49 79.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.066 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.51 -47.85 91.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.787 0.327 . . . . 1.0 110.974 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.9 mt -55.91 -42.42 76.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 1.0 111.056 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.24 -35.29 62.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -34.6 70.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.065 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 42' ' ' VAL . 64.5 p -73.1 -41.22 64.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.498 -0.774 . . . . 1.0 112.271 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.607 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 8.2 p -70.44 -37.66 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.23 -46.65 79.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.151 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -59.89 -47.92 83.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.78 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 38' ' ' THR . 71.0 t -53.58 -38.43 33.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.986 -0.285 . . . . 1.0 111.115 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.541 ' NH1' ' O ' ' A' ' 69' ' ' ARG . 54.1 ttp180 -53.62 -44.11 69.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.339 . . . . 1.0 110.85 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.38 -34.2 70.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.117 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -74.14 -43.92 55.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.549 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.57 -30.12 19.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.421 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.5 20.88 1.12 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.534 HG21 ' CD2' ' A' ' 170' ' ' HIS . 5.5 p -63.64 -96.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.81 0.338 . . . . 1.0 110.236 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -155.6 -47.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 1.0 111.658 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -154.76 124.23 6.47 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.954 -0.699 . . . . 1.0 112.515 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.8 t -128.35 129.39 69.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -141.08 149.74 42.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.888 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 23.8 t -111.84 138.16 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.495 ' CD1' ' C ' ' A' ' 54' ' ' TYR . 2.4 p90 -136.15 139.09 42.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.314 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -93.31 141.38 28.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.294 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.64 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 64.0 t80 -92.69 117.54 30.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 1.0 112.123 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 17.3 p-10 -88.17 150.72 47.83 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.41 -20.11 67.05 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.516 2.144 . . . . 1.0 112.476 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -87.02 -19.82 28.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 1.0 110.096 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.64 -16.07 37.53 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.589 -0.604 . . . . 1.0 111.589 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.547 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 93.7 m-70 -74.25 91.81 2.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 1.0 110.561 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.55 144.36 20.51 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.3 p -122.01 143.47 49.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 1.0 111.666 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.481 ' O ' HD12 ' A' ' 78' ' ' LEU . 61.1 t -79.18 110.87 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.27 2.17 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.387 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.607 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.94 123.98 4.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.112 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -146.09 132.59 19.73 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.519 -0.472 . . . . 1.0 111.797 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.77 141.53 51.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.381 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.541 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 30.0 ptt180 -143.06 144.21 32.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.724 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.14 -34.81 47.87 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -173.27 -168.64 34.72 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.437 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 77.2 mm-40 -72.35 44.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 1.0 110.49 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 71' ' ' GLY . 56.9 ttm-85 -83.47 -48.85 9.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.141 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.36 149.77 41.54 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.906 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.13 165.19 33.21 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.577 2.185 . . . . 1.0 112.094 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.9 p -88.19 129.4 35.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.952 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.512 ' HA ' HD12 ' A' ' 80' ' ' LEU . 25.6 mt -98.47 2.57 47.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.364 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 64' ' ' VAL . 6.0 tp -62.01 131.35 49.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 1.0 112.337 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.17 -14.03 61.86 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.549 -0.75 . . . . 1.0 111.505 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 77' ' ' LEU . 68.3 mt -82.12 151.06 27.15 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.963 -0.295 . . . . 1.0 110.29 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.4 p -104.83 130.55 52.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.657 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -85.61 153.76 58.58 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.28 135.68 59.53 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.704 2.269 . . . . 1.0 111.897 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.23 126.75 29.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.722 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.3 -0.58 43.64 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.49 -37.13 64.92 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.061 ' H ' HD12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -81.55 113.52 42.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.413 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 87' ' ' ILE . 80.4 Cg_exo -49.47 -171.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.468 2.112 . . . . 1.0 112.474 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 79.3 mm-40 -108.43 -55.85 2.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.553 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -59.88 -42.53 93.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.789 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.99 -51.05 59.91 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.922 0.342 . . . . 1.0 111.922 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.783 ' HE ' HH21 ' A' ' 96' ' ' ARG . 59.3 ttt85 -50.17 -35.44 26.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.504 -0.316 . . . . 1.0 111.427 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 78.5 mtt85 -67.78 -35.16 78.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.798 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.7 mt -58.37 -39.03 78.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.273 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.615 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 92.5 m-85 -61.57 -50.44 72.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.052 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.783 HH21 ' HE ' ' A' ' 92' ' ' ARG . 95.6 mtt180 -54.56 -32.68 58.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.811 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.2 mt -101.39 -44.04 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.428 1.27 . . . . 1.0 114.428 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.12 -15.3 11.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 115.057 1.502 . . . . 1.0 115.057 -173.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 19.9 mm-40 44.16 79.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.205 -0.998 . . . . 1.0 108.849 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 100' ' ' VAL . 7.6 p -179.36 107.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.074 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -156.15 150.94 26.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 1.0 110.777 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -170.43 148.51 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.498 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.2 mt -109.37 135.13 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.39 165.16 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 113.243 0.831 . . . . 1.0 113.243 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -46.51 119.38 2.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.91 -1.041 . . . . 1.0 112.13 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.427 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.6 p -56.75 -22.36 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.737 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.01 -44.68 91.88 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.18 -10.17 29.14 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.494 0.664 . . . . 1.0 109.36 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 45.21 71.42 0.27 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.734 -1.121 . . . . 1.0 113.308 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -73.82 132.7 42.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.979 -1.489 . . . . 1.0 106.979 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -121.5 137.99 54.49 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.882 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -132.89 155.85 48.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.528 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 112' ' ' SER . 25.0 pt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.149 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.493 1.446 0 CA-C-O 120.671 0.196 . . . . 1.0 111.991 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.582 HG23 ' CG2' ' A' ' 140' ' ' VAL . 2.9 m -110.97 129.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.915 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -43.96 134.56 4.0 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -40.35 -46.53 4.32 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.124 2.549 . . . . 1.0 114.007 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 3.8 p -39.33 -45.4 1.43 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.686 0.254 . . . . 1.0 111.686 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.668 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.2 t60 -81.36 -29.34 34.09 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.276 0.473 . . . . 1.0 112.276 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.582 ' CG2' HG23 ' A' ' 135' ' ' VAL . 98.6 t -65.67 -52.53 49.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.961 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -66.75 -27.67 67.79 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -60.21 -45.51 92.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.775 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 146' ' ' MET . 65.1 mt -73.44 -35.82 65.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -52.18 -39.13 59.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.593 -1.262 . . . . 1.0 107.593 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 p -65.24 -20.63 66.51 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.779 -1.1 . . . . 1.0 109.158 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 143' ' ' LEU . 89.4 mmm -93.83 1.45 56.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.462 -0.79 . . . . 1.0 110.735 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.5 22.21 78.64 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.66 142.35 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 1.0 110.986 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.89 -42.99 4.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.484 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 7.2 t -129.84 125.8 36.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 1.0 111.17 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 m -112.96 135.49 53.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.458 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tp -115.13 136.85 52.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.291 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.24 113.96 39.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.15 0.5 . . . . 1.0 111.753 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.16 110.52 30.91 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.66 149.21 54.56 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.144 2.562 . . . . 1.0 114.671 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.48 ' CD2' ' HB1' ' A' ' 188' ' ' ALA . 29.6 mt -125.34 68.44 1.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.796 -1.557 . . . . 1.0 106.796 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.4 ptm -148.04 -173.84 4.41 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.594 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 30.7 t-80 -78.26 178.57 7.52 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.321 -0.854 . . . . 1.0 111.373 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.594 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 13.0 m-70 -74.13 -55.39 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.309 -0.859 . . . . 1.0 112.122 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -105.0 11.92 32.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -144.29 137.61 27.35 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.922 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.715 HD22 ' NH2' ' A' ' 92' ' ' ARG . 7.9 tt -112.38 117.42 32.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.258 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -92.19 -34.19 14.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.289 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.77 -167.58 25.55 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.445 HD21 ' CD2' ' A' ' 95' ' ' PHE . 1.4 mt -152.42 144.69 23.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 1.0 111.592 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 167' ' ' VAL . 2.7 tp -114.51 139.18 49.77 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.58 ' N ' HD12 ' A' ' 166' ' ' LEU . 8.4 p -140.4 140.6 34.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 69.5 m -113.53 143.11 45.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.968 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -113.54 131.8 55.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 1.0 111.572 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.666 ' N ' ' ND1' ' A' ' 170' ' ' HIS . 0.0 OUTLIER -124.67 121.19 34.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.844 -0.616 . . . . 1.0 109.961 178.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.0 -16.03 60.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.79 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -107.88 139.0 20.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.012 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 174' ' ' ARG . 72.7 Cg_exo -39.54 -73.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.885 2.39 . . . . 1.0 111.883 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 173' ' ' PRO . 17.0 ttp85 35.41 88.83 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.903 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.87 162.86 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.521 2.148 . . . . 1.0 111.986 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.454 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 50.8 p90 -90.88 131.33 36.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.43 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.1 t -121.21 157.39 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.599 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -53.01 -32.17 45.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.14 -39.38 86.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.731 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.1 -45.29 89.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.429 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.76 -36.29 83.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.581 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -55.41 -39.39 70.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.392 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.4 t -67.85 -55.54 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.545 HG12 ' HB2' ' A' ' 188' ' ' ALA . 3.4 t -70.82 -46.54 68.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.452 0.538 . . . . 1.0 112.452 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -41.48 -46.31 3.44 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.663 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 15.5 tp -71.6 -42.79 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 191' ' ' VAL . 46.4 tp -77.2 -40.44 45.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.86 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.545 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -57.19 -37.9 72.86 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.473 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -61.56 -39.75 92.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.33 -0.395 . . . . 1.0 109.982 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -64.98 -28.62 69.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.104 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 187' ' ' LEU . 20.6 t -84.04 -41.22 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.791 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m -56.7 -36.7 69.95 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 mt -65.46 -38.7 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.445 -0.798 . . . . 1.0 109.221 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.52 83.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.838 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.3 -47.34 92.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.171 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.82 -46.85 62.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.147 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -65.92 -42.54 90.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.508 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.73 -31.83 72.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.679 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.79 -40.14 95.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.521 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 200' ' ' LEU . 20.5 tp -62.85 -36.58 83.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.67 0.272 . . . . 1.0 111.011 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 38.8 t -50.74 -51.48 49.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.594 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.532 179.654 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.8 tp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.9 0.381 . . . . 1.0 110.551 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 25.0 p-10 -76.83 -28.66 55.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.043 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -77.81 -47.09 19.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.086 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 pt -63.41 -38.58 82.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 1.0 110.964 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -60.84 -49.38 77.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.054 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -53.93 -39.5 65.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.71 -28.92 67.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.073 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.443 ' O ' HG23 ' A' ' 42' ' ' VAL . 11.6 m -71.47 -47.46 55.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.445 -0.798 . . . . 1.0 112.196 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.687 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 3.4 p -68.09 -33.27 59.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 111.907 0.336 . . . . 1.0 111.907 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -69.1 -51.36 39.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.829 0.347 . . . . 1.0 111.14 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -61.73 -45.65 93.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.745 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 38' ' ' THR . 84.6 t -61.56 -35.73 68.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.696 0.284 . . . . 1.0 111.169 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.618 ' NH2' ' CA ' ' A' ' 70' ' ' GLY . 15.7 tpt85 -56.51 -42.19 77.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.803 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.97 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.112 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -79.08 -43.2 24.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.624 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.3 mt -86.43 -32.28 20.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.461 -0.336 . . . . 1.0 111.455 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.54 19.28 18.54 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.564 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 67.3 m -69.97 141.21 53.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.859 0.361 . . . . 1.0 110.209 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' THR . 92.3 m-20 -37.16 -45.9 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.578 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.618 ' NH2' ' CE1' ' A' ' 169' ' ' HIS . 19.2 ttp-105 -163.66 126.7 2.62 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.985 -0.686 . . . . 1.0 112.567 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 51' ' ' VAL . 10.6 p -133.91 127.83 52.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 176.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -140.09 155.65 46.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.14 0.495 . . . . 1.0 111.878 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 62.0 t -98.96 133.65 40.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 176.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -115.01 112.27 22.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.262 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -84.45 127.18 33.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.219 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.442 ' CE2' ' CZ ' ' A' ' 92' ' ' ARG . 71.9 t80 -95.26 134.16 38.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 1.0 112.039 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.86 140.32 20.95 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.36 -27.83 7.55 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 C-N-CA 122.495 2.13 . . . . 1.0 112.441 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -83.39 -16.22 46.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 1.0 110.089 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.56 -13.55 46.9 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.572 -0.611 . . . . 1.0 111.572 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -78.23 90.86 4.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.771 0.319 . . . . 1.0 110.616 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.97 150.8 20.44 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.527 -1.029 . . . . 1.0 110.527 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.4 p -124.85 147.79 48.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.372 . . . . 1.0 111.741 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 77' ' ' LEU . 22.1 t -75.82 107.93 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 65' ' ' VAL . 37.2 t -106.51 -1.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.282 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.687 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.64 113.82 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.068 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.4 tt0 -143.74 135.78 26.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.087 0.47 . . . . 1.0 111.758 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.25 131.97 47.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.415 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -124.65 147.21 48.68 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.711 -0.396 . . . . 1.0 110.725 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.618 ' CA ' ' NH2' ' A' ' 43' ' ' ARG . . . -72.25 -134.79 0.18 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.794 -0.922 . . . . 1.0 110.794 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.26 59.12 1.12 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.006 -0.838 . . . . 1.0 111.006 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 41.83 46.73 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.667 0.27 . . . . 1.0 110.486 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 73' ' ' ARG . 2.0 tpm_? -82.73 -48.72 10.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.401 HD13 ' NH1' ' A' ' 50' ' ' ARG . 42.0 mt -107.38 131.44 21.71 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.862 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.48 145.65 11.73 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.575 2.183 . . . . 1.0 112.111 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 p -72.79 123.34 23.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.978 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 80' ' ' LEU . 16.8 mt -98.62 13.6 31.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.309 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 23.9 tp -73.14 129.17 37.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.269 0.557 . . . . 1.0 112.209 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.56 -9.94 71.61 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.602 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 77' ' ' LEU . 68.8 mt -85.12 153.07 22.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.808 0.337 . . . . 1.0 110.243 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.6 m -105.91 132.54 51.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -85.17 152.0 57.78 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.52 127.52 13.33 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.714 2.276 . . . . 1.0 111.854 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 142.33 57.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.623 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.35 1.18 37.99 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.938 ' O ' HG23 ' A' ' 87' ' ' ILE . 20.2 p-10 -50.84 -52.95 36.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.938 HG23 ' O ' ' A' ' 86' ' ' ASP . 1.9 pp -171.42 50.63 0.14 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.437 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 87' ' ' ILE . 4.1 Cg_endo -94.57 -0.84 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.398 2.065 . . . . 1.0 112.531 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -90.67 -82.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.037 -0.528 . . . . 1.0 111.494 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -78.79 -48.23 15.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.772 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.33 74.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.868 0.321 . . . . 1.0 111.868 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.917 HH12 HD22 ' A' ' 162' ' ' LEU . 58.5 ttt85 -71.68 -39.95 69.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.421 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -63.1 -43.32 98.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.824 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.493 HD12 ' NH2' ' A' ' 101' ' ' ARG . 76.1 mt -64.72 -41.73 95.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.297 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.431 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 1.2 t80 -55.04 -44.02 74.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.022 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -56.6 -28.58 60.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.803 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.698 ' C ' HE22 ' A' ' 99' ' ' GLN . 75.1 mt -98.24 -39.63 8.76 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -177.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.594 ' N ' ' NE2' ' A' ' 99' ' ' GLN . . . -119.38 -13.12 9.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.994 1.479 . . . . 1.0 114.994 -174.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.698 HE22 ' C ' ' A' ' 97' ' ' LEU . 0.1 OUTLIER 35.67 81.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.192 -1.003 . . . . 1.0 108.858 -178.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.72 ' O ' HG13 ' A' ' 100' ' ' VAL . 11.0 p -174.64 108.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.075 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.493 ' NH2' HD12 ' A' ' 94' ' ' LEU . 56.6 mmt-85 -141.87 146.01 35.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 1.0 110.781 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.5 p -171.83 135.93 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.573 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.8 137.0 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.459 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 32.8 m -91.04 165.04 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 17.8 p30 -48.65 119.35 3.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.895 -1.048 . . . . 1.0 112.106 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 140' ' ' VAL . 9.3 p -53.77 -21.74 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.785 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -65.85 -45.28 82.77 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.404 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . . . -65.9 -16.02 63.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.557 0.694 . . . . 1.0 109.411 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 46.4 72.71 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.757 -1.111 . . . . 1.0 113.314 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.459 ' OG ' ' CG2' ' A' ' 104' ' ' VAL . 1.1 p -73.51 129.01 37.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.97 -1.493 . . . . 1.0 106.97 174.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -116.61 134.9 54.28 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.96 -0.696 . . . . 1.0 111.937 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.96 163.96 31.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.514 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 pt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.209 178.838 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo . . . . . 0 N--CA 1.491 1.38 0 CA-C-O 120.743 0.226 . . . . 1.0 111.971 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.83 149.31 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.871 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -94.51 156.24 38.75 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -55.39 -29.03 66.36 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.195 2.597 . . . . 1.0 113.974 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.711 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.7 OUTLIER -60.4 -46.25 90.66 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.705 0.261 . . . . 1.0 111.705 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.711 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 4.4 t60 -80.64 -24.16 39.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.271 0.471 . . . . 1.0 112.271 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 106' ' ' VAL . 63.3 t -66.33 -54.11 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.944 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -64.9 -28.84 69.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -60.26 -45.85 91.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.776 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 146' ' ' MET . 27.3 mt -73.02 -37.2 67.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -50.98 -39.52 55.63 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.2 m -64.36 -24.47 67.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.746 -1.115 . . . . 1.0 109.204 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.565 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -91.86 -2.92 56.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.437 -0.801 . . . . 1.0 110.684 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.91 20.36 79.74 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.4 t -108.48 143.06 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 1.0 110.933 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.51 -42.74 4.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.948 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.8 m -131.99 124.22 28.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 1.0 111.164 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.2 p -108.73 139.59 43.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.444 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 tp -121.95 125.82 47.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.232 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -119.74 113.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.182 0.515 . . . . 1.0 111.774 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.13 107.09 54.39 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.745 -1.205 . . . . 1.0 107.745 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -40.43 128.18 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.189 2.593 . . . . 1.0 114.681 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.54 HD11 ' CG1' ' A' ' 191' ' ' VAL . 13.7 tp -116.49 41.4 2.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.868 -1.53 . . . . 1.0 106.868 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 7.9 ptm -146.92 178.81 8.05 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 30.4 t-80 -69.04 -176.92 0.94 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.34 -0.846 . . . . 1.0 111.415 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.641 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 96.3 m-70 -68.77 -55.2 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.426 -0.806 . . . . 1.0 112.066 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -104.15 -42.3 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -83.47 129.43 34.98 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.882 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.917 HD22 HH12 ' A' ' 92' ' ' ARG . 6.7 tt -103.68 117.72 35.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.263 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -92.51 -39.78 11.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.244 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.58 -176.28 36.89 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.1 mt -138.24 136.46 36.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.778 0.323 . . . . 1.0 111.55 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.425 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.9 tp -105.84 130.95 53.71 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.63 142.14 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.743 -0.383 . . . . 1.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 m -112.59 138.52 49.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.054 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.618 ' CE1' ' NH2' ' A' ' 50' ' ' ARG . 56.1 m80 -106.98 121.6 44.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.977 0.418 . . . . 1.0 111.69 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -122.04 112.51 18.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.991 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.76 -15.09 63.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.884 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -87.51 148.39 44.12 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.3 -2.32 11.5 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.95 2.433 . . . . 1.0 111.88 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -41.59 131.25 2.3 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.878 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.82 167.23 25.67 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.578 2.185 . . . . 1.0 111.977 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 43.7 p90 -79.94 126.7 31.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.505 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.7 t -114.54 147.36 39.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.574 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.583 ' H ' ' CD ' ' A' ' 178' ' ' GLN . 11.1 mp0 -53.75 -32.45 52.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 1.0 110.622 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -62.35 -41.49 98.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.749 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -62.93 -43.79 97.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.465 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.5 mt -65.31 -37.76 88.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.558 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -54.1 -36.15 62.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.397 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.6 -54.47 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.1 -32.37 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -54.19 -50.31 67.34 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.627 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.8 tp -70.14 -38.41 75.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.005 0.372 . . . . 1.0 112.005 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 191' ' ' VAL . 38.0 tp -77.75 -38.65 46.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.812 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.18 86.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.502 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.86 -40.14 91.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.964 0.411 . . . . 1.0 110.041 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -71.71 -24.44 61.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.146 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 187' ' ' LEU . 87.5 t -82.79 -48.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.718 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 82.9 p -55.34 -35.4 65.15 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.4 mt -65.61 -33.83 66.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.215 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.58 -38.49 77.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.776 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.1 mm -60.04 -46.6 94.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.123 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.26 -45.51 69.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.087 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -65.99 -40.71 91.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.495 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.91 70.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.308 -0.405 . . . . 1.0 111.733 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.35 -35.68 78.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.51 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.04 -32.28 71.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -54.37 -53.16 57.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.648 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.1 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.559 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.887 0.375 . . . . 1.0 110.563 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -74.98 -50.04 17.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.975 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -57.01 -48.12 79.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.066 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 35' ' ' LEU . 18.8 tt -65.93 -43.31 92.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.759 0.314 . . . . 1.0 110.974 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.549 ' N ' HG23 ' A' ' 34' ' ' ILE . 30.7 mt -61.37 -46.72 89.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.033 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -59.5 -37.5 78.46 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.66 -29.62 67.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.128 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 42' ' ' VAL . 45.8 m -73.5 -48.0 36.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.476 -0.783 . . . . 1.0 112.259 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.654 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.0 p -65.14 -33.41 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.01 0.374 . . . . 1.0 112.01 -178.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -65.72 -49.15 69.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.342 . . . . 1.0 111.112 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.92 -38.61 89.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.748 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 38' ' ' THR . 86.0 t -61.05 -44.8 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.169 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 47' ' ' GLY . 61.7 ttp85 -53.71 -39.42 65.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.778 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.57 -37.84 79.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -79.45 -44.0 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.539 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.12 -33.59 22.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 1.0 111.523 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 60.45 19.52 53.61 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.457 -1.057 . . . . 1.0 110.457 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.515 HG23 ' CD2' ' A' ' 170' ' ' HIS . 93.9 m -72.27 142.31 48.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.349 . . . . 1.0 110.244 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -39.35 -45.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.625 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -163.72 130.91 3.36 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.046 -0.661 . . . . 1.0 112.545 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 51' ' ' VAL . 10.6 p -138.47 128.63 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 176.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -140.35 155.2 46.87 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.897 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.9 t -100.04 136.57 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 176.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.449 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 39.7 t80 -126.61 127.31 45.03 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.35 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.468 ' NE ' HG21 ' A' ' 65' ' ' VAL . 57.4 mtm180 -92.33 127.58 37.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.196 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 67.2 t80 -89.83 118.49 29.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 1.0 112.03 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 17.5 p-10 -90.04 152.37 46.13 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -59.43 -19.26 50.53 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.524 2.15 . . . . 1.0 112.458 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -82.6 -21.22 35.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.921 0.391 . . . . 1.0 110.04 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.11 -17.24 35.06 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.564 -0.614 . . . . 1.0 111.564 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' A' ' 84' ' ' ALA . 40.9 m80 -63.36 -100.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.603 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . 102.3 154.84 25.54 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 p -126.74 149.57 49.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 1.0 111.726 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.3 t -78.21 111.15 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.796 -0.816 . . . . 1.0 108.796 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 65' ' ' VAL . 58.3 t -107.19 -1.04 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.304 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.11 113.23 2.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.025 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 88.4 tt0 -143.12 134.1 25.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.133 0.492 . . . . 1.0 111.816 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.57 139.7 52.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.666 -0.697 . . . . 1.0 109.414 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -135.21 147.72 49.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.861 0.363 . . . . 1.0 110.74 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -51.34 -36.86 38.22 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 168.76 -160.26 33.67 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -65.08 4.31 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.312 . . . . 1.0 110.527 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 71' ' ' GLY . 68.0 ttp85 -66.74 -46.8 74.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.165 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.45 HD11 ' NH2' ' A' ' 73' ' ' ARG . 34.7 mt -118.48 116.84 34.92 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.864 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.28 157.07 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.514 2.143 . . . . 1.0 112.183 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 p -96.61 130.21 43.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.925 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 80' ' ' LEU . 44.4 mt -91.29 13.59 16.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.422 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.9 tp -65.62 130.38 43.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.979 -0.555 . . . . 1.0 112.265 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.46 -10.66 72.55 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.54 -0.754 . . . . 1.0 111.498 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 77' ' ' LEU . 76.0 mt -83.82 148.88 26.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.959 -0.296 . . . . 1.0 110.336 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.5 p -105.31 135.58 46.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.655 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -88.56 151.53 48.2 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.42 138.38 65.25 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.643 2.229 . . . . 1.0 111.863 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 61' ' ' HIS . . . -66.38 128.28 35.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.429 . . . . 1.0 110.7 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.6 -1.6 42.46 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -55.44 -37.42 67.69 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 88' ' ' PRO . 8.5 mm -77.8 113.41 32.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.641 -0.709 . . . . 1.0 109.388 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 87' ' ' ILE . 92.7 Cg_exo -46.8 -176.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.429 2.086 . . . . 1.0 112.48 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.53 -49.34 3.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.502 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.81 -39.33 87.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.868 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.01 -51.71 43.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.928 0.344 . . . . 1.0 111.928 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.634 ' NH2' ' CE2' ' A' ' 56' ' ' PHE . 64.0 ttt180 -53.31 -39.62 64.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.465 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -62.8 -33.07 74.44 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.758 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.16 -36.43 74.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.304 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.669 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 11.0 m-85 -59.62 -29.88 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.996 0.427 . . . . 1.0 110.028 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.516 ' C ' HE22 ' A' ' 99' ' ' GLN . 79.6 ttt-85 -83.28 -25.82 31.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.865 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.6 mt -97.42 -45.42 6.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 114.416 1.265 . . . . 1.0 114.416 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.514 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.83 -6.66 12.65 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.743 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 3.0 mm-40 41.24 78.28 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.133 -1.027 . . . . 1.0 108.787 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.8 p 171.42 116.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.115 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.5 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -169.89 130.59 1.01 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.388 . . . . 1.0 110.808 177.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.5 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 3.5 m -147.02 157.55 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.439 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.6 mt -108.52 132.97 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 105' ' ' ASP . 5.6 p -92.54 159.96 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.299 0.851 . . . . 1.0 113.299 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 104' ' ' VAL . 2.2 p30 -45.21 119.65 2.13 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.94 -1.027 . . . . 1.0 112.128 -177.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.458 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.9 p -53.32 -19.74 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.335 -0.848 . . . . 1.0 110.799 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.17 -46.32 84.54 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.404 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . . . -64.64 -13.55 54.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.492 0.663 . . . . 1.0 109.356 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 44.5 70.37 0.34 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.745 -1.116 . . . . 1.0 113.212 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.6 t -74.97 131.17 40.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.968 -1.493 . . . . 1.0 106.968 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -118.89 134.47 55.15 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.974 -0.69 . . . . 1.0 111.859 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.01 148.35 50.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.501 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.126 179.819 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo . . . . . 0 N--CA 1.492 1.436 0 CA-C-O 120.686 0.202 . . . . 1.0 111.957 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.69 115.2 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.871 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -43.58 139.01 2.79 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -40.51 -44.57 4.4 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 123.255 2.637 . . . . 1.0 114.014 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.738 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.9 p -40.74 -48.6 3.02 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.733 0.272 . . . . 1.0 111.733 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.738 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 15.2 t-80 -81.12 -27.2 35.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.278 0.473 . . . . 1.0 112.278 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.458 ' CG1' HG23 ' A' ' 106' ' ' VAL . 43.6 t -64.23 -53.21 46.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.636 -0.425 . . . . 1.0 111.023 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -65.7 -29.09 69.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.75 -43.46 94.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 1.0 109.737 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 146' ' ' MET . 9.3 mt -72.7 -39.21 67.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -50.82 -38.82 51.0 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 177.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.1 m -65.88 -24.53 66.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.847 -1.069 . . . . 1.0 109.171 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.8 mmm -92.4 -2.03 56.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.682 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.11 19.65 78.61 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.5 t -106.88 143.92 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 1.0 111.061 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.69 -43.91 3.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.993 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -134.35 121.0 20.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.198 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.3 t -111.99 142.98 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.402 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 tp -116.44 139.52 50.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.267 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.81 120.35 52.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.167 0.508 . . . . 1.0 111.745 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.1 t -126.09 120.0 23.82 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.49 ' C ' HD12 ' A' ' 156' ' ' LEU . 98.6 Cg_endo -72.63 124.35 9.72 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.243 2.629 . . . . 1.0 114.655 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 156' ' ' LEU . 8.3 mp -102.37 58.98 0.81 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.846 -1.539 . . . . 1.0 106.846 177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.406 ' N ' ' OG ' ' A' ' 192' ' ' SER . 6.0 ptt? -147.95 -170.15 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.076 0.769 . . . . 1.0 113.076 -176.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.676 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 70.3 t60 -80.52 -179.56 7.24 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.424 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.676 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 60.0 t60 -74.79 -54.06 8.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.392 -0.822 . . . . 1.0 112.093 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -103.66 13.35 33.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.04 0.385 . . . . 1.0 112.04 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -146.39 140.21 26.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.714 -0.395 . . . . 1.0 110.904 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.8 OUTLIER -112.61 119.68 38.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.267 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -92.43 -35.53 13.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.306 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -163.88 -178.02 37.13 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.208 -0.757 . . . . 1.0 111.208 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' TYR . 87.5 mt -138.4 133.4 32.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.841 0.353 . . . . 1.0 111.551 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.5 tp -102.33 133.97 46.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.87 135.14 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.089 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.0 m -109.56 139.17 44.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.003 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.429 ' O ' ' CG2' ' A' ' 48' ' ' THR . 48.5 m80 -108.2 119.29 39.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.674 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.515 ' CD2' HG23 ' A' ' 48' ' ' THR . 72.9 m80 -120.59 113.83 20.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 1.0 109.952 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.2 -16.08 61.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.841 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.99 138.01 72.82 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.013 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.94 10.82 2.19 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.978 2.452 . . . . 1.0 111.919 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -68.76 148.43 98.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.846 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.2 161.92 41.86 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.512 2.141 . . . . 1.0 111.939 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 44.0 p90 -74.87 133.6 41.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.465 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.8 m -112.51 147.91 35.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.69 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -59.88 -28.39 67.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.616 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -55.51 -44.12 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.693 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.3 -36.46 83.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.473 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.4 tp -62.23 -42.16 99.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.516 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.84 -33.74 64.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 1.0 111.371 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.34 -56.86 11.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 188' ' ' ALA . 13.5 m -78.7 -30.61 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.435 0.531 . . . . 1.0 112.435 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -51.06 -54.19 27.05 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.614 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 24.4 tp -75.14 -39.24 60.6 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 191' ' ' VAL . 6.2 tp -76.46 -41.47 47.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.891 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -57.19 -39.8 76.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.519 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -58.29 -39.22 78.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.012 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -66.21 -28.39 68.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.132 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 187' ' ' LEU . 16.3 t -82.98 -44.57 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.782 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.406 ' OG ' ' N ' ' A' ' 157' ' ' MET . 1.5 t -53.71 -29.64 40.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.671 -0.862 . . . . 1.0 108.671 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.1 mm -77.19 -33.46 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.465 -0.789 . . . . 1.0 109.268 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.69 -47.81 44.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.893 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.1 pp -65.53 -37.17 79.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.142 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -72.01 -47.01 55.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.134 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -71.53 -36.0 70.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.519 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.59 74.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.645 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -59.35 -32.49 70.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.483 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.668 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.8 mp -61.32 -33.68 74.0 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.025 -0.27 . . . . 1.0 111.029 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -51.52 -53.66 35.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.571 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.543 179.563 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.867 0.365 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -77.64 -29.34 51.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -77.87 -45.93 22.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.139 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 34' ' ' ILE . 12.3 pt -64.23 -38.66 83.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.46 -0.337 . . . . 1.0 110.884 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 40.3 mt -61.17 -50.64 72.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.033 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -53.81 -38.23 64.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.27 -29.96 66.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.043 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 42' ' ' VAL . 28.3 m -74.17 -45.32 49.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.509 -0.768 . . . . 1.0 112.269 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.629 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.9 p -67.77 -34.53 68.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -67.45 -46.14 73.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.85 0.357 . . . . 1.0 111.173 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -64.42 -41.09 96.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.783 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 38' ' ' THR . 79.6 t -61.19 -43.19 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.1 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLY . 66.8 ttp85 -55.03 -41.03 70.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 1.0 110.824 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.23 -36.55 73.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.026 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -79.37 -42.35 25.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.56 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mt -85.39 -32.52 22.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.466 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 61.81 20.31 59.57 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.474 -1.05 . . . . 1.0 110.474 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.447 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 69.7 m -73.1 141.18 47.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 1.0 110.132 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -40.03 -45.1 1.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 1.0 111.634 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.667 ' HE ' ' CE1' ' A' ' 169' ' ' HIS . 56.9 ttp180 -162.68 130.89 3.91 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.06 -0.656 . . . . 1.0 112.596 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.24 129.82 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' HZ1' HG11 ' A' ' 167' ' ' VAL . 24.8 pttm -141.69 152.86 44.27 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.912 -177.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.6 t -102.32 134.86 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.563 -0.902 . . . . 1.0 108.563 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.488 ' OH ' ' O ' ' A' ' 61' ' ' HIS . 52.1 t80 -120.89 126.29 49.64 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.299 -0.561 . . . . 1.0 111.293 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 163' ' ' TRP . 18.2 tpt85 -87.23 124.76 33.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.276 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -88.76 119.84 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.326 -0.397 . . . . 1.0 112.023 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.87 151.9 43.98 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.87 -21.84 59.53 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.491 2.127 . . . . 1.0 112.493 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -82.23 -15.59 52.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.378 . . . . 1.0 110.032 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.39 -15.79 49.67 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.489 -0.644 . . . . 1.0 111.489 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.488 ' O ' ' OH ' ' A' ' 54' ' ' TYR . 84.8 m-70 -64.09 -104.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.934 -0.307 . . . . 1.0 110.62 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.462 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . 102.61 155.95 25.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 p -127.58 151.07 49.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.935 0.398 . . . . 1.0 111.688 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.82 108.38 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.53 -0.76 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.314 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.629 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -160.09 113.02 2.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.099 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 87.6 tt0 -144.28 132.59 21.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.146 0.498 . . . . 1.0 111.798 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -131.16 140.97 50.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.413 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ptt-85 -142.91 150.1 39.34 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.02 -121.8 0.01 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.856 -0.898 . . . . 1.0 110.856 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -81.01 -175.94 50.39 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.641 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 1.1 pm0 -73.09 45.46 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.777 0.322 . . . . 1.0 110.488 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 71' ' ' GLY . 15.4 tpt180 -84.31 -47.84 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.175 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 23.3 mt -116.64 146.71 38.23 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.168 -0.469 . . . . 1.0 109.878 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.59 163.23 38.92 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.459 2.106 . . . . 1.0 112.218 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -92.79 130.68 38.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.958 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 80' ' ' LEU . 29.7 mt -95.85 12.73 29.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.429 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.406 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 18.8 tp -70.89 131.12 43.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.284 0.564 . . . . 1.0 112.261 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.84 -8.8 78.67 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.608 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 77' ' ' LEU . 74.6 mt -87.01 151.97 22.79 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.325 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.2 p -105.18 134.27 48.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.675 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -89.65 151.24 45.55 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.94 135.87 36.46 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.681 2.254 . . . . 1.0 111.884 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . . . -66.12 136.77 56.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.71 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.29 -3.47 40.41 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.528 -1.029 . . . . 1.0 110.528 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -52.35 -40.78 62.39 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.1 mt -80.99 133.23 54.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.445 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.719 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 85.9 Cg_endo -74.89 -161.97 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.385 2.057 . . . . 1.0 112.513 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.02 -57.99 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.584 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -60.18 -45.76 92.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.8 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.719 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -65.1 -44.61 88.24 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -58.69 -34.99 71.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.459 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -63.71 -34.4 77.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.766 0.317 . . . . 1.0 110.805 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' ALA . 11.9 mt -65.31 -34.16 77.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.297 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.662 ' C ' HE21 ' A' ' 99' ' ' GLN . 17.7 m-85 -64.24 -55.13 23.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.014 0.435 . . . . 1.0 110.01 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 159' ' ' HIS . 79.5 ttt180 -48.04 -33.92 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.843 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 mt -100.69 -37.91 8.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.04 -16.48 11.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -173.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.662 HE21 ' C ' ' A' ' 95' ' ' PHE . 22.4 mm-40 38.06 77.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.205 -0.998 . . . . 1.0 108.826 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.8 p 176.35 113.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.101 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -175.31 141.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 1.0 110.737 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.0 161.51 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.542 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.436 HD11 ' NE2' ' A' ' 139' ' ' HIS . 20.2 mt -104.37 137.5 33.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 105' ' ' ASP . 14.7 t -88.2 157.91 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 113.294 0.85 . . . . 1.0 113.294 -176.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.462 ' N ' HG12 ' A' ' 104' ' ' VAL . 78.6 m-20 -47.16 121.29 3.65 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.974 -1.012 . . . . 1.0 112.082 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.6 p -57.14 -25.15 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.371 -0.832 . . . . 1.0 110.762 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -64.85 -45.5 85.81 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.93 -11.38 27.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.479 0.657 . . . . 1.0 109.326 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.1 tp60 45.94 70.26 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.801 -1.091 . . . . 1.0 113.308 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -74.43 131.85 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.903 -1.517 . . . . 1.0 106.903 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -120.27 137.12 54.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.023 -0.671 . . . . 1.0 111.931 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.538 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -139.36 162.76 34.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.705 -0.679 . . . . 1.0 110.538 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.0 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.105 179.088 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 N--CA 1.491 1.378 0 CA-C-O 120.698 0.207 . . . . 1.0 111.958 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.54 126.0 59.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.844 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.538 ' N ' ' OG ' ' A' ' 112' ' ' SER . 26.4 t70 -46.05 131.07 7.26 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.442 ' HD3' ' H ' ' A' ' 112' ' ' SER . 59.5 Cg_exo -41.61 -47.11 6.1 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.194 2.596 . . . . 1.0 114.041 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.698 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.8 p -37.35 -46.4 0.76 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.723 0.268 . . . . 1.0 111.723 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.698 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 4.4 t60 -82.29 -30.43 30.58 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.2 t -67.73 -50.9 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.963 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -66.0 -29.18 69.51 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -60.03 -42.13 93.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.714 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' MET . 8.4 mt -73.49 -38.15 65.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -51.92 -39.17 58.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 t -63.69 -24.04 67.62 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.76 -1.109 . . . . 1.0 109.16 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -92.26 4.37 53.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.423 -0.808 . . . . 1.0 110.671 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.06 21.04 79.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.29 142.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 1.0 111.097 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.66 -23.2 12.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.964 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.4 m -141.96 160.52 40.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.202 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.73 121.01 9.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.496 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.7 mp -109.95 132.6 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.258 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 166' ' ' LEU . 16.8 t -123.21 119.4 57.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.175 0.512 . . . . 1.0 111.775 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.6 t -131.65 92.47 30.94 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.79 -1.189 . . . . 1.0 107.79 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.04 150.37 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.203 2.602 . . . . 1.0 114.616 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.575 ' H ' ' HE2' ' A' ' 157' ' ' MET . 33.9 mt -124.88 54.5 1.41 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.868 -1.53 . . . . 1.0 106.868 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.575 ' HE2' ' H ' ' A' ' 156' ' ' LEU . 7.5 ptp -148.56 -167.94 2.96 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.141 0.793 . . . . 1.0 113.141 -175.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.688 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 18.1 m-70 -68.83 163.2 24.77 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.342 -0.845 . . . . 1.0 111.408 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 96' ' ' ARG . 80.1 m80 -70.45 -55.36 9.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.44 -0.8 . . . . 1.0 112.042 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -94.98 11.36 32.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.081 0.401 . . . . 1.0 112.081 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -148.12 140.82 24.6 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.93 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.0 mt -113.52 117.14 30.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.304 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.688 ' HE1' ' CD2' ' A' ' 158' ' ' HIS . 81.8 m95 -89.22 -26.07 21.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.246 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.485 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -163.58 -160.85 11.96 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.177 -0.769 . . . . 1.0 111.177 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 13.3 tp -150.37 124.27 9.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 1.0 111.506 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.499 ' O ' HG13 ' A' ' 153' ' ' VAL . 7.3 tp -99.71 129.29 45.82 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.468 HG11 ' HZ1' ' A' ' 52' ' ' LYS . 13.0 p -139.5 134.14 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.077 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.2 p -106.99 141.99 37.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.991 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.667 ' CE1' ' HE ' ' A' ' 50' ' ' ARG . 24.1 m80 -112.75 126.21 55.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.978 0.418 . . . . 1.0 111.689 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -126.12 113.84 17.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.955 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.4 -15.08 63.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.779 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -117.65 151.03 47.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.99 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.48 132.05 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.895 2.397 . . . . 1.0 111.895 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 53.3 ttt85 -157.87 95.02 2.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.895 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.48 161.24 25.39 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.531 2.154 . . . . 1.0 111.916 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 44.0 p90 -91.17 123.79 34.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.441 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 52.3 m -123.75 164.56 18.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.619 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -50.74 -38.38 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.582 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -67.84 -37.45 81.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.756 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -61.46 -49.92 74.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.573 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 185' ' ' GLN . 43.1 mt -64.28 -34.2 77.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.476 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -54.05 -42.13 68.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 88.1 t -69.45 -57.31 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.773 0.656 . . . . 1.0 112.773 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 188' ' ' ALA . 35.3 t -74.11 -46.29 45.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.395 0.517 . . . . 1.0 112.395 -177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.416 ' CB ' ' O ' ' A' ' 181' ' ' LEU . 63.3 tt0 -42.74 -47.74 5.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.59 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.5 tp -72.36 -41.49 66.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.461 -0.336 . . . . 1.0 111.894 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 191' ' ' VAL . 40.5 tp -77.11 -41.84 40.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.818 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.571 ' HB1' ' CD2' ' A' ' 156' ' ' LEU . . . -55.05 -39.55 69.3 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.506 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -61.66 -38.14 86.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.007 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.14 -30.58 71.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.076 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 187' ' ' LEU . 13.0 t -83.8 -42.58 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.756 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.0 p -55.16 -32.85 62.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.5 mt -69.03 -37.34 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.203 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.96 -39.95 83.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.626 -0.715 . . . . 1.0 109.779 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.435 ' HA ' HD13 ' A' ' 195' ' ' ILE . 36.5 mm -61.04 -46.48 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.123 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.69 -47.24 60.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.1 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -65.48 -41.51 93.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.0 111.492 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.02 70.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.675 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.17 -40.95 97.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.509 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.52 -35.68 80.17 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.007 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.5 t -52.42 -52.22 55.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 1.0 110.595 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.583 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.6 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.902 0.382 . . . . 1.0 110.578 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 66.5 t0 -49.05 -34.99 14.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -77.29 -47.44 20.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.069 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.44 -42.44 93.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 1.0 110.977 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -56.87 -45.02 82.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.099 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -53.22 -38.69 63.16 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.56 71.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.055 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -69.08 -45.7 69.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.547 -0.752 . . . . 1.0 112.227 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.688 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.6 p -71.28 -35.26 57.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.995 0.368 . . . . 1.0 111.995 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 43' ' ' ARG . 43.4 tp10 -70.17 -35.7 74.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.776 0.322 . . . . 1.0 111.06 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -80.46 -53.54 6.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 1.0 111.755 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.55 HG13 ' N ' ' A' ' 43' ' ' ARG . 9.6 p -55.08 -44.08 72.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.744 0.306 . . . . 1.0 111.118 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.55 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.6 ppt_? -56.21 -41.7 76.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.85 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.465 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.17 -33.91 59.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.022 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -79.61 -36.2 38.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 1.0 111.581 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -85.34 -30.64 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.501 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 59.33 19.29 46.3 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.442 HG23 ' CE1' ' A' ' 170' ' ' HIS . 93.3 m -72.24 140.77 48.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.792 0.33 . . . . 1.0 110.234 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -39.72 -50.43 2.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.623 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.467 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 59.6 ttp180 -157.97 130.56 7.25 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.018 -0.673 . . . . 1.0 112.591 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.95 131.06 36.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -139.62 155.24 47.55 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.9 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 89.5 t -106.03 138.91 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 177.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.59 ' CE2' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -139.23 131.45 28.22 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.323 -0.551 . . . . 1.0 111.284 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -92.74 145.46 24.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.275 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.469 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 85.6 t80 -96.46 122.13 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 1.0 112.04 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -87.73 164.68 33.51 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 178.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.25 -25.83 15.29 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.521 2.147 . . . . 1.0 112.522 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.94 -15.37 54.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 1.0 110.096 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.37 -17.22 37.31 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.514 -0.635 . . . . 1.0 111.514 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -67.21 101.85 0.97 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.909 -0.316 . . . . 1.0 110.592 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.61 134.89 12.64 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.562 -1.015 . . . . 1.0 110.562 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.6 p -122.24 142.23 50.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 1.0 111.665 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.4 p -89.77 120.53 38.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 65' ' ' VAL . 10.9 t -110.41 5.84 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 1.0 111.356 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.08 118.36 3.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.126 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -143.67 135.91 26.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.073 0.463 . . . . 1.0 111.816 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.92 146.96 52.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.434 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -141.15 145.99 36.42 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.755 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.47 -32.81 46.16 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.881 -0.887 . . . . 1.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 176.63 -161.64 29.75 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -73.94 25.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.339 . . . . 1.0 110.523 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.507 ' H ' ' C ' ' A' ' 71' ' ' GLY . 43.1 mtm180 -77.47 -47.14 20.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.082 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.7 mt -113.04 145.56 33.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 1.0 109.921 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -70.93 160.31 49.77 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.516 2.144 . . . . 1.0 112.148 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.1 p -93.31 128.13 39.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.864 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.537 ' HA ' HD12 ' A' ' 80' ' ' LEU . 18.9 mt -94.44 6.4 48.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.372 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 tp -61.34 128.83 38.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.3 0.572 . . . . 1.0 112.246 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.45 -13.83 62.81 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.514 -0.767 . . . . 1.0 111.526 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 77' ' ' LEU . 76.3 mt -81.29 150.55 28.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.296 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -106.86 133.85 50.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.652 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -87.02 133.28 39.48 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -41.15 132.87 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.633 2.222 . . . . 1.0 111.895 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.91 128.33 35.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 1.0 110.738 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.27 0.63 44.2 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.529 -1.028 . . . . 1.0 110.529 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -58.71 -33.11 69.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.457 HD11 ' OH ' ' A' ' 54' ' ' TYR . 8.4 mt -78.99 132.8 62.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.69 -0.687 . . . . 1.0 109.49 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.716 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 91.0 Cg_endo -73.74 -171.99 0.99 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.452 2.102 . . . . 1.0 112.479 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -106.43 -55.07 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.546 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -63.21 -42.27 99.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.813 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.716 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.77 -44.32 77.72 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.928 0.344 . . . . 1.0 111.928 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -64.11 -39.64 94.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.47 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -60.6 -32.13 71.26 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.762 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 98' ' ' ALA . 96.5 mt -70.1 -28.14 65.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.905 0.383 . . . . 1.0 110.341 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.653 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 0.8 OUTLIER -65.33 -54.25 31.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.036 178.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.99 -31.69 65.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.878 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.3 mt -99.41 -44.51 6.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 114.357 1.243 . . . . 1.0 114.357 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -113.55 -12.51 12.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.112 1.523 . . . . 1.0 115.112 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.653 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 18.2 mm-40 45.34 86.73 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.198 -1.001 . . . . 1.0 108.75 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.5 p 177.54 99.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.12 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 102' ' ' VAL . 9.8 mmp_? -139.49 133.24 30.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.998 0.428 . . . . 1.0 110.737 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 101' ' ' ARG . 71.3 t -161.4 141.81 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.536 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.15 133.65 53.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.515 HG21 ' OG ' ' A' ' 110' ' ' SER . 5.0 m -91.89 164.97 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.318 0.858 . . . . 1.0 113.318 -176.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 20.0 p30 -46.89 118.54 2.1 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.003 -0.999 . . . . 1.0 112.098 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.98 -22.2 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.311 -0.859 . . . . 1.0 110.801 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -67.83 -43.56 79.29 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.55 -11.75 12.44 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.525 0.678 . . . . 1.0 109.389 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 45.54 61.45 2.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.779 -1.1 . . . . 1.0 113.335 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.515 ' OG ' HG21 ' A' ' 104' ' ' VAL . 13.2 m -76.26 133.23 40.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 175.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -119.82 140.29 51.02 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.926 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.8 135.19 54.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.496 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.185 179.432 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo . . . . . 0 N--CA 1.492 1.41 0 CA-C-O 120.759 0.233 . . . . 1.0 111.93 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 p -100.37 119.98 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.811 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.475 ' OD2' ' SG ' ' A' ' 138' ' ' CYS . 49.7 p-10 -43.77 134.1 3.85 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.738 -0.468 . . . . 1.0 109.738 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -42.49 -16.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.095 2.53 . . . . 1.0 114.067 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.743 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -71.55 -48.38 48.91 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.713 0.264 . . . . 1.0 111.713 -176.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.743 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 35.7 t-80 -82.97 -28.24 29.91 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.279 0.474 . . . . 1.0 112.279 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 2.6 p -66.45 -43.76 90.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.004 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.523 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 79.2 t60 -69.86 -30.35 67.8 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -59.82 -42.21 93.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.76 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 146' ' ' MET . 29.8 mt -74.36 -36.14 63.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -52.41 -39.32 60.81 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.7 p -65.08 -18.91 65.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.786 -1.097 . . . . 1.0 109.16 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.2 mmm -96.15 1.14 52.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.12 22.89 78.62 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.944 -0.863 . . . . 1.0 110.944 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.33 142.98 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 1.0 111.006 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.65 -39.76 5.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.964 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.7 t -135.96 126.44 26.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.199 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.4 m -113.91 140.78 48.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.428 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.96 138.48 53.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.262 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -128.3 119.45 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.167 0.508 . . . . 1.0 111.732 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.6 124.52 21.91 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.735 -1.209 . . . . 1.0 107.735 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.47 ' O ' HD23 ' A' ' 156' ' ' LEU . 85.4 Cg_endo -71.97 144.27 42.54 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 123.175 2.584 . . . . 1.0 114.678 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.571 ' CD2' ' HB1' ' A' ' 188' ' ' ALA . 11.3 mt -125.14 47.46 2.16 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.561 ' CE ' ' O ' ' A' ' 164' ' ' GLY . 4.4 ptp -147.36 -167.38 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.104 0.779 . . . . 1.0 113.104 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.492 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 20.7 m-70 -68.71 159.24 32.58 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.45 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -60.63 -50.11 74.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.414 -0.812 . . . . 1.0 112.107 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -97.74 -42.75 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.06 0.393 . . . . 1.0 112.06 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.473 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 85.2 tt0 -86.27 134.3 33.76 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.87 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 19.1 mt -109.17 115.58 30.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.215 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.492 ' HE1' ' CD2' ' A' ' 158' ' ' HIS . 77.8 m95 -88.85 -31.42 18.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.278 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.813 ' C ' HD12 ' A' ' 165' ' ' LEU . . . -169.97 -166.95 29.76 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.229 -0.748 . . . . 1.0 111.229 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.813 HD12 ' C ' ' A' ' 164' ' ' GLY . 5.8 mp -148.65 136.37 20.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 1.0 111.506 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.4 tp -98.58 134.92 40.86 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 167' ' ' VAL . 8.4 p -138.5 127.41 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.695 -0.402 . . . . 1.0 111.097 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.2 p -104.68 137.13 42.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.064 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.467 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 28.4 m80 -105.07 121.24 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.981 0.419 . . . . 1.0 111.601 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.442 ' CE1' HG23 ' A' ' 48' ' ' THR . 91.2 m-70 -122.1 113.45 19.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.936 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.46 -14.23 61.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.781 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.74 135.14 74.85 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.06 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.01 -4.54 14.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.905 2.404 . . . . 1.0 111.813 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 174' ' ' ARG . 1.0 OUTLIER -54.73 151.34 15.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.845 -179.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.65 160.96 46.75 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.53 2.153 . . . . 1.0 111.946 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -81.54 136.64 35.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.483 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -113.03 144.83 41.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.64 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.528 ' NE2' HD22 ' A' ' 181' ' ' LEU . 64.1 tp60 -55.86 -29.32 59.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.537 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -55.82 -37.07 68.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.696 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.01 -37.72 88.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.505 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.0 mp -65.07 -38.94 92.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.48 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.53 -37.98 68.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.371 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.85 -55.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.737 0.643 . . . . 1.0 112.737 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 185' ' ' GLN . 10.9 p -68.38 -38.69 79.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.394 0.516 . . . . 1.0 112.394 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.457 ' N ' HG13 ' A' ' 184' ' ' VAL . 83.7 mt-30 -52.52 -45.22 66.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.644 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 37.2 tp -65.04 -45.52 85.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.873 ' O ' HG23 ' A' ' 191' ' ' VAL . 85.1 mt -78.92 -31.55 45.27 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.571 ' HB1' ' CD2' ' A' ' 156' ' ' LEU . . . -62.88 -44.46 96.06 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.494 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -62.25 -42.23 99.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.067 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -64.12 -27.34 69.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.095 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 187' ' ' LEU . 45.4 t -84.8 -40.86 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.749 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -56.78 -36.11 69.48 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.5 mt -67.58 -38.44 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.228 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -68.02 -40.2 82.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.838 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 195' ' ' ILE . 26.1 mm -59.23 -48.19 87.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.051 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.47 -48.75 47.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.031 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.15 -45.77 79.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.525 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -63.42 -32.65 74.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.711 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -57.32 -29.6 64.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.385 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 200' ' ' LEU . 10.0 mp -62.27 -32.88 73.65 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.058 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.0 t -52.15 -55.85 18.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.551 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.6 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.54 179.439 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.806 0.336 . . . . 1.0 110.589 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -53.01 -54.5 34.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.951 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -54.54 -46.95 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.114 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 mm -62.03 -46.99 95.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.826 0.346 . . . . 1.0 110.972 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 34.2 mt -56.46 -45.14 80.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.08 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -53.59 -38.41 63.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.65 -30.33 66.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.124 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 42' ' ' VAL . 24.7 m -73.59 -44.76 56.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.528 -0.76 . . . . 1.0 112.228 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.71 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.4 p -68.56 -35.94 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.96 0.356 . . . . 1.0 111.96 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -67.16 -49.18 65.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 1.0 111.156 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -58.72 -45.26 90.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.683 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 38' ' ' THR . 73.9 t -57.94 -37.32 60.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.686 0.279 . . . . 1.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 47' ' ' GLY . 36.7 ttp180 -52.53 -40.83 62.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.832 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.89 -35.76 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.056 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.11 -46.36 20.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.538 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.6 mt -86.37 -31.59 21.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.494 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.57 22.22 31.22 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.461 -1.056 . . . . 1.0 110.461 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.2 p -74.02 144.96 44.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.332 . . . . 1.0 110.286 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -41.52 -42.01 2.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.617 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.532 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 56.3 ttm-85 -163.26 129.33 3.24 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.123 -0.631 . . . . 1.0 112.636 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.84 130.29 52.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.469 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 23.5 pttm -140.6 154.97 46.68 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.442 -0.503 . . . . 1.0 111.874 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 95.1 t -109.17 138.76 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.496 ' CE2' HD13 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -138.34 133.47 33.01 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.348 -0.541 . . . . 1.0 111.283 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -92.62 145.58 24.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.201 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -95.62 117.73 31.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 1.0 112.089 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.09 149.47 59.02 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.52 -23.15 74.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.58 2.187 . . . . 1.0 112.45 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -86.14 -14.53 43.85 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.057 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.43 -13.13 47.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.469 -0.652 . . . . 1.0 111.469 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -76.0 94.79 3.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.804 0.335 . . . . 1.0 110.608 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.88 143.54 17.61 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -122.18 144.54 48.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.914 0.388 . . . . 1.0 111.638 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -80.51 112.49 18.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.07 3.63 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.276 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.71 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -160.28 119.71 2.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.076 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.532 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 84.8 tt0 -144.84 132.87 21.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.106 0.479 . . . . 1.0 111.847 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.96 148.82 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.336 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.613 ' NH2' ' N ' ' A' ' 76' ' ' SER . 6.8 ptp180 -139.68 142.21 36.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.895 0.379 . . . . 1.0 110.718 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.41 -33.18 86.54 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -171.26 -178.97 42.08 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -73.61 40.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 1.0 110.581 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 71' ' ' GLY . 10.1 tpt180 -83.06 -47.79 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.144 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.402 ' HB2' HH21 ' A' ' 50' ' ' ARG . 13.6 mt -113.36 150.85 43.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.863 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.462 ' C ' ' NH2' ' A' ' 69' ' ' ARG . 58.3 Cg_endo -69.86 160.3 50.19 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.483 2.122 . . . . 1.0 112.131 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.613 ' N ' ' NH2' ' A' ' 69' ' ' ARG . 21.9 t -88.86 129.55 35.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.942 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 80' ' ' LEU . 22.6 mt -98.14 10.22 41.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.383 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.08 132.58 45.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.003 -0.544 . . . . 1.0 112.305 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.13 -10.02 67.57 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.527 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 77' ' ' LEU . 46.8 mt -85.5 154.11 22.0 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.336 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 p -105.37 130.72 53.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.688 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -84.66 152.67 60.42 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.84 133.94 41.28 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.678 2.252 . . . . 1.0 111.883 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.35 129.14 38.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.67 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.64 0.46 42.91 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -56.42 -35.58 67.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.7 mm -80.16 132.39 59.91 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.66 -0.7 . . . . 1.0 109.434 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.685 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 86.7 Cg_endo -74.39 -167.26 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.398 2.065 . . . . 1.0 112.483 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -107.63 -60.06 1.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.505 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.581 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 39.6 mp0 -57.95 -44.43 86.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.818 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.685 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -66.88 -44.62 80.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -58.62 -36.26 73.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.477 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -63.81 -32.03 73.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.811 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.1 mt -67.11 -36.36 81.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.295 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -57.18 -54.36 47.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.051 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -53.43 -29.81 37.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.838 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.58 ' C ' HE22 ' A' ' 99' ' ' GLN . 75.9 mt -98.97 -41.37 7.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.413 1.264 . . . . 1.0 114.413 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.561 ' N ' ' NE2' ' A' ' 99' ' ' GLN . . . -120.19 -17.09 8.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 115.031 1.493 . . . . 1.0 115.031 -173.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.793 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.2 OUTLIER 45.15 71.45 0.27 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.123 -1.031 . . . . 1.0 108.847 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 99' ' ' GLN . 2.7 m -164.26 113.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.051 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.452 ' HE ' ' CA ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -155.68 148.26 23.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.932 0.396 . . . . 1.0 110.774 178.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.13 143.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.505 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.7 mt -108.94 135.62 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.09 164.39 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 113.275 0.843 . . . . 1.0 113.275 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -43.98 117.27 1.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.95 -1.023 . . . . 1.0 112.145 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.88 -20.02 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.79 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -66.9 -42.27 85.76 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.09 -10.39 40.0 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.45 0.643 . . . . 1.0 109.408 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 45.26 70.63 0.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.734 -1.121 . . . . 1.0 113.354 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 p -75.35 134.43 40.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.984 -1.488 . . . . 1.0 106.984 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -122.02 139.78 53.28 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.893 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.456 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -130.28 153.51 48.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.571 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 112' ' ' SER . 28.6 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.121 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.492 1.403 0 CA-C-O 120.712 0.213 . . . . 1.0 111.95 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.49 124.3 61.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.878 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' HA ' ' H ' ' A' ' 112' ' ' SER . 12.5 t70 -43.22 141.97 1.71 Allowed Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.422 ' HA ' HG12 ' A' ' 140' ' ' VAL . 13.2 Cg_endo -49.18 -13.52 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 123.224 2.616 . . . . 1.0 114.073 -177.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.681 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.4 p -75.59 -44.43 43.1 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.746 0.276 . . . . 1.0 111.746 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.681 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.6 t60 -82.9 -32.86 27.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.226 0.454 . . . . 1.0 112.226 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 141' ' ' HIS . 4.3 p -68.76 -45.03 81.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.936 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.534 ' N ' HG13 ' A' ' 140' ' ' VAL . 35.5 m-70 -68.69 -28.97 67.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -60.83 -41.0 94.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.923 -0.581 . . . . 1.0 109.715 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.6 mt -72.86 -36.49 67.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -52.15 -38.73 58.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -64.44 -23.07 67.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.746 -1.115 . . . . 1.0 109.161 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 143' ' ' LEU . 97.1 mmm -92.74 2.15 56.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.727 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.84 79.28 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.3 t -111.93 142.03 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 1.0 111.019 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.92 -26.67 11.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.012 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.2 m -136.45 160.83 37.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.166 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.35 127.72 13.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.44 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 tp -114.92 136.31 53.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.292 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.4 119.62 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.132 0.491 . . . . 1.0 111.793 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.5 HG21 HG21 ' A' ' 184' ' ' VAL . 45.7 t -129.62 91.1 41.71 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 107.862 -1.162 . . . . 1.0 107.862 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.22 151.68 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.175 2.584 . . . . 1.0 114.693 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.5 mt -126.05 63.18 1.24 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.832 -1.544 . . . . 1.0 106.832 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 ptm -146.35 179.61 7.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.163 0.801 . . . . 1.0 113.163 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.582 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 46.1 t-80 -68.07 176.24 2.76 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.394 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.582 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 97.8 m-70 -64.54 -51.64 61.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.401 -0.818 . . . . 1.0 112.082 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.68 -37.79 6.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.064 0.394 . . . . 1.0 112.064 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -87.67 136.29 33.01 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.689 -0.405 . . . . 1.0 110.846 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.498 ' H ' HD12 ' A' ' 162' ' ' LEU . 1.2 mp -108.63 112.14 24.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.317 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -88.27 -37.49 16.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.257 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.571 ' C ' HD12 ' A' ' 165' ' ' LEU . . . -165.71 -175.75 36.5 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 164' ' ' GLY . 5.3 mp -144.17 141.56 30.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 1.0 111.5 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.4 tp -101.07 135.26 42.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 167' ' ' VAL . 12.4 p -138.64 129.68 35.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 1.0 111.078 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.2 m -106.77 139.37 41.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.057 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.469 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 85.7 m-70 -113.76 132.09 55.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.948 0.404 . . . . 1.0 111.667 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.561 ' CD2' ' N ' ' A' ' 170' ' ' HIS . 1.0 OUTLIER -124.57 125.32 43.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.929 177.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.43 33.63 0.69 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.832 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -161.35 154.38 17.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.029 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.16 112.82 2.18 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.928 2.419 . . . . 1.0 111.84 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -149.16 90.11 4.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.884 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.96 158.42 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.597 2.198 . . . . 1.0 111.905 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 41.6 p90 -84.79 127.27 34.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.487 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.6 p -121.06 162.37 20.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.581 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.666 ' H ' ' CD ' ' A' ' 178' ' ' GLN . 1.7 pm0 -50.33 -30.47 12.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.648 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -61.87 -36.24 80.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.739 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 184' ' ' VAL . 78.3 mm-40 -66.01 -24.43 66.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.486 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.8 mt -81.33 -33.88 32.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.483 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.45 -43.09 99.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.34 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.638 HG23 ' N ' ' A' ' 184' ' ' VAL . 13.1 m -73.41 -49.16 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.708 0.633 . . . . 1.0 112.708 -177.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.638 ' N ' HG23 ' A' ' 183' ' ' VAL . 27.9 m -70.4 -43.87 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.403 0.52 . . . . 1.0 112.403 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.538 ' N ' HG23 ' A' ' 184' ' ' VAL . 88.5 mt-30 -53.28 -43.43 67.46 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.983 -0.287 . . . . 1.0 111.67 -178.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.73 -49.99 59.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.84 ' O ' HG23 ' A' ' 191' ' ' VAL . 71.2 mt -79.86 -35.07 38.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.795 -177.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 184' ' ' VAL . . . -61.1 -43.38 98.97 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.488 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.58 -42.47 86.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 1.0 109.989 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.63 -28.23 68.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.135 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 187' ' ' LEU . 59.4 t -84.3 -43.71 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.785 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.2 p -57.83 -35.63 71.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.655 -0.868 . . . . 1.0 108.655 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.9 mt -67.84 -35.03 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.207 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.57 76.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.646 -0.707 . . . . 1.0 109.843 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.424 HD11 HD21 ' A' ' 35' ' ' LEU . 5.0 mm -61.38 -47.53 93.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.133 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.8 -48.02 60.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.045 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -65.68 -41.19 92.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.558 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.05 -31.3 72.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.677 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.72 -31.92 68.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.497 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.628 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.0 mp -60.62 -34.84 74.84 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.932 -0.307 . . . . 1.0 111.095 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.3 m -55.96 -56.14 24.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.58 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.536 179.715 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.6 tp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.795 0.331 . . . . 1.0 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -60.52 -51.95 67.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.048 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -55.89 -45.91 78.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.127 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 mm -61.4 -48.4 89.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.771 0.32 . . . . 1.0 110.877 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.02 -47.74 84.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.012 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -52.45 -39.54 61.21 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.622 -0.431 . . . . 1.0 109.846 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.56 -29.09 65.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.137 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 42' ' ' VAL . 16.8 m -73.25 -45.32 56.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.477 -0.783 . . . . 1.0 112.312 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.705 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.8 p -68.45 -35.3 70.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -177.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -70.6 -42.31 71.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.784 0.326 . . . . 1.0 111.094 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.71 -54.67 24.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.77 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG23 ' N ' ' A' ' 43' ' ' ARG . 34.2 m -52.45 -39.84 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.171 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -52.76 -41.76 64.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 1.0 110.811 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.3 -38.34 79.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.04 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -75.5 -42.82 51.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.603 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.2 mt -85.6 -26.81 25.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.457 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.76 19.95 16.39 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 169' ' ' HIS . 91.3 m -73.01 143.39 47.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.832 0.349 . . . . 1.0 110.192 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -39.34 -55.43 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.668 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.635 HH22 ' CG2' ' A' ' 148' ' ' VAL . 61.2 mtm-85 -148.92 131.8 16.12 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.053 -0.659 . . . . 1.0 112.576 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 38.4 t -132.69 127.64 56.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.503 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 20.4 pttm -141.4 154.92 45.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.13 0.49 . . . . 1.0 111.939 -178.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 61.6 t -115.15 135.56 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.626 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -133.76 120.06 20.05 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.243 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -74.04 140.2 45.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.273 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.629 ' CE1' ' NH2' ' A' ' 92' ' ' ARG . 58.9 t80 -92.91 117.21 29.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 1.0 112.048 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 41.2 p-10 -93.59 141.35 23.74 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.83 -14.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.573 2.182 . . . . 1.0 112.517 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 57' ' ' ASP . 96.3 mt-10 -87.97 -33.86 18.27 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.729 -0.389 . . . . 1.0 110.104 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.41 -10.79 39.37 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.514 -0.634 . . . . 1.0 111.514 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.685 ' O ' ' O ' ' A' ' 62' ' ' GLY . 64.2 m80 -66.54 -42.81 86.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.926 -0.31 . . . . 1.0 110.61 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.685 ' O ' ' O ' ' A' ' 61' ' ' HIS . . . 47.97 155.98 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.659 -0.976 . . . . 1.0 110.659 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 p -124.81 146.25 49.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 1.0 111.711 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.95 106.82 4.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.793 -0.818 . . . . 1.0 108.793 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 65' ' ' VAL . 57.3 t -106.56 -1.85 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.719 0.295 . . . . 1.0 111.375 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.44 118.04 3.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.103 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -144.43 129.0 18.1 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.566 -0.454 . . . . 1.0 111.865 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.21 145.55 49.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.378 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -142.28 142.7 32.59 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.722 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.6 -36.1 83.85 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -163.63 -179.56 38.07 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -73.47 55.13 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 1.0 110.525 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -86.42 -48.88 8.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.131 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.449 HD12 ' CZ ' ' A' ' 50' ' ' ARG . 66.9 mt -119.09 147.77 43.44 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.867 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.9 138.75 45.34 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.517 2.145 . . . . 1.0 112.131 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.1 m -60.43 130.26 45.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.89 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 80' ' ' LEU . 25.7 mt -91.91 7.04 43.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.346 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tp -59.4 129.55 42.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.29 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.55 -12.82 65.73 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.526 -0.761 . . . . 1.0 111.507 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 77' ' ' LEU . 73.5 mt -83.11 153.1 25.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.742 0.306 . . . . 1.0 110.327 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.7 p -107.65 135.06 49.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.646 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -87.68 154.46 53.28 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.22 124.92 12.75 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.684 2.256 . . . . 1.0 111.847 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.59 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . . . -62.44 137.67 58.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.696 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.87 -2.23 38.64 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -54.6 -38.73 67.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 88' ' ' PRO . 6.1 mm -83.65 111.92 35.85 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.433 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 87' ' ' ILE . 87.9 Cg_exo -51.46 -162.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.486 2.124 . . . . 1.0 112.499 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -107.82 -51.56 2.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.572 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.72 -41.32 92.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.768 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.94 79.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.936 0.346 . . . . 1.0 111.936 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.629 ' NH2' ' CE1' ' A' ' 56' ' ' PHE . 63.2 ttt180 -64.04 -39.15 93.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.519 -0.31 . . . . 1.0 111.457 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -62.3 -34.34 76.4 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.777 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.31 -34.7 75.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.266 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.652 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 2.3 t80 -63.54 -26.36 68.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.99 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.673 HH21 ' NE2' ' A' ' 160' ' ' GLN . 52.3 ttt180 -81.54 -28.32 33.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.786 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.9 mt -98.21 -41.21 8.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.36 -8.13 12.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 115.067 1.506 . . . . 1.0 115.067 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.738 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.6 mm-40 41.64 83.31 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.221 -0.991 . . . . 1.0 108.818 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.7 p 174.7 113.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.973 -178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.634 ' O ' HG23 ' A' ' 102' ' ' VAL . 5.0 tpt180 -153.52 139.26 17.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 1.0 110.799 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 101' ' ' ARG . 55.9 t -161.22 145.91 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.547 -178.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.414 HG23 HG11 ' A' ' 135' ' ' VAL . 65.4 mt -110.18 133.76 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.91 165.86 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 113.322 0.86 . . . . 1.0 113.322 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -45.81 119.72 2.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.964 -1.017 . . . . 1.0 112.139 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.478 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.4 p -56.13 -22.11 13.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.221 -0.899 . . . . 1.0 110.792 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -65.6 -44.11 87.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.6 -0.518 . . . . 1.0 109.6 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.93 -11.23 35.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.535 0.683 . . . . 1.0 109.42 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 44.72 71.12 0.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.731 -1.122 . . . . 1.0 113.327 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 p -74.27 132.75 42.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 176.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -118.8 128.96 54.96 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.017 -0.673 . . . . 1.0 111.884 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.77 152.09 44.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.623 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.1 pt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.117 179.373 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 N--CA 1.493 1.453 0 CA-C-O 120.757 0.232 . . . . 1.0 112.0 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.414 HG11 HG23 ' A' ' 103' ' ' ILE . 1.3 p -107.91 121.34 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.835 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.509 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 2.8 p-10 -45.13 140.57 3.64 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 138' ' ' CYS . 63.0 Cg_exo -42.63 -50.17 6.03 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.09 2.527 . . . . 1.0 114.047 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.757 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.0 OUTLIER -34.46 -49.26 0.39 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.72 0.267 . . . . 1.0 111.72 -177.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.757 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 20.5 t-80 -81.18 -25.66 36.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.319 0.488 . . . . 1.0 112.319 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.478 ' CG1' HG23 ' A' ' 106' ' ' VAL . 42.1 t -65.88 -51.77 57.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.941 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.417 ' O ' ' OG ' ' A' ' 145' ' ' SER . 58.5 t-80 -63.57 -29.6 70.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.06 -44.32 94.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.694 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 146' ' ' MET . 61.8 mt -73.02 -41.54 64.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -50.63 -39.54 50.61 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 141' ' ' HIS . 2.6 m -62.93 -27.19 69.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.784 -1.098 . . . . 1.0 109.19 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.55 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.2 mmm -89.05 -0.46 57.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.7 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.77 21.5 78.48 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.976 -0.85 . . . . 1.0 110.976 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.635 ' CG2' HH22 ' A' ' 50' ' ' ARG . 47.7 t -109.45 142.25 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 1.0 111.035 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.1 -36.82 6.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.011 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 t -138.71 129.4 26.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.136 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.6 m -114.77 137.25 52.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.41 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tp -117.38 137.89 52.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.284 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 166' ' ' LEU . 2.1 t -126.58 113.77 34.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.082 0.468 . . . . 1.0 111.744 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.495 HG11 ' CG1' ' A' ' 184' ' ' VAL . 40.9 t -111.39 106.94 57.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 107.825 -1.176 . . . . 1.0 107.825 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.33 123.72 2.09 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.16 2.573 . . . . 1.0 114.77 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.434 HD11 ' HB ' ' A' ' 191' ' ' VAL . 9.4 tp -115.93 45.9 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.5 ptm -148.02 -178.36 6.24 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.091 0.775 . . . . 1.0 113.091 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.637 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 48.6 t-80 -69.3 178.64 2.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.306 -0.861 . . . . 1.0 111.411 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.637 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 83.6 t60 -67.89 -51.62 45.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 1.0 112.044 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.673 ' NE2' HH21 ' A' ' 96' ' ' ARG . 48.9 tt0 -105.17 -38.6 6.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.047 0.388 . . . . 1.0 112.047 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.512 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.7 tt0 -90.69 139.17 30.98 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.841 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.68 HD23 ' C ' ' A' ' 162' ' ' LEU . 7.9 tt -107.03 115.39 30.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.357 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.512 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 78.6 m95 -91.75 -41.14 10.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.298 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.79 -173.71 24.75 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.543 HD11 ' CZ ' ' A' ' 95' ' ' PHE . 7.2 tp -144.26 128.13 17.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.332 . . . . 1.0 111.558 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 153' ' ' VAL . 9.4 tp -98.04 129.06 44.9 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 177.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.53 136.7 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.087 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.1 m -111.24 149.65 30.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.053 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.562 ' HD1' HG11 ' A' ' 148' ' ' VAL . 93.1 m-70 -124.6 131.21 53.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.003 0.43 . . . . 1.0 111.603 -177.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.03 114.42 15.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.984 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.94 -15.69 63.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.859 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -112.41 151.27 43.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.993 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.18 92.61 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.891 2.394 . . . . 1.0 111.929 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -120.85 91.27 47.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.901 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.97 152.36 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.533 2.156 . . . . 1.0 111.937 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -109.25 143.53 38.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.444 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.2 t -125.24 171.35 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.607 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -50.89 -30.38 14.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.616 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -63.22 -39.45 94.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.708 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.54 -44.85 93.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.524 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.9 mp -63.92 -36.76 84.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.502 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -54.48 -36.64 64.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.884 -0.598 . . . . 1.0 111.331 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.34 -54.98 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.722 0.638 . . . . 1.0 112.722 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.496 HG12 ' HB2' ' A' ' 188' ' ' ALA . 5.1 t -77.68 -42.17 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -44.31 -45.28 8.64 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.951 -0.299 . . . . 1.0 111.631 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 186' ' ' LEU . 7.4 mp -75.96 -37.79 58.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.92 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 191' ' ' VAL . 6.1 tp -77.65 -41.47 38.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.806 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.496 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -62.13 -39.71 93.49 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.474 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -57.67 -39.6 77.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.294 -0.412 . . . . 1.0 109.924 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -71.8 -24.11 61.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.157 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 187' ' ' LEU . 73.1 t -82.5 -48.92 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 1.0 109.798 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 85.8 p -54.25 -34.19 60.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.9 mt -65.59 -33.85 66.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.161 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 191' ' ' VAL . . . -68.74 -38.12 79.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.575 -0.738 . . . . 1.0 109.8 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.59 -46.46 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.14 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.03 -46.55 61.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.059 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -66.61 -44.54 81.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.515 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.34 -33.25 75.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.299 -0.409 . . . . 1.0 111.674 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -60.42 -32.87 71.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.578 -0.283 . . . . 1.0 111.498 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.61 -34.92 78.88 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.012 -0.275 . . . . 1.0 111.052 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.7 m -55.53 -54.74 40.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.802 0.334 . . . . 1.0 110.65 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.539 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.83 0.348 . . . . 1.0 110.562 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' CG ' ' N ' ' A' ' 33' ' ' GLN . 24.1 p-10 -55.63 -54.46 43.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.967 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.404 ' N ' ' CG ' ' A' ' 32' ' ' ASP . 62.9 tt0 -54.35 -44.84 72.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.124 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.694 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -60.91 -52.89 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.955 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.2 mt -58.71 -48.2 81.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.011 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -53.4 -39.41 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.6 -0.44 . . . . 1.0 109.871 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.5 65.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.042 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 42' ' ' VAL . 21.5 m -73.22 -44.59 59.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.529 -0.76 . . . . 1.0 112.197 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.639 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 4.1 p -69.96 -35.79 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.916 0.339 . . . . 1.0 111.916 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.06 -48.92 61.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.753 0.311 . . . . 1.0 111.096 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -66.94 -50.65 61.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.745 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 38' ' ' THR . 83.1 t -58.38 -42.77 84.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.724 0.297 . . . . 1.0 111.169 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -56.21 -43.11 78.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.811 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.76 -33.53 61.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -77.08 -37.93 53.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.608 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -85.78 -27.8 24.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.446 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.93 20.0 24.65 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.458 -1.057 . . . . 1.0 110.458 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.44 ' OG1' HG23 ' A' ' 51' ' ' VAL . 12.5 p -72.11 142.52 49.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.859 0.361 . . . . 1.0 110.217 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -40.39 -47.5 2.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.664 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.53 ' NH1' ' CE1' ' A' ' 169' ' ' HIS . 54.0 ttp85 -154.02 131.29 11.17 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.029 -0.668 . . . . 1.0 112.629 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.44 HG23 ' OG1' ' A' ' 48' ' ' THR . 48.9 t -135.38 127.36 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HE3' HAB1 ' A' ' 203' ' ' CYC . 58.2 pttt -140.94 156.07 46.14 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.478 -0.489 . . . . 1.0 111.967 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.8 t -101.08 140.56 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.437 ' O ' ' N ' ' A' ' 165' ' ' LEU . 55.4 t80 -127.19 111.48 14.02 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.364 -0.534 . . . . 1.0 111.209 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -84.39 133.72 34.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -95.77 125.66 40.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 1.0 112.096 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 60' ' ' GLY . 6.2 m-20 -95.14 138.57 21.96 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.79 -29.11 3.32 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.514 2.142 . . . . 1.0 112.453 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -82.82 -19.71 37.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 1.0 110.03 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.56 -10.91 38.94 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.517 -0.633 . . . . 1.0 111.517 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -82.18 88.26 6.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.63 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.06 154.29 23.6 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.5 p -124.97 148.85 48.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.971 0.415 . . . . 1.0 111.646 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.93 107.9 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 65' ' ' VAL . 60.5 t -106.75 0.16 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.779 0.324 . . . . 1.0 111.413 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.639 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.33 120.44 3.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.5 tt0 -145.46 132.51 20.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 1.0 111.846 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.19 142.42 51.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 1.0 109.406 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -143.09 145.47 32.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.907 0.384 . . . . 1.0 110.76 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.07 -35.03 63.07 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -179.9 -164.49 32.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.037 -0.825 . . . . 1.0 111.037 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -72.42 16.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.309 . . . . 1.0 110.486 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 71' ' ' GLY . 61.5 ttm-85 -66.83 -46.66 74.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.15 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.6 mt -115.19 124.61 29.95 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.87 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.24 154.21 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.535 2.157 . . . . 1.0 112.134 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.7 m -90.13 130.39 36.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.934 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.54 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 23.6 mt -98.48 13.56 31.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.437 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 20.4 tp -71.41 130.42 41.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.224 0.535 . . . . 1.0 112.308 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.18 -10.0 70.54 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.496 -0.774 . . . . 1.0 111.581 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 77' ' ' LEU . 65.7 mt -85.14 153.77 22.45 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.327 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 81' ' ' THR . 14.1 t -107.69 133.5 52.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.658 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.558 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 7.4 m-85 -85.55 152.26 57.12 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.57 133.82 38.59 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.625 2.216 . . . . 1.0 111.808 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 131.13 45.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.712 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.89 0.64 42.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 50.9 t0 -53.71 -33.92 57.13 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.3 mt -91.44 110.37 42.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.377 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 87' ' ' ILE . 88.7 Cg_exo -51.47 -155.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.437 2.091 . . . . 1.0 112.448 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -107.11 -59.38 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.493 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.89 -40.27 79.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.369 . . . . 1.0 111.875 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.553 ' HB2' HBD1 ' A' ' 203' ' ' CYC . . . -68.95 -51.55 38.48 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.969 0.359 . . . . 1.0 111.969 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -53.85 -35.92 62.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.485 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -65.33 -33.42 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.78 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.72 -36.73 78.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.256 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.647 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 23.7 m-85 -58.19 -30.54 66.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.069 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -83.31 -23.93 32.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.824 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.2 mt -97.93 -47.51 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.56 ' N ' HE21 ' A' ' 99' ' ' GLN . . . -114.62 -12.64 12.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.089 1.514 . . . . 1.0 115.089 -173.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.856 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.0 mm-40 45.6 61.43 2.62 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.164 -1.014 . . . . 1.0 108.813 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 99' ' ' GLN . 3.9 m -165.71 105.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.075 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.457 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 9.9 mmt180 -148.29 150.36 33.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.418 . . . . 1.0 110.742 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -169.09 146.7 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.522 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.499 ' CG1' HBA2 ' A' ' 203' ' ' CYC . 27.1 mt -107.42 135.07 47.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 105' ' ' ASP . 6.0 p -90.65 160.28 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.227 0.825 . . . . 1.0 113.227 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.489 ' N ' HG22 ' A' ' 104' ' ' VAL . 4.3 p30 -45.52 121.0 2.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.881 -1.054 . . . . 1.0 112.209 -177.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 140' ' ' VAL . 9.4 p -57.2 -22.11 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.816 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -62.53 -49.03 76.94 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.413 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . . . -62.65 -8.47 6.62 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.504 0.669 . . . . 1.0 109.391 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 43.89 72.07 0.21 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.77 -1.105 . . . . 1.0 113.35 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.42 131.9 41.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.905 -1.517 . . . . 1.0 106.905 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -119.77 139.53 52.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.962 -0.695 . . . . 1.0 111.884 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -147.91 167.64 24.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.544 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.525 ' C ' ' H ' ' A' ' 115' ' ' GLN . 15.8 pt -125.24 138.48 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.133 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.2 m -72.87 25.74 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.64 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.525 ' H ' ' C ' ' A' ' 113' ' ' ILE . 83.1 mm-40 -115.16 82.35 8.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.631 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -84.66 160.35 12.37 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.626 2.217 . . . . 1.0 112.336 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 118' ' ' SER . 84.5 tt0 -100.63 115.58 30.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.492 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 117' ' ' GLU . 4.5 m 39.93 -164.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.638 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.647 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 63.8 t-105 -141.97 170.18 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.543 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.647 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . -80.51 165.6 48.4 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 38.0 mt -90.48 170.23 10.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.715 0.293 . . . . 1.0 110.423 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.1 m -53.68 -42.69 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.478 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.32 84.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.711 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -83.04 141.05 32.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.56 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 125' ' ' VAL . 7.6 p -130.54 85.51 55.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.201 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -48.73 131.49 24.52 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.616 2.21 . . . . 1.0 112.335 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.9 mt -132.32 76.21 1.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 40.39 87.98 0.01 OUTLIER Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.839 -0.904 . . . . 1.0 110.839 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.476 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 1.4 tt0 -48.53 -48.11 68.53 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.548 0.213 . . . . 1.0 110.859 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 40.2 Cg_endo -94.49 158.18 1.97 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.11 2.54 . . . . 1.0 111.671 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.7 mt -82.82 -15.71 50.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.32 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.63 ' O ' ' C ' ' A' ' 133' ' ' ARG . 93.4 mt-30 -91.09 -8.59 48.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.931 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.63 ' C ' ' O ' ' A' ' 132' ' ' GLN . 85.5 mtt180 17.83 68.58 0.22 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.582 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.28 141.77 96.64 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.777 2.318 . . . . 1.0 111.908 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.5 t -106.96 128.03 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.829 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.651 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -44.92 148.36 0.99 Allowed Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.16 -33.95 89.89 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.224 2.616 . . . . 1.0 113.988 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.724 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.8 p -48.32 -47.73 36.61 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.74 0.274 . . . . 1.0 111.74 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.724 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 29.4 t-80 -81.5 -29.38 33.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.274 0.472 . . . . 1.0 112.274 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.414 ' CG1' HG23 ' A' ' 106' ' ' VAL . 98.4 t -64.22 -53.7 40.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.928 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -64.34 -28.02 69.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -59.63 -41.08 89.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.868 -0.606 . . . . 1.0 109.759 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 146' ' ' MET . 12.7 mt -73.52 -39.33 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -51.08 -38.87 54.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.5 m -64.44 -24.72 67.72 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.738 -1.119 . . . . 1.0 109.223 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.58 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.4 mmm -92.0 -1.69 57.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.739 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.6 22.0 77.88 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.03 142.39 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 1.0 111.002 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.54 -39.9 5.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.015 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -133.41 125.38 28.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.118 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 m -119.06 138.37 52.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.449 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -116.27 141.13 48.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.29 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.693 HG21 HAA2 ' A' ' 203' ' ' CYC . 1.6 t -126.24 122.65 61.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.157 0.503 . . . . 1.0 111.77 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 154' ' ' VAL . 1.4 p -132.46 93.03 26.14 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.836 -1.172 . . . . 1.0 107.836 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.698 ' C ' HD12 ' A' ' 156' ' ' LEU . 87.1 Cg_exo -48.14 150.21 5.31 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.149 2.566 . . . . 1.0 114.648 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 155' ' ' PRO . 10.9 mp -123.08 64.19 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -149.63 -161.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.138 0.792 . . . . 1.0 113.138 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.22 -178.72 5.23 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.315 -0.857 . . . . 1.0 111.397 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -73.8 -55.42 6.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 1.0 112.026 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -103.57 8.6 37.64 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.991 0.367 . . . . 1.0 111.991 -177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -140.6 133.45 29.07 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.877 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.532 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.7 OUTLIER -110.63 119.35 38.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.236 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -93.58 -36.65 12.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.241 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.41 -177.38 37.03 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.7 mp -141.16 138.89 33.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 1.0 111.564 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.512 ' HB2' HD13 ' A' ' 156' ' ' LEU . 6.0 tp -104.98 136.99 43.42 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.24 135.39 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.713 -0.395 . . . . 1.0 111.106 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.5 m -112.04 142.4 44.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.019 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.53 ' CE1' ' NH1' ' A' ' 50' ' ' ARG . 42.3 m80 -114.81 127.42 55.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.029 0.442 . . . . 1.0 111.698 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.533 ' CD2' ' OE2' ' A' ' 172' ' ' GLU . 1.7 t-80 -127.42 121.93 32.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.949 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.47 61.44 5.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.803 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.533 ' OE2' ' CD2' ' A' ' 170' ' ' HIS . 26.3 pt-20 -152.04 142.65 15.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.064 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.39 -0.49 10.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.986 2.457 . . . . 1.0 111.854 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -60.67 147.18 84.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.898 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.15 167.48 25.85 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.545 2.163 . . . . 1.0 111.924 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -86.42 142.44 28.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.42 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.2 m -115.0 150.87 35.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.622 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -60.54 -29.88 69.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.57 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 29.8 mp0 -55.34 -34.33 64.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.769 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -63.66 -37.54 87.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.503 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.56 -37.81 85.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.543 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.5 tm0? -54.49 -39.22 67.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.389 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 83.7 t -67.24 -53.9 28.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 19.2 m -74.58 -29.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -51.61 -45.48 63.22 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.873 -0.331 . . . . 1.0 111.686 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 18.5 tp -76.25 -41.17 49.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.878 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.877 ' O ' HG23 ' A' ' 191' ' ' VAL . 47.5 mt -78.39 -39.71 38.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.816 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.44 -44.45 97.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.472 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -61.53 -38.12 86.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 1.0 109.971 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.43 -26.4 60.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.136 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 187' ' ' LEU . 59.9 t -82.73 -49.61 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.734 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 83.1 p -51.47 -30.27 19.24 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 56.9 mt -76.82 -33.85 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.495 -0.775 . . . . 1.0 109.214 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.61 -45.81 77.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.789 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.404 HD11 ' O ' ' A' ' 156' ' ' LEU . 25.0 pt -63.43 -35.11 71.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.138 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.4 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -69.78 -44.51 69.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 1.0 111.199 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.26 -38.44 75.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 1.0 111.518 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.32 -32.88 74.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.666 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.55 -32.85 70.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.478 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.3 mt -60.68 -32.62 71.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.99 -0.284 . . . . 1.0 111.051 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -53.45 -53.0 57.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.563 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 21.7 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.53 179.594 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.693 HAA2 HG21 ' A' ' 153' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.899 0.38 . . . . 1.0 110.59 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -57.29 -52.05 66.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.03 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -55.99 -46.19 78.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.085 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.7 mt -61.61 -53.4 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 1.0 110.91 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.8 mt -53.98 -43.52 70.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.995 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.497 HH12 ' CD2' ' A' ' 78' ' ' LEU . 59.8 ttm-85 -54.02 -35.46 61.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.617 -0.433 . . . . 1.0 109.895 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -36.23 72.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.078 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.8 p -70.83 -42.11 70.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.527 -0.76 . . . . 1.0 112.295 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.708 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p -69.05 -36.52 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.93 0.344 . . . . 1.0 111.93 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -71.6 -40.99 69.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.805 0.336 . . . . 1.0 111.094 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.25 -52.01 65.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.757 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.5 m -56.06 -34.42 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.721 0.296 . . . . 1.0 111.13 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 47' ' ' GLY . 60.9 ttp180 -54.01 -43.08 69.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 1.0 110.81 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.51 76.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.047 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -78.73 -45.63 20.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.611 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.0 mt -86.04 -31.98 21.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.49 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.9 22.6 48.56 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.459 -1.057 . . . . 1.0 110.459 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -73.34 141.99 47.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 1.0 110.229 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -42.12 -43.43 3.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.6 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -158.29 130.53 6.96 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.048 -0.661 . . . . 1.0 112.61 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.48 130.51 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.579 -0.897 . . . . 1.0 108.579 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 166' ' ' LEU . 12.3 pttm -142.08 156.4 45.39 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.453 -0.499 . . . . 1.0 111.871 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 50.6 t -99.99 134.39 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 42.4 t80 -115.59 105.89 13.3 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.335 -0.546 . . . . 1.0 111.306 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -76.68 126.27 30.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.212 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.438 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 68.3 t80 -92.52 136.91 32.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.991 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.438 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 4.8 m-20 -106.57 140.1 20.99 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.31 -28.86 6.22 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.53 2.153 . . . . 1.0 112.45 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -83.31 -17.76 41.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.882 0.373 . . . . 1.0 110.03 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.96 -13.73 41.11 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.574 -0.611 . . . . 1.0 111.574 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -78.15 91.16 4.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.808 0.337 . . . . 1.0 110.613 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.92 152.56 21.06 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.566 -1.014 . . . . 1.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.7 p -125.29 148.17 48.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 1.0 111.727 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -74.41 107.31 4.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.55 -1.58 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.351 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.708 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.94 115.87 3.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.112 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 85.4 tt0 -145.25 131.17 19.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.079 0.466 . . . . 1.0 111.854 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB1' ' HD3' ' A' ' 43' ' ' ARG . . . -130.81 137.47 49.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.409 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -143.33 148.7 36.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.875 0.369 . . . . 1.0 110.718 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.99 -120.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.852 -0.899 . . . . 1.0 110.852 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -78.78 -179.74 51.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.78 43.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 1.0 110.559 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 71' ' ' GLY . 77.6 ttt180 -82.91 -46.72 12.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.177 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 mt -111.68 146.44 34.7 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 1.0 109.84 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.2 160.31 50.01 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.525 2.15 . . . . 1.0 112.132 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 m -89.78 127.42 35.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.941 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 80' ' ' LEU . 28.6 mt -98.28 11.33 38.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.399 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.497 ' CD2' HH12 ' A' ' 36' ' ' ARG . 19.4 tp -72.47 132.76 44.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.012 -0.54 . . . . 1.0 112.306 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.96 -9.72 71.11 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.604 -0.726 . . . . 1.0 111.529 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 77' ' ' LEU . 76.5 mt -86.67 152.96 22.11 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.936 -0.305 . . . . 1.0 110.344 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.6 m -105.26 132.24 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.675 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 7.4 m-85 -86.28 152.25 55.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.45 133.45 37.34 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.653 2.236 . . . . 1.0 111.873 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.78 131.48 46.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.693 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.62 2.12 40.3 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.548 -1.021 . . . . 1.0 110.548 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 54.3 t0 -57.59 -33.46 68.21 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 87' ' ' ILE . 1.6 mp -82.59 127.09 71.8 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.46 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.737 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 89.6 Cg_endo -73.06 -164.86 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.411 2.074 . . . . 1.0 112.54 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -105.87 -58.68 1.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.535 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.19 -45.0 96.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.795 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.06 -40.21 87.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -63.79 -37.77 88.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.424 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -62.05 -36.48 81.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.781 0.324 . . . . 1.0 110.835 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.552 HD12 ' NH2' ' A' ' 101' ' ' ARG . 77.7 mt -69.82 -33.07 71.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.286 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.642 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 2.3 t80 -63.8 -31.42 72.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.003 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.487 ' C ' HE22 ' A' ' 99' ' ' GLN . 74.6 ttt180 -81.87 -27.12 33.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.865 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.85 -42.67 7.85 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 114.356 1.243 . . . . 1.0 114.356 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.74 -6.78 13.84 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -175.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.755 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.4 mm-40 42.58 75.31 0.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.226 -0.99 . . . . 1.0 108.864 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 100' ' ' VAL . 4.1 p 175.79 115.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.023 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.574 ' HD3' HAA2 ' A' ' 203' ' ' CYC . 33.7 ttm-85 -159.18 153.25 23.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 1.0 110.758 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.1 p -168.99 148.07 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.504 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 56.2 mt -105.34 134.79 45.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 105' ' ' ASP . 11.2 t -88.53 158.92 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.25 0.833 . . . . 1.0 113.25 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.7 p30 -49.23 121.0 4.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.937 -1.029 . . . . 1.0 112.151 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.448 HG23 ' CG1' ' A' ' 140' ' ' VAL . 9.1 p -56.09 -22.07 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.342 -0.845 . . . . 1.0 110.784 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -61.79 -50.31 72.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.421 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . . . -64.26 -10.53 24.28 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.465 0.65 . . . . 1.0 109.347 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 44.51 70.74 0.31 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.785 -1.098 . . . . 1.0 113.267 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.55 131.99 42.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.965 -1.495 . . . . 1.0 106.965 175.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -121.13 134.89 55.25 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.967 -0.693 . . . . 1.0 111.937 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -128.61 156.23 43.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.63 -0.713 . . . . 1.0 110.529 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 112' ' ' SER . 21.2 pt -156.83 -179.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.103 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.9 p -59.91 154.01 19.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.685 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -137.9 152.3 71.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.698 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.46 -20.91 10.6 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.727 2.285 . . . . 1.0 112.416 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -122.29 158.2 30.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.357 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.3 m -121.02 148.64 43.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.671 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -86.45 -99.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.522 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.44 169.41 45.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.81 -37.9 88.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 1.0 110.416 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.9 p -57.54 -33.85 68.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.522 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 124' ' ' ARG . . . -71.77 -30.82 65.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.662 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 123' ' ' ALA . 70.2 mtt180 76.32 -178.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.505 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.571 ' O ' ' O ' ' A' ' 126' ' ' PRO . 10.7 t -146.92 86.77 6.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.242 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 125' ' ' VAL . 78.9 Cg_exo -50.5 -131.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.653 2.235 . . . . 1.0 112.239 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.6 mt -56.91 -31.94 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.579 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 117.44 129.01 4.12 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -70.66 149.45 95.35 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.57 0.224 . . . . 1.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -85.98 10.25 3.74 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.177 2.584 . . . . 1.0 111.635 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.8 mp -75.74 -17.42 59.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.336 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 64.77 5.99 3.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.942 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 60.13 71.61 0.85 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.555 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.7 155.23 70.83 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.758 2.305 . . . . 1.0 111.92 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.618 HG12 HBD2 ' A' ' 203' ' ' CYC . 3.0 m -105.55 125.54 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.927 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -43.71 130.37 3.99 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.44 ' HD3' ' H ' ' A' ' 112' ' ' SER . 49.4 Cg_exo -40.23 -46.28 4.18 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.178 2.585 . . . . 1.0 114.051 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.3 p -38.85 -45.24 1.14 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.688 0.255 . . . . 1.0 111.688 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.677 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 17.5 t60 -81.19 -28.68 34.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.482 ' CG2' HG23 ' A' ' 135' ' ' VAL . 85.8 t -64.87 -54.96 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.939 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -65.14 -28.7 69.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -59.78 -44.72 93.78 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.774 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.631 HD11 ' NE2' ' A' ' 139' ' ' HIS . 69.5 mt -72.96 -38.08 66.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -50.64 -39.27 50.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -63.87 -26.87 68.81 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.729 -1.123 . . . . 1.0 109.165 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.564 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.5 mmm -88.75 -1.27 58.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.452 -0.794 . . . . 1.0 110.709 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.98 22.01 77.5 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.9 t -111.62 140.75 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.905 0.383 . . . . 1.0 110.968 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.47 -40.54 4.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.0 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.6 m -133.4 122.53 23.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.12 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.446 ' OG ' ' CG2' ' A' ' 167' ' ' VAL . 3.7 t -116.75 133.63 55.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.436 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 tt -112.19 137.19 50.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.273 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.418 HG21 HAA1 ' A' ' 203' ' ' CYC . 2.1 t -122.3 120.05 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.157 0.503 . . . . 1.0 111.774 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.03 103.74 47.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -40.38 125.91 2.0 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.197 2.598 . . . . 1.0 114.69 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.485 HD11 ' HB ' ' A' ' 191' ' ' VAL . 10.9 tp -113.59 47.53 1.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.861 -1.533 . . . . 1.0 106.861 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.2 ptm -148.59 -174.75 4.69 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.069 0.766 . . . . 1.0 113.069 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.664 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 42.0 t-80 -75.13 -179.33 4.32 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.311 -0.859 . . . . 1.0 111.38 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.664 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 82.2 t60 -75.16 -55.64 5.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.396 -0.82 . . . . 1.0 112.057 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -104.62 9.48 35.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -139.76 137.15 34.84 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.701 -0.399 . . . . 1.0 110.906 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 162' ' ' LEU . 5.7 tt -110.62 113.93 26.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.068 -0.515 . . . . 1.0 111.303 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -90.79 -35.45 14.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.28 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -163.02 -172.95 31.15 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.39 129.01 26.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 1.0 111.562 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 52' ' ' LYS . 37.6 tp -103.54 129.1 50.69 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.446 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 11.5 p -139.14 139.71 39.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.069 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 84.2 p -110.86 140.33 45.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.049 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -111.71 132.3 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.979 0.418 . . . . 1.0 111.601 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -130.1 121.2 25.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 1.0 109.882 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -81.64 55.79 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.808 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -156.77 149.63 18.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.012 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.78 -11.55 31.03 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.907 2.405 . . . . 1.0 111.914 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -39.33 104.17 0.31 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.862 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.81 167.44 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.585 2.19 . . . . 1.0 111.902 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 49.5 p90 -80.09 129.66 34.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.462 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.5 t -111.93 143.0 43.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.635 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -58.04 -27.74 63.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.664 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -57.55 -38.48 74.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.666 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.86 -38.07 89.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.542 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 56.5 mt -64.18 -40.82 96.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.517 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -53.63 -38.21 63.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.33 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.23 -54.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 188' ' ' ALA . 29.3 m -77.34 -29.8 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.404 0.52 . . . . 1.0 112.404 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 189' ' ' ASP . 58.8 tp60 -50.98 -49.9 59.32 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.98 -0.288 . . . . 1.0 111.631 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.6 tp -76.84 -41.33 44.59 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.8 tp -76.75 -43.43 37.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.806 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -60.09 -40.42 89.53 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.511 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 93.5 m-20 -56.52 -38.37 71.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.018 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -71.23 -24.91 62.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.155 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.485 ' HB ' HD11 ' A' ' 156' ' ' LEU . 93.8 t -82.85 -49.01 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 1.0 109.731 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.6 m -51.4 -29.92 17.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 57.9 mt -75.92 -33.28 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.236 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -67.07 -45.41 77.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.825 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 19.0 pt -63.93 -35.53 73.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.149 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -68.78 -43.37 75.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.135 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -70.94 -38.04 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.553 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.21 -32.08 73.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.725 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.92 -39.13 93.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.475 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 200' ' ' LEU . 23.8 tp -62.93 -35.67 80.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.723 0.297 . . . . 1.0 111.119 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.2 t -54.8 -53.68 52.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.612 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.48 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.618 HBD2 HG12 ' A' ' 135' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.814 0.34 . . . . 1.0 110.531 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -60.13 -52.7 64.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.985 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -54.9 -45.98 74.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.087 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 mm -61.01 -48.24 89.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 1.0 110.966 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.628 HD21 HD11 ' A' ' 195' ' ' ILE . 35.5 mt -56.95 -42.78 80.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 1.0 111.03 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -52.91 -35.33 58.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.068 0.461 . . . . 1.0 109.869 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.91 -34.34 71.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.06 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 42' ' ' VAL . 62.4 p -72.28 -40.23 67.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.524 -0.762 . . . . 1.0 112.263 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.654 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.3 p -73.57 -38.76 52.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 111.899 0.333 . . . . 1.0 111.899 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.403 ' N ' HG13 ' A' ' 39' ' ' VAL . 99.5 mt-10 -71.2 -45.46 63.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.772 0.32 . . . . 1.0 111.104 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.85 -47.93 70.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.784 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 38' ' ' THR . 72.0 t -60.39 -39.06 79.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.982 -0.287 . . . . 1.0 111.12 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.4 tmm_? -57.25 -42.9 82.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 1.0 110.823 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.82 -33.59 68.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -78.42 -40.67 35.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.542 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.71 -31.2 22.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.448 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 61.7 21.78 61.09 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 169' ' ' HIS . 5.2 t -73.22 139.48 46.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.35 . . . . 1.0 110.17 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -44.57 -38.68 4.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.609 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.556 HH22 ' H ' ' A' ' 77' ' ' LEU . 53.7 ttt85 -161.53 126.24 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.058 -0.657 . . . . 1.0 112.625 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.23 128.31 29.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.563 ' NZ ' HAB1 ' A' ' 203' ' ' CYC . 20.7 pttp -140.18 155.66 46.84 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.86 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 66.4 t -106.42 137.49 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.473 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -136.62 127.91 28.21 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.252 -0.579 . . . . 1.0 111.288 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -88.03 144.35 26.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.745 -0.662 . . . . 1.0 110.208 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.595 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 80.4 t80 -95.52 117.79 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 1.0 112.027 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.9 m-20 -85.27 135.85 38.56 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -45.83 -24.06 1.92 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.456 2.104 . . . . 1.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.21 -18.48 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.052 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.88 -13.36 38.11 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.583 -0.607 . . . . 1.0 111.583 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -75.07 92.25 2.62 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.642 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.54 142.54 18.0 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 p -121.39 142.75 49.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 1.0 111.751 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.65 110.94 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.748 -0.834 . . . . 1.0 108.748 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.613 ' O ' HG12 ' A' ' 65' ' ' VAL . 95.5 t -106.59 -0.89 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.942 -0.303 . . . . 1.0 111.372 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.97 120.79 3.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.149 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 68.6 tt0 -142.12 131.78 24.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.06 0.457 . . . . 1.0 111.818 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.95 143.11 50.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.375 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.528 ' NH1' ' OG ' ' A' ' 76' ' ' SER . 32.8 ptt180 -142.88 142.44 31.77 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.743 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.44 -33.01 85.04 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.48 -170.92 36.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 77.6 mm-40 -78.25 38.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 1.0 110.556 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -82.83 -48.11 11.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.148 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.46 149.26 36.85 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.826 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.95 146.69 59.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.532 2.155 . . . . 1.0 112.183 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.528 ' OG ' ' NH1' ' A' ' 69' ' ' ARG . 67.2 m -77.28 121.23 23.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.962 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.556 ' H ' HH22 ' A' ' 50' ' ' ARG . 27.5 mt -100.59 12.12 38.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.416 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.2 tp -73.49 132.68 43.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.307 0.575 . . . . 1.0 112.288 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.86 -10.04 63.89 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.505 -0.771 . . . . 1.0 111.546 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 77' ' ' LEU . 64.0 mt -86.43 155.55 20.52 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.001 -0.28 . . . . 1.0 110.329 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.2 p -103.65 126.37 50.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.67 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 6.6 m-85 -77.86 151.8 79.65 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.55 117.7 4.66 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.648 2.232 . . . . 1.0 111.818 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.01 125.09 11.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.677 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.7 0.13 42.59 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.574 -1.011 . . . . 1.0 110.574 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 2.6 p30 -56.76 -32.64 65.8 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.477 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 3.2 tp -84.25 131.05 51.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.384 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.71 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 71.7 Cg_endo -70.19 -169.48 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.427 2.085 . . . . 1.0 112.487 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -107.1 -44.71 4.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.559 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 42.0 mp0 -69.36 -41.15 76.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.796 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.72 ' HB2' HAD2 ' A' ' 203' ' ' CYC . . . -67.35 -44.05 79.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.906 0.336 . . . . 1.0 111.906 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.595 ' NH2' ' CG ' ' A' ' 56' ' ' PHE . 51.6 ttt85 -65.23 -44.09 89.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.472 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -61.05 -34.14 74.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.34 . . . . 1.0 110.879 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.514 ' C ' HH22 ' A' ' 101' ' ' ARG . 47.4 mt -71.18 -38.75 72.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.298 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.609 ' N ' ' NH2' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -58.19 -28.51 64.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.061 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -74.91 -29.87 61.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.87 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.587 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 75.5 mt -97.17 -39.4 9.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.573 ' C ' ' NE2' ' A' ' 99' ' ' GLN . . . -118.34 -7.19 10.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.051 1.5 . . . . 1.0 115.051 -176.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.632 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER 38.51 77.4 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.161 -1.015 . . . . 1.0 108.847 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 100' ' ' VAL . 12.9 p 179.32 114.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.108 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.609 ' NH2' ' N ' ' A' ' 95' ' ' PHE . 4.0 tpp180 -156.79 150.84 24.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.954 0.407 . . . . 1.0 110.75 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.32 145.72 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.456 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.7 mt -108.6 131.84 58.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.141 -0.689 . . . . 1.0 109.141 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.1 m -91.66 164.9 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 113.23 0.826 . . . . 1.0 113.23 -176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -48.07 117.24 1.82 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.89 -1.05 . . . . 1.0 112.139 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.44 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.1 p -53.51 -19.34 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.347 -0.842 . . . . 1.0 110.799 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -66.37 -44.69 82.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.97 -4.77 10.43 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.596 0.712 . . . . 1.0 109.414 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 36.6 69.45 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.713 -1.131 . . . . 1.0 113.295 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.3 p -75.22 131.06 40.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.997 -1.482 . . . . 1.0 106.997 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -121.91 142.14 50.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.888 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 t -130.3 122.57 28.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.55 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.797 ' O ' ' N ' ' A' ' 115' ' ' GLN . 69.3 mt -129.79 174.13 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.191 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.722 ' N ' HG22 ' A' ' 113' ' ' ILE . 29.3 t 38.48 -77.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.654 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.797 ' N ' ' O ' ' A' ' 113' ' ' ILE . 53.1 tp60 -54.23 107.49 0.87 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.639 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -92.6 -43.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.638 2.225 . . . . 1.0 112.372 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -96.6 169.55 9.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.418 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.406 ' CB ' ' NH1' ' A' ' 133' ' ' ARG . 95.8 p -130.11 160.4 33.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.646 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -57.88 120.1 7.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.511 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.43 92.12 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 124' ' ' ARG . 33.7 mt -87.92 139.73 30.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 1.0 110.357 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 t -60.94 -37.12 81.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.45 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.85 90.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.708 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 121' ' ' LEU . 10.4 tpp85 -139.43 144.75 38.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.56 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.29 84.81 23.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.18 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.59 153.94 1.97 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.671 2.247 . . . . 1.0 112.288 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 127' ' ' LEU . 9.0 mp -57.76 -19.77 30.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.58 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.67 74.79 0.01 OUTLIER Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.786 -0.925 . . . . 1.0 110.786 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 127' ' ' LEU . 42.4 mt-10 -143.78 74.74 16.45 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.559 0.219 . . . . 1.0 110.877 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -86.88 163.37 8.97 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 123.099 2.533 . . . . 1.0 111.679 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 48.8 mt -76.36 -5.87 49.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.361 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -85.52 88.33 7.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.939 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.406 ' NH1' ' CB ' ' A' ' 118' ' ' SER . 22.1 mmt180 -124.33 80.35 59.64 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.506 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.87 138.94 20.3 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.691 2.261 . . . . 1.0 111.997 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 t -105.84 122.82 59.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.85 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -42.43 152.74 0.33 Allowed Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.746 -0.464 . . . . 1.0 109.746 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -58.89 -34.72 99.21 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.223 2.615 . . . . 1.0 114.068 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.705 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -48.16 -46.31 34.48 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.684 0.253 . . . . 1.0 111.684 -178.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.705 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 19.1 t-80 -82.91 -27.75 30.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.272 0.471 . . . . 1.0 112.272 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.44 ' CG1' HG23 ' A' ' 106' ' ' VAL . 86.4 t -65.2 -52.26 55.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.965 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -66.47 -27.87 68.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -60.02 -41.98 93.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.732 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 146' ' ' MET . 8.9 mt -73.03 -37.83 66.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -51.95 -38.24 55.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.9 p -66.85 -20.66 65.97 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.761 -1.109 . . . . 1.0 109.188 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.568 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -95.43 -0.02 52.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.406 -0.816 . . . . 1.0 110.711 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.61 20.68 78.65 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.69 143.96 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 1.0 110.968 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.66 -42.29 4.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.982 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 t -135.35 122.85 22.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.135 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.6 m -110.99 141.91 43.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.503 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.511 HD13 ' CE1' ' A' ' 176' ' ' TYR . 2.4 tp -118.27 136.35 53.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.292 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.7 t -123.14 114.85 43.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.12 0.486 . . . . 1.0 111.772 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.5 t -113.26 131.2 23.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 107.806 -1.183 . . . . 1.0 107.806 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.75 125.45 8.17 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.152 2.568 . . . . 1.0 114.676 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.2 mt -118.52 48.95 1.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -146.14 176.55 9.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.502 ' ND1' ' N ' ' A' ' 159' ' ' HIS . 49.9 t-80 -67.72 171.68 6.16 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.379 -0.828 . . . . 1.0 111.391 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.502 ' N ' ' ND1' ' A' ' 158' ' ' HIS . 73.5 m80 -61.98 -52.82 62.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.039 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -103.79 -39.32 6.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.541 ' OE1' ' CD2' ' A' ' 163' ' ' TRP . 11.0 tm-20 -87.54 133.55 33.76 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.909 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.567 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.6 OUTLIER -107.2 117.52 34.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 1.0 111.301 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.541 ' CD2' ' OE1' ' A' ' 161' ' ' GLU . 54.2 m95 -92.0 -41.04 10.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.231 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.515 ' C ' HD12 ' A' ' 165' ' ' LEU . . . -163.34 -176.86 35.76 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.204 -0.759 . . . . 1.0 111.204 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 164' ' ' GLY . 5.3 mp -143.87 140.19 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 1.0 111.569 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.5 tp -98.97 135.67 40.06 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 167' ' ' VAL . 10.8 p -138.59 129.11 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.371 . . . . 1.0 111.051 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.5 t -107.6 150.7 26.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.996 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.442 ' O ' ' OG1' ' A' ' 48' ' ' THR . 91.7 m-70 -127.81 134.84 49.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.961 0.41 . . . . 1.0 111.626 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -132.62 113.93 13.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.015 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.78 -14.24 62.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.857 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -108.04 150.0 39.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.01 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.2 140.59 34.35 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.902 2.401 . . . . 1.0 111.896 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -172.31 129.66 0.62 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.898 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.58 157.81 28.55 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.517 2.144 . . . . 1.0 111.932 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.511 ' CE1' HD13 ' A' ' 152' ' ' LEU . 75.7 m-85 -102.2 139.0 38.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.444 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.496 ' N ' ' OE1' ' A' ' 180' ' ' GLU . 8.7 t -126.94 -177.35 4.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.591 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' A' ' 182' ' ' GLN . 95.0 mt-30 -59.98 -34.1 72.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.657 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -56.17 -36.93 68.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.764 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 177' ' ' SER . 40.5 mp0 -65.15 -24.21 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.497 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.6 tp -80.88 -30.53 35.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.497 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.497 ' NE2' ' N ' ' A' ' 182' ' ' GLN . 0.3 OUTLIER -63.28 -43.36 98.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.32 -178.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.67 HG23 ' N ' ' A' ' 184' ' ' VAL . 22.9 m -73.7 -51.56 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.67 ' N ' HG23 ' A' ' 183' ' ' VAL . 16.9 m -68.57 -46.26 80.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.445 0.535 . . . . 1.0 112.445 -177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.6 ' N ' HG23 ' A' ' 184' ' ' VAL . 52.7 tp60 -53.09 -36.62 60.89 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.664 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 186' ' ' LEU . 1.1 tt -74.55 -53.48 9.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.875 ' O ' HG23 ' A' ' 191' ' ' VAL . 71.0 mt -78.91 -39.27 35.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.883 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 184' ' ' VAL . . . -62.18 -45.52 93.04 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.487 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.415 ' OD2' ' NE2' ' A' ' 185' ' ' GLN . 93.0 m-20 -60.01 -40.19 88.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.069 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -69.21 -23.85 63.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.117 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 187' ' ' LEU . 57.9 t -83.79 -45.58 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.041 -0.527 . . . . 1.0 109.775 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.5 p -57.58 -34.59 69.38 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.677 -0.861 . . . . 1.0 108.677 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.8 mt -69.15 -34.3 62.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.394 -0.821 . . . . 1.0 109.156 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.6 -38.03 77.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.783 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.628 HD11 HD21 ' A' ' 35' ' ' LEU . 4.7 mm -64.24 -40.24 88.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.087 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.36 -49.06 53.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.132 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -69.99 -35.98 74.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.492 -178.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.441 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.49 -33.5 74.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.673 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.75 -33.25 72.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.449 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.79 -30.54 71.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.002 -0.279 . . . . 1.0 111.067 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -51.67 -51.99 51.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.551 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 23.7 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.56 179.495 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.72 HAD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.847 0.356 . . . . 1.0 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -79.13 -29.73 43.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.942 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -77.41 -47.72 19.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.11 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.507 HG23 ' N ' ' A' ' 35' ' ' LEU . 2.9 tp -61.61 -41.15 89.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.74 0.305 . . . . 1.0 110.859 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.6 ' O ' ' OG1' ' A' ' 38' ' ' THR . 20.2 mt -57.0 -44.43 82.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.089 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -55.35 -33.95 63.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.1 -33.22 69.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.154 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.6 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 82.8 p -72.15 -40.94 67.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.416 -0.811 . . . . 1.0 112.264 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.684 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 8.5 p -71.33 -37.23 64.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.04 -48.17 66.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 1.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.82 -52.69 59.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.687 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 38' ' ' THR . 77.6 t -53.49 -40.72 42.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.953 -0.299 . . . . 1.0 111.153 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.2 tmm_? -53.28 -39.3 63.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.737 0.303 . . . . 1.0 110.816 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.05 74.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.028 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -77.18 -42.22 38.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.578 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.14 -28.32 24.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.459 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.43 20.65 17.44 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.655 HG23 ' CE1' ' A' ' 170' ' ' HIS . 87.5 m -71.73 142.52 49.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 1.0 110.253 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -41.91 -45.53 3.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.596 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.529 HH21 ' CD ' ' A' ' 67' ' ' GLU . 64.0 ttt-85 -159.87 128.14 4.88 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.022 -0.671 . . . . 1.0 112.572 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.48 131.32 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.661 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 56.4 pttt -140.2 156.47 46.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.478 -0.489 . . . . 1.0 111.918 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 63.9 t -110.8 135.69 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -134.39 125.78 28.23 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.358 -0.537 . . . . 1.0 111.339 -178.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -84.17 143.47 29.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.235 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.609 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 72.7 t80 -95.51 119.23 33.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.065 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.43 149.48 52.06 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -60.93 -23.43 77.16 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.51 2.14 . . . . 1.0 112.456 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.5 -11.87 53.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.924 0.392 . . . . 1.0 110.116 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.69 -15.15 53.07 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.547 -0.621 . . . . 1.0 111.547 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.429 ' NE2' ' HB2' ' A' ' 84' ' ' ALA . 45.5 m80 -73.13 94.98 2.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.759 0.314 . . . . 1.0 110.6 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.6 139.59 16.04 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.1 p -120.64 142.14 49.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.862 0.363 . . . . 1.0 111.756 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 t -79.22 110.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.18 0.71 10.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.886 -0.325 . . . . 1.0 111.306 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.684 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.99 117.97 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.035 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.529 ' CD ' HH21 ' A' ' 50' ' ' ARG . 85.8 tt0 -143.58 132.4 22.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.122 0.487 . . . . 1.0 111.784 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.49 143.14 50.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.393 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -141.59 145.78 35.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.784 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -52.39 -34.09 40.93 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 177.31 -161.61 29.19 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.06 16.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 1.0 110.54 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 71' ' ' GLY . 30.3 ttm180 -65.31 -49.07 70.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.195 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.8 mt -111.82 146.77 35.42 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.887 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.33 159.32 54.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.486 2.124 . . . . 1.0 112.19 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.3 m -95.02 127.95 41.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.915 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 80' ' ' LEU . 28.7 mt -94.95 11.29 32.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.371 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.5 tp -68.0 132.21 46.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 1.0 112.241 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.08 -11.65 66.61 Favored Glycine 0 CA--C 1.523 0.594 0 CA-C-N 115.615 -0.721 . . . . 1.0 111.54 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 77' ' ' LEU . 80.4 mt -83.99 151.62 24.91 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.944 -0.303 . . . . 1.0 110.306 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.7 p -105.25 132.69 51.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.679 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.755 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 9.2 m-85 -86.97 130.53 47.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -40.39 138.49 1.31 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.686 2.257 . . . . 1.0 111.864 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.429 ' HB2' ' NE2' ' A' ' 61' ' ' HIS . . . -65.86 125.63 25.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.676 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.32 -1.51 43.4 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -60.54 -33.38 72.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 87' ' ' ILE . 1.5 mp -69.31 130.28 91.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.417 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.59 168.9 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.35 2.033 . . . . 1.0 112.499 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -100.45 -56.04 2.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.572 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -64.59 -41.67 96.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.813 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.929 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -66.84 -44.01 82.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.609 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 42.2 ttt85 -62.42 -41.3 98.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.436 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -62.87 -34.88 78.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.768 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.495 ' C ' HH22 ' A' ' 101' ' ' ARG . 71.2 mt -70.84 -38.21 73.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.225 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.657 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 1.7 t80 -62.03 -20.71 64.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.58 ' C ' HE22 ' A' ' 99' ' ' GLN . 38.2 ttt180 -82.96 -28.38 29.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.824 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.24 -42.65 7.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.499 ' N ' HE21 ' A' ' 99' ' ' GLN . . . -114.07 -8.06 13.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 115.07 1.508 . . . . 1.0 115.07 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.741 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.4 mm-40 42.43 81.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.186 -1.005 . . . . 1.0 108.817 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.8 p 174.41 114.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.985 -0.552 . . . . 1.0 111.101 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.608 ' NH2' ' N ' ' A' ' 95' ' ' PHE . 3.8 tpp180 -155.23 147.02 23.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 1.0 110.714 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 p -170.76 146.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.514 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.591 HD11 ' CD2' ' A' ' 139' ' ' HIS . 67.2 mt -108.65 136.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.608 HG11 ' H ' ' A' ' 133' ' ' ARG . 3.2 m -93.02 165.79 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.262 0.838 . . . . 1.0 113.262 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -48.07 117.22 1.82 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.899 -1.046 . . . . 1.0 112.109 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.429 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.4 p -58.38 -25.79 28.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.401 -0.818 . . . . 1.0 110.773 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 109' ' ' GLN . 84.5 tt0 -63.78 -44.98 91.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.47 -8.07 1.68 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.457 0.646 . . . . 1.0 109.338 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.646 ' NE2' HH21 ' A' ' 111' ' ' ARG . 45.9 tt0 45.04 60.91 2.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.744 -1.116 . . . . 1.0 113.266 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 t -75.15 133.46 41.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.954 -1.499 . . . . 1.0 106.954 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.646 HH21 ' NE2' ' A' ' 109' ' ' GLN . 80.0 mtt180 -119.57 139.52 52.01 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.038 -0.665 . . . . 1.0 111.9 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.29 163.51 32.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.564 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.9 pt -127.31 140.96 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.153 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.489 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 28.6 p -80.47 15.22 1.71 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.644 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 116' ' ' PRO . 65.0 mt-30 -64.51 151.67 91.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.598 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' GLN . 33.9 Cg_exo -34.0 -64.96 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.655 2.237 . . . . 1.0 112.365 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 118' ' ' SER . 72.4 tt0 41.58 61.24 1.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.405 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 117' ' ' GLU . 51.6 p 50.39 176.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.668 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -118.55 144.27 46.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.548 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 72.21 179.34 33.61 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.6 mt -102.47 89.58 3.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 1.0 110.423 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.0 p -66.6 -32.3 73.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.481 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.75 -23.37 64.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.71 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.51 ' NH2' ' O ' ' A' ' 125' ' ' VAL . 2.1 tpm_? 51.45 83.28 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.55 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.51 ' O ' ' NH2' ' A' ' 124' ' ' ARG . 1.6 m -68.38 143.46 95.56 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.23 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -80.96 4.6 6.84 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.577 2.185 . . . . 1.0 112.322 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.0 mp 55.59 26.15 8.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.571 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.73 -130.33 1.2 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 129' ' ' GLU . 10.7 mp0 -127.23 78.17 74.73 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.655 0.264 . . . . 1.0 110.875 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -87.35 -175.52 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.136 2.557 . . . . 1.0 111.654 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.8 mt -50.87 -61.21 2.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.339 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 179.5 153.74 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.956 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.608 ' H ' HG11 ' A' ' 104' ' ' VAL . 73.4 mtp180 -97.6 111.35 58.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.585 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.06 138.33 12.82 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.774 2.316 . . . . 1.0 111.977 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 26.4 t -125.89 140.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.808 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 114' ' ' SER . 3.7 t70 -43.68 138.88 2.92 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -58.48 -32.45 96.44 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.153 2.569 . . . . 1.0 114.005 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.6 p -49.79 -45.18 49.56 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.693 0.257 . . . . 1.0 111.693 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.668 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 6.5 t60 -81.39 -28.6 34.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.229 0.455 . . . . 1.0 112.229 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.429 ' CG1' HG23 ' A' ' 106' ' ' VAL . 60.2 t -68.77 -52.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.668 -0.413 . . . . 1.0 111.017 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -67.07 -24.84 66.01 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -64.56 -39.52 93.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.673 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 146' ' ' MET . 10.4 mt -73.35 -36.01 66.09 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -52.72 -38.22 60.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.625 -1.25 . . . . 1.0 107.625 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.3 p -66.69 -19.47 65.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.728 -1.124 . . . . 1.0 109.199 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.504 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.9 mmm -96.49 3.25 52.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.477 -0.783 . . . . 1.0 110.715 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.7 21.28 77.85 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 150' ' ' SER . 55.2 t -110.54 144.13 19.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.381 . . . . 1.0 110.971 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.95 -17.92 13.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.961 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.409 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 5.6 t -149.83 163.36 38.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.227 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.471 ' OG ' HD12 ' A' ' 103' ' ' ILE . 9.3 p -148.08 125.06 11.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.482 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -109.03 133.01 53.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.318 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.578 HG21 HAA1 ' A' ' 203' ' ' CYC . 3.7 t -123.57 116.25 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.11 0.481 . . . . 1.0 111.77 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.11 129.27 25.21 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 107.81 -1.181 . . . . 1.0 107.81 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.479 ' C ' HD12 ' A' ' 156' ' ' LEU . 95.1 Cg_endo -74.21 123.48 8.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.091 2.527 . . . . 1.0 114.685 -175.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.571 HD23 HG11 ' A' ' 191' ' ' VAL . 10.8 mp -116.4 49.3 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.866 -1.531 . . . . 1.0 106.866 177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -147.2 179.29 7.74 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.112 0.782 . . . . 1.0 113.112 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -67.6 164.58 18.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.286 -0.87 . . . . 1.0 111.434 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -57.89 -50.55 72.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.463 -0.789 . . . . 1.0 112.064 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -103.93 -39.64 6.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -88.28 137.92 31.9 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.863 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.61 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER -108.93 112.94 25.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.269 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -88.9 -42.56 11.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.195 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.71 -175.71 25.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.428 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 5.1 tp -145.44 134.15 22.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.352 . . . . 1.0 111.517 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.5 tp -101.63 131.33 47.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 167' ' ' VAL . 12.0 p -137.61 131.33 43.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.811 -0.356 . . . . 1.0 111.12 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.9 m -108.59 139.77 42.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.071 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.462 ' O ' ' CG2' ' A' ' 48' ' ' THR . 62.0 m80 -110.43 125.37 53.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.006 0.432 . . . . 1.0 111.636 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.655 ' CE1' HG23 ' A' ' 48' ' ' THR . 88.8 m-70 -123.78 114.62 20.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.875 -0.602 . . . . 1.0 109.952 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.36 -14.8 63.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.837 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.89 148.33 34.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.051 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' A' ' 174' ' ' ARG . 80.9 Cg_endo -74.83 -98.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.891 2.394 . . . . 1.0 111.917 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.507 ' O ' ' O ' ' A' ' 173' ' ' PRO . 16.2 mtp-105 56.38 144.94 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.838 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.87 152.0 40.93 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.603 2.202 . . . . 1.0 111.921 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -90.69 146.98 23.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.473 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.434 ' OG ' ' OE1' ' A' ' 180' ' ' GLU . 95.2 p -121.97 156.66 32.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.652 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.832 ' NE2' ' H ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -60.31 -26.16 66.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.558 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -54.58 -39.55 67.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.765 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.434 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 1.5 mp0 -63.96 -39.39 94.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.525 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.27 -38.84 91.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.429 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -56.21 -37.61 69.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.361 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 73.3 t -67.69 -56.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.667 0.617 . . . . 1.0 112.667 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 188' ' ' ALA . 1.8 t -73.47 -42.7 56.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -43.38 -47.7 6.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.605 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 19.7 tp -70.95 -41.06 71.6 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.919 0.34 . . . . 1.0 111.919 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.636 ' O ' HG23 ' A' ' 191' ' ' VAL . 8.4 tp -77.91 -38.4 45.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.821 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -62.24 -37.97 87.42 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.53 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -61.37 -40.11 93.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.031 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.86 -25.36 63.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.12 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 187' ' ' LEU . 59.2 t -83.25 -45.25 18.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.767 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.6 t -56.67 -37.02 70.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.3 mt -66.83 -33.65 64.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.448 -0.796 . . . . 1.0 109.171 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.9 -38.94 73.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.784 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.4 mm -65.21 -41.56 91.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.154 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.63 -47.96 61.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.115 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 0.5 OUTLIER -70.33 -34.52 72.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.532 -178.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -67.52 -32.78 73.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.667 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.14 -34.59 75.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.588 -0.278 . . . . 1.0 111.424 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 41.3 mt -61.09 -33.24 73.04 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.091 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 17.5 m -54.04 -53.19 56.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.796 0.331 . . . . 1.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.624 179.658 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.929 HBD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.815 0.341 . . . . 1.0 110.56 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -49.5 -35.25 19.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.993 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -75.4 -46.92 29.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.138 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 38' ' ' THR . 18.1 mm -64.99 -38.79 83.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.544 -0.298 . . . . 1.0 110.962 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.583 ' O ' ' OG1' ' A' ' 38' ' ' THR . 18.9 mt -57.88 -35.83 71.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.005 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -66.37 -33.47 75.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.084 0.468 . . . . 1.0 109.833 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.19 -30.94 67.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.107 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -73.0 -45.33 58.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.505 -0.77 . . . . 1.0 112.241 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.7 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.1 p -65.41 -35.23 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 111.929 0.344 . . . . 1.0 111.929 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.85 -40.1 65.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 1.0 111.071 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.12 -51.63 67.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.749 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.21 -30.6 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.203 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.647 HH22 ' CA ' ' A' ' 70' ' ' GLY . 8.1 tpt180 -55.38 -43.9 75.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.76 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.74 77.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.041 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -80.31 -45.48 17.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.526 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.92 -34.74 20.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.427 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.87 20.04 17.37 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.471 -1.052 . . . . 1.0 110.471 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.541 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 10.1 t -69.15 141.06 54.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.796 0.331 . . . . 1.0 110.23 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD2' ' CB ' ' A' ' 171' ' ' ALA . 84.5 m-20 -38.03 -39.82 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.659 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.436 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 24.3 ttm180 -167.75 131.95 1.77 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.007 -0.677 . . . . 1.0 112.588 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 p -138.81 130.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -139.88 157.55 45.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.131 0.491 . . . . 1.0 111.948 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.5 t -99.88 135.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -118.25 108.46 15.15 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.257 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -83.17 125.08 31.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.236 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.523 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 84.1 t80 -90.68 141.19 29.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 1.0 112.039 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.523 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 7.1 m-20 -112.13 151.05 43.35 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.11 -23.5 69.32 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.512 2.141 . . . . 1.0 112.49 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -87.46 -11.72 48.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.17 -11.63 60.29 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.552 -0.619 . . . . 1.0 111.552 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -80.14 90.74 5.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 1.0 110.627 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.52 151.05 21.12 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.576 -1.009 . . . . 1.0 110.576 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 p -125.44 148.47 48.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 1.0 111.711 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.71 109.26 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.78 0.69 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.366 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.7 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.6 115.72 2.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.066 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 85.5 tt0 -144.98 134.41 23.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.047 0.451 . . . . 1.0 111.834 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.87 132.37 45.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.433 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' C ' HH12 ' A' ' 43' ' ' ARG . 35.6 ptt-85 -134.97 150.94 50.44 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.733 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.647 ' CA ' HH22 ' A' ' 43' ' ' ARG . . . -56.76 -119.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.18 -76.94 1.03 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -169.22 46.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.747 0.308 . . . . 1.0 110.546 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -83.43 -45.99 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.1 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 28.6 mt -108.17 145.46 31.51 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.474 . . . . 1.0 109.874 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.3 139.57 42.16 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.485 2.123 . . . . 1.0 112.17 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.8 m -66.9 124.31 22.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.957 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 80' ' ' LEU . 26.9 mt -100.08 13.11 35.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.334 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.464 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 26.9 tp -71.65 128.36 35.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.284 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.42 -9.86 75.45 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.492 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 77' ' ' LEU . 73.7 mt -84.88 151.6 24.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.757 0.313 . . . . 1.0 110.292 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.9 m -104.07 131.0 51.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.688 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 6.1 m-85 -82.82 152.44 66.08 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.568 -0.53 . . . . 1.0 109.568 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.62 133.5 39.86 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.594 2.196 . . . . 1.0 111.877 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.27 127.88 33.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.681 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.09 2.76 45.26 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.539 -1.024 . . . . 1.0 110.539 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -58.44 -33.66 69.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.77 129.33 52.97 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.429 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.671 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 86.2 Cg_endo -73.89 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.459 2.106 . . . . 1.0 112.484 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -109.95 -59.02 1.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.531 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -58.42 -44.65 89.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.833 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.897 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -66.79 -48.03 70.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -54.72 -35.07 63.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.464 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -64.4 -34.15 77.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.0 mt -63.44 -37.58 87.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.281 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.66 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 56.2 m-85 -63.99 -27.18 68.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.04 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.549 ' C ' HE22 ' A' ' 99' ' ' GLN . 65.9 ttt180 -82.68 -29.36 29.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.77 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.1 mt -98.64 -42.41 7.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 114.416 1.265 . . . . 1.0 114.416 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.539 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.69 -7.87 13.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.019 1.489 . . . . 1.0 115.019 -174.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.76 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.7 mm-40 39.55 74.18 0.1 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.201 -1.0 . . . . 1.0 108.821 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 100' ' ' VAL . 6.8 p 174.27 121.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.059 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.571 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -171.04 147.65 2.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 1.0 110.811 177.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.571 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 21.9 m -157.25 157.63 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.515 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.754 HD11 HAA1 ' A' ' 203' ' ' CYC . 49.6 mt -106.06 135.59 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 105' ' ' ASP . 10.7 t -87.12 158.2 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.248 0.833 . . . . 1.0 113.248 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.46 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.0 p-10 -50.67 121.95 6.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.865 -1.061 . . . . 1.0 112.095 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.2 -23.06 12.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.792 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 109' ' ' GLN . 82.1 tt0 -63.15 -49.24 75.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . . . -66.4 -4.56 8.41 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.554 0.692 . . . . 1.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 36.34 72.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.787 -1.097 . . . . 1.0 113.282 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.4 p -72.83 129.75 38.88 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.968 -1.493 . . . . 1.0 106.968 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -118.4 133.18 56.09 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.918 -0.713 . . . . 1.0 111.835 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -125.91 153.47 44.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.556 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 112' ' ' SER . 23.1 pt -156.0 175.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.172 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.7 m -58.28 150.83 20.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.663 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -139.57 153.02 70.02 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.635 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.18 -12.15 19.3 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.709 2.273 . . . . 1.0 112.401 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -171.51 134.83 0.87 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.396 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.9 m -165.43 -23.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.635 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 81.3 t90 -68.85 137.42 53.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.507 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 72.31 -102.15 1.14 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.4 tp 47.39 93.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.332 . . . . 1.0 110.374 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 26.7 t -58.64 -34.13 70.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.489 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 124' ' ' ARG . . . -59.75 -52.11 66.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.681 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.51 ' HE ' ' H ' ' A' ' 125' ' ' VAL . 18.1 ttp180 80.54 -142.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.549 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.51 ' H ' ' HE ' ' A' ' 124' ' ' ARG . 3.2 m -115.82 83.65 11.98 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.186 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -86.86 -6.31 7.65 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.582 2.188 . . . . 1.0 112.309 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.24 146.27 39.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.567 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -76.43 161.19 51.46 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.754 -0.938 . . . . 1.0 110.754 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 42.24 62.6 7.67 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 121.144 -0.223 . . . . 1.0 110.823 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -86.61 160.78 9.34 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.197 2.598 . . . . 1.0 111.649 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.9 mt -73.22 -0.16 13.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.374 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 57.79 53.89 6.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.955 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? 64.11 89.87 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.593 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.37 146.31 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.733 2.289 . . . . 1.0 111.948 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.01 122.74 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.87 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -43.32 151.76 0.43 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.56 -43.46 50.69 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.217 2.612 . . . . 1.0 114.005 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.666 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.3 p -38.97 -44.75 1.11 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.679 0.252 . . . . 1.0 111.679 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.666 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.3 t60 -82.76 -31.78 28.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.249 0.463 . . . . 1.0 112.249 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.64 -52.8 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.639 -0.425 . . . . 1.0 110.982 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -65.79 -29.39 69.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -63.53 -44.86 93.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.707 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 146' ' ' MET . 12.6 mt -73.33 -36.67 66.24 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -48.23 -39.07 20.08 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.507 -1.294 . . . . 1.0 107.507 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.3 m -58.26 -32.64 68.56 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.786 -1.097 . . . . 1.0 109.214 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.574 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.2 mmm -79.1 0.72 26.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.743 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.49 26.07 74.7 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.39 142.28 30.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.976 0.417 . . . . 1.0 110.932 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.54 -26.43 12.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.969 -0.559 . . . . 1.0 111.027 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 p -141.5 127.11 18.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.413 . . . . 1.0 111.137 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.15 131.43 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.47 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 152' ' ' LEU . 8.3 mp -110.49 139.9 45.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.285 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.492 HG21 HMA3 ' A' ' 203' ' ' CYC . 2.4 t -123.97 116.24 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.113 0.482 . . . . 1.0 111.74 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.561 HG21 HG21 ' A' ' 184' ' ' VAL . 41.1 t -117.94 121.29 31.72 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 107.791 -1.189 . . . . 1.0 107.791 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.452 ' C ' HD12 ' A' ' 156' ' ' LEU . 86.4 Cg_endo -75.54 123.86 7.87 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.247 2.631 . . . . 1.0 114.7 -176.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.452 HD12 ' C ' ' A' ' 155' ' ' PRO . 10.8 mp -111.85 56.15 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.807 -1.553 . . . . 1.0 106.807 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -147.84 178.51 8.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -65.76 161.54 20.6 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.299 -0.864 . . . . 1.0 111.427 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -55.04 -49.26 72.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.083 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -105.0 -39.76 6.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.404 ' OE1' ' CH2' ' A' ' 163' ' ' TRP . 96.1 mt-10 -88.05 138.04 31.8 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.689 -0.405 . . . . 1.0 110.876 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 162' ' ' LEU . 1.8 mp -109.09 112.51 24.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.039 -0.528 . . . . 1.0 111.288 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.404 ' CH2' ' OE1' ' A' ' 161' ' ' GLU . 46.9 m95 -88.04 -36.93 16.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.214 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.0 -171.85 28.64 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.412 HD11 ' CG1' ' A' ' 153' ' ' VAL . 42.1 tp -144.66 131.84 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 1.0 111.585 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.46 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.4 tp -105.16 134.18 48.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.03 133.83 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.631 -0.428 . . . . 1.0 111.039 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.403 ' OG ' HG21 ' A' ' 48' ' ' THR . 28.5 t -107.8 136.99 46.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.02 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.463 ' O ' ' OG1' ' A' ' 48' ' ' THR . 27.7 m80 -111.71 131.37 55.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.999 0.428 . . . . 1.0 111.668 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -126.68 130.87 51.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.998 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.418 ' CB ' ' OD2' ' A' ' 49' ' ' ASP . . . -88.64 56.44 3.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.812 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -148.11 136.64 11.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.981 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.3 4.69 5.67 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.866 2.377 . . . . 1.0 111.924 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -64.87 148.39 97.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.895 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.78 165.28 31.82 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.603 2.202 . . . . 1.0 111.897 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 38.4 p90 -86.4 138.46 31.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.425 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 88.3 p -116.8 155.48 28.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.63 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.523 ' NE2' HD23 ' A' ' 181' ' ' LEU . 62.5 tp60 -58.53 -31.78 68.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.676 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -55.81 -40.42 72.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.758 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.47 -38.5 90.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.54 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.523 HD23 ' NE2' ' A' ' 178' ' ' GLN . 15.5 tp -65.7 -37.71 87.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.547 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -55.34 -37.12 67.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.402 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.2 t -68.84 -52.91 30.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.561 HG21 HG21 ' A' ' 154' ' ' VAL . 20.8 m -75.14 -36.87 38.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.411 0.523 . . . . 1.0 112.411 -177.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.422 ' N ' HG23 ' A' ' 184' ' ' VAL . 53.0 tp60 -50.88 -48.19 60.36 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.7 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.8 -44.33 41.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.963 0.357 . . . . 1.0 111.963 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 191' ' ' VAL . 43.1 tp -77.43 -42.44 36.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.906 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 184' ' ' VAL . . . -58.24 -39.3 78.74 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.544 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.401 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 86.8 m-20 -59.46 -38.86 81.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.999 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -65.8 -25.74 67.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.115 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 187' ' ' LEU . 17.0 t -85.09 -42.29 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.719 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.4 t -58.05 -38.93 77.22 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.1 mt -65.98 -34.77 72.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.209 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -70.89 -39.3 72.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.781 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.441 HD11 HD21 ' A' ' 35' ' ' LEU . 4.6 mm -60.91 -47.53 93.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.199 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.23 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.132 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -70.86 -41.98 70.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.466 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -64.19 -34.49 78.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.73 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -54.83 -25.86 31.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.509 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.35 -34.54 75.46 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.043 -0.263 . . . . 1.0 111.057 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.9 t -45.1 -55.68 5.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.596 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.635 179.703 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.897 HBD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.838 0.351 . . . . 1.0 110.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.97 -29.55 66.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.99 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -78.64 -46.51 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.161 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 mm -62.56 -46.2 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.758 0.313 . . . . 1.0 110.908 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.1 mt -58.29 -48.07 81.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.069 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -52.98 -38.72 62.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.23 -29.31 64.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.087 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.4 m -73.44 -47.02 44.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.547 -0.751 . . . . 1.0 112.263 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.1 p -65.73 -36.36 77.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 111.941 0.348 . . . . 1.0 111.941 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.75 -44.38 86.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.823 0.344 . . . . 1.0 111.077 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -42.0 98.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.705 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.9 t -59.64 -40.68 82.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.964 -0.294 . . . . 1.0 111.15 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 47' ' ' GLY . 52.1 ttp180 -50.67 -42.59 56.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.8 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.2 78.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.063 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -77.27 -47.01 21.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.549 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.71 -29.88 22.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.502 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.2 22.13 35.29 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.478 -1.049 . . . . 1.0 110.478 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.504 ' OG1' ' CG2' ' A' ' 51' ' ' VAL . 17.7 p -74.74 145.31 43.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.836 0.351 . . . . 1.0 110.193 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -40.77 -43.3 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.654 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.407 HH22 ' HG ' ' A' ' 77' ' ' LEU . 44.7 ttt180 -158.55 134.94 9.34 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.031 -0.668 . . . . 1.0 112.578 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.504 ' CG2' ' OG1' ' A' ' 48' ' ' THR . 10.0 t -135.69 129.04 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -140.11 153.94 46.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.449 -0.501 . . . . 1.0 111.872 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 64.8 t -100.71 136.74 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 30.3 t80 -119.06 107.45 13.51 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.382 -0.527 . . . . 1.0 111.258 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -79.48 127.15 31.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.217 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.493 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 87.5 t80 -90.97 141.31 28.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.971 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.493 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -112.22 150.81 43.07 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 178.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -59.91 -23.63 73.3 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.541 2.161 . . . . 1.0 112.494 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -87.88 -12.48 44.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 1.0 110.072 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.21 58.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.605 -0.598 . . . . 1.0 111.605 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -78.31 90.22 4.36 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.931 -0.307 . . . . 1.0 110.631 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.04 151.43 20.76 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -125.48 148.21 48.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.392 . . . . 1.0 111.719 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 78' ' ' LEU . 61.5 t -77.01 108.34 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.624 ' O ' HG12 ' A' ' 65' ' ' VAL . 96.7 t -106.02 0.03 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.341 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.79 122.79 3.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.052 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -147.78 133.78 19.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.136 0.493 . . . . 1.0 111.809 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.72 141.51 51.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.681 -0.69 . . . . 1.0 109.341 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.528 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 84.6 mtm-85 -138.7 142.81 38.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.74 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -47.43 -28.01 4.49 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.2 -88.91 0.07 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -152.17 52.09 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 1.0 110.509 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -86.22 -45.65 11.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.174 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.3 mt -109.15 146.35 33.7 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.902 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.87 145.84 63.68 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.551 2.168 . . . . 1.0 112.203 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 p -62.18 124.52 21.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 80' ' ' LEU . 29.4 mt -98.57 3.48 48.04 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.366 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 64' ' ' VAL . 6.2 tp -66.25 131.45 46.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.213 0.53 . . . . 1.0 112.26 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.17 -15.39 53.95 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.584 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 77' ' ' LEU . 59.0 mt -82.05 153.84 25.94 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.987 -0.285 . . . . 1.0 110.35 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.0 p -107.04 131.29 54.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.686 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.779 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 4.9 m-85 -85.63 154.32 58.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.11 129.6 26.25 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.638 2.225 . . . . 1.0 111.935 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.26 130.05 41.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.739 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.0 -1.11 44.46 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.614 -0.995 . . . . 1.0 110.614 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -53.19 -38.33 62.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mt -78.59 131.55 67.71 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.447 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.722 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 91.1 Cg_endo -72.81 -165.57 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.438 2.092 . . . . 1.0 112.477 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -107.54 -60.99 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.506 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -57.46 -43.11 83.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.804 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.722 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.42 -40.58 85.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -69.04 -41.65 77.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.488 -0.323 . . . . 1.0 111.442 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -60.98 -31.82 71.4 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.8 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.477 ' CD1' HH12 ' A' ' 101' ' ' ARG . 78.1 mt -71.58 -38.02 70.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.227 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.73 -42.08 83.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 1.0 110.018 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 159' ' ' HIS . 77.1 ttt-85 -58.3 -33.09 69.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.798 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.574 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 56.6 mt -98.14 -35.85 10.26 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.584 ' C ' ' NE2' ' A' ' 99' ' ' GLN . . . -118.52 -10.19 10.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.115 1.524 . . . . 1.0 115.115 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.652 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 40.39 82.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.177 -1.009 . . . . 1.0 108.812 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.8 p 175.98 116.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.056 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.599 ' O ' HG13 ' A' ' 102' ' ' VAL . 8.0 tpt180 -160.37 143.31 13.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 1.0 110.766 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 101' ' ' ARG . 17.4 m -159.78 150.38 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.532 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.421 ' O ' ' OH ' ' A' ' 176' ' ' TYR . 42.9 mt -108.32 136.46 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.098 -0.704 . . . . 1.0 109.098 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 105' ' ' ASP . 30.9 t -88.24 158.3 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.215 0.82 . . . . 1.0 113.215 -175.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 104' ' ' VAL . 33.0 m-20 -48.05 123.95 6.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.904 -1.044 . . . . 1.0 112.193 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.511 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.1 p -56.63 -24.72 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.746 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.419 ' C ' ' H ' ' A' ' 109' ' ' GLN . 83.9 tt0 -65.27 -47.76 75.59 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.8 -3.49 6.92 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.532 0.682 . . . . 1.0 109.388 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 36.03 71.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.794 -1.093 . . . . 1.0 113.296 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.7 t -72.44 130.68 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.984 -1.488 . . . . 1.0 106.984 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -118.53 138.57 52.44 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.937 -0.705 . . . . 1.0 111.885 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.423 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.2 OUTLIER -146.62 166.41 26.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.694 -0.684 . . . . 1.0 110.502 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' GLN . 26.9 pt -127.63 153.21 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.103 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 86.9 p -45.53 -10.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.631 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.585 ' N ' ' O ' ' A' ' 113' ' ' ILE . 64.4 mm-40 -116.27 77.0 7.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.668 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -87.25 -165.27 0.23 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.664 2.243 . . . . 1.0 112.349 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.72 ' H ' ' NH1' ' A' ' 133' ' ' ARG . 97.4 mt-10 -116.49 -99.99 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.443 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.563 ' N ' ' NH2' ' A' ' 133' ' ' ARG . 2.0 t 39.59 93.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.644 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.3 m95 40.65 -93.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.52 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 118' ' ' SER . . . 66.68 -130.3 31.0 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.72 141.18 29.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.738 0.304 . . . . 1.0 110.389 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.7 p -63.63 -24.97 68.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.521 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.75 78.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.745 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -66.93 146.75 54.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.609 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 125' ' ' VAL . 10.2 p -70.01 129.51 90.77 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.224 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -80.62 154.98 20.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.565 2.177 . . . . 1.0 112.333 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.488 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 4.0 tp -151.81 -140.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.581 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.488 ' H ' ' CG ' ' A' ' 127' ' ' LEU . . . -59.03 -33.93 76.67 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 49.22 65.32 7.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.584 0.231 . . . . 1.0 110.873 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -87.15 159.7 8.5 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.128 2.552 . . . . 1.0 111.725 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.5 mt -83.74 1.07 44.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.335 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.632 ' O ' ' C ' ' A' ' 133' ' ' ARG . 73.4 mm-40 -59.76 -31.4 69.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.943 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.72 ' NH1' ' H ' ' A' ' 117' ' ' GLU . 4.2 tpp180 15.99 77.91 0.12 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.493 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.86 147.78 17.98 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.829 2.353 . . . . 1.0 111.92 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 135' ' ' VAL . 2.1 p -92.56 109.83 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.908 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.504 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 0.7 OUTLIER -45.36 142.31 3.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 140' ' ' VAL . 72.9 Cg_exo -43.87 -47.63 9.81 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.223 2.615 . . . . 1.0 113.988 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.719 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.3 p -35.83 -46.87 0.48 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.734 0.272 . . . . 1.0 111.734 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.719 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 2.1 t60 -82.99 -24.64 32.83 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.511 ' CG1' HG23 ' A' ' 106' ' ' VAL . 44.7 t -65.92 -55.01 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.664 -0.414 . . . . 1.0 110.963 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -65.88 -29.25 69.66 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -60.24 -47.35 86.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.666 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.1 mt -73.0 -36.72 67.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.311 -0.625 . . . . 1.0 109.311 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -49.8 -39.68 39.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.597 -1.26 . . . . 1.0 107.597 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -63.69 -28.74 70.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.713 -1.13 . . . . 1.0 109.181 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.5 mmm -85.92 -1.92 57.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.726 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.05 22.01 78.41 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.18 142.32 23.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 1.0 110.966 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.76 -38.17 5.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.932 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.7 t -133.75 125.2 28.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.104 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.2 p -112.91 135.61 53.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.479 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.83 133.89 55.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.296 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.508 HG21 HAA1 ' A' ' 203' ' ' CYC . 2.0 t -122.23 108.76 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.099 0.476 . . . . 1.0 111.792 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.433 HG11 HG12 ' A' ' 184' ' ' VAL . 48.0 t -105.06 114.6 63.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 107.8 -1.185 . . . . 1.0 107.8 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -41.7 134.74 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 123.161 2.574 . . . . 1.0 114.664 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.4 tp -132.4 41.41 3.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.6 ptm -148.92 -172.69 4.17 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.133 0.79 . . . . 1.0 113.133 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.655 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 52.2 t-80 -77.84 178.1 7.67 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.436 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.655 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 72.4 m80 -74.84 -54.94 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.051 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -104.01 11.57 35.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.032 0.382 . . . . 1.0 112.032 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.536 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.8 tt0 -146.49 140.18 26.03 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.856 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.729 HD23 ' O ' ' A' ' 162' ' ' LEU . 6.9 tt -109.55 116.18 31.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.243 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.536 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 69.0 m95 -92.68 -37.31 12.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.175 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -158.34 -171.72 24.57 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.152 -0.779 . . . . 1.0 111.152 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.412 HD21 HBA2 ' A' ' 203' ' ' CYC . 16.0 tp -145.14 125.96 14.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 1.0 111.599 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.421 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.6 tp -100.58 131.53 46.44 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.17 138.23 41.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.702 -0.399 . . . . 1.0 111.069 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.1 m -110.86 141.76 43.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.96 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -115.57 131.61 56.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.01 0.433 . . . . 1.0 111.572 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -128.01 123.03 33.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.957 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.73 36.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.829 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -164.37 126.11 1.5 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.009 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -42.68 139.55 3.16 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.988 2.459 . . . . 1.0 111.847 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -176.57 97.75 0.24 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.825 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.98 155.64 4.13 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.596 2.197 . . . . 1.0 111.887 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.421 ' OH ' ' O ' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -85.25 133.66 34.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.51 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.2 m -118.31 150.79 38.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.597 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -50.61 -35.97 32.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.663 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.01 -38.24 85.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.729 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.43 -50.79 70.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.526 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.12 -36.07 80.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.569 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.548 HE21 HD11 ' A' ' 186' ' ' LEU . 61.9 tp60 -53.67 -37.2 62.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.406 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.6 -54.47 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.743 0.646 . . . . 1.0 112.743 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.433 HG12 HG11 ' A' ' 154' ' ' VAL . 3.3 t -78.04 -40.13 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.451 0.537 . . . . 1.0 112.451 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -46.9 -45.64 20.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.653 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.548 HD11 HE21 ' A' ' 182' ' ' GLN . 55.1 mt -74.64 -39.09 62.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.6 tp -76.0 -41.45 51.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.851 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -60.71 -38.55 85.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.479 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.27 -37.72 70.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.279 -0.418 . . . . 1.0 109.953 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -71.83 -24.21 61.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.114 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 194' ' ' ALA . 61.4 t -83.18 -47.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.793 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.5 m -51.97 -30.41 24.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.42 -33.29 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.154 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -70.36 -48.36 56.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.811 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 196' ' ' ALA . 1.9 pp -67.14 -37.07 78.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.132 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.463 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -70.83 -46.13 63.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.093 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -74.1 -35.14 64.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.549 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -61.92 -34.51 76.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.703 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.28 -27.61 47.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.475 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.07 -36.29 74.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.685 0.279 . . . . 1.0 111.054 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.9 m -52.45 -55.8 19.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.589 179.608 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.779 HAB2 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.892 0.377 . . . . 1.0 110.577 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 35.6 p-10 -51.21 -32.62 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 62.8 tt0 -77.07 -48.33 18.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.147 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.3 mt -60.33 -42.49 90.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 1.0 110.945 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.06 -46.55 82.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.412 . . . . 1.0 111.041 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.55 HH12 ' CD2' ' A' ' 78' ' ' LEU . 51.8 ttt85 -51.95 -38.27 55.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.95 -29.67 65.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.833 -0.622 . . . . 1.0 110.089 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 42' ' ' VAL . 20.8 m -73.5 -45.07 56.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.557 -0.747 . . . . 1.0 112.21 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.646 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.2 p -68.12 -35.6 72.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 111.976 0.362 . . . . 1.0 111.976 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -70.17 -45.48 66.63 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.104 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -63.76 -44.42 93.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.779 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 38' ' ' THR . 75.4 t -59.37 -42.53 87.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.155 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 47' ' ' GLY . 63.7 ttp85 -53.99 -40.76 67.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.851 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.15 -37.28 74.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.03 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -78.29 -43.41 28.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.581 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.7 mt -85.2 -30.4 23.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.512 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 59.28 20.11 49.21 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.509 -1.036 . . . . 1.0 110.509 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.613 HG23 ' CE1' ' A' ' 170' ' ' HIS . 89.8 m -72.93 142.18 47.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.83 0.348 . . . . 1.0 110.224 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -39.89 -54.72 2.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.566 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.529 ' NH2' ' O ' ' A' ' 74' ' ' LEU . 80.6 mtt-85 -152.5 131.89 12.91 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.99 -0.684 . . . . 1.0 112.501 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.64 129.34 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -138.83 156.01 47.67 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.915 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 58.7 t -108.35 136.35 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.63 134.61 47.78 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.366 -0.534 . . . . 1.0 111.311 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -94.01 137.92 32.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.21 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 66.9 t80 -94.29 117.55 30.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 1.0 112.035 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -88.07 140.93 30.89 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.02 -26.77 5.27 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.55 2.167 . . . . 1.0 112.397 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.37 -19.64 38.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.915 0.388 . . . . 1.0 110.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.69 -13.45 38.71 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.556 -0.618 . . . . 1.0 111.556 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -71.92 99.57 2.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.339 . . . . 1.0 110.593 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.62 142.57 16.06 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.626 -0.99 . . . . 1.0 110.626 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.5 p -123.07 145.77 48.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 1.0 111.743 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 t -77.74 106.99 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.09 -2.03 9.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.341 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.646 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -156.86 116.51 3.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.106 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 81.6 tt0 -144.06 132.5 22.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.802 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.433 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -128.35 138.8 52.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.343 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -118.55 137.08 53.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.906 0.384 . . . . 1.0 110.722 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.42 -81.31 0.52 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.849 -0.9 . . . . 1.0 110.849 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.507 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -114.04 50.81 0.75 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.997 -0.841 . . . . 1.0 110.997 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' A' ' 71' ' ' GLY . 15.0 pt-20 31.18 55.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 1.0 110.491 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -84.52 -50.43 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.165 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.529 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 23.8 mt -109.4 153.46 42.76 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.86 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.28 164.71 3.61 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.486 2.124 . . . . 1.0 112.126 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.1 t -87.72 128.58 35.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.878 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.549 ' HA ' HD12 ' A' ' 80' ' ' LEU . 24.3 mt -101.08 13.48 35.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.39 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.55 ' CD2' HH12 ' A' ' 36' ' ' ARG . 23.9 tp -73.08 128.9 36.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.032 -0.531 . . . . 1.0 112.343 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.9 -8.62 77.37 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.541 -0.754 . . . . 1.0 111.532 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 77' ' ' LEU . 69.8 mt -85.73 152.6 22.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.768 0.318 . . . . 1.0 110.31 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 81' ' ' THR . 11.7 t -106.26 133.67 50.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.702 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.711 ' CD2' HAB2 ' A' ' 203' ' ' CYC . 9.4 m-85 -87.59 152.09 51.4 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.68 137.01 56.69 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.61 2.207 . . . . 1.0 111.863 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.46 129.14 38.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.683 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.1 43.53 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.551 -1.019 . . . . 1.0 110.551 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.9 -37.78 66.77 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.754 ' H ' HD12 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -80.08 113.57 39.53 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.394 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 87' ' ' ILE . 86.5 Cg_exo -48.76 -171.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.455 2.103 . . . . 1.0 112.509 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.93 -59.0 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.558 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 20.8 pt-20 -58.24 -42.74 87.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.813 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -66.27 -47.84 72.38 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.971 0.36 . . . . 1.0 111.971 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.519 ' NH2' ' CE2' ' A' ' 56' ' ' PHE . 72.1 ttt180 -52.99 -35.63 59.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.498 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -66.1 -35.95 81.89 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.838 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.463 HD12 HH21 ' A' ' 101' ' ' ARG . 66.6 mt -60.69 -37.31 81.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.317 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.609 ' C ' HE21 ' A' ' 99' ' ' GLN . 66.9 m-85 -60.73 -55.07 37.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.038 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -51.19 -29.72 14.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.773 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 63.2 mt -99.14 -42.42 7.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.335 1.235 . . . . 1.0 114.335 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.551 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.93 -14.47 10.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.053 1.501 . . . . 1.0 115.053 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.609 HE21 ' C ' ' A' ' 95' ' ' PHE . 20.0 mm-40 37.58 81.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.148 -1.021 . . . . 1.0 108.835 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.7 p 176.49 97.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.103 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.604 ' O ' HG23 ' A' ' 102' ' ' VAL . 6.6 mmt180 -147.99 146.35 28.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.992 0.425 . . . . 1.0 110.746 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 101' ' ' ARG . 62.8 t -159.79 150.07 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.514 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.415 HD12 ' OG ' ' A' ' 151' ' ' SER . 49.5 mt -108.35 136.57 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.03 163.93 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 113.279 0.844 . . . . 1.0 113.279 -176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 21.8 p30 -46.46 119.68 2.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.93 -1.032 . . . . 1.0 112.125 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.472 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.7 p -55.18 -20.42 6.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.331 -0.849 . . . . 1.0 110.808 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -65.78 -43.51 88.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.02 -12.86 55.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.529 0.68 . . . . 1.0 109.362 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.436 ' HG2' ' HE ' ' A' ' 111' ' ' ARG . 40.0 tp60 45.17 73.44 0.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.782 -1.099 . . . . 1.0 113.284 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.463 ' OG ' HG12 ' A' ' 135' ' ' VAL . 9.7 p -74.23 129.9 38.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.025 -1.472 . . . . 1.0 107.025 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.436 ' HE ' ' HG2' ' A' ' 109' ' ' GLN . 96.1 mtt180 -118.29 132.86 56.27 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.937 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.518 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -134.65 162.55 31.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.595 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.541 ' C ' ' H ' ' A' ' 115' ' ' GLN . 6.6 pt -125.22 131.03 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.164 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.4 t -55.41 -3.22 0.06 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.62 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.541 ' H ' ' C ' ' A' ' 113' ' ' ILE . 0.7 OUTLIER -57.1 153.15 25.91 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.68 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 115' ' ' GLN . 39.4 Cg_exo -34.48 134.7 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.624 2.216 . . . . 1.0 112.388 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' OE2' ' OE2' ' A' ' 90' ' ' GLU . 23.5 pt-20 -171.23 -0.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.44 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 120' ' ' GLY . 40.8 t -64.31 -90.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.642 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 91.6 m95 53.05 8.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.547 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 118' ' ' SER . . . 44.65 64.83 1.95 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.4 mt -67.96 -7.73 31.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 1.0 110.478 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.8 t -53.27 -18.54 2.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.468 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.12 -43.18 61.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.658 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -151.95 157.4 41.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.506 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 125' ' ' VAL . 7.7 p -116.61 87.86 22.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.235 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.88 150.75 12.35 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.606 2.204 . . . . 1.0 112.318 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.9 mt -65.29 -30.47 71.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.578 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.33 -174.54 49.2 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -130.09 120.51 19.26 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.619 0.247 . . . . 1.0 110.863 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -86.39 168.07 8.83 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 123.104 2.536 . . . . 1.0 111.701 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.7 tp -58.13 -32.03 67.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.358 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.49 ' O ' ' CB ' ' A' ' 133' ' ' ARG . 65.3 mt-30 -76.29 126.47 31.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.891 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.709 ' N ' ' HD2' ' A' ' 134' ' ' PRO . 10.4 ttp180 160.84 -52.29 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.585 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 133' ' ' ARG . 11.9 Cg_endo -50.79 160.42 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.706 2.271 . . . . 1.0 111.962 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.463 HG12 ' OG ' ' A' ' 110' ' ' SER . 1.5 p -95.33 114.19 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.947 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -44.0 137.17 3.63 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.518 ' HD3' ' H ' ' A' ' 112' ' ' SER . 54.8 Cg_exo -41.97 -48.52 6.12 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.238 2.625 . . . . 1.0 114.001 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.702 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER -35.96 -45.93 0.44 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.8 0.296 . . . . 1.0 111.8 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.715 ' NE2' ' HHB' ' A' ' 203' ' ' CYC . 8.1 t-80 -82.2 -26.97 32.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.472 ' CG1' HG23 ' A' ' 106' ' ' VAL . 48.0 t -63.92 -53.82 39.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.986 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -65.3 -29.1 69.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -58.97 -45.62 90.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.734 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.2 mt -73.23 -41.76 63.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -38.61 56.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.544 -1.28 . . . . 1.0 107.544 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.7 t -63.5 -26.61 68.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.823 -1.081 . . . . 1.0 109.209 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.6 mmm -90.21 3.55 53.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.731 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.25 20.31 79.11 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.08 143.56 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 1.0 110.964 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.59 -19.95 13.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.942 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.5 m -145.87 161.82 39.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 1.0 111.177 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.415 ' OG ' HD12 ' A' ' 103' ' ' ILE . 1.7 p -147.48 122.55 10.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.49 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 tp -106.27 131.67 53.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.287 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.535 HG11 HD21 ' A' ' 165' ' ' LEU . 3.5 t -124.44 120.38 58.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.126 0.489 . . . . 1.0 111.784 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.814 HG13 ' O ' ' A' ' 154' ' ' VAL . 12.6 p -130.76 91.53 36.94 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.829 -1.174 . . . . 1.0 107.829 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.27 152.09 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 123.175 2.583 . . . . 1.0 114.677 -176.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 56.2 mt -126.07 66.64 1.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.829 -1.545 . . . . 1.0 106.829 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.475 ' SD ' ' OE1' ' A' ' 99' ' ' GLN . 2.1 ptt? -146.98 -167.53 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.145 0.795 . . . . 1.0 113.145 -175.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.697 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 59.5 t60 -86.26 -176.0 5.73 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.446 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.697 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 59.3 t-80 -75.32 -55.27 5.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.463 -0.789 . . . . 1.0 112.103 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -105.66 13.72 29.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.014 0.376 . . . . 1.0 112.014 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -144.04 138.91 28.67 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.839 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 162' ' ' LEU . 9.1 tt -110.52 116.67 31.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.239 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -92.4 -36.51 13.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.222 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.91 -171.35 27.9 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.535 HD21 HG11 ' A' ' 153' ' ' VAL . 7.6 tp -149.72 133.31 16.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 1.0 111.532 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.434 ' CD1' HG22 ' A' ' 53' ' ' VAL . 8.3 tp -98.71 135.91 39.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 167' ' ' VAL . 11.0 p -139.25 131.68 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.047 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 m -109.11 142.9 39.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.017 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' A' ' 48' ' ' THR . 43.5 m80 -113.16 123.3 49.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.053 0.454 . . . . 1.0 111.69 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.613 ' CE1' HG23 ' A' ' 48' ' ' THR . 82.6 m-70 -123.55 115.23 21.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.859 -0.61 . . . . 1.0 109.97 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.12 -16.12 63.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.782 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -94.48 150.15 37.68 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.963 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 174' ' ' ARG . 59.9 Cg_endo -70.83 -2.6 11.2 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.96 2.44 . . . . 1.0 111.825 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 173' ' ' PRO . 0.0 OUTLIER -32.54 98.06 0.12 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.921 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 173' ' ' PRO . 78.2 Cg_exo -50.15 167.68 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.577 2.185 . . . . 1.0 111.933 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.539 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 46.4 p90 -86.75 125.66 34.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.471 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.2 t -115.74 154.1 30.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.681 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -54.34 -31.76 55.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.626 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.81 -39.99 86.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.748 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -63.47 -42.6 98.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.551 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.55 -38.47 87.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.502 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -55.36 -36.4 66.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.899 -0.591 . . . . 1.0 111.394 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.1 -55.93 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.735 0.643 . . . . 1.0 112.735 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 188' ' ' ALA . 26.8 m -74.09 -35.3 40.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.434 0.531 . . . . 1.0 112.434 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -50.28 -45.84 54.68 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.655 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 41.5 mt -79.61 -43.97 21.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.894 0.331 . . . . 1.0 111.894 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.72 ' O ' HG23 ' A' ' 191' ' ' VAL . 34.2 tp -77.9 -40.53 39.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.835 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -60.67 -41.11 94.42 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.493 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.66 -40.26 87.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.991 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -67.81 -25.81 65.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.149 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 187' ' ' LEU . 37.0 t -84.13 -45.01 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.78 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.2 p -57.13 -35.33 69.34 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.01 -34.81 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.465 -0.789 . . . . 1.0 109.24 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.93 77.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.819 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.4 mm -59.57 -48.58 86.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.128 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.52 -48.13 57.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.127 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -65.0 -42.77 94.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.466 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.63 -31.87 73.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.706 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.14 -30.97 66.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.464 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.7 mp -59.99 -34.17 72.96 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.981 -0.288 . . . . 1.0 111.072 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.3 p -55.56 -55.58 30.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.566 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.534 179.896 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.715 ' HHB' ' NE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.868 0.366 . . . . 1.0 110.605 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 33' ' ' GLN . 24.1 p-10 -50.74 -55.48 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.998 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.408 ' N ' ' CG ' ' A' ' 32' ' ' ASP . 63.9 tt0 -52.65 -42.56 64.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.101 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.1 mm -59.64 -50.46 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 1.0 110.966 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.46 HD11 HD22 ' A' ' 31' ' ' LEU . 83.4 mt -58.42 -46.86 85.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.987 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -49.58 -39.68 35.98 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.816 -0.438 . . . . 1.0 109.816 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 -29.4 65.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.073 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 35' ' ' LEU . 24.1 m -74.53 -41.47 60.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 1.0 112.263 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.648 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.5 p -72.32 -37.82 59.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 111.922 0.341 . . . . 1.0 111.922 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -67.79 -41.61 82.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.783 0.325 . . . . 1.0 111.067 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -67.36 -44.72 78.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.734 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 38' ' ' THR . 69.3 t -61.77 -36.36 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.176 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.558 ' NH2' ' CA ' ' A' ' 70' ' ' GLY . 16.3 tpt85 -59.79 -47.47 85.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 1.0 110.802 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.55 -33.33 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 1.0 111.051 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -74.27 -41.2 61.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.607 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' A' ' 48' ' ' THR . 5.4 mt -87.12 -29.03 22.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.514 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.81 19.19 0.85 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.421 ' N ' ' C ' ' A' ' 46' ' ' LEU . 1.6 p -62.7 -97.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 1.0 110.211 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -155.13 -48.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.613 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -157.16 125.92 5.78 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.089 -0.644 . . . . 1.0 112.644 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 12.6 p -137.03 129.05 43.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.547 -0.908 . . . . 1.0 108.547 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -140.18 159.33 42.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.958 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -99.82 136.25 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.608 -0.886 . . . . 1.0 108.608 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.566 ' CG ' HAB2 ' A' ' 203' ' ' CYC . 74.2 t80 -117.09 108.45 15.73 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.295 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -83.31 126.47 32.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.274 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.621 ' CZ ' ' NH2' ' A' ' 92' ' ' ARG . 77.8 t80 -93.32 137.12 32.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 1.0 112.035 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.84 140.85 22.26 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.88 -27.27 5.57 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.573 2.182 . . . . 1.0 112.442 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.97 -18.19 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 1.0 110.096 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.96 -13.85 41.06 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.574 -0.61 . . . . 1.0 111.574 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -78.22 90.39 4.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.765 0.317 . . . . 1.0 110.63 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.48 151.46 20.97 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.635 -0.986 . . . . 1.0 110.635 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.8 p -123.51 146.62 47.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 1.0 111.692 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 77' ' ' LEU . 39.4 t -75.81 110.38 10.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.87 2.97 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.339 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.648 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.69 122.58 3.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.072 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -144.26 130.16 19.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.109 0.481 . . . . 1.0 111.826 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.62 139.25 52.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.359 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -140.85 145.8 36.69 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.793 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.558 ' CA ' ' NH2' ' A' ' 43' ' ' ARG . . . -47.31 -39.08 13.32 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.864 -0.894 . . . . 1.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 171.64 -154.27 21.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 72' ' ' GLU . 3.0 pp20? -72.54 20.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 1.0 110.523 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 71' ' ' GLY . 35.0 mtm180 -76.44 -47.8 21.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.117 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.89 150.36 52.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.92 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.42 157.91 55.4 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.486 2.124 . . . . 1.0 112.155 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.7 p -95.55 132.04 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.918 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.545 ' HA ' HD12 ' A' ' 80' ' ' LEU . 22.7 mt -90.6 17.16 7.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.41 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.44 128.8 37.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.016 -0.538 . . . . 1.0 112.28 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.91 -11.49 64.54 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.536 -0.756 . . . . 1.0 111.577 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 77' ' ' LEU . 72.1 mt -82.92 152.05 25.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.914 -0.314 . . . . 1.0 110.341 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.8 m -107.16 134.15 50.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.713 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CD2' HBB2 ' A' ' 203' ' ' CYC . 5.3 m-85 -84.95 152.19 58.69 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.36 130.66 27.5 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.636 2.224 . . . . 1.0 111.89 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 131.45 46.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.705 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.64 2.13 43.33 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -62.41 -17.02 58.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.573 ' O ' ' O ' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -105.1 103.24 40.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.397 178.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 87' ' ' ILE . 83.1 Cg_exo -49.74 -154.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.407 2.072 . . . . 1.0 112.489 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -109.21 -54.63 2.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.53 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -63.31 -45.04 93.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.78 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.765 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -66.4 -48.17 70.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.947 0.351 . . . . 1.0 111.947 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.621 ' NH2' ' CZ ' ' A' ' 56' ' ' PHE . 67.1 ttt180 -56.57 -34.68 67.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.426 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.5 ttt85 -64.25 -35.63 81.45 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.872 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.89 -38.47 91.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.281 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.614 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 40.0 m-85 -60.26 -29.97 69.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.977 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.489 ' C ' HE22 ' A' ' 99' ' ' GLN . 80.0 ttt-85 -84.2 -26.44 28.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.888 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.92 -46.92 6.03 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.434 1.272 . . . . 1.0 114.434 -175.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.526 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.58 -6.05 13.96 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.052 1.501 . . . . 1.0 115.052 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.769 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.7 mm-40 40.5 73.6 0.12 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.191 -1.004 . . . . 1.0 108.821 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 100' ' ' VAL . 6.2 p 176.1 118.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.993 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.837 HH21 HAD2 ' A' ' 203' ' ' CYC . 30.6 tpt85 -168.66 134.6 1.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 1.0 110.715 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.456 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 4.5 m -149.82 155.28 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.564 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.655 HD11 HMA3 ' A' ' 203' ' ' CYC . 96.9 mt -112.04 134.42 54.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.074 -0.713 . . . . 1.0 109.074 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.01 163.62 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 113.315 0.857 . . . . 1.0 113.315 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 173' ' ' PRO . 49.7 m-20 -45.92 120.11 2.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.986 -1.006 . . . . 1.0 112.156 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.8 -20.62 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.792 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.98 -44.86 83.65 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.16 -13.45 60.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.491 0.662 . . . . 1.0 109.387 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 46.66 72.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.675 -1.148 . . . . 1.0 113.327 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.82 131.98 42.98 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.002 -1.481 . . . . 1.0 107.002 175.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -118.75 134.16 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.003 -0.679 . . . . 1.0 111.904 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.1 164.49 30.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.555 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.3 pt -125.12 138.24 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.084 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 53.3 p -79.93 22.47 0.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.666 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -120.27 79.25 27.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.632 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.68 151.42 13.07 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.64 2.227 . . . . 1.0 112.395 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.78 -35.7 80.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.405 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 119' ' ' TRP . 31.1 t -173.21 -124.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.684 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.511 ' CE3' ' O ' ' A' ' 120' ' ' GLY . 37.0 t90 -71.69 147.02 47.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.532 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 122' ' ' SER . . . -79.89 179.37 53.25 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.622 ' N ' HD12 ' A' ' 121' ' ' LEU . 9.5 mp 54.42 5.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 1.0 110.455 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 120' ' ' GLY . 82.6 p -68.07 -22.13 64.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.393 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -63.17 -23.83 67.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.616 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 123' ' ' ALA . 69.4 ttt180 43.91 97.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.631 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.78 150.4 36.11 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.268 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.99 -34.91 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.581 2.187 . . . . 1.0 112.325 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.55 -37.21 85.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.507 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.42 43.01 47.02 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.842 -0.903 . . . . 1.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -133.04 67.95 78.0 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.625 0.25 . . . . 1.0 110.819 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.79 -168.91 0.67 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.102 2.535 . . . . 1.0 111.657 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.7 mt -85.82 -27.15 25.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.364 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -65.36 -36.61 84.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.412 . . . . 1.0 110.873 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.61 HH12 ' CD1' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -61.17 -60.16 11.47 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.568 -178.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 133' ' ' ARG . 33.2 Cg_exo -36.94 148.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.784 2.322 . . . . 1.0 111.951 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.71 147.46 6.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.869 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -92.32 136.13 25.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -41.65 -21.51 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.226 2.618 . . . . 1.0 114.018 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.683 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 4.8 p -71.24 -46.12 61.75 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.751 0.278 . . . . 1.0 111.751 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.852 ' CE1' HAA2 ' A' ' 203' ' ' CYC . 42.1 t60 -84.13 -29.11 26.99 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 1.8 p -62.65 -44.56 99.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.941 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.537 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 83.5 t60 -69.53 -30.3 68.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.738 -0.467 . . . . 1.0 109.738 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -58.2 -43.01 87.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.76 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.676 HD11 ' NE2' ' A' ' 139' ' ' HIS . 63.6 mt -72.99 -40.11 65.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.279 -0.637 . . . . 1.0 109.279 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -51.01 -39.1 54.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.568 -1.271 . . . . 1.0 107.568 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 m -65.17 -22.94 66.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.783 -1.099 . . . . 1.0 109.203 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.4 mmm -94.52 0.64 55.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.645 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.7 21.11 79.72 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 64.9 t -110.7 142.74 22.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.841 0.353 . . . . 1.0 111.063 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.55 -40.78 5.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.945 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.1 m -131.98 127.14 35.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.217 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.34 129.1 55.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.472 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.02 126.74 54.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.234 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.32 120.49 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 1.0 111.802 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.0 t -128.07 118.04 20.64 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -71.8 145.2 45.39 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.164 2.576 . . . . 1.0 114.721 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.3 mt -121.68 62.27 0.92 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -147.04 -163.31 1.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.099 0.777 . . . . 1.0 113.099 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.625 ' CE1' ' HE1' ' A' ' 163' ' ' TRP . 76.1 m80 -89.06 -178.4 5.68 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.357 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -74.22 -54.09 8.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.054 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.68 11.16 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.03 0.381 . . . . 1.0 112.03 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.5 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.7 tt0 -143.15 136.82 28.59 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 162' ' ' LEU . 5.6 tt -111.89 119.64 39.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.044 -0.526 . . . . 1.0 111.259 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.625 ' HE1' ' CE1' ' A' ' 158' ' ' HIS . 82.1 m95 -92.85 -41.07 10.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.265 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.442 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -160.15 -176.31 32.1 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.179 -0.768 . . . . 1.0 111.179 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.527 HD21 HD11 ' A' ' 162' ' ' LEU . 97.0 mt -140.09 133.72 30.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 1.0 111.522 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.8 tp -105.23 134.17 48.78 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.33 138.2 40.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.048 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m -114.4 132.25 56.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 1.0 109.98 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -109.77 137.01 48.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.999 0.428 . . . . 1.0 111.676 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -130.04 130.4 44.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.015 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.17 45.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.773 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -144.05 150.74 50.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.07 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.446 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 65.4 Cg_endo -71.51 -12.31 29.22 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.905 2.404 . . . . 1.0 111.92 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -40.97 104.54 0.34 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.904 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.07 168.2 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.532 2.155 . . . . 1.0 111.95 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -97.71 136.46 38.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.518 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.2 m -120.65 152.47 38.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.638 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -51.05 -31.47 18.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.665 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -56.5 -34.86 67.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.731 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -64.3 -43.56 94.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.504 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.0 mp -67.76 -35.06 78.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.575 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.463 ' NE2' HD11 ' A' ' 186' ' ' LEU . 23.1 tm0? -54.76 -39.74 68.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.367 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.35 -52.46 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.6 t -71.53 -34.92 54.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.401 0.519 . . . . 1.0 112.401 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -50.42 -46.99 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.646 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.463 HD11 ' NE2' ' A' ' 182' ' ' GLN . 51.2 mt -68.8 -40.1 79.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.914 0.339 . . . . 1.0 111.914 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.727 ' O ' HG23 ' A' ' 191' ' ' VAL . 6.3 tp -78.45 -37.71 42.92 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.86 0.319 . . . . 1.0 111.86 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.92 86.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.482 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -63.38 -41.17 98.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.002 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -69.03 -29.11 67.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.085 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 187' ' ' LEU . 49.0 t -82.4 -46.15 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.681 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.9 t -53.75 -35.6 61.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.0 mt -64.93 -34.69 72.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.2 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.65 -39.5 80.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.617 -0.72 . . . . 1.0 109.845 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.9 mm -59.55 -47.45 90.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.189 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.465 ' HB2' ' CE1' ' A' ' 158' ' ' HIS . . . -71.17 -46.28 61.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.09 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -66.54 -45.4 79.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.457 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.55 -32.7 74.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.669 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.43 -33.13 70.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.55 -0.296 . . . . 1.0 111.427 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.38 -35.09 76.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.664 0.269 . . . . 1.0 111.077 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 90.5 p -56.91 -55.69 31.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.564 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.551 179.567 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.852 HAA2 ' CE1' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.882 0.372 . . . . 1.0 110.557 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -77.2 -29.76 54.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.942 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -78.53 -45.76 21.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.084 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 38' ' ' THR . 10.2 pt -64.8 -39.71 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.968 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.434 ' O ' ' OG1' ' A' ' 38' ' ' THR . 26.7 mt -59.72 -45.49 92.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.005 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -55.59 -34.46 64.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.42 -35.92 71.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.105 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 34' ' ' ILE . 82.8 p -70.26 -43.35 70.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.548 -0.751 . . . . 1.0 112.188 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.649 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.0 p -67.91 -36.59 76.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 111.911 0.337 . . . . 1.0 111.911 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' A' ' 43' ' ' ARG . 39.6 tp10 -66.31 -46.32 77.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.808 0.337 . . . . 1.0 111.076 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.84 -46.69 86.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.722 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 38' ' ' THR . 75.6 t -52.73 -45.06 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.955 -0.298 . . . . 1.0 111.138 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 47' ' ' GLY . 56.5 ttp180 -49.59 -39.52 35.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.825 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.56 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -76.46 -46.46 26.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.546 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.58 -27.73 25.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.507 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.4 21.49 34.1 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 169' ' ' HIS . 7.3 t -74.11 143.93 45.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 1.0 110.234 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 94.6 m-20 -43.6 -43.89 5.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.662 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' NH1' ' CD1' ' A' ' 74' ' ' LEU . 58.4 mtm-85 -154.98 131.71 10.67 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.078 -0.649 . . . . 1.0 112.56 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 51' ' ' VAL . 12.0 p -135.8 128.2 46.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -138.4 154.1 48.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.491 -0.484 . . . . 1.0 111.949 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 86.5 t -99.63 136.3 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 37.9 t80 -116.75 110.93 19.06 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.324 -0.55 . . . . 1.0 111.307 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.531 ' NH1' ' O ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -84.43 122.6 29.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.266 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.531 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 69.4 t80 -88.78 141.28 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 1.0 112.034 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.466 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 41.0 m-20 -111.97 140.0 22.95 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -46.03 -30.65 7.55 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.458 2.105 . . . . 1.0 112.46 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -81.17 -19.22 43.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 1.0 110.043 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.42 38.17 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.56 -0.616 . . . . 1.0 111.56 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -79.22 90.39 4.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.747 0.308 . . . . 1.0 110.699 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.85 152.09 21.2 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 p -125.69 148.87 48.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 1.0 111.711 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.78 109.3 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.623 ' O ' HG12 ' A' ' 65' ' ' VAL . 65.1 t -107.87 0.8 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.925 -0.31 . . . . 1.0 111.292 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.649 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.34 118.69 2.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.017 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -147.04 133.85 20.09 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.874 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.97 148.36 51.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 1.0 109.388 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.524 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 36.3 ptt180 -141.73 145.38 34.76 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.797 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -50.34 -37.17 31.34 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -175.1 -167.97 35.04 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.952 -0.859 . . . . 1.0 110.952 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.78 43.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 1.0 110.546 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 71' ' ' GLY . 53.9 mtt-85 -84.05 -46.68 11.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.13 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.454 ' CD1' ' NH1' ' A' ' 50' ' ' ARG . 13.3 mt -123.37 150.85 61.66 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.881 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.57 165.28 31.27 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.532 2.155 . . . . 1.0 112.191 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.9 p -93.33 131.81 38.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.981 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 80' ' ' LEU . 26.3 mt -89.78 9.04 28.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.454 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.83 130.46 45.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.989 -0.55 . . . . 1.0 112.263 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.62 -14.88 58.74 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.524 -0.762 . . . . 1.0 111.567 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 77' ' ' LEU . 77.3 mt -80.77 150.37 29.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.282 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.2 m -104.59 129.53 52.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.75 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.558 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 6.7 m-85 -82.16 128.72 66.74 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -40.26 125.34 1.82 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.663 2.242 . . . . 1.0 111.882 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.07 132.68 52.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.74 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.39 1.6 44.08 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.539 -1.024 . . . . 1.0 110.539 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -56.78 -35.66 68.94 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 mt -88.76 126.95 57.97 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.425 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.664 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 85.6 Cg_endo -73.83 -155.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.477 2.118 . . . . 1.0 112.503 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -107.76 -68.78 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 1.0 111.557 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.671 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -49.44 -46.63 48.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.855 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.664 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -65.99 -45.48 81.43 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.719 HH12 ' NH2' ' A' ' 96' ' ' ARG . 71.8 ttt-85 -59.62 -35.34 74.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.475 -0.33 . . . . 1.0 111.513 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.434 ' HD3' ' HE1' ' A' ' 119' ' ' TRP . 56.6 ttt85 -63.51 -31.14 72.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.792 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.432 ' CD1' HH12 ' A' ' 101' ' ' ARG . 87.0 mt -69.25 -35.76 76.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.248 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.626 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 17.6 m-85 -59.14 -31.14 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.017 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.719 ' NH2' HH12 ' A' ' 92' ' ' ARG . 80.7 mtt180 -83.44 -23.61 32.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.815 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.4 mt -99.18 -47.5 5.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.0 -8.51 13.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -173.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.727 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.5 mm-40 39.21 80.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.16 -1.016 . . . . 1.0 108.817 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 100' ' ' VAL . 4.2 p 173.69 120.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.037 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -169.72 146.58 3.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.011 0.434 . . . . 1.0 110.716 177.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 101' ' ' ARG . 54.1 t -159.35 150.24 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.565 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.6 mt -108.06 134.63 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.03 165.11 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 15.4 p30 -45.99 117.89 1.68 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.988 -1.005 . . . . 1.0 112.114 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.81 -21.46 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.326 -0.852 . . . . 1.0 110.769 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.54 -43.22 90.63 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.12 -11.83 44.31 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.502 0.668 . . . . 1.0 109.356 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 45.29 69.26 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.748 -1.115 . . . . 1.0 113.291 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 m -76.29 132.36 39.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 174.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -119.44 139.22 52.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.0 -0.68 . . . . 1.0 111.886 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.422 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -124.4 149.91 46.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.576 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.1 pt -152.98 172.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.146 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.9 p -66.8 154.09 41.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.707 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -139.42 152.15 68.46 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.7 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -83.9 -14.39 7.51 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.657 2.238 . . . . 1.0 112.345 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.7 145.5 23.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.422 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.6 m -66.14 165.39 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.434 ' HE1' ' HD3' ' A' ' 93' ' ' ARG . 43.0 t-105 -94.34 155.72 16.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.493 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.93 178.11 45.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.9 tp -108.31 89.32 2.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.759 0.314 . . . . 1.0 110.429 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.9 p -75.05 -14.84 60.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.522 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.15 -33.79 28.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.632 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -51.6 -40.91 60.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.593 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 127' ' ' LEU . 2.1 m -115.12 85.92 13.15 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.205 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -42.92 84.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.605 2.203 . . . . 1.0 112.354 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 125' ' ' VAL . 39.9 tp -143.51 139.54 29.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.602 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.74 13.35 53.69 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.814 -0.914 . . . . 1.0 110.814 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 61.96 76.94 0.37 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.632 0.253 . . . . 1.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -85.8 -16.83 4.3 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.224 2.616 . . . . 1.0 111.698 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.8 tp -56.68 -32.3 65.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.394 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -132.99 129.63 38.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.846 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -126.0 145.69 52.98 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.575 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.15 141.6 20.89 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.741 2.294 . . . . 1.0 111.945 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.709 HG12 HBD2 ' A' ' 203' ' ' CYC . 0.7 OUTLIER -109.38 123.61 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.909 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -41.3 153.48 0.25 Allowed Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -57.08 -21.59 43.1 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.194 2.596 . . . . 1.0 114.038 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.691 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 5.6 p -63.02 -46.57 86.97 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.691 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 16.4 t-80 -81.27 -27.15 35.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.245 0.461 . . . . 1.0 112.245 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' A' ' 135' ' ' VAL . 71.1 t -65.4 -53.61 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.915 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -65.74 -28.17 68.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -59.17 -42.98 92.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.7 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 146' ' ' MET . 17.5 mt -73.32 -38.85 65.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -52.12 -39.06 59.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.594 -1.261 . . . . 1.0 107.594 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.9 p -65.14 -20.55 66.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.769 -1.105 . . . . 1.0 109.186 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 143' ' ' LEU . 81.5 mmm -95.65 2.81 54.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.412 -0.813 . . . . 1.0 110.707 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.81 21.86 78.85 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.88 142.54 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 1.0 111.02 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.38 -21.03 13.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.931 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -147.82 160.63 42.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.155 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 p -148.38 126.37 12.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.469 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.43 128.7 55.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.302 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.82 121.05 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.173 0.511 . . . . 1.0 111.801 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.509 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 3.1 m -126.16 92.99 44.51 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.816 -1.179 . . . . 1.0 107.816 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.645 ' C ' HD12 ' A' ' 156' ' ' LEU . 90.4 Cg_exo -44.84 143.86 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.148 2.565 . . . . 1.0 114.672 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 155' ' ' PRO . 10.9 mp -121.91 60.24 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.818 -1.549 . . . . 1.0 106.818 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.3 ptm -147.66 -178.63 6.36 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.139 0.792 . . . . 1.0 113.139 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.606 ' CG ' ' N ' ' A' ' 159' ' ' HIS . 57.7 t-80 -71.08 172.66 8.74 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.289 -0.869 . . . . 1.0 111.368 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.606 ' N ' ' CG ' ' A' ' 158' ' ' HIS . 55.9 t-80 -61.48 -50.59 72.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.326 -0.852 . . . . 1.0 112.039 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -105.36 -37.66 6.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -89.97 136.13 33.23 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.957 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.722 HD23 ' O ' ' A' ' 162' ' ' LEU . 6.3 tt -107.39 118.46 36.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.279 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -92.55 -44.17 8.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.205 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -161.53 -176.11 33.28 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.63 138.16 34.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 1.0 111.534 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.437 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.5 tp -103.81 134.19 47.53 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.23 140.07 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.699 -0.401 . . . . 1.0 111.089 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.3 m -114.12 137.89 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.994 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.48 ' O ' ' OG1' ' A' ' 48' ' ' THR . 77.5 m-70 -111.46 135.65 51.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.003 0.43 . . . . 1.0 111.611 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -128.27 121.9 30.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.966 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.51 -12.54 60.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.817 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -129.83 148.02 67.81 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.018 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -44.32 146.48 1.93 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.952 2.435 . . . . 1.0 111.821 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -172.82 79.42 0.43 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.03 151.17 12.21 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.569 2.179 . . . . 1.0 111.933 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -99.41 136.16 39.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.482 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.7 m -125.65 172.45 9.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.593 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -50.47 -35.41 28.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.667 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -62.35 -50.11 72.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.682 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -62.34 -37.21 84.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.477 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.7 tp -61.47 -36.2 79.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.561 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -61.33 -30.12 70.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 1.0 111.36 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 74.4 t -71.35 -53.54 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 188' ' ' ALA . 34.7 m -77.94 -36.09 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.398 0.518 . . . . 1.0 112.398 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -54.9 -49.68 70.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.707 0.289 . . . . 1.0 111.631 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 33.4 tp -73.46 -39.73 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 187' ' ' LEU . 28.3 tp -79.21 -40.15 31.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.418 -0.355 . . . . 1.0 111.813 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.454 ' O ' ' OG ' ' A' ' 192' ' ' SER . . . -55.8 -36.38 67.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.56 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -77.68 -38.8 46.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 1.0 109.97 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.98 -35.99 82.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.127 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 192' ' ' SER . 7.6 p -83.65 -40.06 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.722 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.459 ' N ' HG13 ' A' ' 191' ' ' VAL . 68.7 m -54.43 -35.8 63.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.1 mt -61.42 -35.67 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.217 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.33 -38.58 78.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.756 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.13 -49.5 83.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.154 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.39 -46.84 65.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.864 -0.607 . . . . 1.0 111.138 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -64.23 -40.58 96.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 1.0 111.518 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.97 67.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.321 -0.399 . . . . 1.0 111.699 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -63.1 -37.91 89.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.495 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 48.6 mt -61.42 -31.77 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.983 -0.287 . . . . 1.0 111.083 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.6 m -54.6 -52.55 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.529 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 202' ' ' LEU . 31.0 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.521 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.709 HBD2 HG12 ' A' ' 135' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.534 ' CD2' ' NH2' ' A' ' 55' ' ' ARG . 39.4 tp . . . . . 0 C--O 1.23 0.028 0 CA-C-O 120.91 0.385 . . . . 1.0 110.594 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 65.5 t0 -79.61 -30.5 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.984 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -79.38 -45.16 20.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.08 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 35' ' ' LEU . 21.3 tt -61.52 -39.92 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 1.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.493 ' N ' HG23 ' A' ' 34' ' ' ILE . 58.7 mt -61.1 -45.51 94.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.049 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.477 HH12 ' CD2' ' A' ' 78' ' ' LEU . 77.9 mtt-85 -53.75 -38.55 64.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.564 -0.455 . . . . 1.0 109.938 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.92 -29.34 65.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.082 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.419 ' O ' HG13 ' A' ' 42' ' ' VAL . 25.5 m -73.08 -44.52 60.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.544 -0.753 . . . . 1.0 112.249 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.689 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 5.9 p -69.16 -37.57 76.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.55 -37.23 71.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.796 0.332 . . . . 1.0 111.112 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -67.49 -49.01 65.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.78 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 38' ' ' THR . 28.4 m -64.4 -31.22 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.136 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.8 tmt_? -61.09 -45.83 93.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.811 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.02 72.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.09 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -78.33 -41.35 33.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.58 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.7 mt -85.55 -30.23 23.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.427 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.02 20.07 32.92 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.455 -1.058 . . . . 1.0 110.455 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.6 p -72.59 143.23 48.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.343 . . . . 1.0 110.239 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -39.58 -53.55 2.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.607 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -154.04 130.75 10.76 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.048 -0.661 . . . . 1.0 112.588 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -136.95 128.97 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.582 -0.896 . . . . 1.0 108.582 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.576 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 51.4 pttt -139.73 154.51 47.46 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.532 -0.467 . . . . 1.0 111.932 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 59.0 t -109.69 137.18 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -132.86 134.25 44.37 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.26 -178.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.534 ' NH2' ' CD2' ' A' ' 31' ' ' LEU . 42.4 ttm-85 -90.61 138.21 31.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.241 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -92.99 117.01 29.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 1.0 112.077 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -84.09 149.85 56.86 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.35 -23.97 72.43 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.517 2.145 . . . . 1.0 112.481 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.66 -16.48 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.0 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.67 -12.36 42.41 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.534 -0.626 . . . . 1.0 111.534 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -75.3 96.11 3.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.784 0.326 . . . . 1.0 110.662 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.15 143.09 16.78 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.7 p -122.21 146.02 47.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 1.0 111.693 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.73 109.47 13.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 65' ' ' VAL . 20.5 t -108.74 -1.66 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.97 -0.292 . . . . 1.0 111.242 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.689 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.68 114.62 2.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.044 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.41 ' C ' ' OE1' ' A' ' 67' ' ' GLU . 1.6 pp20? -145.22 135.29 23.82 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.523 -0.471 . . . . 1.0 111.833 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.39 144.83 51.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.692 -0.685 . . . . 1.0 109.386 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.473 ' NH1' ' C ' ' A' ' 71' ' ' GLY . 34.3 ptt85 -136.55 143.65 43.78 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.746 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -49.17 -41.68 30.86 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -173.31 -167.46 33.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -70.96 39.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.735 0.302 . . . . 1.0 110.515 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 71' ' ' GLY . 39.2 ttm180 -83.08 -49.72 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.18 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.93 151.18 49.95 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 1.0 109.849 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.66 164.2 35.33 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.522 2.148 . . . . 1.0 112.144 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -94.88 131.14 41.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.988 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.492 ' HA ' HD12 ' A' ' 80' ' ' LEU . 43.7 mt -90.26 11.51 20.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.411 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' CD2' HH12 ' A' ' 36' ' ' ARG . 11.3 tp -63.2 130.19 43.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 1.0 112.288 -177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.99 -12.36 66.33 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.498 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 77' ' ' LEU . 79.6 mt -81.68 150.0 28.24 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.285 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -109.35 137.61 46.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.646 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.831 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 9.3 m-85 -90.45 152.58 45.55 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.495 -0.557 . . . . 1.0 109.495 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.18 140.13 87.42 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.691 2.261 . . . . 1.0 111.816 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.02 126.83 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.709 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.89 -0.52 45.0 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.484 -1.046 . . . . 1.0 110.484 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -57.43 -37.87 73.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 87' ' ' ILE . 1.6 mp -70.96 114.34 26.31 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.429 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 99.9 Cg_exo -46.55 173.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.467 2.111 . . . . 1.0 112.481 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.523 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 96.2 mt-10 -104.5 -52.1 2.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.495 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.648 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 3.1 pm0 -68.55 -41.51 79.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.762 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.555 ' HB2' ' CBD' ' A' ' 203' ' ' CYC . . . -66.04 -42.01 90.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.966 0.358 . . . . 1.0 111.966 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.501 ' NH2' HD13 ' A' ' 162' ' ' LEU . 67.0 ttt-85 -60.44 -36.44 78.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.487 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 75.3 mtt85 -66.58 -41.49 88.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.833 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.543 HD12 ' NH2' ' A' ' 101' ' ' ARG . 86.3 mt -64.9 -39.24 93.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.277 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.662 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 8.4 t80 -64.39 -28.76 69.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.02 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.457 ' C ' HE22 ' A' ' 99' ' ' GLN . 73.4 ttt-85 -81.95 -26.41 34.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.814 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.9 mt -98.18 -43.28 7.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.382 1.253 . . . . 1.0 114.382 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -111.8 -7.39 14.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.996 1.48 . . . . 1.0 114.996 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.713 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.6 mm-40 47.02 82.85 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.239 -0.984 . . . . 1.0 108.769 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.6 p 174.13 103.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.048 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.543 ' NH2' HD12 ' A' ' 94' ' ' LEU . 7.7 mmt-85 -143.87 139.54 29.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 1.0 110.825 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -171.6 147.25 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.539 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.603 HD11 ' CD2' ' A' ' 139' ' ' HIS . 71.0 mt -108.75 138.06 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.95 165.37 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -48.31 119.83 3.23 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.133 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.423 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.9 p -58.27 -27.58 32.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.296 -0.866 . . . . 1.0 110.793 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -66.67 -42.84 85.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.68 -9.79 4.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.519 0.676 . . . . 1.0 109.395 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 45.41 58.42 4.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.704 -1.134 . . . . 1.0 113.28 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.8 p -77.55 134.65 38.22 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.919 -1.511 . . . . 1.0 106.919 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -123.1 144.64 49.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.952 -0.699 . . . . 1.0 111.903 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -132.37 156.48 46.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.527 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 112' ' ' SER . 24.9 pt -155.39 177.09 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.193 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 p -59.96 157.2 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.654 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -140.15 153.76 69.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.702 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -36.1 153.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.655 2.237 . . . . 1.0 112.34 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.664 ' H ' ' CD ' ' A' ' 117' ' ' GLU . 4.6 pm0 -48.05 144.15 3.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.43 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 t -159.03 148.32 18.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.631 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -136.27 152.12 50.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.59 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.37 132.19 22.82 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 38.5 mt -85.87 156.11 20.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.75 0.309 . . . . 1.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 124' ' ' ARG . 22.6 m -53.37 -28.08 27.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.484 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 125' ' ' VAL . . . -61.4 0.75 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.649 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' A' ' 122' ' ' SER . 78.9 mtm180 62.71 -65.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.566 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 125' ' ' VAL . 7.3 p -127.52 86.48 58.4 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.209 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -83.93 0.67 9.2 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.621 2.214 . . . . 1.0 112.248 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 tp 66.5 1.52 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.568 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.52 -36.98 59.49 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.93 163.51 48.31 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.553 0.216 . . . . 1.0 110.826 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -87.4 -169.06 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.1 2.534 . . . . 1.0 111.621 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 131' ' ' LEU . 11.1 mp -82.21 -2.0 50.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.364 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 58.97 22.76 10.75 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.958 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.558 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 4.0 mtp-105 -43.07 -44.71 11.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.589 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 5.0 Cg_exo -83.97 137.0 7.26 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.71 2.273 . . . . 1.0 111.956 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.55 HG13 ' CG2' ' A' ' 140' ' ' VAL . 2.3 p -122.69 134.26 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.861 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.64 ' OD2' HMD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -46.53 151.22 1.05 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 138' ' ' CYS . 36.2 Cg_endo -59.62 -46.93 18.04 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.263 2.642 . . . . 1.0 113.991 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -36.66 -44.84 0.48 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.682 0.253 . . . . 1.0 111.682 -178.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.688 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.6 t60 -83.79 -27.87 28.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.55 ' CG2' HG13 ' A' ' 135' ' ' VAL . 91.7 t -68.09 -51.0 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.979 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -66.75 -30.86 71.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -58.54 -43.85 89.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.67 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 146' ' ' MET . 13.1 mt -73.28 -37.79 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -50.86 -39.17 53.09 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -64.38 -25.5 68.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.765 -1.107 . . . . 1.0 109.195 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.562 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.2 mmm -90.56 1.95 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.705 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.55 21.57 78.73 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.81 142.47 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.89 0.376 . . . . 1.0 111.062 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.47 -20.39 13.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.908 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -145.62 160.6 41.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.203 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.479 ' OG ' HD12 ' A' ' 103' ' ' ILE . 3.7 p -147.7 122.08 9.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.411 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.2 mp -108.6 139.81 42.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.293 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.44 HG21 HAA1 ' A' ' 203' ' ' CYC . 9.8 t -128.81 118.41 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.128 0.49 . . . . 1.0 111.726 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.8 t -122.5 127.35 25.86 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.427 ' HB3' ' CE2' ' A' ' 95' ' ' PHE . 83.4 Cg_endo -76.33 148.62 30.5 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.135 2.557 . . . . 1.0 114.692 -176.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -136.63 49.01 2.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.814 -1.551 . . . . 1.0 106.814 177.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.02 -175.72 4.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -174.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.38 163.09 28.36 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.383 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.526 ' ND1' ' OE1' ' A' ' 160' ' ' GLN . 58.4 t-80 -66.65 -53.99 28.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.37 -0.832 . . . . 1.0 112.023 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.526 ' OE1' ' ND1' ' A' ' 159' ' ' HIS . 12.1 mm100 -99.78 8.81 43.95 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.047 0.388 . . . . 1.0 112.047 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -143.13 134.83 26.57 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.834 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 162' ' ' LEU . 1.1 mp -110.41 116.98 32.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.188 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -92.19 -41.01 10.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.263 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.607 ' O ' HD12 ' A' ' 165' ' ' LEU . . . -153.72 -177.95 27.71 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 164' ' ' GLY . 0.7 OUTLIER -146.02 143.71 29.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.897 0.379 . . . . 1.0 111.531 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.538 ' HB2' HD11 ' A' ' 156' ' ' LEU . 8.8 tp -112.18 132.75 54.72 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 167' ' ' VAL . 14.8 p -136.08 132.84 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.982 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 21.3 m -107.49 149.44 27.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.074 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -124.87 131.85 53.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.02 0.438 . . . . 1.0 111.648 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.6 113.8 14.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.98 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.45 -15.89 63.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.84 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -96.18 147.43 32.96 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.942 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.86 76.18 2.06 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.98 2.453 . . . . 1.0 111.886 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -113.77 97.76 45.37 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.836 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.75 164.83 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.494 2.129 . . . . 1.0 111.972 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 44.6 p90 -92.0 130.68 37.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.488 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 98.4 p -119.17 157.64 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.607 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -54.79 -34.75 63.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.638 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -57.12 -36.71 70.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.81 -36.59 83.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.499 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.4 mp -67.97 -38.13 82.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.53 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -53.58 -40.88 65.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.356 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 88.5 t -70.32 -56.43 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.39 -38.89 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.477 0.547 . . . . 1.0 112.477 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 181' ' ' LEU . 62.9 tt0 -49.98 -49.82 49.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.667 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 31.7 tp -70.16 -40.38 74.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.938 0.347 . . . . 1.0 111.938 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 187' ' ' LEU . 44.7 tp -76.44 -38.79 54.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.787 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.46 77.93 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.517 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.68 -39.27 80.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.94 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -65.66 -27.87 68.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.084 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -83.71 -41.8 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.736 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.8 p -56.64 -33.24 66.14 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.4 mt -69.94 -38.23 74.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.213 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.11 76.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.602 -0.727 . . . . 1.0 109.832 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.6 mm -60.59 -46.55 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.162 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.98 -45.64 66.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -67.59 -41.21 84.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.517 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.56 72.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.69 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.06 -39.79 93.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.559 -0.291 . . . . 1.0 111.492 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.32 -36.26 83.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.986 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 98.6 p -56.89 -52.92 63.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.784 0.326 . . . . 1.0 110.588 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.568 179.547 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.831 HAB2 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.808 0.337 . . . . 1.0 110.585 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.7 -28.72 56.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.032 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -79.84 -46.49 16.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.128 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.566 HG23 ' N ' ' A' ' 35' ' ' LEU . 3.2 tp -63.8 -43.96 98.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.955 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.566 ' N ' HG23 ' A' ' 34' ' ' ILE . 83.6 mt -61.39 -49.26 77.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.015 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -53.84 -37.68 63.86 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 -30.14 66.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.013 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.4 m -73.54 -45.0 56.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.591 -0.731 . . . . 1.0 112.204 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.672 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.1 p -67.39 -34.98 72.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -70.5 -39.33 74.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 1.0 111.098 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -65.54 -50.78 63.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.829 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.23 -28.81 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.683 0.278 . . . . 1.0 111.128 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.3 tmm_? -61.88 -46.4 89.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.865 0.364 . . . . 1.0 110.882 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.15 -33.45 69.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.097 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -79.68 -41.18 27.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.551 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 mt -85.34 -35.42 21.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.453 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 62.31 20.54 61.01 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.521 -1.031 . . . . 1.0 110.521 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -73.42 141.63 46.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.808 0.337 . . . . 1.0 110.173 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' CG ' HH21 ' A' ' 73' ' ' ARG . 92.3 m-20 -39.45 -44.3 1.36 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.622 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -164.76 130.43 2.77 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.025 -0.67 . . . . 1.0 112.57 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.16 129.01 42.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.464 ' O ' HD12 ' A' ' 166' ' ' LEU . 51.6 pttt -140.83 154.81 46.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.867 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 58.1 t -98.47 135.04 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 176.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 47.5 t80 -115.74 105.36 12.64 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.323 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -76.16 124.81 28.04 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.232 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 86.7 t80 -90.87 142.18 28.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 1.0 112.02 -178.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 1.1 m-20 -112.04 151.36 43.53 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 108.617 -0.882 . . . . 1.0 108.617 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.48 -23.65 75.78 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.541 2.161 . . . . 1.0 112.469 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -88.32 -12.12 44.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 1.0 110.045 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.61 -13.85 57.92 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.572 -0.611 . . . . 1.0 111.572 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -78.88 89.83 4.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.855 0.36 . . . . 1.0 110.606 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.47 151.63 21.07 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -125.07 146.39 49.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 1.0 111.679 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.96 108.98 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 65' ' ' VAL . 52.5 t -105.79 -1.61 9.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.904 -0.318 . . . . 1.0 111.333 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.672 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.03 115.38 2.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.143 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.482 ' CD ' ' NH2' ' A' ' 69' ' ' ARG . 87.7 tt0 -143.14 132.49 23.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.074 0.464 . . . . 1.0 111.856 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.98 147.77 50.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.4 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.482 ' NH2' ' CD ' ' A' ' 67' ' ' GLU . 42.3 mtt85 -141.23 142.33 33.96 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.77 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.98 -31.21 80.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.41 -173.66 38.53 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -79.26 40.0 0.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 1.0 110.517 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.563 HH21 ' CG ' ' A' ' 49' ' ' ASP . 22.3 ttp-105 -83.19 -48.64 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.22 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -103.37 149.93 37.48 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.167 -0.47 . . . . 1.0 109.905 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.61 148.58 72.61 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.535 2.157 . . . . 1.0 112.138 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.0 m -76.83 125.2 28.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.907 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 80' ' ' LEU . 25.1 mt -103.99 9.75 36.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.323 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.54 132.43 41.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.182 0.515 . . . . 1.0 112.305 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.88 -7.96 75.05 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.624 -0.716 . . . . 1.0 111.521 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 77' ' ' LEU . 63.4 mt -88.38 154.87 20.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.76 0.314 . . . . 1.0 110.246 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -103.07 129.02 49.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.663 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.561 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 6.3 m-85 -82.49 152.06 66.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.57 132.08 31.89 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.617 2.211 . . . . 1.0 111.848 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 128.72 37.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.052 0.454 . . . . 1.0 110.686 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.42 -0.17 40.29 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -59.24 -15.71 17.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.57 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.7 mt -104.14 105.62 49.77 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.696 -0.683 . . . . 1.0 109.465 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 87' ' ' ILE . 92.8 Cg_exo -48.11 -162.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.4 2.067 . . . . 1.0 112.485 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -107.21 -58.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.543 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.55 -42.04 86.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.835 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.84 -48.63 68.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.98 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -59.38 -37.94 79.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.445 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -64.51 -33.31 75.6 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.9 -0.32 . . . . 1.0 110.807 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.446 HD13 ' NH1' ' A' ' 101' ' ' ARG . 92.3 mt -64.49 -38.12 89.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.256 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.601 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 21.0 m-85 -61.45 -48.5 80.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.041 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -51.5 -34.57 36.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.835 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.4 mt -99.07 -38.01 9.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 114.4 1.259 . . . . 1.0 114.4 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.596 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.25 -13.25 11.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 115.105 1.52 . . . . 1.0 115.105 -174.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 21.6 mm-40 34.65 74.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.249 -0.98 . . . . 1.0 108.788 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.566 ' O ' HG13 ' A' ' 100' ' ' VAL . 7.6 p 177.17 117.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.122 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.545 HH22 ' CD ' ' A' ' 129' ' ' GLU . 2.0 tpt180 -176.0 145.36 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.922 0.391 . . . . 1.0 110.791 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.0 m -151.22 158.05 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.515 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.7 136.06 44.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 3.4 m -93.03 166.12 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 113.321 0.86 . . . . 1.0 113.321 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 173' ' ' PRO . 57.8 m-20 -46.31 118.42 1.93 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.918 -1.037 . . . . 1.0 112.166 -176.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.466 HG23 ' CG1' ' A' ' 140' ' ' VAL . 9.9 p -56.05 -22.73 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.789 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -62.56 -44.02 97.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.71 -10.97 31.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.56 0.695 . . . . 1.0 109.351 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 44.12 72.06 0.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.743 -1.117 . . . . 1.0 113.294 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.478 ' OG ' ' CG2' ' A' ' 104' ' ' VAL . 2.0 m -73.74 131.81 41.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.951 -1.499 . . . . 1.0 106.951 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -119.93 137.35 54.09 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.029 -0.668 . . . . 1.0 111.936 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.2 t -135.27 158.72 43.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.482 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.627 ' C ' ' H ' ' A' ' 115' ' ' GLN . 44.9 mm -121.82 133.94 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.15 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.5 m -57.01 5.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.702 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.627 ' H ' ' C ' ' A' ' 113' ' ' ILE . 26.6 mt-30 -116.72 81.3 11.57 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.646 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -83.72 150.26 12.81 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.73 2.287 . . . . 1.0 112.345 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.81 -42.99 99.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.434 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 59.1 p -169.0 176.01 5.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.706 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 120' ' ' GLY . 38.9 p90 -140.13 171.17 14.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.488 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 119' ' ' TRP . . . 55.23 111.98 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.648 ' N ' HD12 ' A' ' 121' ' ' LEU . 9.2 mp -85.82 126.18 33.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 1.0 110.408 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.548 ' C ' ' H ' ' A' ' 124' ' ' ARG . 50.5 m -74.23 -14.95 61.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.512 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -68.91 16.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.675 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' A' ' 122' ' ' SER . 18.6 mmm180 41.92 92.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.602 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 128' ' ' GLY . 4.1 t -110.25 129.96 23.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.234 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.438 ' HG2' ' H ' ' A' ' 127' ' ' LEU . 87.1 Cg_endo -78.82 -56.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.619 2.212 . . . . 1.0 112.291 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.438 ' H ' ' HG2' ' A' ' 126' ' ' PRO . 8.4 mp -68.9 -18.21 64.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.607 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.415 ' H ' HG12 ' A' ' 125' ' ' VAL . . . 97.89 172.14 32.94 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.545 ' CD ' HH22 ' A' ' 101' ' ' ARG . 8.9 pt-20 -52.64 149.9 10.26 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 121.136 -0.226 . . . . 1.0 110.921 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' GLU . 24.7 Cg_exo -33.39 150.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 123.168 2.578 . . . . 1.0 111.661 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.9 mt -70.79 -7.67 46.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.332 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.529 ' O ' ' NE ' ' A' ' 133' ' ' ARG . 90.7 mt-30 -82.64 82.88 7.83 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.91 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 132' ' ' GLN . 5.9 mmp_? -118.8 114.81 35.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.485 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.02 143.1 14.12 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.791 2.327 . . . . 1.0 111.895 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.518 HG23 ' CG2' ' A' ' 140' ' ' VAL . 1.5 m -104.77 119.0 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.887 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 112' ' ' SER . 18.7 t70 -44.13 137.38 3.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.754 -0.462 . . . . 1.0 109.754 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -37.82 -46.72 2.01 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.141 2.561 . . . . 1.0 114.034 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.684 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -41.31 -45.28 2.95 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.668 0.247 . . . . 1.0 111.668 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.684 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 17.4 t60 -81.86 -28.19 33.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.235 0.458 . . . . 1.0 112.235 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.518 ' CG2' HG23 ' A' ' 135' ' ' VAL . 85.2 t -66.97 -54.09 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.963 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -63.99 -29.36 70.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -57.68 -45.15 85.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.68 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 146' ' ' MET . 16.8 mt -73.02 -38.81 66.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -51.07 -39.7 56.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 m -63.78 -24.91 67.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.766 -1.106 . . . . 1.0 109.147 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.549 ' N ' ' O ' ' A' ' 143' ' ' LEU . 80.6 mmm -91.08 2.09 56.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.731 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.14 20.69 79.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.21 141.63 22.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 1.0 111.014 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.63 -21.65 13.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.919 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.6 p -146.35 161.29 40.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.166 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 p -146.54 131.93 18.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.449 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -119.51 125.15 48.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.315 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 166' ' ' LEU . 2.8 t -113.32 114.14 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.129 0.49 . . . . 1.0 111.754 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.6 t -120.62 93.69 48.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.751 -1.203 . . . . 1.0 107.751 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -44.94 140.24 7.21 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.142 2.562 . . . . 1.0 114.666 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.473 HD23 HG11 ' A' ' 191' ' ' VAL . 6.6 mp -122.04 50.31 1.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.87 -1.53 . . . . 1.0 106.87 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.446 ' CE ' ' O ' ' A' ' 164' ' ' GLY . 0.1 OUTLIER -146.45 -174.18 4.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.118 0.784 . . . . 1.0 113.118 -176.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.745 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 8.2 m-70 -65.37 154.1 39.32 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.305 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -56.23 -46.04 79.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.342 -0.845 . . . . 1.0 112.035 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -103.6 -44.02 5.21 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.049 0.388 . . . . 1.0 112.049 -177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.492 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 88.3 tt0 -84.75 138.03 32.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.895 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.412 ' HG ' ' SD ' ' A' ' 157' ' ' MET . 3.1 tt -105.72 113.85 27.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.324 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.745 ' HE1' ' CD2' ' A' ' 158' ' ' HIS . 68.7 m95 -94.15 -39.95 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.255 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -156.87 -173.4 25.27 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.179 -0.769 . . . . 1.0 111.179 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 95' ' ' PHE . 11.4 tp -141.27 130.0 22.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.857 0.361 . . . . 1.0 111.526 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.579 ' O ' HG13 ' A' ' 153' ' ' VAL . 56.5 tp -101.96 133.01 47.43 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.4 p -142.2 134.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.059 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.3 p -107.41 146.54 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.016 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -119.73 131.44 55.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.989 0.423 . . . . 1.0 111.634 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.89 113.76 13.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.971 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.83 -17.07 64.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.815 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -83.57 146.79 50.91 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.031 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.446 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 71.2 Cg_endo -72.38 5.99 2.49 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.898 2.399 . . . . 1.0 111.863 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -51.42 131.49 34.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.39 167.12 26.3 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.557 2.172 . . . . 1.0 111.883 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 50.4 p90 -88.95 132.8 34.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.466 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.1 t -117.25 147.22 42.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.565 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -50.96 -34.66 29.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.63 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -55.3 -41.1 71.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.709 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.47 -41.3 98.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.491 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.1 tp -63.82 -38.96 93.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.534 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -54.83 -35.03 63.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.308 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 97.7 t -70.61 -52.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.805 0.668 . . . . 1.0 112.805 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.1 t -77.31 -30.97 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -52.67 -49.87 64.38 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.026 -0.27 . . . . 1.0 111.646 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 186' ' ' LEU . 7.5 mp -70.71 -37.27 73.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.876 ' O ' HG23 ' A' ' 191' ' ' VAL . 8.0 tp -77.57 -37.83 49.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.828 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.27 95.81 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.552 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -61.11 -39.29 89.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 1.0 109.958 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -71.99 -29.05 63.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.115 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 187' ' ' LEU . 26.3 t -82.38 -48.78 17.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.712 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 84.2 p -50.66 -27.57 7.23 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.5 mt -77.51 -32.54 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.2 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -69.47 -47.69 63.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.617 -0.719 . . . . 1.0 109.803 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.1 pp -67.47 -35.53 73.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.134 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.46 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -70.68 -49.7 44.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.15 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.19 -32.36 66.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.496 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.09 -34.25 77.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.701 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -56.26 -29.85 61.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.575 -0.284 . . . . 1.0 111.445 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.593 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.9 mp -60.13 -33.28 71.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.702 0.287 . . . . 1.0 111.033 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 63.3 p -52.95 -54.62 32.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.566 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.2 mp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.488 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.661 ' O2A' ' HHA' ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.342 . . . . 1.0 110.542 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -48.43 -32.78 8.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.987 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -78.72 -45.56 20.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.065 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.8 mm -64.5 -39.93 87.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.878 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.7 mt -59.83 -45.94 90.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.006 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -57.31 -37.25 72.18 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.45 -28.48 65.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.079 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 42' ' ' VAL . 23.7 m -74.05 -47.24 38.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.526 -0.761 . . . . 1.0 112.244 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.673 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p -65.27 -34.52 71.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.949 0.351 . . . . 1.0 111.949 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.48 -49.55 70.95 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.9 -47.24 81.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.766 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 38' ' ' THR . 68.9 t -53.51 -46.49 59.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.989 -0.284 . . . . 1.0 111.165 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 47' ' ' GLY . 15.5 ttt-85 -49.87 -38.48 35.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.771 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.52 75.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -76.8 -44.12 33.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.552 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mt -86.2 -27.58 24.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.502 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.68 22.02 24.01 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.449 -1.061 . . . . 1.0 110.449 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.5 p -74.44 144.18 44.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.884 0.373 . . . . 1.0 110.194 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -42.35 -39.83 2.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.659 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 42.9 ttm180 -162.73 129.08 3.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.038 -0.665 . . . . 1.0 112.574 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.81 130.95 53.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.828 ' NZ ' HAB1 ' A' ' 203' ' ' CYC . 17.4 pttp -141.57 158.64 43.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.073 0.464 . . . . 1.0 111.969 -177.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 62.7 t -100.48 136.85 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 177.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -119.08 104.78 10.78 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.392 -0.523 . . . . 1.0 111.272 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.638 HH22 ' CG2' ' A' ' 195' ' ' ILE . 42.5 mmt-85 -77.3 128.0 33.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.264 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.498 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 78.9 t80 -93.32 139.21 30.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 1.0 112.024 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.498 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 1.6 m-20 -109.03 151.24 41.82 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.658 -0.867 . . . . 1.0 108.658 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.44 -23.93 72.61 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.516 2.144 . . . . 1.0 112.483 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -87.08 -13.26 44.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.64 -11.56 57.91 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.569 -0.613 . . . . 1.0 111.569 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -80.69 90.54 5.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.793 0.33 . . . . 1.0 110.642 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.7 151.43 20.88 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.617 -0.993 . . . . 1.0 110.617 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -124.77 149.01 47.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 1.0 111.679 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.5 t -77.93 109.16 12.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.0 t -107.06 -0.3 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.327 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.673 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.39 115.97 2.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.038 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 86.0 tt0 -144.5 132.73 21.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.839 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.3 142.31 50.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.415 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -140.04 144.79 37.06 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.721 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.441 ' CA ' HH21 ' A' ' 43' ' ' ARG . . . -60.55 -35.31 88.86 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -172.7 -164.33 27.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.59 25.69 0.33 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.76 0.314 . . . . 1.0 110.536 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -72.19 -48.0 46.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.117 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.432 ' C ' HH22 ' A' ' 50' ' ' ARG . 15.1 mt -106.65 148.35 36.67 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.879 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.526 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 58.1 Cg_endo -69.59 137.99 37.27 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.49 2.127 . . . . 1.0 112.166 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.1 t -72.44 123.46 23.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.936 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HA ' HD12 ' A' ' 80' ' ' LEU . 19.9 mt -99.02 11.32 39.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.397 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.7 tp -71.43 128.89 37.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.241 0.543 . . . . 1.0 112.261 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.79 -9.44 76.33 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.455 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 77' ' ' LEU . 60.8 mt -85.7 152.06 23.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.307 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.1 p -104.51 132.89 50.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.731 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.635 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 9.5 m-85 -87.23 128.15 56.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.557 -0.534 . . . . 1.0 109.557 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -41.28 133.08 3.24 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.675 2.25 . . . . 1.0 111.862 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.36 132.48 49.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.657 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.77 0.58 42.53 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.53 -1.028 . . . . 1.0 110.53 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -54.52 -33.85 60.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 88' ' ' PRO . 1.9 mt -90.61 111.71 49.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.361 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' A' ' 87' ' ' ILE . 87.2 Cg_exo -51.89 -157.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.411 2.074 . . . . 1.0 112.467 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 74.8 mm-40 -109.43 -54.59 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.536 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.83 -43.86 97.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.822 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.27 76.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.436 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 51.2 ttt85 -56.06 -35.38 66.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.393 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 75.4 mtt85 -64.22 -34.01 77.12 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.812 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.407 HD12 ' NH2' ' A' ' 101' ' ' ARG . 12.8 mt -65.19 -37.42 87.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.332 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE2' ' HG3' ' A' ' 101' ' ' ARG . 32.2 m-85 -59.88 -30.78 69.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.096 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -79.93 -26.26 40.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.829 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.548 ' C ' ' NE2' ' A' ' 99' ' ' GLN . 82.3 mt -100.65 -44.66 5.76 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.44 1.274 . . . . 1.0 114.44 -175.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.53 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -118.23 -12.45 9.97 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 115.078 1.511 . . . . 1.0 115.078 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.572 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 38.8 79.72 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.166 -1.014 . . . . 1.0 108.827 -178.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.751 ' O ' HG13 ' A' ' 100' ' ' VAL . 11.1 p -177.11 102.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.066 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.435 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 11.1 mmt180 -148.07 151.18 35.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.923 0.392 . . . . 1.0 110.746 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -169.54 147.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.476 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.894 HD11 HAA1 ' A' ' 203' ' ' CYC . 76.8 mt -109.41 134.8 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 m -92.16 164.65 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.331 0.863 . . . . 1.0 113.331 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 18.0 p30 -43.98 117.7 1.27 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.98 -1.009 . . . . 1.0 112.156 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.74 -19.55 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.734 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.28 -43.04 92.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.03 -13.28 62.07 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.56 0.695 . . . . 1.0 109.453 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.556 ' CD ' HH21 ' A' ' 111' ' ' ARG . 55.4 tt0 45.74 72.59 0.21 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.684 -1.143 . . . . 1.0 113.334 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.0 t -73.86 131.66 41.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.556 HH21 ' CD ' ' A' ' 109' ' ' GLN . 93.9 mtt180 -118.99 139.14 52.19 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.943 -0.703 . . . . 1.0 111.886 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.416 ' H ' ' HD3' ' A' ' 137' ' ' PRO . 0.2 OUTLIER -130.97 152.11 50.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.513 179.199 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.5 pt -152.89 174.24 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.146 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.8 m -65.14 161.43 19.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.599 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -136.6 151.37 72.64 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.655 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -35.07 -69.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.772 2.315 . . . . 1.0 112.281 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -135.2 145.16 47.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.443 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.8 t -156.59 133.23 10.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.617 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -144.09 158.87 43.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.596 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -158.28 127.31 1.86 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.462 ' CG ' ' H ' ' A' ' 122' ' ' SER . 2.7 tp -164.64 -149.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 1.0 110.392 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.462 ' H ' ' CG ' ' A' ' 121' ' ' LEU . 23.0 t -70.44 -34.35 72.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.493 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.33 6.69 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.641 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HB2' ' H ' ' A' ' 121' ' ' LEU . 55.8 ttt85 -56.18 143.29 33.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.55 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 127' ' ' LEU . 2.9 t -127.34 86.27 59.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.229 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -44.22 89.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.655 2.236 . . . . 1.0 112.29 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 125' ' ' VAL . 94.8 mt -136.94 -97.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.527 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -73.92 102.97 1.39 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.842 -0.903 . . . . 1.0 110.842 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.498 ' N ' ' HD3' ' A' ' 130' ' ' PRO . 73.3 tt0 -160.24 57.62 0.97 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.541 0.21 . . . . 1.0 110.862 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 129' ' ' GLU . 41.4 Cg_endo -97.24 -53.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 123.192 2.595 . . . . 1.0 111.64 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.421 ' H ' ' CD ' ' A' ' 130' ' ' PRO . 31.2 mt -63.5 -25.86 68.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.339 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -75.8 -34.71 60.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.012 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.472 ' NH1' ' CD ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -47.08 -56.34 12.42 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.545 -178.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 133' ' ' ARG . 70.2 Cg_exo -42.65 149.62 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.77 2.314 . . . . 1.0 111.956 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.41 HG11 HG23 ' A' ' 103' ' ' ILE . 1.6 p -98.88 116.51 42.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.797 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' A' ' 112' ' ' SER . 10.7 t70 -43.1 136.95 2.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD3' ' H ' ' A' ' 112' ' ' SER . 62.3 Cg_exo -42.42 -49.5 6.22 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 123.213 2.609 . . . . 1.0 114.019 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.689 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -36.88 -45.33 0.55 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.645 0.239 . . . . 1.0 111.645 -178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.689 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.5 t60 -81.55 -27.73 34.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.254 0.464 . . . . 1.0 112.254 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 137' ' ' PRO . 40.2 t -65.39 -52.97 45.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.967 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -64.77 -27.62 69.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.419 ' O ' ' OG ' ' A' ' 145' ' ' SER . 76.4 t80 -61.21 -46.45 90.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.678 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 146' ' ' MET . 54.0 mt -73.11 -37.62 66.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -38.69 58.74 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.561 -1.274 . . . . 1.0 107.561 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 5.7 p -62.82 -20.4 65.01 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.782 -1.099 . . . . 1.0 109.201 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 143' ' ' LEU . 95.4 mmm -95.49 1.21 53.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.774 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.92 24.5 71.79 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.25 140.8 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 1.0 111.014 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.63 -38.12 6.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.934 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.3 m -133.59 125.77 29.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 1.0 111.109 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.8 m -115.42 138.29 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.45 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.5 mt -116.55 139.5 50.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.313 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.467 HG21 HMA3 ' A' ' 203' ' ' CYC . 3.0 t -125.44 114.81 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.482 . . . . 1.0 111.818 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 184' ' ' VAL . 95.7 t -123.43 91.28 49.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.477 ' O ' HD12 ' A' ' 156' ' ' LEU . 85.7 Cg_exo -48.31 144.57 12.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 123.144 2.563 . . . . 1.0 114.705 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.481 HD23 ' CG1' ' A' ' 191' ' ' VAL . 7.9 mp -121.54 66.87 0.89 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -149.58 -172.92 4.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.129 0.788 . . . . 1.0 113.129 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.584 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 54.8 t-80 -77.6 173.89 11.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.413 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.584 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 92.9 m-70 -61.73 -52.46 64.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.387 -0.824 . . . . 1.0 112.058 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -104.53 -40.52 6.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.054 0.391 . . . . 1.0 112.054 -177.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE1' ' CD2' ' A' ' 163' ' ' TRP . 7.7 tm-20 -87.81 136.6 32.89 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.691 -0.403 . . . . 1.0 110.93 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.536 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER -111.55 116.3 30.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.272 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.533 ' CD2' ' OE1' ' A' ' 161' ' ' GLU . 25.1 m95 -88.67 -33.91 17.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.277 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.82 -173.79 36.19 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.233 -0.747 . . . . 1.0 111.233 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.3 135.41 30.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 1.0 111.495 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.14 136.2 43.38 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.461 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 9.5 p -140.36 135.01 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.121 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.5 m -108.93 139.86 43.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.029 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -116.33 133.68 55.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.948 0.404 . . . . 1.0 111.653 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.71 123.16 30.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.94 178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.43 41.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.794 -177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -165.07 148.52 7.3 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.041 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.475 ' O ' ' C ' ' A' ' 174' ' ' ARG . 77.8 Cg_exo -41.42 -75.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.884 2.389 . . . . 1.0 111.897 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.475 ' C ' ' O ' ' A' ' 173' ' ' PRO . 54.3 ttt85 33.65 84.59 0.18 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.875 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.0 162.93 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.541 2.161 . . . . 1.0 111.894 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 51.6 p90 -82.69 125.93 31.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.464 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.0 t -113.6 148.59 35.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.565 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -52.9 -27.01 16.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.631 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -58.14 -43.25 87.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.685 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -64.13 -35.85 82.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.479 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 18.8 tp -60.68 -41.78 95.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.536 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -58.35 -34.94 71.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.342 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 64.0 t -67.84 -53.33 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 185' ' ' GLN . 33.6 m -70.35 -43.71 78.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.395 0.517 . . . . 1.0 112.395 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 184' ' ' VAL . 65.8 mm-40 -43.51 -42.12 4.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.954 -0.299 . . . . 1.0 111.644 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.9 mt -74.97 -44.9 45.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.889 ' O ' HG23 ' A' ' 191' ' ' VAL . 57.3 mt -80.55 -39.79 27.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.827 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.64 84.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.492 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -65.84 -39.64 90.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.002 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -67.69 -29.43 68.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 187' ' ' LEU . 58.6 t -84.08 -45.03 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.714 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 57.9 p -55.37 -31.38 61.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 52.6 mt -76.73 -34.31 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.234 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.11 -42.4 84.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.82 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.638 ' CG2' HH22 ' A' ' 55' ' ' ARG . 37.4 pt -68.15 -33.72 62.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.163 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -70.13 -50.71 37.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.14 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -71.67 -36.51 70.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.479 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.66 -35.04 79.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -56.93 -29.58 63.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.472 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.622 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.2 mp -61.91 -34.15 75.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.682 0.277 . . . . 1.0 111.069 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 35.0 m -49.92 -54.08 22.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.563 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.579 179.695 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.894 HAA1 HD11 ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.888 0.375 . . . . 1.0 110.604 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -55.71 -50.93 69.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.978 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.596 HE22 ' NH2' ' A' ' 36' ' ' ARG . 84.7 mm-40 -57.03 -45.54 83.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.077 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.22 -47.15 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 1.0 110.939 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -58.68 -48.41 81.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.048 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.596 ' NH2' HE22 ' A' ' 33' ' ' GLN . 66.3 mtm180 -56.42 -36.32 68.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.442 . . . . 1.0 109.83 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.88 65.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.061 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 42' ' ' VAL . 27.2 m -73.29 -47.82 39.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.556 -0.747 . . . . 1.0 112.149 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.676 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.3 p -65.6 -35.07 74.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.38 -50.93 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 1.0 111.105 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -61.03 -43.36 99.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.784 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 38' ' ' THR . 79.8 t -57.36 -42.57 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.714 0.293 . . . . 1.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 47' ' ' GLY . 62.7 ttp85 -51.29 -40.18 58.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.763 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.41 78.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.041 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -78.38 -45.97 21.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 1.0 111.56 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.87 -31.8 22.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.53 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.93 20.71 27.71 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.6 p -70.92 142.0 51.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 1.0 110.167 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -40.98 -41.28 1.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.633 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.536 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -163.34 128.7 3.08 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.079 -0.648 . . . . 1.0 112.606 -178.582 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.9 130.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.538 ' CE ' HBB2 ' A' ' 203' ' ' CYC . 25.4 pttm -139.98 157.2 46.05 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.441 -0.504 . . . . 1.0 111.903 -178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.8 t -100.23 136.95 29.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.525 -0.917 . . . . 1.0 108.525 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 50.1 t80 -130.28 128.96 42.64 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.322 -0.551 . . . . 1.0 111.227 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -94.94 132.43 39.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.18 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -91.33 118.63 30.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -87.79 151.4 49.88 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 108.639 -0.875 . . . . 1.0 108.639 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.76 -20.85 60.84 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.48 2.12 . . . . 1.0 112.444 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -82.77 -17.51 43.92 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.06 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.73 -15.41 37.78 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.549 -0.621 . . . . 1.0 111.549 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 40.5 m80 -64.14 -104.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.773 0.32 . . . . 1.0 110.632 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.453 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . 103.89 152.97 23.09 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -128.09 147.51 50.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 1.0 111.696 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.458 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.5 p -81.66 117.06 27.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.93 4.87 9.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.696 0.284 . . . . 1.0 111.37 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.676 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.99 118.58 2.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.104 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 85.8 tt0 -144.37 133.21 22.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 1.0 111.846 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.2 151.5 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.393 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -139.74 142.26 36.82 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.762 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -39.96 -68.96 0.5 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.96 83.84 0.13 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 41.7 38.65 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.746 0.308 . . . . 1.0 110.522 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -82.62 -53.53 5.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.215 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.2 mt -110.27 141.42 23.85 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.888 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.14 165.67 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.479 2.12 . . . . 1.0 112.176 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.8 t -93.38 123.41 36.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.871 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.508 ' HA ' HD12 ' A' ' 80' ' ' LEU . 20.9 mt -90.59 2.59 55.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.376 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.16 131.12 49.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.179 0.514 . . . . 1.0 112.28 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.67 -13.55 63.89 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.545 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 77' ' ' LEU . 78.0 mt -82.1 150.93 27.24 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.309 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.5 m -106.14 134.4 49.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.703 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.824 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 8.2 m-85 -88.92 153.04 49.29 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.92 136.16 51.52 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.692 2.262 . . . . 1.0 111.879 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.465 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . . . -67.21 130.56 43.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.708 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.4 -2.43 39.93 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.497 -1.041 . . . . 1.0 110.497 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 20.8 p-10 -54.61 -38.19 66.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.4 mm -75.08 133.49 75.39 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.42 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.736 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 98.9 Cg_endo -72.28 -175.21 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.426 2.084 . . . . 1.0 112.526 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -105.46 -51.25 3.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.556 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.43 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 21.5 pt-20 -67.5 -41.97 83.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 1.0 111.843 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 1.013 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -68.16 -42.47 80.01 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.876 0.324 . . . . 1.0 111.876 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.604 HH22 HD22 ' A' ' 162' ' ' LEU . 61.0 ttt85 -63.83 -41.82 97.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.471 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -60.23 -32.96 71.62 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.879 -0.329 . . . . 1.0 110.847 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HB2' HH22 ' A' ' 101' ' ' ARG . 96.4 mt -71.46 -35.91 71.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.289 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.53 -40.85 96.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.02 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -63.66 -33.57 75.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.81 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.553 ' C ' HE22 ' A' ' 99' ' ' GLN . 72.0 mt -97.18 -37.11 10.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 114.389 1.255 . . . . 1.0 114.389 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.563 ' C ' ' NE2' ' A' ' 99' ' ' GLN . . . -118.01 -10.1 10.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.11 1.522 . . . . 1.0 115.11 -175.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.648 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER 41.58 79.48 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.114 -1.034 . . . . 1.0 108.864 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 100' ' ' VAL . 7.8 p 179.78 107.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.096 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.575 ' HD3' HAA2 ' A' ' 203' ' ' CYC . 8.9 ttm105 -153.27 148.76 27.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.954 0.407 . . . . 1.0 110.803 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 p -167.62 150.26 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.502 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.3 mt -106.91 136.43 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 105' ' ' ASP . 22.4 t -88.78 158.64 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.259 0.837 . . . . 1.0 113.259 -176.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.502 ' N ' HG12 ' A' ' 104' ' ' VAL . 64.5 m-20 -48.37 122.77 5.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.913 -1.039 . . . . 1.0 112.121 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.19 -26.71 26.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.786 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.9 -46.75 83.45 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.79 -12.67 50.29 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.49 0.662 . . . . 1.0 109.359 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 45.86 72.2 0.24 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.767 -1.106 . . . . 1.0 113.275 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 p -73.74 130.53 40.17 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.915 -1.513 . . . . 1.0 106.915 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -118.57 133.99 55.44 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.946 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 t -125.96 145.32 50.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.55 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 114' ' ' SER . 2.4 mt -148.18 169.61 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.201 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.475 ' H ' HG22 ' A' ' 113' ' ' ILE . 22.6 t -53.47 149.22 8.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.658 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 117' ' ' GLU . 3.2 pt20 -139.42 158.85 67.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.632 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -40.9 -13.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.714 2.276 . . . . 1.0 112.344 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 115' ' ' GLN . 69.4 tt0 65.04 113.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.446 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.8 m -140.32 158.26 44.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.673 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -58.59 141.89 50.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.538 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.39 14.03 5.66 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.5 mt 48.12 65.53 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 1.0 110.446 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 83.1 p -61.64 -23.6 66.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.513 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.93 -45.95 82.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.66 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.2 tpp85 -148.95 144.55 26.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.538 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 127' ' ' LEU . 34.2 m -79.69 147.91 68.09 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.246 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -38.25 -27.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.679 2.253 . . . . 1.0 112.293 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' VAL . 16.6 tp 51.55 81.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.563 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.97 -94.23 0.12 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -131.08 71.9 81.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.592 0.234 . . . . 1.0 110.865 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -85.99 -12.59 5.97 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 123.102 2.535 . . . . 1.0 111.636 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.95 -16.22 61.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.376 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -79.14 89.57 4.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.869 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -124.1 79.91 58.46 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.569 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.99 143.52 13.58 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.729 2.286 . . . . 1.0 111.904 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.562 HG23 ' CG2' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -103.24 117.9 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.824 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 138' ' ' CYS . 19.4 t70 -43.72 137.8 3.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -39.45 -20.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 123.153 2.569 . . . . 1.0 114.005 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.701 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.1 p -64.91 -46.06 83.28 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.662 0.245 . . . . 1.0 111.662 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.701 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 3.8 t60 -82.75 -24.53 33.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.562 ' CG2' HG23 ' A' ' 135' ' ' VAL . 72.0 t -65.85 -52.03 54.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.651 -0.42 . . . . 1.0 110.947 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.9 -29.71 69.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.778 -0.452 . . . . 1.0 109.778 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -58.49 -46.66 86.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.74 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 146' ' ' MET . 11.6 mt -72.73 -38.13 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -51.29 -38.71 54.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -65.04 -25.33 67.78 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.153 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.1 mmm -90.77 0.36 57.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.668 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.87 79.1 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.06 142.19 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.889 0.376 . . . . 1.0 110.969 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.53 -29.31 9.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.912 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.441 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 37.8 m -138.5 155.3 48.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.198 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 p -145.49 126.77 14.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.446 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tp -110.3 134.91 51.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.284 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.523 HG21 HAA1 ' A' ' 203' ' ' CYC . 5.7 t -122.81 120.92 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.182 0.515 . . . . 1.0 111.725 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 184' ' ' VAL . 1.2 m -114.81 167.37 9.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -83.27 122.36 3.24 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.187 2.591 . . . . 1.0 114.667 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.3 tp -124.24 35.56 4.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -146.34 177.7 8.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.158 0.799 . . . . 1.0 113.158 -176.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.677 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 40.8 t60 -68.73 -171.51 0.29 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.344 -0.843 . . . . 1.0 111.365 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.677 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 56.1 t-80 -73.68 -54.27 8.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.403 -0.817 . . . . 1.0 112.097 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -104.95 -32.01 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.046 0.387 . . . . 1.0 112.046 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 85.1 tt0 -94.05 141.41 28.57 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.88 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.604 HD22 HH22 ' A' ' 92' ' ' ARG . 7.2 tt -108.15 116.02 31.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.263 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.515 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 77.8 m95 -89.86 -37.64 14.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.266 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.04 -174.69 35.01 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.56 132.61 31.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.807 0.337 . . . . 1.0 111.563 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.5 tp -101.61 133.79 45.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 167' ' ' VAL . 11.7 p -140.13 133.25 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.796 -0.361 . . . . 1.0 111.147 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 78.6 p -109.76 139.89 44.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.025 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -113.66 133.34 55.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.026 0.441 . . . . 1.0 111.651 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -130.93 130.85 43.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.597 . . . . 1.0 109.973 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.32 59.02 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.785 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -160.14 128.7 2.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.993 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.426 ' O ' ' OD2' ' A' ' 105' ' ' ASP . 90.0 Cg_endo -77.21 22.36 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.922 2.414 . . . . 1.0 111.883 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -72.57 126.24 90.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.883 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -46.7 153.01 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.609 2.206 . . . . 1.0 111.882 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -86.24 141.86 28.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.481 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.7 m -118.07 150.24 39.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.598 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -57.74 -29.4 64.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.623 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -56.24 -38.47 71.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.756 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.25 -40.03 94.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.548 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.03 -37.94 89.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.509 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -53.62 -39.36 64.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.917 -0.583 . . . . 1.0 111.382 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.25 -54.33 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.592 HG21 HG11 ' A' ' 154' ' ' VAL . 7.3 p -78.9 -36.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -47.53 -49.22 26.77 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.656 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 33.5 mt -75.19 -38.35 60.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.97 -41.32 51.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.801 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.39 86.96 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.504 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.29 -37.76 70.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.976 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -68.85 -24.73 64.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.118 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.8 t -83.99 -45.35 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.793 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 85.5 p -56.86 -35.25 68.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.0 mt -66.96 -33.95 66.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.426 -0.806 . . . . 1.0 109.185 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.42 -38.35 74.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.778 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 195' ' ' ILE . 38.2 mm -59.28 -49.35 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.112 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.454 ' O ' ' CD1' ' A' ' 200' ' ' LEU . . . -71.59 -48.61 47.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.836 -0.62 . . . . 1.0 111.122 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -63.96 -42.9 97.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.496 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.89 -31.11 71.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.673 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -58.29 -31.97 67.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.592 -0.277 . . . . 1.0 111.417 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.7 mp -60.63 -34.58 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.045 -0.262 . . . . 1.0 111.054 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 31.7 t -55.31 -56.72 16.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.538 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.587 179.829 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 1.013 HBD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.911 0.386 . . . . 1.0 110.574 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.45 -51.07 69.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.964 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -56.64 -47.49 79.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.066 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.51 -47.85 91.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.787 0.327 . . . . 1.0 110.974 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.9 mt -55.91 -42.42 76.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 1.0 111.056 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.24 -35.29 62.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -34.6 70.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.065 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 42' ' ' VAL . 64.5 p -73.1 -41.22 64.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.498 -0.774 . . . . 1.0 112.271 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.607 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 8.2 p -70.44 -37.66 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.23 -46.65 79.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.893 -0.323 . . . . 1.0 111.151 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -59.89 -47.92 83.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.78 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 38' ' ' THR . 71.0 t -53.58 -38.43 33.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.986 -0.285 . . . . 1.0 111.115 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.541 ' NH1' ' O ' ' A' ' 69' ' ' ARG . 54.1 ttp180 -53.62 -44.11 69.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.339 . . . . 1.0 110.85 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.38 -34.2 70.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.117 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -74.14 -43.92 55.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.549 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.57 -30.12 19.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.421 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.5 20.88 1.12 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.534 HG21 ' CD2' ' A' ' 170' ' ' HIS . 5.5 p -63.64 -96.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.81 0.338 . . . . 1.0 110.236 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -155.6 -47.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 1.0 111.658 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -154.76 124.23 6.47 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.954 -0.699 . . . . 1.0 112.515 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.8 t -128.35 129.39 69.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.431 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 19.5 pttp -141.08 149.74 42.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.888 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 23.8 t -111.84 138.16 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.495 ' CD1' ' C ' ' A' ' 54' ' ' TYR . 2.4 p90 -136.15 139.09 42.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.314 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -93.31 141.38 28.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.294 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.64 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 64.0 t80 -92.69 117.54 30.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 1.0 112.123 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 17.3 p-10 -88.17 150.72 47.83 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.41 -20.11 67.05 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.516 2.144 . . . . 1.0 112.476 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -87.02 -19.82 28.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 1.0 110.096 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.64 -16.07 37.53 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.589 -0.604 . . . . 1.0 111.589 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.547 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 93.7 m-70 -74.25 91.81 2.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 1.0 110.561 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.55 144.36 20.51 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.3 p -122.01 143.47 49.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 1.0 111.666 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.481 ' O ' HD12 ' A' ' 78' ' ' LEU . 61.1 t -79.18 110.87 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.27 2.17 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.387 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.607 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.94 123.98 4.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.112 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -146.09 132.59 19.73 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.519 -0.472 . . . . 1.0 111.797 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.77 141.53 51.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.381 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.541 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 30.0 ptt180 -143.06 144.21 32.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.724 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.14 -34.81 47.87 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -173.27 -168.64 34.72 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.437 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 77.2 mm-40 -72.35 44.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 1.0 110.49 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 71' ' ' GLY . 56.9 ttm-85 -83.47 -48.85 9.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.141 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.36 149.77 41.54 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.906 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.13 165.19 33.21 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.577 2.185 . . . . 1.0 112.094 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.9 p -88.19 129.4 35.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.952 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.512 ' HA ' HD12 ' A' ' 80' ' ' LEU . 25.6 mt -98.47 2.57 47.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.364 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 64' ' ' VAL . 6.0 tp -62.01 131.35 49.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 1.0 112.337 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.17 -14.03 61.86 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.549 -0.75 . . . . 1.0 111.505 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 77' ' ' LEU . 68.3 mt -82.12 151.06 27.15 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.963 -0.295 . . . . 1.0 110.29 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.4 p -104.83 130.55 52.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.657 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.763 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 6.8 m-85 -85.61 153.76 58.58 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.28 135.68 59.53 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.704 2.269 . . . . 1.0 111.897 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.23 126.75 29.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.722 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.3 -0.58 43.64 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.49 -37.13 64.92 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.061 ' H ' HD12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -81.55 113.52 42.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.413 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 87' ' ' ILE . 80.4 Cg_exo -49.47 -171.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.468 2.112 . . . . 1.0 112.474 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 79.3 mm-40 -108.43 -55.85 2.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.553 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -59.88 -42.53 93.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.789 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.893 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -66.99 -51.05 59.91 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.922 0.342 . . . . 1.0 111.922 -178.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.783 ' HE ' HH21 ' A' ' 96' ' ' ARG . 59.3 ttt85 -50.17 -35.44 26.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.504 -0.316 . . . . 1.0 111.427 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' A' ' 89' ' ' GLU . 78.5 mtt85 -67.78 -35.16 78.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.798 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.7 mt -58.37 -39.03 78.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.273 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.615 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 92.5 m-85 -61.57 -50.44 72.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.052 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.783 HH21 ' HE ' ' A' ' 92' ' ' ARG . 95.6 mtt180 -54.56 -32.68 58.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.811 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.2 mt -101.39 -44.04 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.428 1.27 . . . . 1.0 114.428 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.12 -15.3 11.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 115.057 1.502 . . . . 1.0 115.057 -173.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 19.9 mm-40 44.16 79.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.205 -0.998 . . . . 1.0 108.849 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 100' ' ' VAL . 7.6 p -179.36 107.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.074 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.48 ' HE ' ' NE ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -156.15 150.94 26.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 1.0 110.777 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -170.43 148.51 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.498 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.2 mt -109.37 135.13 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.39 165.16 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 113.243 0.831 . . . . 1.0 113.243 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -46.51 119.38 2.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.91 -1.041 . . . . 1.0 112.13 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.427 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.6 p -56.75 -22.36 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.737 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.01 -44.68 91.88 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.18 -10.17 29.14 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.494 0.664 . . . . 1.0 109.36 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 45.21 71.42 0.27 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.734 -1.121 . . . . 1.0 113.308 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -73.82 132.7 42.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.979 -1.489 . . . . 1.0 106.979 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.548 ' NH1' HD11 ' A' ' 131' ' ' LEU . 36.6 ptt-85 -121.5 137.99 54.49 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.882 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -132.89 155.85 48.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.528 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 112' ' ' SER . 25.0 pt -156.1 177.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.149 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.1 t -54.93 156.33 3.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.623 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.404 ' O ' ' OE1' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -136.34 156.05 76.85 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.716 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 117' ' ' GLU . 86.5 Cg_endo -78.6 93.68 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.616 2.211 . . . . 1.0 112.324 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 116' ' ' PRO . 44.7 tp10 50.82 101.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.409 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.3 m -123.36 146.85 47.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.692 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -104.99 142.6 34.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.405 ' C ' ' N ' ' A' ' 122' ' ' SER . . . -58.24 -23.05 52.07 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.0 mt -51.92 -14.04 0.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 1.0 110.394 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 120' ' ' GLY . 15.8 t -53.61 -34.24 57.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.472 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.62 69.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.696 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -57.27 -56.23 24.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.596 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 m -150.45 87.56 4.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.205 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -41.28 127.84 3.08 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.588 2.192 . . . . 1.0 112.268 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.2 tp -58.22 -38.8 77.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.529 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -165.74 -81.79 0.05 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.816 -0.914 . . . . 1.0 110.816 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 132' ' ' GLN . 5.7 mm-40 57.3 66.98 2.69 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.613 0.244 . . . . 1.0 110.865 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -45.33 -41.47 17.4 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 123.136 2.557 . . . . 1.0 111.685 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.548 HD11 ' NH1' ' A' ' 111' ' ' ARG . 19.2 mt -76.56 -9.06 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.377 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 133' ' ' ARG . 73.3 mt-30 63.86 117.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.831 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.48 ' NE ' ' HE ' ' A' ' 101' ' ' ARG . 1.1 mmm180 36.2 76.0 0.47 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.584 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -85.15 136.04 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.793 2.328 . . . . 1.0 111.991 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.582 HG23 ' CG2' ' A' ' 140' ' ' VAL . 2.9 m -110.97 129.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.915 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.549 ' OD2' HMD3 ' A' ' 203' ' ' CYC . 37.2 m-20 -43.96 134.56 4.0 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -40.35 -46.53 4.32 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.124 2.549 . . . . 1.0 114.007 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 3.8 p -39.33 -45.4 1.43 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.686 0.254 . . . . 1.0 111.686 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.668 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.2 t60 -81.36 -29.34 34.09 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.276 0.473 . . . . 1.0 112.276 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.582 ' CG2' HG23 ' A' ' 135' ' ' VAL . 98.6 t -65.67 -52.53 49.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.961 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -66.75 -27.67 67.79 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -60.21 -45.51 92.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.775 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 146' ' ' MET . 65.1 mt -73.44 -35.82 65.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -52.18 -39.13 59.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.593 -1.262 . . . . 1.0 107.593 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 p -65.24 -20.63 66.51 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.779 -1.1 . . . . 1.0 109.158 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 143' ' ' LEU . 89.4 mmm -93.83 1.45 56.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.462 -0.79 . . . . 1.0 110.735 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.5 22.21 78.64 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.66 142.35 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 1.0 110.986 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.89 -42.99 4.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.484 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 7.2 t -129.84 125.8 36.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 1.0 111.17 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 m -112.96 135.49 53.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.458 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tp -115.13 136.85 52.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.291 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.24 113.96 39.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.15 0.5 . . . . 1.0 111.753 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.16 110.52 30.91 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.66 149.21 54.56 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.144 2.562 . . . . 1.0 114.671 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.48 ' CD2' ' HB1' ' A' ' 188' ' ' ALA . 29.6 mt -125.34 68.44 1.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.796 -1.557 . . . . 1.0 106.796 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.4 ptm -148.04 -173.84 4.41 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.594 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 30.7 t-80 -78.26 178.57 7.52 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.321 -0.854 . . . . 1.0 111.373 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.594 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 13.0 m-70 -74.13 -55.39 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.309 -0.859 . . . . 1.0 112.122 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -105.0 11.92 32.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -144.29 137.61 27.35 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.922 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.715 HD22 ' NH2' ' A' ' 92' ' ' ARG . 7.9 tt -112.38 117.42 32.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.258 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -92.19 -34.19 14.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.289 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.77 -167.58 25.55 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.445 HD21 ' CD2' ' A' ' 95' ' ' PHE . 1.4 mt -152.42 144.69 23.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 1.0 111.592 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 167' ' ' VAL . 2.7 tp -114.51 139.18 49.77 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.58 ' N ' HD12 ' A' ' 166' ' ' LEU . 8.4 p -140.4 140.6 34.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 69.5 m -113.53 143.11 45.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.968 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -113.54 131.8 55.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 1.0 111.572 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.666 ' N ' ' ND1' ' A' ' 170' ' ' HIS . 0.0 OUTLIER -124.67 121.19 34.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.844 -0.616 . . . . 1.0 109.961 178.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.0 -16.03 60.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.79 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -107.88 139.0 20.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.012 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 174' ' ' ARG . 72.7 Cg_exo -39.54 -73.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.885 2.39 . . . . 1.0 111.883 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 173' ' ' PRO . 17.0 ttp85 35.41 88.83 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.903 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.87 162.86 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.521 2.148 . . . . 1.0 111.986 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.454 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 50.8 p90 -90.88 131.33 36.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.43 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.1 t -121.21 157.39 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.599 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -53.01 -32.17 45.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.14 -39.38 86.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.731 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.1 -45.29 89.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.429 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.76 -36.29 83.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.581 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -55.41 -39.39 70.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.392 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.4 t -67.85 -55.54 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.545 HG12 ' HB2' ' A' ' 188' ' ' ALA . 3.4 t -70.82 -46.54 68.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.452 0.538 . . . . 1.0 112.452 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -41.48 -46.31 3.44 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.663 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 15.5 tp -71.6 -42.79 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 191' ' ' VAL . 46.4 tp -77.2 -40.44 45.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.86 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.545 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -57.19 -37.9 72.86 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.473 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -61.56 -39.75 92.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.33 -0.395 . . . . 1.0 109.982 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -64.98 -28.62 69.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.104 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 187' ' ' LEU . 20.6 t -84.04 -41.22 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.791 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m -56.7 -36.7 69.95 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 mt -65.46 -38.7 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.445 -0.798 . . . . 1.0 109.221 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.52 83.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.838 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.3 -47.34 92.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.171 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.82 -46.85 62.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.147 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -65.92 -42.54 90.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.508 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.73 -31.83 72.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.679 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.79 -40.14 95.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.521 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 200' ' ' LEU . 20.5 tp -62.85 -36.58 83.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.67 0.272 . . . . 1.0 111.011 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 38.8 t -50.74 -51.48 49.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.594 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.532 179.654 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.893 HBD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.8 tp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.9 0.381 . . . . 1.0 110.551 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 25.0 p-10 -76.83 -28.66 55.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.043 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -77.81 -47.09 19.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.086 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 pt -63.41 -38.58 82.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 1.0 110.964 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -60.84 -49.38 77.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.054 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -53.93 -39.5 65.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.71 -28.92 67.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.073 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.443 ' O ' HG23 ' A' ' 42' ' ' VAL . 11.6 m -71.47 -47.46 55.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.445 -0.798 . . . . 1.0 112.196 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.687 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 3.4 p -68.09 -33.27 59.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 111.907 0.336 . . . . 1.0 111.907 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -69.1 -51.36 39.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.829 0.347 . . . . 1.0 111.14 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -61.73 -45.65 93.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.745 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 38' ' ' THR . 84.6 t -61.56 -35.73 68.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.696 0.284 . . . . 1.0 111.169 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.618 ' NH2' ' CA ' ' A' ' 70' ' ' GLY . 15.7 tpt85 -56.51 -42.19 77.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.803 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.97 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.112 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -79.08 -43.2 24.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.624 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.3 mt -86.43 -32.28 20.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.461 -0.336 . . . . 1.0 111.455 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.54 19.28 18.54 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.564 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 67.3 m -69.97 141.21 53.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.859 0.361 . . . . 1.0 110.209 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' THR . 92.3 m-20 -37.16 -45.9 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.578 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.618 ' NH2' ' CE1' ' A' ' 169' ' ' HIS . 19.2 ttp-105 -163.66 126.7 2.62 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.985 -0.686 . . . . 1.0 112.567 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 51' ' ' VAL . 10.6 p -133.91 127.83 52.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 176.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.555 ' HE3' HAB1 ' A' ' 203' ' ' CYC . 44.0 pttt -140.09 155.65 46.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.14 0.495 . . . . 1.0 111.878 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 62.0 t -98.96 133.65 40.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 176.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -115.01 112.27 22.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.262 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -84.45 127.18 33.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.219 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.442 ' CE2' ' CZ ' ' A' ' 92' ' ' ARG . 71.9 t80 -95.26 134.16 38.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 1.0 112.039 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.86 140.32 20.95 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.36 -27.83 7.55 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 C-N-CA 122.495 2.13 . . . . 1.0 112.441 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -83.39 -16.22 46.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 1.0 110.089 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.56 -13.55 46.9 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.572 -0.611 . . . . 1.0 111.572 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -78.23 90.86 4.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.771 0.319 . . . . 1.0 110.616 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.97 150.8 20.44 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.527 -1.029 . . . . 1.0 110.527 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.4 p -124.85 147.79 48.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.372 . . . . 1.0 111.741 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 77' ' ' LEU . 22.1 t -75.82 107.93 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 65' ' ' VAL . 37.2 t -106.51 -1.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.282 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.687 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.64 113.82 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.068 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.4 tt0 -143.74 135.78 26.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.087 0.47 . . . . 1.0 111.758 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.25 131.97 47.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.415 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -124.65 147.21 48.68 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.711 -0.396 . . . . 1.0 110.725 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.618 ' CA ' ' NH2' ' A' ' 43' ' ' ARG . . . -72.25 -134.79 0.18 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.794 -0.922 . . . . 1.0 110.794 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.26 59.12 1.12 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.006 -0.838 . . . . 1.0 111.006 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 41.83 46.73 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.667 0.27 . . . . 1.0 110.486 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 73' ' ' ARG . 2.0 tpm_? -82.73 -48.72 10.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.401 HD13 ' NH1' ' A' ' 50' ' ' ARG . 42.0 mt -107.38 131.44 21.71 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.862 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.48 145.65 11.73 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.575 2.183 . . . . 1.0 112.111 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 p -72.79 123.34 23.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.978 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 80' ' ' LEU . 16.8 mt -98.62 13.6 31.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.309 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 23.9 tp -73.14 129.17 37.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.269 0.557 . . . . 1.0 112.209 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.56 -9.94 71.61 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.602 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 77' ' ' LEU . 68.8 mt -85.12 153.07 22.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.808 0.337 . . . . 1.0 110.243 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.6 m -105.91 132.54 51.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.703 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 8.1 m-85 -85.17 152.0 57.78 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.52 127.52 13.33 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.714 2.276 . . . . 1.0 111.854 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.85 142.33 57.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.623 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.35 1.18 37.99 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.938 ' O ' HG23 ' A' ' 87' ' ' ILE . 20.2 p-10 -50.84 -52.95 36.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.938 HG23 ' O ' ' A' ' 86' ' ' ASP . 1.9 pp -171.42 50.63 0.14 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.437 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 87' ' ' ILE . 4.1 Cg_endo -94.57 -0.84 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.398 2.065 . . . . 1.0 112.531 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -90.67 -82.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.037 -0.528 . . . . 1.0 111.494 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -78.79 -48.23 15.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.772 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.415 ' HB2' ' O1D' ' A' ' 203' ' ' CYC . . . -59.82 -35.33 74.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.868 0.321 . . . . 1.0 111.868 -176.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.917 HH12 HD22 ' A' ' 162' ' ' LEU . 58.5 ttt85 -71.68 -39.95 69.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.421 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -63.1 -43.32 98.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.824 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.493 HD12 ' NH2' ' A' ' 101' ' ' ARG . 76.1 mt -64.72 -41.73 95.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.297 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.431 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 1.2 t80 -55.04 -44.02 74.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.022 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -56.6 -28.58 60.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.803 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.698 ' C ' HE22 ' A' ' 99' ' ' GLN . 75.1 mt -98.24 -39.63 8.76 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -177.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.594 ' N ' ' NE2' ' A' ' 99' ' ' GLN . . . -119.38 -13.12 9.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.994 1.479 . . . . 1.0 114.994 -174.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.698 HE22 ' C ' ' A' ' 97' ' ' LEU . 0.1 OUTLIER 35.67 81.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.192 -1.003 . . . . 1.0 108.858 -178.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.72 ' O ' HG13 ' A' ' 100' ' ' VAL . 11.0 p -174.64 108.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.075 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.495 ' HD2' HAA2 ' A' ' 203' ' ' CYC . 56.6 mmt-85 -141.87 146.01 35.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 1.0 110.781 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.5 p -171.83 135.93 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.573 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.8 137.0 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.459 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 32.8 m -91.04 165.04 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 17.8 p30 -48.65 119.35 3.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.895 -1.048 . . . . 1.0 112.106 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 140' ' ' VAL . 9.3 p -53.77 -21.74 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.785 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -65.85 -45.28 82.77 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.404 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . . . -65.9 -16.02 63.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.557 0.694 . . . . 1.0 109.411 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 46.4 72.71 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.757 -1.111 . . . . 1.0 113.314 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.459 ' OG ' ' CG2' ' A' ' 104' ' ' VAL . 1.1 p -73.51 129.01 37.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.97 -1.493 . . . . 1.0 106.97 174.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -116.61 134.9 54.28 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.96 -0.696 . . . . 1.0 111.937 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.96 163.96 31.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.514 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.574 ' C ' ' H ' ' A' ' 115' ' ' GLN . 17.6 pt -126.54 138.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.209 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.0 t -67.1 16.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.631 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.574 ' H ' ' C ' ' A' ' 113' ' ' ILE . 50.6 mt-30 -119.85 79.45 24.24 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.65 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.79 151.26 12.88 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.633 2.222 . . . . 1.0 112.349 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -65.61 -48.3 72.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.464 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 t -175.12 161.05 2.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.713 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.522 ' CE3' ' N ' ' A' ' 120' ' ' GLY . 15.0 t90 -145.42 177.01 9.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.591 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.522 ' N ' ' CE3' ' A' ' 119' ' ' TRP . . . 104.06 -42.38 1.91 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.998 -0.841 . . . . 1.0 110.998 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.656 ' N ' HD12 ' A' ' 121' ' ' LEU . 8.9 mp -61.55 -30.37 70.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 1.0 110.436 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.5 p -58.18 -18.55 26.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.481 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.38 -25.03 63.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.711 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -119.22 -34.8 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.505 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 125' ' ' VAL . 7.6 p -150.68 113.67 3.2 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.222 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -40.43 138.89 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.546 2.164 . . . . 1.0 112.309 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 128' ' ' GLY . 2.8 tt -152.6 116.56 4.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.584 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.626 ' N ' HD23 ' A' ' 127' ' ' LEU . . . 85.0 30.58 25.5 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.891 -0.883 . . . . 1.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 129' ' ' GLU . 1.9 mp0 50.22 66.09 6.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.574 0.226 . . . . 1.0 110.89 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.64 -34.92 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 123.143 2.562 . . . . 1.0 111.631 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 26.0 tp -58.43 -41.37 84.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.378 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 133' ' ' ARG . 90.6 mt-30 -74.2 -29.35 61.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.929 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 132' ' ' GLN . 12.7 tpt85 34.79 65.72 1.6 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.615 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -49.79 146.6 15.65 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.749 2.299 . . . . 1.0 111.971 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.83 149.31 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.871 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -94.51 156.24 38.75 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -55.39 -29.03 66.36 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.195 2.597 . . . . 1.0 113.974 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.711 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.7 OUTLIER -60.4 -46.25 90.66 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.705 0.261 . . . . 1.0 111.705 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.711 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 4.4 t60 -80.64 -24.16 39.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.271 0.471 . . . . 1.0 112.271 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 106' ' ' VAL . 63.3 t -66.33 -54.11 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.944 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -64.9 -28.84 69.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -60.26 -45.85 91.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.776 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 146' ' ' MET . 27.3 mt -73.02 -37.2 67.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -50.98 -39.52 55.63 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.2 m -64.36 -24.47 67.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.746 -1.115 . . . . 1.0 109.204 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.565 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -91.86 -2.92 56.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.437 -0.801 . . . . 1.0 110.684 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.91 20.36 79.74 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.4 t -108.48 143.06 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 1.0 110.933 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.51 -42.74 4.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.948 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.8 m -131.99 124.22 28.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 1.0 111.164 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.2 p -108.73 139.59 43.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.444 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 tp -121.95 125.82 47.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.232 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.424 HG21 HAA1 ' A' ' 203' ' ' CYC . 2.5 t -119.74 113.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.182 0.515 . . . . 1.0 111.774 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.13 107.09 54.39 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.745 -1.205 . . . . 1.0 107.745 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -40.43 128.18 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.189 2.593 . . . . 1.0 114.681 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.54 HD11 ' CG1' ' A' ' 191' ' ' VAL . 13.7 tp -116.49 41.4 2.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.868 -1.53 . . . . 1.0 106.868 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 7.9 ptm -146.92 178.81 8.05 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 30.4 t-80 -69.04 -176.92 0.94 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.34 -0.846 . . . . 1.0 111.415 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.641 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 96.3 m-70 -68.77 -55.2 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.426 -0.806 . . . . 1.0 112.066 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -104.15 -42.3 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -83.47 129.43 34.98 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.882 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.917 HD22 HH12 ' A' ' 92' ' ' ARG . 6.7 tt -103.68 117.72 35.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.263 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -92.51 -39.78 11.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.244 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -165.58 -176.28 36.89 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.1 mt -138.24 136.46 36.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.778 0.323 . . . . 1.0 111.55 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.425 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.9 tp -105.84 130.95 53.71 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.63 142.14 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.743 -0.383 . . . . 1.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 m -112.59 138.52 49.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.054 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.618 ' CE1' ' NH2' ' A' ' 50' ' ' ARG . 56.1 m80 -106.98 121.6 44.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.977 0.418 . . . . 1.0 111.69 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -122.04 112.51 18.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.991 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.76 -15.09 63.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.884 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -87.51 148.39 44.12 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.3 -2.32 11.5 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.95 2.433 . . . . 1.0 111.88 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -41.59 131.25 2.3 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.878 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.82 167.23 25.67 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.578 2.185 . . . . 1.0 111.977 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 43.7 p90 -79.94 126.7 31.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.505 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.7 t -114.54 147.36 39.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.574 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.583 ' H ' ' CD ' ' A' ' 178' ' ' GLN . 11.1 mp0 -53.75 -32.45 52.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 1.0 110.622 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -62.35 -41.49 98.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.749 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -62.93 -43.79 97.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.465 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.5 mt -65.31 -37.76 88.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.558 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -54.1 -36.15 62.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.397 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.6 -54.47 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.1 -32.37 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.447 0.536 . . . . 1.0 112.447 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -54.19 -50.31 67.34 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.627 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.8 tp -70.14 -38.41 75.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.005 0.372 . . . . 1.0 112.005 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 191' ' ' VAL . 38.0 tp -77.75 -38.65 46.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.812 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.18 86.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.502 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.86 -40.14 91.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.964 0.411 . . . . 1.0 110.041 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -71.71 -24.44 61.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.146 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 187' ' ' LEU . 87.5 t -82.79 -48.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.718 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 82.9 p -55.34 -35.4 65.15 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.4 mt -65.61 -33.83 66.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.215 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.58 -38.49 77.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.776 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.1 mm -60.04 -46.6 94.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.123 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.26 -45.51 69.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.087 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -65.99 -40.71 91.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.495 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.91 70.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.308 -0.405 . . . . 1.0 111.733 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.35 -35.68 78.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.51 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.04 -32.28 71.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -54.37 -53.16 57.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.648 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.1 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.559 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.703 HBB3 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.887 0.375 . . . . 1.0 110.563 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -74.98 -50.04 17.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.975 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -57.01 -48.12 79.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.066 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 35' ' ' LEU . 18.8 tt -65.93 -43.31 92.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.759 0.314 . . . . 1.0 110.974 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.549 ' N ' HG23 ' A' ' 34' ' ' ILE . 30.7 mt -61.37 -46.72 89.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.033 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -59.5 -37.5 78.46 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.66 -29.62 67.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.128 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 42' ' ' VAL . 45.8 m -73.5 -48.0 36.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.476 -0.783 . . . . 1.0 112.259 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.654 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.0 p -65.14 -33.41 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.01 0.374 . . . . 1.0 112.01 -178.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -65.72 -49.15 69.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.342 . . . . 1.0 111.112 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.92 -38.61 89.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.748 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 38' ' ' THR . 86.0 t -61.05 -44.8 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.169 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 47' ' ' GLY . 61.7 ttp85 -53.71 -39.42 65.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.778 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.57 -37.84 79.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -79.45 -44.0 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.539 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.12 -33.59 22.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 1.0 111.523 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 60.45 19.52 53.61 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.457 -1.057 . . . . 1.0 110.457 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.515 HG23 ' CD2' ' A' ' 170' ' ' HIS . 93.9 m -72.27 142.31 48.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.349 . . . . 1.0 110.244 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -39.35 -45.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.625 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -163.72 130.91 3.36 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.046 -0.661 . . . . 1.0 112.545 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 51' ' ' VAL . 10.6 p -138.47 128.63 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 176.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -140.35 155.2 46.87 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.897 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.9 t -100.04 136.57 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 176.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.449 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 39.7 t80 -126.61 127.31 45.03 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.35 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.468 ' NE ' HG21 ' A' ' 65' ' ' VAL . 57.4 mtm180 -92.33 127.58 37.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.196 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 67.2 t80 -89.83 118.49 29.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 1.0 112.03 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 17.5 p-10 -90.04 152.37 46.13 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -59.43 -19.26 50.53 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.524 2.15 . . . . 1.0 112.458 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -82.6 -21.22 35.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.921 0.391 . . . . 1.0 110.04 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.11 -17.24 35.06 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.564 -0.614 . . . . 1.0 111.564 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' A' ' 84' ' ' ALA . 40.9 m80 -63.36 -100.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.603 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . 102.3 154.84 25.54 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 p -126.74 149.57 49.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 1.0 111.726 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.3 t -78.21 111.15 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.796 -0.816 . . . . 1.0 108.796 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 65' ' ' VAL . 58.3 t -107.19 -1.04 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.304 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -159.11 113.23 2.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.025 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 88.4 tt0 -143.12 134.1 25.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.133 0.492 . . . . 1.0 111.816 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.57 139.7 52.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.666 -0.697 . . . . 1.0 109.414 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -135.21 147.72 49.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.861 0.363 . . . . 1.0 110.74 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -51.34 -36.86 38.22 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 168.76 -160.26 33.67 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -65.08 4.31 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.312 . . . . 1.0 110.527 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 71' ' ' GLY . 68.0 ttp85 -66.74 -46.8 74.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.165 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.45 HD11 ' NH2' ' A' ' 73' ' ' ARG . 34.7 mt -118.48 116.84 34.92 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.864 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.28 157.07 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.514 2.143 . . . . 1.0 112.183 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 p -96.61 130.21 43.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.925 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 80' ' ' LEU . 44.4 mt -91.29 13.59 16.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.422 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.9 tp -65.62 130.38 43.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.979 -0.555 . . . . 1.0 112.265 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.46 -10.66 72.55 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.54 -0.754 . . . . 1.0 111.498 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 77' ' ' LEU . 76.0 mt -83.82 148.88 26.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.959 -0.296 . . . . 1.0 110.336 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.5 p -105.31 135.58 46.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.655 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.416 ' CD2' HBB2 ' A' ' 203' ' ' CYC . 8.8 m-85 -88.56 151.53 48.2 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.42 138.38 65.25 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.643 2.229 . . . . 1.0 111.863 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 61' ' ' HIS . . . -66.38 128.28 35.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.429 . . . . 1.0 110.7 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.6 -1.6 42.46 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -55.44 -37.42 67.69 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 88' ' ' PRO . 8.5 mm -77.8 113.41 32.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.641 -0.709 . . . . 1.0 109.388 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 87' ' ' ILE . 92.7 Cg_exo -46.8 -176.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.429 2.086 . . . . 1.0 112.48 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.53 -49.34 3.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.502 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 123' ' ' ALA . 88.2 tt0 -66.81 -39.33 87.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.868 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.883 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -68.01 -51.71 43.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.928 0.344 . . . . 1.0 111.928 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.634 ' NH2' ' CE2' ' A' ' 56' ' ' PHE . 64.0 ttt180 -53.31 -39.62 64.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.465 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -62.8 -33.07 74.44 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.758 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.16 -36.43 74.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.304 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.669 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 11.0 m-85 -59.62 -29.88 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.996 0.427 . . . . 1.0 110.028 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.516 ' C ' HE22 ' A' ' 99' ' ' GLN . 79.6 ttt-85 -83.28 -25.82 31.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.865 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.6 mt -97.42 -45.42 6.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 114.416 1.265 . . . . 1.0 114.416 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.514 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.83 -6.66 12.65 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.743 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 3.0 mm-40 41.24 78.28 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.133 -1.027 . . . . 1.0 108.787 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.8 p 171.42 116.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.115 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.5 ' NH1' ' O ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -169.89 130.59 1.01 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.388 . . . . 1.0 110.808 177.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.5 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 3.5 m -147.02 157.55 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.439 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.6 mt -108.52 132.97 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 105' ' ' ASP . 5.6 p -92.54 159.96 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.299 0.851 . . . . 1.0 113.299 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 104' ' ' VAL . 2.2 p30 -45.21 119.65 2.13 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.94 -1.027 . . . . 1.0 112.128 -177.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.458 HG23 ' CG1' ' A' ' 140' ' ' VAL . 8.9 p -53.32 -19.74 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.335 -0.848 . . . . 1.0 110.799 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.17 -46.32 84.54 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.404 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . . . -64.64 -13.55 54.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.492 0.663 . . . . 1.0 109.356 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 44.5 70.37 0.34 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.745 -1.116 . . . . 1.0 113.212 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.6 t -74.97 131.17 40.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.968 -1.493 . . . . 1.0 106.968 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -118.89 134.47 55.15 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.974 -0.69 . . . . 1.0 111.859 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.01 148.35 50.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.501 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 114' ' ' SER . 2.7 mt -147.91 167.37 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.126 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.443 ' H ' HG22 ' A' ' 113' ' ' ILE . 53.1 p -64.33 161.04 17.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.634 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -135.66 151.99 75.34 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.633 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -36.39 -25.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.573 2.182 . . . . 1.0 112.417 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 115' ' ' GLN . 78.3 mm-40 -128.66 151.43 49.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.428 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.5 p -103.55 -101.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.648 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -51.43 141.58 15.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.517 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 76.99 -169.92 55.07 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 125' ' ' VAL . 69.7 mt 41.5 -95.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 1.0 110.373 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 120' ' ' GLY . 22.7 t -56.68 -39.75 74.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.487 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 124' ' ' ARG . . . -79.69 -2.81 44.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.601 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 123' ' ' ALA . 49.1 ttp180 177.04 75.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.586 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 121' ' ' LEU . 26.2 m -66.61 149.09 98.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.245 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 128' ' ' GLY . 50.9 Cg_exo -37.42 147.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.647 2.231 . . . . 1.0 112.278 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.1 mt 62.48 -76.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.574 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 74.08 161.25 7.47 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.746 -0.942 . . . . 1.0 110.746 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.617 ' H ' ' HD2' ' A' ' 130' ' ' PRO . 1.5 tp10 178.89 -44.78 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.624 0.25 . . . . 1.0 110.852 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.617 ' HD2' ' H ' ' A' ' 129' ' ' GLU . 44.5 Cg_endo -90.49 147.2 4.2 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.182 2.588 . . . . 1.0 111.676 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 133' ' ' ARG . 46.8 mt -93.93 10.22 34.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.358 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -56.52 88.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.852 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 131' ' ' LEU . 92.8 mtt-85 -129.37 82.17 68.47 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.517 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.01 148.86 3.76 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.717 2.278 . . . . 1.0 111.957 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.402 ' HA ' HMD1 ' A' ' 203' ' ' CYC . 0.5 OUTLIER -98.69 115.2 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.871 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.492 ' OD2' HMD3 ' A' ' 203' ' ' CYC . 6.7 m-20 -43.58 139.01 2.79 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -40.51 -44.57 4.4 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 123.255 2.637 . . . . 1.0 114.014 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.738 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.9 p -40.74 -48.6 3.02 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.733 0.272 . . . . 1.0 111.733 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.738 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 15.2 t-80 -81.12 -27.2 35.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.278 0.473 . . . . 1.0 112.278 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.458 ' CG1' HG23 ' A' ' 106' ' ' VAL . 43.6 t -64.23 -53.21 46.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.636 -0.425 . . . . 1.0 111.023 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -65.7 -29.09 69.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.75 -43.46 94.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 1.0 109.737 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 146' ' ' MET . 9.3 mt -72.7 -39.21 67.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -50.82 -38.82 51.0 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 177.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.1 m -65.88 -24.53 66.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.847 -1.069 . . . . 1.0 109.171 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.8 mmm -92.4 -2.03 56.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.682 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.11 19.65 78.61 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.5 t -106.88 143.92 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 1.0 111.061 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.69 -43.91 3.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.993 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -134.35 121.0 20.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.198 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.3 t -111.99 142.98 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.402 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 tp -116.44 139.52 50.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.267 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.5 HG21 HAA1 ' A' ' 203' ' ' CYC . 1.5 t -128.81 120.35 52.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.167 0.508 . . . . 1.0 111.745 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.1 t -126.09 120.0 23.82 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.49 ' C ' HD12 ' A' ' 156' ' ' LEU . 98.6 Cg_endo -72.63 124.35 9.72 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.243 2.629 . . . . 1.0 114.655 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 156' ' ' LEU . 8.3 mp -102.37 58.98 0.81 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.846 -1.539 . . . . 1.0 106.846 177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.406 ' N ' ' OG ' ' A' ' 192' ' ' SER . 6.0 ptt? -147.95 -170.15 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.076 0.769 . . . . 1.0 113.076 -176.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.676 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 70.3 t60 -80.52 -179.56 7.24 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.424 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.676 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 60.0 t60 -74.79 -54.06 8.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.392 -0.822 . . . . 1.0 112.093 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -103.66 13.35 33.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.04 0.385 . . . . 1.0 112.04 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -146.39 140.21 26.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.714 -0.395 . . . . 1.0 110.904 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.8 OUTLIER -112.61 119.68 38.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.267 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -92.43 -35.53 13.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.306 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -163.88 -178.02 37.13 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.208 -0.757 . . . . 1.0 111.208 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' TYR . 87.5 mt -138.4 133.4 32.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.841 0.353 . . . . 1.0 111.551 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 53' ' ' VAL . 6.5 tp -102.33 133.97 46.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.87 135.14 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.089 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.0 m -109.56 139.17 44.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.003 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.429 ' O ' ' CG2' ' A' ' 48' ' ' THR . 48.5 m80 -108.2 119.29 39.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.674 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.515 ' CD2' HG23 ' A' ' 48' ' ' THR . 72.9 m80 -120.59 113.83 20.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 1.0 109.952 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.2 -16.08 61.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.841 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.99 138.01 72.82 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.013 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.94 10.82 2.19 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.978 2.452 . . . . 1.0 111.919 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -68.76 148.43 98.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.846 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.2 161.92 41.86 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.512 2.141 . . . . 1.0 111.939 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 44.0 p90 -74.87 133.6 41.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.465 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.8 m -112.51 147.91 35.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.69 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -59.88 -28.39 67.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.616 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -55.51 -44.12 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.693 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.3 -36.46 83.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.473 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.4 tp -62.23 -42.16 99.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.516 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.84 -33.74 64.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 1.0 111.371 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.34 -56.86 11.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 188' ' ' ALA . 13.5 m -78.7 -30.61 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.435 0.531 . . . . 1.0 112.435 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -51.06 -54.19 27.05 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.614 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 24.4 tp -75.14 -39.24 60.6 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 191' ' ' VAL . 6.2 tp -76.46 -41.47 47.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.891 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 184' ' ' VAL . . . -57.19 -39.8 76.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.519 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -58.29 -39.22 78.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.012 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -66.21 -28.39 68.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.132 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 187' ' ' LEU . 16.3 t -82.98 -44.57 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.782 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.406 ' OG ' ' N ' ' A' ' 157' ' ' MET . 1.5 t -53.71 -29.64 40.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.671 -0.862 . . . . 1.0 108.671 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.1 mm -77.19 -33.46 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.465 -0.789 . . . . 1.0 109.268 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.69 -47.81 44.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.893 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.1 pp -65.53 -37.17 79.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.142 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -72.01 -47.01 55.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.134 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -71.53 -36.0 70.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.519 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.59 74.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.645 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -59.35 -32.49 70.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.483 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.668 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.8 mp -61.32 -33.68 74.0 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.025 -0.27 . . . . 1.0 111.029 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -51.52 -53.66 35.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.571 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.543 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.883 HBD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.867 0.365 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -77.64 -29.34 51.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -77.87 -45.93 22.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.139 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 34' ' ' ILE . 12.3 pt -64.23 -38.66 83.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.46 -0.337 . . . . 1.0 110.884 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 40.3 mt -61.17 -50.64 72.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.033 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -53.81 -38.23 64.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.27 -29.96 66.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.043 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 42' ' ' VAL . 28.3 m -74.17 -45.32 49.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.509 -0.768 . . . . 1.0 112.269 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.629 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 9.9 p -67.77 -34.53 68.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -67.45 -46.14 73.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.85 0.357 . . . . 1.0 111.173 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -64.42 -41.09 96.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.783 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 38' ' ' THR . 79.6 t -61.19 -43.19 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.1 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLY . 66.8 ttp85 -55.03 -41.03 70.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 1.0 110.824 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.23 -36.55 73.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.026 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -79.37 -42.35 25.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.56 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mt -85.39 -32.52 22.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.466 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 61.81 20.31 59.57 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.474 -1.05 . . . . 1.0 110.474 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.447 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 69.7 m -73.1 141.18 47.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 1.0 110.132 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -40.03 -45.1 1.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 1.0 111.634 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.667 ' HE ' ' CE1' ' A' ' 169' ' ' HIS . 56.9 ttp180 -162.68 130.89 3.91 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.06 -0.656 . . . . 1.0 112.596 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.24 129.82 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' HZ1' HG11 ' A' ' 167' ' ' VAL . 24.8 pttm -141.69 152.86 44.27 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.912 -177.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.6 t -102.32 134.86 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.563 -0.902 . . . . 1.0 108.563 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.488 ' OH ' ' O ' ' A' ' 61' ' ' HIS . 52.1 t80 -120.89 126.29 49.64 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.299 -0.561 . . . . 1.0 111.293 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 163' ' ' TRP . 18.2 tpt85 -87.23 124.76 33.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.276 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -88.76 119.84 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.326 -0.397 . . . . 1.0 112.023 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.87 151.9 43.98 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.87 -21.84 59.53 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.491 2.127 . . . . 1.0 112.493 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -82.23 -15.59 52.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.378 . . . . 1.0 110.032 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.39 -15.79 49.67 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.489 -0.644 . . . . 1.0 111.489 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.488 ' O ' ' OH ' ' A' ' 54' ' ' TYR . 84.8 m-70 -64.09 -104.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.934 -0.307 . . . . 1.0 110.62 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . 102.61 155.95 25.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 p -127.58 151.07 49.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.935 0.398 . . . . 1.0 111.688 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.82 108.38 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.53 -0.76 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.314 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.629 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -160.09 113.02 2.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.099 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 87.6 tt0 -144.28 132.59 21.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.146 0.498 . . . . 1.0 111.798 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -131.16 140.97 50.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.413 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ptt-85 -142.91 150.1 39.34 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.02 -121.8 0.01 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.856 -0.898 . . . . 1.0 110.856 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -81.01 -175.94 50.39 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.641 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 1.1 pm0 -73.09 45.46 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.777 0.322 . . . . 1.0 110.488 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 71' ' ' GLY . 15.4 tpt180 -84.31 -47.84 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.175 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 23.3 mt -116.64 146.71 38.23 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.168 -0.469 . . . . 1.0 109.878 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.59 163.23 38.92 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.459 2.106 . . . . 1.0 112.218 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -92.79 130.68 38.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.958 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 80' ' ' LEU . 29.7 mt -95.85 12.73 29.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.429 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 18.8 tp -70.89 131.12 43.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.284 0.564 . . . . 1.0 112.261 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.84 -8.8 78.67 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.608 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 77' ' ' LEU . 74.6 mt -87.01 151.97 22.79 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.325 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.2 p -105.18 134.27 48.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.675 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.717 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 8.6 m-85 -89.65 151.24 45.55 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.94 135.87 36.46 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.681 2.254 . . . . 1.0 111.884 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . . . -66.12 136.77 56.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.71 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.29 -3.47 40.41 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.528 -1.029 . . . . 1.0 110.528 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -52.35 -40.78 62.39 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.1 mt -80.99 133.23 54.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.665 -0.698 . . . . 1.0 109.445 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.719 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 85.9 Cg_endo -74.89 -161.97 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.385 2.057 . . . . 1.0 112.513 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.02 -57.99 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.584 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -60.18 -45.76 92.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.8 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.719 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -65.1 -44.61 88.24 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.917 0.34 . . . . 1.0 111.917 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -58.69 -34.99 71.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.459 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -63.71 -34.4 77.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.766 0.317 . . . . 1.0 110.805 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' ALA . 11.9 mt -65.31 -34.16 77.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.297 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.662 ' C ' HE21 ' A' ' 99' ' ' GLN . 17.7 m-85 -64.24 -55.13 23.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.014 0.435 . . . . 1.0 110.01 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 159' ' ' HIS . 79.5 ttt180 -48.04 -33.92 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.843 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 mt -100.69 -37.91 8.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.04 -16.48 11.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -173.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.662 HE21 ' C ' ' A' ' 95' ' ' PHE . 22.4 mm-40 38.06 77.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.205 -0.998 . . . . 1.0 108.826 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.8 p 176.35 113.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.101 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -175.31 141.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 1.0 110.737 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.0 161.51 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.542 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.436 HD11 ' NE2' ' A' ' 139' ' ' HIS . 20.2 mt -104.37 137.5 33.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 105' ' ' ASP . 14.7 t -88.2 157.91 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 113.294 0.85 . . . . 1.0 113.294 -176.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.462 ' N ' HG12 ' A' ' 104' ' ' VAL . 78.6 m-20 -47.16 121.29 3.65 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.974 -1.012 . . . . 1.0 112.082 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.6 p -57.14 -25.15 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.371 -0.832 . . . . 1.0 110.762 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -64.85 -45.5 85.81 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.93 -11.38 27.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.479 0.657 . . . . 1.0 109.326 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.1 tp60 45.94 70.26 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.801 -1.091 . . . . 1.0 113.308 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -74.43 131.85 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.903 -1.517 . . . . 1.0 106.903 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -120.27 137.12 54.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.023 -0.671 . . . . 1.0 111.931 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.538 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -139.36 162.76 34.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.705 -0.679 . . . . 1.0 110.538 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.535 ' C ' ' H ' ' A' ' 115' ' ' GLN . 30.0 pt -126.15 141.93 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.105 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 81.0 p -52.74 -4.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.692 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 113' ' ' ILE . 23.6 mt-30 -121.81 76.29 38.06 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.646 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.58 -23.16 3.46 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.657 2.238 . . . . 1.0 112.36 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 55.41 39.94 31.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.418 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.0 m -125.88 143.59 51.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.709 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -144.43 156.07 44.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.601 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -122.1 116.46 3.07 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.982 -0.847 . . . . 1.0 110.982 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.805 ' N ' HD12 ' A' ' 121' ' ' LEU . 5.7 mp -90.48 -133.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.72 0.295 . . . . 1.0 110.379 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.2 t -63.68 -51.52 64.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.14 -28.93 62.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.637 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 64.82 153.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.56 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 125' ' ' VAL . 7.3 p -114.31 87.64 13.95 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.27 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 128' ' ' GLY . 85.9 Cg_endo -83.06 157.56 15.29 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.556 2.17 . . . . 1.0 112.306 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 127' ' ' LEU . 11.1 mp 42.49 -97.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.556 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 66.49 -67.64 0.16 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 127' ' ' LEU . 8.3 mm-40 -51.49 153.0 4.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 121.174 -0.211 . . . . 1.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.83 -26.28 3.76 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.088 2.525 . . . . 1.0 111.598 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -88.54 2.48 52.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.415 179.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 131' ' ' LEU . 74.2 mt-30 71.21 64.28 0.16 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.853 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 129' ' ' GLU . 90.2 mtm180 55.03 82.33 0.24 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.577 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.73 144.02 96.81 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.714 2.276 . . . . 1.0 111.958 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.54 126.0 59.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.844 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.538 ' N ' ' OG ' ' A' ' 112' ' ' SER . 26.4 t70 -46.05 131.07 7.26 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.442 ' HD3' ' H ' ' A' ' 112' ' ' SER . 59.5 Cg_exo -41.61 -47.11 6.1 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.194 2.596 . . . . 1.0 114.041 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.698 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.8 p -37.35 -46.4 0.76 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.723 0.268 . . . . 1.0 111.723 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.698 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 4.4 t60 -82.29 -30.43 30.58 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.2 t -67.73 -50.9 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.963 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -66.0 -29.18 69.51 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -60.03 -42.13 93.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.714 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' MET . 8.4 mt -73.49 -38.15 65.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -51.92 -39.17 58.71 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 t -63.69 -24.04 67.62 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.76 -1.109 . . . . 1.0 109.16 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.3 mmm -92.26 4.37 53.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.423 -0.808 . . . . 1.0 110.671 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.06 21.04 79.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.29 142.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 1.0 111.097 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.66 -23.2 12.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.964 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.4 m -141.96 160.52 40.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.202 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.73 121.01 9.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.496 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.7 mp -109.95 132.6 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.258 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.548 HG21 HAA2 ' A' ' 203' ' ' CYC . 16.8 t -123.21 119.4 57.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.175 0.512 . . . . 1.0 111.775 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.6 t -131.65 92.47 30.94 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.79 -1.189 . . . . 1.0 107.79 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.04 150.37 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.203 2.602 . . . . 1.0 114.616 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.575 ' H ' ' HE2' ' A' ' 157' ' ' MET . 33.9 mt -124.88 54.5 1.41 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.868 -1.53 . . . . 1.0 106.868 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.575 ' HE2' ' H ' ' A' ' 156' ' ' LEU . 7.5 ptp -148.56 -167.94 2.96 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.141 0.793 . . . . 1.0 113.141 -175.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.688 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 18.1 m-70 -68.83 163.2 24.77 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.342 -0.845 . . . . 1.0 111.408 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 96' ' ' ARG . 80.1 m80 -70.45 -55.36 9.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.44 -0.8 . . . . 1.0 112.042 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -94.98 11.36 32.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.081 0.401 . . . . 1.0 112.081 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -148.12 140.82 24.6 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.93 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.0 mt -113.52 117.14 30.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.304 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.688 ' HE1' ' CD2' ' A' ' 158' ' ' HIS . 81.8 m95 -89.22 -26.07 21.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.246 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.485 ' O ' ' CE ' ' A' ' 157' ' ' MET . . . -163.58 -160.85 11.96 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.177 -0.769 . . . . 1.0 111.177 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 13.3 tp -150.37 124.27 9.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 1.0 111.506 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.499 ' O ' HG13 ' A' ' 153' ' ' VAL . 7.3 tp -99.71 129.29 45.82 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.468 HG11 ' HZ1' ' A' ' 52' ' ' LYS . 13.0 p -139.5 134.14 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.077 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.2 p -106.99 141.99 37.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.991 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.667 ' CE1' ' HE ' ' A' ' 50' ' ' ARG . 24.1 m80 -112.75 126.21 55.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.978 0.418 . . . . 1.0 111.689 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -126.12 113.84 17.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.955 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.4 -15.08 63.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.779 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -117.65 151.03 47.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.99 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.48 132.05 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.895 2.397 . . . . 1.0 111.895 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 53.3 ttt85 -157.87 95.02 2.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.895 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.48 161.24 25.39 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.531 2.154 . . . . 1.0 111.916 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 44.0 p90 -91.17 123.79 34.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.441 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 52.3 m -123.75 164.56 18.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.619 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -50.74 -38.38 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.582 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -67.84 -37.45 81.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.756 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -61.46 -49.92 74.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.573 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 185' ' ' GLN . 43.1 mt -64.28 -34.2 77.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.476 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -54.05 -42.13 68.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 88.1 t -69.45 -57.31 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.773 0.656 . . . . 1.0 112.773 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 188' ' ' ALA . 35.3 t -74.11 -46.29 45.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.395 0.517 . . . . 1.0 112.395 -177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.416 ' CB ' ' O ' ' A' ' 181' ' ' LEU . 63.3 tt0 -42.74 -47.74 5.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.59 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.5 tp -72.36 -41.49 66.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.461 -0.336 . . . . 1.0 111.894 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 191' ' ' VAL . 40.5 tp -77.11 -41.84 40.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.818 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.571 ' HB1' ' CD2' ' A' ' 156' ' ' LEU . . . -55.05 -39.55 69.3 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.506 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -61.66 -38.14 86.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.007 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.14 -30.58 71.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.076 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 187' ' ' LEU . 13.0 t -83.8 -42.58 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.756 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.0 p -55.16 -32.85 62.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.5 mt -69.03 -37.34 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.203 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.96 -39.95 83.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.626 -0.715 . . . . 1.0 109.779 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.435 ' HA ' HD13 ' A' ' 195' ' ' ILE . 36.5 mm -61.04 -46.48 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.123 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.69 -47.24 60.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.1 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -65.48 -41.51 93.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.0 111.492 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.02 70.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.675 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.17 -40.95 97.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.509 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.52 -35.68 80.17 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.007 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.5 t -52.42 -52.22 55.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 1.0 110.595 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.583 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.788 ' HHA' HBA1 ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.6 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.902 0.382 . . . . 1.0 110.578 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 66.5 t0 -49.05 -34.99 14.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -77.29 -47.44 20.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.069 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.44 -42.44 93.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 1.0 110.977 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -56.87 -45.02 82.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.099 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -53.22 -38.69 63.16 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.56 71.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.055 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -69.08 -45.7 69.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.547 -0.752 . . . . 1.0 112.227 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.688 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.6 p -71.28 -35.26 57.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.995 0.368 . . . . 1.0 111.995 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 43' ' ' ARG . 43.4 tp10 -70.17 -35.7 74.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.776 0.322 . . . . 1.0 111.06 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -80.46 -53.54 6.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 1.0 111.755 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.55 HG13 ' N ' ' A' ' 43' ' ' ARG . 9.6 p -55.08 -44.08 72.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.744 0.306 . . . . 1.0 111.118 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.55 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.6 ppt_? -56.21 -41.7 76.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.85 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.17 -33.91 59.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.022 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -79.61 -36.2 38.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 1.0 111.581 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -85.34 -30.64 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.501 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 59.33 19.29 46.3 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.442 HG23 ' CE1' ' A' ' 170' ' ' HIS . 93.3 m -72.24 140.77 48.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.792 0.33 . . . . 1.0 110.234 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -39.72 -50.43 2.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.623 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.467 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 59.6 ttp180 -157.97 130.56 7.25 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.018 -0.673 . . . . 1.0 112.591 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.95 131.06 36.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -139.62 155.24 47.55 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.9 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 89.5 t -106.03 138.91 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 177.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.59 ' CE2' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -139.23 131.45 28.22 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.323 -0.551 . . . . 1.0 111.284 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -92.74 145.46 24.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.275 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.469 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 85.6 t80 -96.46 122.13 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 1.0 112.04 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -87.73 164.68 33.51 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 178.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.25 -25.83 15.29 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.521 2.147 . . . . 1.0 112.522 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.94 -15.37 54.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 1.0 110.096 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.37 -17.22 37.31 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.514 -0.635 . . . . 1.0 111.514 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -67.21 101.85 0.97 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.909 -0.316 . . . . 1.0 110.592 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.61 134.89 12.64 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.562 -1.015 . . . . 1.0 110.562 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.6 p -122.24 142.23 50.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 1.0 111.665 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.4 p -89.77 120.53 38.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 65' ' ' VAL . 10.9 t -110.41 5.84 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 1.0 111.356 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -158.08 118.36 3.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.126 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -143.67 135.91 26.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.073 0.463 . . . . 1.0 111.816 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.92 146.96 52.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.434 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -141.15 145.99 36.42 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.755 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.47 -32.81 46.16 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.881 -0.887 . . . . 1.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 176.63 -161.64 29.75 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -73.94 25.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.339 . . . . 1.0 110.523 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.507 ' H ' ' C ' ' A' ' 71' ' ' GLY . 43.1 mtm180 -77.47 -47.14 20.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.082 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.7 mt -113.04 145.56 33.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 1.0 109.921 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -70.93 160.31 49.77 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.516 2.144 . . . . 1.0 112.148 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.1 p -93.31 128.13 39.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.864 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.537 ' HA ' HD12 ' A' ' 80' ' ' LEU . 18.9 mt -94.44 6.4 48.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.372 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 tp -61.34 128.83 38.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.3 0.572 . . . . 1.0 112.246 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.45 -13.83 62.81 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.514 -0.767 . . . . 1.0 111.526 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 77' ' ' LEU . 76.3 mt -81.29 150.55 28.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.296 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -106.86 133.85 50.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.652 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.585 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 9.9 m-85 -87.02 133.28 39.48 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -41.15 132.87 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.633 2.222 . . . . 1.0 111.895 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.91 128.33 35.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 1.0 110.738 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.27 0.63 44.2 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.529 -1.028 . . . . 1.0 110.529 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -58.71 -33.11 69.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.457 HD11 ' OH ' ' A' ' 54' ' ' TYR . 8.4 mt -78.99 132.8 62.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.69 -0.687 . . . . 1.0 109.49 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.716 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 91.0 Cg_endo -73.74 -171.99 0.99 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.452 2.102 . . . . 1.0 112.479 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -106.43 -55.07 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.546 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -63.21 -42.27 99.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.813 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.716 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -67.77 -44.32 77.72 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.928 0.344 . . . . 1.0 111.928 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -64.11 -39.64 94.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.47 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -60.6 -32.13 71.26 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.762 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.564 HD11 HH22 ' A' ' 133' ' ' ARG . 96.5 mt -70.1 -28.14 65.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.905 0.383 . . . . 1.0 110.341 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.653 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 0.8 OUTLIER -65.33 -54.25 31.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.036 178.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.99 -31.69 65.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.878 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.3 mt -99.41 -44.51 6.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 114.357 1.243 . . . . 1.0 114.357 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -113.55 -12.51 12.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.112 1.523 . . . . 1.0 115.112 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.653 ' NE2' ' O ' ' A' ' 95' ' ' PHE . 18.2 mm-40 45.34 86.73 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.198 -1.001 . . . . 1.0 108.75 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.5 p 177.54 99.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.12 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 102' ' ' VAL . 9.8 mmp_? -139.49 133.24 30.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.998 0.428 . . . . 1.0 110.737 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 101' ' ' ARG . 71.3 t -161.4 141.81 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.536 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.15 133.65 53.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.515 HG21 ' OG ' ' A' ' 110' ' ' SER . 5.0 m -91.89 164.97 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.318 0.858 . . . . 1.0 113.318 -176.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 20.0 p30 -46.89 118.54 2.1 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.003 -0.999 . . . . 1.0 112.098 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.98 -22.2 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.311 -0.859 . . . . 1.0 110.801 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -67.83 -43.56 79.29 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.55 -11.75 12.44 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.525 0.678 . . . . 1.0 109.389 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 45.54 61.45 2.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.779 -1.1 . . . . 1.0 113.335 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.515 ' OG ' HG21 ' A' ' 104' ' ' VAL . 13.2 m -76.26 133.23 40.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 175.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -119.82 140.29 51.02 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.926 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.8 135.19 54.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.616 -0.72 . . . . 1.0 110.496 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 114' ' ' SER . 89.3 mt -136.86 165.95 27.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.185 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.614 ' N ' HG22 ' A' ' 113' ' ' ILE . 52.2 p -52.28 156.92 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 117' ' ' GLU . 15.3 mm100 -137.86 79.04 34.56 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.647 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -39.0 85.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.709 2.273 . . . . 1.0 112.363 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 115' ' ' GLN . 84.7 tt0 -171.95 134.79 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.458 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.1 p -76.07 157.0 33.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.681 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -153.44 168.51 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.601 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.79 -100.94 0.19 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 124' ' ' ARG . 23.0 mt 54.76 50.79 14.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 1.0 110.394 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -57.23 -28.89 63.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.534 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.85 -31.66 66.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.512 . . . . 1.0 110.657 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 121' ' ' LEU . 75.8 mtp180 -131.96 140.29 48.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.575 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 125' ' ' VAL . 5.5 m -75.2 139.24 72.15 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.296 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.15 83.36 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.558 2.172 . . . . 1.0 112.322 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.8 mt -92.68 -0.8 57.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.585 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.81 10.81 73.78 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.829 -0.908 . . . . 1.0 110.829 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -67.86 136.21 92.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.617 0.246 . . . . 1.0 110.913 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -37.05 151.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 123.164 2.576 . . . . 1.0 111.626 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.59 -24.17 67.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.362 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -130.99 135.84 47.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.898 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.564 HH22 HD11 ' A' ' 94' ' ' LEU . 17.6 mmm-85 -124.16 94.27 45.58 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.56 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -45.41 145.87 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.674 2.249 . . . . 1.0 111.93 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 p -100.37 119.98 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.811 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.743 ' CG ' HMD2 ' A' ' 203' ' ' CYC . 49.7 p-10 -43.77 134.1 3.85 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.738 -0.468 . . . . 1.0 109.738 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -42.49 -16.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.095 2.53 . . . . 1.0 114.067 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.743 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.7 p -71.55 -48.38 48.91 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.713 0.264 . . . . 1.0 111.713 -176.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.743 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 35.7 t-80 -82.97 -28.24 29.91 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.279 0.474 . . . . 1.0 112.279 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 141' ' ' HIS . 2.6 p -66.45 -43.76 90.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.004 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.523 ' N ' ' CG1' ' A' ' 140' ' ' VAL . 79.2 t60 -69.86 -30.35 67.8 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -59.82 -42.21 93.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.76 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 146' ' ' MET . 29.8 mt -74.36 -36.14 63.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -52.41 -39.32 60.81 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.7 p -65.08 -18.91 65.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.786 -1.097 . . . . 1.0 109.16 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 143' ' ' LEU . 79.2 mmm -96.15 1.14 52.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.12 22.89 78.62 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.944 -0.863 . . . . 1.0 110.944 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.33 142.98 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 1.0 111.006 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.65 -39.76 5.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.964 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.7 t -135.96 126.44 26.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.199 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.4 m -113.91 140.78 48.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.428 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.96 138.48 53.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.262 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.568 HG21 HAA1 ' A' ' 203' ' ' CYC . 2.8 t -128.3 119.45 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.167 0.508 . . . . 1.0 111.732 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.6 124.52 21.91 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.735 -1.209 . . . . 1.0 107.735 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.47 ' O ' HD23 ' A' ' 156' ' ' LEU . 85.4 Cg_endo -71.97 144.27 42.54 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 123.175 2.584 . . . . 1.0 114.678 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.571 ' CD2' ' HB1' ' A' ' 188' ' ' ALA . 11.3 mt -125.14 47.46 2.16 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.561 ' CE ' ' O ' ' A' ' 164' ' ' GLY . 4.4 ptp -147.36 -167.38 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.104 0.779 . . . . 1.0 113.104 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.492 ' CD2' ' HE1' ' A' ' 163' ' ' TRP . 20.7 m-70 -68.71 159.24 32.58 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.45 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -60.63 -50.11 74.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.414 -0.812 . . . . 1.0 112.107 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -97.74 -42.75 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.06 0.393 . . . . 1.0 112.06 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.473 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 85.2 tt0 -86.27 134.3 33.76 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.87 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 19.1 mt -109.17 115.58 30.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.215 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.492 ' HE1' ' CD2' ' A' ' 158' ' ' HIS . 77.8 m95 -88.85 -31.42 18.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.278 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.813 ' C ' HD12 ' A' ' 165' ' ' LEU . . . -169.97 -166.95 29.76 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.229 -0.748 . . . . 1.0 111.229 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.813 HD12 ' C ' ' A' ' 164' ' ' GLY . 5.8 mp -148.65 136.37 20.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 1.0 111.506 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.4 tp -98.58 134.92 40.86 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 167' ' ' VAL . 8.4 p -138.5 127.41 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.695 -0.402 . . . . 1.0 111.097 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.2 p -104.68 137.13 42.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.064 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.467 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 28.4 m80 -105.07 121.24 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.981 0.419 . . . . 1.0 111.601 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.442 ' CE1' HG23 ' A' ' 48' ' ' THR . 91.2 m-70 -122.1 113.45 19.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.936 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.46 -14.23 61.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.781 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.74 135.14 74.85 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.06 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.01 -4.54 14.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.905 2.404 . . . . 1.0 111.813 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 174' ' ' ARG . 1.0 OUTLIER -54.73 151.34 15.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.845 -179.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.65 160.96 46.75 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.53 2.153 . . . . 1.0 111.946 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -81.54 136.64 35.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.483 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -113.03 144.83 41.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.64 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.528 ' NE2' HD22 ' A' ' 181' ' ' LEU . 64.1 tp60 -55.86 -29.32 59.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.537 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -55.82 -37.07 68.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.696 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.01 -37.72 88.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.505 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.0 mp -65.07 -38.94 92.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.48 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.53 -37.98 68.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.371 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.85 -55.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.737 0.643 . . . . 1.0 112.737 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 185' ' ' GLN . 10.9 p -68.38 -38.69 79.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.394 0.516 . . . . 1.0 112.394 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.457 ' N ' HG13 ' A' ' 184' ' ' VAL . 83.7 mt-30 -52.52 -45.22 66.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.644 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 37.2 tp -65.04 -45.52 85.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.873 ' O ' HG23 ' A' ' 191' ' ' VAL . 85.1 mt -78.92 -31.55 45.27 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.571 ' HB1' ' CD2' ' A' ' 156' ' ' LEU . . . -62.88 -44.46 96.06 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.494 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -62.25 -42.23 99.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.067 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -64.12 -27.34 69.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.095 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 187' ' ' LEU . 45.4 t -84.8 -40.86 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.749 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -56.78 -36.11 69.48 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.5 mt -67.58 -38.44 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.228 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -68.02 -40.2 82.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.838 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 195' ' ' ILE . 26.1 mm -59.23 -48.19 87.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.051 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.47 -48.75 47.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.031 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.15 -45.77 79.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.525 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 194' ' ' ALA . . . -63.42 -32.65 74.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.711 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -57.32 -29.6 64.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.385 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 200' ' ' LEU . 10.0 mp -62.27 -32.88 73.65 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.058 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.0 t -52.15 -55.85 18.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.551 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.6 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.54 179.439 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.743 HMD2 ' CG ' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.806 0.336 . . . . 1.0 110.589 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -53.01 -54.5 34.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.951 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -54.54 -46.95 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.114 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 mm -62.03 -46.99 95.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.826 0.346 . . . . 1.0 110.972 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 34.2 mt -56.46 -45.14 80.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.08 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -53.59 -38.41 63.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.65 -30.33 66.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.124 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 42' ' ' VAL . 24.7 m -73.59 -44.76 56.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.528 -0.76 . . . . 1.0 112.228 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.71 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 6.4 p -68.56 -35.94 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.96 0.356 . . . . 1.0 111.96 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -67.16 -49.18 65.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 1.0 111.156 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -58.72 -45.26 90.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.683 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 38' ' ' THR . 73.9 t -57.94 -37.32 60.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.686 0.279 . . . . 1.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 47' ' ' GLY . 36.7 ttp180 -52.53 -40.83 62.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.832 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.89 -35.76 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.056 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.11 -46.36 20.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.538 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.6 mt -86.37 -31.59 21.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.494 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.57 22.22 31.22 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.461 -1.056 . . . . 1.0 110.461 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.2 p -74.02 144.96 44.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.332 . . . . 1.0 110.286 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -41.52 -42.01 2.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.617 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.532 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 56.3 ttm-85 -163.26 129.33 3.24 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.123 -0.631 . . . . 1.0 112.636 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.84 130.29 52.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.499 ' HE2' HAB1 ' A' ' 203' ' ' CYC . 23.5 pttm -140.6 154.97 46.68 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.442 -0.503 . . . . 1.0 111.874 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 95.1 t -109.17 138.76 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.496 ' CE2' HD13 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -138.34 133.47 33.01 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.348 -0.541 . . . . 1.0 111.283 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -92.62 145.58 24.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.201 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -95.62 117.73 31.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 1.0 112.089 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.09 149.47 59.02 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.52 -23.15 74.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.58 2.187 . . . . 1.0 112.45 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -86.14 -14.53 43.85 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.057 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.43 -13.13 47.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.469 -0.652 . . . . 1.0 111.469 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -76.0 94.79 3.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.804 0.335 . . . . 1.0 110.608 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.88 143.54 17.61 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -122.18 144.54 48.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.914 0.388 . . . . 1.0 111.638 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -80.51 112.49 18.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.07 3.63 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.276 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.71 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -160.28 119.71 2.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.076 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.532 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 84.8 tt0 -144.84 132.87 21.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.106 0.479 . . . . 1.0 111.847 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.96 148.82 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.336 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.613 ' NH2' ' N ' ' A' ' 76' ' ' SER . 6.8 ptp180 -139.68 142.21 36.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.895 0.379 . . . . 1.0 110.718 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.41 -33.18 86.54 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . -171.26 -178.97 42.08 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -73.61 40.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 1.0 110.581 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 71' ' ' GLY . 10.1 tpt180 -83.06 -47.79 11.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.144 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.402 ' HB2' HH21 ' A' ' 50' ' ' ARG . 13.6 mt -113.36 150.85 43.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.863 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.462 ' C ' ' NH2' ' A' ' 69' ' ' ARG . 58.3 Cg_endo -69.86 160.3 50.19 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.483 2.122 . . . . 1.0 112.131 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.613 ' N ' ' NH2' ' A' ' 69' ' ' ARG . 21.9 t -88.86 129.55 35.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.942 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 80' ' ' LEU . 22.6 mt -98.14 10.22 41.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.383 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.08 132.58 45.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.003 -0.544 . . . . 1.0 112.305 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.13 -10.02 67.57 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.527 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 77' ' ' LEU . 46.8 mt -85.5 154.11 22.0 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.336 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 p -105.37 130.72 53.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.688 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.738 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 8.1 m-85 -84.66 152.67 60.42 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.84 133.94 41.28 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.678 2.252 . . . . 1.0 111.883 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.35 129.14 38.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.67 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.64 0.46 42.91 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -56.42 -35.58 67.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.7 mm -80.16 132.39 59.91 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.66 -0.7 . . . . 1.0 109.434 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.685 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 86.7 Cg_endo -74.39 -167.26 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.398 2.065 . . . . 1.0 112.483 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -107.63 -60.06 1.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.505 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.581 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 39.6 mp0 -57.95 -44.43 86.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.818 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.685 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -66.88 -44.62 80.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -58.62 -36.26 73.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.477 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -63.81 -32.03 73.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.811 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.1 mt -67.11 -36.36 81.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.295 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.439 ' CZ ' HBA2 ' A' ' 203' ' ' CYC . 24.2 m-85 -57.18 -54.36 47.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.051 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -53.43 -29.81 37.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.838 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.58 ' C ' HE22 ' A' ' 99' ' ' GLN . 75.9 mt -98.97 -41.37 7.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.413 1.264 . . . . 1.0 114.413 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.561 ' N ' ' NE2' ' A' ' 99' ' ' GLN . . . -120.19 -17.09 8.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 115.031 1.493 . . . . 1.0 115.031 -173.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.793 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.2 OUTLIER 45.15 71.45 0.27 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.123 -1.031 . . . . 1.0 108.847 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 99' ' ' GLN . 2.7 m -164.26 113.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.051 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.474 ' CZ ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -155.68 148.26 23.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.932 0.396 . . . . 1.0 110.774 178.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.13 143.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.505 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.7 mt -108.94 135.62 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.09 164.39 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 113.275 0.843 . . . . 1.0 113.275 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -43.98 117.27 1.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.95 -1.023 . . . . 1.0 112.145 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.88 -20.02 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.79 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -66.9 -42.27 85.76 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.09 -10.39 40.0 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.45 0.643 . . . . 1.0 109.408 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 45.26 70.63 0.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.734 -1.121 . . . . 1.0 113.354 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 p -75.35 134.43 40.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.984 -1.488 . . . . 1.0 106.984 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -122.02 139.78 53.28 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.997 -0.681 . . . . 1.0 111.893 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.456 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -130.28 153.51 48.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.571 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 112' ' ' SER . 28.6 pt -154.88 178.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.121 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.7 p -51.49 150.54 3.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.577 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -141.22 153.66 66.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.668 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -36.26 99.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.677 2.251 . . . . 1.0 112.309 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 44.35 -121.89 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.433 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.4 m -129.31 149.6 51.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.65 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -70.51 -61.04 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.589 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.75 -162.77 52.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.5 mt 42.07 73.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 1.0 110.437 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 76.9 p -63.19 -16.42 60.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.511 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.82 -20.46 8.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.736 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -141.96 147.43 36.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.574 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 125' ' ' VAL . 4.2 m -78.78 150.74 76.01 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.289 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.05 152.02 31.13 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.647 2.231 . . . . 1.0 112.32 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.656 ' N ' HD12 ' A' ' 127' ' ' LEU . 8.4 mp -88.07 161.06 17.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.575 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.26 59.23 2.07 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -134.72 78.97 54.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.585 0.231 . . . . 1.0 110.843 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -87.1 -46.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.159 2.573 . . . . 1.0 111.652 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.5 mt -79.08 -0.49 31.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.416 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.529 ' O ' ' C ' ' A' ' 133' ' ' ARG . 61.1 mm-40 63.86 114.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.94 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.529 ' C ' ' O ' ' A' ' 132' ' ' GLN . 23.6 ttm105 29.0 77.38 0.3 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.564 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -81.54 141.71 12.6 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.767 2.311 . . . . 1.0 111.95 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.458 HG12 HBD2 ' A' ' 203' ' ' CYC . 2.7 m -106.49 124.3 61.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.878 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' HA ' ' H ' ' A' ' 112' ' ' SER . 12.5 t70 -43.22 141.97 1.71 Allowed Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.422 ' HA ' HG12 ' A' ' 140' ' ' VAL . 13.2 Cg_endo -49.18 -13.52 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 123.224 2.616 . . . . 1.0 114.073 -177.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.681 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.4 p -75.59 -44.43 43.1 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.746 0.276 . . . . 1.0 111.746 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.681 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 7.6 t60 -82.9 -32.86 27.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.226 0.454 . . . . 1.0 112.226 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 141' ' ' HIS . 4.3 p -68.76 -45.03 81.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.936 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.534 ' N ' HG13 ' A' ' 140' ' ' VAL . 35.5 m-70 -68.69 -28.97 67.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -60.83 -41.0 94.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.923 -0.581 . . . . 1.0 109.715 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 146' ' ' MET . 14.6 mt -72.86 -36.49 67.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -52.15 -38.73 58.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -64.44 -23.07 67.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 114.746 -1.115 . . . . 1.0 109.161 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 143' ' ' LEU . 97.1 mmm -92.74 2.15 56.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.727 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.84 79.28 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.3 t -111.93 142.03 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 1.0 111.019 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.92 -26.67 11.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.012 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.2 m -136.45 160.83 37.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.166 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.35 127.72 13.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.44 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 tp -114.92 136.31 53.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.292 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.4 119.62 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.132 0.491 . . . . 1.0 111.793 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.5 HG21 HG21 ' A' ' 184' ' ' VAL . 45.7 t -129.62 91.1 41.71 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 107.862 -1.162 . . . . 1.0 107.862 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.22 151.68 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.175 2.584 . . . . 1.0 114.693 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.5 mt -126.05 63.18 1.24 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.832 -1.544 . . . . 1.0 106.832 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 ptm -146.35 179.61 7.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.163 0.801 . . . . 1.0 113.163 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.582 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 46.1 t-80 -68.07 176.24 2.76 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.394 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.582 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 97.8 m-70 -64.54 -51.64 61.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.401 -0.818 . . . . 1.0 112.082 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.68 -37.79 6.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.064 0.394 . . . . 1.0 112.064 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -87.67 136.29 33.01 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.689 -0.405 . . . . 1.0 110.846 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.498 ' H ' HD12 ' A' ' 162' ' ' LEU . 1.2 mp -108.63 112.14 24.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.317 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -88.27 -37.49 16.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.257 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.571 ' C ' HD12 ' A' ' 165' ' ' LEU . . . -165.71 -175.75 36.5 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 164' ' ' GLY . 5.3 mp -144.17 141.56 30.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 1.0 111.5 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.4 tp -101.07 135.26 42.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 167' ' ' VAL . 12.4 p -138.64 129.68 35.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 1.0 111.078 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.2 m -106.77 139.37 41.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.057 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.469 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 85.7 m-70 -113.76 132.09 55.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.948 0.404 . . . . 1.0 111.667 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.561 ' CD2' ' N ' ' A' ' 170' ' ' HIS . 1.0 OUTLIER -124.57 125.32 43.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.929 177.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.43 33.63 0.69 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.832 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -161.35 154.38 17.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.029 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.16 112.82 2.18 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.928 2.419 . . . . 1.0 111.84 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -149.16 90.11 4.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.884 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.96 158.42 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.597 2.198 . . . . 1.0 111.905 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 41.6 p90 -84.79 127.27 34.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.487 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.6 p -121.06 162.37 20.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.581 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.666 ' H ' ' CD ' ' A' ' 178' ' ' GLN . 1.7 pm0 -50.33 -30.47 12.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.648 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -61.87 -36.24 80.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.739 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 184' ' ' VAL . 78.3 mm-40 -66.01 -24.43 66.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.486 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.8 mt -81.33 -33.88 32.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.483 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.45 -43.09 99.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.34 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.638 HG23 ' N ' ' A' ' 184' ' ' VAL . 13.1 m -73.41 -49.16 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.708 0.633 . . . . 1.0 112.708 -177.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.638 ' N ' HG23 ' A' ' 183' ' ' VAL . 27.9 m -70.4 -43.87 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.403 0.52 . . . . 1.0 112.403 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.538 ' N ' HG23 ' A' ' 184' ' ' VAL . 88.5 mt-30 -53.28 -43.43 67.46 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.983 -0.287 . . . . 1.0 111.67 -178.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.73 -49.99 59.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.84 ' O ' HG23 ' A' ' 191' ' ' VAL . 71.2 mt -79.86 -35.07 38.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.795 -177.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 184' ' ' VAL . . . -61.1 -43.38 98.97 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.488 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.58 -42.47 86.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 1.0 109.989 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.63 -28.23 68.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.135 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 187' ' ' LEU . 59.4 t -84.3 -43.71 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.785 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.2 p -57.83 -35.63 71.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.655 -0.868 . . . . 1.0 108.655 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.9 mt -67.84 -35.03 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.207 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.57 76.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.646 -0.707 . . . . 1.0 109.843 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.424 HD11 HD21 ' A' ' 35' ' ' LEU . 5.0 mm -61.38 -47.53 93.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.133 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.8 -48.02 60.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.045 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -65.68 -41.19 92.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.558 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.05 -31.3 72.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.677 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.72 -31.92 68.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.497 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.628 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.0 mp -60.62 -34.84 74.84 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.932 -0.307 . . . . 1.0 111.095 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.3 m -55.96 -56.14 24.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.58 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.536 179.715 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.738 HBB3 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.6 tp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.795 0.331 . . . . 1.0 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -60.52 -51.95 67.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.048 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -55.89 -45.91 78.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.127 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 mm -61.4 -48.4 89.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.771 0.32 . . . . 1.0 110.877 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.02 -47.74 84.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.012 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -52.45 -39.54 61.21 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.622 -0.431 . . . . 1.0 109.846 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.56 -29.09 65.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.137 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 42' ' ' VAL . 16.8 m -73.25 -45.32 56.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.477 -0.783 . . . . 1.0 112.312 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.705 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 7.8 p -68.45 -35.3 70.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -177.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -70.6 -42.31 71.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.784 0.326 . . . . 1.0 111.094 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.71 -54.67 24.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.77 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG23 ' N ' ' A' ' 43' ' ' ARG . 34.2 m -52.45 -39.84 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.171 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -52.76 -41.76 64.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 1.0 110.811 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.3 -38.34 79.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.04 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -75.5 -42.82 51.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.603 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.2 mt -85.6 -26.81 25.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.457 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.76 19.95 16.39 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 169' ' ' HIS . 91.3 m -73.01 143.39 47.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.832 0.349 . . . . 1.0 110.192 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -39.34 -55.43 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.668 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.635 HH22 ' CG2' ' A' ' 148' ' ' VAL . 61.2 mtm-85 -148.92 131.8 16.12 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.053 -0.659 . . . . 1.0 112.576 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 38.4 t -132.69 127.64 56.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.521 ' HE2' HAB1 ' A' ' 203' ' ' CYC . 20.4 pttm -141.4 154.92 45.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.13 0.49 . . . . 1.0 111.939 -178.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 61.6 t -115.15 135.56 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.626 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -133.76 120.06 20.05 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.243 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -74.04 140.2 45.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.273 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.629 ' CE1' ' NH2' ' A' ' 92' ' ' ARG . 58.9 t80 -92.91 117.21 29.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 1.0 112.048 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 41.2 p-10 -93.59 141.35 23.74 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -43.83 -14.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.573 2.182 . . . . 1.0 112.517 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 57' ' ' ASP . 96.3 mt-10 -87.97 -33.86 18.27 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.729 -0.389 . . . . 1.0 110.104 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 107.41 -10.79 39.37 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.514 -0.634 . . . . 1.0 111.514 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.685 ' O ' ' O ' ' A' ' 62' ' ' GLY . 64.2 m80 -66.54 -42.81 86.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.926 -0.31 . . . . 1.0 110.61 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.685 ' O ' ' O ' ' A' ' 61' ' ' HIS . . . 47.97 155.98 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.659 -0.976 . . . . 1.0 110.659 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 p -124.81 146.25 49.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 1.0 111.711 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.95 106.82 4.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.793 -0.818 . . . . 1.0 108.793 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 65' ' ' VAL . 57.3 t -106.56 -1.85 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.719 0.295 . . . . 1.0 111.375 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -157.44 118.04 3.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.103 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -144.43 129.0 18.1 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.566 -0.454 . . . . 1.0 111.865 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.21 145.55 49.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.378 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -142.28 142.7 32.59 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.722 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.6 -36.1 83.85 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -163.63 -179.56 38.07 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -73.47 55.13 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 1.0 110.525 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -86.42 -48.88 8.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.131 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.449 HD12 ' CZ ' ' A' ' 50' ' ' ARG . 66.9 mt -119.09 147.77 43.44 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.867 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.9 138.75 45.34 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.517 2.145 . . . . 1.0 112.131 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.1 m -60.43 130.26 45.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.89 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 80' ' ' LEU . 25.7 mt -91.91 7.04 43.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.346 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tp -59.4 129.55 42.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.29 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.55 -12.82 65.73 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.526 -0.761 . . . . 1.0 111.507 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 77' ' ' LEU . 73.5 mt -83.11 153.1 25.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.742 0.306 . . . . 1.0 110.327 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.7 p -107.65 135.06 49.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.646 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.655 ' CE2' HBB3 ' A' ' 203' ' ' CYC . 7.1 m-85 -87.68 154.46 53.28 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.22 124.92 12.75 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.684 2.256 . . . . 1.0 111.847 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.59 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . . . -62.44 137.67 58.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.696 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.87 -2.23 38.64 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -54.6 -38.73 67.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 88' ' ' PRO . 6.1 mm -83.65 111.92 35.85 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.433 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 87' ' ' ILE . 87.9 Cg_exo -51.46 -162.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.486 2.124 . . . . 1.0 112.499 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -107.82 -51.56 2.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.572 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.72 -41.32 92.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.768 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.94 79.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.936 0.346 . . . . 1.0 111.936 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.629 ' NH2' ' CE1' ' A' ' 56' ' ' PHE . 63.2 ttt180 -64.04 -39.15 93.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.519 -0.31 . . . . 1.0 111.457 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -62.3 -34.34 76.4 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.777 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.31 -34.7 75.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.266 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.652 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 2.3 t80 -63.54 -26.36 68.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.99 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.673 HH21 ' NE2' ' A' ' 160' ' ' GLN . 52.3 ttt180 -81.54 -28.32 33.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.786 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.9 mt -98.21 -41.21 8.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.36 -8.13 12.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 115.067 1.506 . . . . 1.0 115.067 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.738 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 2.6 mm-40 41.64 83.31 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.221 -0.991 . . . . 1.0 108.818 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.7 p 174.7 113.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.973 -178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.634 ' O ' HG23 ' A' ' 102' ' ' VAL . 5.0 tpt180 -153.52 139.26 17.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 1.0 110.799 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 101' ' ' ARG . 55.9 t -161.22 145.91 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.547 -178.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.414 HG23 HG11 ' A' ' 135' ' ' VAL . 65.4 mt -110.18 133.76 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.91 165.86 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 113.322 0.86 . . . . 1.0 113.322 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -45.81 119.72 2.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.964 -1.017 . . . . 1.0 112.139 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.478 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.4 p -56.13 -22.11 13.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.221 -0.899 . . . . 1.0 110.792 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -65.6 -44.11 87.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.6 -0.518 . . . . 1.0 109.6 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.93 -11.23 35.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.535 0.683 . . . . 1.0 109.42 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 44.72 71.12 0.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.731 -1.122 . . . . 1.0 113.327 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 p -74.27 132.75 42.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 176.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -118.8 128.96 54.96 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.017 -0.673 . . . . 1.0 111.884 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.77 152.09 44.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.623 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.1 pt -154.21 177.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.117 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 m -56.14 160.98 2.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.691 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -129.59 152.86 80.4 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.667 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.19 -53.67 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.666 2.244 . . . . 1.0 112.351 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 118' ' ' SER . 0.9 OUTLIER -66.88 -40.83 87.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.397 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.508 ' OG ' ' CD2' ' A' ' 119' ' ' TRP . 37.2 t 55.29 156.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.659 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.508 ' CD2' ' OG ' ' A' ' 118' ' ' SER . 2.2 m-90 40.33 -152.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.594 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 70.35 -134.78 24.93 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.4 tp 58.92 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.8 0.333 . . . . 1.0 110.359 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' GLY . 87.0 p -62.18 -29.81 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.494 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.96 95.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.614 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -69.44 -64.28 0.91 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.547 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.19 85.39 51.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.19 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -45.37 154.35 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.556 2.171 . . . . 1.0 112.292 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.3 mt 59.48 59.18 2.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.615 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -150.07 60.94 0.42 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.842 -0.903 . . . . 1.0 110.842 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 129' ' ' GLU . 1.6 pm0 -126.54 76.03 74.11 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.577 0.227 . . . . 1.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -38.09 151.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 123.206 2.604 . . . . 1.0 111.672 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.9 mt -64.24 -14.8 57.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.383 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -79.34 84.86 5.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.895 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.417 HH21 ' CB ' ' A' ' 129' ' ' GLU . 55.0 mtt-85 -120.21 114.62 33.35 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.52 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.13 140.27 13.93 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.713 2.276 . . . . 1.0 112.0 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.414 HG11 HG23 ' A' ' 103' ' ' ILE . 1.3 p -107.91 121.34 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.835 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.648 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 2.8 p-10 -45.13 140.57 3.64 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 138' ' ' CYS . 63.0 Cg_exo -42.63 -50.17 6.03 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.09 2.527 . . . . 1.0 114.047 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.757 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.0 OUTLIER -34.46 -49.26 0.39 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.72 0.267 . . . . 1.0 111.72 -177.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.757 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 20.5 t-80 -81.18 -25.66 36.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.319 0.488 . . . . 1.0 112.319 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.478 ' CG1' HG23 ' A' ' 106' ' ' VAL . 42.1 t -65.88 -51.77 57.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.941 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.417 ' O ' ' OG ' ' A' ' 145' ' ' SER . 58.5 t-80 -63.57 -29.6 70.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.06 -44.32 94.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.694 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 146' ' ' MET . 61.8 mt -73.02 -41.54 64.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -50.63 -39.54 50.61 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 141' ' ' HIS . 2.6 m -62.93 -27.19 69.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.784 -1.098 . . . . 1.0 109.19 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.55 ' N ' ' O ' ' A' ' 143' ' ' LEU . 96.2 mmm -89.05 -0.46 57.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.7 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.77 21.5 78.48 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.976 -0.85 . . . . 1.0 110.976 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.635 ' CG2' HH22 ' A' ' 50' ' ' ARG . 47.7 t -109.45 142.25 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 1.0 111.035 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.1 -36.82 6.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.011 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 t -138.71 129.4 26.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.136 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.6 m -114.77 137.25 52.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.41 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tp -117.38 137.89 52.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.284 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 166' ' ' LEU . 2.1 t -126.58 113.77 34.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.082 0.468 . . . . 1.0 111.744 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.495 HG11 ' CG1' ' A' ' 184' ' ' VAL . 40.9 t -111.39 106.94 57.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 107.825 -1.176 . . . . 1.0 107.825 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.33 123.72 2.09 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.16 2.573 . . . . 1.0 114.77 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.434 HD11 ' HB ' ' A' ' 191' ' ' VAL . 9.4 tp -115.93 45.9 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.5 ptm -148.02 -178.36 6.24 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.091 0.775 . . . . 1.0 113.091 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.637 ' CG ' ' H ' ' A' ' 159' ' ' HIS . 48.6 t-80 -69.3 178.64 2.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.306 -0.861 . . . . 1.0 111.411 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.637 ' H ' ' CG ' ' A' ' 158' ' ' HIS . 83.6 t60 -67.89 -51.62 45.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 1.0 112.044 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.673 ' NE2' HH21 ' A' ' 96' ' ' ARG . 48.9 tt0 -105.17 -38.6 6.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.047 0.388 . . . . 1.0 112.047 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.512 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 82.7 tt0 -90.69 139.17 30.98 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.841 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.68 HD23 ' C ' ' A' ' 162' ' ' LEU . 7.9 tt -107.03 115.39 30.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.357 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.512 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 78.6 m95 -91.75 -41.14 10.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.298 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.79 -173.71 24.75 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.543 HD11 ' CZ ' ' A' ' 95' ' ' PHE . 7.2 tp -144.26 128.13 17.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.332 . . . . 1.0 111.558 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 153' ' ' VAL . 9.4 tp -98.04 129.06 44.9 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 177.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.53 136.7 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.087 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.1 m -111.24 149.65 30.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.053 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.562 ' HD1' HG11 ' A' ' 148' ' ' VAL . 93.1 m-70 -124.6 131.21 53.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.003 0.43 . . . . 1.0 111.603 -177.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.03 114.42 15.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.984 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.94 -15.69 63.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.859 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -112.41 151.27 43.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.993 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.18 92.61 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.891 2.394 . . . . 1.0 111.929 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -120.85 91.27 47.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.901 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.97 152.36 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.533 2.156 . . . . 1.0 111.937 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -109.25 143.53 38.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.444 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.2 t -125.24 171.35 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.607 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -50.89 -30.38 14.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.616 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -63.22 -39.45 94.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.708 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.54 -44.85 93.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.524 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 181' ' ' LEU . 9.9 mp -63.92 -36.76 84.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.502 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -54.48 -36.64 64.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.884 -0.598 . . . . 1.0 111.331 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.34 -54.98 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.722 0.638 . . . . 1.0 112.722 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.496 HG12 ' HB2' ' A' ' 188' ' ' ALA . 5.1 t -77.68 -42.17 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -44.31 -45.28 8.64 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.951 -0.299 . . . . 1.0 111.631 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 186' ' ' LEU . 7.4 mp -75.96 -37.79 58.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.92 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 191' ' ' VAL . 6.1 tp -77.65 -41.47 38.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.806 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.496 ' HB2' HG12 ' A' ' 184' ' ' VAL . . . -62.13 -39.71 93.49 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.474 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -57.67 -39.6 77.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.294 -0.412 . . . . 1.0 109.924 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -71.8 -24.11 61.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.157 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 187' ' ' LEU . 73.1 t -82.5 -48.92 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 1.0 109.798 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 85.8 p -54.25 -34.19 60.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.9 mt -65.59 -33.85 66.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.161 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 191' ' ' VAL . . . -68.74 -38.12 79.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.575 -0.738 . . . . 1.0 109.8 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.59 -46.46 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.14 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.03 -46.55 61.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.059 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -66.61 -44.54 81.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.515 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.34 -33.25 75.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.299 -0.409 . . . . 1.0 111.674 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -60.42 -32.87 71.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.578 -0.283 . . . . 1.0 111.498 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.61 -34.92 78.88 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.012 -0.275 . . . . 1.0 111.052 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.7 m -55.53 -54.74 40.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.802 0.334 . . . . 1.0 110.65 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.539 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.655 HBB3 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_